<SEC-DOCUMENT>0001171843-14-005281.txt : 20141106
<SEC-HEADER>0001171843-14-005281.hdr.sgml : 20141106
<ACCEPTANCE-DATETIME>20141105201813
ACCESSION NUMBER:		0001171843-14-005281
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		11
CONFORMED PERIOD OF REPORT:	20140930
FILED AS OF DATE:		20141106
DATE AS OF CHANGE:		20141105

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Anika Therapeutics, Inc.
		CENTRAL INDEX KEY:			0000898437
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				043145961
		STATE OF INCORPORATION:			MA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14027
		FILM NUMBER:		141198468

	BUSINESS ADDRESS:	
		STREET 1:		32 WIGGINS AVENUE
		CITY:			BEDFORD
		STATE:			MA
		ZIP:			01730
		BUSINESS PHONE:		(781) 457-9000

	MAIL ADDRESS:	
		STREET 1:		32 WIGGINS AVENUE
		CITY:			BEDFORD
		STATE:			MA
		ZIP:			01730

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANIKA THERAPEUTICS INC
		DATE OF NAME CHANGE:	19970114

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANIKA RESEARCH INC
		DATE OF NAME CHANGE:	19930309
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>gff10q_110314.htm
<DESCRIPTION>FORM 10-Q
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 100%; border-bottom: Black 2.75pt double">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>WASHINGTON, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<HR NOSHADE STYLE="color: Black; width: 100%; height: 1.1pt; margin-top: 0pt; margin-bottom: 0pt">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FORM&nbsp;10-Q</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 15%; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Wingdings"><b>x</b></font></td>
    <td style="width: 85%; font: 10pt Times New Roman, Times, Serif"><b>QUARTERLY REPORT PURSUANT TO SECTION&nbsp;13 OR 15 (d)&nbsp;OF THE SECURITIES EXCHANGE ACT OF 1934</b></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>For the quarterly period ended September
30, 2014</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 15%; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Wingdings"><b>o</b></font></td>
    <td style="width: 85%; font: 10pt Times New Roman, Times, Serif"><b>TRANSITION REPORT PURSUANT TO SECTION&nbsp;13 OR 15 (d)&nbsp;OF THE SECURITIES EXCHANGE ACT OF 1934</b></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>For the transition period from&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<HR NOSHADE STYLE="color: Black; width: 100%; height: 1.1pt; margin-top: 0pt; margin-bottom: 0pt">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Commission File Number 000-21326</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Anika Therapeutics,&nbsp;Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Exact Name of Registrant as Specified in Its
Charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 50%; text-align: center"><b>Massachusetts</b></td>
    <td style="width: 50%; text-align: center"><b>04-3145961</b></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center">(State or Other Jurisdiction of</td>
    <td style="text-align: center">(I.R.S. Employer Identification No.)</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center">Incorporation or Organization)</td>
    <td>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center"><b>32 Wiggins Avenue, Bedford, Massachusetts</b></td>
    <td style="text-align: center"><b>01730</b></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center">(Address of Principal Executive Offices)</td>
    <td style="text-align: center">(Zip Code)</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Registrant&rsquo;s Telephone Number, Including
Area Code:<B> (781)&nbsp;457-9000</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Former Name, Former Address
and Former Fiscal Year, if Changed Since Last Report:<B> N/A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 49.5pt">Indicate by check mark whether the registrant
(1)&nbsp;has filed all reports required to be filed by Section&nbsp;13 or 15 (d)&nbsp;of the Securities Exchange Act of 1934 during
the preceding 12&nbsp;months (or for such shorter period that the registrant was required to file such reports), and (2)&nbsp;has
been subject to such filing requirements for the past 90&nbsp;days.&#9;Yes<FONT STYLE="font-family: Wingdings"> x</FONT> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No<FONT STYLE="font-family: Wingdings">
o</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 49.5pt">Indicate by check mark whether the registrant
has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted
and posted pursuant to Rule&nbsp;405 of Regulation S-T (&sect;232.405 of this chapter) during the preceding 12 months (or for such
shorter period that the registrant was required to submit and post such files).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 13.5pt">Yes <FONT STYLE="font-family: Wingdings">x</FONT>
No <FONT STYLE="font-family: Wingdings">o</FONT></P>

<P STYLE="font: 10pt Wingdings; margin: 0; text-indent: 49.5pt"></P>

<P STYLE="font: 10pt Wingdings; margin: 0; text-indent: 49.5pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 49.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 49.5pt">Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions
of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer&rdquo; and &ldquo;smaller reporting company&rdquo; in Rule&nbsp;12b-2
of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<tr>
    <td style="vertical-align: top; width: 19%">Large accelerated filer&nbsp;<font style="font-family: Wingdings"> o</font></td>
    <td style="vertical-align: bottom; width: 4%">&nbsp;</td>
    <td style="vertical-align: top; width: 18%; text-align: center">Accelerated filer&nbsp;<font style="font-family: Wingdings">x</font></td>
    <td style="vertical-align: bottom; width: 4%">&nbsp;</td>
    <td style="vertical-align: top; width: 28%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Non-accelerated filer&nbsp;<font style="font-family: Wingdings">o</font></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Do not check if a smaller</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">reporting company)</P></td>
    <td style="vertical-align: bottom; width: 4%">&nbsp;</td>
    <td style="vertical-align: top; width: 23%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Smaller reporting</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">company&nbsp;<font style="font-family: Wingdings">o</font></P></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.5pt">Indicate by check mark whether the registrant is a shell
company (as defined in Rule&nbsp;12b-2 of the Exchange Act)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.5pt">Yes&nbsp;<FONT STYLE="font-family: Wingdings"> o</FONT>
&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;<FONT STYLE="font-family: Wingdings"> x</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 49.5pt">As of October
31, 2014 there were 14,504,014 outstanding shares of Common Stock, par
value $.01&nbsp;per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 10%"><B>PART&nbsp;I:</B></TD>
    <TD STYLE="width: 90%"><B>FINANCIAL INFORMATION</B></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><B>ITEM 1.</B></TD>
    <TD><B>FINANCIAL STATEMENTS</B></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><B>Anika Therapeutics,
Inc. and Subsidiaries</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><B>Condensed Consolidated
Balance Sheets</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><B>(unaudited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.1pt">ASSETS</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">September 30,</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">2014</P></TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">December 31,</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">2013</P></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Current assets:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 78%; text-align: left; padding-left: 10pt">Cash and cash equivalents</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">71,772,194</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">63,333,160</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Marketable securities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19,999,600</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Accounts receivable, net of reserves of $546,455 and $593,023 at September 30, 2014 and December 31, 2013, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,170,095</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18,736,845</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Inventories</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,582,456</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,996,785</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Prepaid income taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,343,576</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Current portion deferred income taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">659,040</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">659,040</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Prepaid expenses and other</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">1,128,693</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">865,957</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 20pt">Total current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">128,655,654</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">94,591,787</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Property and equipment, at cost</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">53,379,965</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">52,413,423</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.1pt">Less: accumulated depreciation</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">(21,343,322</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">)</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">(19,474,712</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">32,036,643</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">32,938,711</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Long-term deposits and other</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">69,054</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">69,080</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Intangible assets, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,033,944</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18,998,409</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.1pt">Goodwill</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">8,702,295</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">9,443,894</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.75pt">Total assets</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">185,497,590</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">156,041,881</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: center">LIABILITIES AND STOCKHOLDERS&rsquo; EQUITY</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Current liabilities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Accounts payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,167,545</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2,793,911</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Accrued expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,253,693</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,537,881</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Deferred revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,885</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">180,433</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Income taxes payable</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">-</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">770,276</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.1pt; padding-left: 20pt">Total current liabilities</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">6,434,123</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">9,282,501</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Other long-term liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">948,858</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,133,544</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Long-term deferred revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">56,573</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,054,941</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Deferred tax liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,353,531</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,936,864</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Commitments and contingencies (Note 10)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Stockholders&rsquo; equity:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Preferred stock, $.01 par value; 1,250,000 shares authorized, no shares issued and outstanding at September 30, 2014 and December 31, 2013, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Common stock, $.01 par value; 30,000,000 shares authorized, 14,800,453 and 14,289,308 shares issued and outstanding at September 30, 2014 and December 31, 2013, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">148,004</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">142,893</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Additional paid-in-capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">76,064,383</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">70,606,031</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Accumulated other comprehensive loss</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,595,487</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,699,095</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Retained earnings</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">97,087,605</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">66,584,202</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.1pt; padding-left: 20pt">Total stockholders&rsquo; equity</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">169,704,505</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">135,634,031</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.75pt">Total Liabilities and Stockholders&rsquo; Equity</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">185,497,590</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">156,041,881</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">The accompanying notes are an integral part
of these unaudited condensed consolidated financial statements.<FONT STYLE="font-size: 10pt"> </FONT><FONT STYLE="font: 9pt Sans-Serif; color: Red"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Anika Therapeutics, Inc. and Subsidiaries</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Condensed Consolidated Statements of Operations
and Comprehensive Income</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(unaudited)</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="7" STYLE="font-weight: bold; text-align: center">Three Months Ended September 30,</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="7" STYLE="font-weight: bold; text-align: center">Nine Months Ended September 30,</TD></TR>
<TR>
    <TD STYLE="text-align: left; padding-bottom: 1.1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.1pt solid">&nbsp;</TD><TD STYLE="text-align: center; border-bottom: Black 1.1pt solid"><B>2014</B></TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.1pt solid">&nbsp;</TD><TD STYLE="text-align: center; border-bottom: Black 1.1pt solid"><B>2013</B></TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.1pt solid">&nbsp;</TD><TD STYLE="text-align: center; border-bottom: Black 1.1pt solid"><B>2014</B></TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.1pt solid">&nbsp;</TD><TD STYLE="text-align: center; border-bottom: Black 1.1pt solid"><B>2013</B></TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 56%; text-align: left">Product revenue</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">21,975,312</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">17,023,346</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">57,593,873</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">51,585,242</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.1pt">Licensing, milestone and contract revenue</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">80,111</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">731,092</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">24,746,497</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">2,244,584</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Total revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,055,423</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17,754,438</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">82,340,370</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">53,829,826</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Operating expenses:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Cost of product revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,724,800</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,377,568</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15,418,732</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,530,070</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Research&nbsp;&amp; development</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,999,867</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,618,012</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,160,740</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,029,974</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Selling, general&nbsp;&amp; administrative</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,044,538</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,188,669</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,401,399</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,536,462</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Restructuring credits</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">-</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">(196,084</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">)</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">-</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">(442,869</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.1pt">Total operating expenses</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">11,769,205</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">9,988,165</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">32,980,871</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">31,653,637</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Income from operations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,286,218</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,766,273</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">49,359,499</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,176,189</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Interest income (expense), net</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">9,937</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">(32,816</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">)</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">16,339</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">(108,755</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Income before income taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,296,155</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,733,457</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">49,375,838</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,067,434</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Provision for income taxes</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">4,125,355</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">2,776,199</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">18,872,435</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">8,147,282</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.75pt">Net income</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">6,170,800</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">4,957,258</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">30,503,403</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">13,920,152</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Basic net income per share:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Net income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.42</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.36</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2.09</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.03</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Basic weighted average common shares outstanding</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,758,781</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,682,449</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,626,933</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,534,334</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Diluted net income per share:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Net income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.40</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.33</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.97</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.95</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Diluted weighted average common shares outstanding</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15,434,875</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,958,965</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15,469,237</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,673,879</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Net income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">6,170,800</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">4,957,258</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">30,503,403</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">13,920,152</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Other comprehensive income (loss):</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Unrealized gain on securities, net of tax</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">431</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">431</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Foreign currency translation adjustment</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">(1,679,968</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">)</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">916,474</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">(1,896,823</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">)</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">507,119</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.1pt; padding-left: 20pt">Total other comprehensive income (loss)</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">(1,679,537</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">)</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">916,474</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">(1,896,392</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">)</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">507,119</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.75pt">Comprehensive income</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">4,491,263</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">5,873,732</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">28,607,011</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">14,427,271</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">The accompanying notes are an integral part
of these unaudited condensed consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Anika Therapeutics, Inc. and Subsidiaries</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Condensed Consolidated Statements of Cash
Flows</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;(unaudited)&nbsp;</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="7" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Nine Months Ended September 30,</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2014</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2013</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Cash flows from operating activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 78%; text-align: left; padding-left: 10pt">Net income</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">30,503,403</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">13,920,152</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Adjustments to reconcile net income to net cash provided by operating activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 20pt">Depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,576,441</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,579,474</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 20pt">Stock-based compensation expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,196,361</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,156,929</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 20pt">Provision for doubtful accounts</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">24,098</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 20pt">Provision for inventory</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">220,207</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">165,803</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 20pt">Gain on sale of assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(442,341</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 20pt">Tax benefit from exercise of stock options</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(9,236,708</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(764,181</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 20pt">Changes in operating assets and liabilities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 30pt">Accounts receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,840,407</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,667,839</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 30pt">Inventories</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,923,628</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,430,655</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 30pt">Prepaid expenses, other current and long-term assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">183,481</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">531,449</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 30pt">Long-term deposits and other</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,497</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 30pt">Accounts payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(992,822</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">124,679</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 30pt">Accrued expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(989,291</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(642,430</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 30pt">Deferred revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,078,543</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,150,000</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 30pt">Income taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,771,001</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">766,598</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.1pt; padding-left: 30pt">Other long-term liabilities</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">(167,123</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">)</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">(373,712</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Net cash provided by operating activities</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">25,222,372</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">17,159,199</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="color: red; font-weight: bold">&nbsp;</TD>
    <TD STYLE="color: red; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="color: red; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="color: red; font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Cash flows from investing activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 20pt">Purchase of marketable securities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(19,999,169</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 20pt">Proceeds from sale of assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">530,865</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.1pt; padding-left: 20pt">Purchase of property and equipment</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">(920,132</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">)</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">(235,803</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Net cash provided by (used in) investing activities</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">(20,919,301</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">)</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">295,062</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="color: red; font-weight: bold">&nbsp;</TD>
    <TD STYLE="color: red; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="color: red; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="color: red; font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Cash flows from financing activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 20pt">Proceeds from exercise of stock options</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,379,294</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,932,649</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 20pt">Tax benefit from exercise of stock options</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,236,708</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">764,181</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 20pt">Minimum tax withholding on share based awards</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6,348,900</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.1pt; padding-left: 20pt">Principal payments on debt</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">-</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">(1,200,000</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Net cash provided by financing activities</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">4,267,102</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">2,496,830</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.1pt">&nbsp;</TD><TD STYLE="color: red; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; color: red; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Exchange rate impact on cash</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">(131,139</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">)</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">36,870</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="color: red; font-weight: bold">&nbsp;</TD>
    <TD STYLE="color: red; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="color: red; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="color: red; font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Increase in cash and cash equivalents</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,439,034</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19,987,961</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Cash and cash equivalents at beginning of period</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">63,333,160</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">44,067,477</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.75pt; padding-left: 10pt">Cash and cash equivalents at end of period</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">71,772,194</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">64,055,438</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">The accompanying notes are an integral part
of these unaudited condensed consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>ANIKA THERAPEUTICS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>NOTES TO CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(<B>unaudited</B>)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 6%"><b>1.</b></td>
    <td style="width: 94%"><b>Nature of Business</b></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Anika Therapeutics,&nbsp;Inc. (together with
its subsidiaries, &ldquo;Anika,&rdquo; the &ldquo;Company,&rdquo; &ldquo;we,&rdquo; &ldquo;us,&rdquo; or &ldquo;our&rdquo;) develops,
manufactures and commercializes therapeutic products for tissue protection, healing and repair. These products are based on hyaluronic
acid (&ldquo;HA&rdquo;), a naturally occurring, biocompatible polymer found throughout the body. Due to its unique biophysical
and biochemical properties, HA plays an important role in a number of physiological functions such as the protection and lubrication
of soft tissues and joints, the maintenance of the structural integrity of tissues, and the transport of molecules to and within
cells.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company is subject to risks common to companies
in the biotechnology and medical device industries including, but not limited to, development by the Company or its competitors
of new technological innovations, dependence on key personnel, protection of proprietary information and technology, commercialization
of existing and new products, and compliance with the U.S. Food and Drug Administration (&ldquo;FDA&rdquo;) and foreign regulations
and approval requirements, as well as the ability to grow the Company&rsquo;s business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 6%"><b>2.</b></td>
    <td style="width: 94%"><b>Basis of Presentation</b></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 49.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The accompanying unaudited condensed consolidated
financial statements and related notes have been prepared by the Company pursuant to the rules&nbsp;and regulations of the Securities
and Exchange Commission (the &ldquo;SEC&rdquo;) and in accordance with accounting principles generally accepted in the United States
(&ldquo;U.S.&rdquo;). The financial statements include the accounts of Anika Therapeutics, Inc. and its subsidiaries. Inter-company
transactions and balances have been eliminated. The year-end consolidated balance sheet is derived from our audited financial statements,
but does not include all disclosures required by accounting principles generally accepted in the U.S. In the opinion of management,
these unaudited condensed consolidated financial statements contain all adjustments (consisting only of normal recurring adjustments)
necessary to fairly state the condensed consolidated financial position of the Company as of September 30, 2014, the results of
its operations for the three and nine-month periods ended September 30, 2014 and 2013, and cash flows for the nine-month periods
ended September 30, 2014 and 2013.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The accompanying unaudited condensed consolidated
financial statements and related notes should be read in conjunction with the Company&rsquo;s annual financial statements filed
with its Annual Report on Form&nbsp;10-K for the year ended December 31, 2013. The results of operations for the three and nine-month
periods ended September 30, 2014 are not necessarily indicative of the results to be expected for the year ending December&nbsp;31,
2014. Certain prior period amounts have been reclassified to conform to the current period presentation. There was no impact on
operating income.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0">A revision was made on the condensed consolidated statement of cash flows
for the six months ended June 30, 2014 to correctly reflect the tax benefit from exercise of certain equity awards. This revision
has an impact on the statement of cash flows as a reduction of cash provided by operating activities of $2.5 million with a corresponding
increase to cash provided by financing activities related to the tax benefit from exercise of stock options for the six months
ended June 30, 2014 of the same amount. This revision has no impact on the statement of operations or cash position. The revision
to the condensed consolidated statement of cash flows represents amounts that are not deemed to be material, individually or in
the aggregate, to the prior period condensed consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 6%"><b>3.</b></td>
    <td style="width: 94%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Marketable Securities</b></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><b></b></P></td></tr>
</table>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">September 30, 2014</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">Amortized</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">Cost</P></TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">Unrealized</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">Gains, Net of Tax</P></TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">Unrealized</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">Losses, Net of Tax</P></TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">Fair</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">Value</P></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 56%; text-align: left">United States Treasury securities</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">14,999,169</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">699</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">(268</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">14,999,600</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.1pt">Bank certificates of deposit</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">5,000,000</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">-</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">-</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">5,000,000</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.75pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">19,999,169</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">699</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">(268</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">)</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">19,999,600</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Company considers securities with maturities
of three months or less from the purchase date to be cash equivalents. Interest is recorded when earned. All of the Company&rsquo;s
investments are classified as available-for-sale and are carried at fair value with unrealized gains and losses recorded as a component
of accumulated other comprehensive income, net of related income taxes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 6%"><b>4.</b></td>
    <td style="width: 94%"><b>Fair Value Measurements</b></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Fair value is an exit price, representing the
amount that would be received from the sale of an asset or paid to transfer a liability in an orderly transaction between market
participants based on assumptions that market participants would use in pricing an asset or liability. As a basis for classifying
the fair value measurements, a three-tier fair value hierarchy, which classifies the fair value measurements based on the inputs
used in measuring fair value, was established as follows: (Level 1) observable inputs such as quoted prices in active markets for
identical assets or liabilities; (Level 2) significant other observable inputs that are observable either directly or indirectly;
and (Level 3) significant unobservable inputs in which there is little or no market data, which requires the Company to develop
its own assumptions. This hierarchy requires the Company to use observable market data, when available, and to minimize the use
of unobservable inputs when determining fair value. On a recurring basis, the Company records its marketable securities at fair
value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Company&rsquo;s investments are all classified
within Level 1 and Level 2 of the fair value hierarchy. The Company&rsquo;s investments classified within Level 1 of the fair value
hierarchy are valued using quoted market prices. The Company&rsquo;s investments classified within Level 2 of the fair value hierarchy
are valued based on matrix pricing compiled by third party pricing vendors, using observable market inputs such as interest rates,
yield curves, and credit risk.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The fair value hierarchy of the Company&rsquo;s
cash equivalents and marketable securities at fair value is as follows:</P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; padding-bottom: 1.1pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; padding-bottom: 1.1pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="11" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">Fair Value Measurements at Reporting</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">Date Using</P></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; padding-bottom: 1.1pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">September 30, 2014</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">Quoted Prices in</P>
                                                                                                    <P STYLE="margin-top: 0; margin-bottom: 0">Active Markets</P>
                                                                                                    <P STYLE="margin-top: 0; margin-bottom: 0">for Identical Assets</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">(Level 1)</P></TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">Significant Other</P>
                                                                                                    <P STYLE="margin-top: 0; margin-bottom: 0">Observable Inputs</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">(Level 2)</P></TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">Significant</P>
                                                                                                    <P STYLE="margin-top: 0; margin-bottom: 0">Unobservable</P>
                                                                                                    <P STYLE="margin-top: 0; margin-bottom: 0">Inputs</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">(Level 3)</P></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 56%; text-align: left; padding-bottom: 2.75pt">Money market funds</TD><TD STYLE="width: 1%; padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="width: 8%; border-bottom: Black 2.75pt double; text-align: right">49,285,168</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left; width: 1%">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="width: 8%; border-bottom: Black 2.75pt double; text-align: right">-</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left; width: 1%">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="width: 8%; border-bottom: Black 2.75pt double; text-align: right">49,285,168</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left; width: 1%">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="width: 8%; border-bottom: Black 2.75pt double; text-align: right">-</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left; width: 1%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Marketable securities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">United States Treasury securities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,999,600</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,999,600</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.1pt">Bank certificates of deposit</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">5,000,000</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">-</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">5,000,000</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">-</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.75pt">Total marketable securities</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">19,999,600</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">14,999,600</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">5,000,000</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">-</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; padding-bottom: 1.1pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="11" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Fair Value Measurements at Reporting <BR>Date Using</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">December 31, 2013</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Quoted Prices in <BR>Active Markets <BR>&nbsp;for Identical Assets&nbsp; <BR>&nbsp;(Level 1)</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Significant Other <BR>Observable Inputs&nbsp; <BR>(Level 2)</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">Significant</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">Unobservable</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">Inputs</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">(Level 3)</P></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 56%; text-align: left; padding-bottom: 2.75pt">Money market funds</TD><TD STYLE="width: 1%; padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="width: 8%; border-bottom: Black 2.75pt double; text-align: right">34,266,501</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left; width: 1%">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="width: 8%; border-bottom: Black 2.75pt double; text-align: right">-</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left; width: 1%">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="width: 8%; border-bottom: Black 2.75pt double; text-align: right">34,266,501</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left; width: 1%">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="width: 8%; border-bottom: Black 2.75pt double; text-align: right">-</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left; width: 1%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 6%"><b>5.</b></td>
    <td style="width: 94%"><b>Equity Incentive Plan</b></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Company estimates the fair value of stock
options and stock appreciation rights using the Black-Scholes valuation model. Fair value of restricted stock is measured by the
grant-date price of the Company&rsquo;s shares. The fair value of each stock option award during the three and nine-month periods
ended September 30, 2014 and 2013, respectively, was estimated on the grant date using the Black-Scholes option-pricing model with
the following assumptions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<tr>
    <TD STYLE="font-weight: bold">&nbsp;</td>
    <TD COLSPAN="7" STYLE="text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"><B>Three Months Ended</B></P>
                                               <P STYLE="margin-top: 0; margin-bottom: 0"><B>September 30,</B></P></td></tr>
<tr>
    <TD STYLE="padding-bottom: 1.1pt">&nbsp;</td>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1.1pt solid"><B>2014</B></td>
    <TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.1pt">&nbsp;</td>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1.1pt solid"><B>2013</B></td></tr>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="width: 71%">Risk free interest rate</td>
    <TD STYLE="width: 3%; text-align: center">1.30%</TD>
    <TD STYLE="width: 7%; text-align: center">-</TD>
    <TD STYLE="text-align: center; width: 3%">  1.39%</td>
    <TD STYLE="text-align: right; width: 3%">&nbsp;</td>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 7%; text-align: center">-</TD>
    <TD STYLE="text-align: center; width: 3%"></td></tr>
<TR STYLE="background-color: White">
    <TD>Expected volatility</td>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">53.28%</TD>
    <TD STYLE="text-align: center"></td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">-</TD>
    <TD STYLE="text-align: center"></td></tr>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>Expected lives (years)</td>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">4</TD>
    <TD STYLE="text-align: center"></td>
    <TD STYLE="text-align: right">&nbsp;</td>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">-</TD>
    <TD STYLE="text-align: center"></td></tr>
<TR STYLE="background-color: White">
    <TD>Expected dividend yield</td>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">0.00%</TD>
    <TD STYLE="text-align: center"></td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">-</TD>
    <TD STYLE="text-align: center"></td></tr>
</table>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<tr>
    <TD STYLE="font-weight: bold">&nbsp;</td>
    <TD COLSPAN="7"><P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><B>Nine Months Ended</B></P>
                    <P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><B>September 30,</B></P></td></tr>
<tr>
    <TD STYLE="padding-bottom: 1.1pt">&nbsp;</td>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1.1pt solid"><B>2014</B></td>
    <TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.1pt">&nbsp;</td>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1.1pt solid"><B>2013</B></td></tr>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="width: 71%">Risk free interest rate</td>
    <TD STYLE="width: 3%; text-align: center">1.16%</TD>
    <TD STYLE="width: 7%; text-align: center">-</TD>
    <TD STYLE="text-align: center; width: 3%"> 1.39%</td>
    <TD STYLE="text-align: right; width: 3%">&nbsp;</td>
    <TD STYLE="width: 3%; text-align: center">0.61%</TD>
    <TD STYLE="width: 7%; text-align: center">-</TD>
    <TD STYLE="text-align: center; width: 3%"> 0.70%</td></tr>
<TR STYLE="background-color: White">
    <TD>Expected volatility</td>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">53.28%</TD>
    <TD STYLE="text-align: center"></td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">57.60%</TD>
    <TD STYLE="text-align: center"></td></tr>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>Expected lives (years)</td>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">4</TD>
    <TD STYLE="text-align: center"></td>
    <TD STYLE="text-align: right">&nbsp;</td>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">4</TD>
    <TD STYLE="text-align: center"></td></tr>
<TR STYLE="background-color: White">
    <TD>Expected dividend yield</td>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">0.00%</TD>
    <TD STYLE="text-align: center"></td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">0.00%</TD>
    <TD STYLE="text-align: center"></td></tr>
</table>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Company recorded $390,578 and
$368,603 of share-based compensation expense for the three-month periods ended September 30, 2014 and 2013, respectively, for equity
compensation awards. The Company recorded $1,196,361 and $1,156,929 of share-based compensation expense for the nine-month periods
ended September 30, 2014 and 2013, respectively, for equity compensation awards. The Company presents the expenses related to stock-based
compensation awards in the same expense line items as cash compensation paid to the respective recipients.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">There were 7,000 and 139,240 stock options granted
under the Plan during the three and nine-month periods ended September 30, 2014, respectively. There were no Restricted Stock Awards
(&ldquo;RSAs&rdquo;) or Restricted Stock Units (&ldquo;RSUs&rdquo;) granted under the Plan during the three-month period ended
September 30, 2014. There were 9,365 RSUs granted to members of the Company&rsquo;s Board of Directors under the Plan during the
nine-month period ended September 30, 2014. There were 30,700 RSAs granted to Company employees under the Plan during the nine-month
period ended September 30, 2014. The stock options, RSAs and RSUs granted to employees and directors become exercisable or vest
ratably over four years from the date of grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">A portion of the stock options granted
during the nine-month period ended September 30, 2014 contained certain performance features, as compared to established targets, in addition to time-based vesting conditions. The
compensation costs associated with these grants was estimated using the Black-Scholes valuation method factored for the
estimated probability of achieving the performance goals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">As of September 30, 2014, there was approximately
$4.2 million of total unrecognized compensation cost related to non-vested stock options, stock appreciation rights (&ldquo;SARs&rdquo;),
RSAs and RSUs granted under the Company&rsquo;s incentive Plans. This cost is expected to be recognized over a weighted-average
period of 3.0 years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The total intrinsic value of stock options and
SARs exercised during the nine-month periods ended September 30, 2014 and 2013 was $25,473,089 and $4,095,833, respectively. Cash
received from the exercise of stock options during the three and nine-month periods ended September 30, 2014 and 2013 were $17,513
and $1,379,294, and $1,804,773 and $2,932,649, respectively. During the second quarter of 2014, the Company acquired and subsequently
retired 133,774 common shares related to an employee SARs exercise, to meet minimum statutory tax withholding requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">There were 936,097 options
and SARs outstanding under the Company&rsquo;s incentive Plans as of September 30, 2014 with a weighted-average exercise price
of $13.54 per share, an aggregate intrinsic value of approximately $21.8 million, and a weighted-average remaining contractual
term of 6.8 years. None of the options or SARs outstanding at September 30, 2014 or 2013, respectively, had cash-settlement features.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Company may satisfy the awards upon exercise,
or upon fulfillment of the vesting requirements for other equity-based awards, with either authorized but unissued shares or shares
reacquired by the Company. Stock-based awards are granted with an exercise price equal to the market price of the Company&rsquo;s
stock on the date of grant. Awards containing service conditions generally become exercisable ratably over one to four years,
have a ten year contractual term and sometimes contain performance conditions.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 6%"><b>6.</b></td>
    <td style="width: 94%"><b>Earnings Per Share</b></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Company reports earnings per share in accordance
with ASC 260,<I> Earnings Per Share</I>, which establishes standards for computing and presenting earnings per share. Basic earnings
per share is computed by dividing net income available to common shareholders by the weighted average number of common shares outstanding
during the period. Diluted earnings per share is computed by dividing net income available to common shareholders by the weighted
average number of common shares outstanding and the number of dilutive potential common share equivalents during the period. Under
the treasury stock method, unexercised &ldquo;in-the-money&rdquo; stock options are assumed to be exercised at the beginning of
the period or at issuance, if later. The assumed proceeds are then used to purchase common shares at the average market price during
the period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Basic and diluted earnings per share for the
three and nine-month periods ended September 30, 2014 and 2013 are as follows:&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="7" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Three Months Ended September 30,</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="7" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Nine Months Ended September 30,</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2014</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2013</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2014</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2013</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 56%; text-align: left">Shares used in the calculation of basic earnings per share</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">14,758,781</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">13,682,449</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">14,626,933</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">13,534,334</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Effect of dilutive securities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Stock options, SARs, and RSAs</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">676,094</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">1,276,516</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">842,304</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">1,139,545</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.75pt">Diluted shares used in the calculation of earnings per share</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">15,434,875</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">14,958,965</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">15,469,237</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">14,673,879</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Equity awards of 122,967 and 118,725 shares
were outstanding for the three and nine-month periods ended September 30, 2014, respectively, and were not included in the computation
of diluted earnings per share because the awards&rsquo; impact on earnings per share was anti-dilutive. There were no anti-dilutive
equity awards for the three month period ended September 30, 2013. Equity awards of 88,278 shares were outstanding for the nine-month
period ended September 30, 2013, and were not included in the computation of diluted earnings per share because the awards&rsquo;
impact on earnings per share was anti-dilutive.&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 6%"><b>7.</b></td>
    <td style="width: 94%"><b>Inventories</b></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Inventories consist of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">September 30,</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">2014</P></TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">December 31,</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">2013</P></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 78%; text-align: left">Raw materials</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">6,843,441</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">5,926,030</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Work-in-process</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,325,667</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,308,233</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.1pt">Finished goods</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">4,413,348</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">2,762,522</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.75pt; padding-left: 10pt">Total</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">13,582,456</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">10,996,785</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Inventories are stated at the lower of cost
or market, with cost being determined using the first-in, first-out method. Work-in-process and finished goods inventories include
materials, labor, and manufacturing overhead.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 6%"><b>8.&nbsp;&nbsp;</b></td>
    <td style="width: 94%; text-align: justify"><b>Intangible Assets and Goodwill</b></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">In connection with the acquisition of Anika
Therapeutics S.r.l. (&ldquo;Anika S.r.l.&rdquo;), the Company acquired various intangible assets and goodwill.&nbsp;The Company
evaluated the various intangible assets and related cash flows from these intangible assets, as well as the useful lives and amortization
methods related to these intangible assets.&nbsp;The in-process research and development (&ldquo;IPR&amp;D&rdquo;) intangible assets
initially have indefinite lives and are reviewed periodically to assess the project status, valuation, and disposition, including
write-off(s) for abandoned projects.&nbsp;Until such determination is made, they are not amortized.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Company reviews its long-lived assets for
impairment at least annually. Additionally, the Company will initiate a review for impairment if events or changes in business
circumstances indicate that the carrying amount of the assets may not be fully recoverable or that the useful lives of the assets
are no longer appropriate. Each impairment test will be based on a comparison of the undiscounted cash flows to the recorded value
of the asset. If impairment is indicated, the asset is written down to its estimated fair value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Intangible assets as of September 30, 2014 and
December 31, 2013 consist of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="11" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">September 30, 2014</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="7" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">December 31, 2013</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Gross Value</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">Currency</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">Translation</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">Adjustment</P></TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">Accumulated</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">Amortization</P></TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">Net Book</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">Value</P></TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">Net Book</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">Value</P></TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Useful Life</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 34%; text-align: left">Developed technology</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">16,700,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">(1,828,214</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">(4,779,123</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">10,092,663</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">11,753,003</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: center">15</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">In-process research &amp; development</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,502,686</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(638,426</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,864,260</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,286,127</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">Indefinite</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Distributor relationships</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,700,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(440,953</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,084,944</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">174,103</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">863,655</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">5</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Patents</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(107,910</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(271,208</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">620,882</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">719,574</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">16</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.1pt">Elevess trade name</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">1,000,000</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">-</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">(717,964</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">)</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">282,036</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">376,050</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt; text-align: center">9</TD><TD STYLE="padding-bottom: 1.1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.75pt; padding-left: 10pt">Total</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">28,902,686</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">(3,015,503</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">)</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">(9,853,239</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">)</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">16,033,944</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">18,998,409</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.75pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The aggregate amortization expense related to
intangible assets was $518,699 and $521,387 for the three-month periods ended September 30, 2014 and 2013, respectively. The aggregate
amortization expense related to intangible assets was $1,593,260 and $1,555,796 for the nine-month periods ended September 30,
2014 and 2013, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Changes in the carrying value of goodwill for
the three and nine-month periods ended September 30, 2014 were as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; padding-bottom: 1.1pt">Goodwill</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">Three</P>
                                                                                                    <P STYLE="margin-top: 0; margin-bottom: 0">Months Ended</P>
                                                                                                    <P STYLE="margin-top: 0; margin-bottom: 0">September 30,</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">2014</P></TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">Nine</P>
                                                                                                    <P STYLE="margin-top: 0; margin-bottom: 0">Months Ended</P>
                                                                                                    <P STYLE="margin-top: 0; margin-bottom: 0">September 30,</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">2014</P></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 78%; text-align: left">Balance, beginning</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">9,360,884</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">9,443,894</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.1pt">Effect of foreign currency adjustments</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">(658,589</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">)</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">(741,599</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.75pt">Balance, ending</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">8,702,295</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">8,702,295</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 6%"><b>9.</b></td>
    <td style="width: 94%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Accrued Expenses</b></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">Accrued expenses consist of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; padding-bottom: 1.1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" NOWRAP STYLE="text-align: center; border-bottom: Black 1.1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0"><B>September 30,</B></P>
                                               <P STYLE="margin-top: 0; margin-bottom: 0"><B>2014</B></P></TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" NOWRAP STYLE="text-align: right; border-bottom: Black 1.1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><B>December&nbsp;31,</B></P>
                                              <P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><B>2013</B></P></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 78%; text-align: left">Labor and related expenses</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">2,842,234</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">2,870,147</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Clinical trial costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">962,031</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">882,651</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Professional fees</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">382,423</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">383,231</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Research grants</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">562,558</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">610,498</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Restructuring costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,909</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">24,638</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.1pt">Other</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">492,538</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">766,716</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.75pt; padding-left: 10pt">Total</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">5,253,693</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">5,537,881</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 6%"><b>10.</b></td>
    <td style="width: 94%"><b>Commitments and Contingencies</b></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">In certain of its contracts, the Company warrants
to its customers that the products it manufactures conform to the product specifications as in effect at the time of delivery of
the product. The Company may also warrant that the products it manufactures do not infringe, violate or breach any patent or intellectual
property rights, trade secret or other proprietary information of any third party. On occasion, the Company contractually indemnifies
its customers against any and all losses arising out of, or in any way connected with, any claim or claims of breach of its warranties
or any actual or alleged defect in any product caused by the negligence or acts or omissions of the Company.&nbsp;The Company maintains
a products liability insurance policy that limits its exposure. Based on the Company&rsquo;s historical activity in combination
with its insurance policy coverage, the Company believes the estimated fair value of these indemnification agreements is minimal.
The Company has no accrued warranties and has no history of claims paid.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">On July 7, 2010, Genzyme Corporation filed a
complaint against the Company in the United States District Court for the District of Massachusetts seeking unspecified damages
and equitable relief. The complaint alleged that the Company infringed U.S. Patent No. 5,143,724 by manufacturing MONOVISC&reg; in the
United States for sale outside the United States and would infringe U.S. Patent Nos. 5,143,724 and 5,399,351&nbsp;if the Company
manufactured and sold MONOVISC in the United States. On March 7, 2014, Genzyme and the Company filed a joint motion to
lift the stay in Genzyme&rsquo;s lawsuit against the Company and to dismiss with prejudice all of Genzyme&rsquo;s claims. On March
10, 2014, the District Court granted the motion to dismiss with prejudice all of Genzyme&rsquo;s claims against the Company and
the case was terminated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Company is also involved in various other
legal proceedings arising in the normal course of business.&nbsp;Although the outcomes of these other legal proceedings are inherently
difficult to predict, the Company does not expect the resolution of these other legal proceedings to have a material adverse effect
on its financial position, results of operations or cash flow.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 6%"><b>11.</b></td>
    <td style="width: 94%"><b>Mitek Monovisc Agreement</b></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">In December 2011, the Company entered into a
fifteen-year licensing agreement (the &ldquo;Mitek MONOVISC Agreement&rdquo;) with DePuy Synthes Mitek Sports Medicine, a division
of DePuy Orthopaedics, Inc., to exclusively market MONOVISC in the U.S. The Company received an upfront payment of $2,500,000 in
December 2011. This non-refundable upfront payment did not have standalone value without Anika&rsquo;s completion of development
obligations which included obtaining regulatory approval of the product and resolving the patent litigation. As a result, we recognized
the upfront payment over the development obligation period. During the first quarter of 2014, the Company received FDA approval
of MONOVISC and resolved the patent lawsuit with Genzyme Corporation. As a result of the full delivery of its development obligations
under this agreement, the Company recognized approximately $2,200,000 which represents the remaining balance of deferred revenue
relating to the initial $2,500,000 payment in accordance with current generally accepted principles on revenue recognition. In
the first quarter of 2014, the Company also received a milestone payment of $17,500,000 as a result of achieving FDA approval for
MONOVISC and resolving the patent litigation with Genzyme. This milestone payment was fully recognized as revenue during the three
months ended March 31, 2014. On April 15, 2014 the first U.S. commercial sale of MONOVISC was made by our commercial partner, DePuy
Synthes Mitek Sports Medicine. Under the terms of the Mitek MONOVISC Agreement, the Company earned and collected a milestone payment
of $5 million, which was fully recognized as revenue in the second quarter of 2014.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 6%"><b>12.</b></td>
    <td style="width: 94%"><b>Income Taxes</b></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Provisions for income taxes were $4,125,355
and $18,872,435 for the three and nine-month periods ended September 30, 2014, respectively, based on effective tax rates of 40%
and 38%. Provisions for income taxes were $2,776,199 and $8,147,282 for the three and nine-month periods ended September 30, 2013,
respectively, based on effective tax rates of 36% and 37%, respectively. The increase in income taxes over the three-month period
ended September 30, 2014 was primarily due to increased net income. The increase in income taxes over the nine-month period ended
September 30, 2014 was primarily due to increased net income, which reflected $24,652,778 in milestone and contract revenue associated
with our U.S. license agreement for MONOVISC. See the previous discussion under Note 11. The increase in the effective tax rate
for each of the periods ended 2014, as compared to the same periods ended in 2013, was driven primarily by the unavailability of
the federal R&amp;D tax credit in 2014, due to its expiration on December 31, 2013, and a relative decrease to our estimated
production activities deduction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Company files income tax returns in the
U.S. on a federal basis, in certain U.S. states, and in Italy. The associated tax filings remain subject to examination by applicable
tax authorities for a certain length of time following the tax year to which those filings relate. Our filings from 2011 through
the present tax year remain subject to examination by the IRS and other taxing authorities for U.S. federal and state tax purposes.
Our filings from 2009 through the present tax year remain subject to examination by the appropriate governmental authorities in
Italy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">In connection with the preparation of the financial
statements, the Company performed an analysis to ascertain if it was more likely than not that it would be able to utilize, in
future periods, the net deferred tax assets associated with its net operating loss carryforward. We have concluded that the positive
evidence outweighs the negative evidence and, thus, those deferred tax assets are realizable on a &ldquo;more likely than not&rdquo;
basis. As such, we have not recorded a valuation allowance at September 30, 2014 or December 31, 2013.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 6%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;13.</B></P></td>
    <td style="width: 94%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;Segment and Geographic Information</B></P></td></tr>
</table>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Company has one reportable operating segment,
the results of which are disclosed in the accompanying unaudited condensed consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>



<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Product revenue by product group is as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="3" STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="7" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Three Months Ended September 30,</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="7" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Nine Months Ended September 30,</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="3" STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2014</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2013</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2014</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2013</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 54%; text-align: left">Orthobiologics</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">18,899,873</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">12,830,566</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">48,750,277</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">40,620,339</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: left">Dermal</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">401,355</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">267,766</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">938,966</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,066,409</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: left">Surgical</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,452,946</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,136,248</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,581,496</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,955,134</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: left">Ophthalmic</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">366,138</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,425,609</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">938,134</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,818,407</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt; text-align: left">Veterinary</TD><TD STYLE="padding-bottom: 1.1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">855,000</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">1,363,157</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">2,385,000</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">3,124,953</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.75pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">21,975,312</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">17,023,346</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">57,593,873</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">51,585,242</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Total revenue by geographic location and as
a percentage of overall total revenue, for the three and nine-month periods ended September 30, 2014 and 2013 are as follows;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="font-weight: bold; text-align: center">Three Months Ended September 30,</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="7" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2014</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="7" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2013</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">Total</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">Revenue</P></TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">Percentage of</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">Revenue</P></TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">Total</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">Revenue</P></TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">Percentage of</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">Revenue</P></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Geographic Location:</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 56%; text-align: left; padding-left: 10pt">United States</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">18,455,167</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">84</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">14,485,821</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">82</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Europe</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,784,414</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,656,656</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Other</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">1,815,842</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">8</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">%</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">1,611,961</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">9</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.75pt; padding-left: 20pt">Total</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">22,055,423</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">100</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">%</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">17,754,438</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">100</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">%</TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="font-weight: bold; text-align: center">Nine Months Ended September 30,</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="7" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2014</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="7" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2013</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">Total</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">Revenue</P></TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">Percentage of</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">Revenue</P></TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">Total</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">Revenue</P></TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">Percentage of</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">Revenue</P></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Geographic Location:</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 56%; text-align: left; padding-left: 10pt">United States</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">72,935,722</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">89</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">42,251,336</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">78</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Europe</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,274,071</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,226,619</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Other</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">4,130,577</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">5</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">%</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">6,351,871</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">12</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.75pt; padding-left: 20pt">Total</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">82,340,370</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">100</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">%</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">53,829,826</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">100</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">%</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 6%; font: 10pt Times New Roman, Times, Serif"><b>14.</b></td>
    <td style="width: 94%; font: 10pt Times New Roman, Times, Serif"><b>Restructuring Credits</b></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">In December 2012, the Company announced
the closure of its tissue engineering facility in Abano Terme, Italy due to the Company&rsquo;s inability to meet strict
regulatory standards established by the European Medicines Agency (&ldquo;EMA&rdquo;) for Advanced Therapy Medicinal
Products, which became effective on January 1, 2013. The restructuring plan involved a workforce reduction as well as
associated asset abandonments. The Company recorded restructuring and impairment charges in the fourth quarter of 2012 of
approximately $2.5 million. Of the total restructuring and impairment charges related to the tissue engineering operation,
approximately $1.2 million was related to the non-cash termination and related impairment of an IPR&amp;D project, $0.3
million was related to the disposal of property and equipment, and $0.1 million was related to the disposal of inventory. We
completed the restructuring plan and related activities in 2013. Certain previously impaired and written-off equipment was
sold, resulting in restructuring credits of $196,084 and $442,869 in the three and nine months ended September 30, 2013,
respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The following table summarizes restructuring
accrual activity for the nine-period ended September 30, 2014:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="11" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Restructuring Accrual</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">Employee</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">Severance and</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">Related Benefits</P></TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">Activity</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">Termination and</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">Facility Closure</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">Costs</P></TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Total</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 67%; text-align: left">December 31, 2013</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">21,709</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">2,929</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">24,638</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Cash Proceeds (Disbursements)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(10,130</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,425</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(11,555</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.1pt">Foreign Exchange Impact</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">(1,050</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">)</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">(124</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">)</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">(1,174</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.75pt">September 30, 2014</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">10,529</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">1,380</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">11,909</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 6%; font: 10pt Times New Roman, Times, Serif"><b>15.</b></td>
    <td style="width: 94%; font: 10pt Times New Roman, Times, Serif"><b>New Accounting Standards</b></td></tr>
</table>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">In June 2014,
the Financial Accounting Standards Board (&ldquo;FASB&rdquo;) issued Accounting Standards Update (&quot;ASU&quot;) No.</FONT>
<FONT STYLE="font-size: 10pt">2014-12, &ldquo;Compensation - Stock Compensation (Topic 718): Accounting for Share-Based Payments
When the Terms of an Award Provide that a Performance Target Could be Achieved after the Requisite Service Period,</FONT>&rdquo;
<FONT STYLE="font-size: 10pt">which requires that a performance target that affects vesting, and that could be achieved after
the requisite service period, be treated as a performance condition. Thus, the performance target should not be reflected in estimating
the grant date fair value of the award. This update further clarifies that compensation cost should be recognized in the period
in which it becomes probable that the performance target will be achieved and should represent the compensation cost attributable
to the period(s) for which the requisite service has already been rendered. The new guidance is effective for the Company beginning
January 1, 2016. Early adoption is permitted. The Company is currently evaluating the impact of this new standard on its consolidated
financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In May 2014, the FASB
issued ASU No. 2014-09, &quot;Revenue from Contracts with Customers.&quot; ASU 2014-09 supersedes the revenue recognition requirements
in &quot;Topic 605, Revenue Recognition&quot; and requires entities to recognize revenue in a way that depicts the transfer of
promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled
in exchange for those goods or services. ASU 2014-09 is effective retrospectively for annual or interim reporting periods beginning
after December 15, 2016, with early application not permitted. The Company is currently evaluating the impact of this new standard
on its consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">In
April 2014, the FASB issued ASU No. 2014-08, &quot;Reporting of Discontinued Operations and Disclosures of Disposals of Components
of an Entity.&quot; ASU 2014-08 provides a narrower definition of discontinued operations than that provided under existing U.S.
GAAP. ASU 2014-08 requires that only a disposal of a component of an entity, or a group of components of an entity, which disposal
represents a strategic shift that has, or will have, a major effect on the reporting entity's operations and financial results,
should be reported in the financial statements as a discontinued operation. ASU 2014-08 also provides guidance on the financial
statement presentations and disclosures of discontinued operations. ASU 2014-08 is effective prospectively for disposals (or classifications
as held for disposal) of components of an entity that occur in annual or interim periods beginning after December 15, 2014. The
Company does not expect the adoption of ASU 2014-08 to have a material impact on its consolidated financial statements.<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">
</FONT></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif"><b>ITEM 2.</b></td>
    <TD STYLE="width: 90%; font: 10pt Times New Roman, Times, Serif"><b>MANAGEMENT&rsquo;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</b></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.55in"><I>This Quarterly Report on Form&nbsp;10-Q
contains forward-looking statements within the meaning of Section&nbsp;27A of the Securities Act of 1933 and Section&nbsp;21E of
the Securities Exchange Act of 1934, including statements regarding:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>Our future sales and product revenue, including geographic expansions, possible retroactive price adjustments, and expectations
of unit volumes or other offsets to price reductions;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>Our manufacturing capacity, efficiency gains and work-in-process manufacturing operations;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>The timing, scope and rate of patient enrollment for clinical trials;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>The development of possible line extensions and new products;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>Our ability to achieve and/or maintain compliance with laws and regulations;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>The timing of and/or receipt of Food and Drug Administration (&ldquo;FDA&rdquo;), foreign or other regulatory approvals, clearances,
and/or reimbursement approvals of current, new or potential products, and any limitations on such approvals;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>Our intention to seek patent protection for our products and processes, and to protect our intellectual property;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>Our ability to effectively compete against current and future competitors;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>Negotiations with potential and existing partners, including our performance under any of our existing and future distribution,
license or supply agreements, and our expectations with respect to sales and sales threshold milestones pursuant to such agreements;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>The level of our revenue or sales in particular geographic areas and/or for particular products, and the market share for any
of our products;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>Our expectations of product revenue results in future quarters and for the full year 2014;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>Our current strategy, including our corporate objectives, research and development activities and collaboration activities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>Our expectations regarding our orthobiologics products, including existing products and expectations regarding new products,
expanded uses of existing products, new distribution partnerships and revenue growth;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>Our intention to increase our market share for orthobiologics products in domestic and international markets or otherwise penetrate
growing markets for osteoarthritis of the knee and other joints;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>Our expectations regarding next generation orthobiologics product development, clinical trials, regulatory approvals and commercial
launches;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>Our and Bausch &amp; Lomb&rsquo;s performance under the non-exclusive, three-year contract for the supply of AMVISC<SUP>&reg;</SUP>
and AMVISC<SUP>&reg;</SUP> Plus ophthalmic viscoelastic products, our expectations regarding revenue from ophthalmic products,
and the impact that such agreement&rsquo;s expiration will have on our results of operations going forward;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD><P STYLE="font-size: 10pt; margin: 0">Our ability to commercialize ANIKAVISC&reg; and ANIKAVISC&reg; Plus and our expectations
regarding such commercialization and the potential profits generated thereby;</P>


</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>Our ability to license our aesthetics product to new distribution partners domestically and outside the U.S., and our expectations
regarding development of aesthetics product line extensions;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD><P STYLE="font-size: 10pt; margin: 0"></P>

<P STYLE="font-size: 10pt; margin: 0">Our ability and the ability of our distribution partners, to market our aesthetics dermatology
product; and our expectations regarding the distribution and sales of our ELEVESS&reg; product and the timing thereof;</P>



<P STYLE="font-size: 10pt; margin: 0"></P>


</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>Our expectations regarding HYVISC<SUP>&reg;</SUP> sales;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>Our expectations regarding product gross margin;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>Our expectations regarding CINGAL<SUP>&reg;</SUP>, including the expense associated therewith, the timing of submission of our
CE Mark application, and our ability to obtain regulatory approvals for this product;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>Possible negotiations or re-negotiations with existing or new distribution or collaboration partners;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>Our ability to continue streamlining operations and improving our manufacturing capabilities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>Our expectation for changes in operating expenses, including research and development, and selling, general and administrative
expenses;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>The rate at which we use cash, the amounts used and generated by operations, and our expectations regarding the adequacy and
usage of such cash;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>Our expectation for capital expenditures and future amounts of interest income and expense;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>Our ability to obtain additional funds through equity or debt financings, strategic alliances with corporate partners and other
sources, to the extent our current sources of funds are insufficient;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>Our ability to manage the operations of Anika S.r.l. as a company generating continued profits;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>The strength of the economies in which the Company operates or will operate, as well as the political stability of any of those
geographic areas;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>Our ability to effectively prioritize the many research and development projects underway;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>Our ability to expand the therapeutic applications of our existing products and create new applications for our HA technology;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>Our ability to obtain U.S. approval for orthopedic and other product franchises of Anika S.r.l., including the timing and potential
success of such efforts, and to expand sales of these products in the U.S., including the impact such efforts may have on our revenue;
and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>Our ability to successfully defend the Company against lawsuits and claims, and the&nbsp;uncertain financial impact such lawsuits
and claims and related defense costs may have on the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><I>Furthermore, additional
statements identified by words such as &ldquo;will,&rdquo; &ldquo;likely,&rdquo; &ldquo;may,&rdquo; &ldquo;believe,&rdquo; &ldquo;expect,&rdquo;
&ldquo;anticipate,&rdquo; &ldquo;intend,&rdquo; &ldquo;seek,&rdquo; &ldquo;designed,&rdquo; &ldquo;develop,&rdquo; &ldquo;would,&rdquo;
&ldquo;future,&rdquo; &ldquo;can,&rdquo; &ldquo;could,&rdquo; and other expressions that are predictions of or indicate future
events and trends and which do not relate to historical matters, also identify forward-looking statements. </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><I>You should not rely
on forward-looking statements because they involve known and unknown risks, uncertainties and other factors, some of which are
beyond our control, including those factors described in the section titled &ldquo;Item 1A. Risk Factors&rdquo; in the Company&rsquo;s
Annual Report on Form&nbsp;10-K for the year ended December 31, 2013. These risks, uncertainties and other factors may cause our
actual results, performance or achievement to be materially different from anticipated future results, performance or achievement,
expressed or implied by the forward-looking statements. These forward-looking statements are based upon the current assumptions
of our management and are only expectations of future results. You should carefully review all of these factors, and you should
be aware that there may be other factors that could cause these differences, including those factors discussed herein and in the
&ldquo;Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations&rdquo; section of this Quarterly
Report on Form&nbsp;10-Q, as well as the risk factors described in our Annual Report on Form&nbsp;10-K for the year ended December
31, 2013 and in our press releases and other filings with the Securities and Exchange Commission. We undertake no obligation to
publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors of new information,
future events or other changes.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>Management Overview </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Anika Therapeutics,&nbsp;Inc. (together with
its subsidiaries, &ldquo;Anika,&rdquo; the &ldquo;Company,&rdquo; &ldquo;we,&rdquo; &ldquo;us,&rdquo; or &ldquo;our&rdquo;) develops,
manufactures and commercializes therapeutic products for tissue protection, healing, and repair. These products are based on hyaluronic
acid (&ldquo;HA&rdquo;), a naturally occurring, biocompatible polymer found throughout the body. Due to its unique biophysical
and biochemical properties, HA plays an important role in a number of physiological functions such as the protection and lubrication
of soft tissues and joints, the maintenance of the structural integrity of tissues, and the transport of molecules to and within
cells.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Anika&rsquo;s proprietary technologies for modifying
the HA molecule allow product properties to be tailored specifically to intended therapeutic uses. Our patented technologies chemically
modify the HA molecule to allow for longer residence time in the body. Anika Therapeutics, Inc.&rsquo;s wholly-owned subsidiary,
Anika Therapeutics S.r.l., has over 20 products currently commercialized. These products are also all made from HA,
based on two technologies: &ldquo;HYAFF,&rdquo; which is a solid form of HA, and ACP gel, an autocross-linked polymer of HA. Both
technologies are protected by an extensive portfolio of owned and licensed patents. We offer therapeutic products from these aforementioned
technologies in the following areas:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="width: 40%; border: black 1.1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</td>
    <TD STYLE="width: 10%; border-top: black 1.1pt solid; border-right: black 1.1pt solid; border-bottom: black 1.1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Anika</td>
    <TD STYLE="width: 10%; border-top: black 1.1pt solid; border-right: black 1.1pt solid; border-bottom: black 1.1pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Anika</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">S.r.l.</P></td>
    <TD STYLE="width: 20%">&nbsp;</TD></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-right: black 1.1pt solid; border-bottom: black 1.1pt solid; border-left: black 1.1pt solid; font: 10pt Times New Roman, Times, Serif">Orthobiologics</td>
    <TD STYLE="border-right: black 1.1pt solid; border-bottom: black 1.1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">X</td>
    <TD STYLE="border-right: black 1.1pt solid; border-bottom: black 1.1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">X</td>
    <TD>&nbsp;</TD></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-right: black 1.1pt solid; border-bottom: black 1.1pt solid; border-left: black 1.1pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Dermal</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;<i>Advanced wound care</i></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><i>&nbsp;&nbsp;&nbsp;&nbsp;Aesthetic dermatology</i></P></td>
    <TD STYLE="border-right: black 1.1pt solid; border-bottom: black 1.1pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">X</P></td>
    <TD STYLE="border-right: black 1.1pt solid; border-bottom: black 1.1pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">X</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P></td>
    <TD>&nbsp;</TD></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-right: black 1.1pt solid; border-bottom: black 1.1pt solid; border-left: black 1.1pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Surgical</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;<i>Anti-adhesion</i></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><i>&nbsp;&nbsp;&nbsp;&nbsp;Ear, nose and throat
        care (&ldquo;ENT&rdquo;)</i></P></td>
    <TD STYLE="border-right: black 1.1pt solid; border-bottom: black 1.1pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">X</P></td>
    <TD STYLE="border-right: black 1.1pt solid; border-bottom: black 1.1pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">X</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">X</P></td>
    <TD>&nbsp;</TD></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-right: black 1.1pt solid; border-bottom: black 1.1pt solid; border-left: black 1.1pt solid; font: 10pt Times New Roman, Times, Serif">Ophthalmic</td>
    <TD STYLE="border-right: black 1.1pt solid; border-bottom: black 1.1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">X</td>
    <TD STYLE="border-right: black 1.1pt solid; border-bottom: black 1.1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</td>
    <TD>&nbsp;</TD></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-right: black 1.1pt solid; border-bottom: black 1.1pt solid; border-left: black 1.1pt solid; font: 10pt Times New Roman, Times, Serif">Veterinary</td>
    <TD STYLE="border-right: black 1.1pt solid; border-bottom: black 1.1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">X</td>
    <TD STYLE="border-right: black 1.1pt solid; border-bottom: black 1.1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</td>
    <TD>&nbsp;</TD></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Please see Management&rsquo;s Discussion and
Analysis of Financial Condition and Results of Operations-Management Overview (Item 7) to the Company&rsquo;s Annual Report on
Form 10-K for the year ended December 31, 2013, for a description of each of the above therapeutic areas, including the individual
products.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>Research and Development</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Anika&rsquo;s research and development efforts
primarily consist of the development of new medical applications for our HA-based technologies, the management of clinical trials
and studies for certain product candidates, the preparation and processing of applications for regulatory approvals or clearances
at all relevant stages of product development, and process development and scale-up manufacturing activities related to our existing
and new products. Our development focus includes products for tissue protection, healing and repair. Our investment in R&amp;D
varies considerably depending on the timing, number and size of clinical trials and studies underway. We anticipate that we will
commit significant resources to research and development, including clinical trials, in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">During the first quarter of 2014, the
Company received FDA approval of MONOVISC and resolved the patent lawsuit with Genzyme Corporation. The Company received a
milestone payment of $17,500,000 under the Mitek MONOVISC Agreement related to FDA approval of MONOVISC and the successful
resolution of the Genzyme patent litigation. As a result of the full delivery of our development obligations under this
agreement, the Company also recognized the remaining balance of deferred revenue relating to the initial $2,500,000
non-refundable up-front payment. Both amounts were fully recognized as revenue during the three months ended March 31,
2014.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">A key product currently under development is
CINGAL, which is based on our HA material with an added active therapeutic molecule designed to provide broad pain
relief for a longer period of time. We completed the formulation and biocompatibility studies of the product. During the second
quarter of 2013, we commenced a multinational phase III clinical trial to obtain the clinical data necessary for a CE Mark submission
and approval, and to support other product registrations including in the United States. Enrollment in the clinical trial was completed
in February 2014, and the last patient follow-up was completed in September 2014. We expect to submit our CE
Mark application by December 31, 2014, or shortly thereafter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">HYALOFAST&trade; is an innovative biodegradable
matrix for human bone marrow mesenchymal stem cells used in connection with soft tissue regeneration. HYALOFAST received CE Mark
approval in September 2009, and it is currently commercially available in Europe and certain international countries. During the
second quarter of 2014, we submitted a proposed investigational device protocol to the FDA. Our current plan is to begin a phase
III clinical trial in 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The technologies obtained through our acquisition
of Anika S.r.l. have enhanced our research and development capabilities, and our pipeline of product candidates. Anika S.r.l. has
research and development programs for new products including HYALOFAST and HYALOSPINE&trade;, an adhesion prevention gel for use after
spinal surgery. Our research and development efforts may not be successful in (1) developing our existing product candidates, (2)
expanding the therapeutic applications of our existing products, or (3) resulting in new applications for our HA technology. There
is also a risk that we may choose not to pursue development of potential product candidates. We also may not be able to obtain
regulatory approval for any new applications we develop.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>Litigation and Other Legal Matters </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">On July 7, 2010, Genzyme Corporation filed a
complaint against the Company in the United States District Court for the District of Massachusetts seeking unspecified damages
and equitable relief. The complaint alleged that the Company infringed U.S. Patent No. 5,143,724 by manufacturing MONOVISC in the
United States for sale outside the United States and would infringe U.S. Patent Nos. 5,143,724 and 5,399,351&nbsp;if the Company
manufactured and sold MONOVISC in the United States. On March 7, 2014 Genzyme and the Company filed a joint motion to lift
the stay in Genzyme&rsquo;s lawsuit against the Company and to dismiss with prejudice all of Genzyme&rsquo;s claims. On March 10,
2014, the District Court granted the motion to dismiss with prejudice all of Genzyme&rsquo;s claims against the Company and the
case was terminated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We are also involved in
various other legal proceedings arising in the normal course of business.&nbsp;Although the outcomes of these other legal proceedings
are inherently difficult to predict, we do not expect the resolution of these other legal proceedings to have a material adverse
effect on our financial position, results of operations or cash flows.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Results of Operations </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><B><I>&nbsp;</I>Three and Nine Months Ended September 30, 2014
Compared to the Three and Nine Months Ended September 30, 2013</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="11" STYLE="font-weight: bold; text-align: center">Three Months Ended September 30,</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="11" STYLE="font-weight: bold; text-align: center">Nine Months Ended September 30,</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2014</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2013</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Inc/(Dec)</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2014</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2013</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Inc/(Dec)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 34%; text-align: left">Product revenue</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">21,975,312</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">17,023,346</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">29</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">57,593,873</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">51,585,242</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">12</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.1pt">Licensing, milestone and contract revenue</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">80,111</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">731,092</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">(89</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">%)</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">24,746,497</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">2,244,584</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">1002</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Total revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,055,423</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17,754,438</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">24</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">82,340,370</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">53,829,826</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">53</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Operating expenses:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Cost of product revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,724,800</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,377,568</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15,418,732</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,530,070</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(7</TD><TD STYLE="text-align: left">%)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Research&nbsp;&amp; development</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,999,867</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,618,012</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">24</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,160,740</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,029,974</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Selling, general&nbsp;&amp; administrative</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,044,538</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,188,669</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">27</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,401,399</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,536,462</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Restructuring credits</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(196,084</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: right">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(100</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">%)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(442,869</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(100</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: left">%)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.1pt">Total operating expenses</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">11,769,205</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">9,988,165</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">18</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">%</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">32,980,871</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">31,653,637</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">4</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Income from operations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,286,218</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,766,273</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">32</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">49,359,499</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,176,189</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">123</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Interest income (expense), net</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">9,937</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">(32,816</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">)</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">(130</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">%)</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">16,339</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">(108,755</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">)</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">(115</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">%)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Income before income taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,296,155</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,733,457</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">33</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">49,375,838</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,067,434</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">124</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Provision for income taxes</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">4,125,355</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">2,776,199</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">49</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">%</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">18,872,435</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">8,147,282</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">132</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.75pt">Net income</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">6,170,800</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">4,957,258</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">24</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">%</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">30,503,403</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">13,920,152</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">119</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Product gross profit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">16,250,512</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">11,645,778</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">40</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">42,175,141</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">35,055,172</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Product gross margin</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">74</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">68</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">73</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">68</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>&nbsp;</I></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>Product Revenue</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Product revenue for the quarter ended September
30, 2014 was $21,975,312, an increase of 29%, as compared to $17,023,346 for the quarter ended September 30, 2013. Product revenue
for the nine-month period ended September 30, 2014 was $57,593,873, an increase of 12%, as compared to $51,585,242 for the nine-month
period ended September 30, 2013. For the three months ended September 30, 2014, increases in product revenue from our Orthobiologics,
Dermal and Surgical franchises were partially offset by timing related decreases in revenue from our Ophthalmic and Veterinary
products. The increase in the nine-month period ended September 30, 2014 from the prior year period was primarily driven by MONOVISC
product sales increases both domestically and internationally.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The following table presents product revenue
by group for the three and nine-month periods ended September 30, 2014 and 2013:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="3" STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="7" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Three Months Ended September 30,</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="7" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Increase&nbsp;(Decrease)</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="3" STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2014</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2013</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">$</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 54%; text-align: left">Orthobiologics</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">18,899,873</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">12,830,566</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">6,069,307</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">47</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: left">Dermal</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">401,355</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">267,766</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">133,589</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">50</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: left">Surgical</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,452,946</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,136,248</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">316,698</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">28</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: left">Ophthalmic</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">366,138</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,425,609</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,059,471</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(74</TD><TD STYLE="text-align: left">%)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt; text-align: left">Veterinary</TD><TD STYLE="padding-bottom: 1.1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">855,000</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">1,363,157</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">(508,157</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">)</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">(37</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">%)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.75pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">21,975,312</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">17,023,346</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">4,951,966</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">29</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">%</TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="3" STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="7" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Nine Months Ended September 30,</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="7" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Increase&nbsp;(Decrease)</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="3" STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2014</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2013</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">$</TD><TD STYLE="font-weight: bold; padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 54%; text-align: left">Orthobiologics</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">48,750,277</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">40,620,339</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">8,129,938</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">20</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: left">Dermal</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">938,966</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,066,409</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(127,443</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(12</TD><TD STYLE="text-align: left">%)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: left">Surgical</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,581,496</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,955,134</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">626,362</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: left">Ophthalmic</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">938,134</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,818,407</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,880,273</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(67</TD><TD STYLE="text-align: left">%)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt; text-align: left">Veterinary</TD><TD STYLE="padding-bottom: 1.1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">2,385,000</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">3,124,953</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">(739,953</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">)</TD><TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: right">(24</TD><TD STYLE="border-bottom: Black 1.1pt solid; text-align: left">%)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.75pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">57,593,873</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">51,585,242</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">6,008,631</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.75pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.75pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: right">12</TD><TD STYLE="border-bottom: Black 2.75pt double; text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>Orthobiologics</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Our orthobiologics franchise consists of our
joint health and orthopedic products. Overall, sales increased 47% and 20% for the three and nine-month periods ended September
30, 2014, as compared to the same periods in 2013. The growth in the third quarter of 2014 reflected revenue from MONOVISC sales
in the U.S. as a result of the product launch in April 2014. We expect orthobiologics product revenue to increase in 2014 as compared
to 2013.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>Dermal</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Our dermal franchise consists of advanced wound
care products and aesthetic dermal fillers. In July 2014, the Company entered into a new agreement with Medline Industries Inc.
to commercialize HYALOMATRIX in the U.S. on an exclusive basis through 2019. For the three and nine month periods ended September
30, 2014, dermal product sales increased 50% and decreased 12%, respectively to $401,355 and $938,966, as compared to the same
periods in 2013. The fluctuations primarily reflect order timing by our distribution partners. Anika&rsquo;s advanced wound care
products treat complex skin wounds ranging from burns to diabetic ulcers, with HYALOMATRIX&reg; and HYALOFILL&reg; as the lead products.
We expect revenue from our dermal products to grow in the fourth quarter from the third quarter of 2014.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>Surgical</I>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Our surgical franchise consists of products
used to prevent post-surgical adhesions in abdominal-pelvic, spinal, and ear, nose and throat (&ldquo;ENT&rdquo;) disorders. Sales
of our surgical&nbsp;products increased 28% and 16% for the three and nine-month periods ended September 30, 2014 to $1,452,946
and $4,581,496 respectively, as compared to the same periods in 2013. The year-to-date increase of surgical product revenue was
primarily due to strong demand for our HYALOBARRIER&reg; product from our European and Asian partners. For the full year 2014, we expect
revenue from our surgical products to increase as compared to 2013.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>&nbsp;</I></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>Ophthalmic</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Our ophthalmic franchise consists of HA
viscoelastic products used in ophthalmic surgery. Ophthalmic product sales decreased 74% and 67% to $366,138 and $938,134,
respectively, for the three and nine-month periods ended September 30, 2014, as compared to the same periods in 2013. The
decrease was primarily attributable to Bausch &amp; Lomb (&ldquo;B&amp;L&rdquo;) delaying its contractual minimum
purchases until the fourth quarter of 2014. We expect the overall ophthalmic revenue to be lower in 2014, as compared to
2013, due to the terms of the current Bausch &amp; Lomb supply agreement. B&amp;L&rsquo;s current contract expires at the end
of this year and will not be renewed. Given that the ophthalmic franchise is not part of our core business, and that it has
been steadily diminishing for the past few years, we do not expect this event to have a material impact on our results going
forward.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>Veterinary</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Veterinary revenue from HYVISC decreased
by 37% to $855,000 and 24% to $2,385,000 for the three and nine-month periods ended September 30, 2014, respectively, as
compared to the same periods in 2013. We expect the overall veterinary revenue to be slightly lower in 2014, as compared to
2013 due to order timing and a slight downward trend in the number of performance horses in the U.S. We continue to look at other
veterinary applications and opportunities to expand geographic territories.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>Licensing, milestone and contract revenue</I>&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Licensing, milestone and contract revenue for
the three and nine-month periods ended September 30, 2014 was $80,111 and $24,746,497, respectively, as compared to $731,092 and
$2,244,584 for the same periods in 2013. Revenue for the quarter ended June 30, 2014 included a $5,000,000 milestone payment associated
with our U.S. license agreement for MONOVISC. The year to date September 30, 2014 increase in licensing, milestone and contract
revenue included a $17,500,000 milestone payment resulting from the resolution of the patent litigation with Genzyme and the FDA
approval of MONOVISC, and the recognition of an approximately $2,200,000 remaining unamortized upfront payment previously received
in December 2011. These payments are related to development obligations under the license agreement. The FDA&rsquo;s approval of
our MONOVISC product during the quarter ended March 31, 2014 completed the delivery of our development obligations under the license
agreement, and resulted in the immediate recognition of the $17.5 million milestone payment, as well as the full recognition of
prior deferred revenue in the first quarter of 2014. During the second quarter of 2014, a $5,000,000 milestone payment associated
with the first commercial sale of MONOVISC in the U.S. was earned, received, and recognized as revenue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>Product gross profit and margin</I>&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Product gross profit and margin for the three
and nine-month periods ended September 30, 2014 was $16,250,512 and $42,175,141, or 74% and 73%, respectively, of the product revenue.
Product gross margin for the three and nine-month periods ended September 30, 2013 was $11,645,778 and $35,055,172, or 68% of the
product revenue for each period, respectively. The increase in product gross margin for the three and nine-month periods ended
September 30, 2014, as compared to the same periods in 2013, is attributable to a more favorable product mix, materials cost reduction,
and continued efficiency gains at our Bedford, Massachusetts manufacturing facility. This quarter&rsquo;s product gross margin
may not be indicative of the rest of the year due to dynamics including the future mix of our product sales and other factors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>Research and development</I>&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Research and development expenses for the three
and nine-month periods ended September 30, 2014 were $1,999,867 and $6,160,740, or 9% and 8% of total revenue, respectively. This
primarily reflects the completion of patient follow-up activities of our phase III Cingal clinical trial during the first nine
months of 2014, as compared to trial start-up activities in the same periods last year. Research and development spending is expected
to increase in future quarters as we further develop new products based on our existing technology assets.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>Selling, general and administrative</I>&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Selling, general and administrative (&ldquo;SG&amp;A&rdquo;)
expenses for the three and nine-month periods ended September 30, 2014 were $4,044,538 and $11,401,399, or, representing 19% and
14% of total revenue, respectively. SG&amp;A expenses increased for both the three and nine-month periods ending September 30,
2014, as compared to the same periods in 2013, primarly as a result of increases in personnel related costs, external professional
fees, and corporate goverance costs. Included in the first quarter of 2013 were certain non-recurring external professional fees
and personnel costs. We expect general and administrative expenses to increase in 2014, as compared to 2013, reflective of the
support required to grow our business both domestically and internationally.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>&nbsp;</I></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>Income taxes</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Provisions for income taxes were $4,125,355
and $18,872,435 for the three and nine-month periods ended September 30, 2014, based on effective tax rates of 40% and 38%, respectively.
Provisions for income taxes were $2,776,199 and $8,147,282 for the three and nine-month periods ended September 30, 2013, respectively,
based on effective tax rates of 36% and 37%, respectively. The increase in income taxes over the three-month period ended September
30, 2014 was primarily due to increased net income. The increase in income taxes over the nine-month period ended September 30,
2014 was primarily due to increased net income, which reflected $24,652,778 in milestone and contract revenue associated with our
U.S. license agreement for MONOVISC. The increase in the effective tax rate for each of the periods ended 2014, as compared to
the same periods ended in 2013, was driven primarily by the unavailability of the federal R&amp;D tax credit in 2014, due to its
expiration on December 31, 2013, and a relative decrease to our estimated production activities deduction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Company files income tax returns in the
U.S. on a federal basis, in certain U.S. states, and in Italy. The associated tax filings remain subject to examination by applicable
tax authorities for a certain length of time following the tax year to which those filings relate. Our filings from 2011 through
the present tax year remain subject to examination by the IRS and other taxing authorities for U.S. federal and state tax purposes.
Our filings from 2009 through the present tax year remain subject to examination by the appropriate governmental authorities in
Italy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">In connection with the preparation of the financial
statements, the Company performed an analysis to ascertain if it was more likely than not that it would be able to utilize, in
future periods, the net deferred tax assets associated with its net operating loss carryforward. We have concluded that the positive
evidence outweighs the negative evidence and, thus, those deferred tax assets are realizable on a &ldquo;more likely than not&rdquo;
basis. As such, we have not recorded a valuation allowance at September 30, 2014 or December 31, 2013.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>Liquidity and Capital Resources </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">We require cash to fund our operating expenses
and capital expenditures. We expect that our requirements for cash to fund operations will increase as the scope of our operations
expands. Historically, we have generated positive cash flow from operations, which together with our available cash and investments,
have met our cash requirements. Cash, cash equivalents and investments totaled approximately $91.8 million and $63.3 million at
September 30, 2014 and December 31, 2013, respectively. Working capital totaled approximately $122.2 million at September 30, 2014
and $85.3 million at December 31, 2013.&nbsp;The Company believes it has adequate financial resources to support its business for
the next twelve months.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Cash provided by operating activities was $25,222,372
for the nine months ended September 30, 2014, as compared to cash provided by operating activities of $17,159,199 for the same
period in the prior year.&nbsp;This increase in cash provided by operations was due primarily to a total of $22.5 million milestone
payments received under the Mitek MONOVISC Agreement. This cash inflow is partially offset by an increase in inventory due to anticipated
future sales demand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Cash used in investing activities was $20,919,301
for the nine months ended September 30, 2014 as compared to cash provided by investing activities of $295,062 for the same period
in 2013.&nbsp;The increase in cash used in investing activities is primarily the result of the purchase of approximately $20.0 million
in marketable securities during the third quarter as well as higher capital expenditures in 2014 as compared to the same period
in 2013, which included the proceeds received from the sale of property and equipment in the prior year period relating to our
reorganization of Anika S.r.l. in the beginning of 2013.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 49.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Cash provided by financing activities was $4,267,102
for the nine months ended September 30, 2014, as compared to cash provided by financing activities of $2,496,830 for the same period
in 2013. The increase in cash provided by financing activities in the current year&rsquo;s period is attributable to the increased
tax benefits received in regards to employees&rsquo; exercise of stock options during the first nine months of 2014, partially
offset by minimum tax withholdings on share-based awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>Critical Accounting Estimates </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 49.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During the nine months
ended September 30, 2014, the Company received FDA approval of MONOVISC and the patent litigation related to MONOVISC was also
resolved. As a result, the Company shortened the estimate of the performance period related to the Mitek MONOVISC Agreement. There
were no other significant changes in our critical accounting estimates during the nine months ended September 30, 2014, as compared
to the estimates disclosed in Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations included
in our Annual Report on Form&nbsp;10-K for the fiscal year ended December 31, 2013.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>&nbsp;</I></B></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Recent Accounting Pronouncements</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">In June 2014,
the Financial Accounting Standards Board (&ldquo;FASB&rdquo;) issued Accounting Standards Update (&ldquo;ASU&rdquo;) </FONT>No.
<FONT STYLE="font-size: 10pt">2014-12, &ldquo;Compensation - Stock Compensation (Topic 718): Accounting for Share-Based Payments
When the Terms of an Award Provide that a Performance Target Could be Achieved after the Requisite Service Period,</FONT>&rdquo;
<FONT STYLE="font-size: 10pt">which requires that a performance target that affects vesting, and that could be achieved after
the requisite service period, be treated as a performance condition. Thus, the performance target should not be reflected in estimating
the grant date fair value of the award. This update further clarifies that compensation cost should be recognized in the period
in which it becomes probable that the performance target will be achieved and should represent the compensation cost attributable
to the period(s) for which the requisite service has already been rendered. The new guidance is effective for the Company beginning
January 1, 2016. Early adoption is permitted. The Company is currently evaluating the impact of this new standard on its financial
statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In May 2014, the FASB
issued ASU No. 2014-09, &quot;Revenue from Contracts with Customers.&quot; ASU 2014-09 supersedes the revenue recognition requirements
in &quot;Topic 605, Revenue Recognition&quot; and requires entities to recognize revenue in a way that depicts the transfer of
promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled
in exchange for those goods or services. ASU 2014-09 is effective retrospectively for annual or interim reporting periods beginning
after December 15, 2016, with early application not permitted. The Company is currently evaluating the impact of this new standard
on its financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">In
April 2014, the FASB issued ASU No. 2014-08, &quot;Reporting of Discontinued Operations and Disclosures of Disposals of Components
of an Entity.&quot; ASU 2014-08 provides a narrower definition of discontinued operations than under existing U.S. GAAP. ASU 2014-08
requires that only a disposal of a component of an entity, or a group of components of an entity, that represents a strategic shift
that has, or will have, a major effect on the reporting entity's operations and financial results should be reported in the financial
statements as discontinued operations. ASU 2014-08 also provides guidance on the financial statement presentations and disclosures
of discontinued operations. ASU 2014-08 is effective prospectively for disposals (or classifications as held for disposal) of components
of an entity that occur in annual or interim periods beginning after December 15, 2014. The Company does not expect the adoption
of ASU 2014-08 to have a material impact on the consolidated financial statements.</FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Contractual Obligations and Other Commercial Commitments</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">We have had no material changes outside the
ordinary course to our contractual obligations disclosed in our Annual Report on Form 10-K for the period ended December 31, 2013.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">To the extent that funds generated from our
operations, together with our existing capital resources, are insufficient to meet future requirements, we will be required to
obtain additional funds through equity or debt financings, strategic alliances with corporate partners and others, or through other
sources. No assurance can be given that any additional financing will be made available to us or will be available on acceptable
terms should such a need arise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>Off-balance Sheet Arrangements</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Company does not use special purpose entities
or other off-balance sheet financing techniques, except for operating leases, that we believe have, or are reasonably likely to
have, a current or future material effect on our financial condition, changes in financial condition, revenues or expenses, results
of operations, liquidity or capital resources.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif"><b>ITEM 3.</b></td>
    <TD STYLE="width: 90%; font: 10pt Times New Roman, Times, Serif"><b>QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</b></td></tr>
</table>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">There have been no material changes to our market
risks since the date of our Annual Report on Form&nbsp;10-K for the year ended December 31, 2013.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">As of September 30, 2014, we did not utilize
any derivative financial or commodity instruments for which fair value disclosure would be required under ASC 825,<I> Financial
Instruments</I>, or ASC 815, <I>Derivatives and Hedging</I>. Our marketable securities investments consist of money market funds
primarily invested in certificates of deposit, commercial paper, U.S.&nbsp;Treasury obligations and repurchase agreements secured
by U.S.&nbsp;Treasury obligations that are carried on our books at fair market value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>Primary Market Risk Exposures</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Our primary market risk exposure is in the area
of currency rate risk. We have three supplier contracts denominated in foreign currencies. Unfavorable fluctuations in exchange
rates would have a negative impact on our financial statements. The impact of changes in currency exchange rates for these supplier
contracts on our financial statements was immaterial for the three months ended September 30, 2014.&nbsp;The impact of exchange
rates related to the consolidation of the balance sheet amounts for our Anika S.r.l. subsidiary resulted in an unfavorable currency
translation adjustment of $1,896,823 during the first nine months of 2014.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Our investment portfolio of cash equivalents
and marketable securities is subject to interest rate fluctuations, changes in credit quality of the issuer or other factors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif"><b>ITEM 4.</b></td>
    <TD STYLE="width: 90%; font: 10pt Times New Roman, Times, Serif"><b>CONTROLS AND PROCEDURES</b></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<tr>
    <TD STYLE="width: 5%; font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</td>
    <TD STYLE="width: 5%; font: 10pt Times New Roman, Times, Serif; text-align: left">(a)</td>
    <TD STYLE="vertical-align: top; width: 90%; font: 10pt Times New Roman, Times, Serif">Evaluation of disclosure controls and procedures.</td></tr>
<TR>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">As required by Rule&nbsp;13a-15 under the Securities Exchange
Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), we carried out an evaluation under the supervision and with the participation
of our management, including our chief executive officer and chief financial officer, of the effectiveness of the design and operation
of our disclosure controls and procedures as of the end of the period covered by this report. Based upon that evaluation, the chief
executive officer and principal financial officer have concluded that our disclosure controls and procedures are effective to ensure
that information required to be disclosed by us in reports we file or submit under the Exchange Act is recorded, processed, summarized
and reported, within the time periods specified in Securities and Exchange Commission rules&nbsp;and forms. Disclosure controls
and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed
by the Company in the reports it files or submits under the Exchange Act is accumulated and communicated to the Company&rsquo;s
management, including our chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding
required disclosure. On an on-going basis, we review and document our disclosure controls and procedures, and our internal control
over financial reporting, and may from time to time make changes aimed at enhancing their effectiveness and to ensure that our
systems evolve with our business.</TD></TR>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<tr>
    <TD STYLE="width: 5%; font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</td>
    <TD STYLE="width: 5%; font: 10pt Times New Roman, Times, Serif; text-align: left">(b)</td>
    <TD STYLE="vertical-align: top; width: 90%; font: 10pt Times New Roman, Times, Serif">Changes in internal controls over financial reporting.</td></tr>
<TR>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">There were no changes in our internal control over financial
reporting during the three-month period ended September 30, 2014 that have materially affected, or that are reasonably likely to
materially affect, our internal controls over financial reporting.</TD></TR>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>PART&nbsp;II: OTHER INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif"><b>ITEM 1.</b></td>
    <TD STYLE="width: 90%; font: 10pt Times New Roman, Times, Serif"><b>&nbsp;LEGAL PROCEEDINGS</b></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">On July 7, 2010, Genzyme Corporation filed a
complaint against the Company in the United States District Court for the District of Massachusetts seeking unspecified damages
and equitable relief. The complaint alleged that the Company infringed U.S. Patent No. 5,143,724 by manufacturing MONOVISC in the
United States for sale outside the United States and would infringe U.S. Patent Nos. 5,143,724 and 5,399,351&nbsp;if the Company
manufactured and sold MONOVISC in the United States. On March 7, 2014, Genzyme and the Company filed a joint motion to
lift the stay in Genzyme&rsquo;s lawsuit against the Company and to dismiss with prejudice all of Genzyme&rsquo;s claims. On March
10, 2014, the District Court granted the motion to dismiss with prejudice all of Genzyme&rsquo;s claims against the Company and
the case was terminated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">We are also involved in various other legal
proceedings arising in the normal course of business.&nbsp;Although the outcomes of these other legal proceedings are inherently
difficult to predict, we do not expect the resolution of these other legal proceedings to have a material adverse effect on our
financial position, results of operations or cash flow.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif"><b>ITEM 1A.</b></td>
    <TD STYLE="width: 90%; font: 10pt Times New Roman, Times, Serif"><b>RISK FACTORS</b></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">To our knowledge there have been no material
changes to the risk factors described in &ldquo;Part I., Item 1A. Risk Factors&rdquo; in our Annual Report on Form&nbsp;10-K for
the year ended December 31, 2013.&nbsp;In addition to the other information set forth in this report, you should carefully consider
the factors discussed in &ldquo;Part&nbsp;I, Item 1A. Risk Factors&rdquo; in our Annual Report on Form&nbsp;10-K for the year ended
December 31, 2013, which could materially affect our business, financial condition or future results. The risks described in our
Annual Report on Form&nbsp;10-K are not the only risks facing our Company. Additional risks and uncertainties not currently known
to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or
operating results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 10%"><B>ITEM 5.</B></TD>
    <TD STYLE="width: 90%"><B>OTHER INFORMATION</B></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0.5in">On
November 5, 2014, our Board of Directors approved a form of indemnification agreement for our directors and authorized the
Company to enter into such an agreement with each of our directors.&nbsp; Under the terms of the agreement, consistent with
the provisions of our Articles of Incorporation, Bylaws and applicable law, the Company agrees to indemnify each director, to
the maximum extent permitted by the laws of the Commonwealth of Massachusetts, from claims and losses arising from their
service as a director.&nbsp; Subject to certain procedures outlined in the agreement, we are required to advance expenses
incurred as a result of any such proceeding as to which a director could be indemnified.&nbsp; The agreement provides
procedures for the determination of a person&rsquo;s right to receive indemnification consistent with applicable laws.&nbsp;
We anticipate that we will enter into substantially similar agreements with any new directors.&nbsp; The form of
indemnification agreement is attached hereto as Exhibit 10.1 and incorporated by reference herein.&nbsp; The foregoing
summary of the indemnification agreement is qualified in its entirety by the text of the Exhibit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 10%"><B>ITEM 6.</B></TD>
    <TD STYLE="width: 90%"><B>EXHIBITS</B></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-bottom: Black 1.1pt solid"><B>Exhibit&nbsp;No.</B></TD>
    <TD STYLE="padding-bottom: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1.1pt solid"><B>Description</B></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 82%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>*10.1</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">Form of Director Indemnification Agreement</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>(31)</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">Rule&nbsp;13a-14(a)/15d-14(a)&nbsp;Certifications</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>*31.1</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">Certification of Charles H. Sherwood, Ph.D., pursuant to Rules&nbsp;13a-15(e)&nbsp;and 15d-15(e), as adopted pursuant to Section&nbsp;302 of the Sarbanes-Oxley Act of 2002.</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>*31.2</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">Certification of Sylvia Cheung pursuant to Rules&nbsp;13a-15(e)&nbsp;and 15d-15(e), as adopted pursuant to Section&nbsp;302 of the Sarbanes-Oxley Act of 2002.</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>(32)</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">Section&nbsp;1350 Certifications</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>**32.1</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">Certification of Charles H. Sherwood, Ph.D., and Sylvia Cheung, pursuant to 18 U.S.C. Section&nbsp;1350, as adopted pursuant to Section&nbsp;906 of the Sarbanes-Oxley Act of 2002.</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>(101)</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">XBRL</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">The following materials from Anika Therapeutics, Inc.&rsquo;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2014, as filed with the SEC on November 5, 2014, formatted in XBRL (eXtensible Business Reporting Language), as follows:</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">i.</TD>
    <TD>&nbsp;</TD>
    <TD>Condensed Consolidated Balance Sheets as of September 30, 2014 (unaudited) and December 31, 2013</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">ii.</TD>
    <TD>&nbsp;</TD>
    <TD>Condensed Consolidated Statements of Operations and Comprehensive Income for the Three and Nine Months Ended
        September 30, 2014 and September 30, 2013 (unaudited)</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">iii.</TD>
    <TD>&nbsp;</TD>
    <TD>Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2014 and September
        30, 2013 (unaudited)</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">iv.</TD>
    <TD>&nbsp;</TD>
    <TD>Notes to Condensed Consolidated Financial Statements (unaudited)</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 5%">*</td>
    <TD STYLE="width: 95%">Filed herewith</td></tr>
<tr style="vertical-align: top">
    <TD>**&nbsp;</td>
    <TD>Furnished herewith.</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.55in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</td>
    <TD STYLE="width: 5%">&nbsp;</td>
    <TD STYLE="width: 45%">ANIKA THERAPEUTICS,&nbsp;INC.</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <td colspan="2">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD>Date: November 5, 2014</td>
    <TD>By:</td>
    <TD STYLE="border-bottom: Black 1.1pt solid">/s/ SYLVIA CHEUNG</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>Sylvia Cheung</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD><i>Chief Financial Officer</i></td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>(Authorized Officer and Principal Financial Officer)</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0">23</P>

<HR NOSHADE STYLE="color: Black; width: 100%; height: 4pt; margin-top: 0pt; margin-bottom: 0pt">

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>exh_101.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><B>Exhibit 10.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><FONT STYLE="font-style: normal"><B>DIRECTOR
INDEMNIFICATION AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.35in 0 0; text-align: left; text-indent: 0.5in">This
Indemnification Agreement (&ldquo;<U>Agreement</U>&rdquo;) is made as of November 5, 2014 by and between Anika Therapeutics,
Inc., a Massachusetts corporation (the &ldquo;<U>Company</U>&rdquo;), and ____________ (&ldquo;<U>Indemnitee</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">RECITALS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: left; text-indent: 0.5in">WHEREAS, the Company desires
to attract and retain the services of highly qualified individuals, such as Indemnitee, to serve the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: left; text-indent: 0.5in">WHEREAS, in order to induce
Indemnitee to provide or continue to provide services to the Company, the Company wishes to provide for the indemnification of,
and advancement of expenses to, Indemnitee to the maximum extent permitted by law;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: left; text-indent: 0.5in">WHEREAS, the Articles
of Organization (as amended and in effect on the date hereof, the &ldquo;<U>Charter</U>&rdquo;) and the Bylaws (as amended and
in effect on the date hereof, the &ldquo;<U>Bylaws</U>&rdquo; and, together with the Charter, the &ldquo;<U>Organizational Documents</U>&rdquo;)
of the Company require indemnification of the directors, officers and employees of the Company, and Indemnitee may also be entitled
to indemnification pursuant to the Massachusetts Business Corporation Act (the &ldquo;<U>MBCA</U>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: left; text-indent: 0.5in">WHEREAS, the Bylaws
and the MBCA expressly provide that the indemnification provisions set forth therein are not exclusive, and thereby contemplate
that contracts may be entered into between the Company and members of the board of directors, officers and other persons with respect
to indemnification;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: left; text-indent: 0.5in">WHEREAS, the Board
of Directors of the Company (the &ldquo;<U>Board</U>&rdquo;) has determined that the increased difficulty in attracting and retaining
highly qualified persons such as Indemnitee is detrimental to the best interests of the Company&rsquo;s shareholders;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: left; text-indent: 0.5in">WHEREAS, it is reasonable,
prudent and necessary for the Company contractually to obligate itself to indemnify, and to advance expenses on behalf of, such
persons to the fullest extent permitted by applicable law, regardless of any amendment or revocation of the Organizational Documents
so that they will serve or continue to serve the Company free from undue concern that they will not be so indemnified; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: left; text-indent: 0.45in">WHEREAS, this Agreement
is a supplement to and in furtherance of the indemnification provided in the Organizational Documents and any resolutions adopted
pursuant thereto, and shall not be deemed a substitute therefor, nor to diminish or abrogate any rights of Indemnitee thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: left; text-indent: 0.5in">NOW, THEREFORE, in
consideration of the premises and the covenants contained herein, the Company and Indemnitee do hereby covenant and agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: left; text-indent: 0.5in">Section 1. <U>Services
to the Company</U>. Indemnitee agrees to serve as a director of the Company. Indemnitee may at any time and for any reason resign
from such position (subject to any other contractual obligation or any obligation imposed by law), in which event the Company shall
have no obligation under this Agreement to continue Indemnitee in such position. This Agreement shall not be deemed an employment
contract between the Company (or any of its subsidiaries or any Enterprise) and Indemnitee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0 0.5in; text-align: left">Section 2. <U>Definitions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0 0.5in; text-align: left">As used in this Agreement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in">(a)&#9;&ldquo;<U>Change in Control</U>&rdquo;
shall mean (i) the sale of all or substantially all of the assets of the Company on a consolidated basis to an unrelated person
or entity, (ii) a merger, reorganization or consolidation pursuant to which the holders of the Company&rsquo;s outstanding voting
power and outstanding stock immediately prior to such transaction do not own a majority of the outstanding voting power and outstanding
stock or other equity interests of the resulting or successor entity (or its ultimate parent, if applicable) immediately upon completion
of such transaction, (iii) the sale of all of the capital stock of the Company to an unrelated person, entity or group thereof
acting in concert, or (iv) any other transaction in which the owners of the Company&rsquo;s outstanding voting power immediately
prior to such transaction do not own at least a majority of the outstanding voting power of the Company or any successor entity
immediately upon completion of the transaction other than as a result of the acquisition of securities directly from the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in">(b)&#9; &ldquo;<U>Corporate
Status</U>&rdquo; describes the status of a person as a current or former director of the Company or current or former director,
manager, partner, officer, employee, agent or trustee of any other Enterprise which such person is or was serving at the request
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in">(c)&#9;&ldquo;<U>Enforcement
Expenses</U>&rdquo; shall include all reasonable attorneys&rsquo; fees, court costs, transcript costs, fees of experts, travel
expenses, duplicating costs, printing and binding costs, telephone charges, postage, delivery service fees, and all other out-of-pocket
disbursements or expenses of the types customarily incurred in connection with an action to enforce indemnification or advancement
rights, or an appeal from such action. Expenses, however, shall not include fees, salaries, wages or benefits owed to Indemnitee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in">(d)&#9;&ldquo;<U>Enterprise</U>&rdquo;
shall mean any corporation (other than the Company), partnership, joint venture, trust, employee benefit plan, limited liability
company, or other legal entity of which Indemnitee is or was serving at the request of the Company as a director, manager, partner,
officer, employee, agent or trustee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in">(e)&#9;&ldquo;<U>Expenses</U>&rdquo;
shall include all reasonable attorneys&rsquo; fees, court costs, transcript costs, fees of experts, travel expenses, duplicating
costs, printing and binding costs, telephone charges, postage, delivery service fees, and all other out-of-pocket disbursements
or expenses of the types customarily incurred in connection with prosecuting, defending, preparing to prosecute or defend, investigating,
being or preparing to be a witness in, or otherwise participating in, a Proceeding or an appeal resulting from a Proceeding. Expenses,
however, shall not include amounts paid in settlement by Indemnitee, the amount of judgments or fines against Indemnitee or compensatory,
service or similar fees, salaries, wages or benefits owed to Indemnitee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in">(f)&#9;&ldquo;<U>Special Legal
Counsel</U>&rdquo; means a law firm, or a partner (or, if applicable, member or shareholder) of such a law firm, that is experienced
in matters of Massachusetts corporation law and neither presently is, nor in the past has been, retained to represent: (i) the
Company, any subsidiary of the Company, any Enterprise or Indemnitee in any matter material to any such party; or (ii) any other
party to the Proceeding giving rise to a claim for indemnification hereunder. Notwithstanding the foregoing, the term &ldquo;Special
Legal Counsel&rdquo; shall not include any person who, under the applicable standards of professional conduct then prevailing,
would have a conflict of interest in representing either the Company or Indemnitee in an action to determine Indemnitee&rsquo;s
rights under this Agreement. The Company agrees to pay the reasonable fees and expenses of the Special Legal Counsel referred to
above and to fully indemnify such counsel against any and all expenses, claims, liabilities and damages arising out of or relating
to this Agreement or its engagement pursuant hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in">(g)&#9;The term &ldquo;<U>Proceeding</U>&rdquo;
shall include any threatened, pending or completed action, suit, alternate dispute resolution mechanism, or proceeding, whether
brought in the right of the Company or otherwise and whether of a civil, criminal, administrative, arbitrative or investigative
nature, and whether formal or informal, in which Indemnitee was, is or will be involved as a party or otherwise, by reason of the
fact that Indemnitee is or was a director of the Company or is or was serving at the request of the Company as a director, manager,
partner, officer, employee, agent or trustee of any Enterprise or by reason of any action taken by Indemnitee or of any action
taken on his or her part while acting as a director of the Company or while serving at the request of the Company as a director,
manager, partner, officer, employee, agent or trustee of any Enterprise, in each case whether or not serving in such capacity at
the time any liability or expense is incurred for which indemnification, reimbursement or advancement of expenses can be provided
under this Agreement; <U>provided</U>, <U>however</U>, that the term &ldquo;Proceeding&rdquo; shall not include any action, suit
or arbitration, or part thereof, initiated by Indemnitee to enforce Indemnitee&rsquo;s rights under this Agreement as provided
for in Section 12(a) of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">Section 3.&#9;<U>Indemnity
in Third-Party Proceedings</U>. The Company shall indemnify Indemnitee to the extent set forth in this Section 3 if Indemnitee
is, or is threatened to be made, a party to or a participant in any Proceeding, other than a Proceeding by or in the right of the
Company to procure a judgment in its favor. Pursuant to this Section 3, Indemnitee shall be indemnified against all Expenses, judgments,
fines, penalties, excise taxes, and amounts paid in settlement actually and reasonably incurred by Indemnitee or on his or her
behalf in connection with such Proceeding or any claim, issue or matter therein, if (A) Indemnitee conducted himself or herself
in good faith and in a manner he or she reasonably believed to be in the best interests of the Company, or at least not opposed
to the best interests of the Company, and, in the case of a criminal proceeding, had no reasonable cause to believe that his or
her conduct was unlawful, or (B) Indemnitee engaged in conduct for which he or she shall not be liable under a provision of the
Charter as authorized by Section 2.02(b)(4) of the MBCA (or any successor provision). The conduct of Indemnitee with respect to
an employee benefit plan for a purpose Indemnitee reasonably believed to be in the best interests of the participants in, and the
beneficiaries of, the plan is conduct that satisfies clause (A) of the preceding sentence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">Section 4.&#9;<U>Indemnity
in Proceedings by or in the Right of the Company</U>. The Company shall indemnify Indemnitee to the extent set forth in this Section
4 if Indemnitee is, or is threatened to be made, a party to or a participant in any Proceeding by or in the right of the Company
to procure a judgment in its favor. Pursuant to this Section 4, Indemnitee shall be indemnified against all Expenses, judgments,
fines, penalties, excise taxes, and amounts paid in settlement actually and reasonably incurred by Indemnitee or on his or her
behalf in connection with such Proceeding or any claim, issue or matter therein, if (A) Indemnitee conducted himself in good faith
and in a manner he or she reasonably believed to be in the best interests of the Company, or at least not opposed to the best interests
of the Company, or (B) Indemnitee engaged in conduct for which he or she shall not be liable under a provision of the Charter as
authorized by Section 2.02(b)(4) of the MBCA (or any successor provision). The conduct of Indemnitee with respect to an employee
benefit plan for a purpose Indemnitee reasonably believed to be in the best interests of the participants in, and the beneficiaries
of, the plan is conduct that satisfies clause (A) of the preceding sentence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">Section 5.&#9;<U>Indemnification
for Expenses of a Party Who is Successful</U>. Notwithstanding any other provisions of this Agreement and except as provided in
Section 7, to the extent that Indemnitee is a party to or a participant in any Proceeding and is wholly successful, on the merits
or otherwise, in such Proceeding, the Company shall indemnify Indemnitee against all Expenses actually and reasonably incurred
by him or her in connection therewith. If in such Proceeding Indemnitee is successful, on the merits or otherwise, as to one or
more but less than all claims, issues or matters in such Proceeding, the Company shall indemnify Indemnitee against all Expenses
actually and reasonably incurred by Indemnitee or on his or her behalf in connection with each successfully resolved claim, issue
or matter to the extent permitted by law. For purposes of this Section 5 and without limitation, the termination of any claim,
issue or matter in such a Proceeding by dismissal, with or without prejudice, shall be deemed to be a successful result as to such
claim, issue or matter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">Section 6.&#9;<U>Reimbursement
for Expenses of a Witness or in Response to a Subpoena</U>. Notwithstanding any other provision of this Agreement, to the extent
that Indemnitee, by reason of his or her Corporate Status, (i) is a witness in any Proceeding to which Indemnitee is not a party
and is not threatened to be made a party or (ii) receives a subpoena with respect to any Proceeding to which Indemnitee is not
a party and is not threatened to be made a party, the Company shall reimburse Indemnitee for all Expenses actually and reasonably
incurred by him or her or on his or her behalf in connection therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Section 7.&#9;<U>Exclusions</U>.
Notwithstanding any provision in this Agreement to the contrary, the Company shall not be obligated under this Agreement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">(a)&#9;to indemnify
for amounts otherwise indemnifiable hereunder (or for which advancement is provided hereunder) if and to the extent that Indemnitee
has otherwise actually received such amounts under any insurance policy, contract, agreement or otherwise;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">(b)&#9;to indemnify
for an accounting of profits made from the purchase and sale (or sale and purchase) by Indemnitee of securities of the Company
within the meaning of Section 16(b) of the Securities Exchange Act of 1934, as amended, or similar provisions of state statutory
law or common law;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">(c)&#9;to indemnify
with respect to any Proceeding, or part thereof, brought by Indemnitee against the Company, any legal entity which it controls,
any director or officer thereof or any third party, unless (i) the Board has consented to the initiation of such Proceeding or
part thereof and (ii) the Company provides the indemnification, in its sole discretion, pursuant to the powers vested in the Company
under applicable law; <U>provided</U>, <U>however</U>, that this Section 7(c) shall not apply to (A) counterclaims or affirmative
defenses asserted by Indemnitee in an action brought against Indemnitee or (B) any action brought by Indemnitee for indemnification
or advancement from the Company under this Agreement or under any directors&rsquo; and officers&rsquo; liability insurance policies
maintained by the Company in the suit for which indemnification or advancement is being sought as described in Section 12; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">(d)&#9;to provide
any indemnification or advancement of expenses that is prohibited by applicable law (as such law exists at the time payment would
otherwise be required pursuant to this Agreement).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 443.7pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Section 8.&#9;<U>Advancement
of Expenses</U>. Subject to Section 9(b), the Company shall advance, to the extent not prohibited by law, the Expenses incurred
by Indemnitee in connection with any Proceeding, and such advancement shall be made within thirty (30) days after the receipt by
the Company of a statement or statements requesting such advances (which shall include invoices received by Indemnitee in connection
with such Expenses but, in the case of invoices in connection with legal services, any references to legal work performed or to
expenditures made that would cause Indemnitee to waive any privilege accorded by applicable law need not be included with the invoice)
from time to time, whether prior to or after final disposition of any Proceeding. Advances shall be unsecured and interest free.
Advances shall be made without regard to Indemnitee&rsquo;s ability to repay the expenses and without regard to Indemnitee&rsquo;s
ultimate entitlement to indemnification under the other provisions of this Agreement. Indemnitee shall qualify for advances upon
the execution and delivery to the Company of an undertaking in the form attached hereto as <U>Exhibit A</U>. The right to advances
under this Section 8 shall in all events continue until final disposition of any Proceeding, including any appeal therein. Nothing
in this Section 8 shall limit Indemnitee&rsquo;s right to advancement pursuant to Section 12(e) of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 37.8pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 37.8pt; text-align: left">Section 9.&#9;<U>Procedure for Notification
and Defense of Claim</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.15in 0 0; text-align: left; text-indent: 1in">(a)&#9;To obtain indemnification
under this Agreement, Indemnitee shall submit to the Company a written request therefor specifying the basis for the claim, the
amounts for which Indemnitee is seeking payment under this Agreement, and all documentation related thereto as reasonably requested
by the Company (a &ldquo;<U>Written Indemnification Request</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in">(b)&#9;In the event that the
Company shall be obligated hereunder to provide indemnification for or make any advancement of Expenses with respect to any Proceeding,
the Company shall be entitled to assume the defense of such Proceeding, or any claim, issue or matter therein, with counsel approved
by Indemnitee (which approval shall not be unreasonably withheld or delayed) upon the delivery to Indemnitee of written notice
of the Company&rsquo;s election to do so. After delivery of such notice, approval of such counsel by Indemnitee and the retention
of such counsel by the Company, the Company will not be liable to Indemnitee under this Agreement for any fees or expenses of separate
counsel subsequently employed by or on behalf of Indemnitee with respect to the same Proceeding; <U>provided</U> that (i) Indemnitee
shall have the right to employ separate counsel in any such Proceeding at Indemnitee&rsquo;s expense and (ii) if (A) the employment
of separate counsel by Indemnitee has been previously authorized by the Company, (B) Indemnitee shall have reasonably concluded
that there may be a conflict of interest between the Company and Indemnitee in the conduct of such defense, or (C) the Company
shall not continue to retain such counsel to defend such Proceeding, then the reasonable fees and expenses actually and reasonably
incurred by Indemnitee with respect to his or her separate counsel shall be Expenses hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in">(c) &#9;In the event that the
Company does not assume the defense in a Proceeding pursuant to paragraph (b) above, then the Company will be entitled to participate
in the Proceeding at its own expense.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in">(d) &#9;The Company shall not
be liable to indemnify Indemnitee under this Agreement for any amounts paid in settlement of any Proceeding effected without its
prior written consent (which consent shall not be unreasonably withheld or delayed). The Company shall not, without the prior written
consent of Indemnitee (which consent shall not be unreasonably withheld or delayed), enter into any settlement which (i) includes
an admission of fault of Indemnitee, any non-monetary remedy imposed on Indemnitee or any monetary damages for which Indemnitee
is not wholly and actually indemnified hereunder or (ii) with respect to any Proceeding with respect to which Indemnitee may be
or is made a party or may be otherwise entitled to seek indemnification hereunder, does not include the full release of Indemnitee
from all liability in respect of such Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.15in 0 0; text-align: left; text-indent: 0.5in">Section 10.&#9;<U>Procedure
Upon Application for Indemnification</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: left; text-indent: 1in">(a)&#9;Upon written request
by Indemnitee for indemnification pursuant to Section 9(a), a determination, if such determination is required by applicable law,
with respect to the permissibility thereof shall be made in the specific case: (i) if a Change in Control shall have occurred,
by Special Legal Counsel in a written opinion to the Board, or (ii) if a Change in Control shall not have occurred, by the Company
in accordance with applicable law. In the case that such determination is made by Special Legal Counsel, a copy of Special Legal
Counsel&rsquo;s written opinion shall be delivered to Indemnitee and, if it is so determined that Indemnitee is entitled to indemnification,
payment to Indemnitee shall be made within thirty (30) days after such determination. Indemnitee shall cooperate with the Special
Legal Counsel or the Company, as applicable, in making such determination with respect to the permissibility of indemnification
of Indemnitee, including providing to such counsel or the Company, upon reasonable advance request, any documentation or information
which is not privileged or otherwise protected from disclosure and which is reasonably available to Indemnitee and reasonably necessary
to such determination. Any out-of-pocket costs or expenses (including reasonable attorneys&rsquo; fees and disbursements) actually
and reasonably incurred by Indemnitee in so cooperating with the Special Legal Counsel or the Company shall be borne by the Company
(irrespective of the determination as to the permissibility of indemnification) and the Company hereby indemnifies and agrees to
hold Indemnitee harmless therefrom.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: left; text-indent: 1in">(b)&#9;If the determination
of permissibility of indemnification is to be made by Special Legal Counsel pursuant to Section 10(a), the Special Legal Counsel
shall be selected by the Company in accordance with applicable law. The Indemnitee may, within ten (10) days after written notice
of such selection, deliver to the Company a written objection to such selection; <U>provided</U>, <U>however</U>, that such objection
may be asserted only on the ground that the Special Legal Counsel so selected does not meet the requirements of &ldquo;Special
Legal Counsel&rdquo; as defined in Section 2 of this Agreement, and the objection shall set forth with particularity the factual
basis of such assertion. Absent a proper and timely objection, the person so selected shall act as Special Legal Counsel. If such
written objection is so made and substantiated, the Special Legal Counsel so selected may not serve as Special Legal Counsel unless
and until such objection is withdrawn or the Massachusetts Court (as defined in Section 22) has determined that such objection
is without merit. If, within twenty (20) days after the later of (i) submission by Indemnitee of a Written Indemnification Request,
and (ii) the final disposition of the Proceeding, including any appeal therein, no Special Legal Counsel shall have been selected
without objection, Indemnitee may petition the Massachusetts Court for resolution of any objection which shall have been made by
Indemnitee to the selection of Special Legal Counsel and/or for the appointment as Special Legal Counsel of a person selected by
the court or by such other person as the court shall designate. The person with respect to whom all objections are so resolved
or the person so appointed shall act as Special Legal Counsel under Section 10(a) hereof. Upon the due commencement of any judicial
proceeding or arbitration pursuant to Section 12(a) of this Agreement, Special Legal Counsel shall be discharged and relieved of
any further responsibility in such capacity (subject to the applicable standards of professional conduct then prevailing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 37.8pt; text-align: left">Section 11.&#9;<U>Presumptions and
Effect of Certain Proceedings</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.15in 0 0; text-align: left; text-indent: 1in">(a)&#9;To the extent
permitted by applicable law, in making a determination with respect to the permissibility of indemnification hereunder, it shall
be presumed that Indemnitee is entitled to indemnification under this Agreement if Indemnitee has submitted a Written Indemnification
Request in accordance with Section 9(a) of this Agreement, and the Company shall have the burden of proof to overcome that presumption
in connection with the making of any determination contrary to that presumption. Neither (i) the failure of the Company or of Special
Legal Counsel to have made a determination prior to the commencement of any action pursuant to this Agreement that indemnification
is proper in the circumstances because Indemnitee has met the applicable standard of conduct, nor (ii) an actual determination
by the Company or by Special Legal Counsel that Indemnitee has not met such applicable standard of conduct, shall be a defense
to the action or create a presumption that Indemnitee has not met the applicable standard of conduct.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: left; text-indent: 1in">(b)&#9;The termination of any
Proceeding or of any claim, issue or matter therein, by judgment, order, settlement or conviction, or upon a plea of <I>nolo contendere</I>
or its equivalent, shall not (except as otherwise expressly provided in this Agreement) of itself adversely affect the right of
Indemnitee to indemnification or create a presumption that Indemnitee did not meet the applicable standard of conduct for indemnification
under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: left; text-indent: 1in">(c)&#9;The knowledge
and/or actions, or failure to act, of any director, manager, partner, officer, employee, agent or trustee of the Company, any subsidiary
of the Company, or any Enterprise shall not be imputed to Indemnitee for purposes of determining the right to indemnification under
this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0 0.5in; text-align: left">Section 12.&#9;<U>Remedies of Indemnitee</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: left; text-indent: 1in">(a)&#9;Subject to Section
12(f), in the event that (i) a determination is made pursuant to Section 10 of this Agreement that Indemnitee is not entitled to
indemnification under this Agreement, (ii) advancement of Expenses is not timely made pursuant to Section 8 of this Agreement,
(iii) no determination of entitlement to indemnification shall have been made pursuant to Section 10(a) of this Agreement within
sixty (60) days after receipt by the Company of the Written Indemnification Request for which a determination of permissibility
thereof is to be made other than by Special Legal Counsel, (iv) payment of indemnification or reimbursement of expenses is not
made pursuant to Section 5 or 6 or the last sentence of Section 10(a) of this Agreement within thirty (30) days after receipt by
the Company of a Written Indemnification Request therefor (which shall include any invoices received by Indemnitee but, in the
case of invoices in connection with legal services, any references to legal work performed or to expenditures made that would cause
Indemnitee to waive any privilege accorded by applicable law need not be included with the invoice) or (v) payment of indemnification
pursuant to Section 3 or 4 of this Agreement is not made within thirty (30) days after a determination has been made that Indemnitee
is entitled to indemnification, Indemnitee shall be entitled to an adjudication by the Massachusetts Court of his or her entitlement
to such indemnification or advancement. Alternatively, Indemnitee, at his or her option, may seek an award in arbitration to be
conducted by a single arbitrator pursuant to the Commercial Arbitration Rules of the American Arbitration Association. Indemnitee
shall commence such proceeding seeking an adjudication or an award in arbitration within one hundred and eighty (180) days following
the date on which Indemnitee first has the right to commence such proceeding pursuant to this Section 12(a); <U>provided</U>, <U>however</U>,
that the foregoing time limitation shall not apply in respect of a proceeding brought by Indemnitee to enforce his or her rights
under Section 5 of this Agreement. The Company shall not oppose Indemnitee&rsquo;s right to seek any such adjudication or award
in arbitration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in">(b)&#9;In the event that a determination
shall have been made pursuant to Section 10(a) of this Agreement that Indemnitee is not entitled to indemnification, any judicial
proceeding or arbitration commenced pursuant to this Section 12 shall be conducted in all respects as a <I>de novo</I> trial, or
arbitration, on the merits and Indemnitee shall not be prejudiced by reason of that adverse determination. In any judicial proceeding
or arbitration commenced pursuant to this Section 12, the Company shall have the burden of proving Indemnitee is not entitled to
indemnification or advancement, as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in">(c) &#9;If a determination shall
have been made pursuant to Section 10(a) of this Agreement that Indemnitee is entitled to indemnification, the Company shall be
bound by such determination in any judicial proceeding or arbitration commenced pursuant to this Section 12, absent (i) a misstatement
by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee&rsquo;s statement not materially
misleading, in connection with the request for indemnification, or (ii) a prohibition of such indemnification under applicable
law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in">(d)&#9;The Company shall be
precluded from asserting in any judicial proceeding or arbitration commenced pursuant to this Section 12 that the procedures and
presumptions of this Agreement are not valid, binding and enforceable and shall stipulate in any such court or before any such
arbitrator that the Company is bound by all the provisions of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in">(e)&#9;The Company shall indemnify
Indemnitee to the fullest extent permitted by law against any and all Enforcement Expenses and, if requested by Indemnitee, shall
(within thirty (30) days after receipt by the Company of a Written Indemnification Request therefor) advance, to the extent not
prohibited by law, such Enforcement Expenses to Indemnitee, which are incurred by Indemnitee in connection with any action brought
by Indemnitee for indemnification or advancement from the Company under this Agreement or under any directors&rsquo; and officers&rsquo;
liability insurance policies maintained by the Company, regardless of whether Indemnitee ultimately is determined to be entitled
to such indemnification, advancement or insurance recovery, as the case may be, in the suit for which indemnification or advancement
is being sought. Such Written Indemnification Request for advancement shall include invoices received by Indemnitee in connection
with such Enforcement Expenses but, in the case of invoices in connection with legal services, any references to legal work performed
or to expenditures made that would cause Indemnitee to waive any privilege accorded by applicable law need not be included with
the invoice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.15in 0 0; text-align: left; text-indent: 1in">(f)&#9;Notwithstanding
anything in this Agreement to the contrary, no determination as to entitlement to indemnification under this Agreement shall be
required to be made prior to the final disposition of the Proceeding, including any appeal therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 37.8pt; text-align: left">Section 13.&#9;<U>Non-exclusivity;
Survival of Rights; Insurance; Subrogation</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in">(a)&#9;The rights of indemnification
and to receive advancement as provided by this Agreement shall not be deemed exclusive of any other rights to which Indemnitee
may at any time be entitled under applicable law, the Organizational Documents, any agreement, a vote of shareholders or a resolution
of directors, or otherwise. No amendment, alteration or repeal of this Agreement or of any provision hereof shall limit or restrict
any right of Indemnitee under this Agreement in respect of any action taken or omitted by such Indemnitee in his or her Corporate
Status prior to such amendment, alteration or repeal. To the extent that a change in Massachusetts law, whether by statute or judicial
decision, permits greater indemnification or advancement than would be afforded currently under the Organizational Documents and
this Agreement, it is the intent of the parties hereto that Indemnitee shall enjoy by this Agreement the greater benefits so afforded
by such change. No right or remedy herein conferred is intended to be exclusive of any other right or remedy, and every other right
and remedy shall be cumulative and in addition to every other right and remedy given hereunder or now or hereafter existing at
law or in equity or otherwise. The assertion or employment of any right or remedy hereunder, or otherwise, shall not prevent the
concurrent assertion or employment of any other right or remedy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.15in 0 0; text-align: left; text-indent: 1in">(b)&#9;To the extent
that the Company maintains an insurance policy or policies providing liability insurance for directors, managers, partners, officers,
employees, agents or trustees of the Company or of any other Enterprise, Indemnitee shall be covered by such policy or policies
in accordance with its or their terms to the maximum extent of the coverage available for any such director, manager, partner,
officer, employee, agent or trustee under such policy or policies. If, at the time of the receipt of a notice of a claim pursuant
to the terms hereof, the Company has director and officer liability insurance in effect, the Company shall give prompt notice of
the commencement of such proceeding to the insurers in accordance with the procedures set forth in the respective policies. The
Company shall thereafter take all necessary or desirable action to cause such insurers to pay, on behalf of Indemnitee, all amounts
payable as a result of such proceeding in accordance with the terms of such policies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.15in 0 0; text-align: left; text-indent: 1in">(c)&#9;In the event
of any payment under this Agreement, the Company shall be subrogated to the extent of such payment to all of the rights of recovery
of Indemnitee, who shall execute all papers required and take all action necessary to secure such rights, including execution of
such documents as are necessary to enable the Company to bring suit to enforce such rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.15in 0 0; text-align: left; text-indent: 1in">(d)&#9;The Company&rsquo;s
obligation to provide indemnification or advancement hereunder to Indemnitee who is or was serving at the request of the Company
as a director, manager, partner, officer, employee, agent or trustee of any other Enterprise shall be reduced by any amount Indemnitee
has actually received as indemnification or advancement from such other Enterprise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.15in 0 0; text-align: left; text-indent: 0.5in">Section 14.&#9; <U>Duration
of Agreement</U>. This Agreement shall continue until and terminate upon the later of: (a) ten (10) years after the date that Indemnitee
shall have ceased to serve as a director of the Company or (b) one (1) year after the final termination of any Proceeding, including
any appeal, then pending in respect of which Indemnitee is granted rights of indemnification or advancement hereunder and of any
proceeding commenced by Indemnitee pursuant to Section 12 of this Agreement relating thereto. This Agreement shall be binding upon
the Company and its successors and assigns and shall inure to the benefit of Indemnitee and his or her heirs, executors and administrators.
The Company shall require and cause any successor (whether direct or indirect by purchase, merger, consolidation or otherwise)
to all, substantially all or a substantial part, of the business and/or assets of the Company, by written agreement in form and
substance satisfactory to Indemnitee, expressly to assume and agree to perform this Agreement in the same manner and to the same
extent that the Company would be required to perform if no such succession had taken place.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.15in 0 0; text-align: left; text-indent: 0.5in">Section 15.&#9;<U>Severability</U>.
If any provision or provisions of this Agreement shall be held to be invalid, illegal or unenforceable for any reason whatsoever:
(a) the validity, legality and enforceability of the remaining provisions of this Agreement (including, without limitation, each
portion of any section of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that is not
itself invalid, illegal or unenforceable) shall not in any way be affected or impaired thereby and shall remain enforceable to
the fullest extent permitted by law; (b) such provision or provisions shall be deemed reformed to the extent necessary to conform
to applicable law and to give the maximum effect to the intent of the parties hereto; and (c) to the fullest extent possible, the
provisions of this Agreement (including, without limitation, each portion of any section of this Agreement containing any such
provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall be construed
so as to give effect to the intent manifested thereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: left">Section 16.&#9;<U>Enforcement</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in">(a)&#9;The Company expressly
confirms and agrees that it has entered into this Agreement and assumed the obligations imposed on it hereby in order to induce
Indemnitee to serve, or continue to serve, as a director of the Company, and the Company acknowledges that Indemnitee is relying
upon this Agreement in serving as a director of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.15in 0 0; text-align: left; text-indent: 1in">(b)&#9;This Agreement
constitutes the entire agreement between the parties hereto with respect to the subject matter hereof and supersedes all prior
agreements and understandings, oral, written and implied, between the parties hereto with respect to the subject matter hereof;
<U>provided</U>, <U>however</U>, that this Agreement is a supplement to and in furtherance of the Organizational Documents and
applicable law, and shall not be deemed a substitute therefor, nor to diminish or abrogate any rights of Indemnitee thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.15in 0 0; text-align: left; text-indent: 0.5in">Section 17.&#9;<U>Modification
and Waiver</U>. No supplement, modification or amendment, or waiver of any provision, of this Agreement shall be binding unless
executed in writing by the parties thereto. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute
a waiver of any other provisions of this Agreement nor shall any waiver constitute a continuing waiver. No supplement, modification
or amendment of this Agreement or of any provision hereof shall limit or restrict any right of Indemnitee under this Agreement
in respect of any action taken or omitted by such Indemnitee prior to such supplement, modification or amendment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">Section 18.&#9;<U>Notice by
Indemnitee</U>. Indemnitee agrees promptly to notify the Company in writing upon being served with any summons, citation, subpoena,
complaint, indictment, information or other document relating to any Proceeding or matter which may be subject to indemnification,
reimbursement or advancement as provided hereunder. The failure of Indemnitee to so notify the Company shall not relieve the Company
of any obligation which it may have to Indemnitee under this Agreement or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">Section 19.&#9;<U>Notices</U>.
All notices, requests, demands and other communications under this Agreement shall be in writing and shall be deemed to have been
duly given if (i) delivered by hand and receipted for by the party to whom said notice or other communication shall have been directed,
(ii) mailed by certified or registered mail with postage prepaid, on the third (3<SUP>rd</SUP>) business day after the date on
which it is so mailed, (iii) mailed by reputable overnight courier and receipted for by the party to whom said notice or other
communication shall have been directed or (iv) sent by facsimile or e-mail transmission, with receipt of oral confirmation that
such transmission has been received:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in">(a)&#9;If to Indemnitee, at
such address as Indemnitee shall provide to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: left">(b)&#9;If to the Company to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 2.25in 0 1.5in; text-align: left">Anika Therapeutics, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 2.25in 0 1.5in; text-align: left">32 Wiggins Avenue</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 2.25in 0 1.5in; text-align: left">Bedford, Massachusetts 01730</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 135pt 0 1.5in; text-align: left">Attention: Chief Financial Officer<BR>
Fax:&#9;(781) 305-9720<BR>
E-Mail:&#9;scheung@anikatherapeutics.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">or to any other address as may have been furnished
to Indemnitee by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: left; text-indent: 0.5in">Section 20.&#9;<U>Contribution</U>.
To the fullest extent permissible under applicable law, if the indemnification provided for in this Agreement is unavailable to
Indemnitee for any reason whatsoever, the Company, in lieu of indemnifying Indemnitee, shall contribute to the amount incurred
by Indemnitee, whether for judgments, fines, penalties, excise taxes, amounts paid or to be paid in settlement and/or for Expenses,
in connection with any Proceeding in such proportion as is deemed fair and reasonable in light of all of the circumstances in order
to reflect (i) the relative benefits received by the Company and Indemnitee in connection with the event(s) and/or transaction(s)
giving rise to such Proceeding; and/or (ii) the relative fault of the Company (and its directors, officers, employees and agents)
and Indemnitee in connection with such event(s) and/or transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: left; text-indent: 0.5in">Section 21.&#9;<U>Internal
Revenue Code Section 409A</U>. The Company intends for this Agreement to comply with the Indemnification exception under Section
1.409A-1(b)(10) of the regulations promulgated under the Internal Revenue Code of 1986, as amended (the &ldquo;<U>Code</U>&rdquo;),
which provides that indemnification of, or the purchase of an insurance policy providing for payments of, all or part of the expenses
incurred or damages paid or payable by Indemnitee with respect to a bona fide claim against Indemnitee or the Company do not provide
for a deferral of compensation, subject to Section 409A of the Code, where such claim is based on actions or failures to act by
Indemnitee in his capacity as a service provider of the Company. The parties intend that this Agreement be interpreted and construed
with such intent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Courier10 BT; margin: 0pt 0 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Section
22.&#9;<U>Applicable Law and Consent to Jurisdiction</U>. This Agreement and the legal relations between the parties shall be governed
by, and construed and enforced in accordance with, the laws of the Commonwealth of Massachusetts, without regard to its conflict
of laws rules. Except with respect to any arbitration commenced by Indemnitee pursuant to Section 12(a) of this Agreement, the
Company and Indemnitee hereby irrevocably and unconditionally (i) agree that any action or proceeding arising out of or in connection
with this Agreement shall be brought only in the Business Litigation Session of the Massachusetts Superior Court</FONT><FONT STYLE="font: 10pt Arial, Helvetica, Sans-Serif">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">(the &ldquo;<U>Massachusetts Court</U>&rdquo;), and not in any
other state or federal court in the United States of America or any court in any other country, (ii) consent to submit to the exclusive
jurisdiction of the Massachusetts Court for purposes of any action or proceeding arising out of or in connection with this Agreement,
(iii) consent to service of process at the address set forth in Section 19 of this Agreement with the same legal force and validity
as if served upon such party personally within the Commonwealth of Massachusetts, (iv) waive any objection to the laying of venue
of any such action or proceeding in the Massachusetts Court, and (v) waive, and agree not to plead or to make, any claim that any
such action or proceeding brought in the Massachusetts Court has been brought in an improper or inconvenient forum.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: left; text-indent: 0.5in">Section 23.&#9;<U>Headings</U>.
The headings of the paragraphs of this Agreement are inserted for convenience only and shall not be deemed to constitute part of
this Agreement or to affect the construction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: left; text-indent: 0.5in">Section 24.&#9;<U>Identical
Counterparts</U>. This Agreement may be executed in one or more counterparts, each of which shall for all purposes be deemed to
be an original but all of which together shall constitute one and the same Agreement. Only one such counterpart signed by the party
against whom enforceability is sought needs to be produced to evidence the existence of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.15in 0 0; text-align: left; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.15in 0 0; text-align: center">[Remainder of Page Intentionally Left
Blank]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.15in 0 0; text-align: left; text-indent: 0.5in">IN WITNESS WHEREOF,
the parties have caused this Agreement to be signed as of the day and year first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">ANIKA THERAPEUTICS, INC.</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 45%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Name:</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title:</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>[Name of Indemnitee]</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Exhibit A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>Form of Undertaking</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">[Date]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 2.25in 0 0; text-align: justify">Anika Therapeutics, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 2.25in 0 0; text-align: left">32 Wiggins Avenue</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 2.25in 0 0; text-align: left">Bedford, Massachusetts 01730</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 2.25in 0 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Re: &#9;<U>Request for Advancement of Expenses</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Reference is made to the Indemnification Agreement (the &ldquo;<U>Agreement</U>&rdquo;)
by and between Anika Therapeutics, Inc. (the &ldquo;<U>Company</U>&rdquo;) and the undersigned, ________ (&ldquo;<U>Indemnitee</U>&rdquo;).
Capitalized terms not defined herein shall have those meanings as set forth in the Agreement. Pursuant to Section 8 of the Agreement,
Indemnitee hereby requests advancement of Expenses incurred as a result of Indemnitee being, or being threatened to be made, a
party in the following Proceeding(s): _________________________________.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">In accordance with Section 8 of the Agreement, Indemnitee hereby:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(1)</TD><TD STYLE="text-align: justify">affirms [his/her] good faith belief that [he/she] has met the relevant standard of conduct described
in Section 8.51 of the Massachusetts Business Corporation Act (&ldquo;MBCA&rdquo;) or the Proceeding involves conduct for which
liability has been eliminated under a provision of the Company&rsquo;s articles of organization as authorized by Section 2.02(b)(4)
of the MBCA; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(2)</TD><TD>undertakes to repay the advancement of Expenses if [he/she] is not entitled to mandatory indemnification under Section 8.52
of the MBCA and it is ultimately determined that [he/she] has not met the relevant standard of conduct described in Section 8.51
of the MBCA.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Very truly yours,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">___________, Indemnitee</P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">15</P>

<P STYLE="margin: 0"></P>

<HR NOSHADE STYLE="color: Black; width: 100%; height: 4pt; margin-top: 3pt; margin-bottom: 3pt">
<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>exh_311.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Exhibit&nbsp;31.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">CERTIFICATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">I, Charles H. Sherwood, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 7%">1.</TD>
    <TD STYLE="width: 87%">I have reviewed this report on Form&nbsp;10-Q for the quarterly period ended September 30, 2014 of Anika Therapeutics,&nbsp;Inc.;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 7%">2.</TD>
    <TD STYLE="width: 87%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 7%">3.</TD>
    <TD STYLE="width: 87%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 7%">4.</TD>
    <TD STYLE="width: 87%">The registrant&rsquo;s other certifying officer(s)&nbsp;and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&nbsp;13a-15(e)&nbsp;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&nbsp;13a-15(f)&nbsp;and 15d-15(f)) for the registrant and have:</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 7%">(a)</TD>
    <TD STYLE="width: 83%">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 7%">(b)</TD>
    <TD STYLE="width: 83%">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 7%">(c)</TD>
    <TD STYLE="width: 83%">Evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 7%">(d)</TD>
    <TD STYLE="width: 83%">Disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 7%">5.</TD>
    <TD STYLE="width: 87%">The registrant&rsquo;s other certifying officer(s)&nbsp;and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 7%">(a)</TD>
    <TD STYLE="width: 83%">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information; and</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 7%">(b)</TD>
    <TD STYLE="width: 83%">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">Date: November 5, 2014</TD>
    <TD STYLE="width: 50%; border-bottom: Black 1.1pt solid">/s/ CHARLES H. SHERWOOD</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Charles H. Sherwood, Ph.D.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Chief Executive Officer</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Principal Executive Officer</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>





</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>exh_312.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Exhibit&nbsp;31.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">CERTIFICATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">I, Sylvia Cheung, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 7%">1.</TD>
    <TD STYLE="width: 87%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">I have reviewed this report on Form&nbsp;10-Q for the quarterly
        period ended September 30, 2014 of Anika Therapeutics,&nbsp;Inc.;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>2.</TD>
    <TD>Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 7%">3.</TD>
    <TD STYLE="width: 87%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 7%">4.</TD>
    <TD STYLE="width: 87%">The registrant&rsquo;s other certifying officer(s)&nbsp;and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&nbsp;13a-15(e)&nbsp;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&nbsp;13a-15(f)&nbsp;and 15d-15(f)) for the registrant and have:</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 7%">(a)</TD>
    <TD STYLE="width: 83%">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 7%">(b)</TD>
    <TD STYLE="width: 83%">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 7%">(c)</TD>
    <TD STYLE="width: 83%">Evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 7%">(d)</TD>
    <TD STYLE="width: 83%">Disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 7%">5.</TD>
    <TD STYLE="width: 87%">The registrant&rsquo;s other certifying officer(s)&nbsp;and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 7%">(a)</TD>
    <TD STYLE="width: 83%">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information; and</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 7%">(b)</TD>
    <TD STYLE="width: 83%">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;Date:&nbsp;&nbsp;November 5, 2014</TD>
    <TD STYLE="width: 50%; border-bottom: Black 1.1pt solid">/s/ SYLVIA CHEUNG</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Sylvia Cheung</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Chief Financial Officer</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Principal Financial Officer</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>exh_321.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Exhibit&nbsp;32.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Section&nbsp;906 Certification</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 49.5pt">The undersigned officers of Anika Therapeutics,&nbsp;Inc.
(the &ldquo;Company&rdquo;) hereby certify to their knowledge and in their respective capacities that the Company&rsquo;s quarterly
report on Form&nbsp;10-Q to which this certification is attached (the &ldquo;Report&rdquo;), as filed with the Securities and Exchange
Commission on the date hereof, fully complies with the requirements of Section&nbsp;13(a)&nbsp;or 15(d), as applicable, of the
Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), and that the information contained in the Report
fairly presents, in all material respects, the financial condition and results of operations of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 49.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">Date: November 5, 2014</TD>
    <TD STYLE="width: 50%; border-bottom: Black 1.1pt solid">/s/ CHARLES H. SHERWOOD</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Charles H. Sherwood, Ph.D.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Chief Executive Officer</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Principal Executive Officer</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;Date: November 5, 2014</TD>
    <TD STYLE="border-bottom: Black 1.1pt solid">/s/ SYLVIA CHEUNG</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Sylvia Cheung</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Chief Financial Officer</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Principal Financial Officer</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 49.5pt">This certification shall not be deemed &ldquo;filed&rdquo;
for any purpose, nor shall it be deemed to be incorporated by reference into any filing, under the Securities Act of 1933, as amended,
or the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>6
<FILENAME>anik-20140930.xml
<DESCRIPTION>XBRL INSTANCE FILE
<TEXT>
<XBRL>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Wed Nov 05 23:59:00 UTC 2014 -->
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2014-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:us-types="http://fasb.org/us-types/2014-01-31" xmlns:anik="http://www.anikatherapeutics.com/20140930" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:compsci="http://compsciresources.com" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance">
  <link:schemaRef xlink:type="simple" xlink:href="anik-20140930.xsd"/>
  <context id="c0_AsOf30Sep2014">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
    </entity>
    <period>
      <instant>2014-09-30</instant>
    </period>
  </context>
  <context id="c1_AsOf31Dec2013">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="c2_From1Jul2014To30Sep2014">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
    </entity>
    <period>
      <startDate>2014-07-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c3_From1Jul2013To30Sep2013">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
    </entity>
    <period>
      <startDate>2013-07-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="c4_From1Jan2014To30Sep2014">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c5_From1Jan2013To30Sep2013">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="c6_AsOf31Dec2012">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="c7_AsOf30Sep2013">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="c8_AsOf31Oct2014">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
    </entity>
    <period>
      <instant>2014-10-31</instant>
    </period>
  </context>
  <context id="c9_From1Jan2014To30Jun2014_IncreaseToCashProvidedByFinancingActivitiesMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">anik:IncreaseToCashProvidedByFinancingActivitiesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-06-30</endDate>
    </period>
  </context>
  <context id="c10_From1Jan2014To30Jun2014_DereaseToCashProvidedByOperatingActivitiesMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">anik:DereaseToCashProvidedByOperatingActivitiesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-06-30</endDate>
    </period>
  </context>
  <context id="c11_AsOf30Sep2014_USStatesAndPoliticalSubdivisionsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-09-30</instant>
    </period>
  </context>
  <context id="c12_AsOf31Dec2013_CertificatesOfDepositMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="c13_AsOf30Sep2014_MoneyMarketFundsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-09-30</instant>
    </period>
  </context>
  <context id="c14_AsOf30Sep2014_MoneyMarketFundsMember_FairValueInputsLevel2Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-09-30</instant>
    </period>
  </context>
  <context id="c15_AsOf30Sep2014_USStatesAndPoliticalSubdivisionsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-09-30</instant>
    </period>
  </context>
  <context id="c16_AsOf30Sep2014_USStatesAndPoliticalSubdivisionsMember_FairValueInputsLevel1Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-09-30</instant>
    </period>
  </context>
  <context id="c17_AsOf30Sep2014_CertificatesOfDepositMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-09-30</instant>
    </period>
  </context>
  <context id="c18_AsOf30Sep2014_CertificatesOfDepositMember_FairValueInputsLevel2Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-09-30</instant>
    </period>
  </context>
  <context id="c19_AsOf30Sep2014_FairValueInputsLevel1Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-09-30</instant>
    </period>
  </context>
  <context id="c20_AsOf30Sep2014_FairValueInputsLevel2Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-09-30</instant>
    </period>
  </context>
  <context id="c21_AsOf31Dec2013_MoneyMarketFundsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="c22_AsOf31Dec2013_MoneyMarketFundsMember_FairValueInputsLevel2Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="c23_From1Jul2014To30Sep2014_RestrictedStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-07-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c24_From1Jul2014To30Sep2014_RestrictedStockUnitsRSUMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-07-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c25_From1Jan2014To30Sep2014_RestrictedStockUnitsRSUMember_BoardOfDirectorsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">anik:BoardOfDirectorsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c26_From1Jan2014To30Sep2014_RestrictedStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c27_From1Jan2014To30Sep2014_RestrictedStockUnitsRSUMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c28_From1Apr2014To30Jun2014_StockAppreciationRightsSARSMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-04-01</startDate>
      <endDate>2014-06-30</endDate>
    </period>
  </context>
  <context id="c29_From1Jan2014To30Sep2014_MinimumMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c30_From1Jan2014To30Sep2014_MaximumMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c31_From1Jul2014To30Sep2014_MinimumMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-07-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c32_From1Jul2014To30Sep2014_MaximumMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-07-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c33_From1Jan2013To30Sep2013_MinimumMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="c34_From1Jan2013To30Sep2013_MaximumMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="c35_AsOf30Sep2014_DevelopedTechnologyRightsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-09-30</instant>
    </period>
  </context>
  <context id="c36_From1Jan2014To30Sep2014_DevelopedTechnologyRightsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c37_AsOf31Dec2013_DevelopedTechnologyRightsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="c38_From1Jan2013To31Dec2013_DevelopedTechnologyRightsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="c39_AsOf30Sep2014_InProcessResearchAndDevelopmentMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-09-30</instant>
    </period>
  </context>
  <context id="c40_From1Jan2014To30Sep2014_InProcessResearchAndDevelopmentMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c41_AsOf31Dec2013_InProcessResearchAndDevelopmentMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="c42_From1Jan2013To31Dec2013_InProcessResearchAndDevelopmentMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="c43_AsOf30Sep2014_DistributionRightsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DistributionRightsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-09-30</instant>
    </period>
  </context>
  <context id="c44_From1Jan2014To30Sep2014_DistributionRightsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DistributionRightsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c45_AsOf31Dec2013_DistributionRightsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DistributionRightsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="c46_From1Jan2013To31Dec2013_DistributionRightsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DistributionRightsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="c47_AsOf30Sep2014_PatentsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-09-30</instant>
    </period>
  </context>
  <context id="c48_From1Jan2014To30Sep2014_PatentsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c49_AsOf31Dec2013_PatentsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="c50_From1Jan2013To31Dec2013_PatentsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="c51_AsOf30Sep2014_ElevessTradeNameMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">anik:ElevessTradeNameMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-09-30</instant>
    </period>
  </context>
  <context id="c52_AsOf31Dec2013_ElevessTradeNameMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">anik:ElevessTradeNameMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="c53_From1Jan2013To31Dec2013_ElevessTradeNameMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">anik:ElevessTradeNameMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="c54_AsOf30Jun2014">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
    </entity>
    <period>
      <instant>2014-06-30</instant>
    </period>
  </context>
  <context id="c55_From1Dec2011To31Dec2011_MiltekMONOVISCAgreementMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis">anik:MiltekMONOVISCAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-12-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="c56_AsOf31Dec2011_MiltekMONOVISCAgreementMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis">anik:MiltekMONOVISCAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="c57_From1Jan2014To31Mar2014_MiltekMONOVISCAgreementMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis">anik:MiltekMONOVISCAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="c58_From1Apr2014To30Jun2014_MiltekMONOVISCAgreementMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis">anik:MiltekMONOVISCAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-04-01</startDate>
      <endDate>2014-06-30</endDate>
    </period>
  </context>
  <context id="c59_From1Jan2014To30Sep2014_MilestoneAndContractRevenueMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="anik:RevenueComponentsAxis">anik:MilestoneAndContractRevenueMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c60_From1Jan2014To30Sep2014_DomesticCountryMember_InternalRevenueServiceIRSMember_EarliestTaxYearMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:EarliestTaxYearMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c61_From1Jan2014To30Sep2014_ForeignCountryMember_MinistryOfEconomicAffairsAndFinanceItalyMember_EarliestTaxYearMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:MinistryOfEconomicAffairsAndFinanceItalyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:EarliestTaxYearMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c62_From1Jul2014To30Sep2014_OrthobiologicsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">anik:OrthobiologicsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-07-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c63_From1Jul2013To30Sep2013_OrthobiologicsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">anik:OrthobiologicsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-07-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="c64_From1Jan2014To30Sep2014_OrthobiologicsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">anik:OrthobiologicsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c65_From1Jan2013To30Sep2013_OrthobiologicsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">anik:OrthobiologicsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="c66_From1Jul2014To30Sep2014_DermalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">anik:DermalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-07-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c67_From1Jul2013To30Sep2013_DermalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">anik:DermalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-07-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="c68_From1Jan2014To30Sep2014_DermalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">anik:DermalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c69_From1Jan2013To30Sep2013_DermalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">anik:DermalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="c70_From1Jul2014To30Sep2014_SurgicalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">anik:SurgicalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-07-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c71_From1Jul2013To30Sep2013_SurgicalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">anik:SurgicalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-07-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="c72_From1Jan2014To30Sep2014_SurgicalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">anik:SurgicalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c73_From1Jan2013To30Sep2013_SurgicalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">anik:SurgicalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="c74_From1Jul2014To30Sep2014_OphthalmicMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">anik:OphthalmicMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-07-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c75_From1Jul2013To30Sep2013_OphthalmicMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">anik:OphthalmicMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-07-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="c76_From1Jan2014To30Sep2014_OphthalmicMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">anik:OphthalmicMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c77_From1Jan2013To30Sep2013_OphthalmicMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">anik:OphthalmicMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="c78_From1Jul2014To30Sep2014_VeterinaryMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">anik:VeterinaryMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-07-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c79_From1Jul2013To30Sep2013_VeterinaryMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">anik:VeterinaryMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-07-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="c80_From1Jan2014To30Sep2014_VeterinaryMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">anik:VeterinaryMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c81_From1Jan2013To30Sep2013_VeterinaryMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">anik:VeterinaryMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="c82_From1Jul2014To30Sep2014_UnitedStatesMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">anik:UnitedStatesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-07-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c83_From1Jul2013To30Sep2013_UnitedStatesMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">anik:UnitedStatesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-07-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="c84_From1Jan2014To30Sep2014_UnitedStatesMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">anik:UnitedStatesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c85_From1Jan2013To30Sep2013_UnitedStatesMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">anik:UnitedStatesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="c86_From1Jul2014To30Sep2014_EuropeMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">us-gaap:EuropeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-07-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c87_From1Jul2013To30Sep2013_EuropeMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">us-gaap:EuropeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-07-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="c88_From1Jan2014To30Sep2014_EuropeMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">us-gaap:EuropeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c89_From1Jan2013To30Sep2013_EuropeMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">us-gaap:EuropeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="c90_From1Jul2014To30Sep2014_OtherLocationMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">anik:OtherLocationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-07-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c91_From1Jul2013To30Sep2013_OtherLocationMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">anik:OtherLocationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-07-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="c92_From1Jan2014To30Sep2014_OtherLocationMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">anik:OtherLocationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c93_From1Jan2013To30Sep2013_OtherLocationMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">anik:OtherLocationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="c94_From1Oct2012To31Dec2012">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="c95_From1Oct2012To31Dec2012_NonCashTerminationAndImpairmentOfIPRDProjectMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">anik:NonCashTerminationAndImpairmentOfIPRDProjectMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="c96_From1Oct2012To31Dec2012_NoncashDisposalOfPropertyAndEquipmentMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">anik:NoncashDisposalOfPropertyAndEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="c97_From1Oct2012To31Dec2012_DisposalOfInventoryMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">anik:DisposalOfInventoryMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="c98_AsOf31Dec2013_EmployeeTerminationCostsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">anik:EmployeeTerminationCostsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="c99_AsOf31Dec2013_ActivityTerminationAndFacilityClosureCostsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">anik:ActivityTerminationAndFacilityClosureCostsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="c100_From1Jan2014To30Sep2014_EmployeeTerminationCostsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">anik:EmployeeTerminationCostsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c101_From1Jan2014To30Sep2014_ActivityTerminationAndFacilityClosureCostsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">anik:ActivityTerminationAndFacilityClosureCostsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="c102_AsOf30Sep2014_EmployeeTerminationCostsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">anik:EmployeeTerminationCostsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-09-30</instant>
    </period>
  </context>
  <context id="c103_AsOf30Sep2014_ActivityTerminationAndFacilityClosureCostsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">anik:ActivityTerminationAndFacilityClosureCostsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-09-30</instant>
    </period>
  </context>
  <unit id="usd">
    <measure>iso4217:USD</measure>
  </unit>
  <unit id="usdPershares">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>xbrli:shares</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="shares">
    <measure>xbrli:shares</measure>
  </unit>
  <unit id="pure">
    <measure>xbrli:pure</measure>
  </unit>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">71772194</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="0">63333160</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:MarketableSecuritiesCurrent unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">19999600</us-gaap:MarketableSecuritiesCurrent>
  <us-gaap:AccountsReceivableNetCurrent unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">20170095</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:AccountsReceivableNetCurrent unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="0">18736845</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:InventoryNet unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">13582456</us-gaap:InventoryNet>
  <us-gaap:InventoryNet unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="0">10996785</us-gaap:InventoryNet>
  <us-gaap:PrepaidTaxes unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">1343576</us-gaap:PrepaidTaxes>
  <us-gaap:DeferredTaxAssetsNetCurrent unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">659040</us-gaap:DeferredTaxAssetsNetCurrent>
  <us-gaap:DeferredTaxAssetsNetCurrent unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="0">659040</us-gaap:DeferredTaxAssetsNetCurrent>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">1128693</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="0">865957</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:AssetsCurrent unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">128655654</us-gaap:AssetsCurrent>
  <us-gaap:AssetsCurrent unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="0">94591787</us-gaap:AssetsCurrent>
  <us-gaap:PropertyPlantAndEquipmentGross unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">53379965</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="0">52413423</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">21343322</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="0">19474712</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:PropertyPlantAndEquipmentNet unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">32036643</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:PropertyPlantAndEquipmentNet unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="0">32938711</us-gaap:PropertyPlantAndEquipmentNet>
  <anik:DepositsAndOtherAssetsNoncurrent unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">69054</anik:DepositsAndOtherAssetsNoncurrent>
  <anik:DepositsAndOtherAssetsNoncurrent unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="0">69080</anik:DepositsAndOtherAssetsNoncurrent>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">16033944</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="0">18998409</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:Goodwill unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">8702295</us-gaap:Goodwill>
  <us-gaap:Goodwill unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="0">9443894</us-gaap:Goodwill>
  <us-gaap:Assets unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">185497590</us-gaap:Assets>
  <us-gaap:Assets unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="0">156041881</us-gaap:Assets>
  <us-gaap:AccountsPayableCurrent unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">1167545</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccountsPayableCurrent unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="0">2793911</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccruedLiabilitiesCurrent unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">5253693</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:AccruedLiabilitiesCurrent unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="0">5537881</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:DeferredRevenueCurrent unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">12885</us-gaap:DeferredRevenueCurrent>
  <us-gaap:DeferredRevenueCurrent unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="0">180433</us-gaap:DeferredRevenueCurrent>
  <us-gaap:AccruedIncomeTaxesCurrent unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="0">770276</us-gaap:AccruedIncomeTaxesCurrent>
  <us-gaap:LiabilitiesCurrent unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">6434123</us-gaap:LiabilitiesCurrent>
  <us-gaap:LiabilitiesCurrent unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="0">9282501</us-gaap:LiabilitiesCurrent>
  <us-gaap:OtherLiabilitiesNoncurrent unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">948858</us-gaap:OtherLiabilitiesNoncurrent>
  <us-gaap:OtherLiabilitiesNoncurrent unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="0">1133544</us-gaap:OtherLiabilitiesNoncurrent>
  <us-gaap:DeferredRevenueNoncurrent unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">56573</us-gaap:DeferredRevenueNoncurrent>
  <us-gaap:DeferredRevenueNoncurrent unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="0">2054941</us-gaap:DeferredRevenueNoncurrent>
  <us-gaap:DeferredTaxLiabilitiesNoncurrent unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">8353531</us-gaap:DeferredTaxLiabilitiesNoncurrent>
  <us-gaap:DeferredTaxLiabilitiesNoncurrent unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="0">7936864</us-gaap:DeferredTaxLiabilitiesNoncurrent>
  <us-gaap:CommitmentsAndContingencies unitRef="usd" contextRef="c0_AsOf30Sep2014" xs:nil="true"/>
  <us-gaap:CommitmentsAndContingencies unitRef="usd" contextRef="c1_AsOf31Dec2013" xs:nil="true"/>
  <us-gaap:PreferredStockValue unitRef="usd" contextRef="c0_AsOf30Sep2014" xs:nil="true"/>
  <us-gaap:PreferredStockValue unitRef="usd" contextRef="c1_AsOf31Dec2013" xs:nil="true"/>
  <us-gaap:CommonStockValue unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">148004</us-gaap:CommonStockValue>
  <us-gaap:CommonStockValue unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="0">142893</us-gaap:CommonStockValue>
  <us-gaap:AdditionalPaidInCapitalCommonStock unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">76064383</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:AdditionalPaidInCapitalCommonStock unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="0">70606031</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">-3595487</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="0">-1699095</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
  <us-gaap:RetainedEarningsAccumulatedDeficit unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">97087605</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:RetainedEarningsAccumulatedDeficit unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="0">66584202</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">169704505</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="0">135634031</us-gaap:StockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">185497590</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="0">156041881</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">546455</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
  <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="0">593023</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
  <us-gaap:PreferredStockParOrStatedValuePerShare unitRef="usdPershares" contextRef="c0_AsOf30Sep2014" decimals="2">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockParOrStatedValuePerShare unitRef="usdPershares" contextRef="c1_AsOf31Dec2013" decimals="2">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesAuthorized unitRef="shares" contextRef="c0_AsOf30Sep2014" decimals="INF">1250000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesAuthorized unitRef="shares" contextRef="c1_AsOf31Dec2013" decimals="INF">1250000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesIssued unitRef="shares" contextRef="c0_AsOf30Sep2014" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesIssued unitRef="shares" contextRef="c1_AsOf31Dec2013" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesOutstanding unitRef="shares" contextRef="c0_AsOf30Sep2014" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockSharesOutstanding unitRef="shares" contextRef="c1_AsOf31Dec2013" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:CommonStockParOrStatedValuePerShare unitRef="usdPershares" contextRef="c0_AsOf30Sep2014" decimals="2">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockParOrStatedValuePerShare unitRef="usdPershares" contextRef="c1_AsOf31Dec2013" decimals="2">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized unitRef="shares" contextRef="c0_AsOf30Sep2014" decimals="INF">30000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesAuthorized unitRef="shares" contextRef="c1_AsOf31Dec2013" decimals="INF">30000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesIssued unitRef="shares" contextRef="c0_AsOf30Sep2014" decimals="INF">14800453</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued unitRef="shares" contextRef="c1_AsOf31Dec2013" decimals="INF">14289308</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding unitRef="shares" contextRef="c0_AsOf30Sep2014" decimals="INF">14800453</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockSharesOutstanding unitRef="shares" contextRef="c1_AsOf31Dec2013" decimals="INF">14289308</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:SalesRevenueGoodsNet unitRef="usd" contextRef="c2_From1Jul2014To30Sep2014" decimals="0">21975312</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet unitRef="usd" contextRef="c3_From1Jul2013To30Sep2013" decimals="0">17023346</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">57593873</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">51585242</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueServicesNet unitRef="usd" contextRef="c2_From1Jul2014To30Sep2014" decimals="0">80111</us-gaap:SalesRevenueServicesNet>
  <us-gaap:SalesRevenueServicesNet unitRef="usd" contextRef="c3_From1Jul2013To30Sep2013" decimals="0">731092</us-gaap:SalesRevenueServicesNet>
  <us-gaap:SalesRevenueServicesNet unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">24746497</us-gaap:SalesRevenueServicesNet>
  <us-gaap:SalesRevenueServicesNet unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">2244584</us-gaap:SalesRevenueServicesNet>
  <us-gaap:SalesRevenueNet unitRef="usd" contextRef="c2_From1Jul2014To30Sep2014" decimals="0">22055423</us-gaap:SalesRevenueNet>
  <us-gaap:SalesRevenueNet unitRef="usd" contextRef="c3_From1Jul2013To30Sep2013" decimals="0">17754438</us-gaap:SalesRevenueNet>
  <us-gaap:SalesRevenueNet unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">82340370</us-gaap:SalesRevenueNet>
  <us-gaap:SalesRevenueNet unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">53829826</us-gaap:SalesRevenueNet>
  <us-gaap:CostOfGoodsSold unitRef="usd" contextRef="c2_From1Jul2014To30Sep2014" decimals="0">5724800</us-gaap:CostOfGoodsSold>
  <us-gaap:CostOfGoodsSold unitRef="usd" contextRef="c3_From1Jul2013To30Sep2013" decimals="0">5377568</us-gaap:CostOfGoodsSold>
  <us-gaap:CostOfGoodsSold unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">15418732</us-gaap:CostOfGoodsSold>
  <us-gaap:CostOfGoodsSold unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">16530070</us-gaap:CostOfGoodsSold>
  <us-gaap:ResearchAndDevelopmentExpense unitRef="usd" contextRef="c2_From1Jul2014To30Sep2014" decimals="0">1999867</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense unitRef="usd" contextRef="c3_From1Jul2013To30Sep2013" decimals="0">1618012</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">6160740</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">5029974</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:SellingGeneralAndAdministrativeExpense unitRef="usd" contextRef="c2_From1Jul2014To30Sep2014" decimals="0">4044538</us-gaap:SellingGeneralAndAdministrativeExpense>
  <us-gaap:SellingGeneralAndAdministrativeExpense unitRef="usd" contextRef="c3_From1Jul2013To30Sep2013" decimals="0">3188669</us-gaap:SellingGeneralAndAdministrativeExpense>
  <us-gaap:SellingGeneralAndAdministrativeExpense unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">11401399</us-gaap:SellingGeneralAndAdministrativeExpense>
  <us-gaap:SellingGeneralAndAdministrativeExpense unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">10536462</us-gaap:SellingGeneralAndAdministrativeExpense>
  <anik:RestructuringCredit unitRef="usd" contextRef="c3_From1Jul2013To30Sep2013" decimals="0">196084</anik:RestructuringCredit>
  <anik:RestructuringCredit unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">442869</anik:RestructuringCredit>
  <us-gaap:CostsAndExpenses unitRef="usd" contextRef="c2_From1Jul2014To30Sep2014" decimals="0">11769205</us-gaap:CostsAndExpenses>
  <us-gaap:CostsAndExpenses unitRef="usd" contextRef="c3_From1Jul2013To30Sep2013" decimals="0">9988165</us-gaap:CostsAndExpenses>
  <us-gaap:CostsAndExpenses unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">32980871</us-gaap:CostsAndExpenses>
  <us-gaap:CostsAndExpenses unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">31653637</us-gaap:CostsAndExpenses>
  <us-gaap:OperatingIncomeLoss unitRef="usd" contextRef="c2_From1Jul2014To30Sep2014" decimals="0">10286218</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss unitRef="usd" contextRef="c3_From1Jul2013To30Sep2013" decimals="0">7766273</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">49359499</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">22176189</us-gaap:OperatingIncomeLoss>
  <us-gaap:InterestIncomeExpenseNonoperatingNet unitRef="usd" contextRef="c2_From1Jul2014To30Sep2014" decimals="0">9937</us-gaap:InterestIncomeExpenseNonoperatingNet>
  <us-gaap:InterestIncomeExpenseNonoperatingNet unitRef="usd" contextRef="c3_From1Jul2013To30Sep2013" decimals="0">-32816</us-gaap:InterestIncomeExpenseNonoperatingNet>
  <us-gaap:InterestIncomeExpenseNonoperatingNet unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">16339</us-gaap:InterestIncomeExpenseNonoperatingNet>
  <us-gaap:InterestIncomeExpenseNonoperatingNet unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">-108755</us-gaap:InterestIncomeExpenseNonoperatingNet>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest unitRef="usd" contextRef="c2_From1Jul2014To30Sep2014" decimals="0">10296155</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest unitRef="usd" contextRef="c3_From1Jul2013To30Sep2013" decimals="0">7733457</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">49375838</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">22067434</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:IncomeTaxExpenseBenefit unitRef="usd" contextRef="c2_From1Jul2014To30Sep2014" decimals="0">4125355</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:IncomeTaxExpenseBenefit unitRef="usd" contextRef="c3_From1Jul2013To30Sep2013" decimals="0">2776199</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:IncomeTaxExpenseBenefit unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">18872435</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:IncomeTaxExpenseBenefit unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">8147282</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c2_From1Jul2014To30Sep2014" decimals="0">6170800</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c3_From1Jul2013To30Sep2013" decimals="0">4957258</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">30503403</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">13920152</us-gaap:NetIncomeLoss>
  <us-gaap:EarningsPerShareBasic unitRef="usdPershares" contextRef="c2_From1Jul2014To30Sep2014" decimals="2">0.42</us-gaap:EarningsPerShareBasic>
  <us-gaap:EarningsPerShareBasic unitRef="usdPershares" contextRef="c3_From1Jul2013To30Sep2013" decimals="2">0.36</us-gaap:EarningsPerShareBasic>
  <us-gaap:EarningsPerShareBasic unitRef="usdPershares" contextRef="c4_From1Jan2014To30Sep2014" decimals="2">2.09</us-gaap:EarningsPerShareBasic>
  <us-gaap:EarningsPerShareBasic unitRef="usdPershares" contextRef="c5_From1Jan2013To30Sep2013" decimals="2">1.03</us-gaap:EarningsPerShareBasic>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic unitRef="shares" contextRef="c2_From1Jul2014To30Sep2014" decimals="INF">14758781</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic unitRef="shares" contextRef="c3_From1Jul2013To30Sep2013" decimals="INF">13682449</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic unitRef="shares" contextRef="c4_From1Jan2014To30Sep2014" decimals="INF">14626933</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic unitRef="shares" contextRef="c5_From1Jan2013To30Sep2013" decimals="INF">13534334</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:EarningsPerShareDiluted unitRef="usdPershares" contextRef="c2_From1Jul2014To30Sep2014" decimals="2">0.40</us-gaap:EarningsPerShareDiluted>
  <us-gaap:EarningsPerShareDiluted unitRef="usdPershares" contextRef="c3_From1Jul2013To30Sep2013" decimals="2">0.33</us-gaap:EarningsPerShareDiluted>
  <us-gaap:EarningsPerShareDiluted unitRef="usdPershares" contextRef="c4_From1Jan2014To30Sep2014" decimals="2">1.97</us-gaap:EarningsPerShareDiluted>
  <us-gaap:EarningsPerShareDiluted unitRef="usdPershares" contextRef="c5_From1Jan2013To30Sep2013" decimals="2">0.95</us-gaap:EarningsPerShareDiluted>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding unitRef="shares" contextRef="c2_From1Jul2014To30Sep2014" decimals="INF">15434875</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding unitRef="shares" contextRef="c3_From1Jul2013To30Sep2013" decimals="INF">14958965</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding unitRef="shares" contextRef="c4_From1Jan2014To30Sep2014" decimals="INF">15469237</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding unitRef="shares" contextRef="c5_From1Jan2013To30Sep2013" decimals="INF">14673879</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax unitRef="usd" contextRef="c2_From1Jul2014To30Sep2014" decimals="0">431</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">431</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax unitRef="usd" contextRef="c2_From1Jul2014To30Sep2014" decimals="0">-1679968</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax unitRef="usd" contextRef="c3_From1Jul2013To30Sep2013" decimals="0">916474</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">-1896823</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">507119</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax unitRef="usd" contextRef="c2_From1Jul2014To30Sep2014" decimals="0">-1679537</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax unitRef="usd" contextRef="c3_From1Jul2013To30Sep2013" decimals="0">916474</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">-1896392</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">507119</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:ComprehensiveIncomeNetOfTax unitRef="usd" contextRef="c2_From1Jul2014To30Sep2014" decimals="0">4491263</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:ComprehensiveIncomeNetOfTax unitRef="usd" contextRef="c3_From1Jul2013To30Sep2013" decimals="0">5873732</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:ComprehensiveIncomeNetOfTax unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">28607011</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:ComprehensiveIncomeNetOfTax unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">14427271</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:DepreciationAndAmortization unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">3576441</us-gaap:DepreciationAndAmortization>
  <us-gaap:DepreciationAndAmortization unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">3579474</us-gaap:DepreciationAndAmortization>
  <us-gaap:ShareBasedCompensation unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">1196361</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">1156929</us-gaap:ShareBasedCompensation>
  <us-gaap:ProvisionForDoubtfulAccounts unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">24098</us-gaap:ProvisionForDoubtfulAccounts>
  <us-gaap:InventoryWriteDown unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">220207</us-gaap:InventoryWriteDown>
  <us-gaap:InventoryWriteDown unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">165803</us-gaap:InventoryWriteDown>
  <us-gaap:GainLossOnDispositionOfAssets1 unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">442341</us-gaap:GainLossOnDispositionOfAssets1>
  <us-gaap:ExcessTaxBenefitFromShareBasedCompensationOperatingActivities unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">9236708</us-gaap:ExcessTaxBenefitFromShareBasedCompensationOperatingActivities>
  <us-gaap:ExcessTaxBenefitFromShareBasedCompensationOperatingActivities unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">764181</us-gaap:ExcessTaxBenefitFromShareBasedCompensationOperatingActivities>
  <us-gaap:IncreaseDecreaseInAccountsReceivable unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">1840407</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <us-gaap:IncreaseDecreaseInAccountsReceivable unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">-4667839</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <us-gaap:IncreaseDecreaseInInventories unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">2923628</us-gaap:IncreaseDecreaseInInventories>
  <us-gaap:IncreaseDecreaseInInventories unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">3430655</us-gaap:IncreaseDecreaseInInventories>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">-183481</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">-531449</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IncreaseDecreaseInOtherOperatingAssets unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">-25497</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
  <us-gaap:IncreaseDecreaseInAccountsPayable unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">-992822</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:IncreaseDecreaseInAccountsPayable unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">124679</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:IncreaseDecreaseInAccruedLiabilities unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">-989291</us-gaap:IncreaseDecreaseInAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInAccruedLiabilities unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">-642430</us-gaap:IncreaseDecreaseInAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInDeferredRevenue unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">-2078543</us-gaap:IncreaseDecreaseInDeferredRevenue>
  <us-gaap:IncreaseDecreaseInDeferredRevenue unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">-2150000</us-gaap:IncreaseDecreaseInDeferredRevenue>
  <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">7771001</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
  <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">766598</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
  <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">-167123</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
  <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">-373712</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">25222372</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">17159199</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:PaymentsToAcquireMarketableSecurities unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">19999169</us-gaap:PaymentsToAcquireMarketableSecurities>
  <us-gaap:PaymentsToAcquireMarketableSecurities unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">0</us-gaap:PaymentsToAcquireMarketableSecurities>
  <us-gaap:ProceedsFromSaleOfOtherAssets1 unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">530865</us-gaap:ProceedsFromSaleOfOtherAssets1>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">920132</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">235803</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">-20919301</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">295062</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:ProceedsFromStockOptionsExercised unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">1379294</us-gaap:ProceedsFromStockOptionsExercised>
  <us-gaap:ProceedsFromStockOptionsExercised unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">2932649</us-gaap:ProceedsFromStockOptionsExercised>
  <us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">9236708</us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities>
  <us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">764181</us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities>
  <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">6348900</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
  <us-gaap:RepaymentsOfLongTermDebt unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">1200000</us-gaap:RepaymentsOfLongTermDebt>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">4267102</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">2496830</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">-131139</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
  <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">36870</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">8439034</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">19987961</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef="usd" contextRef="c6_AsOf31Dec2012" decimals="0">44067477</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef="usd" contextRef="c7_AsOf30Sep2013" decimals="0">64055438</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <dei:EntityRegistrantName contextRef="c4_From1Jan2014To30Sep2014">Anika Therapeutics, Inc.</dei:EntityRegistrantName>
  <dei:DocumentType contextRef="c4_From1Jan2014To30Sep2014">10-Q</dei:DocumentType>
  <dei:CurrentFiscalYearEndDate contextRef="c4_From1Jan2014To30Sep2014">--12-31</dei:CurrentFiscalYearEndDate>
  <dei:EntityCommonStockSharesOutstanding unitRef="shares" contextRef="c8_AsOf31Oct2014" decimals="INF">14504014</dei:EntityCommonStockSharesOutstanding>
  <dei:AmendmentFlag contextRef="c4_From1Jan2014To30Sep2014">false</dei:AmendmentFlag>
  <dei:EntityCentralIndexKey contextRef="c4_From1Jan2014To30Sep2014">0000898437</dei:EntityCentralIndexKey>
  <dei:EntityCurrentReportingStatus contextRef="c4_From1Jan2014To30Sep2014">Yes</dei:EntityCurrentReportingStatus>
  <dei:EntityVoluntaryFilers contextRef="c4_From1Jan2014To30Sep2014">No</dei:EntityVoluntaryFilers>
  <dei:EntityFilerCategory contextRef="c4_From1Jan2014To30Sep2014">Accelerated Filer</dei:EntityFilerCategory>
  <dei:EntityWellKnownSeasonedIssuer contextRef="c4_From1Jan2014To30Sep2014">No</dei:EntityWellKnownSeasonedIssuer>
  <dei:DocumentFiscalYearFocus contextRef="c4_From1Jan2014To30Sep2014">2014</dei:DocumentFiscalYearFocus>
  <dei:DocumentFiscalPeriodFocus contextRef="c4_From1Jan2014To30Sep2014">Q3</dei:DocumentFiscalPeriodFocus>
  <dei:DocumentPeriodEndDate contextRef="c4_From1Jan2014To30Sep2014">2014-09-30</dei:DocumentPeriodEndDate>
  <us-gaap:NatureOfOperations contextRef="c4_From1Jan2014To30Sep2014">&lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse&quot;&gt;
      &lt;tr style=&quot;vertical-align: top&quot;&gt;
        &lt;td style=&quot;width: 6%&quot;&gt;
          &lt;b&gt;1.&lt;/b&gt;
        &lt;/td&gt;
        &lt;td style=&quot;width: 94%&quot;&gt;
          &lt;b&gt;Nature of Business&lt;/b&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in&quot;&gt;
      Anika Therapeutics,&amp;#160;Inc. (together with its subsidiaries, &amp;#8220;Anika,&amp;#8221; the &amp;#8220;Company,&amp;#8221; &amp;#8220;we,&amp;#8221; &amp;#8220;us,&amp;#8221; or &amp;#8220;our&amp;#8221;) develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair. These products are based on hyaluronic acid (&amp;#8220;HA&amp;#8221;), a naturally occurring, biocompatible polymer found throughout the body. Due to its unique biophysical and biochemical properties, HA plays an important role in a number of physiological functions such as the protection and lubrication of soft tissues and joints, the maintenance of the structural integrity of tissues, and the transport of molecules to and within cells.
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in&quot;&gt;
      The Company is subject to risks common to companies in the biotechnology and medical device industries including, but not limited to, development by the Company or its competitors of new technological innovations, dependence on key personnel, protection of proprietary information and technology, commercialization of existing and new products, and compliance with the U.S. Food and Drug Administration (&amp;#8220;FDA&amp;#8221;) and foreign regulations and approval requirements, as well as the ability to grow the Company&amp;#8217;s business.
    &lt;/p&gt;&lt;br/&gt;</us-gaap:NatureOfOperations>
  <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="c4_From1Jan2014To30Sep2014">&lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse&quot;&gt;
      &lt;tr style=&quot;vertical-align: top&quot;&gt;
        &lt;td style=&quot;width: 6%&quot;&gt;
          &lt;b&gt;2.&lt;/b&gt;
        &lt;/td&gt;
        &lt;td style=&quot;width: 94%&quot;&gt;
          &lt;b&gt;Basis of Presentation&lt;/b&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in&quot;&gt;
      The accompanying unaudited condensed consolidated financial statements and related notes have been prepared by the Company pursuant to the rules&amp;#160;and regulations of the Securities and Exchange Commission (the &amp;#8220;SEC&amp;#8221;) and in accordance with accounting principles generally accepted in the United States (&amp;#8220;U.S.&amp;#8221;). The financial statements include the accounts of Anika Therapeutics, Inc. and its subsidiaries. Inter-company transactions and balances have been eliminated. The year-end consolidated balance sheet is derived from our audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the U.S. In the opinion of management, these unaudited condensed consolidated financial statements contain all adjustments (consisting only of normal recurring adjustments) necessary to fairly state the condensed consolidated financial position of the Company as of September 30, 2014, the results of its
      operations for the three and nine-month periods ended September 30, 2014 and 2013, and cash flows for the nine-month periods ended September 30, 2014 and 2013.
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in&quot;&gt;
      The accompanying unaudited condensed consolidated financial statements and related notes should be read in conjunction with the Company&amp;#8217;s annual financial statements filed with its Annual Report on Form&amp;#160;10-K for the year ended December 31, 2013. The results of operations for the three and nine-month periods ended September 30, 2014 are not necessarily indicative of the results to be expected for the year ending December&amp;#160;31, 2014. Certain prior period amounts have been reclassified to conform to the current period presentation. There was no impact on operating income.
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 10pt; text-indent: 0.5in; margin: 0&quot;&gt;
      A revision was made on the condensed consolidated statement of cash flows for the six months ended June 30, 2014 to correctly reflect the tax benefit from exercise of certain equity awards. This revision has an impact on the statement of cash flows as a reduction of cash provided by operating activities of $2.5 million with a corresponding increase to cash provided by financing activities related to the tax benefit from exercise of stock options for the six months ended June 30, 2014 of the same amount. This revision has no impact on the statement of operations or cash position. The revision to the condensed consolidated statement of cash flows represents amounts that are not deemed to be material, individually or in the aggregate, to the prior period condensed consolidated financial statements.
    &lt;/p&gt;&lt;br/&gt;</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
  <us-gaap:PriorPeriodReclassificationAdjustment unitRef="usd" contextRef="c9_From1Jan2014To30Jun2014_IncreaseToCashProvidedByFinancingActivitiesMember" decimals="-5">2500000</us-gaap:PriorPeriodReclassificationAdjustment>
  <us-gaap:PriorPeriodReclassificationAdjustment unitRef="usd" contextRef="c10_From1Jan2014To30Jun2014_DereaseToCashProvidedByOperatingActivitiesMember" decimals="-5">-2500000</us-gaap:PriorPeriodReclassificationAdjustment>
  <us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock contextRef="c4_From1Jan2014To30Sep2014">&lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse&quot;&gt;
      &lt;tr style=&quot;vertical-align: top&quot;&gt;
        &lt;td style=&quot;width: 6%&quot;&gt;
          &lt;b&gt;3.&lt;/b&gt;
        &lt;/td&gt;
        &lt;td style=&quot;width: 94%&quot;&gt;
          &lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;
            &lt;b&gt;Marketable Securities&lt;/b&gt;
          &lt;/p&gt;
          &lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;
            &lt;b&gt;&lt;/b&gt;
          &lt;/p&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif&quot;&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td style=&quot;font-weight: bold&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;15&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          September 30, 2014
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td style=&quot;font-weight: bold&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Amortized
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Cost
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Unrealized
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Gains, Net of Tax
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Unrealized
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Losses, Net of Tax
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Fair
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Value
          &lt;/p&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;width: 56%; text-align: left&quot;&gt;
          United States Treasury securities
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          14,999,169
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          699
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          (268
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          )
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          14,999,600
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-bottom: 1.1pt&quot;&gt;
          Bank certificates of deposit
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          5,000,000
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          -
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          -
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          5,000,000
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          19,999,169
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          699
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          (268
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          )
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          19,999,600
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in&quot;&gt;
      The Company considers securities with maturities of three months or less from the purchase date to be cash equivalents. Interest is recorded when earned. All of the Company&amp;#8217;s investments are classified as available-for-sale and are carried at fair value with unrealized gains and losses recorded as a component of accumulated other comprehensive income, net of related income taxes.
    &lt;/p&gt;&lt;br/&gt;</us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock>
  <us-gaap:MarketableSecuritiesTextBlock contextRef="c4_From1Jan2014To30Sep2014">&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif&quot;&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td style=&quot;font-weight: bold&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;15&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          September 30, 2014
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td style=&quot;font-weight: bold&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Amortized
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Cost
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Unrealized
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Gains, Net of Tax
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Unrealized
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Losses, Net of Tax
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Fair
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Value
          &lt;/p&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;width: 56%; text-align: left&quot;&gt;
          United States Treasury securities
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          14,999,169
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          699
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          (268
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          )
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          14,999,600
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-bottom: 1.1pt&quot;&gt;
          Bank certificates of deposit
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          5,000,000
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          -
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          -
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          5,000,000
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          19,999,169
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          699
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          (268
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          )
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          19,999,600
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;</us-gaap:MarketableSecuritiesTextBlock>
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost unitRef="usd" contextRef="c11_AsOf30Sep2014_USStatesAndPoliticalSubdivisionsMember" decimals="0">14999169</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax unitRef="usd" contextRef="c11_AsOf30Sep2014_USStatesAndPoliticalSubdivisionsMember" decimals="0">699</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
  <us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax unitRef="usd" contextRef="c11_AsOf30Sep2014_USStatesAndPoliticalSubdivisionsMember" decimals="0">-268</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
  <us-gaap:AvailableForSaleSecurities unitRef="usd" contextRef="c11_AsOf30Sep2014_USStatesAndPoliticalSubdivisionsMember" decimals="0">14999600</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost unitRef="usd" contextRef="c12_AsOf31Dec2013_CertificatesOfDepositMember" decimals="0">5000000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
  <us-gaap:AvailableForSaleSecurities unitRef="usd" contextRef="c12_AsOf31Dec2013_CertificatesOfDepositMember" decimals="0">5000000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">19999169</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">699</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
  <us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">-268</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
  <us-gaap:AvailableForSaleSecurities unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">19999600</us-gaap:AvailableForSaleSecurities>
  <us-gaap:FairValueDisclosuresTextBlock contextRef="c4_From1Jan2014To30Sep2014">&lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse&quot;&gt;
      &lt;tr style=&quot;vertical-align: top&quot;&gt;
        &lt;td style=&quot;width: 6%&quot;&gt;
          &lt;b&gt;4.&lt;/b&gt;
        &lt;/td&gt;
        &lt;td style=&quot;width: 94%&quot;&gt;
          &lt;b&gt;Fair Value Measurements&lt;/b&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in&quot;&gt;
      Fair value is an exit price, representing the amount that would be received from the sale of an asset or paid to transfer a liability in an orderly transaction between market participants based on assumptions that market participants would use in pricing an asset or liability. As a basis for classifying the fair value measurements, a three-tier fair value hierarchy, which classifies the fair value measurements based on the inputs used in measuring fair value, was established as follows: (Level 1) observable inputs such as quoted prices in active markets for identical assets or liabilities; (Level 2) significant other observable inputs that are observable either directly or indirectly; and (Level 3) significant unobservable inputs in which there is little or no market data, which requires the Company to develop its own assumptions. This hierarchy requires the Company to use observable market data, when available, and to minimize the use of unobservable inputs when determining
      fair value. On a recurring basis, the Company records its marketable securities at fair value.
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in&quot;&gt;
      The Company&amp;#8217;s investments are all classified within Level 1 and Level 2 of the fair value hierarchy. The Company&amp;#8217;s investments classified within Level 1 of the fair value hierarchy are valued using quoted market prices. The Company&amp;#8217;s investments classified within Level 2 of the fair value hierarchy are valued based on matrix pricing compiled by third party pricing vendors, using observable market inputs such as interest rates, yield curves, and credit risk.
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in&quot;&gt;
      The fair value hierarchy of the Company&amp;#8217;s cash equivalents and marketable securities at fair value is as follows:
    &lt;/p&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif&quot;&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;11&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Fair Value Measurements at Reporting
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Date Using
          &lt;/p&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; nowrap=&quot;nowrap&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          September 30, 2014
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; nowrap=&quot;nowrap&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Quoted Prices in
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Active Markets
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            for Identical Assets
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            (Level 1)
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; nowrap=&quot;nowrap&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Significant Other
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Observable Inputs
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            (Level 2)
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; nowrap=&quot;nowrap&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Significant
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Unobservable
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Inputs
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            (Level 3)
          &lt;/p&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;width: 56%; text-align: left; padding-bottom: 2.75pt&quot;&gt;
          Money market funds
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          49,285,168
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left; width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          -
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left; width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          49,285,168
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left; width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          -
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left; width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          Marketable securities:
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          United States Treasury securities
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          14,999,600
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          14,999,600
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          -
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          -
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-bottom: 1.1pt&quot;&gt;
          Bank certificates of deposit
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          5,000,000
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          -
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          5,000,000
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          -
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-bottom: 2.75pt&quot;&gt;
          Total marketable securities
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          19,999,600
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          14,999,600
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          5,000,000
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          -
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif&quot;&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;11&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          Fair Value Measurements at Reporting&lt;br /&gt;
          Date Using
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; nowrap=&quot;nowrap&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          December 31, 2013
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; nowrap=&quot;nowrap&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          Quoted Prices in&lt;br /&gt;
          Active Markets&lt;br /&gt;
          &amp;#160;for Identical Assets&amp;#160;&lt;br /&gt;
          &amp;#160;(Level 1)
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; nowrap=&quot;nowrap&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          Significant Other&lt;br /&gt;
          Observable Inputs&amp;#160;&lt;br /&gt;
          (Level 2)
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; nowrap=&quot;nowrap&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Significant
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Unobservable
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Inputs
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            (Level 3)
          &lt;/p&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;width: 56%; text-align: left; padding-bottom: 2.75pt&quot;&gt;
          Money market funds
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          34,266,501
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left; width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          -
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left; width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          34,266,501
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left; width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          -
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left; width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;&lt;br/&gt;</us-gaap:FairValueDisclosuresTextBlock>
  <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock contextRef="c4_From1Jan2014To30Sep2014">&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif&quot;&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;11&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Fair Value Measurements at Reporting
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Date Using
          &lt;/p&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; nowrap=&quot;nowrap&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          September 30, 2014
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; nowrap=&quot;nowrap&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Quoted Prices in
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Active Markets
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            for Identical Assets
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            (Level 1)
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; nowrap=&quot;nowrap&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Significant Other
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Observable Inputs
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            (Level 2)
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; nowrap=&quot;nowrap&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Significant
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Unobservable
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Inputs
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            (Level 3)
          &lt;/p&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;width: 56%; text-align: left; padding-bottom: 2.75pt&quot;&gt;
          Money market funds
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          49,285,168
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left; width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          -
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left; width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          49,285,168
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left; width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          -
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left; width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          Marketable securities:
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          United States Treasury securities
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          14,999,600
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          14,999,600
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          -
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          -
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-bottom: 1.1pt&quot;&gt;
          Bank certificates of deposit
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          5,000,000
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          -
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          5,000,000
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          -
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-bottom: 2.75pt&quot;&gt;
          Total marketable securities
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          19,999,600
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          14,999,600
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          5,000,000
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          -
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif&quot;&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;11&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          Fair Value Measurements at Reporting&lt;br /&gt;
          Date Using
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; nowrap=&quot;nowrap&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          December 31, 2013
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; nowrap=&quot;nowrap&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          Quoted Prices in&lt;br /&gt;
          Active Markets&lt;br /&gt;
          &amp;#160;for Identical Assets&amp;#160;&lt;br /&gt;
          &amp;#160;(Level 1)
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; nowrap=&quot;nowrap&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          Significant Other&lt;br /&gt;
          Observable Inputs&amp;#160;&lt;br /&gt;
          (Level 2)
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; nowrap=&quot;nowrap&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Significant
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Unobservable
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Inputs
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            (Level 3)
          &lt;/p&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;width: 56%; text-align: left; padding-bottom: 2.75pt&quot;&gt;
          Money market funds
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          34,266,501
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left; width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          -
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left; width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          34,266,501
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left; width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          -
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left; width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure unitRef="usd" contextRef="c13_AsOf30Sep2014_MoneyMarketFundsMember" decimals="0">49285168</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure unitRef="usd" contextRef="c14_AsOf30Sep2014_MoneyMarketFundsMember_FairValueInputsLevel2Member" decimals="0">49285168</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:AvailableForSaleSecurities unitRef="usd" contextRef="c15_AsOf30Sep2014_USStatesAndPoliticalSubdivisionsMember" decimals="0">14999600</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities unitRef="usd" contextRef="c16_AsOf30Sep2014_USStatesAndPoliticalSubdivisionsMember_FairValueInputsLevel1Member" decimals="0">14999600</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities unitRef="usd" contextRef="c17_AsOf30Sep2014_CertificatesOfDepositMember" decimals="0">5000000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities unitRef="usd" contextRef="c18_AsOf30Sep2014_CertificatesOfDepositMember_FairValueInputsLevel2Member" decimals="0">5000000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities unitRef="usd" contextRef="c19_AsOf30Sep2014_FairValueInputsLevel1Member" decimals="0">14999600</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities unitRef="usd" contextRef="c20_AsOf30Sep2014_FairValueInputsLevel2Member" decimals="0">5000000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure unitRef="usd" contextRef="c21_AsOf31Dec2013_MoneyMarketFundsMember" decimals="0">34266501</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure unitRef="usd" contextRef="c22_AsOf31Dec2013_MoneyMarketFundsMember_FairValueInputsLevel2Member" decimals="0">34266501</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c4_From1Jan2014To30Sep2014">&lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse&quot;&gt;
      &lt;tr style=&quot;vertical-align: top&quot;&gt;
        &lt;td style=&quot;width: 6%&quot;&gt;
          &lt;b&gt;5.&lt;/b&gt;
        &lt;/td&gt;
        &lt;td style=&quot;width: 94%&quot;&gt;
          &lt;b&gt;Equity Incentive Plan&lt;/b&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in&quot;&gt;
      The Company estimates the fair value of stock options and stock appreciation rights using the Black-Scholes valuation model. Fair value of restricted stock is measured by the grant-date price of the Company&amp;#8217;s shares. The fair value of each stock option award during the three and nine-month periods ended September 30, 2014 and 2013, respectively, was estimated on the grant date using the Black-Scholes option-pricing model with the following assumptions:
    &lt;/p&gt;&lt;br/&gt;&lt;table border=&quot;0&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif&quot;&gt;
      &lt;tr&gt;
        &lt;td style=&quot;font-weight: bold&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;7&quot; style=&quot;text-align: center&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            &lt;b&gt;Three Months Ended&lt;/b&gt;
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            &lt;b&gt;September 30,&lt;/b&gt;
          &lt;/p&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;b&gt;2014&lt;/b&gt;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; text-align: center; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;b&gt;2013&lt;/b&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;width: 71%&quot;&gt;
          Risk free interest rate
        &lt;/td&gt;
        &lt;td style=&quot;width: 3%; text-align: center&quot;&gt;
          1.30%
        &lt;/td&gt;
        &lt;td style=&quot;width: 7%; text-align: center&quot;&gt;
          -
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center; width: 3%&quot;&gt;
          1.39%
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right; width: 3%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 3%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 7%; text-align: center&quot;&gt;
          -
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center; width: 3%&quot;&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;background-color: White&quot;&gt;
        &lt;td&gt;
          Expected volatility
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
          53.28%
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
          -
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: top; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td&gt;
          Expected lives (years)
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
          4
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
          -
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;background-color: White&quot;&gt;
        &lt;td&gt;
          Expected dividend yield
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
          0.00%
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
          -
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;&lt;br/&gt;&lt;table border=&quot;0&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif&quot;&gt;
      &lt;tr&gt;
        &lt;td style=&quot;font-weight: bold&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;7&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0; text-align: center&quot;&gt;
            &lt;b&gt;Nine Months Ended&lt;/b&gt;
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0; text-align: center&quot;&gt;
            &lt;b&gt;September 30,&lt;/b&gt;
          &lt;/p&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;b&gt;2014&lt;/b&gt;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; text-align: center; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;b&gt;2013&lt;/b&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;width: 71%&quot;&gt;
          Risk free interest rate
        &lt;/td&gt;
        &lt;td style=&quot;width: 3%; text-align: center&quot;&gt;
          1.16%
        &lt;/td&gt;
        &lt;td style=&quot;width: 7%; text-align: center&quot;&gt;
          -
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center; width: 3%&quot;&gt;
          1.39%
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right; width: 3%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 3%; text-align: center&quot;&gt;
          0.61%
        &lt;/td&gt;
        &lt;td style=&quot;width: 7%; text-align: center&quot;&gt;
          -
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center; width: 3%&quot;&gt;
          0.70%
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;background-color: White&quot;&gt;
        &lt;td&gt;
          Expected volatility
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
          53.28%
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
          57.60%
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: top; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td&gt;
          Expected lives (years)
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
          4
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
          4
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;background-color: White&quot;&gt;
        &lt;td&gt;
          Expected dividend yield
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
          0.00%
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
          0.00%
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in&quot;&gt;
      The Company recorded $390,578 and $368,603 of share-based compensation expense for the three-month periods ended September 30, 2014 and 2013, respectively, for equity compensation awards. The Company recorded $1,196,361 and $1,156,929 of share-based compensation expense for the nine-month periods ended September 30, 2014 and 2013, respectively, for equity compensation awards. The Company presents the expenses related to stock-based compensation awards in the same expense line items as cash compensation paid to the respective recipients.
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in&quot;&gt;
      There were 7,000 and 139,240 stock options granted under the Plan during the three and nine-month periods ended September 30, 2014, respectively. There were no Restricted Stock Awards (&amp;#8220;RSAs&amp;#8221;) or Restricted Stock Units (&amp;#8220;RSUs&amp;#8221;) granted under the Plan during the three-month period ended September 30, 2014. There were 9,365 RSUs granted to members of the Company&amp;#8217;s Board of Directors under the Plan during the nine-month period ended September 30, 2014. There were 30,700 RSAs granted to Company employees under the Plan during the nine-month period ended September 30, 2014. The stock options, RSAs and RSUs granted to employees and directors become exercisable or vest ratably over four years from the date of grant.
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in&quot;&gt;
      A portion of the stock options granted during the nine-month period ended September 30, 2014 contained certain performance features, as compared to established targets, in addition to time-based vesting conditions. The compensation costs associated with these grants was estimated using the Black-Scholes valuation method factored for the estimated probability of achieving the performance goals.
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in&quot;&gt;
      As of September 30, 2014, there was approximately $4.2 million of total unrecognized compensation cost related to non-vested stock options, stock appreciation rights (&amp;#8220;SARs&amp;#8221;), RSAs and RSUs granted under the Company&amp;#8217;s incentive Plans. This cost is expected to be recognized over a weighted-average period of 3.0 years.
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in&quot;&gt;
      The total intrinsic value of stock options and SARs exercised during the nine-month periods ended September 30, 2014 and 2013 was $25,473,089 and $4,095,833, respectively. Cash received from the exercise of stock options during the three and nine-month periods ended September 30, 2014 and 2013 were $17,513 and $1,379,294, and $1,804,773 and $2,932,649, respectively. During the second quarter of 2014, the Company acquired and subsequently retired 133,774 common shares related to an employee SARs exercise, to meet minimum statutory tax withholding requirements.
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in&quot;&gt;
      There were 936,097 options and SARs outstanding under the Company&amp;#8217;s incentive Plans as of September 30, 2014 with a weighted-average exercise price of $13.54 per share, an aggregate intrinsic value of approximately $21.8 million, and a weighted-average remaining contractual term of 6.8 years. None of the options or SARs outstanding at September 30, 2014 or 2013, respectively, had cash-settlement features.
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in&quot;&gt;
      The Company may satisfy the awards upon exercise, or upon fulfillment of the vesting requirements for other equity-based awards, with either authorized but unissued shares or shares reacquired by the Company. Stock-based awards are granted with an exercise price equal to the market price of the Company&amp;#8217;s stock on the date of grant. Awards containing service conditions generally become exercisable ratably over one to four years, have a ten year contractual term and sometimes contain performance conditions.&amp;#160;
    &lt;/p&gt;&lt;br/&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c2_From1Jul2014To30Sep2014" decimals="0">390578</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c3_From1Jul2013To30Sep2013" decimals="0">368603</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">1196361</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">1156929</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross unitRef="shares" contextRef="c2_From1Jul2014To30Sep2014" decimals="INF">7000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross unitRef="shares" contextRef="c4_From1Jan2014To30Sep2014" decimals="INF">139240</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod unitRef="shares" contextRef="c23_From1Jul2014To30Sep2014_RestrictedStockMember" decimals="INF">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod unitRef="shares" contextRef="c24_From1Jul2014To30Sep2014_RestrictedStockUnitsRSUMember" decimals="INF">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod unitRef="shares" contextRef="c25_From1Jan2014To30Sep2014_RestrictedStockUnitsRSUMember_BoardOfDirectorsMember" decimals="INF">9365</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod unitRef="shares" contextRef="c26_From1Jan2014To30Sep2014_RestrictedStockMember" decimals="INF">30700</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c26_From1Jan2014To30Sep2014_RestrictedStockMember">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c27_From1Jan2014To30Sep2014_RestrictedStockUnitsRSUMember">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="-5">4200000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c4_From1Jan2014To30Sep2014">P3Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
  <anik:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriodTotalIntrinsicValue unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">25473089</anik:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriodTotalIntrinsicValue>
  <anik:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriodTotalIntrinsicValue unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">4095833</anik:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriodTotalIntrinsicValue>
  <us-gaap:ProceedsFromStockOptionsExercised unitRef="usd" contextRef="c2_From1Jul2014To30Sep2014" decimals="0">17513</us-gaap:ProceedsFromStockOptionsExercised>
  <us-gaap:ProceedsFromStockOptionsExercised unitRef="usd" contextRef="c3_From1Jul2013To30Sep2013" decimals="0">1804773</us-gaap:ProceedsFromStockOptionsExercised>
  <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares unitRef="shares" contextRef="c28_From1Apr2014To30Jun2014_StockAppreciationRightsSARSMember" decimals="INF">133774</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
  <anik:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingNumber unitRef="shares" contextRef="c4_From1Jan2014To30Sep2014" decimals="INF">936097</anik:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingNumber>
  <anik:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c0_AsOf30Sep2014" decimals="2">13.54</anik:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsWeightedAverageExercisePrice>
  <anik:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingIntrinsicValue unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="-5">21800000</anik:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingIntrinsicValue>
  <anik:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm contextRef="c4_From1Jan2014To30Sep2014">P6Y292D</anik:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c29_From1Jan2014To30Sep2014_MinimumMember">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c30_From1Jan2014To30Sep2014_MaximumMember">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
  <anik:ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTermRange contextRef="c4_From1Jan2014To30Sep2014">P10Y</anik:ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTermRange>
  <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="c4_From1Jan2014To30Sep2014">&lt;table border=&quot;0&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif&quot;&gt;
      &lt;tr&gt;
        &lt;td style=&quot;font-weight: bold&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;7&quot; style=&quot;text-align: center&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            &lt;b&gt;Three Months Ended&lt;/b&gt;
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            &lt;b&gt;September 30,&lt;/b&gt;
          &lt;/p&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;b&gt;2014&lt;/b&gt;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; text-align: center; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;b&gt;2013&lt;/b&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;width: 71%&quot;&gt;
          Risk free interest rate
        &lt;/td&gt;
        &lt;td style=&quot;width: 3%; text-align: center&quot;&gt;
          1.30%
        &lt;/td&gt;
        &lt;td style=&quot;width: 7%; text-align: center&quot;&gt;
          -
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center; width: 3%&quot;&gt;
          1.39%
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right; width: 3%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 3%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 7%; text-align: center&quot;&gt;
          -
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center; width: 3%&quot;&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;background-color: White&quot;&gt;
        &lt;td&gt;
          Expected volatility
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
          53.28%
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
          -
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: top; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td&gt;
          Expected lives (years)
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
          4
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
          -
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;background-color: White&quot;&gt;
        &lt;td&gt;
          Expected dividend yield
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
          0.00%
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
          -
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;&lt;table border=&quot;0&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif&quot;&gt;
      &lt;tr&gt;
        &lt;td style=&quot;font-weight: bold&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;7&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0; text-align: center&quot;&gt;
            &lt;b&gt;Nine Months Ended&lt;/b&gt;
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0; text-align: center&quot;&gt;
            &lt;b&gt;September 30,&lt;/b&gt;
          &lt;/p&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;b&gt;2014&lt;/b&gt;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; text-align: center; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;b&gt;2013&lt;/b&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;width: 71%&quot;&gt;
          Risk free interest rate
        &lt;/td&gt;
        &lt;td style=&quot;width: 3%; text-align: center&quot;&gt;
          1.16%
        &lt;/td&gt;
        &lt;td style=&quot;width: 7%; text-align: center&quot;&gt;
          -
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center; width: 3%&quot;&gt;
          1.39%
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right; width: 3%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 3%; text-align: center&quot;&gt;
          0.61%
        &lt;/td&gt;
        &lt;td style=&quot;width: 7%; text-align: center&quot;&gt;
          -
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center; width: 3%&quot;&gt;
          0.70%
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;background-color: White&quot;&gt;
        &lt;td&gt;
          Expected volatility
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
          53.28%
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
          57.60%
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: top; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td&gt;
          Expected lives (years)
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
          4
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
          4
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;background-color: White&quot;&gt;
        &lt;td&gt;
          Expected dividend yield
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
          0.00%
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
          0.00%
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
  <us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate unitRef="pure" contextRef="c31_From1Jul2014To30Sep2014_MinimumMember" decimals="4">0.0130</us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate>
  <us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate unitRef="pure" contextRef="c32_From1Jul2014To30Sep2014_MaximumMember" decimals="4">0.0139</us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate>
  <us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate unitRef="pure" contextRef="c29_From1Jan2014To30Sep2014_MinimumMember" decimals="4">0.0116</us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate>
  <us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate unitRef="pure" contextRef="c30_From1Jan2014To30Sep2014_MaximumMember" decimals="4">0.0139</us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate>
  <us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate unitRef="pure" contextRef="c33_From1Jan2013To30Sep2013_MinimumMember" decimals="4">0.0061</us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate>
  <us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate unitRef="pure" contextRef="c34_From1Jan2013To30Sep2013_MaximumMember" decimals="4">0.0070</us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate unitRef="pure" contextRef="c2_From1Jul2014To30Sep2014" decimals="4">0.5328</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate unitRef="pure" contextRef="c4_From1Jan2014To30Sep2014" decimals="4">0.5328</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate unitRef="pure" contextRef="c5_From1Jan2013To30Sep2013" decimals="4">0.5760</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c2_From1Jul2014To30Sep2014">P4Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c4_From1Jan2014To30Sep2014">P4Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c5_From1Jan2013To30Sep2013">P4Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate unitRef="pure" contextRef="c2_From1Jul2014To30Sep2014" decimals="4">0.0000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate unitRef="pure" contextRef="c4_From1Jan2014To30Sep2014" decimals="4">0.0000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate unitRef="pure" contextRef="c5_From1Jan2013To30Sep2013" decimals="4">0.0000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:EarningsPerShareTextBlock contextRef="c4_From1Jan2014To30Sep2014">&lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse&quot;&gt;
      &lt;tr style=&quot;vertical-align: top&quot;&gt;
        &lt;td style=&quot;width: 6%&quot;&gt;
          &lt;b&gt;6.&lt;/b&gt;
        &lt;/td&gt;
        &lt;td style=&quot;width: 94%&quot;&gt;
          &lt;b&gt;Earnings Per Share&lt;/b&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in&quot;&gt;
      The Company reports earnings per share in accordance with ASC 260, &lt;i&gt;Earnings Per Share&lt;/i&gt;, which establishes standards for computing and presenting earnings per share. Basic earnings per share is computed by dividing net income available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing net income available to common shareholders by the weighted average number of common shares outstanding and the number of dilutive potential common share equivalents during the period. Under the treasury stock method, unexercised &amp;#8220;in-the-money&amp;#8221; stock options are assumed to be exercised at the beginning of the period or at issuance, if later. The assumed proceeds are then used to purchase common shares at the average market price during the period.
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in&quot;&gt;
      Basic and diluted earnings per share for the three and nine-month periods ended September 30, 2014 and 2013 are as follows:&amp;#160;
    &lt;/p&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif&quot;&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;7&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          Three Months Ended September 30,
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;7&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          Nine Months Ended September 30,
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td style=&quot;font-weight: bold&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          2014
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          2013
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          2014
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          2013
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;width: 56%; text-align: left&quot;&gt;
          Shares used in the calculation of basic earnings per share
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          14,758,781
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          13,682,449
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          14,626,933
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          13,534,334
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          Effect of dilutive securities:
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-bottom: 1.1pt; padding-left: 10pt&quot;&gt;
          Stock options, SARs, and RSAs
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          676,094
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          1,276,516
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          842,304
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          1,139,545
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-bottom: 2.75pt&quot;&gt;
          Diluted shares used in the calculation of earnings per share
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          15,434,875
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          14,958,965
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          15,469,237
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          14,673,879
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in&quot;&gt;
      Equity awards of 122,967 and 118,725 shares were outstanding for the three and nine-month periods ended September 30, 2014, respectively, and were not included in the computation of diluted earnings per share because the awards&amp;#8217; impact on earnings per share was anti-dilutive. There were no anti-dilutive equity awards for the three month period ended September 30, 2013. Equity awards of 88,278 shares were outstanding for the nine-month period ended September 30, 2013, and were not included in the computation of diluted earnings per share because the awards&amp;#8217; impact on earnings per share was anti-dilutive.&amp;#160;&amp;#160;&amp;#160;
    &lt;/p&gt;&lt;br/&gt;</us-gaap:EarningsPerShareTextBlock>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c2_From1Jul2014To30Sep2014" decimals="INF">122967</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c4_From1Jan2014To30Sep2014" decimals="INF">118725</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c3_From1Jul2013To30Sep2013" decimals="INF">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c5_From1Jan2013To30Sep2013" decimals="INF">88278</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c4_From1Jan2014To30Sep2014">&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif&quot;&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;7&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          Three Months Ended September 30,
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;7&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          Nine Months Ended September 30,
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td style=&quot;font-weight: bold&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          2014
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          2013
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          2014
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          2013
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;width: 56%; text-align: left&quot;&gt;
          Shares used in the calculation of basic earnings per share
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          14,758,781
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          13,682,449
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          14,626,933
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          13,534,334
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          Effect of dilutive securities:
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-bottom: 1.1pt; padding-left: 10pt&quot;&gt;
          Stock options, SARs, and RSAs
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          676,094
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          1,276,516
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          842,304
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          1,139,545
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-bottom: 2.75pt&quot;&gt;
          Diluted shares used in the calculation of earnings per share
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          15,434,875
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          14,958,965
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          15,469,237
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          14,673,879
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
  <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment unitRef="shares" contextRef="c2_From1Jul2014To30Sep2014" decimals="INF">676094</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
  <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment unitRef="shares" contextRef="c3_From1Jul2013To30Sep2013" decimals="INF">1276516</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
  <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment unitRef="shares" contextRef="c4_From1Jan2014To30Sep2014" decimals="INF">842304</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
  <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment unitRef="shares" contextRef="c5_From1Jan2013To30Sep2013" decimals="INF">1139545</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
  <us-gaap:InventoryDisclosureTextBlock contextRef="c4_From1Jan2014To30Sep2014">&lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse&quot;&gt;
      &lt;tr style=&quot;vertical-align: top&quot;&gt;
        &lt;td style=&quot;width: 6%&quot;&gt;
          &lt;b&gt;7.&lt;/b&gt;
        &lt;/td&gt;
        &lt;td style=&quot;width: 94%&quot;&gt;
          &lt;b&gt;Inventories&lt;/b&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in&quot;&gt;
      Inventories consist of the following:
    &lt;/p&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif&quot;&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td style=&quot;font-weight: bold&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; nowrap=&quot;nowrap&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            September 30,
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            2014
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; nowrap=&quot;nowrap&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            December 31,
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            2013
          &lt;/p&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;width: 78%; text-align: left&quot;&gt;
          Raw materials
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          6,843,441
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          5,926,030
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          Work-in-process
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          2,325,667
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          2,308,233
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-bottom: 1.1pt&quot;&gt;
          Finished goods
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          4,413,348
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          2,762,522
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-bottom: 2.75pt; padding-left: 10pt&quot;&gt;
          Total
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          13,582,456
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          10,996,785
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in&quot;&gt;
      Inventories are stated at the lower of cost or market, with cost being determined using the first-in, first-out method. Work-in-process and finished goods inventories include materials, labor, and manufacturing overhead.
    &lt;/p&gt;&lt;br/&gt;</us-gaap:InventoryDisclosureTextBlock>
  <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="c4_From1Jan2014To30Sep2014">&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif&quot;&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td style=&quot;font-weight: bold&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; nowrap=&quot;nowrap&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            September 30,
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            2014
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; nowrap=&quot;nowrap&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            December 31,
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            2013
          &lt;/p&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;width: 78%; text-align: left&quot;&gt;
          Raw materials
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          6,843,441
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          5,926,030
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          Work-in-process
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          2,325,667
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          2,308,233
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-bottom: 1.1pt&quot;&gt;
          Finished goods
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          4,413,348
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          2,762,522
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-bottom: 2.75pt; padding-left: 10pt&quot;&gt;
          Total
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          13,582,456
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          10,996,785
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
  <us-gaap:InventoryRawMaterials unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">6843441</us-gaap:InventoryRawMaterials>
  <us-gaap:InventoryRawMaterials unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="0">5926030</us-gaap:InventoryRawMaterials>
  <us-gaap:InventoryWorkInProcess unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">2325667</us-gaap:InventoryWorkInProcess>
  <us-gaap:InventoryWorkInProcess unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="0">2308233</us-gaap:InventoryWorkInProcess>
  <us-gaap:InventoryFinishedGoods unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">4413348</us-gaap:InventoryFinishedGoods>
  <us-gaap:InventoryFinishedGoods unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="0">2762522</us-gaap:InventoryFinishedGoods>
<!-- [WMV4][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt8UCLPdYZl35nXbOCDIyGTq8kWYS5mE4nIDdhC6ZUZ3C7uZIfzBVpwVZvunzSNea5mQTTlY4E6meqyItzXsZeYoFfvM/Avp17arPuR/GW0mknfKp3JQjUBUq0bHVHYbNAE8Fh5fiLkIMcVQlbp04OxRRXjc+Ssu9cPRpFdgx0G2vpzwAswTXRmMT0FZiyY6i+pESiYgInqphFbCJaX13L4V] CSR-->
  <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock contextRef="c4_From1Jan2014To30Sep2014">&lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse&quot;&gt;
      &lt;tr style=&quot;vertical-align: top&quot;&gt;
        &lt;td style=&quot;width: 6%&quot;&gt;
          &lt;b&gt;8.&amp;#160;&amp;#160;&lt;/b&gt;
        &lt;/td&gt;
        &lt;td style=&quot;width: 94%; text-align: justify&quot;&gt;
          &lt;b&gt;Intangible Assets and Goodwill&lt;/b&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in&quot;&gt;
      In connection with the acquisition of Anika Therapeutics S.r.l. (&amp;#8220;Anika S.r.l.&amp;#8221;), the Company acquired various intangible assets and goodwill.&amp;#160;The Company evaluated the various intangible assets and related cash flows from these intangible assets, as well as the useful lives and amortization methods related to these intangible assets.&amp;#160;The in-process research and development (&amp;#8220;IPR&amp;amp;D&amp;#8221;) intangible assets initially have indefinite lives and are reviewed periodically to assess the project status, valuation, and disposition, including write-off(s) for abandoned projects.&amp;#160;Until such determination is made, they are not amortized.&amp;#160;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in&quot;&gt;
      The Company reviews its long-lived assets for impairment at least annually. Additionally, the Company will initiate a review for impairment if events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable or that the useful lives of the assets are no longer appropriate. Each impairment test will be based on a comparison of the undiscounted cash flows to the recorded value of the asset. If impairment is indicated, the asset is written down to its estimated fair value.
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in&quot;&gt;
      Intangible assets as of September 30, 2014 and December 31, 2013 consist of the following:
    &lt;/p&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif&quot;&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;11&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          September 30, 2014
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;7&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          December 31, 2013
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          Gross Value
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Currency
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Translation
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Adjustment
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Accumulated
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Amortization
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Net Book
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Value
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Net Book
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Value
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          Useful Life
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;width: 34%; text-align: left&quot;&gt;
          Developed technology
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          16,700,000
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          (1,828,214
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          )
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          (4,779,123
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          )
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          10,092,663
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          11,753,003
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: center&quot;&gt;
          15
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          In-process research &amp;amp; development
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          5,502,686
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          (638,426
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          )
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          -
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          4,864,260
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          5,286,127
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
          Indefinite
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          Distributor relationships
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          4,700,000
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          (440,953
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          )
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          (4,084,944
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          )
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          174,103
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          863,655
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
          5
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td&gt;
          Patents
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          1,000,000
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          (107,910
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          )
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          (271,208
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          )
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          620,882
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          719,574
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
          16
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-bottom: 1.1pt&quot;&gt;
          Elevess trade name
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          1,000,000
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          -
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          (717,964
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          )
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          282,036
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          376,050
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt; text-align: center&quot;&gt;
          9
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt; padding-left: 10pt&quot;&gt;
          Total
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          28,902,686
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          (3,015,503
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          )
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          (9,853,239
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          )
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          16,033,944
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          18,998,409
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt; text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in&quot;&gt;
      The aggregate amortization expense related to intangible assets was $518,699 and $521,387 for the three-month periods ended September 30, 2014 and 2013, respectively. The aggregate amortization expense related to intangible assets was $1,593,260 and $1,555,796 for the nine-month periods ended September 30, 2014 and 2013, respectively.
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in&quot;&gt;
      Changes in the carrying value of goodwill for the three and nine-month periods ended September 30, 2014 were as follows:
    &lt;/p&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif&quot;&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          Goodwill
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; nowrap=&quot;nowrap&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Three
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Months Ended
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            September 30,
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            2014
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; nowrap=&quot;nowrap&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Nine
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Months Ended
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            September 30,
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            2014
          &lt;/p&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;font-weight: bold&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;width: 78%; text-align: left&quot;&gt;
          Balance, beginning
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          9,360,884
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          9,443,894
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-bottom: 1.1pt&quot;&gt;
          Effect of foreign currency adjustments
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          (658,589
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          )
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          (741,599
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          )
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          Balance, ending
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          8,702,295
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          8,702,295
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;&lt;br/&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
  <us-gaap:AmortizationOfIntangibleAssets unitRef="usd" contextRef="c2_From1Jul2014To30Sep2014" decimals="0">518699</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:AmortizationOfIntangibleAssets unitRef="usd" contextRef="c3_From1Jul2013To30Sep2013" decimals="0">521387</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:AmortizationOfIntangibleAssets unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">1593260</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:AmortizationOfIntangibleAssets unitRef="usd" contextRef="c5_From1Jan2013To30Sep2013" decimals="0">1555796</us-gaap:AmortizationOfIntangibleAssets>
  <anik:ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTableTextBlock contextRef="c4_From1Jan2014To30Sep2014">&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif&quot;&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;11&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          September 30, 2014
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;7&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          December 31, 2013
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          Gross Value
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Currency
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Translation
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Adjustment
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Accumulated
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Amortization
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Net Book
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Value
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Net Book
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Value
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          Useful Life
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;width: 34%; text-align: left&quot;&gt;
          Developed technology
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          16,700,000
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          (1,828,214
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          )
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          (4,779,123
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          )
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          10,092,663
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          11,753,003
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: center&quot;&gt;
          15
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          In-process research &amp;amp; development
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          5,502,686
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          (638,426
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          )
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          -
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          4,864,260
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          5,286,127
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
          Indefinite
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          Distributor relationships
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          4,700,000
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          (440,953
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          )
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          (4,084,944
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          )
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          174,103
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          863,655
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
          5
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td&gt;
          Patents
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          1,000,000
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          (107,910
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          )
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          (271,208
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          )
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          620,882
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          719,574
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: center&quot;&gt;
          16
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-bottom: 1.1pt&quot;&gt;
          Elevess trade name
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          1,000,000
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          -
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          (717,964
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          )
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          282,036
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          376,050
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt; text-align: center&quot;&gt;
          9
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt; padding-left: 10pt&quot;&gt;
          Total
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          28,902,686
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          (3,015,503
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          )
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          (9,853,239
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          )
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          16,033,944
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          18,998,409
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt; text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;</anik:ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTableTextBlock>
  <anik:IntangibleAssetsGrossCarryingAmount unitRef="usd" contextRef="c35_AsOf30Sep2014_DevelopedTechnologyRightsMember" decimals="0">16700000</anik:IntangibleAssetsGrossCarryingAmount>
  <anik:IntangibleAssetsTranslationAdjustments unitRef="usd" contextRef="c36_From1Jan2014To30Sep2014_DevelopedTechnologyRightsMember" decimals="0">-1828214</anik:IntangibleAssetsTranslationAdjustments>
  <anik:IntangibleAssetsAccumulatedAmortization unitRef="usd" contextRef="c35_AsOf30Sep2014_DevelopedTechnologyRightsMember" decimals="0">-4779123</anik:IntangibleAssetsAccumulatedAmortization>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill unitRef="usd" contextRef="c35_AsOf30Sep2014_DevelopedTechnologyRightsMember" decimals="0">10092663</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill unitRef="usd" contextRef="c37_AsOf31Dec2013_DevelopedTechnologyRightsMember" decimals="0">11753003</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c38_From1Jan2013To31Dec2013_DevelopedTechnologyRightsMember">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <anik:IntangibleAssetsGrossCarryingAmount unitRef="usd" contextRef="c39_AsOf30Sep2014_InProcessResearchAndDevelopmentMember" decimals="0">5502686</anik:IntangibleAssetsGrossCarryingAmount>
  <anik:IntangibleAssetsTranslationAdjustments unitRef="usd" contextRef="c40_From1Jan2014To30Sep2014_InProcessResearchAndDevelopmentMember" decimals="0">-638426</anik:IntangibleAssetsTranslationAdjustments>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill unitRef="usd" contextRef="c39_AsOf30Sep2014_InProcessResearchAndDevelopmentMember" decimals="0">4864260</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill unitRef="usd" contextRef="c41_AsOf31Dec2013_InProcessResearchAndDevelopmentMember" decimals="0">5286127</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c42_From1Jan2013To31Dec2013_InProcessResearchAndDevelopmentMember" xs:nil="true"/>
  <anik:IntangibleAssetsGrossCarryingAmount unitRef="usd" contextRef="c43_AsOf30Sep2014_DistributionRightsMember" decimals="0">4700000</anik:IntangibleAssetsGrossCarryingAmount>
  <anik:IntangibleAssetsTranslationAdjustments unitRef="usd" contextRef="c44_From1Jan2014To30Sep2014_DistributionRightsMember" decimals="0">-440953</anik:IntangibleAssetsTranslationAdjustments>
  <anik:IntangibleAssetsAccumulatedAmortization unitRef="usd" contextRef="c43_AsOf30Sep2014_DistributionRightsMember" decimals="0">-4084944</anik:IntangibleAssetsAccumulatedAmortization>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill unitRef="usd" contextRef="c43_AsOf30Sep2014_DistributionRightsMember" decimals="0">174103</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill unitRef="usd" contextRef="c45_AsOf31Dec2013_DistributionRightsMember" decimals="0">863655</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c46_From1Jan2013To31Dec2013_DistributionRightsMember">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <anik:IntangibleAssetsGrossCarryingAmount unitRef="usd" contextRef="c47_AsOf30Sep2014_PatentsMember" decimals="0">1000000</anik:IntangibleAssetsGrossCarryingAmount>
  <anik:IntangibleAssetsTranslationAdjustments unitRef="usd" contextRef="c48_From1Jan2014To30Sep2014_PatentsMember" decimals="0">-107910</anik:IntangibleAssetsTranslationAdjustments>
  <anik:IntangibleAssetsAccumulatedAmortization unitRef="usd" contextRef="c47_AsOf30Sep2014_PatentsMember" decimals="0">-271208</anik:IntangibleAssetsAccumulatedAmortization>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill unitRef="usd" contextRef="c47_AsOf30Sep2014_PatentsMember" decimals="0">620882</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill unitRef="usd" contextRef="c49_AsOf31Dec2013_PatentsMember" decimals="0">719574</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c50_From1Jan2013To31Dec2013_PatentsMember">P16Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <anik:IntangibleAssetsGrossCarryingAmount unitRef="usd" contextRef="c51_AsOf30Sep2014_ElevessTradeNameMember" decimals="0">1000000</anik:IntangibleAssetsGrossCarryingAmount>
  <anik:IntangibleAssetsAccumulatedAmortization unitRef="usd" contextRef="c51_AsOf30Sep2014_ElevessTradeNameMember" decimals="0">-717964</anik:IntangibleAssetsAccumulatedAmortization>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill unitRef="usd" contextRef="c51_AsOf30Sep2014_ElevessTradeNameMember" decimals="0">282036</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill unitRef="usd" contextRef="c52_AsOf31Dec2013_ElevessTradeNameMember" decimals="0">376050</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c53_From1Jan2013To31Dec2013_ElevessTradeNameMember">P9Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <anik:IntangibleAssetsGrossCarryingAmount unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">28902686</anik:IntangibleAssetsGrossCarryingAmount>
  <anik:IntangibleAssetsTranslationAdjustments unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">-3015503</anik:IntangibleAssetsTranslationAdjustments>
  <anik:IntangibleAssetsAccumulatedAmortization unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">-9853239</anik:IntangibleAssetsAccumulatedAmortization>
  <us-gaap:ScheduleOfGoodwillTextBlock contextRef="c4_From1Jan2014To30Sep2014">&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif&quot;&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          Goodwill
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; nowrap=&quot;nowrap&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Three
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Months Ended
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            September 30,
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            2014
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; nowrap=&quot;nowrap&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Nine
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Months Ended
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            September 30,
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            2014
          &lt;/p&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;font-weight: bold&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;width: 78%; text-align: left&quot;&gt;
          Balance, beginning
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          9,360,884
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          9,443,894
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-bottom: 1.1pt&quot;&gt;
          Effect of foreign currency adjustments
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          (658,589
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          )
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          (741,599
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          )
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          Balance, ending
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          8,702,295
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          8,702,295
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
  <us-gaap:Goodwill unitRef="usd" contextRef="c54_AsOf30Jun2014" decimals="0">9360884</us-gaap:Goodwill>
  <us-gaap:GoodwillTranslationAdjustments unitRef="usd" contextRef="c2_From1Jul2014To30Sep2014" decimals="0">-658589</us-gaap:GoodwillTranslationAdjustments>
  <us-gaap:GoodwillTranslationAdjustments unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">-741599</us-gaap:GoodwillTranslationAdjustments>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="c4_From1Jan2014To30Sep2014">&lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse&quot;&gt;
      &lt;tr style=&quot;vertical-align: top&quot;&gt;
        &lt;td style=&quot;width: 6%&quot;&gt;
          &lt;b&gt;9.&lt;/b&gt;
        &lt;/td&gt;
        &lt;td style=&quot;width: 94%&quot;&gt;
          &lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;
            &lt;b&gt;Accrued Expenses&lt;/b&gt;
          &lt;/p&gt;
          &lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;
          &lt;/p&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in&quot;&gt;
      Accrued expenses consist of the following:
    &lt;/p&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif&quot;&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; nowrap=&quot;nowrap&quot; style=&quot;text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            &lt;b&gt;September 30,&lt;/b&gt;
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            &lt;b&gt;2014&lt;/b&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; nowrap=&quot;nowrap&quot; style=&quot;text-align: right; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0; text-align: center&quot;&gt;
            &lt;b&gt;December&amp;#160;31,&lt;/b&gt;
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0; text-align: center&quot;&gt;
            &lt;b&gt;2013&lt;/b&gt;
          &lt;/p&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;width: 78%; text-align: left&quot;&gt;
          Labor and related expenses
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          2,842,234
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          2,870,147
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          Clinical trial costs
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          962,031
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          882,651
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          Professional fees
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          382,423
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          383,231
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          Research grants
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          562,558
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          610,498
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          Restructuring costs
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          11,909
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          24,638
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-bottom: 1.1pt&quot;&gt;
          Other
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          492,538
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          766,716
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-bottom: 2.75pt; padding-left: 10pt&quot;&gt;
          Total
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          5,253,693
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          5,537,881
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;&lt;br/&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
  <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="c4_From1Jan2014To30Sep2014">&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif&quot;&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; nowrap=&quot;nowrap&quot; style=&quot;text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            &lt;b&gt;September 30,&lt;/b&gt;
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            &lt;b&gt;2014&lt;/b&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; nowrap=&quot;nowrap&quot; style=&quot;text-align: right; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0; text-align: center&quot;&gt;
            &lt;b&gt;December&amp;#160;31,&lt;/b&gt;
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0; text-align: center&quot;&gt;
            &lt;b&gt;2013&lt;/b&gt;
          &lt;/p&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;width: 78%; text-align: left&quot;&gt;
          Labor and related expenses
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          2,842,234
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          2,870,147
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          Clinical trial costs
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          962,031
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          882,651
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          Professional fees
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          382,423
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          383,231
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          Research grants
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          562,558
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          610,498
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          Restructuring costs
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          11,909
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          24,638
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-bottom: 1.1pt&quot;&gt;
          Other
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          492,538
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          766,716
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-bottom: 2.75pt; padding-left: 10pt&quot;&gt;
          Total
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          5,253,693
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          5,537,881
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">2842234</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="0">2870147</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <anik:AccruedClinicalTrialCostsCurrent unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">962031</anik:AccruedClinicalTrialCostsCurrent>
  <anik:AccruedClinicalTrialCostsCurrent unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="0">882651</anik:AccruedClinicalTrialCostsCurrent>
  <us-gaap:AccruedProfessionalFeesCurrent unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">382423</us-gaap:AccruedProfessionalFeesCurrent>
  <us-gaap:AccruedProfessionalFeesCurrent unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="0">383231</us-gaap:AccruedProfessionalFeesCurrent>
  <anik:AccruedResearchGrantsCurrent unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">562558</anik:AccruedResearchGrantsCurrent>
  <anik:AccruedResearchGrantsCurrent unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="0">610498</anik:AccruedResearchGrantsCurrent>
  <us-gaap:RestructuringReserveCurrent unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">11909</us-gaap:RestructuringReserveCurrent>
  <us-gaap:RestructuringReserveCurrent unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="0">24638</us-gaap:RestructuringReserveCurrent>
  <us-gaap:OtherAccruedLiabilitiesCurrent unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">492538</us-gaap:OtherAccruedLiabilitiesCurrent>
  <us-gaap:OtherAccruedLiabilitiesCurrent unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="0">766716</us-gaap:OtherAccruedLiabilitiesCurrent>
  <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c4_From1Jan2014To30Sep2014">&lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse&quot;&gt;
      &lt;tr style=&quot;vertical-align: top&quot;&gt;
        &lt;td style=&quot;width: 6%&quot;&gt;
          &lt;b&gt;10.&lt;/b&gt;
        &lt;/td&gt;
        &lt;td style=&quot;width: 94%&quot;&gt;
          &lt;b&gt;Commitments and Contingencies&lt;/b&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in&quot;&gt;
      In certain of its contracts, the Company warrants to its customers that the products it manufactures conform to the product specifications as in effect at the time of delivery of the product. The Company may also warrant that the products it manufactures do not infringe, violate or breach any patent or intellectual property rights, trade secret or other proprietary information of any third party. On occasion, the Company contractually indemnifies its customers against any and all losses arising out of, or in any way connected with, any claim or claims of breach of its warranties or any actual or alleged defect in any product caused by the negligence or acts or omissions of the Company.&amp;#160;The Company maintains a products liability insurance policy that limits its exposure. Based on the Company&amp;#8217;s historical activity in combination with its insurance policy coverage, the Company believes the estimated fair value of these indemnification agreements is minimal. The Company
      has no accrued warranties and has no history of claims paid.
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in&quot;&gt;
      On July 7, 2010, Genzyme Corporation filed a complaint against the Company in the United States District Court for the District of Massachusetts seeking unspecified damages and equitable relief. The complaint alleged that the Company infringed U.S. Patent No. 5,143,724 by manufacturing MONOVISC&amp;#174; in the United States for sale outside the United States and would infringe U.S. Patent Nos. 5,143,724 and 5,399,351&amp;#160;if the Company manufactured and sold MONOVISC in the United States. On March 7, 2014, Genzyme and the Company filed a joint motion to lift the stay in Genzyme&amp;#8217;s lawsuit against the Company and to dismiss with prejudice all of Genzyme&amp;#8217;s claims. On March 10, 2014, the District Court granted the motion to dismiss with prejudice all of Genzyme&amp;#8217;s claims against the Company and the case was terminated.
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in&quot;&gt;
      The Company is also involved in various other legal proceedings arising in the normal course of business.&amp;#160;Although the outcomes of these other legal proceedings are inherently difficult to predict, the Company does not expect the resolution of these other legal proceedings to have a material adverse effect on its financial position, results of operations or cash flow.&amp;#160;
    &lt;/p&gt;&lt;br/&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
  <us-gaap:ProductWarrantyAccrual unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">0</us-gaap:ProductWarrantyAccrual>
  <us-gaap:ProductWarrantyExpense unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">0</us-gaap:ProductWarrantyExpense>
  <us-gaap:DeferredRevenueDisclosureTextBlock contextRef="c4_From1Jan2014To30Sep2014">&lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse&quot;&gt;
      &lt;tr style=&quot;vertical-align: top&quot;&gt;
        &lt;td style=&quot;width: 6%&quot;&gt;
          &lt;b&gt;11.&lt;/b&gt;
        &lt;/td&gt;
        &lt;td style=&quot;width: 94%&quot;&gt;
          &lt;b&gt;Mitek Monovisc Agreement&lt;/b&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in&quot;&gt;
      In December 2011, the Company entered into a fifteen-year licensing agreement (the &amp;#8220;Mitek MONOVISC Agreement&amp;#8221;) with DePuy Synthes Mitek Sports Medicine, a division of DePuy Orthopaedics, Inc., to exclusively market MONOVISC in the U.S. The Company received an upfront payment of $2,500,000 in December 2011. This non-refundable upfront payment did not have standalone value without Anika&amp;#8217;s completion of development obligations which included obtaining regulatory approval of the product and resolving the patent litigation. As a result, we recognized the upfront payment over the development obligation period. During the first quarter of 2014, the Company received FDA approval of MONOVISC and resolved the patent lawsuit with Genzyme Corporation. As a result of the full delivery of its development obligations under this agreement, the Company recognized approximately $2,200,000 which represents the remaining balance of deferred revenue relating to the initial
      $2,500,000 payment in accordance with current generally accepted principles on revenue recognition. In the first quarter of 2014, the Company also received a milestone payment of $17,500,000 as a result of achieving FDA approval for MONOVISC and resolving the patent litigation with Genzyme. This milestone payment was fully recognized as revenue during the three months ended March 31, 2014. On April 15, 2014 the first U.S. commercial sale of MONOVISC was made by our commercial partner, DePuy Synthes Mitek Sports Medicine. Under the terms of the Mitek MONOVISC Agreement, the Company earned and collected a milestone payment of $5 million, which was fully recognized as revenue in the second quarter of 2014.
    &lt;/p&gt;&lt;br/&gt;</us-gaap:DeferredRevenueDisclosureTextBlock>
  <anik:ContractTermYears contextRef="c55_From1Dec2011To31Dec2011_MiltekMONOVISCAgreementMember">P15Y</anik:ContractTermYears>
  <us-gaap:DeferredRevenue unitRef="usd" contextRef="c56_AsOf31Dec2011_MiltekMONOVISCAgreementMember" decimals="0">2500000</us-gaap:DeferredRevenue>
  <us-gaap:DeferredRevenueRevenueRecognized unitRef="usd" contextRef="c57_From1Jan2014To31Mar2014_MiltekMONOVISCAgreementMember" decimals="0">2200000</us-gaap:DeferredRevenueRevenueRecognized>
  <us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized unitRef="usd" contextRef="c57_From1Jan2014To31Mar2014_MiltekMONOVISCAgreementMember" decimals="0">17500000</us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized>
  <us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized unitRef="usd" contextRef="c58_From1Apr2014To30Jun2014_MiltekMONOVISCAgreementMember" decimals="-6">5000000</us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized>
  <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c4_From1Jan2014To30Sep2014">&lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse&quot;&gt;
      &lt;tr style=&quot;vertical-align: top&quot;&gt;
        &lt;td style=&quot;width: 6%&quot;&gt;
          &lt;b&gt;12.&lt;/b&gt;
        &lt;/td&gt;
        &lt;td style=&quot;width: 94%&quot;&gt;
          &lt;b&gt;Income Taxes&lt;/b&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in&quot;&gt;
      Provisions for income taxes were $4,125,355 and $18,872,435 for the three and nine-month periods ended September 30, 2014, respectively, based on effective tax rates of 40% and 38%. Provisions for income taxes were $2,776,199 and $8,147,282 for the three and nine-month periods ended September 30, 2013, respectively, based on effective tax rates of 36% and 37%, respectively. The increase in income taxes over the three-month period ended September 30, 2014 was primarily due to increased net income. The increase in income taxes over the nine-month period ended September 30, 2014 was primarily due to increased net income, which reflected $24,652,778 in milestone and contract revenue associated with our U.S. license agreement for MONOVISC. See the previous discussion under Note 11. The increase in the effective tax rate for each of the periods ended 2014, as compared to the same periods ended in 2013, was driven primarily by the unavailability of the federal R&amp;amp;D tax credit in
      2014, due to its expiration on December 31, 2013, and a relative decrease to our estimated production activities deduction.
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in&quot;&gt;
      The Company files income tax returns in the U.S. on a federal basis, in certain U.S. states, and in Italy. The associated tax filings remain subject to examination by applicable tax authorities for a certain length of time following the tax year to which those filings relate. Our filings from 2011 through the present tax year remain subject to examination by the IRS and other taxing authorities for U.S. federal and state tax purposes. Our filings from 2009 through the present tax year remain subject to examination by the appropriate governmental authorities in Italy.
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in&quot;&gt;
      In connection with the preparation of the financial statements, the Company performed an analysis to ascertain if it was more likely than not that it would be able to utilize, in future periods, the net deferred tax assets associated with its net operating loss carryforward. We have concluded that the positive evidence outweighs the negative evidence and, thus, those deferred tax assets are realizable on a &amp;#8220;more likely than not&amp;#8221; basis. As such, we have not recorded a valuation allowance at September 30, 2014 or December 31, 2013.&amp;#160;
    &lt;/p&gt;&lt;br/&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations unitRef="pure" contextRef="c2_From1Jul2014To30Sep2014" decimals="2">0.40</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations unitRef="pure" contextRef="c4_From1Jan2014To30Sep2014" decimals="2">0.38</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations unitRef="pure" contextRef="c3_From1Jul2013To30Sep2013" decimals="2">0.36</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations unitRef="pure" contextRef="c5_From1Jan2013To30Sep2013" decimals="2">0.37</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
  <us-gaap:ContractsRevenue unitRef="usd" contextRef="c59_From1Jan2014To30Sep2014_MilestoneAndContractRevenueMember" decimals="0">24652778</us-gaap:ContractsRevenue>
  <us-gaap:OpenTaxYear contextRef="c60_From1Jan2014To30Sep2014_DomesticCountryMember_InternalRevenueServiceIRSMember_EarliestTaxYearMember">2011</us-gaap:OpenTaxYear>
  <us-gaap:OpenTaxYear contextRef="c61_From1Jan2014To30Sep2014_ForeignCountryMember_MinistryOfEconomicAffairsAndFinanceItalyMember_EarliestTaxYearMember">2009</us-gaap:OpenTaxYear>
  <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c4_From1Jan2014To30Sep2014">&lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;font-size: 10pt; width: 100%; border-collapse: collapse&quot;&gt;
      &lt;tr style=&quot;vertical-align: top&quot;&gt;
        &lt;td style=&quot;width: 6%&quot;&gt;
          &lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;
            &lt;b&gt;&amp;#160;13.&lt;/b&gt;
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td style=&quot;width: 94%&quot;&gt;
          &lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0&quot;&gt;
            &lt;b&gt;&amp;#160;Segment and Geographic Information&lt;/b&gt;
          &lt;/p&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in&quot;&gt;
      The Company has one reportable operating segment, the results of which are disclosed in the accompanying unaudited condensed consolidated financial statements.
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in&quot;&gt;
      Product revenue by product group is as follows:
    &lt;/p&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif&quot;&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;7&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          Three Months Ended September 30,
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;7&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          Nine Months Ended September 30,
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          2014
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          2013
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          2014
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          2013
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 54%; text-align: left&quot;&gt;
          Orthobiologics
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          18,899,873
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          12,830,566
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          48,750,277
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          40,620,339
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          Dermal
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          401,355
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          267,766
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          938,966
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          1,066,409
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          Surgical
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          1,452,946
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          1,136,248
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          4,581,496
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          3,955,134
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          Ophthalmic
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          366,138
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          1,425,609
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          938,134
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          2,818,407
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt; text-align: left&quot;&gt;
          Veterinary
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          855,000
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          1,363,157
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          2,385,000
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          3,124,953
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt; text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          21,975,312
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          17,023,346
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          57,593,873
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          51,585,242
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in&quot;&gt;
      Total revenue by geographic location and as a percentage of overall total revenue, for the three and nine-month periods ended September 30, 2014 and 2013 are as follows;
    &lt;/p&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif&quot;&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td style=&quot;font-weight: bold&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;15&quot; style=&quot;font-weight: bold; text-align: center&quot;&gt;
          Three Months Ended September 30,
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td style=&quot;font-weight: bold&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;7&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          2014
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;7&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          2013
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td style=&quot;font-weight: bold&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Total
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Revenue
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Percentage of
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Revenue
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Total
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Revenue
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Percentage of
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Revenue
          &lt;/p&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;font-weight: bold; text-align: left&quot;&gt;
          Geographic Location:
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;width: 56%; text-align: left; padding-left: 10pt&quot;&gt;
          United States
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          18,455,167
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          84
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          %
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          14,485,821
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          82
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          %
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-left: 10pt&quot;&gt;
          Europe
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          1,784,414
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          8
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          %
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          1,656,656
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          9
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          %
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-bottom: 1.1pt; padding-left: 10pt&quot;&gt;
          Other
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          1,815,842
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          8
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          %
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          1,611,961
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          9
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          %
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-bottom: 2.75pt; padding-left: 20pt&quot;&gt;
          Total
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          22,055,423
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          100
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          %
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          17,754,438
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          100
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          %
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif&quot;&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td style=&quot;font-weight: bold&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;15&quot; style=&quot;font-weight: bold; text-align: center&quot;&gt;
          Nine Months Ended September 30,
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td style=&quot;font-weight: bold&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;7&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          2014
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;7&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          2013
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td style=&quot;font-weight: bold&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Total
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Revenue
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Percentage of
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Revenue
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Total
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Revenue
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Percentage of
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Revenue
          &lt;/p&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;font-weight: bold; text-align: left&quot;&gt;
          Geographic Location:
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;width: 56%; text-align: left; padding-left: 10pt&quot;&gt;
          United States
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          72,935,722
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          89
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          %
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          42,251,336
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          78
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          %
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-left: 10pt&quot;&gt;
          Europe
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          5,274,071
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          6
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          %
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          5,226,619
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          10
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          %
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-bottom: 1.1pt; padding-left: 10pt&quot;&gt;
          Other
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          4,130,577
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          5
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          %
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          6,351,871
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          12
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          %
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-bottom: 2.75pt; padding-left: 20pt&quot;&gt;
          Total
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          82,340,370
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          100
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          %
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          53,829,826
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          100
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          %
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;&lt;br/&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
  <us-gaap:NumberOfReportableSegments unitRef="pure" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">1</us-gaap:NumberOfReportableSegments>
  <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="c4_From1Jan2014To30Sep2014">&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif&quot;&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;7&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          Three Months Ended September 30,
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;7&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          Nine Months Ended September 30,
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          2014
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          2013
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          2014
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          2013
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 54%; text-align: left&quot;&gt;
          Orthobiologics
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          18,899,873
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          12,830,566
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          48,750,277
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          40,620,339
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          Dermal
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          401,355
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          267,766
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          938,966
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          1,066,409
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          Surgical
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          1,452,946
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          1,136,248
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          4,581,496
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          3,955,134
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          Ophthalmic
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          366,138
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          1,425,609
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          938,134
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          2,818,407
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt; text-align: left&quot;&gt;
          Veterinary
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          855,000
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          1,363,157
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          2,385,000
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          3,124,953
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt; text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          21,975,312
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          17,023,346
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          57,593,873
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          51,585,242
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
  <us-gaap:SalesRevenueGoodsNet unitRef="usd" contextRef="c62_From1Jul2014To30Sep2014_OrthobiologicsMember" decimals="0">18899873</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet unitRef="usd" contextRef="c63_From1Jul2013To30Sep2013_OrthobiologicsMember" decimals="0">12830566</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet unitRef="usd" contextRef="c64_From1Jan2014To30Sep2014_OrthobiologicsMember" decimals="0">48750277</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet unitRef="usd" contextRef="c65_From1Jan2013To30Sep2013_OrthobiologicsMember" decimals="0">40620339</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet unitRef="usd" contextRef="c66_From1Jul2014To30Sep2014_DermalMember" decimals="0">401355</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet unitRef="usd" contextRef="c67_From1Jul2013To30Sep2013_DermalMember" decimals="0">267766</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet unitRef="usd" contextRef="c68_From1Jan2014To30Sep2014_DermalMember" decimals="0">938966</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet unitRef="usd" contextRef="c69_From1Jan2013To30Sep2013_DermalMember" decimals="0">1066409</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet unitRef="usd" contextRef="c70_From1Jul2014To30Sep2014_SurgicalMember" decimals="0">1452946</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet unitRef="usd" contextRef="c71_From1Jul2013To30Sep2013_SurgicalMember" decimals="0">1136248</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet unitRef="usd" contextRef="c72_From1Jan2014To30Sep2014_SurgicalMember" decimals="0">4581496</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet unitRef="usd" contextRef="c73_From1Jan2013To30Sep2013_SurgicalMember" decimals="0">3955134</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet unitRef="usd" contextRef="c74_From1Jul2014To30Sep2014_OphthalmicMember" decimals="0">366138</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet unitRef="usd" contextRef="c75_From1Jul2013To30Sep2013_OphthalmicMember" decimals="0">1425609</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet unitRef="usd" contextRef="c76_From1Jan2014To30Sep2014_OphthalmicMember" decimals="0">938134</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet unitRef="usd" contextRef="c77_From1Jan2013To30Sep2013_OphthalmicMember" decimals="0">2818407</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet unitRef="usd" contextRef="c78_From1Jul2014To30Sep2014_VeterinaryMember" decimals="0">855000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet unitRef="usd" contextRef="c79_From1Jul2013To30Sep2013_VeterinaryMember" decimals="0">1363157</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet unitRef="usd" contextRef="c80_From1Jan2014To30Sep2014_VeterinaryMember" decimals="0">2385000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet unitRef="usd" contextRef="c81_From1Jan2013To30Sep2013_VeterinaryMember" decimals="0">3124953</us-gaap:SalesRevenueGoodsNet>
  <anik:ScheduleOfRevenueAndOperatingIncomeByGeographicalAreasTableTextBlock contextRef="c4_From1Jan2014To30Sep2014">&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif&quot;&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td style=&quot;font-weight: bold&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;15&quot; style=&quot;font-weight: bold; text-align: center&quot;&gt;
          Three Months Ended September 30,
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td style=&quot;font-weight: bold&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;7&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          2014
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;7&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          2013
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td style=&quot;font-weight: bold&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Total
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Revenue
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Percentage of
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Revenue
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Total
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Revenue
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Percentage of
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Revenue
          &lt;/p&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;font-weight: bold; text-align: left&quot;&gt;
          Geographic Location:
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;width: 56%; text-align: left; padding-left: 10pt&quot;&gt;
          United States
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          18,455,167
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          84
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          %
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          14,485,821
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          82
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          %
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-left: 10pt&quot;&gt;
          Europe
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          1,784,414
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          8
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          %
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          1,656,656
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          9
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          %
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-bottom: 1.1pt; padding-left: 10pt&quot;&gt;
          Other
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          1,815,842
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          8
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          %
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          1,611,961
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          9
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          %
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-bottom: 2.75pt; padding-left: 20pt&quot;&gt;
          Total
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          22,055,423
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          100
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          %
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          17,754,438
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          100
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          %
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif&quot;&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td style=&quot;font-weight: bold&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;15&quot; style=&quot;font-weight: bold; text-align: center&quot;&gt;
          Nine Months Ended September 30,
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td style=&quot;font-weight: bold&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;7&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          2014
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;7&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          2013
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td style=&quot;font-weight: bold&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Total
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Revenue
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Percentage of
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Revenue
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Total
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Revenue
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Percentage of
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Revenue
          &lt;/p&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;font-weight: bold; text-align: left&quot;&gt;
          Geographic Location:
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;width: 56%; text-align: left; padding-left: 10pt&quot;&gt;
          United States
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          72,935,722
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          89
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          %
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          42,251,336
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          78
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          %
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-left: 10pt&quot;&gt;
          Europe
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          5,274,071
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          6
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          %
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          5,226,619
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          10
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          %
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-bottom: 1.1pt; padding-left: 10pt&quot;&gt;
          Other
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          4,130,577
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          5
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          %
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          6,351,871
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          12
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          %
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-bottom: 2.75pt; padding-left: 20pt&quot;&gt;
          Total
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          82,340,370
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          100
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          %
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          53,829,826
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          100
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          %
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;</anik:ScheduleOfRevenueAndOperatingIncomeByGeographicalAreasTableTextBlock>
  <us-gaap:SalesRevenueNet unitRef="usd" contextRef="c82_From1Jul2014To30Sep2014_UnitedStatesMember" decimals="0">18455167</us-gaap:SalesRevenueNet>
  <anik:PercentageOfNetRevenue unitRef="pure" contextRef="c82_From1Jul2014To30Sep2014_UnitedStatesMember" decimals="2">0.84</anik:PercentageOfNetRevenue>
  <us-gaap:SalesRevenueNet unitRef="usd" contextRef="c83_From1Jul2013To30Sep2013_UnitedStatesMember" decimals="0">14485821</us-gaap:SalesRevenueNet>
  <anik:PercentageOfNetRevenue unitRef="pure" contextRef="c83_From1Jul2013To30Sep2013_UnitedStatesMember" decimals="2">0.82</anik:PercentageOfNetRevenue>
  <us-gaap:SalesRevenueNet unitRef="usd" contextRef="c84_From1Jan2014To30Sep2014_UnitedStatesMember" decimals="0">72935722</us-gaap:SalesRevenueNet>
  <anik:PercentageOfNetRevenue unitRef="pure" contextRef="c84_From1Jan2014To30Sep2014_UnitedStatesMember" decimals="2">0.89</anik:PercentageOfNetRevenue>
  <us-gaap:SalesRevenueNet unitRef="usd" contextRef="c85_From1Jan2013To30Sep2013_UnitedStatesMember" decimals="0">42251336</us-gaap:SalesRevenueNet>
  <anik:PercentageOfNetRevenue unitRef="pure" contextRef="c85_From1Jan2013To30Sep2013_UnitedStatesMember" decimals="2">0.78</anik:PercentageOfNetRevenue>
  <us-gaap:SalesRevenueNet unitRef="usd" contextRef="c86_From1Jul2014To30Sep2014_EuropeMember" decimals="0">1784414</us-gaap:SalesRevenueNet>
  <anik:PercentageOfNetRevenue unitRef="pure" contextRef="c86_From1Jul2014To30Sep2014_EuropeMember" decimals="2">0.08</anik:PercentageOfNetRevenue>
  <us-gaap:SalesRevenueNet unitRef="usd" contextRef="c87_From1Jul2013To30Sep2013_EuropeMember" decimals="0">1656656</us-gaap:SalesRevenueNet>
  <anik:PercentageOfNetRevenue unitRef="pure" contextRef="c87_From1Jul2013To30Sep2013_EuropeMember" decimals="2">0.09</anik:PercentageOfNetRevenue>
  <us-gaap:SalesRevenueNet unitRef="usd" contextRef="c88_From1Jan2014To30Sep2014_EuropeMember" decimals="0">5274071</us-gaap:SalesRevenueNet>
  <anik:PercentageOfNetRevenue unitRef="pure" contextRef="c88_From1Jan2014To30Sep2014_EuropeMember" decimals="2">0.06</anik:PercentageOfNetRevenue>
  <us-gaap:SalesRevenueNet unitRef="usd" contextRef="c89_From1Jan2013To30Sep2013_EuropeMember" decimals="0">5226619</us-gaap:SalesRevenueNet>
  <anik:PercentageOfNetRevenue unitRef="pure" contextRef="c89_From1Jan2013To30Sep2013_EuropeMember" decimals="2">0.10</anik:PercentageOfNetRevenue>
  <us-gaap:SalesRevenueNet unitRef="usd" contextRef="c90_From1Jul2014To30Sep2014_OtherLocationMember" decimals="0">1815842</us-gaap:SalesRevenueNet>
  <anik:PercentageOfNetRevenue unitRef="pure" contextRef="c90_From1Jul2014To30Sep2014_OtherLocationMember" decimals="2">0.08</anik:PercentageOfNetRevenue>
  <us-gaap:SalesRevenueNet unitRef="usd" contextRef="c91_From1Jul2013To30Sep2013_OtherLocationMember" decimals="0">1611961</us-gaap:SalesRevenueNet>
  <anik:PercentageOfNetRevenue unitRef="pure" contextRef="c91_From1Jul2013To30Sep2013_OtherLocationMember" decimals="2">0.09</anik:PercentageOfNetRevenue>
  <us-gaap:SalesRevenueNet unitRef="usd" contextRef="c92_From1Jan2014To30Sep2014_OtherLocationMember" decimals="0">4130577</us-gaap:SalesRevenueNet>
  <anik:PercentageOfNetRevenue unitRef="pure" contextRef="c92_From1Jan2014To30Sep2014_OtherLocationMember" decimals="2">0.05</anik:PercentageOfNetRevenue>
  <us-gaap:SalesRevenueNet unitRef="usd" contextRef="c93_From1Jan2013To30Sep2013_OtherLocationMember" decimals="0">6351871</us-gaap:SalesRevenueNet>
  <anik:PercentageOfNetRevenue unitRef="pure" contextRef="c93_From1Jan2013To30Sep2013_OtherLocationMember" decimals="2">0.12</anik:PercentageOfNetRevenue>
  <anik:PercentageOfNetRevenue unitRef="pure" contextRef="c2_From1Jul2014To30Sep2014" decimals="2">1.00</anik:PercentageOfNetRevenue>
  <anik:PercentageOfNetRevenue unitRef="pure" contextRef="c3_From1Jul2013To30Sep2013" decimals="2">1.00</anik:PercentageOfNetRevenue>
  <anik:PercentageOfNetRevenue unitRef="pure" contextRef="c4_From1Jan2014To30Sep2014" decimals="2">1.00</anik:PercentageOfNetRevenue>
  <anik:PercentageOfNetRevenue unitRef="pure" contextRef="c5_From1Jan2013To30Sep2013" decimals="2">1.00</anik:PercentageOfNetRevenue>
  <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock contextRef="c4_From1Jan2014To30Sep2014">&lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;font-size: 10pt; width: 100%; border-collapse: collapse&quot;&gt;
      &lt;tr style=&quot;vertical-align: top&quot;&gt;
        &lt;td style=&quot;width: 6%; font: 10pt Times New Roman, Times, Serif&quot;&gt;
          &lt;b&gt;14.&lt;/b&gt;
        &lt;/td&gt;
        &lt;td style=&quot;width: 94%; font: 10pt Times New Roman, Times, Serif&quot;&gt;
          &lt;b&gt;Restructuring Credits&lt;/b&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in&quot;&gt;
      In December 2012, the Company announced the closure of its tissue engineering facility in Abano Terme, Italy due to the Company&amp;#8217;s inability to meet strict regulatory standards established by the European Medicines Agency (&amp;#8220;EMA&amp;#8221;) for Advanced Therapy Medicinal Products, which became effective on January 1, 2013. The restructuring plan involved a workforce reduction as well as associated asset abandonments. The Company recorded restructuring and impairment charges in the fourth quarter of 2012 of approximately $2.5 million. Of the total restructuring and impairment charges related to the tissue engineering operation, approximately $1.2 million was related to the non-cash termination and related impairment of an IPR&amp;amp;D project, $0.3 million was related to the disposal of property and equipment, and $0.1 million was related to the disposal of inventory. We completed the restructuring plan and related activities in 2013. Certain previously impaired and
      written-off equipment was sold, resulting in restructuring credits of $196,084 and $442,869 in the three and nine months ended September 30, 2013, respectively.
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in&quot;&gt;
      The following table summarizes restructuring accrual activity for the nine-period ended September 30, 2014:
    &lt;/p&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif&quot;&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;11&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          Restructuring Accrual
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; nowrap=&quot;nowrap&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Employee
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Severance and
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Related Benefits
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; nowrap=&quot;nowrap&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Activity
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Termination and
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Facility Closure
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Costs
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; nowrap=&quot;nowrap&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          Total
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;width: 67%; text-align: left&quot;&gt;
          December 31, 2013
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          21,709
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          2,929
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          24,638
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          Cash Proceeds (Disbursements)
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          (10,130
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          )
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          (1,425
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          )
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          (11,555
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          )
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-bottom: 1.1pt&quot;&gt;
          Foreign Exchange Impact
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          (1,050
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          )
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          (124
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          )
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          (1,174
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          )
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-bottom: 2.75pt&quot;&gt;
          September 30, 2014
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          10,529
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          1,380
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          11,909
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;&lt;br/&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
  <us-gaap:RestructuringCostsAndAssetImpairmentCharges unitRef="usd" contextRef="c94_From1Oct2012To31Dec2012" decimals="-5">2500000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
  <us-gaap:RestructuringCostsAndAssetImpairmentCharges unitRef="usd" contextRef="c95_From1Oct2012To31Dec2012_NonCashTerminationAndImpairmentOfIPRDProjectMember" decimals="-5">1200000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
  <us-gaap:RestructuringCostsAndAssetImpairmentCharges unitRef="usd" contextRef="c96_From1Oct2012To31Dec2012_NoncashDisposalOfPropertyAndEquipmentMember" decimals="-5">300000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
  <us-gaap:RestructuringCostsAndAssetImpairmentCharges unitRef="usd" contextRef="c97_From1Oct2012To31Dec2012_DisposalOfInventoryMember" decimals="-5">100000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
  <anik:RestructuringCredit unitRef="usd" contextRef="c2_From1Jul2014To30Sep2014" decimals="0">196084</anik:RestructuringCredit>
  <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock contextRef="c4_From1Jan2014To30Sep2014">&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; style=&quot;border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif&quot;&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;11&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          Restructuring Accrual
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom&quot;&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; nowrap=&quot;nowrap&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Employee
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Severance and
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Related Benefits
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; nowrap=&quot;nowrap&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Activity
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Termination and
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Facility Closure
          &lt;/p&gt;
          &lt;p style=&quot;margin-top: 0; margin-bottom: 0&quot;&gt;
            Costs
          &lt;/p&gt;
        &lt;/td&gt;
        &lt;td style=&quot;font-weight: bold; padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td colspan=&quot;3&quot; nowrap=&quot;nowrap&quot; style=&quot;font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid&quot;&gt;
          Total
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;width: 67%; text-align: left&quot;&gt;
          December 31, 2013
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          21,709
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          2,929
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;width: 8%; text-align: right&quot;&gt;
          24,638
        &lt;/td&gt;
        &lt;td style=&quot;width: 1%; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          Cash Proceeds (Disbursements)
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          (10,130
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          )
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          (1,425
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          )
        &lt;/td&gt;
        &lt;td&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;text-align: right&quot;&gt;
          (11,555
        &lt;/td&gt;
        &lt;td style=&quot;text-align: left&quot;&gt;
          )
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204,238,255)&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-bottom: 1.1pt&quot;&gt;
          Foreign Exchange Impact
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          (1,050
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          )
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          (124
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          )
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 1.1pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: right&quot;&gt;
          (1,174
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 1.1pt solid; text-align: left&quot;&gt;
          )
        &lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style=&quot;vertical-align: bottom; background-color: White&quot;&gt;
        &lt;td style=&quot;text-align: left; padding-bottom: 2.75pt&quot;&gt;
          September 30, 2014
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          10,529
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          1,380
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;padding-bottom: 2.75pt&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          $
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: right&quot;&gt;
          11,909
        &lt;/td&gt;
        &lt;td style=&quot;border-bottom: Black 2.75pt double; text-align: left&quot;&gt;
          &amp;#160;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
  <us-gaap:RestructuringReserve unitRef="usd" contextRef="c98_AsOf31Dec2013_EmployeeTerminationCostsMember" decimals="0">21709</us-gaap:RestructuringReserve>
  <us-gaap:RestructuringReserve unitRef="usd" contextRef="c99_AsOf31Dec2013_ActivityTerminationAndFacilityClosureCostsMember" decimals="0">2929</us-gaap:RestructuringReserve>
  <us-gaap:RestructuringReserve unitRef="usd" contextRef="c1_AsOf31Dec2013" decimals="0">24638</us-gaap:RestructuringReserve>
  <us-gaap:PaymentsForRestructuring unitRef="usd" contextRef="c100_From1Jan2014To30Sep2014_EmployeeTerminationCostsMember" decimals="0">10130</us-gaap:PaymentsForRestructuring>
  <us-gaap:PaymentsForRestructuring unitRef="usd" contextRef="c101_From1Jan2014To30Sep2014_ActivityTerminationAndFacilityClosureCostsMember" decimals="0">1425</us-gaap:PaymentsForRestructuring>
  <us-gaap:PaymentsForRestructuring unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">11555</us-gaap:PaymentsForRestructuring>
  <us-gaap:RestructuringReserveTranslationAdjustment unitRef="usd" contextRef="c100_From1Jan2014To30Sep2014_EmployeeTerminationCostsMember" decimals="0">-1050</us-gaap:RestructuringReserveTranslationAdjustment>
  <us-gaap:RestructuringReserveTranslationAdjustment unitRef="usd" contextRef="c101_From1Jan2014To30Sep2014_ActivityTerminationAndFacilityClosureCostsMember" decimals="0">-124</us-gaap:RestructuringReserveTranslationAdjustment>
  <us-gaap:RestructuringReserveTranslationAdjustment unitRef="usd" contextRef="c4_From1Jan2014To30Sep2014" decimals="0">-1174</us-gaap:RestructuringReserveTranslationAdjustment>
  <us-gaap:RestructuringReserve unitRef="usd" contextRef="c102_AsOf30Sep2014_EmployeeTerminationCostsMember" decimals="0">10529</us-gaap:RestructuringReserve>
  <us-gaap:RestructuringReserve unitRef="usd" contextRef="c103_AsOf30Sep2014_ActivityTerminationAndFacilityClosureCostsMember" decimals="0">1380</us-gaap:RestructuringReserve>
  <us-gaap:RestructuringReserve unitRef="usd" contextRef="c0_AsOf30Sep2014" decimals="0">11909</us-gaap:RestructuringReserve>
  <us-gaap:DescriptionOfNewAccountingPronouncementsNotYetAdopted contextRef="c4_From1Jan2014To30Sep2014">&lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;font-size: 10pt; width: 100%; border-collapse: collapse&quot;&gt;
      &lt;tr style=&quot;vertical-align: top&quot;&gt;
        &lt;td style=&quot;width: 6%; font: 10pt Times New Roman, Times, Serif&quot;&gt;
          &lt;b&gt;15.&lt;/b&gt;
        &lt;/td&gt;
        &lt;td style=&quot;width: 94%; font: 10pt Times New Roman, Times, Serif&quot;&gt;
          &lt;b&gt;New Accounting Standards&lt;/b&gt;
        &lt;/td&gt;
      &lt;/tr&gt;
    &lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in&quot;&gt;
      &lt;font style=&quot;font-size: 10pt&quot;&gt;In June 2014, the Financial Accounting Standards Board (&amp;#8220;FASB&amp;#8221;) issued Accounting Standards Update (&quot;ASU&quot;) No.&lt;/font&gt; &lt;font style=&quot;font-size: 10pt&quot;&gt;2014-12, &amp;#8220;Compensation - Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide that a Performance Target Could be Achieved after the Requisite Service Period,&lt;/font&gt;&amp;#8221; &lt;font style=&quot;font-size: 10pt&quot;&gt;which requires that a performance target that affects vesting, and that could be achieved after the requisite service period, be treated as a performance condition. Thus, the performance target should not be reflected in estimating the grant date fair value of the award. This update further clarifies that compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved and should represent the compensation cost attributable to the period(s) for which the requisite service has
      already been rendered. The new guidance is effective for the Company beginning January 1, 2016. Early adoption is permitted. The Company is currently evaluating the impact of this new standard on its consolidated financial statements.&lt;/font&gt;
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in&quot;&gt;
      In May 2014, the FASB issued ASU No. 2014-09, &quot;Revenue from Contracts with Customers.&quot; ASU 2014-09 supersedes the revenue recognition requirements in &quot;Topic 605, Revenue Recognition&quot; and requires entities to recognize revenue in a way that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. ASU 2014-09 is effective retrospectively for annual or interim reporting periods beginning after December 15, 2016, with early application not permitted. The Company is currently evaluating the impact of this new standard on its consolidated financial statements.
    &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in&quot;&gt;
      &lt;font style=&quot;font-size: 10pt&quot;&gt;In April 2014, the FASB issued ASU No. 2014-08, &quot;Reporting of Discontinued Operations and Disclosures of Disposals of Components of an Entity.&quot; ASU 2014-08 provides a narrower definition of discontinued operations than that provided under existing U.S. GAAP. ASU 2014-08 requires that only a disposal of a component of an entity, or a group of components of an entity, which disposal represents a strategic shift that has, or will have, a major effect on the reporting entity&apos;s operations and financial results, should be reported in the financial statements as a discontinued operation. ASU 2014-08 also provides guidance on the financial statement presentations and disclosures of discontinued operations. ASU 2014-08 is effective prospectively for disposals (or classifications as held for disposal) of components of an entity that occur in annual or interim periods beginning after December 15, 2014. The Company does not expect the adoption of ASU 2014-08 to
      have a material impact on its consolidated financial statements.&lt;font style=&quot;font-family: Arial, Helvetica, Sans-Serif&quot;&gt;&lt;/font&gt;&lt;/font&gt;&amp;#160;
    &lt;/p&gt;&lt;br/&gt;</us-gaap:DescriptionOfNewAccountingPronouncementsNotYetAdopted>
</xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>anik-20140930.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Wed Nov 05 23:59:00 UTC 2014 -->
<xs:schema xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:num="http://www.xbrl.org/dtr/type/numeric" targetNamespace="http://www.anikatherapeutics.com/20140930" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:us-types="http://fasb.org/us-types/2014-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" elementFormDefault="qualified" xmlns:anik="http://www.anikatherapeutics.com/20140930" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="anik-20140930_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="anik-20140930_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="anik-20140930_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="anik-20140930_cal.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef"/>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/ConsolidatedBalanceSheet" id="anik_r_ConsolidatedBalanceSheet">
        <link:definition>001 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/ConsolidatedBalanceSheet_Parentheticals" id="anik_r_ConsolidatedBalanceSheet_Parentheticals">
        <link:definition>002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/ConsolidatedComprehensiveIncome" id="anik_r_ConsolidatedComprehensiveIncome">
        <link:definition>003 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/ConsolidatedComprehensiveIncomeAlt0" id="anik_r_ConsolidatedComprehensiveIncomeAlt0">
        <link:definition>003 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited) Alternate 0</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/ShareholdersEquityType1" id="anik_r_ShareholdersEquityType1">
        <link:definition>004 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/Note1NatureofBusiness" id="anik_r_Note1NatureofBusiness">
        <link:definition>005 - Disclosure - Note 1 - Nature of Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/Note2BasisofPresentation" id="anik_r_Note2BasisofPresentation">
        <link:definition>006 - Disclosure - Note 2 - Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/Note3MarketableSecurities" id="anik_r_Note3MarketableSecurities">
        <link:definition>007 - Disclosure - Note 3 - Marketable Securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/Note4FairValueMeasurements" id="anik_r_Note4FairValueMeasurements">
        <link:definition>008 - Disclosure - Note 4 - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/Note5EquityIncentivePlan" id="anik_r_Note5EquityIncentivePlan">
        <link:definition>009 - Disclosure - Note 5 - Equity Incentive Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/Note6EarningsPerShare" id="anik_r_Note6EarningsPerShare">
        <link:definition>010 - Disclosure - Note 6 - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/Note7Inventories" id="anik_r_Note7Inventories">
        <link:definition>011 - Disclosure - Note 7 - Inventories</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/Note8IntangibleAssetsandGoodwill" id="anik_r_Note8IntangibleAssetsandGoodwill">
        <link:definition>012 - Disclosure - Note 8 - Intangible Assets and Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/Note9AccruedExpenses" id="anik_r_Note9AccruedExpenses">
        <link:definition>013 - Disclosure - Note 9 - Accrued Expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/Note10CommitmentsandContingencies" id="anik_r_Note10CommitmentsandContingencies">
        <link:definition>014 - Disclosure - Note 10 - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/Note11MitekMonoviscAgreement" id="anik_r_Note11MitekMonoviscAgreement">
        <link:definition>015 - Disclosure - Note 11 - Mitek Monovisc Agreement</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/Note12IncomeTaxes" id="anik_r_Note12IncomeTaxes">
        <link:definition>016 - Disclosure - Note 12 - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/Note13SegmentandGeographicInformation" id="anik_r_Note13SegmentandGeographicInformation">
        <link:definition>017 - Disclosure - Note 13 - Segment and Geographic Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/Note14RestructuringCredits" id="anik_r_Note14RestructuringCredits">
        <link:definition>018 - Disclosure - Note 14 - Restructuring Credits</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/Note15NewAccountingStandards" id="anik_r_Note15NewAccountingStandards">
        <link:definition>019 - Disclosure - Note 15 - New Accounting Standards</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/Note3MarketableSecuritiesTables" id="anik_r_Note3MarketableSecuritiesTables">
        <link:definition>020 - Disclosure - Note 3 - Marketable Securities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/Note4FairValueMeasurementsTables" id="anik_r_Note4FairValueMeasurementsTables">
        <link:definition>021 - Disclosure - Note 4 - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/Note5EquityIncentivePlanTables" id="anik_r_Note5EquityIncentivePlanTables">
        <link:definition>022 - Disclosure - Note 5 - Equity Incentive Plan (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/Note6EarningsPerShareTables" id="anik_r_Note6EarningsPerShareTables">
        <link:definition>023 - Disclosure - Note 6 - Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/Note7InventoriesTables" id="anik_r_Note7InventoriesTables">
        <link:definition>024 - Disclosure - Note 7 - Inventories (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/Note8IntangibleAssetsandGoodwillTables" id="anik_r_Note8IntangibleAssetsandGoodwillTables">
        <link:definition>025 - Disclosure - Note 8 - Intangible Assets and Goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/Note9AccruedExpensesTables" id="anik_r_Note9AccruedExpensesTables">
        <link:definition>026 - Disclosure - Note 9 - Accrued Expenses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/Note13SegmentandGeographicInformationTables" id="anik_r_Note13SegmentandGeographicInformationTables">
        <link:definition>027 - Disclosure - Note 13 - Segment and Geographic Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/Note14RestructuringCreditsTables" id="anik_r_Note14RestructuringCreditsTables">
        <link:definition>028 - Disclosure - Note 14 - Restructuring Credits (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/Note2BasisofPresentationDetails" id="anik_r_Note2BasisofPresentationDetails">
        <link:definition>029 - Disclosure - Note 2 - Basis of Presentation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/MarketableSecuritiesTable" id="anik_r_MarketableSecuritiesTable">
        <link:definition>030 - Disclosure - Note 3 - Marketable Securities (Details) - Marketable Securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
<!-- [WMV4][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt8UCLPdYZl35nXbOCDIyGTq8kWYS5mE4nIDdhC6ZUZ3C7uZIfzBVpwVZvunzSNea5mQTTlY4E6meqyItzXsZeYoFfvM/Avp17arPuR/GW0mknfKp3JQjUBUq0bHVHYbNAE8Fh5fiLkIMcVQlbp04OxRRXjc+Ssu9cPRpFdgx0G2vpzwAswTXRmMT0FZiyY6i+rg7fLLlOtgaOTKCK9dqe8N] CSR-->
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/FairValueofFinancialInstrumentsTable" id="anik_r_FairValueofFinancialInstrumentsTable">
        <link:definition>031 - Disclosure - Note 4 - Fair Value Measurements (Details) - Fair Value of Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/Note5EquityIncentivePlanDetails" id="anik_r_Note5EquityIncentivePlanDetails">
        <link:definition>032 - Disclosure - Note 5 - Equity Incentive Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/AssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsTable" id="anik_r_AssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsTable">
        <link:definition>033 - Disclosure - Note 5 - Equity Incentive Plan (Details) - Assumptions Used to Estimate Fair Value of Stock Options and Stock Appreciation Rights Awards</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/Note6EarningsPerShareDetails" id="anik_r_Note6EarningsPerShareDetails">
        <link:definition>034 - Disclosure - Note 6 - Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/BasicandDilutedEarningsPerShareTable" id="anik_r_BasicandDilutedEarningsPerShareTable">
        <link:definition>035 - Disclosure - Note 6 - Earnings Per Share (Details) - Basic and Diluted Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/InventoriesTable" id="anik_r_InventoriesTable">
        <link:definition>036 - Disclosure - Note 7 - Inventories (Details) - Inventories</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/Note8IntangibleAssetsandGoodwillDetails" id="anik_r_Note8IntangibleAssetsandGoodwillDetails">
        <link:definition>037 - Disclosure - Note 8 - Intangible Assets and Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/IntangibleAssetsTable" id="anik_r_IntangibleAssetsTable">
        <link:definition>038 - Disclosure - Note 8 -  Intangible Assets and Goodwill (Details) - Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/ChangesinCarryingValueofGoodwillTable" id="anik_r_ChangesinCarryingValueofGoodwillTable">
        <link:definition>039 - Disclosure - Note 8 -  Intangible Assets and Goodwill (Details) - Changes in Carrying Value of Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/AccruedExpensesTable" id="anik_r_AccruedExpensesTable">
        <link:definition>040 - Disclosure - Note 9 - Accrued Expenses (Details) - Accrued Expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/Note10CommitmentsandContingenciesDetails" id="anik_r_Note10CommitmentsandContingenciesDetails">
        <link:definition>041 - Disclosure - Note 10 - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/Note11MitekMonoviscAgreementDetails" id="anik_r_Note11MitekMonoviscAgreementDetails">
        <link:definition>042 - Disclosure - Note 11 - Mitek Monovisc Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/Note12IncomeTaxesDetails" id="anik_r_Note12IncomeTaxesDetails">
        <link:definition>043 - Disclosure - Note 12 - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/Note13SegmentandGeographicInformationDetails" id="anik_r_Note13SegmentandGeographicInformationDetails">
        <link:definition>044 - Disclosure - Note 13 - Segment and Geographic Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/ProductRevenuebyProductGroupTable" id="anik_r_ProductRevenuebyProductGroupTable">
        <link:definition>045 - Disclosure - Note 13 - Segment and Geographic Information (Details) - Product Revenue by Product Group</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/ProductRevenuebyGeographicLocationTable" id="anik_r_ProductRevenuebyGeographicLocationTable">
        <link:definition>046 - Disclosure - Note 13 - Segment and Geographic Information (Details) - Product Revenue by Geographic Location</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/Note14RestructuringCreditsDetails" id="anik_r_Note14RestructuringCreditsDetails">
        <link:definition>047 - Disclosure - Note 14 - Restructuring Credits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/RestructuringAccrualActivityTable" id="anik_r_RestructuringAccrualActivityTable">
        <link:definition>048 - Disclosure - Note 14 - Restructuring Credits (Details) - Restructuring Accrual Activity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anikatherapeutics.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000 - Disclosure - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2014-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2014/elts/us-types-2014-01-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:element name="FairValueOfFinancialInstrumentsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_FairValueOfFinancialInstrumentsAbstract"/>
  <xs:element name="AssumptionsUsedToEstimateFairValueOfStockOptionsAndStockAppreciationRightsAwardsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_AssumptionsUsedToEstimateFairValueOfStockOptionsAndStockAppreciationRightsAwardsAbstract"/>
  <xs:element name="BasicAndDilutedEarningsPerShareAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_BasicAndDilutedEarningsPerShareAbstract"/>
  <xs:element name="InventoriesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_InventoriesAbstract"/>
  <xs:element name="IntangibleAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_IntangibleAssetsAbstract"/>
  <xs:element name="ChangesInCarryingValueOfGoodwillAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_ChangesInCarryingValueOfGoodwillAbstract"/>
  <xs:element name="AccruedExpensesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_AccruedExpensesAbstract"/>
  <xs:element name="ProductRevenueByProductGroupAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_ProductRevenueByProductGroupAbstract"/>
  <xs:element name="ProductRevenueByGeographicLocationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_ProductRevenueByGeographicLocationAbstract"/>
  <xs:element name="RestructuringAccrualActivityAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_RestructuringAccrualActivityAbstract"/>
  <xs:element name="BasicNetIncomePerShareAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_BasicNetIncomePerShareAbstract"/>
  <xs:element name="DilutedNetIncomePerShareAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_DilutedNetIncomePerShareAbstract"/>
  <xs:element name="OtherComprehensiveIncomeLossAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_OtherComprehensiveIncomeLossAbstract"/>
  <xs:element name="CashFlowsFromOperatingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_CashFlowsFromOperatingActivitiesAbstract"/>
  <xs:element name="AdjustmentsToReconcileNetIncomeToNetCashProvidedByOperatingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_AdjustmentsToReconcileNetIncomeToNetCashProvidedByOperatingActivitiesAbstract"/>
  <xs:element name="ChangesInOperatingAssetsAndLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_ChangesInOperatingAssetsAndLiabilitiesAbstract"/>
  <xs:element name="CashFlowsFromInvestingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_CashFlowsFromInvestingActivitiesAbstract"/>
  <xs:element name="CashFlowsFromFinancingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_CashFlowsFromFinancingActivitiesAbstract"/>
  <xs:element name="MarketableSecuritiesAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_MarketableSecuritiesAbstract0"/>
  <xs:element name="EffectOfDilutiveSecuritiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_EffectOfDilutiveSecuritiesAbstract"/>
  <xs:element name="GeographicLocationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_GeographicLocationAbstract"/>
  <xs:element name="DepositsAndOtherAssetsNoncurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="anik_DepositsAndOtherAssetsNoncurrent"/>
  <xs:element name="RestructuringCredit" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="anik_RestructuringCredit"/>
  <xs:element name="ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTableTextBlock"/>
  <xs:element name="ScheduleOfRevenueAndOperatingIncomeByGeographicalAreasTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_ScheduleOfRevenueAndOperatingIncomeByGeographicalAreasTableTextBlock"/>
  <xs:element name="Note3MarketableSecuritiesDetailsMarketableSecuritiesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="anik_Note3MarketableSecuritiesDetailsMarketableSecuritiesTable"/>
  <xs:element name="Note3MarketableSecuritiesDetailsMarketableSecuritiesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_Note3MarketableSecuritiesDetailsMarketableSecuritiesLineItems"/>
  <xs:element name="Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="anik_Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsTable"/>
  <xs:element name="Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsLineItems"/>
  <xs:element name="Note5EquityIncentivePlanDetailsAssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="anik_Note5EquityIncentivePlanDetailsAssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsTable"/>
  <xs:element name="Note5EquityIncentivePlanDetailsAssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_Note5EquityIncentivePlanDetailsAssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsLineItems"/>
  <xs:element name="Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="anik_Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsTable"/>
  <xs:element name="Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsLineItems"/>
  <xs:element name="IntangibleAssetsGrossCarryingAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="anik_IntangibleAssetsGrossCarryingAmount"/>
  <xs:element name="IntangibleAssetsTranslationAdjustments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="anik_IntangibleAssetsTranslationAdjustments"/>
  <xs:element name="IntangibleAssetsAccumulatedAmortization" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="anik_IntangibleAssetsAccumulatedAmortization"/>
  <xs:element name="AccruedClinicalTrialCostsCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="anik_AccruedClinicalTrialCostsCurrent"/>
  <xs:element name="AccruedResearchGrantsCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="anik_AccruedResearchGrantsCurrent"/>
  <xs:element name="Note13SegmentandGeographicInformationDetailsProductRevenuebyGeographicLocationTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="anik_Note13SegmentandGeographicInformationDetailsProductRevenuebyGeographicLocationTable"/>
  <xs:element name="Note13SegmentandGeographicInformationDetailsProductRevenuebyGeographicLocationLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_Note13SegmentandGeographicInformationDetailsProductRevenuebyGeographicLocationLineItems"/>
  <xs:element name="PercentageOfNetRevenue" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_PercentageOfNetRevenue"/>
  <xs:element name="Note14RestructuringCreditsDetailsRestructuringAccrualActivityTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="anik_Note14RestructuringCreditsDetailsRestructuringAccrualActivityTable"/>
  <xs:element name="Note14RestructuringCreditsDetailsRestructuringAccrualActivityLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_Note14RestructuringCreditsDetailsRestructuringAccrualActivityLineItems"/>
  <xs:element name="Note2BasisofPresentationDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="anik_Note2BasisofPresentationDetailsTable"/>
  <xs:element name="Note2BasisofPresentationDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_Note2BasisofPresentationDetailsLineItems"/>
  <xs:element name="Note5EquityIncentivePlanDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="anik_Note5EquityIncentivePlanDetailsTable"/>
  <xs:element name="Note5EquityIncentivePlanDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_Note5EquityIncentivePlanDetailsLineItems"/>
  <xs:element name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriodTotalIntrinsicValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="anik_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriodTotalIntrinsicValue"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingNumber" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingNumber"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsWeightedAverageExercisePrice" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsWeightedAverageExercisePrice"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingIntrinsicValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingIntrinsicValue"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTermRange" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTermRange"/>
  <xs:element name="Note11MitekMonoviscAgreementDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="anik_Note11MitekMonoviscAgreementDetailsTable"/>
  <xs:element name="Note11MitekMonoviscAgreementDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_Note11MitekMonoviscAgreementDetailsLineItems"/>
  <xs:element name="ContractTermYears" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_ContractTermYears"/>
  <xs:element name="RevenueComponentsDomain" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_RevenueComponentsDomain"/>
  <xs:element name="Note12IncomeTaxesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="anik_Note12IncomeTaxesDetailsTable"/>
  <xs:element name="Note12IncomeTaxesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_Note12IncomeTaxesDetailsLineItems"/>
  <xs:element name="Note14RestructuringCreditsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="anik_Note14RestructuringCreditsDetailsTable"/>
  <xs:element name="Note14RestructuringCreditsDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_Note14RestructuringCreditsDetailsLineItems"/>
  <xs:element name="RevenueComponentsAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:dimensionItem" id="anik_RevenueComponentsAxis"/>
  <xs:element name="ActivityTerminationAndFacilityClosureCostsMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_ActivityTerminationAndFacilityClosureCostsMember"/>
  <xs:element name="BoardOfDirectorsMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_BoardOfDirectorsMember"/>
  <xs:element name="DereaseToCashProvidedByOperatingActivitiesMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_DereaseToCashProvidedByOperatingActivitiesMember"/>
  <xs:element name="DermalMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_DermalMember"/>
  <xs:element name="DisposalOfInventoryMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_DisposalOfInventoryMember"/>
  <xs:element name="ElevessTradeNameMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_ElevessTradeNameMember"/>
  <xs:element name="EmployeeTerminationCostsMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_EmployeeTerminationCostsMember"/>
  <xs:element name="IncreaseToCashProvidedByFinancingActivitiesMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_IncreaseToCashProvidedByFinancingActivitiesMember"/>
  <xs:element name="MilestoneAndContractRevenueMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_MilestoneAndContractRevenueMember"/>
  <xs:element name="MiltekMONOVISCAgreementMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_MiltekMONOVISCAgreementMember"/>
  <xs:element name="NonCashTerminationAndImpairmentOfIPRDProjectMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_NonCashTerminationAndImpairmentOfIPRDProjectMember"/>
  <xs:element name="NoncashDisposalOfPropertyAndEquipmentMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_NoncashDisposalOfPropertyAndEquipmentMember"/>
  <xs:element name="OphthalmicMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_OphthalmicMember"/>
  <xs:element name="OrthobiologicsMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_OrthobiologicsMember"/>
  <xs:element name="OtherLocationMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_OtherLocationMember"/>
  <xs:element name="SurgicalMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_SurgicalMember"/>
  <xs:element name="TaxBenefitFromExerciseOfStockOptionsCorrectionMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_TaxBenefitFromExerciseOfStockOptionsCorrectionMember"/>
  <xs:element name="UnitedStatesMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_UnitedStatesMember"/>
  <xs:element name="VeterinaryMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_VeterinaryMember"/>
  <xs:element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="anik_DocumentAndEntityInformationAbstract"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>anik-20140930_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Wed Nov 05 23:59:00 UTC 2014 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_ConsolidatedBalanceSheet" roleURI="http://www.anikatherapeutics.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_ConsolidatedComprehensiveIncome" roleURI="http://www.anikatherapeutics.com/role/ConsolidatedComprehensiveIncome"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_ShareholdersEquityType1" roleURI="http://www.anikatherapeutics.com/role/ShareholdersEquityType1"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_BasicandDilutedEarningsPerShareTable" roleURI="http://www.anikatherapeutics.com/role/BasicandDilutedEarningsPerShareTable"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_InventoriesTable" roleURI="http://www.anikatherapeutics.com/role/InventoriesTable"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_AccruedExpensesTable" roleURI="http://www.anikatherapeutics.com/role/AccruedExpensesTable"/>
  <calculationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_MarketableSecuritiesCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InventoryNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_InventoryNet" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidTaxes" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsNetCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_DeferredTaxAssetsNetCurrent" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Assets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="anik_DepositsAndOtherAssetsNoncurrent" xlink:href="anik-20140930.xsd#anik_DepositsAndOtherAssetsNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="anik_DepositsAndOtherAssetsNoncurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Goodwill"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Goodwill" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="6" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_DeferredRevenueCurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedIncomeTaxesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedIncomeTaxesCurrent" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquity"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_DeferredRevenueNoncurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_DeferredTaxLiabilitiesNoncurrent" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies" order="5" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="6" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/ConsolidatedComprehensiveIncome">
    <loc xlink:type="locator" xlink:label="us-gaap_SalesRevenueNet" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SalesRevenueNet"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesRevenueGoodsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SalesRevenueGoodsNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_SalesRevenueNet" xlink:to="us-gaap_SalesRevenueGoodsNet" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesRevenueServicesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SalesRevenueServicesNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_SalesRevenueNet" xlink:to="us-gaap_SalesRevenueServicesNet" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfGoodsSold" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CostOfGoodsSold"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostOfGoodsSold" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="anik_RestructuringCredit" xlink:href="anik-20140930.xsd#anik_RestructuringCredit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="anik_RestructuringCredit" order="4" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_SalesRevenueNet" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_CostsAndExpenses" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_OperatingIncomeLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_InterestIncomeExpenseNonoperatingNet" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
<!-- [WMV4][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt8UCLPdYZl35nXbOCDIyGTq8kWYS5mE4nIDdhC6ZUZ3C7uZIfzBVpwVZvunzSNea5mQTTlY4E6meqyItzXsZeYoFfvM/Avp17arPuR/GW0mknfKp3JQjUBUq0bHVHYbNAE8Fh5fiLkIMcVQlbp04OxRRXjc+Ssu9cPRpFdgx0G2vpzwAswTXRmMT0FZiyY6i+qY0HC3Zji76mr1tZ8e3gl5] CSR-->
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_NetIncomeLoss" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/ShareholdersEquityType1">
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetIncomeLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DepreciationAndAmortization" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ProvisionForDoubtfulAccounts" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryWriteDown" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_InventoryWriteDown" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue" order="8" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" order="9" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" order="10" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnDispositionOfAssets1" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_GainLossOnDispositionOfAssets1" order="11" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities" order="12" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="13" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="14" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="15" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets" order="16" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfOtherAssets1" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromSaleOfOtherAssets1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleOfOtherAssets1" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_RepaymentsOfLongTermDebt" order="4" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" order="4" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/BasicandDilutedEarningsPerShareTable">
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/InventoriesTable">
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InventoryNet"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryRawMaterials" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InventoryRawMaterials"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryRawMaterials" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryWorkInProcess" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryWorkInProcess" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryFinishedGoods" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryFinishedGoods" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/AccruedExpensesTable">
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="anik_AccruedClinicalTrialCostsCurrent" xlink:href="anik-20140930.xsd#anik_AccruedClinicalTrialCostsCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="anik_AccruedClinicalTrialCostsCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="anik_AccruedResearchGrantsCurrent" xlink:href="anik-20140930.xsd#anik_AccruedResearchGrantsCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="anik_AccruedResearchGrantsCurrent" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestructuringReserveCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestructuringReserveCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_RestructuringReserveCurrent" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="6" weight="1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>anik-20140930_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Wed Nov 05 23:59:00 UTC 2014 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_ConsolidatedBalanceSheet" roleURI="http://www.anikatherapeutics.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://www.anikatherapeutics.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_ConsolidatedComprehensiveIncome" roleURI="http://www.anikatherapeutics.com/role/ConsolidatedComprehensiveIncome"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_ShareholdersEquityType1" roleURI="http://www.anikatherapeutics.com/role/ShareholdersEquityType1"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note1NatureofBusiness" roleURI="http://www.anikatherapeutics.com/role/Note1NatureofBusiness"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note2BasisofPresentation" roleURI="http://www.anikatherapeutics.com/role/Note2BasisofPresentation"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note3MarketableSecurities" roleURI="http://www.anikatherapeutics.com/role/Note3MarketableSecurities"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note4FairValueMeasurements" roleURI="http://www.anikatherapeutics.com/role/Note4FairValueMeasurements"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note5EquityIncentivePlan" roleURI="http://www.anikatherapeutics.com/role/Note5EquityIncentivePlan"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note6EarningsPerShare" roleURI="http://www.anikatherapeutics.com/role/Note6EarningsPerShare"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note7Inventories" roleURI="http://www.anikatherapeutics.com/role/Note7Inventories"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note8IntangibleAssetsandGoodwill" roleURI="http://www.anikatherapeutics.com/role/Note8IntangibleAssetsandGoodwill"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note9AccruedExpenses" roleURI="http://www.anikatherapeutics.com/role/Note9AccruedExpenses"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note10CommitmentsandContingencies" roleURI="http://www.anikatherapeutics.com/role/Note10CommitmentsandContingencies"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note11MitekMonoviscAgreement" roleURI="http://www.anikatherapeutics.com/role/Note11MitekMonoviscAgreement"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note12IncomeTaxes" roleURI="http://www.anikatherapeutics.com/role/Note12IncomeTaxes"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note13SegmentandGeographicInformation" roleURI="http://www.anikatherapeutics.com/role/Note13SegmentandGeographicInformation"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note14RestructuringCredits" roleURI="http://www.anikatherapeutics.com/role/Note14RestructuringCredits"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note15NewAccountingStandards" roleURI="http://www.anikatherapeutics.com/role/Note15NewAccountingStandards"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note3MarketableSecuritiesTables" roleURI="http://www.anikatherapeutics.com/role/Note3MarketableSecuritiesTables"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note4FairValueMeasurementsTables" roleURI="http://www.anikatherapeutics.com/role/Note4FairValueMeasurementsTables"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note5EquityIncentivePlanTables" roleURI="http://www.anikatherapeutics.com/role/Note5EquityIncentivePlanTables"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note6EarningsPerShareTables" roleURI="http://www.anikatherapeutics.com/role/Note6EarningsPerShareTables"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note7InventoriesTables" roleURI="http://www.anikatherapeutics.com/role/Note7InventoriesTables"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note8IntangibleAssetsandGoodwillTables" roleURI="http://www.anikatherapeutics.com/role/Note8IntangibleAssetsandGoodwillTables"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note9AccruedExpensesTables" roleURI="http://www.anikatherapeutics.com/role/Note9AccruedExpensesTables"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note13SegmentandGeographicInformationTables" roleURI="http://www.anikatherapeutics.com/role/Note13SegmentandGeographicInformationTables"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note14RestructuringCreditsTables" roleURI="http://www.anikatherapeutics.com/role/Note14RestructuringCreditsTables"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_MarketableSecuritiesTable" roleURI="http://www.anikatherapeutics.com/role/MarketableSecuritiesTable"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_FairValueofFinancialInstrumentsTable" roleURI="http://www.anikatherapeutics.com/role/FairValueofFinancialInstrumentsTable"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_AssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsTable" roleURI="http://www.anikatherapeutics.com/role/AssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsTable"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_BasicandDilutedEarningsPerShareTable" roleURI="http://www.anikatherapeutics.com/role/BasicandDilutedEarningsPerShareTable"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_InventoriesTable" roleURI="http://www.anikatherapeutics.com/role/InventoriesTable"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_IntangibleAssetsTable" roleURI="http://www.anikatherapeutics.com/role/IntangibleAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_ChangesinCarryingValueofGoodwillTable" roleURI="http://www.anikatherapeutics.com/role/ChangesinCarryingValueofGoodwillTable"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_AccruedExpensesTable" roleURI="http://www.anikatherapeutics.com/role/AccruedExpensesTable"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_ProductRevenuebyProductGroupTable" roleURI="http://www.anikatherapeutics.com/role/ProductRevenuebyProductGroupTable"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_ProductRevenuebyGeographicLocationTable" roleURI="http://www.anikatherapeutics.com/role/ProductRevenuebyGeographicLocationTable"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_RestructuringAccrualActivityTable" roleURI="http://www.anikatherapeutics.com/role/RestructuringAccrualActivityTable"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note2BasisofPresentationDetails" roleURI="http://www.anikatherapeutics.com/role/Note2BasisofPresentationDetails"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note5EquityIncentivePlanDetails" roleURI="http://www.anikatherapeutics.com/role/Note5EquityIncentivePlanDetails"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note6EarningsPerShareDetails" roleURI="http://www.anikatherapeutics.com/role/Note6EarningsPerShareDetails"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note8IntangibleAssetsandGoodwillDetails" roleURI="http://www.anikatherapeutics.com/role/Note8IntangibleAssetsandGoodwillDetails"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note10CommitmentsandContingenciesDetails" roleURI="http://www.anikatherapeutics.com/role/Note10CommitmentsandContingenciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note11MitekMonoviscAgreementDetails" roleURI="http://www.anikatherapeutics.com/role/Note11MitekMonoviscAgreementDetails"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note12IncomeTaxesDetails" roleURI="http://www.anikatherapeutics.com/role/Note12IncomeTaxesDetails"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note13SegmentandGeographicInformationDetails" roleURI="http://www.anikatherapeutics.com/role/Note13SegmentandGeographicInformationDetails"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note14RestructuringCreditsDetails" roleURI="http://www.anikatherapeutics.com/role/Note14RestructuringCreditsDetails"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#DocumentAndEntityInformation" roleURI="http://www.anikatherapeutics.com/role/DocumentAndEntityInformation"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsCurrentAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_MarketableSecuritiesCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InventoryNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_InventoryNet" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidTaxes" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsNetCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_DeferredTaxAssetsNetCurrent" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_AssetsCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_DepositsAndOtherAssetsNoncurrent" xlink:href="anik-20140930.xsd#anik_DepositsAndOtherAssetsNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="anik_DepositsAndOtherAssetsNoncurrent" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Goodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Goodwill" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Assets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Assets" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredRevenueCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedIncomeTaxesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedIncomeTaxesCurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccruedIncomeTaxesCurrent" xlink:to="us-gaap_LiabilitiesCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_DeferredRevenueNoncurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesNoncurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PreferredStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_StockholdersEquity" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/ConsolidatedBalanceSheet_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="9" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/ConsolidatedComprehensiveIncome">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesRevenueGoodsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SalesRevenueGoodsNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SalesRevenueGoodsNet" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesRevenueServicesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SalesRevenueServicesNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SalesRevenueServicesNet" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesRevenueNet" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SalesRevenueNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SalesRevenueServicesNet" xlink:to="us-gaap_SalesRevenueNet" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingExpensesAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfGoodsSold" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CostOfGoodsSold"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_CostOfGoodsSold" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_RestructuringCredit" xlink:href="anik-20140930.xsd#anik_RestructuringCredit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="anik_RestructuringCredit" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CostsAndExpenses" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_InterestIncomeExpenseNonoperatingNet" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_BasicNetIncomePerShareAbstract" xlink:href="anik-20140930.xsd#anik_BasicNetIncomePerShareAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="anik_BasicNetIncomePerShareAbstract" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_BasicNetIncomePerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_BasicNetIncomePerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_DilutedNetIncomePerShareAbstract" xlink:href="anik-20140930.xsd#anik_DilutedNetIncomePerShareAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="anik_DilutedNetIncomePerShareAbstract" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_DilutedNetIncomePerShareAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_DilutedNetIncomePerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_OtherComprehensiveIncomeLossAbstract" xlink:href="anik-20140930.xsd#anik_OtherComprehensiveIncomeLossAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="anik_OtherComprehensiveIncomeLossAbstract" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="13" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/ShareholdersEquityType1">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_CashFlowsFromOperatingActivitiesAbstract" xlink:href="anik-20140930.xsd#anik_CashFlowsFromOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="anik_CashFlowsFromOperatingActivitiesAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_CashFlowsFromOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_AdjustmentsToReconcileNetIncomeToNetCashProvidedByOperatingActivitiesAbstract" xlink:href="anik-20140930.xsd#anik_AdjustmentsToReconcileNetIncomeToNetCashProvidedByOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_CashFlowsFromOperatingActivitiesAbstract" xlink:to="anik_AdjustmentsToReconcileNetIncomeToNetCashProvidedByOperatingActivitiesAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_AdjustmentsToReconcileNetIncomeToNetCashProvidedByOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationAndAmortization" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_AdjustmentsToReconcileNetIncomeToNetCashProvidedByOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_AdjustmentsToReconcileNetIncomeToNetCashProvidedByOperatingActivitiesAbstract" xlink:to="us-gaap_ProvisionForDoubtfulAccounts" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryWriteDown" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_AdjustmentsToReconcileNetIncomeToNetCashProvidedByOperatingActivitiesAbstract" xlink:to="us-gaap_InventoryWriteDown" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnDispositionOfAssets1" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_AdjustmentsToReconcileNetIncomeToNetCashProvidedByOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnDispositionOfAssets1" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_AdjustmentsToReconcileNetIncomeToNetCashProvidedByOperatingActivitiesAbstract" xlink:to="us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:href="anik-20140930.xsd#anik_ChangesInOperatingAssetsAndLiabilitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_AdjustmentsToReconcileNetIncomeToNetCashProvidedByOperatingActivitiesAbstract" xlink:to="anik_ChangesInOperatingAssetsAndLiabilitiesAbstract" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_CashFlowsFromOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_CashFlowsFromInvestingActivitiesAbstract" xlink:href="anik-20140930.xsd#anik_CashFlowsFromInvestingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_CashFlowsFromOperatingActivitiesAbstract" xlink:to="anik_CashFlowsFromInvestingActivitiesAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_CashFlowsFromInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfOtherAssets1" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromSaleOfOtherAssets1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_CashFlowsFromInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleOfOtherAssets1" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_CashFlowsFromInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_CashFlowsFromOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_CashFlowsFromFinancingActivitiesAbstract" xlink:href="anik-20140930.xsd#anik_CashFlowsFromFinancingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_CashFlowsFromOperatingActivitiesAbstract" xlink:to="anik_CashFlowsFromFinancingActivitiesAbstract" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfLongTermDebt" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_CashFlowsFromOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_CashFlowsFromOperatingActivitiesAbstract" xlink:to="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_CashFlowsFromOperatingActivitiesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_CashFlowsFromOperatingActivitiesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="9" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note1NatureofBusiness">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NatureOfOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NatureOfOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_NatureOfOperations" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note2BasisofPresentation">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note3MarketableSecurities">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DisclosureTextBlockSupplementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note4FairValueMeasurements">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note5EquityIncentivePlan">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note6EarningsPerShare">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note7Inventories">
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note8IntangibleAssetsandGoodwill">
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note9AccruedExpenses">
    <loc xlink:type="locator" xlink:label="us-gaap_PayablesAndAccrualsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note10CommitmentsandContingencies">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note11MitekMonoviscAgreement">
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredRevenueDisclosureAbstract" xlink:to="us-gaap_DeferredRevenueDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note12IncomeTaxes">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note13SegmentandGeographicInformation">
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note14RestructuringCredits">
    <loc xlink:type="locator" xlink:label="us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note15NewAccountingStandards">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note3MarketableSecuritiesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DisclosureTextBlockSupplementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_MarketableSecuritiesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note4FairValueMeasurementsTables">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note5EquityIncentivePlanTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note6EarningsPerShareTables">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note7InventoriesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note8IntangibleAssetsandGoodwillTables">
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="anik_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTableTextBlock" xlink:href="anik-20140930.xsd#anik_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="anik_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleOfGoodwillTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note9AccruedExpensesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_PayablesAndAccrualsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note13SegmentandGeographicInformationTables">
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_ScheduleOfRevenueAndOperatingIncomeByGeographicalAreasTableTextBlock" xlink:href="anik-20140930.xsd#anik_ScheduleOfRevenueAndOperatingIncomeByGeographicalAreasTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="anik_ScheduleOfRevenueAndOperatingIncomeByGeographicalAreasTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note14RestructuringCreditsTables">
    <loc xlink:type="locator" xlink:label="us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/MarketableSecuritiesTable">
    <loc xlink:type="locator" xlink:label="anik_Note3MarketableSecuritiesDetailsMarketableSecuritiesLineItems" xlink:href="anik-20140930.xsd#anik_Note3MarketableSecuritiesDetailsMarketableSecuritiesLineItems"/>
    <loc xlink:type="locator" xlink:label="anik_Note3MarketableSecuritiesDetailsMarketableSecuritiesTable" xlink:href="anik-20140930.xsd#anik_Note3MarketableSecuritiesDetailsMarketableSecuritiesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="anik_Note3MarketableSecuritiesDetailsMarketableSecuritiesLineItems" xlink:to="anik_Note3MarketableSecuritiesDetailsMarketableSecuritiesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="anik_Note3MarketableSecuritiesDetailsMarketableSecuritiesTable" xlink:to="us-gaap_InvestmentTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember_0" order="1" xbrldt:closed="true"/>
<!-- [WMV4][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt8UCLPdYZl35nXbOCDIyGTq8kWYS5mE4nIDdhC6ZUZ3C7uZIfzBVpwVZvunzSNea5mQTTlY4E6meqyItzXsZeYoFfvM/Avp17arPuR/GW0mknfKp3JQjUBUq0bHVHYbNAE8Fh5fiLkIMcVQlbp04OxRRXjc+Ssu9cPRpFdgx0G2vpzwAswTXRmMT0FZiyY6i+qLq5PRP2wtDNRIwlEdbo6a] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_USStatesAndPoliticalSubdivisionsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CertificatesOfDepositMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_CertificatesOfDepositMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesAmortizedCost" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAmortizedCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_Note3MarketableSecuritiesDetailsMarketableSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesAmortizedCost" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_Note3MarketableSecuritiesDetailsMarketableSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_Note3MarketableSecuritiesDetailsMarketableSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleSecurities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_Note3MarketableSecuritiesDetailsMarketableSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecurities" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/FairValueofFinancialInstrumentsTable">
    <loc xlink:type="locator" xlink:label="anik_Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsLineItems" xlink:href="anik-20140930.xsd#anik_Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsLineItems"/>
    <loc xlink:type="locator" xlink:label="anik_Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsTable" xlink:href="anik-20140930.xsd#anik_Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="anik_Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsLineItems" xlink:to="anik_Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="anik_Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByAssetClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="anik_Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsTable" xlink:to="us-gaap_FairValueByAssetClassAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_MoneyMarketFundsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_USStatesAndPoliticalSubdivisionsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CertificatesOfDepositMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_CertificatesOfDepositMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsLineItems" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_MarketableSecuritiesAbstract0" xlink:href="anik-20140930.xsd#anik_MarketableSecuritiesAbstract0"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsLineItems" xlink:to="anik_MarketableSecuritiesAbstract0" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleSecurities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsLineItems" xlink:to="us-gaap_AvailableForSaleSecurities" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/AssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsTable">
    <loc xlink:type="locator" xlink:label="anik_Note5EquityIncentivePlanDetailsAssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsLineItems" xlink:href="anik-20140930.xsd#anik_Note5EquityIncentivePlanDetailsAssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsLineItems"/>
    <loc xlink:type="locator" xlink:label="anik_Note5EquityIncentivePlanDetailsAssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsTable" xlink:href="anik-20140930.xsd#anik_Note5EquityIncentivePlanDetailsAssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="anik_Note5EquityIncentivePlanDetailsAssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsLineItems" xlink:to="anik_Note5EquityIncentivePlanDetailsAssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="anik_Note5EquityIncentivePlanDetailsAssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsTable" xlink:to="us-gaap_RangeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeMember_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MinimumMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MaximumMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_Note5EquityIncentivePlanDetailsAssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsLineItems" xlink:to="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_Note5EquityIncentivePlanDetailsAssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_Note5EquityIncentivePlanDetailsAssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_Note5EquityIncentivePlanDetailsAssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/BasicandDilutedEarningsPerShareTable">
    <loc xlink:type="locator" xlink:label="anik_BasicAndDilutedEarningsPerShareAbstract" xlink:href="anik-20140930.xsd#anik_BasicAndDilutedEarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_BasicAndDilutedEarningsPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_EffectOfDilutiveSecuritiesAbstract" xlink:href="anik-20140930.xsd#anik_EffectOfDilutiveSecuritiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_BasicAndDilutedEarningsPerShareAbstract" xlink:to="anik_EffectOfDilutiveSecuritiesAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_EffectOfDilutiveSecuritiesAbstract" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_BasicAndDilutedEarningsPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/InventoriesTable">
    <loc xlink:type="locator" xlink:label="anik_InventoriesAbstract" xlink:href="anik-20140930.xsd#anik_InventoriesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryRawMaterials" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InventoryRawMaterials"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_InventoriesAbstract" xlink:to="us-gaap_InventoryRawMaterials" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryWorkInProcess" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_InventoriesAbstract" xlink:to="us-gaap_InventoryWorkInProcess" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryFinishedGoods" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_InventoriesAbstract" xlink:to="us-gaap_InventoryFinishedGoods" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InventoryNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InventoryFinishedGoods" xlink:to="us-gaap_InventoryNet" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/IntangibleAssetsTable">
    <loc xlink:type="locator" xlink:label="anik_Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsLineItems" xlink:href="anik-20140930.xsd#anik_Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsLineItems"/>
    <loc xlink:type="locator" xlink:label="anik_Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsTable" xlink:href="anik-20140930.xsd#anik_Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="anik_Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsLineItems" xlink:to="anik_Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="anik_Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DevelopedTechnologyRightsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_DevelopedTechnologyRightsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_InProcessResearchAndDevelopmentMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DistributionRightsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DistributionRightsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_DistributionRightsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PatentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PatentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_PatentsMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_ElevessTradeNameMember" xlink:href="anik-20140930.xsd#anik_ElevessTradeNameMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="anik_ElevessTradeNameMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_IntangibleAssetsGrossCarryingAmount" xlink:href="anik-20140930.xsd#anik_IntangibleAssetsGrossCarryingAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsLineItems" xlink:to="anik_IntangibleAssetsGrossCarryingAmount" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_IntangibleAssetsTranslationAdjustments" xlink:href="anik-20140930.xsd#anik_IntangibleAssetsTranslationAdjustments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsLineItems" xlink:to="anik_IntangibleAssetsTranslationAdjustments" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_IntangibleAssetsAccumulatedAmortization" xlink:href="anik-20140930.xsd#anik_IntangibleAssetsAccumulatedAmortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsLineItems" xlink:to="anik_IntangibleAssetsAccumulatedAmortization" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsLineItems" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/ChangesinCarryingValueofGoodwillTable">
    <loc xlink:type="locator" xlink:label="anik_ChangesInCarryingValueOfGoodwillAbstract" xlink:href="anik-20140930.xsd#anik_ChangesInCarryingValueOfGoodwillAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Goodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_ChangesInCarryingValueOfGoodwillAbstract" xlink:to="us-gaap_Goodwill" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillTranslationAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GoodwillTranslationAdjustments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_ChangesInCarryingValueOfGoodwillAbstract" xlink:to="us-gaap_GoodwillTranslationAdjustments" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/AccruedExpensesTable">
    <loc xlink:type="locator" xlink:label="anik_AccruedExpensesAbstract" xlink:href="anik-20140930.xsd#anik_AccruedExpensesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_AccruedExpensesAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_AccruedClinicalTrialCostsCurrent" xlink:href="anik-20140930.xsd#anik_AccruedClinicalTrialCostsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_AccruedExpensesAbstract" xlink:to="anik_AccruedClinicalTrialCostsCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_AccruedExpensesAbstract" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_AccruedResearchGrantsCurrent" xlink:href="anik-20140930.xsd#anik_AccruedResearchGrantsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_AccruedExpensesAbstract" xlink:to="anik_AccruedResearchGrantsCurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestructuringReserveCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestructuringReserveCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_AccruedExpensesAbstract" xlink:to="us-gaap_RestructuringReserveCurrent" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_AccruedExpensesAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_AccruedExpensesAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/ProductRevenuebyProductGroupTable">
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProductOrServiceAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_ProductOrServiceAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProductsAndServicesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ProductOrServiceAxis" xlink:to="us-gaap_ProductsAndServicesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProductsAndServicesDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProductsAndServicesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ProductOrServiceAxis" xlink:to="us-gaap_ProductsAndServicesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_OrthobiologicsMember" xlink:href="anik-20140930.xsd#anik_OrthobiologicsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ProductsAndServicesDomain" xlink:to="anik_OrthobiologicsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_DermalMember" xlink:href="anik-20140930.xsd#anik_DermalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ProductsAndServicesDomain" xlink:to="anik_DermalMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_SurgicalMember" xlink:href="anik-20140930.xsd#anik_SurgicalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ProductsAndServicesDomain" xlink:to="anik_SurgicalMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_OphthalmicMember" xlink:href="anik-20140930.xsd#anik_OphthalmicMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ProductsAndServicesDomain" xlink:to="anik_OphthalmicMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_VeterinaryMember" xlink:href="anik-20140930.xsd#anik_VeterinaryMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ProductsAndServicesDomain" xlink:to="anik_VeterinaryMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesRevenueGoodsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SalesRevenueGoodsNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_SalesRevenueGoodsNet" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/ProductRevenuebyGeographicLocationTable">
    <loc xlink:type="locator" xlink:label="anik_Note13SegmentandGeographicInformationDetailsProductRevenuebyGeographicLocationLineItems" xlink:href="anik-20140930.xsd#anik_Note13SegmentandGeographicInformationDetailsProductRevenuebyGeographicLocationLineItems"/>
    <loc xlink:type="locator" xlink:label="anik_Note13SegmentandGeographicInformationDetailsProductRevenuebyGeographicLocationTable" xlink:href="anik-20140930.xsd#anik_Note13SegmentandGeographicInformationDetailsProductRevenuebyGeographicLocationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="anik_Note13SegmentandGeographicInformationDetailsProductRevenuebyGeographicLocationLineItems" xlink:to="anik_Note13SegmentandGeographicInformationDetailsProductRevenuebyGeographicLocationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementGeographicalAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementGeographicalAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="anik_Note13SegmentandGeographicInformationDetailsProductRevenuebyGeographicLocationTable" xlink:to="us-gaap_StatementGeographicalAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentGeographicalDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_SegmentGeographicalDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentGeographicalDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_SegmentGeographicalDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_UnitedStatesMember" xlink:href="anik-20140930.xsd#anik_UnitedStatesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="anik_UnitedStatesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EuropeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EuropeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="us-gaap_EuropeMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_OtherLocationMember" xlink:href="anik-20140930.xsd#anik_OtherLocationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="anik_OtherLocationMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_GeographicLocationAbstract" xlink:href="anik-20140930.xsd#anik_GeographicLocationAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_Note13SegmentandGeographicInformationDetailsProductRevenuebyGeographicLocationLineItems" xlink:to="anik_GeographicLocationAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesRevenueNet" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SalesRevenueNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_GeographicLocationAbstract" xlink:to="us-gaap_SalesRevenueNet" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_PercentageOfNetRevenue" xlink:href="anik-20140930.xsd#anik_PercentageOfNetRevenue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_GeographicLocationAbstract" xlink:to="anik_PercentageOfNetRevenue" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/RestructuringAccrualActivityTable">
    <loc xlink:type="locator" xlink:label="anik_Note14RestructuringCreditsDetailsRestructuringAccrualActivityLineItems" xlink:href="anik-20140930.xsd#anik_Note14RestructuringCreditsDetailsRestructuringAccrualActivityLineItems"/>
    <loc xlink:type="locator" xlink:label="anik_Note14RestructuringCreditsDetailsRestructuringAccrualActivityTable" xlink:href="anik-20140930.xsd#anik_Note14RestructuringCreditsDetailsRestructuringAccrualActivityTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="anik_Note14RestructuringCreditsDetailsRestructuringAccrualActivityLineItems" xlink:to="anik_Note14RestructuringCreditsDetailsRestructuringAccrualActivityTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestructuringCostAndReserveAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="anik_Note14RestructuringCreditsDetailsRestructuringAccrualActivityTable" xlink:to="us-gaap_RestructuringCostAndReserveAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TypeOfRestructuringDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RestructuringCostAndReserveAxis" xlink:to="us-gaap_TypeOfRestructuringDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TypeOfRestructuringDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RestructuringCostAndReserveAxis" xlink:to="us-gaap_TypeOfRestructuringDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_EmployeeTerminationCostsMember" xlink:href="anik-20140930.xsd#anik_EmployeeTerminationCostsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfRestructuringDomain" xlink:to="anik_EmployeeTerminationCostsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_ActivityTerminationAndFacilityClosureCostsMember" xlink:href="anik-20140930.xsd#anik_ActivityTerminationAndFacilityClosureCostsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfRestructuringDomain" xlink:to="anik_ActivityTerminationAndFacilityClosureCostsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestructuringReserve" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestructuringReserve"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_Note14RestructuringCreditsDetailsRestructuringAccrualActivityLineItems" xlink:to="us-gaap_RestructuringReserve" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRestructuring" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_Note14RestructuringCreditsDetailsRestructuringAccrualActivityLineItems" xlink:to="us-gaap_PaymentsForRestructuring" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestructuringReserveTranslationAdjustment" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestructuringReserveTranslationAdjustment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_Note14RestructuringCreditsDetailsRestructuringAccrualActivityLineItems" xlink:to="us-gaap_RestructuringReserveTranslationAdjustment" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note2BasisofPresentationDetails">
    <loc xlink:type="locator" xlink:label="anik_Note2BasisofPresentationDetailsLineItems" xlink:href="anik-20140930.xsd#anik_Note2BasisofPresentationDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="anik_Note2BasisofPresentationDetailsTable" xlink:href="anik-20140930.xsd#anik_Note2BasisofPresentationDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="anik_Note2BasisofPresentationDetailsLineItems" xlink:to="anik_Note2BasisofPresentationDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="anik_Note2BasisofPresentationDetailsTable" xlink:to="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:to="us-gaap_AdjustmentsForErrorCorrectionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsForErrorCorrectionDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:to="us-gaap_AdjustmentsForErrorCorrectionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_IncreaseToCashProvidedByFinancingActivitiesMember" xlink:href="anik-20140930.xsd#anik_IncreaseToCashProvidedByFinancingActivitiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:to="anik_IncreaseToCashProvidedByFinancingActivitiesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_DereaseToCashProvidedByOperatingActivitiesMember" xlink:href="anik-20140930.xsd#anik_DereaseToCashProvidedByOperatingActivitiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:to="anik_DereaseToCashProvidedByOperatingActivitiesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PriorPeriodReclassificationAdjustment" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_Note2BasisofPresentationDetailsLineItems" xlink:to="us-gaap_PriorPeriodReclassificationAdjustment" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note5EquityIncentivePlanDetails">
    <loc xlink:type="locator" xlink:label="anik_Note5EquityIncentivePlanDetailsLineItems" xlink:href="anik-20140930.xsd#anik_Note5EquityIncentivePlanDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="anik_Note5EquityIncentivePlanDetailsTable" xlink:href="anik-20140930.xsd#anik_Note5EquityIncentivePlanDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="anik_Note5EquityIncentivePlanDetailsLineItems" xlink:to="anik_Note5EquityIncentivePlanDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="anik_Note5EquityIncentivePlanDetailsTable" xlink:to="us-gaap_AwardTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="anik_Note5EquityIncentivePlanDetailsTable" xlink:to="us-gaap_RangeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeMember_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TitleOfIndividualAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TitleOfIndividualAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="anik_Note5EquityIncentivePlanDetailsTable" xlink:to="us-gaap_TitleOfIndividualAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TitleOfIndividualAxis" xlink:to="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TitleOfIndividualAxis" xlink:to="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_BoardOfDirectorsMember" xlink:href="anik-20140930.xsd#anik_BoardOfDirectorsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="anik_BoardOfDirectorsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockAppreciationRightsSARSMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_StockAppreciationRightsSARSMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MinimumMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MaximumMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_Note5EquityIncentivePlanDetailsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_Note5EquityIncentivePlanDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_Note5EquityIncentivePlanDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_Note5EquityIncentivePlanDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_Note5EquityIncentivePlanDetailsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_Note5EquityIncentivePlanDetailsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriodTotalIntrinsicValue" xlink:href="anik-20140930.xsd#anik_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriodTotalIntrinsicValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_Note5EquityIncentivePlanDetailsLineItems" xlink:to="anik_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriodTotalIntrinsicValue" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_Note5EquityIncentivePlanDetailsLineItems" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_Note5EquityIncentivePlanDetailsLineItems" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingNumber" xlink:href="anik-20140930.xsd#anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_Note5EquityIncentivePlanDetailsLineItems" xlink:to="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingNumber" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsWeightedAverageExercisePrice" xlink:href="anik-20140930.xsd#anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_Note5EquityIncentivePlanDetailsLineItems" xlink:to="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsWeightedAverageExercisePrice" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingIntrinsicValue" xlink:href="anik-20140930.xsd#anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingIntrinsicValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_Note5EquityIncentivePlanDetailsLineItems" xlink:to="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingIntrinsicValue" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm" xlink:href="anik-20140930.xsd#anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_Note5EquityIncentivePlanDetailsLineItems" xlink:to="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTermRange" xlink:href="anik-20140930.xsd#anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTermRange"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_Note5EquityIncentivePlanDetailsLineItems" xlink:to="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTermRange" order="14" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note6EarningsPerShareDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note8IntangibleAssetsandGoodwillDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note10CommitmentsandContingenciesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProductWarrantyAccrual" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProductWarrantyAccrual"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_ProductWarrantyAccrual" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProductWarrantyExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProductWarrantyExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_ProductWarrantyExpense" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note11MitekMonoviscAgreementDetails">
    <loc xlink:type="locator" xlink:label="anik_Note11MitekMonoviscAgreementDetailsLineItems" xlink:href="anik-20140930.xsd#anik_Note11MitekMonoviscAgreementDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="anik_Note11MitekMonoviscAgreementDetailsTable" xlink:href="anik-20140930.xsd#anik_Note11MitekMonoviscAgreementDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="anik_Note11MitekMonoviscAgreementDetailsLineItems" xlink:to="anik_Note11MitekMonoviscAgreementDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="anik_Note11MitekMonoviscAgreementDetailsTable" xlink:to="us-gaap_DeferredRevenueArrangementTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="us-gaap_DeferredRevenueArrangementTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueArrangementTypeDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="us-gaap_DeferredRevenueArrangementTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_MiltekMONOVISCAgreementMember" xlink:href="anik-20140930.xsd#anik_MiltekMONOVISCAgreementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:to="anik_MiltekMONOVISCAgreementMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_ContractTermYears" xlink:href="anik-20140930.xsd#anik_ContractTermYears"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_Note11MitekMonoviscAgreementDetailsLineItems" xlink:to="anik_ContractTermYears" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_Note11MitekMonoviscAgreementDetailsLineItems" xlink:to="us-gaap_DeferredRevenue" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueRevenueRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueRevenueRecognized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_Note11MitekMonoviscAgreementDetailsLineItems" xlink:to="us-gaap_DeferredRevenueRevenueRecognized" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_Note11MitekMonoviscAgreementDetailsLineItems" xlink:to="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note12IncomeTaxesDetails">
    <loc xlink:type="locator" xlink:label="anik_Note12IncomeTaxesDetailsLineItems" xlink:href="anik-20140930.xsd#anik_Note12IncomeTaxesDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="anik_Note12IncomeTaxesDetailsTable" xlink:href="anik-20140930.xsd#anik_Note12IncomeTaxesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="anik_Note12IncomeTaxesDetailsLineItems" xlink:to="anik_Note12IncomeTaxesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TaxPeriodAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="anik_Note12IncomeTaxesDetailsTable" xlink:to="us-gaap_TaxPeriodAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TaxPeriodDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TaxPeriodAxis" xlink:to="us-gaap_TaxPeriodDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TaxPeriodDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TaxPeriodAxis" xlink:to="us-gaap_TaxPeriodDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="anik_Note12IncomeTaxesDetailsTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="anik_Note12IncomeTaxesDetailsTable" xlink:to="us-gaap_IncomeTaxAuthorityNameAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_IncomeTaxAuthorityNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_IncomeTaxAuthorityNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_RevenueComponentsAxis" xlink:href="anik-20140930.xsd#anik_RevenueComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="anik_Note12IncomeTaxesDetailsTable" xlink:to="anik_RevenueComponentsAxis" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_RevenueComponentsDomain" xlink:href="anik-20140930.xsd#anik_RevenueComponentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="anik_RevenueComponentsAxis" xlink:to="anik_RevenueComponentsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_RevenueComponentsDomain_0" xlink:href="anik-20140930.xsd#anik_RevenueComponentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="anik_RevenueComponentsAxis" xlink:to="anik_RevenueComponentsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_MilestoneAndContractRevenueMember" xlink:href="anik-20140930.xsd#anik_MilestoneAndContractRevenueMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_RevenueComponentsDomain" xlink:to="anik_MilestoneAndContractRevenueMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DomesticCountryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCountryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_ForeignCountryMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarliestTaxYearMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarliestTaxYearMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxPeriodDomain" xlink:to="us-gaap_EarliestTaxYearMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InternalRevenueServiceIRSMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="us-gaap_InternalRevenueServiceIRSMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MinistryOfEconomicAffairsAndFinanceItalyMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MinistryOfEconomicAffairsAndFinanceItalyMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="us-gaap_MinistryOfEconomicAffairsAndFinanceItalyMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_Note12IncomeTaxesDetailsLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_Note12IncomeTaxesDetailsLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContractsRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ContractsRevenue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_Note12IncomeTaxesDetailsLineItems" xlink:to="us-gaap_ContractsRevenue" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OpenTaxYear" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OpenTaxYear"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_Note12IncomeTaxesDetailsLineItems" xlink:to="us-gaap_OpenTaxYear" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note13SegmentandGeographicInformationDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NumberOfReportableSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_NumberOfReportableSegments" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note14RestructuringCreditsDetails">
    <loc xlink:type="locator" xlink:label="anik_Note14RestructuringCreditsDetailsLineItems" xlink:href="anik-20140930.xsd#anik_Note14RestructuringCreditsDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="anik_Note14RestructuringCreditsDetailsTable" xlink:href="anik-20140930.xsd#anik_Note14RestructuringCreditsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="anik_Note14RestructuringCreditsDetailsLineItems" xlink:to="anik_Note14RestructuringCreditsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestructuringCostAndReserveAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="anik_Note14RestructuringCreditsDetailsTable" xlink:to="us-gaap_RestructuringCostAndReserveAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TypeOfRestructuringDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RestructuringCostAndReserveAxis" xlink:to="us-gaap_TypeOfRestructuringDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TypeOfRestructuringDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RestructuringCostAndReserveAxis" xlink:to="us-gaap_TypeOfRestructuringDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_NonCashTerminationAndImpairmentOfIPRDProjectMember" xlink:href="anik-20140930.xsd#anik_NonCashTerminationAndImpairmentOfIPRDProjectMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfRestructuringDomain" xlink:to="anik_NonCashTerminationAndImpairmentOfIPRDProjectMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_NoncashDisposalOfPropertyAndEquipmentMember" xlink:href="anik-20140930.xsd#anik_NoncashDisposalOfPropertyAndEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfRestructuringDomain" xlink:to="anik_NoncashDisposalOfPropertyAndEquipmentMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_DisposalOfInventoryMember" xlink:href="anik-20140930.xsd#anik_DisposalOfInventoryMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfRestructuringDomain" xlink:to="anik_DisposalOfInventoryMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_Note14RestructuringCreditsDetailsLineItems" xlink:to="us-gaap_RestructuringCostsAndAssetImpairmentCharges" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="anik_RestructuringCredit" xlink:href="anik-20140930.xsd#anik_RestructuringCredit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="anik_Note14RestructuringCreditsDetailsLineItems" xlink:to="anik_RestructuringCredit" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentInformationLineItems"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityPublicFloat" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityPublicFloat" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentDescription" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentDescription" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="14" xbrldt:closed="true"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>anik-20140930_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Wed Nov 05 23:59:00 UTC 2014 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0" xml:lang="en-US">Cash and cash equivalents at beginning of period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1" xml:lang="en-US">Cash and cash equivalents at end of period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesCurrent_lbl" xml:lang="en-US">Marketable securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesCurrent" xlink:to="us-gaap_MarketableSecuritiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts receivable, net of reserves of $546,455 and $593,023 at September 30, 2014 and December 31, 2013, respectively</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xml:lang="en-US">Accounts receivable, net of reserves (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InventoryNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">Inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_InventoryNet_lbl0" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidTaxes_lbl" xml:lang="en-US">Prepaid income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidTaxes" xlink:to="us-gaap_PrepaidTaxes_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsNetCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNetCurrent_lbl" xml:lang="en-US">Current portion deferred income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNetCurrent" xlink:to="us-gaap_DeferredTaxAssetsNetCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Property and equipment, at cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Less: accumulated depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_DepositsAndOtherAssetsNoncurrent" xlink:href="anik-20140930.xsd#anik_DepositsAndOtherAssetsNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_DepositsAndOtherAssetsNoncurrent_lbl" xml:lang="en-US">Long-term deposits and other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_DepositsAndOtherAssetsNoncurrent" xlink:to="anik_DepositsAndOtherAssetsNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">Intangible assets, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl0" xml:lang="en-US">Net Book Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Goodwill"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Goodwill_lbl" xml:lang="en-US">Goodwill</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_Goodwill_lbl0" xml:lang="en-US">Balance, beginning</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_Goodwill_lbl1" xml:lang="en-US">Balance, ending</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Assets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl0" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xml:lang="en-US">Deferred revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedIncomeTaxesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedIncomeTaxesCurrent_lbl" xml:lang="en-US">Income taxes payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedIncomeTaxesCurrent" xlink:to="us-gaap_AccruedIncomeTaxesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xml:lang="en-US">Other long-term liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueNoncurrent_lbl" xml:lang="en-US">Long-term deferred revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueNoncurrent" xlink:to="us-gaap_DeferredRevenueNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesNoncurrent_lbl" xml:lang="en-US">Deferred tax liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:to="us-gaap_DeferredTaxLiabilitiesNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and contingencies (Note 10)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PreferredStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock, $.01 par value; 1,250,000 shares authorized, no shares issued and outstanding at September 30, 2014 and December 31, 2013, respectively</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, $.01 par value; 30,000,000 shares authorized, 14,800,453 and 14,289,308 shares issued and outstanding at September 30, 2014 and December 31, 2013, respectively</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock,shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xml:lang="en-US">Additional paid-in-capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_lbl" xml:lang="en-US">Accumulated other comprehensive loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Retained earnings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total stockholders&#8217; equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total Liabilities and Stockholders&#8217; Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_lbl" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesRevenueGoodsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SalesRevenueGoodsNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueGoodsNet_lbl" xml:lang="en-US">Product revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueGoodsNet" xlink:to="us-gaap_SalesRevenueGoodsNet_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SalesRevenueGoodsNet_lbl0" xml:lang="en-US">Product Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueGoodsNet" xlink:to="us-gaap_SalesRevenueGoodsNet_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesRevenueServicesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SalesRevenueServicesNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueServicesNet_lbl" xml:lang="en-US">Licensing, milestone and contract revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueServicesNet" xlink:to="us-gaap_SalesRevenueServicesNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesRevenueNet" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SalesRevenueNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_SalesRevenueNet_lbl" xml:lang="en-US">Total revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNet" xlink:to="us-gaap_SalesRevenueNet_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNet_lbl0" xml:lang="en-US">Total Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNet" xlink:to="us-gaap_SalesRevenueNet_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfGoodsSold" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CostOfGoodsSold"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsSold_lbl" xml:lang="en-US">Cost of product revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsSold" xlink:to="us-gaap_CostOfGoodsSold_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research &amp; development</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Selling, general &amp; administrative</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_RestructuringCredit" xlink:href="anik-20140930.xsd#anik_RestructuringCredit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="anik_RestructuringCredit_lbl" xml:lang="en-US">Restructuring credits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_RestructuringCredit" xlink:to="anik_RestructuringCredit_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_RestructuringCredit_lbl0" xml:lang="en-US">Restructuring Credit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_RestructuringCredit" xlink:to="anik_RestructuringCredit_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CostsAndExpenses_lbl" xml:lang="en-US">Total operating expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Income from operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestIncomeExpenseNonoperatingNet_lbl" xml:lang="en-US">Interest income (expense), net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:to="us-gaap_InterestIncomeExpenseNonoperatingNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Income before income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Provision for income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl0" xml:lang="en-US">Income Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl0" xml:lang="en-US">Net income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Net income (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Basic weighted average common shares outstanding (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl0" xml:lang="en-US">Shares used in the calculation of basic earnings per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Net income (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Diluted weighted average common shares outstanding (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl0" xml:lang="en-US">Diluted shares used in the calculation of earnings per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl" xml:lang="en-US">Unrealized gain on securities, net of tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xml:lang="en-US">Foreign currency translation adjustment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US">Total other comprehensive income (loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US">Comprehensive income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US">Statement of Stockholders&apos; Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock-based compensation expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_lbl" xml:lang="en-US">Provision for doubtful accounts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProvisionForDoubtfulAccounts" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryWriteDown" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWriteDown_lbl" xml:lang="en-US">Provision for inventory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWriteDown" xlink:to="us-gaap_InventoryWriteDown_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnDispositionOfAssets1" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainLossOnDispositionOfAssets1_lbl" xml:lang="en-US">Gain on sale of assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDispositionOfAssets1" xlink:to="us-gaap_GainLossOnDispositionOfAssets1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities_lbl" xml:lang="en-US">Tax benefit from exercise of stock options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities" xlink:to="us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid expenses, other current and long-term assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xml:lang="en-US">Long-term deposits and other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US">Accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xml:lang="en-US">Accrued expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl" xml:lang="en-US">Deferred revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_lbl" xml:lang="en-US">Income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_lbl" xml:lang="en-US">Other long-term liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash provided by operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xml:lang="en-US">Purchase of marketable securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfOtherAssets1" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromSaleOfOtherAssets1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfOtherAssets1_lbl" xml:lang="en-US">Proceeds from sale of assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfOtherAssets1" xlink:to="us-gaap_ProceedsFromSaleOfOtherAssets1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchase of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash provided by (used in) investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xml:lang="en-US">Proceeds from exercise of stock options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl0" xml:lang="en-US">Proceeds from Stock Options Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_lbl" xml:lang="en-US">Tax benefit from exercise of stock options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" xlink:to="us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" xml:lang="en-US">Minimum tax withholding on share based awards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfLongTermDebt_lbl" xml:lang="en-US">Principal payments on debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLongTermDebt" xlink:to="us-gaap_RepaymentsOfLongTermDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_lbl" xml:lang="en-US">Exchange rate impact on cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:to="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xml:lang="en-US">Increase in cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureTextBlockAbstract_lbl" xml:lang="en-US">Disclosure Text Block [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_DisclosureTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DisclosureTextBlockSupplementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract_lbl" xml:lang="en-US">Disclosure Text Block Supplement [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_DisclosureTextBlockSupplementAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecuritiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesAbstract_lbl" xml:lang="en-US">Marketable Securities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesAbstract" xlink:to="us-gaap_MarketableSecuritiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xml:lang="en-US">Investment Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_USStatesAndPoliticalSubdivisionsMember_lbl" xml:lang="en-US">US States and Political Subdivisions Debt Securities [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:to="us-gaap_USStatesAndPoliticalSubdivisionsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesAmortizedCost" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAmortizedCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleSecuritiesAmortizedCost_lbl" xml:lang="en-US">Amortized Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesAmortizedCost" xlink:to="us-gaap_AvailableForSaleSecuritiesAmortizedCost_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xml:lang="en-US">Unrealized Gains</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xml:lang="en-US">Unrealized Losses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleSecurities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleSecurities_lbl" xml:lang="en-US">Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecurities" xlink:to="us-gaap_AvailableForSaleSecurities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AvailableForSaleSecurities_lbl0" xml:lang="en-US">Marketable securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecurities" xlink:to="us-gaap_AvailableForSaleSecurities_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CertificatesOfDepositMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CertificatesOfDepositMember_lbl" xml:lang="en-US">Certificates of Deposit [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CertificatesOfDepositMember" xlink:to="us-gaap_CertificatesOfDepositMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xml:lang="en-US">Fair Value Disclosures [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_FairValueOfFinancialInstrumentsAbstract" xlink:href="anik-20140930.xsd#anik_FairValueOfFinancialInstrumentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_FairValueOfFinancialInstrumentsAbstract_lbl" xml:lang="en-US">Fair Value of Financial Instruments [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_FairValueOfFinancialInstrumentsAbstract" xlink:to="anik_FairValueOfFinancialInstrumentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByAssetClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByAssetClassAxis_lbl" xml:lang="en-US">Asset Class [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueByAssetClassAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xml:lang="en-US">Money Market Funds [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsMember" xlink:to="us-gaap_MoneyMarketFundsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xml:lang="en-US">Money market funds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US">Fair Value, Hierarchy [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_AssumptionsUsedToEstimateFairValueOfStockOptionsAndStockAppreciationRightsAwardsAbstract" xlink:href="anik-20140930.xsd#anik_AssumptionsUsedToEstimateFairValueOfStockOptionsAndStockAppreciationRightsAwardsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_AssumptionsUsedToEstimateFairValueOfStockOptionsAndStockAppreciationRightsAwardsAbstract_lbl" xml:lang="en-US">Assumptions Used to Estimate Fair Value of Stock Options and Stock Appreciation Rights Awards [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_AssumptionsUsedToEstimateFairValueOfStockOptionsAndStockAppreciationRightsAwardsAbstract" xlink:to="anik_AssumptionsUsedToEstimateFairValueOfStockOptionsAndStockAppreciationRightsAwardsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate_lbl" xml:lang="en-US">Risk free interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Expected volatility</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Expected lives (years)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Expected dividend yield</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RangeAxis_lbl" xml:lang="en-US">Range [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MinimumMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MinimumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinimumMember" xlink:to="us-gaap_MinimumMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MaximumMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MaximumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MaximumMember" xlink:to="us-gaap_MaximumMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US">Earnings Per Share [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_BasicAndDilutedEarningsPerShareAbstract" xlink:href="anik-20140930.xsd#anik_BasicAndDilutedEarningsPerShareAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_BasicAndDilutedEarningsPerShareAbstract_lbl" xml:lang="en-US">Basic and Diluted Earnings Per Share [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_BasicAndDilutedEarningsPerShareAbstract" xlink:to="anik_BasicAndDilutedEarningsPerShareAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl" xml:lang="en-US">Stock options, SARs, and RSAs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US">Inventory Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_InventoriesAbstract" xlink:href="anik-20140930.xsd#anik_InventoriesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_InventoriesAbstract_lbl" xml:lang="en-US">Inventories [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_InventoriesAbstract" xlink:to="anik_InventoriesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryRawMaterials" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InventoryRawMaterials"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryRawMaterials_lbl" xml:lang="en-US">Raw materials</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterials" xlink:to="us-gaap_InventoryRawMaterials_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryWorkInProcess" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWorkInProcess_lbl" xml:lang="en-US">Work-in-process</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcess" xlink:to="us-gaap_InventoryWorkInProcess_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryFinishedGoods" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryFinishedGoods_lbl" xml:lang="en-US">Finished goods</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoods" xlink:to="us-gaap_InventoryFinishedGoods_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_IntangibleAssetsAbstract" xlink:href="anik-20140930.xsd#anik_IntangibleAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_IntangibleAssetsAbstract_lbl" xml:lang="en-US">Intangible Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_IntangibleAssetsAbstract" xlink:to="anik_IntangibleAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DevelopedTechnologyRightsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DevelopedTechnologyRightsMember_lbl" xml:lang="en-US">Developed Technology Rights [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DevelopedTechnologyRightsMember" xlink:to="us-gaap_DevelopedTechnologyRightsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_IntangibleAssetsGrossCarryingAmount" xlink:href="anik-20140930.xsd#anik_IntangibleAssetsGrossCarryingAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_IntangibleAssetsGrossCarryingAmount_lbl" xml:lang="en-US">Gross Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_IntangibleAssetsGrossCarryingAmount" xlink:to="anik_IntangibleAssetsGrossCarryingAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_IntangibleAssetsTranslationAdjustments" xlink:href="anik-20140930.xsd#anik_IntangibleAssetsTranslationAdjustments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_IntangibleAssetsTranslationAdjustments_lbl" xml:lang="en-US">Currency Translation Adjustment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_IntangibleAssetsTranslationAdjustments" xlink:to="anik_IntangibleAssetsTranslationAdjustments_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_IntangibleAssetsAccumulatedAmortization" xlink:href="anik-20140930.xsd#anik_IntangibleAssetsAccumulatedAmortization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_IntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Accumulated Amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_IntangibleAssetsAccumulatedAmortization" xlink:to="anik_IntangibleAssetsAccumulatedAmortization_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US">Useful Life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InProcessResearchAndDevelopmentMember_lbl" xml:lang="en-US">In Process Research and Development [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="us-gaap_InProcessResearchAndDevelopmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DistributionRightsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DistributionRightsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DistributionRightsMember_lbl" xml:lang="en-US">Distribution Rights [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DistributionRightsMember" xlink:to="us-gaap_DistributionRightsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PatentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PatentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PatentsMember_lbl" xml:lang="en-US">Patents [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PatentsMember" xlink:to="us-gaap_PatentsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_ElevessTradeNameMember" xlink:href="anik-20140930.xsd#anik_ElevessTradeNameMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anik_ElevessTradeNameMember_lbl" xml:lang="en-US">Elevess Trade Name [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_ElevessTradeNameMember" xlink:to="anik_ElevessTradeNameMember_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_ChangesInCarryingValueOfGoodwillAbstract" xlink:href="anik-20140930.xsd#anik_ChangesInCarryingValueOfGoodwillAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_ChangesInCarryingValueOfGoodwillAbstract_lbl" xml:lang="en-US">Changes in Carrying Value of Goodwill [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_ChangesInCarryingValueOfGoodwillAbstract" xlink:to="anik_ChangesInCarryingValueOfGoodwillAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillTranslationAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GoodwillTranslationAdjustments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillTranslationAdjustments_lbl" xml:lang="en-US">Effect of foreign currency adjustments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillTranslationAdjustments" xlink:to="us-gaap_GoodwillTranslationAdjustments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PayablesAndAccrualsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_AccruedExpensesAbstract" xlink:href="anik-20140930.xsd#anik_AccruedExpensesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_AccruedExpensesAbstract_lbl" xml:lang="en-US">Accrued Expenses [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_AccruedExpensesAbstract" xlink:to="anik_AccruedExpensesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US">Labor and related expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_AccruedClinicalTrialCostsCurrent" xlink:href="anik-20140930.xsd#anik_AccruedClinicalTrialCostsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_AccruedClinicalTrialCostsCurrent_lbl" xml:lang="en-US">Clinical trial costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_AccruedClinicalTrialCostsCurrent" xlink:to="anik_AccruedClinicalTrialCostsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xml:lang="en-US">Professional fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_AccruedResearchGrantsCurrent" xlink:href="anik-20140930.xsd#anik_AccruedResearchGrantsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_AccruedResearchGrantsCurrent_lbl" xml:lang="en-US">Research grants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_AccruedResearchGrantsCurrent" xlink:to="anik_AccruedResearchGrantsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestructuringReserveCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestructuringReserveCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestructuringReserveCurrent_lbl" xml:lang="en-US">Restructuring costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringReserveCurrent" xlink:to="us-gaap_RestructuringReserveCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueDisclosureAbstract_lbl" xml:lang="en-US">Deferred Revenue Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueDisclosureAbstract" xlink:to="us-gaap_DeferredRevenueDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xml:lang="en-US">Segment Reporting [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_ProductRevenueByProductGroupAbstract" xlink:href="anik-20140930.xsd#anik_ProductRevenueByProductGroupAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_ProductRevenueByProductGroupAbstract_lbl" xml:lang="en-US">Product Revenue by Product Group [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_ProductRevenueByProductGroupAbstract" xlink:to="anik_ProductRevenueByProductGroupAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProductOrServiceAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductOrServiceAxis_lbl" xml:lang="en-US">Products and Services [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductOrServiceAxis" xlink:to="us-gaap_ProductOrServiceAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_OrthobiologicsMember" xlink:href="anik-20140930.xsd#anik_OrthobiologicsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anik_OrthobiologicsMember_lbl" xml:lang="en-US">Orthobiologics [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_OrthobiologicsMember" xlink:to="anik_OrthobiologicsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_DermalMember" xlink:href="anik-20140930.xsd#anik_DermalMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anik_DermalMember_lbl" xml:lang="en-US">Dermal [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_DermalMember" xlink:to="anik_DermalMember_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_SurgicalMember" xlink:href="anik-20140930.xsd#anik_SurgicalMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anik_SurgicalMember_lbl" xml:lang="en-US">Surgical [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_SurgicalMember" xlink:to="anik_SurgicalMember_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_OphthalmicMember" xlink:href="anik-20140930.xsd#anik_OphthalmicMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anik_OphthalmicMember_lbl" xml:lang="en-US">Ophthalmic [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_OphthalmicMember" xlink:to="anik_OphthalmicMember_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_VeterinaryMember" xlink:href="anik-20140930.xsd#anik_VeterinaryMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anik_VeterinaryMember_lbl" xml:lang="en-US">Veterinary [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_VeterinaryMember" xlink:to="anik_VeterinaryMember_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_ProductRevenueByGeographicLocationAbstract" xlink:href="anik-20140930.xsd#anik_ProductRevenueByGeographicLocationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_ProductRevenueByGeographicLocationAbstract_lbl" xml:lang="en-US">Product Revenue by Geographic Location [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_ProductRevenueByGeographicLocationAbstract" xlink:to="anik_ProductRevenueByGeographicLocationAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementGeographicalAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementGeographicalAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementGeographicalAxis_lbl" xml:lang="en-US">Geographical [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_StatementGeographicalAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_UnitedStatesMember" xlink:href="anik-20140930.xsd#anik_UnitedStatesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anik_UnitedStatesMember_lbl" xml:lang="en-US">United States [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_UnitedStatesMember" xlink:to="anik_UnitedStatesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_PercentageOfNetRevenue" xlink:href="anik-20140930.xsd#anik_PercentageOfNetRevenue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_PercentageOfNetRevenue_lbl" xml:lang="en-US">Percentage of Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_PercentageOfNetRevenue" xlink:to="anik_PercentageOfNetRevenue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EuropeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EuropeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EuropeMember_lbl" xml:lang="en-US">Europe [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EuropeMember" xlink:to="us-gaap_EuropeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_OtherLocationMember" xlink:href="anik-20140930.xsd#anik_OtherLocationMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anik_OtherLocationMember_lbl" xml:lang="en-US">Other location [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_OtherLocationMember" xlink:to="anik_OtherLocationMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestructuringAndRelatedActivitiesAbstract_lbl" xml:lang="en-US">Restructuring and Related Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="us-gaap_RestructuringAndRelatedActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_RestructuringAccrualActivityAbstract" xlink:href="anik-20140930.xsd#anik_RestructuringAccrualActivityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_RestructuringAccrualActivityAbstract_lbl" xml:lang="en-US">Restructuring Accrual Activity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_RestructuringAccrualActivityAbstract" xlink:to="anik_RestructuringAccrualActivityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestructuringReserve" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestructuringReserve"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_RestructuringReserve_lbl" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringReserve" xlink:to="us-gaap_RestructuringReserve_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_RestructuringReserve_lbl0" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringReserve" xlink:to="us-gaap_RestructuringReserve_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRestructuring" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsForRestructuring_lbl" xml:lang="en-US">Cash Proceeds (Disbursements)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRestructuring" xlink:to="us-gaap_PaymentsForRestructuring_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestructuringReserveTranslationAdjustment" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestructuringReserveTranslationAdjustment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestructuringReserveTranslationAdjustment_lbl" xml:lang="en-US">Foreign Exchange Impact</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringReserveTranslationAdjustment" xlink:to="us-gaap_RestructuringReserveTranslationAdjustment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestructuringCostAndReserveAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestructuringCostAndReserveAxis_lbl" xml:lang="en-US">Restructuring Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringCostAndReserveAxis" xlink:to="us-gaap_RestructuringCostAndReserveAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_EmployeeTerminationCostsMember" xlink:href="anik-20140930.xsd#anik_EmployeeTerminationCostsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anik_EmployeeTerminationCostsMember_lbl" xml:lang="en-US">Employee termination costs [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_EmployeeTerminationCostsMember" xlink:to="anik_EmployeeTerminationCostsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_ActivityTerminationAndFacilityClosureCostsMember" xlink:href="anik-20140930.xsd#anik_ActivityTerminationAndFacilityClosureCostsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anik_ActivityTerminationAndFacilityClosureCostsMember_lbl" xml:lang="en-US">Activity Termination and Facility Closure Costs [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_ActivityTerminationAndFacilityClosureCostsMember" xlink:to="anik_ActivityTerminationAndFacilityClosureCostsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders&#8217; equity:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating expenses:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_BasicNetIncomePerShareAbstract" xlink:href="anik-20140930.xsd#anik_BasicNetIncomePerShareAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_BasicNetIncomePerShareAbstract_lbl" xml:lang="en-US">Basic net income per share:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_BasicNetIncomePerShareAbstract" xlink:to="anik_BasicNetIncomePerShareAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_DilutedNetIncomePerShareAbstract" xlink:href="anik-20140930.xsd#anik_DilutedNetIncomePerShareAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_DilutedNetIncomePerShareAbstract_lbl" xml:lang="en-US">Diluted net income per share:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_DilutedNetIncomePerShareAbstract" xlink:to="anik_DilutedNetIncomePerShareAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_OtherComprehensiveIncomeLossAbstract" xlink:href="anik-20140930.xsd#anik_OtherComprehensiveIncomeLossAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_OtherComprehensiveIncomeLossAbstract_lbl" xml:lang="en-US">Other comprehensive income (loss):</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_OtherComprehensiveIncomeLossAbstract" xlink:to="anik_OtherComprehensiveIncomeLossAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_CashFlowsFromOperatingActivitiesAbstract" xlink:href="anik-20140930.xsd#anik_CashFlowsFromOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_CashFlowsFromOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_CashFlowsFromOperatingActivitiesAbstract" xlink:to="anik_CashFlowsFromOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_AdjustmentsToReconcileNetIncomeToNetCashProvidedByOperatingActivitiesAbstract" xlink:href="anik-20140930.xsd#anik_AdjustmentsToReconcileNetIncomeToNetCashProvidedByOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_AdjustmentsToReconcileNetIncomeToNetCashProvidedByOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_AdjustmentsToReconcileNetIncomeToNetCashProvidedByOperatingActivitiesAbstract" xlink:to="anik_AdjustmentsToReconcileNetIncomeToNetCashProvidedByOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:href="anik-20140930.xsd#anik_ChangesInOperatingAssetsAndLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_ChangesInOperatingAssetsAndLiabilitiesAbstract_lbl" xml:lang="en-US">Changes in operating assets and liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:to="anik_ChangesInOperatingAssetsAndLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_CashFlowsFromInvestingActivitiesAbstract" xlink:href="anik-20140930.xsd#anik_CashFlowsFromInvestingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_CashFlowsFromInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from investing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_CashFlowsFromInvestingActivitiesAbstract" xlink:to="anik_CashFlowsFromInvestingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_CashFlowsFromFinancingActivitiesAbstract" xlink:href="anik-20140930.xsd#anik_CashFlowsFromFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_CashFlowsFromFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from financing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_CashFlowsFromFinancingActivitiesAbstract" xlink:to="anik_CashFlowsFromFinancingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NatureOfOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NatureOfOperations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NatureOfOperations_lbl" xml:lang="en-US">Nature of Operations [Text Block]</label>
<!-- [WMV4][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt8UCLPdYZl35nXbOCDIyGTq8kWYS5mE4nIDdhC6ZUZ3C7uZIfzBVpwVZvunzSNea5mQTTlY4E6meqyItzXsZeYoFfvM/Avp17arPuR/GW0mknfKp3JQjUBUq0bHVHYbNAE8Fh5fiLkIMcVQlbp04OxRRXjc+Ssu9cPRpFdgx0G2vpzwAswTXRmMT0FZiyY6i+ohdYQSBnzAGiSpW04J1e+6] CSR-->
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NatureOfOperations" xlink:to="us-gaap_NatureOfOperations_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xml:lang="en-US">Business Description and Basis of Presentation [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_lbl" xml:lang="en-US">Cash, Cash Equivalents, and Marketable Securities [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:to="us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesTextBlock_lbl" xml:lang="en-US">Marketable Securities [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesTextBlock" xlink:to="us-gaap_MarketableSecuritiesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xml:lang="en-US">Fair Value Disclosures [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_MarketableSecuritiesAbstract0" xlink:href="anik-20140930.xsd#anik_MarketableSecuritiesAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_MarketableSecuritiesAbstract0_lbl" xml:lang="en-US">Marketable securities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_MarketableSecuritiesAbstract0" xlink:to="anik_MarketableSecuritiesAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US">Earnings Per Share [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_EffectOfDilutiveSecuritiesAbstract" xlink:href="anik-20140930.xsd#anik_EffectOfDilutiveSecuritiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_EffectOfDilutiveSecuritiesAbstract_lbl" xml:lang="en-US">Effect of dilutive securities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_EffectOfDilutiveSecuritiesAbstract" xlink:to="anik_EffectOfDilutiveSecuritiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US">Inventory Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTableTextBlock" xlink:href="anik-20140930.xsd#anik_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTableTextBlock_lbl" xml:lang="en-US">Schedule of Finite Lived and Indefinite Lived Intangible Assets by Major Class [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTableTextBlock" xlink:to="anik_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfGoodwillTextBlock_lbl" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="us-gaap_ScheduleOfGoodwillTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueDisclosureTextBlock_lbl" xml:lang="en-US">Deferred Revenue Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueDisclosureTextBlock" xlink:to="us-gaap_DeferredRevenueDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">Income Tax Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_ScheduleOfRevenueAndOperatingIncomeByGeographicalAreasTableTextBlock" xlink:href="anik-20140930.xsd#anik_ScheduleOfRevenueAndOperatingIncomeByGeographicalAreasTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_ScheduleOfRevenueAndOperatingIncomeByGeographicalAreasTableTextBlock_lbl" xml:lang="en-US">Schedule of Revenue and Operating Income by Geographical Areas [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_ScheduleOfRevenueAndOperatingIncomeByGeographicalAreasTableTextBlock" xlink:to="anik_ScheduleOfRevenueAndOperatingIncomeByGeographicalAreasTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_GeographicLocationAbstract" xlink:href="anik-20140930.xsd#anik_GeographicLocationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_GeographicLocationAbstract_lbl" xml:lang="en-US">Geographic Location:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_GeographicLocationAbstract" xlink:to="anik_GeographicLocationAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_lbl" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_lbl" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted_lbl" xml:lang="en-US">Description of New Accounting Pronouncements Not yet Adopted [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:to="us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_lbl" xml:lang="en-US">Adjustments for Error Corrections [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:to="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_IncreaseToCashProvidedByFinancingActivitiesMember" xlink:href="anik-20140930.xsd#anik_IncreaseToCashProvidedByFinancingActivitiesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anik_IncreaseToCashProvidedByFinancingActivitiesMember_lbl" xml:lang="en-US">Increase to Cash Provided by Financing Activities [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_IncreaseToCashProvidedByFinancingActivitiesMember" xlink:to="anik_IncreaseToCashProvidedByFinancingActivitiesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_DereaseToCashProvidedByOperatingActivitiesMember" xlink:href="anik-20140930.xsd#anik_DereaseToCashProvidedByOperatingActivitiesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anik_DereaseToCashProvidedByOperatingActivitiesMember_lbl" xml:lang="en-US">Decrease to Cash Provided by Operating Activities [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_DereaseToCashProvidedByOperatingActivitiesMember" xlink:to="anik_DereaseToCashProvidedByOperatingActivitiesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockMember_lbl" xml:lang="en-US">Restricted Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TitleOfIndividualAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TitleOfIndividualAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title of Individual [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TitleOfIndividualAxis" xlink:to="us-gaap_TitleOfIndividualAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_BoardOfDirectorsMember" xlink:href="anik-20140930.xsd#anik_BoardOfDirectorsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anik_BoardOfDirectorsMember_lbl" xml:lang="en-US">Board of Directors [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_BoardOfDirectorsMember" xlink:to="anik_BoardOfDirectorsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockAppreciationRightsSARSMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockAppreciationRightsSARSMember_lbl" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockAppreciationRightsSARSMember" xlink:to="us-gaap_StockAppreciationRightsSARSMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueArrangementTypeAxis_lbl" xml:lang="en-US">Deferred Revenue Arrangement Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="us-gaap_DeferredRevenueArrangementTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_MiltekMONOVISCAgreementMember" xlink:href="anik-20140930.xsd#anik_MiltekMONOVISCAgreementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anik_MiltekMONOVISCAgreementMember_lbl" xml:lang="en-US">Miltek MONOVISC Agreement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_MiltekMONOVISCAgreementMember" xlink:to="anik_MiltekMONOVISCAgreementMember_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_RevenueComponentsAxis" xlink:href="anik-20140930.xsd#anik_RevenueComponentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anik_RevenueComponentsAxis_lbl" xml:lang="en-US">Revenue Components [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_RevenueComponentsAxis" xlink:to="anik_RevenueComponentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_MilestoneAndContractRevenueMember" xlink:href="anik-20140930.xsd#anik_MilestoneAndContractRevenueMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anik_MilestoneAndContractRevenueMember_lbl" xml:lang="en-US">Milestone and Contract Revenue [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_MilestoneAndContractRevenueMember" xlink:to="anik_MilestoneAndContractRevenueMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xml:lang="en-US">Income Tax Authority [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DomesticCountryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DomesticCountryMember_lbl" xml:lang="en-US">Domestic Tax Authority [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis_lbl" xml:lang="en-US">Income Tax Authority, Name [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_IncomeTaxAuthorityNameAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InternalRevenueServiceIRSMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InternalRevenueServiceIRSMember_lbl" xml:lang="en-US">Internal Revenue Service (IRS) [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InternalRevenueServiceIRSMember" xlink:to="us-gaap_InternalRevenueServiceIRSMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TaxPeriodAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TaxPeriodAxis_lbl" xml:lang="en-US">Tax Period [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxPeriodAxis" xlink:to="us-gaap_TaxPeriodAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarliestTaxYearMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarliestTaxYearMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarliestTaxYearMember_lbl" xml:lang="en-US">Earliest Tax Year [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarliestTaxYearMember" xlink:to="us-gaap_EarliestTaxYearMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCountryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCountryMember_lbl" xml:lang="en-US">Foreign Tax Authority [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCountryMember" xlink:to="us-gaap_ForeignCountryMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MinistryOfEconomicAffairsAndFinanceItalyMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MinistryOfEconomicAffairsAndFinanceItalyMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinistryOfEconomicAffairsAndFinanceItalyMember_lbl" xml:lang="en-US">Ministry of Economic Affairs and Finance, Italy [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinistryOfEconomicAffairsAndFinanceItalyMember" xlink:to="us-gaap_MinistryOfEconomicAffairsAndFinanceItalyMember_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_NonCashTerminationAndImpairmentOfIPRDProjectMember" xlink:href="anik-20140930.xsd#anik_NonCashTerminationAndImpairmentOfIPRDProjectMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anik_NonCashTerminationAndImpairmentOfIPRDProjectMember_lbl" xml:lang="en-US">Non-Cash Termination And Impairment Of IPR&amp;D [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_NonCashTerminationAndImpairmentOfIPRDProjectMember" xlink:to="anik_NonCashTerminationAndImpairmentOfIPRDProjectMember_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_NoncashDisposalOfPropertyAndEquipmentMember" xlink:href="anik-20140930.xsd#anik_NoncashDisposalOfPropertyAndEquipmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anik_NoncashDisposalOfPropertyAndEquipmentMember_lbl" xml:lang="en-US">Noncash Disposal of Property and Equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_NoncashDisposalOfPropertyAndEquipmentMember" xlink:to="anik_NoncashDisposalOfPropertyAndEquipmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_DisposalOfInventoryMember" xlink:href="anik-20140930.xsd#anik_DisposalOfInventoryMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="anik_DisposalOfInventoryMember_lbl" xml:lang="en-US">Disposal of inventory [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_DisposalOfInventoryMember" xlink:to="anik_DisposalOfInventoryMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PriorPeriodReclassificationAdjustment" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PriorPeriodReclassificationAdjustment_lbl" xml:lang="en-US">Prior Period Reclassification Adjustment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PriorPeriodReclassificationAdjustment" xlink:to="us-gaap_PriorPeriodReclassificationAdjustment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US">Allocated Share-based Compensation Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriodTotalIntrinsicValue" xlink:href="anik-20140930.xsd#anik_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriodTotalIntrinsicValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriodTotalIntrinsicValue_lbl" xml:lang="en-US">SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriodTotalIntrinsicValue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriodTotalIntrinsicValue" xlink:to="anik_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriodTotalIntrinsicValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_lbl" xml:lang="en-US">Stock Repurchased and Retired During Period, Shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingNumber" xlink:href="anik-20140930.xsd#anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingNumber_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingNumber (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingNumber" xlink:to="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsWeightedAverageExercisePrice" xlink:href="anik-20140930.xsd#anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsWeightedAverageExercisePrice_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsWeightedAverageExercisePrice (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsWeightedAverageExercisePrice" xlink:to="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingIntrinsicValue" xlink:href="anik-20140930.xsd#anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingIntrinsicValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingIntrinsicValue_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingIntrinsicValue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingIntrinsicValue" xlink:to="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingIntrinsicValue_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm" xlink:href="anik-20140930.xsd#anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm" xlink:to="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTermRange" xlink:href="anik-20140930.xsd#anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTermRange"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTermRange_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTermRange</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTermRange" xlink:to="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTermRange_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization of Intangible Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProductWarrantyAccrual" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProductWarrantyAccrual"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductWarrantyAccrual_lbl" xml:lang="en-US">Product Warranty Accrual</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductWarrantyAccrual" xlink:to="us-gaap_ProductWarrantyAccrual_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProductWarrantyExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProductWarrantyExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductWarrantyExpense_lbl" xml:lang="en-US">Product Warranty Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductWarrantyExpense" xlink:to="us-gaap_ProductWarrantyExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_ContractTermYears" xlink:href="anik-20140930.xsd#anik_ContractTermYears"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_ContractTermYears_lbl" xml:lang="en-US">Contract Term, Years</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_ContractTermYears" xlink:to="anik_ContractTermYears_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenue_lbl" xml:lang="en-US">Deferred Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenue" xlink:to="us-gaap_DeferredRevenue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueRevenueRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueRevenueRecognized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueRevenueRecognized_lbl" xml:lang="en-US">Deferred Revenue, Revenue Recognized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueRevenueRecognized" xlink:to="us-gaap_DeferredRevenueRevenueRecognized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized_lbl" xml:lang="en-US">Revenue Recognition, Milestone Method, Revenue Recognized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" xlink:to="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContractsRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ContractsRevenue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractsRevenue_lbl" xml:lang="en-US">Contracts Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractsRevenue" xlink:to="us-gaap_ContractsRevenue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OpenTaxYear" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OpenTaxYear"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OpenTaxYear_lbl" xml:lang="en-US">Open Tax Year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OpenTaxYear" xlink:to="us-gaap_OpenTaxYear_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NumberOfReportableSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NumberOfReportableSegments_lbl" xml:lang="en-US">Number of Reportable Segments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfReportableSegments" xlink:to="us-gaap_NumberOfReportableSegments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestructuringCostsAndAssetImpairmentCharges_lbl" xml:lang="en-US">Restructuring Costs and Asset Impairment Charges</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:to="us-gaap_RestructuringCostsAndAssetImpairmentCharges_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentTypeCategorizationMember_lbl" xml:lang="en-US">Investments [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_InvestmentTypeCategorizationMember_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_Note3MarketableSecuritiesDetailsMarketableSecuritiesTable" xlink:href="anik-20140930.xsd#anik_Note3MarketableSecuritiesDetailsMarketableSecuritiesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_Note3MarketableSecuritiesDetailsMarketableSecuritiesTable_lbl" xml:lang="en-US">Note 3 - Marketable Securities (Details) - Marketable Securities [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_Note3MarketableSecuritiesDetailsMarketableSecuritiesTable" xlink:to="anik_Note3MarketableSecuritiesDetailsMarketableSecuritiesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_Note3MarketableSecuritiesDetailsMarketableSecuritiesLineItems" xlink:href="anik-20140930.xsd#anik_Note3MarketableSecuritiesDetailsMarketableSecuritiesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_Note3MarketableSecuritiesDetailsMarketableSecuritiesLineItems_lbl" xml:lang="en-US">Note 3 - Marketable Securities (Details) - Marketable Securities [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_Note3MarketableSecuritiesDetailsMarketableSecuritiesLineItems" xlink:to="anik_Note3MarketableSecuritiesDetailsMarketableSecuritiesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xml:lang="en-US">Fair Value Hierarchy [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl" xml:lang="en-US">Asset Class [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsTable" xlink:href="anik-20140930.xsd#anik_Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsTable_lbl" xml:lang="en-US">Note 4 - Fair Value Measurements (Details) - Fair Value of Financial Instruments [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsTable" xlink:to="anik_Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsLineItems" xlink:href="anik-20140930.xsd#anik_Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsLineItems_lbl" xml:lang="en-US">Note 4 - Fair Value Measurements (Details) - Fair Value of Financial Instruments [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsLineItems" xlink:to="anik_Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RangeMember_lbl" xml:lang="en-US">Range [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_RangeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_Note5EquityIncentivePlanDetailsAssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsTable" xlink:href="anik-20140930.xsd#anik_Note5EquityIncentivePlanDetailsAssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_Note5EquityIncentivePlanDetailsAssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsTable_lbl" xml:lang="en-US">Note 5 - Equity Incentive Plan (Details) - Assumptions Used to Estimate Fair Value of Stock Options and Stock Appreciation Rights Awards [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_Note5EquityIncentivePlanDetailsAssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsTable" xlink:to="anik_Note5EquityIncentivePlanDetailsAssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_Note5EquityIncentivePlanDetailsAssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsLineItems" xlink:href="anik-20140930.xsd#anik_Note5EquityIncentivePlanDetailsAssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_Note5EquityIncentivePlanDetailsAssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsLineItems_lbl" xml:lang="en-US">Note 5 - Equity Incentive Plan (Details) - Assumptions Used to Estimate Fair Value of Stock Options and Stock Appreciation Rights Awards [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_Note5EquityIncentivePlanDetailsAssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsLineItems" xlink:to="anik_Note5EquityIncentivePlanDetailsAssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsTable" xlink:href="anik-20140930.xsd#anik_Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsTable_lbl" xml:lang="en-US">Note 8 - Intangible Assets and Goodwill (Details) - Intangible Assets [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsTable" xlink:to="anik_Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsLineItems" xlink:href="anik-20140930.xsd#anik_Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsLineItems_lbl" xml:lang="en-US">Note 8 - Intangible Assets and Goodwill (Details) - Intangible Assets [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsLineItems" xlink:to="anik_Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProductsAndServicesDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductsAndServicesDomain_lbl" xml:lang="en-US">Products and Services [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductsAndServicesDomain" xlink:to="us-gaap_ProductsAndServicesDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingInformationLineItems_lbl" xml:lang="en-US">Segment Reporting Information [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_SegmentReportingInformationLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentGeographicalDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SegmentGeographicalDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentGeographicalDomain_lbl" xml:lang="en-US">Geographical [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="us-gaap_SegmentGeographicalDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_Note13SegmentandGeographicInformationDetailsProductRevenuebyGeographicLocationTable" xlink:href="anik-20140930.xsd#anik_Note13SegmentandGeographicInformationDetailsProductRevenuebyGeographicLocationTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_Note13SegmentandGeographicInformationDetailsProductRevenuebyGeographicLocationTable_lbl" xml:lang="en-US">Note 13 - Segment and Geographic Information (Details) - Product Revenue by Geographic Location [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_Note13SegmentandGeographicInformationDetailsProductRevenuebyGeographicLocationTable" xlink:to="anik_Note13SegmentandGeographicInformationDetailsProductRevenuebyGeographicLocationTable_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_Note13SegmentandGeographicInformationDetailsProductRevenuebyGeographicLocationLineItems" xlink:href="anik-20140930.xsd#anik_Note13SegmentandGeographicInformationDetailsProductRevenuebyGeographicLocationLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_Note13SegmentandGeographicInformationDetailsProductRevenuebyGeographicLocationLineItems_lbl" xml:lang="en-US">Note 13 - Segment and Geographic Information (Details) - Product Revenue by Geographic Location [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_Note13SegmentandGeographicInformationDetailsProductRevenuebyGeographicLocationLineItems" xlink:to="anik_Note13SegmentandGeographicInformationDetailsProductRevenuebyGeographicLocationLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TypeOfRestructuringDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfRestructuringDomain_lbl" xml:lang="en-US">Type of Restructuring [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfRestructuringDomain" xlink:to="us-gaap_TypeOfRestructuringDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_Note14RestructuringCreditsDetailsRestructuringAccrualActivityTable" xlink:href="anik-20140930.xsd#anik_Note14RestructuringCreditsDetailsRestructuringAccrualActivityTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_Note14RestructuringCreditsDetailsRestructuringAccrualActivityTable_lbl" xml:lang="en-US">Note 14 - Restructuring Credits (Details) - Restructuring Accrual Activity [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_Note14RestructuringCreditsDetailsRestructuringAccrualActivityTable" xlink:to="anik_Note14RestructuringCreditsDetailsRestructuringAccrualActivityTable_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_Note14RestructuringCreditsDetailsRestructuringAccrualActivityLineItems" xlink:href="anik-20140930.xsd#anik_Note14RestructuringCreditsDetailsRestructuringAccrualActivityLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_Note14RestructuringCreditsDetailsRestructuringAccrualActivityLineItems_lbl" xml:lang="en-US">Note 14 - Restructuring Credits (Details) - Restructuring Accrual Activity [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_Note14RestructuringCreditsDetailsRestructuringAccrualActivityLineItems" xlink:to="anik_Note14RestructuringCreditsDetailsRestructuringAccrualActivityLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsForErrorCorrectionDomain_lbl" xml:lang="en-US">Adjustments for Error Correction [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:to="us-gaap_AdjustmentsForErrorCorrectionDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_Note2BasisofPresentationDetailsTable" xlink:href="anik-20140930.xsd#anik_Note2BasisofPresentationDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_Note2BasisofPresentationDetailsTable_lbl" xml:lang="en-US">Note 2 - Basis of Presentation (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_Note2BasisofPresentationDetailsTable" xlink:to="anik_Note2BasisofPresentationDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_Note2BasisofPresentationDetailsLineItems" xlink:href="anik-20140930.xsd#anik_Note2BasisofPresentationDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_Note2BasisofPresentationDetailsLineItems_lbl" xml:lang="en-US">Note 2 - Basis of Presentation (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_Note2BasisofPresentationDetailsLineItems" xlink:to="anik_Note2BasisofPresentationDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xml:lang="en-US">Equity Award [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xml:lang="en-US">Relationship to Entity [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_Note5EquityIncentivePlanDetailsTable" xlink:href="anik-20140930.xsd#anik_Note5EquityIncentivePlanDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_Note5EquityIncentivePlanDetailsTable_lbl" xml:lang="en-US">Note 5 - Equity Incentive Plan (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_Note5EquityIncentivePlanDetailsTable" xlink:to="anik_Note5EquityIncentivePlanDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_Note5EquityIncentivePlanDetailsLineItems" xlink:href="anik-20140930.xsd#anik_Note5EquityIncentivePlanDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_Note5EquityIncentivePlanDetailsLineItems_lbl" xml:lang="en-US">Note 5 - Equity Incentive Plan (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_Note5EquityIncentivePlanDetailsLineItems" xlink:to="anik_Note5EquityIncentivePlanDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueArrangementTypeDomain_lbl" xml:lang="en-US">Deferred Revenue [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:to="us-gaap_DeferredRevenueArrangementTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_Note11MitekMonoviscAgreementDetailsTable" xlink:href="anik-20140930.xsd#anik_Note11MitekMonoviscAgreementDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_Note11MitekMonoviscAgreementDetailsTable_lbl" xml:lang="en-US">Note 11 - Mitek Monovisc Agreement (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_Note11MitekMonoviscAgreementDetailsTable" xlink:to="anik_Note11MitekMonoviscAgreementDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_Note11MitekMonoviscAgreementDetailsLineItems" xlink:href="anik-20140930.xsd#anik_Note11MitekMonoviscAgreementDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_Note11MitekMonoviscAgreementDetailsLineItems_lbl" xml:lang="en-US">Note 11 - Mitek Monovisc Agreement (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_Note11MitekMonoviscAgreementDetailsLineItems" xlink:to="anik_Note11MitekMonoviscAgreementDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TaxPeriodDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TaxPeriodDomain_lbl" xml:lang="en-US">Tax Period [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxPeriodDomain" xlink:to="us-gaap_TaxPeriodDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xml:lang="en-US">Income Tax Authority [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_IncomeTaxAuthorityDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain_lbl" xml:lang="en-US">Income Tax Authority, Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="us-gaap_IncomeTaxAuthorityNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_RevenueComponentsDomain" xlink:href="anik-20140930.xsd#anik_RevenueComponentsDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_RevenueComponentsDomain_lbl" xml:lang="en-US">RevenueComponents [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_RevenueComponentsDomain" xlink:to="anik_RevenueComponentsDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_Note12IncomeTaxesDetailsTable" xlink:href="anik-20140930.xsd#anik_Note12IncomeTaxesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_Note12IncomeTaxesDetailsTable_lbl" xml:lang="en-US">Note 12 - Income Taxes (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_Note12IncomeTaxesDetailsTable" xlink:to="anik_Note12IncomeTaxesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_Note12IncomeTaxesDetailsLineItems" xlink:href="anik-20140930.xsd#anik_Note12IncomeTaxesDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_Note12IncomeTaxesDetailsLineItems_lbl" xml:lang="en-US">Note 12 - Income Taxes (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_Note12IncomeTaxesDetailsLineItems" xlink:to="anik_Note12IncomeTaxesDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_Note14RestructuringCreditsDetailsTable" xlink:href="anik-20140930.xsd#anik_Note14RestructuringCreditsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_Note14RestructuringCreditsDetailsTable_lbl" xml:lang="en-US">Note 14 - Restructuring Credits (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_Note14RestructuringCreditsDetailsTable" xlink:to="anik_Note14RestructuringCreditsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="anik_Note14RestructuringCreditsDetailsLineItems" xlink:href="anik-20140930.xsd#anik_Note14RestructuringCreditsDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_Note14RestructuringCreditsDetailsLineItems_lbl" xml:lang="en-US">Note 14 - Restructuring Credits (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_Note14RestructuringCreditsDetailsLineItems" xlink:to="anik_Note14RestructuringCreditsDetailsLineItems_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anik_AccruedClinicalTrialCostsCurrent_lbl0" xml:lang="en-US">Represents current accrued clinical trial costs.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_AccruedClinicalTrialCostsCurrent" xlink:to="anik_AccruedClinicalTrialCostsCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anik_AccruedResearchGrantsCurrent_lbl0" xml:lang="en-US">Represents current accrued research grants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_AccruedResearchGrantsCurrent" xlink:to="anik_AccruedResearchGrantsCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anik_ContractTermYears_lbl0" xml:lang="en-US">The contract term of the Miltek MONOVISC agreement.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_ContractTermYears" xlink:to="anik_ContractTermYears_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anik_DepositsAndOtherAssetsNoncurrent_lbl0" xml:lang="en-US">Represents non-current deposits and other assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_DepositsAndOtherAssetsNoncurrent" xlink:to="anik_DepositsAndOtherAssetsNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anik_IntangibleAssetsAccumulatedAmortization_lbl0" xml:lang="en-US">Represents intangible assets accumulated amortization.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_IntangibleAssetsAccumulatedAmortization" xlink:to="anik_IntangibleAssetsAccumulatedAmortization_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anik_IntangibleAssetsGrossCarryingAmount_lbl0" xml:lang="en-US">Represents the gross carrying amount of intangible assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_IntangibleAssetsGrossCarryingAmount" xlink:to="anik_IntangibleAssetsGrossCarryingAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anik_IntangibleAssetsTranslationAdjustments_lbl0" xml:lang="en-US">Represents intangible assets translation adjustments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_IntangibleAssetsTranslationAdjustments" xlink:to="anik_IntangibleAssetsTranslationAdjustments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anik_PercentageOfNetRevenue_lbl0" xml:lang="en-US">Represents the percentage of net revenue.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_PercentageOfNetRevenue" xlink:to="anik_PercentageOfNetRevenue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anik_RestructuringCredit_lbl1" xml:lang="en-US">Amount of credit associated with exit or disposal activities during the period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_RestructuringCredit" xlink:to="anik_RestructuringCredit_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anik_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTableTextBlock_lbl0" xml:lang="en-US">Represents the schedule of finite-lived and indefinite-lived intangible assets by major class.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTableTextBlock" xlink:to="anik_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anik_ScheduleOfRevenueAndOperatingIncomeByGeographicalAreasTableTextBlock_lbl0" xml:lang="en-US">Represents schedule of revenue and operating income, by geographical areas.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_ScheduleOfRevenueAndOperatingIncomeByGeographicalAreasTableTextBlock" xlink:to="anik_ScheduleOfRevenueAndOperatingIncomeByGeographicalAreasTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTermRange_lbl0" xml:lang="en-US">Represents share based compensation arrangement by share based payment award contractual term range.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTermRange" xlink:to="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTermRange_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingIntrinsicValue_lbl0" xml:lang="en-US">Represents share based compensation arrangement by share based payment award, options and stock appreciation rights, outstanding, intrinsic value.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingIntrinsicValue" xlink:to="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingIntrinsicValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingNumber_lbl0" xml:lang="en-US">Represents share based compensation arrangement by share based payment award options and stock appreciation rights outstanding number.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingNumber" xlink:to="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm_lbl0" xml:lang="en-US">Represents share based compensation arrangement by share based payment award options and stock appreciation rights outstanding weighted average remaining contractual term.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm" xlink:to="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Represents share based compensation arrangement by share based payment award options and stock appreciation rights weighted average exercise price.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsWeightedAverageExercisePrice" xlink:to="anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anik_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriodTotalIntrinsicValue_lbl0" xml:lang="en-US">Represents share-based compensation arrangement by share-based payment award, options, and stock appreciation rights, exercises in period, total intrinsic value.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriodTotalIntrinsicValue" xlink:to="anik_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriodTotalIntrinsicValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_RevenueComponentsAxis_lbl0" xml:lang="en-US">Revenue Components [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_RevenueComponentsAxis" xlink:to="anik_RevenueComponentsAxis_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anik_RevenueComponentsAxis_lbl1" xml:lang="en-US">Represents revenue components.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_RevenueComponentsAxis" xlink:to="anik_RevenueComponentsAxis_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_ActivityTerminationAndFacilityClosureCostsMember_lbl0" xml:lang="en-US">Activity Termination And Facility Closure Costs [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_ActivityTerminationAndFacilityClosureCostsMember" xlink:to="anik_ActivityTerminationAndFacilityClosureCostsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anik_ActivityTerminationAndFacilityClosureCostsMember_lbl1" xml:lang="en-US">Represents activity termination and facility closure costs.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_ActivityTerminationAndFacilityClosureCostsMember" xlink:to="anik_ActivityTerminationAndFacilityClosureCostsMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_BoardOfDirectorsMember_lbl0" xml:lang="en-US">Board Of Directors [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_BoardOfDirectorsMember" xlink:to="anik_BoardOfDirectorsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anik_BoardOfDirectorsMember_lbl1" xml:lang="en-US">Represents the Board of Directors.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_BoardOfDirectorsMember" xlink:to="anik_BoardOfDirectorsMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_DereaseToCashProvidedByOperatingActivitiesMember_lbl0" xml:lang="en-US">Derease To Cash Provided By Operating Activities [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_DereaseToCashProvidedByOperatingActivitiesMember" xlink:to="anik_DereaseToCashProvidedByOperatingActivitiesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anik_DereaseToCashProvidedByOperatingActivitiesMember_lbl1" xml:lang="en-US">Represents the decrease in cash provided by operating activities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_DereaseToCashProvidedByOperatingActivitiesMember" xlink:to="anik_DereaseToCashProvidedByOperatingActivitiesMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_DermalMember_lbl0" xml:lang="en-US">Dermal [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_DermalMember" xlink:to="anik_DermalMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anik_DermalMember_lbl1" xml:lang="en-US">Represents Dermal.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_DermalMember" xlink:to="anik_DermalMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_DisposalOfInventoryMember_lbl0" xml:lang="en-US">Disposal Of Inventory [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_DisposalOfInventoryMember" xlink:to="anik_DisposalOfInventoryMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anik_DisposalOfInventoryMember_lbl1" xml:lang="en-US">Represents disposal of inventory.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_DisposalOfInventoryMember" xlink:to="anik_DisposalOfInventoryMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_ElevessTradeNameMember_lbl0" xml:lang="en-US">Elevess Trade Name [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_ElevessTradeNameMember" xlink:to="anik_ElevessTradeNameMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anik_ElevessTradeNameMember_lbl1" xml:lang="en-US">Represents Elevess trade name.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_ElevessTradeNameMember" xlink:to="anik_ElevessTradeNameMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_EmployeeTerminationCostsMember_lbl0" xml:lang="en-US">Employee Termination Costs [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_EmployeeTerminationCostsMember" xlink:to="anik_EmployeeTerminationCostsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anik_EmployeeTerminationCostsMember_lbl1" xml:lang="en-US">Represents employee termination costs.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_EmployeeTerminationCostsMember" xlink:to="anik_EmployeeTerminationCostsMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_IncreaseToCashProvidedByFinancingActivitiesMember_lbl0" xml:lang="en-US">Increase To Cash Provided By Financing Activities [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_IncreaseToCashProvidedByFinancingActivitiesMember" xlink:to="anik_IncreaseToCashProvidedByFinancingActivitiesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anik_IncreaseToCashProvidedByFinancingActivitiesMember_lbl1" xml:lang="en-US">Represents the increase to cash provided by financing activities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_IncreaseToCashProvidedByFinancingActivitiesMember" xlink:to="anik_IncreaseToCashProvidedByFinancingActivitiesMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_MilestoneAndContractRevenueMember_lbl0" xml:lang="en-US">Milestone And Contract Revenue [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_MilestoneAndContractRevenueMember" xlink:to="anik_MilestoneAndContractRevenueMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anik_MilestoneAndContractRevenueMember_lbl1" xml:lang="en-US">Represents milestone and contract revenue.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_MilestoneAndContractRevenueMember" xlink:to="anik_MilestoneAndContractRevenueMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_MiltekMONOVISCAgreementMember_lbl0" xml:lang="en-US">Miltek MONOVISC Agreement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_MiltekMONOVISCAgreementMember" xlink:to="anik_MiltekMONOVISCAgreementMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anik_MiltekMONOVISCAgreementMember_lbl1" xml:lang="en-US">The Miltek MONOVISC licensing agreement.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_MiltekMONOVISCAgreementMember" xlink:to="anik_MiltekMONOVISCAgreementMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_NonCashTerminationAndImpairmentOfIPRDProjectMember_lbl0" xml:lang="en-US">Non Cash Termination And Impairment Of IPRD Project [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_NonCashTerminationAndImpairmentOfIPRDProjectMember" xlink:to="anik_NonCashTerminationAndImpairmentOfIPRDProjectMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anik_NonCashTerminationAndImpairmentOfIPRDProjectMember_lbl1" xml:lang="en-US">Represents non-cash termination and impairment of IPR&amp;D.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_NonCashTerminationAndImpairmentOfIPRDProjectMember" xlink:to="anik_NonCashTerminationAndImpairmentOfIPRDProjectMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_NoncashDisposalOfPropertyAndEquipmentMember_lbl0" xml:lang="en-US">Noncash Disposal Of Property And Equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_NoncashDisposalOfPropertyAndEquipmentMember" xlink:to="anik_NoncashDisposalOfPropertyAndEquipmentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anik_NoncashDisposalOfPropertyAndEquipmentMember_lbl1" xml:lang="en-US">Represents noncash disposal of property and equipment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_NoncashDisposalOfPropertyAndEquipmentMember" xlink:to="anik_NoncashDisposalOfPropertyAndEquipmentMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_OphthalmicMember_lbl0" xml:lang="en-US">Ophthalmic [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_OphthalmicMember" xlink:to="anik_OphthalmicMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anik_OphthalmicMember_lbl1" xml:lang="en-US">Represents Ophthalmic.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_OphthalmicMember" xlink:to="anik_OphthalmicMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_OrthobiologicsMember_lbl0" xml:lang="en-US">Orthobiologics [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_OrthobiologicsMember" xlink:to="anik_OrthobiologicsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anik_OrthobiologicsMember_lbl1" xml:lang="en-US">Represents Orthobiologics.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_OrthobiologicsMember" xlink:to="anik_OrthobiologicsMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_OtherLocationMember_lbl0" xml:lang="en-US">Other Location [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_OtherLocationMember" xlink:to="anik_OtherLocationMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anik_OtherLocationMember_lbl1" xml:lang="en-US">Represents other location.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_OtherLocationMember" xlink:to="anik_OtherLocationMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_SurgicalMember_lbl0" xml:lang="en-US">Surgical [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_SurgicalMember" xlink:to="anik_SurgicalMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anik_SurgicalMember_lbl1" xml:lang="en-US">Represents surgical.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_SurgicalMember" xlink:to="anik_SurgicalMember_lbl1"/>
    <loc xlink:type="locator" xlink:label="anik_TaxBenefitFromExerciseOfStockOptionsCorrectionMember" xlink:href="anik-20140930.xsd#anik_TaxBenefitFromExerciseOfStockOptionsCorrectionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_TaxBenefitFromExerciseOfStockOptionsCorrectionMember_lbl" xml:lang="en-US">Tax Benefit From Exercise Of Stock Options Correction [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_TaxBenefitFromExerciseOfStockOptionsCorrectionMember" xlink:to="anik_TaxBenefitFromExerciseOfStockOptionsCorrectionMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anik_TaxBenefitFromExerciseOfStockOptionsCorrectionMember_lbl0" xml:lang="en-US">Represents the tax benefit from exercise of stock options correction.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_TaxBenefitFromExerciseOfStockOptionsCorrectionMember" xlink:to="anik_TaxBenefitFromExerciseOfStockOptionsCorrectionMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_UnitedStatesMember_lbl0" xml:lang="en-US">United States [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_UnitedStatesMember" xlink:to="anik_UnitedStatesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anik_UnitedStatesMember_lbl1" xml:lang="en-US">Represents United States.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_UnitedStatesMember" xlink:to="anik_UnitedStatesMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_VeterinaryMember_lbl0" xml:lang="en-US">Veterinary [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_VeterinaryMember" xlink:to="anik_VeterinaryMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="anik_VeterinaryMember_lbl1" xml:lang="en-US">Represents veterinary.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_VeterinaryMember" xlink:to="anik_VeterinaryMember_lbl1"/>
    <loc xlink:type="locator" xlink:label="anik_DocumentAndEntityInformationAbstract" xlink:href="anik-20140930.xsd#anik_DocumentAndEntityInformationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="anik_DocumentAndEntityInformationAbstract_lbl" xml:lang="en-US">Document and Entity Information [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="anik_DocumentAndEntityInformationAbstract" xlink:to="anik_DocumentAndEntityInformationAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_lbl0" xml:lang="en-US">Payments to Acquire Marketable Securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl0" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_lbl0" xml:lang="en-US">Assets, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl0" xml:lang="en-US">Payments Related to Tax Withholding for Share-based Compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl0" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRestructuring_lbl0" xml:lang="en-US">Payments for Restructuring</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRestructuring" xlink:to="us-gaap_PaymentsForRestructuring_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_lbl0" xml:lang="en-US">Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl0" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_lbl0" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl0" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_lbl0" xml:lang="en-US">Operating Income (Loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityPublicFloat" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl0" xml:lang="en-US">Earnings Per Share, Diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsAndExpenses_lbl0" xml:lang="en-US">Costs and Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl0" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl0" xml:lang="en-US">Increase (Decrease) in Inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestructuringReserve_lbl1" xml:lang="en-US">Restructuring Reserve</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringReserve" xlink:to="us-gaap_RestructuringReserve_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl0" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl0" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl0" xml:lang="en-US">Earnings Per Share, Basic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl0" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl0" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl0" xml:lang="en-US">Increase (Decrease) in Accounts Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfLongTermDebt_lbl0" xml:lang="en-US">Repayments of Long-term Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLongTermDebt" xlink:to="us-gaap_RepaymentsOfLongTermDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_lbl0" xml:lang="en-US">Excess Tax Benefit from Share-based Compensation, Financing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" xlink:to="us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl0" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_lbl0" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities_lbl0" xml:lang="en-US">Excess Tax Benefit from Share-based Compensation, Operating Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities" xlink:to="us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnDispositionOfAssets1_lbl0" xml:lang="en-US">Gain (Loss) on Disposition of Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDispositionOfAssets1" xlink:to="us-gaap_GainLossOnDispositionOfAssets1_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl0" xml:lang="en-US">Liabilities and Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_lbl0" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentDescription" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_lbl0" xml:lang="en-US">Stockholders&apos; Equity Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_StatementScenarioAxis_lbl"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>anik-20140930_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Wed Nov 05 23:59:00 UTC 2014 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_ConsolidatedBalanceSheet" roleURI="http://www.anikatherapeutics.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://www.anikatherapeutics.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_ConsolidatedComprehensiveIncome" roleURI="http://www.anikatherapeutics.com/role/ConsolidatedComprehensiveIncome"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_ShareholdersEquityType1" roleURI="http://www.anikatherapeutics.com/role/ShareholdersEquityType1"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note1NatureofBusiness" roleURI="http://www.anikatherapeutics.com/role/Note1NatureofBusiness"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note2BasisofPresentation" roleURI="http://www.anikatherapeutics.com/role/Note2BasisofPresentation"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note3MarketableSecurities" roleURI="http://www.anikatherapeutics.com/role/Note3MarketableSecurities"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note4FairValueMeasurements" roleURI="http://www.anikatherapeutics.com/role/Note4FairValueMeasurements"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note5EquityIncentivePlan" roleURI="http://www.anikatherapeutics.com/role/Note5EquityIncentivePlan"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note6EarningsPerShare" roleURI="http://www.anikatherapeutics.com/role/Note6EarningsPerShare"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note7Inventories" roleURI="http://www.anikatherapeutics.com/role/Note7Inventories"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note8IntangibleAssetsandGoodwill" roleURI="http://www.anikatherapeutics.com/role/Note8IntangibleAssetsandGoodwill"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note9AccruedExpenses" roleURI="http://www.anikatherapeutics.com/role/Note9AccruedExpenses"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note10CommitmentsandContingencies" roleURI="http://www.anikatherapeutics.com/role/Note10CommitmentsandContingencies"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note11MitekMonoviscAgreement" roleURI="http://www.anikatherapeutics.com/role/Note11MitekMonoviscAgreement"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note12IncomeTaxes" roleURI="http://www.anikatherapeutics.com/role/Note12IncomeTaxes"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note13SegmentandGeographicInformation" roleURI="http://www.anikatherapeutics.com/role/Note13SegmentandGeographicInformation"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note14RestructuringCredits" roleURI="http://www.anikatherapeutics.com/role/Note14RestructuringCredits"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note15NewAccountingStandards" roleURI="http://www.anikatherapeutics.com/role/Note15NewAccountingStandards"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note3MarketableSecuritiesTables" roleURI="http://www.anikatherapeutics.com/role/Note3MarketableSecuritiesTables"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note4FairValueMeasurementsTables" roleURI="http://www.anikatherapeutics.com/role/Note4FairValueMeasurementsTables"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note5EquityIncentivePlanTables" roleURI="http://www.anikatherapeutics.com/role/Note5EquityIncentivePlanTables"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note6EarningsPerShareTables" roleURI="http://www.anikatherapeutics.com/role/Note6EarningsPerShareTables"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note7InventoriesTables" roleURI="http://www.anikatherapeutics.com/role/Note7InventoriesTables"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note8IntangibleAssetsandGoodwillTables" roleURI="http://www.anikatherapeutics.com/role/Note8IntangibleAssetsandGoodwillTables"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note9AccruedExpensesTables" roleURI="http://www.anikatherapeutics.com/role/Note9AccruedExpensesTables"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note13SegmentandGeographicInformationTables" roleURI="http://www.anikatherapeutics.com/role/Note13SegmentandGeographicInformationTables"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note14RestructuringCreditsTables" roleURI="http://www.anikatherapeutics.com/role/Note14RestructuringCreditsTables"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_MarketableSecuritiesTable" roleURI="http://www.anikatherapeutics.com/role/MarketableSecuritiesTable"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_FairValueofFinancialInstrumentsTable" roleURI="http://www.anikatherapeutics.com/role/FairValueofFinancialInstrumentsTable"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_AssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsTable" roleURI="http://www.anikatherapeutics.com/role/AssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsTable"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_BasicandDilutedEarningsPerShareTable" roleURI="http://www.anikatherapeutics.com/role/BasicandDilutedEarningsPerShareTable"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_InventoriesTable" roleURI="http://www.anikatherapeutics.com/role/InventoriesTable"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_IntangibleAssetsTable" roleURI="http://www.anikatherapeutics.com/role/IntangibleAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_ChangesinCarryingValueofGoodwillTable" roleURI="http://www.anikatherapeutics.com/role/ChangesinCarryingValueofGoodwillTable"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_AccruedExpensesTable" roleURI="http://www.anikatherapeutics.com/role/AccruedExpensesTable"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_ProductRevenuebyProductGroupTable" roleURI="http://www.anikatherapeutics.com/role/ProductRevenuebyProductGroupTable"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_ProductRevenuebyGeographicLocationTable" roleURI="http://www.anikatherapeutics.com/role/ProductRevenuebyGeographicLocationTable"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_RestructuringAccrualActivityTable" roleURI="http://www.anikatherapeutics.com/role/RestructuringAccrualActivityTable"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note2BasisofPresentationDetails" roleURI="http://www.anikatherapeutics.com/role/Note2BasisofPresentationDetails"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note5EquityIncentivePlanDetails" roleURI="http://www.anikatherapeutics.com/role/Note5EquityIncentivePlanDetails"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note6EarningsPerShareDetails" roleURI="http://www.anikatherapeutics.com/role/Note6EarningsPerShareDetails"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note8IntangibleAssetsandGoodwillDetails" roleURI="http://www.anikatherapeutics.com/role/Note8IntangibleAssetsandGoodwillDetails"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note10CommitmentsandContingenciesDetails" roleURI="http://www.anikatherapeutics.com/role/Note10CommitmentsandContingenciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note11MitekMonoviscAgreementDetails" roleURI="http://www.anikatherapeutics.com/role/Note11MitekMonoviscAgreementDetails"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note12IncomeTaxesDetails" roleURI="http://www.anikatherapeutics.com/role/Note12IncomeTaxesDetails"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note13SegmentandGeographicInformationDetails" roleURI="http://www.anikatherapeutics.com/role/Note13SegmentandGeographicInformationDetails"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#anik_r_Note14RestructuringCreditsDetails" roleURI="http://www.anikatherapeutics.com/role/Note14RestructuringCreditsDetails"/>
  <roleRef xlink:type="simple" xlink:href="anik-20140930.xsd#DocumentAndEntityInformation" roleURI="http://www.anikatherapeutics.com/role/DocumentAndEntityInformation"/>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_MarketableSecuritiesCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InventoryNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_InventoryNet" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidTaxes" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsNetCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_DeferredTaxAssetsNetCurrent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_AssetsCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="DepositsAndOtherAssetsNoncurrent" xlink:href="anik-20140930.xsd#anik_DepositsAndOtherAssetsNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="DepositsAndOtherAssetsNoncurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Goodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Goodwill" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Assets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Assets" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredRevenueCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedIncomeTaxesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedIncomeTaxesCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedIncomeTaxesCurrent" xlink:to="us-gaap_LiabilitiesCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_DeferredRevenueNoncurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesNoncurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PreferredStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_StockholdersEquity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/ConsolidatedBalanceSheet_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/ConsolidatedComprehensiveIncome">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesRevenueGoodsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SalesRevenueGoodsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SalesRevenueGoodsNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesRevenueServicesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SalesRevenueServicesNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SalesRevenueServicesNet" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesRevenueNet" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SalesRevenueNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SalesRevenueServicesNet" xlink:to="us-gaap_SalesRevenueNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingExpensesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfGoodsSold" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CostOfGoodsSold"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_CostOfGoodsSold" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="RestructuringCredit" xlink:href="anik-20140930.xsd#anik_RestructuringCredit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="RestructuringCredit" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CostsAndExpenses" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_InterestIncomeExpenseNonoperatingNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="BasicNetIncomePerShareAbstract" xlink:href="anik-20140930.xsd#anik_BasicNetIncomePerShareAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="BasicNetIncomePerShareAbstract" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BasicNetIncomePerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BasicNetIncomePerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="DilutedNetIncomePerShareAbstract" xlink:href="anik-20140930.xsd#anik_DilutedNetIncomePerShareAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="DilutedNetIncomePerShareAbstract" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DilutedNetIncomePerShareAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DilutedNetIncomePerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss_0" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="OtherComprehensiveIncomeLossAbstract" xlink:href="anik-20140930.xsd#anik_OtherComprehensiveIncomeLossAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLoss_0" xlink:to="OtherComprehensiveIncomeLossAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLoss_0" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLoss_0" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/ShareholdersEquityType1">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="CashFlowsFromOperatingActivitiesAbstract" xlink:href="anik-20140930.xsd#anik_CashFlowsFromOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="CashFlowsFromOperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="AdjustmentsToReconcileNetIncomeToNetCashProvidedByOperatingActivitiesAbstract" xlink:href="anik-20140930.xsd#anik_AdjustmentsToReconcileNetIncomeToNetCashProvidedByOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromOperatingActivitiesAbstract" xlink:to="AdjustmentsToReconcileNetIncomeToNetCashProvidedByOperatingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeToNetCashProvidedByOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationAndAmortization" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeToNetCashProvidedByOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeToNetCashProvidedByOperatingActivitiesAbstract" xlink:to="us-gaap_ProvisionForDoubtfulAccounts" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryWriteDown" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeToNetCashProvidedByOperatingActivitiesAbstract" xlink:to="us-gaap_InventoryWriteDown" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnDispositionOfAssets1" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeToNetCashProvidedByOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnDispositionOfAssets1" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeToNetCashProvidedByOperatingActivitiesAbstract" xlink:to="us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:href="anik-20140930.xsd#anik_ChangesInOperatingAssetsAndLiabilitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeToNetCashProvidedByOperatingActivitiesAbstract" xlink:to="ChangesInOperatingAssetsAndLiabilitiesAbstract" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInOperatingAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="CashFlowsFromInvestingActivitiesAbstract" xlink:href="anik-20140930.xsd#anik_CashFlowsFromInvestingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromOperatingActivitiesAbstract" xlink:to="CashFlowsFromInvestingActivitiesAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfOtherAssets1" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromSaleOfOtherAssets1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleOfOtherAssets1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="CashFlowsFromFinancingActivitiesAbstract" xlink:href="anik-20140930.xsd#anik_CashFlowsFromFinancingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromOperatingActivitiesAbstract" xlink:to="CashFlowsFromFinancingActivitiesAbstract" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfLongTermDebt" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromOperatingActivitiesAbstract" xlink:to="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromOperatingActivitiesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromOperatingActivitiesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromOperatingActivitiesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_0" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note1NatureofBusiness">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NatureOfOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NatureOfOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_NatureOfOperations" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note2BasisofPresentation">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note3MarketableSecurities">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DisclosureTextBlockSupplementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note4FairValueMeasurements">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note5EquityIncentivePlan">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note6EarningsPerShare">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note7Inventories">
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note8IntangibleAssetsandGoodwill">
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note9AccruedExpenses">
    <loc xlink:type="locator" xlink:label="us-gaap_PayablesAndAccrualsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note10CommitmentsandContingencies">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note11MitekMonoviscAgreement">
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueDisclosureAbstract" xlink:to="us-gaap_DeferredRevenueDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note12IncomeTaxes">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note13SegmentandGeographicInformation">
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note14RestructuringCredits">
    <loc xlink:type="locator" xlink:label="us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note15NewAccountingStandards">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note3MarketableSecuritiesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DisclosureTextBlockSupplementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_MarketableSecuritiesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note4FairValueMeasurementsTables">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note5EquityIncentivePlanTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note6EarningsPerShareTables">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note7InventoriesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note8IntangibleAssetsandGoodwillTables">
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTableTextBlock" xlink:href="anik-20140930.xsd#anik_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleOfGoodwillTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note9AccruedExpensesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_PayablesAndAccrualsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note13SegmentandGeographicInformationTables">
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfRevenueAndOperatingIncomeByGeographicalAreasTableTextBlock" xlink:href="anik-20140930.xsd#anik_ScheduleOfRevenueAndOperatingIncomeByGeographicalAreasTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="ScheduleOfRevenueAndOperatingIncomeByGeographicalAreasTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note14RestructuringCreditsTables">
    <loc xlink:type="locator" xlink:label="us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/MarketableSecuritiesTable">
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecuritiesAbstract"/>
    <loc xlink:type="locator" xlink:label="Note3MarketableSecuritiesDetailsMarketableSecuritiesTable" xlink:href="anik-20140930.xsd#anik_Note3MarketableSecuritiesDetailsMarketableSecuritiesTable"/>
    <loc xlink:type="locator" xlink:label="Note3MarketableSecuritiesDetailsMarketableSecuritiesLineItems" xlink:href="anik-20140930.xsd#anik_Note3MarketableSecuritiesDetailsMarketableSecuritiesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesAbstract" xlink:to="Note3MarketableSecuritiesDetailsMarketableSecuritiesTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note3MarketableSecuritiesDetailsMarketableSecuritiesTable" xlink:to="us-gaap_InvestmentTypeAxis" order="1.0"/>
<!-- [WMV4][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt8UCLPdYZl35nXbOCDIyGTq8kWYS5mE4nIDdhC6ZUZ3C7uZIfzBVpwVZvunzSNea5mQTTlY4E6meqyItzXsZeYoFfvM/Avp17arPuR/GW0mknfKp3JQjUBUq0bHVHYbNAE8Fh5fiLkIMcVQlbp04OxRRXjc+Ssu9cPRpFdgx0G2vpzwAswTXRmMT0FZiyY6i+oWQKDd5ebfrtUoToeYZT+S] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_USStatesAndPoliticalSubdivisionsMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CertificatesOfDepositMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_CertificatesOfDepositMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="2.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note3MarketableSecuritiesDetailsMarketableSecuritiesTable" xlink:to="Note3MarketableSecuritiesDetailsMarketableSecuritiesLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesAmortizedCost" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAmortizedCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note3MarketableSecuritiesDetailsMarketableSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesAmortizedCost" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note3MarketableSecuritiesDetailsMarketableSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note3MarketableSecuritiesDetailsMarketableSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleSecurities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note3MarketableSecuritiesDetailsMarketableSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecurities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/FairValueofFinancialInstrumentsTable">
    <loc xlink:type="locator" xlink:label="FairValueOfFinancialInstrumentsAbstract" xlink:href="anik-20140930.xsd#anik_FairValueOfFinancialInstrumentsAbstract"/>
    <loc xlink:type="locator" xlink:label="Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsTable" xlink:href="anik-20140930.xsd#anik_Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsTable"/>
    <loc xlink:type="locator" xlink:label="Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsLineItems" xlink:href="anik-20140930.xsd#anik_Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueOfFinancialInstrumentsAbstract" xlink:to="Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel1Member" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel2Member" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel3Member" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByAssetClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsTable" xlink:to="us-gaap_FairValueByAssetClassAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_MoneyMarketFundsMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_USStatesAndPoliticalSubdivisionsMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CertificatesOfDepositMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_CertificatesOfDepositMember" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" order="3.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsTable" xlink:to="Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsLineItems" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsLineItems" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="MarketableSecuritiesAbstract0" xlink:href="anik-20140930.xsd#anik_MarketableSecuritiesAbstract0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsLineItems" xlink:to="MarketableSecuritiesAbstract0" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleSecurities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsLineItems" xlink:to="us-gaap_AvailableForSaleSecurities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/AssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsTable">
    <loc xlink:type="locator" xlink:label="AssumptionsUsedToEstimateFairValueOfStockOptionsAndStockAppreciationRightsAwardsAbstract" xlink:href="anik-20140930.xsd#anik_AssumptionsUsedToEstimateFairValueOfStockOptionsAndStockAppreciationRightsAwardsAbstract"/>
    <loc xlink:type="locator" xlink:label="Note5EquityIncentivePlanDetailsAssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsTable" xlink:href="anik-20140930.xsd#anik_Note5EquityIncentivePlanDetailsAssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsTable"/>
    <loc xlink:type="locator" xlink:label="Note5EquityIncentivePlanDetailsAssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsLineItems" xlink:href="anik-20140930.xsd#anik_Note5EquityIncentivePlanDetailsAssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssumptionsUsedToEstimateFairValueOfStockOptionsAndStockAppreciationRightsAwardsAbstract" xlink:to="Note5EquityIncentivePlanDetailsAssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5EquityIncentivePlanDetailsAssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsTable" xlink:to="us-gaap_RangeAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MinimumMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MinimumMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MaximumMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MaximumMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="2.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5EquityIncentivePlanDetailsAssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsTable" xlink:to="Note5EquityIncentivePlanDetailsAssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5EquityIncentivePlanDetailsAssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsLineItems" xlink:to="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5EquityIncentivePlanDetailsAssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5EquityIncentivePlanDetailsAssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5EquityIncentivePlanDetailsAssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/BasicandDilutedEarningsPerShareTable">
    <loc xlink:type="locator" xlink:label="BasicAndDilutedEarningsPerShareAbstract" xlink:href="anik-20140930.xsd#anik_BasicAndDilutedEarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BasicAndDilutedEarningsPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="EffectOfDilutiveSecuritiesAbstract" xlink:href="anik-20140930.xsd#anik_EffectOfDilutiveSecuritiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BasicAndDilutedEarningsPerShareAbstract" xlink:to="EffectOfDilutiveSecuritiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EffectOfDilutiveSecuritiesAbstract" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BasicAndDilutedEarningsPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/InventoriesTable">
    <loc xlink:type="locator" xlink:label="InventoriesAbstract" xlink:href="anik-20140930.xsd#anik_InventoriesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryRawMaterials" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InventoryRawMaterials"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InventoriesAbstract" xlink:to="us-gaap_InventoryRawMaterials" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryWorkInProcess" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InventoriesAbstract" xlink:to="us-gaap_InventoryWorkInProcess" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryFinishedGoods" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InventoriesAbstract" xlink:to="us-gaap_InventoryFinishedGoods" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InventoryNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryFinishedGoods" xlink:to="us-gaap_InventoryNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/IntangibleAssetsTable">
    <loc xlink:type="locator" xlink:label="IntangibleAssetsAbstract" xlink:href="anik-20140930.xsd#anik_IntangibleAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsTable" xlink:href="anik-20140930.xsd#anik_Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsTable"/>
    <loc xlink:type="locator" xlink:label="Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsLineItems" xlink:href="anik-20140930.xsd#anik_Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsAbstract" xlink:to="Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DevelopedTechnologyRightsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_DevelopedTechnologyRightsMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_InProcessResearchAndDevelopmentMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DistributionRightsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DistributionRightsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_DistributionRightsMember" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PatentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PatentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_PatentsMember" order="3.0"/>
    <loc xlink:type="locator" xlink:label="ElevessTradeNameMember" xlink:href="anik-20140930.xsd#anik_ElevessTradeNameMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="ElevessTradeNameMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="5.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsTable" xlink:to="Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="IntangibleAssetsGrossCarryingAmount" xlink:href="anik-20140930.xsd#anik_IntangibleAssetsGrossCarryingAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsLineItems" xlink:to="IntangibleAssetsGrossCarryingAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="IntangibleAssetsTranslationAdjustments" xlink:href="anik-20140930.xsd#anik_IntangibleAssetsTranslationAdjustments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsLineItems" xlink:to="IntangibleAssetsTranslationAdjustments" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="IntangibleAssetsAccumulatedAmortization" xlink:href="anik-20140930.xsd#anik_IntangibleAssetsAccumulatedAmortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsLineItems" xlink:to="IntangibleAssetsAccumulatedAmortization" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsLineItems" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/ChangesinCarryingValueofGoodwillTable">
    <loc xlink:type="locator" xlink:label="ChangesInCarryingValueOfGoodwillAbstract" xlink:href="anik-20140930.xsd#anik_ChangesInCarryingValueOfGoodwillAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Goodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInCarryingValueOfGoodwillAbstract" xlink:to="us-gaap_Goodwill" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillTranslationAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GoodwillTranslationAdjustments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInCarryingValueOfGoodwillAbstract" xlink:to="us-gaap_GoodwillTranslationAdjustments" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Goodwill_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Goodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInCarryingValueOfGoodwillAbstract" xlink:to="us-gaap_Goodwill_0" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/AccruedExpensesTable">
    <loc xlink:type="locator" xlink:label="AccruedExpensesAbstract" xlink:href="anik-20140930.xsd#anik_AccruedExpensesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedExpensesAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="AccruedClinicalTrialCostsCurrent" xlink:href="anik-20140930.xsd#anik_AccruedClinicalTrialCostsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedExpensesAbstract" xlink:to="AccruedClinicalTrialCostsCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedExpensesAbstract" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="AccruedResearchGrantsCurrent" xlink:href="anik-20140930.xsd#anik_AccruedResearchGrantsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedExpensesAbstract" xlink:to="AccruedResearchGrantsCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestructuringReserveCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestructuringReserveCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedExpensesAbstract" xlink:to="us-gaap_RestructuringReserveCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedExpensesAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedExpensesAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/ProductRevenuebyProductGroupTable">
    <loc xlink:type="locator" xlink:label="ProductRevenueByProductGroupAbstract" xlink:href="anik-20140930.xsd#anik_ProductRevenueByProductGroupAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProductRevenueByProductGroupAbstract" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProductOrServiceAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_ProductOrServiceAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="OrthobiologicsMember" xlink:href="anik-20140930.xsd#anik_OrthobiologicsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ProductOrServiceAxis" xlink:to="OrthobiologicsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DermalMember" xlink:href="anik-20140930.xsd#anik_DermalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ProductOrServiceAxis" xlink:to="DermalMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SurgicalMember" xlink:href="anik-20140930.xsd#anik_SurgicalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ProductOrServiceAxis" xlink:to="SurgicalMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OphthalmicMember" xlink:href="anik-20140930.xsd#anik_OphthalmicMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ProductOrServiceAxis" xlink:to="OphthalmicMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="VeterinaryMember" xlink:href="anik-20140930.xsd#anik_VeterinaryMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ProductOrServiceAxis" xlink:to="VeterinaryMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProductsAndServicesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ProductOrServiceAxis" xlink:to="us-gaap_ProductsAndServicesDomain" order="5.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_SegmentReportingInformationLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesRevenueGoodsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SalesRevenueGoodsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_SalesRevenueGoodsNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/ProductRevenuebyGeographicLocationTable">
    <loc xlink:type="locator" xlink:label="ProductRevenueByGeographicLocationAbstract" xlink:href="anik-20140930.xsd#anik_ProductRevenueByGeographicLocationAbstract"/>
    <loc xlink:type="locator" xlink:label="Note13SegmentandGeographicInformationDetailsProductRevenuebyGeographicLocationTable" xlink:href="anik-20140930.xsd#anik_Note13SegmentandGeographicInformationDetailsProductRevenuebyGeographicLocationTable"/>
    <loc xlink:type="locator" xlink:label="Note13SegmentandGeographicInformationDetailsProductRevenuebyGeographicLocationLineItems" xlink:href="anik-20140930.xsd#anik_Note13SegmentandGeographicInformationDetailsProductRevenuebyGeographicLocationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProductRevenueByGeographicLocationAbstract" xlink:to="Note13SegmentandGeographicInformationDetailsProductRevenuebyGeographicLocationTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementGeographicalAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementGeographicalAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note13SegmentandGeographicInformationDetailsProductRevenuebyGeographicLocationTable" xlink:to="us-gaap_StatementGeographicalAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="UnitedStatesMember" xlink:href="anik-20140930.xsd#anik_UnitedStatesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="UnitedStatesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EuropeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EuropeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_EuropeMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="OtherLocationMember" xlink:href="anik-20140930.xsd#anik_OtherLocationMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="OtherLocationMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentGeographicalDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SegmentGeographicalDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_SegmentGeographicalDomain" order="3.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note13SegmentandGeographicInformationDetailsProductRevenuebyGeographicLocationTable" xlink:to="Note13SegmentandGeographicInformationDetailsProductRevenuebyGeographicLocationLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="GeographicLocationAbstract" xlink:href="anik-20140930.xsd#anik_GeographicLocationAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note13SegmentandGeographicInformationDetailsProductRevenuebyGeographicLocationLineItems" xlink:to="GeographicLocationAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesRevenueNet" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SalesRevenueNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeographicLocationAbstract" xlink:to="us-gaap_SalesRevenueNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="PercentageOfNetRevenue" xlink:href="anik-20140930.xsd#anik_PercentageOfNetRevenue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeographicLocationAbstract" xlink:to="PercentageOfNetRevenue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/RestructuringAccrualActivityTable">
    <loc xlink:type="locator" xlink:label="RestructuringAccrualActivityAbstract" xlink:href="anik-20140930.xsd#anik_RestructuringAccrualActivityAbstract"/>
    <loc xlink:type="locator" xlink:label="Note14RestructuringCreditsDetailsRestructuringAccrualActivityTable" xlink:href="anik-20140930.xsd#anik_Note14RestructuringCreditsDetailsRestructuringAccrualActivityTable"/>
    <loc xlink:type="locator" xlink:label="Note14RestructuringCreditsDetailsRestructuringAccrualActivityLineItems" xlink:href="anik-20140930.xsd#anik_Note14RestructuringCreditsDetailsRestructuringAccrualActivityLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RestructuringAccrualActivityAbstract" xlink:to="Note14RestructuringCreditsDetailsRestructuringAccrualActivityTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestructuringCostAndReserveAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note14RestructuringCreditsDetailsRestructuringAccrualActivityTable" xlink:to="us-gaap_RestructuringCostAndReserveAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="EmployeeTerminationCostsMember" xlink:href="anik-20140930.xsd#anik_EmployeeTerminationCostsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringCostAndReserveAxis" xlink:to="EmployeeTerminationCostsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ActivityTerminationAndFacilityClosureCostsMember" xlink:href="anik-20140930.xsd#anik_ActivityTerminationAndFacilityClosureCostsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringCostAndReserveAxis" xlink:to="ActivityTerminationAndFacilityClosureCostsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TypeOfRestructuringDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringCostAndReserveAxis" xlink:to="us-gaap_TypeOfRestructuringDomain" order="2.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note14RestructuringCreditsDetailsRestructuringAccrualActivityTable" xlink:to="Note14RestructuringCreditsDetailsRestructuringAccrualActivityLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestructuringReserve" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestructuringReserve"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note14RestructuringCreditsDetailsRestructuringAccrualActivityLineItems" xlink:to="us-gaap_RestructuringReserve" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRestructuring" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note14RestructuringCreditsDetailsRestructuringAccrualActivityLineItems" xlink:to="us-gaap_PaymentsForRestructuring" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestructuringReserveTranslationAdjustment" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestructuringReserveTranslationAdjustment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note14RestructuringCreditsDetailsRestructuringAccrualActivityLineItems" xlink:to="us-gaap_RestructuringReserveTranslationAdjustment" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestructuringReserve_0" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestructuringReserve"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note14RestructuringCreditsDetailsRestructuringAccrualActivityLineItems" xlink:to="us-gaap_RestructuringReserve_0" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note2BasisofPresentationDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="Note2BasisofPresentationDetailsTable" xlink:href="anik-20140930.xsd#anik_Note2BasisofPresentationDetailsTable"/>
    <loc xlink:type="locator" xlink:label="Note2BasisofPresentationDetailsLineItems" xlink:href="anik-20140930.xsd#anik_Note2BasisofPresentationDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="Note2BasisofPresentationDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note2BasisofPresentationDetailsTable" xlink:to="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="IncreaseToCashProvidedByFinancingActivitiesMember" xlink:href="anik-20140930.xsd#anik_IncreaseToCashProvidedByFinancingActivitiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:to="IncreaseToCashProvidedByFinancingActivitiesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DereaseToCashProvidedByOperatingActivitiesMember" xlink:href="anik-20140930.xsd#anik_DereaseToCashProvidedByOperatingActivitiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:to="DereaseToCashProvidedByOperatingActivitiesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:to="us-gaap_AdjustmentsForErrorCorrectionDomain" order="2.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note2BasisofPresentationDetailsTable" xlink:to="Note2BasisofPresentationDetailsLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PriorPeriodReclassificationAdjustment" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note2BasisofPresentationDetailsLineItems" xlink:to="us-gaap_PriorPeriodReclassificationAdjustment" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note5EquityIncentivePlanDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="Note5EquityIncentivePlanDetailsTable" xlink:href="anik-20140930.xsd#anik_Note5EquityIncentivePlanDetailsTable"/>
    <loc xlink:type="locator" xlink:label="Note5EquityIncentivePlanDetailsLineItems" xlink:href="anik-20140930.xsd#anik_Note5EquityIncentivePlanDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="Note5EquityIncentivePlanDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5EquityIncentivePlanDetailsTable" xlink:to="us-gaap_AwardTypeAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_RestrictedStockMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockAppreciationRightsSARSMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_StockAppreciationRightsSARSMember" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5EquityIncentivePlanDetailsTable" xlink:to="us-gaap_RangeAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MinimumMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MinimumMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MaximumMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MaximumMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TitleOfIndividualAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TitleOfIndividualAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5EquityIncentivePlanDetailsTable" xlink:to="us-gaap_TitleOfIndividualAxis" order="3.0"/>
    <loc xlink:type="locator" xlink:label="BoardOfDirectorsMember" xlink:href="anik-20140930.xsd#anik_BoardOfDirectorsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TitleOfIndividualAxis" xlink:to="BoardOfDirectorsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TitleOfIndividualAxis" xlink:to="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5EquityIncentivePlanDetailsTable" xlink:to="Note5EquityIncentivePlanDetailsLineItems" order="4.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5EquityIncentivePlanDetailsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5EquityIncentivePlanDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5EquityIncentivePlanDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5EquityIncentivePlanDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5EquityIncentivePlanDetailsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5EquityIncentivePlanDetailsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriodTotalIntrinsicValue" xlink:href="anik-20140930.xsd#anik_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriodTotalIntrinsicValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5EquityIncentivePlanDetailsLineItems" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriodTotalIntrinsicValue" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5EquityIncentivePlanDetailsLineItems" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5EquityIncentivePlanDetailsLineItems" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingNumber" xlink:href="anik-20140930.xsd#anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5EquityIncentivePlanDetailsLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsWeightedAverageExercisePrice" xlink:href="anik-20140930.xsd#anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5EquityIncentivePlanDetailsLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsWeightedAverageExercisePrice" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingIntrinsicValue" xlink:href="anik-20140930.xsd#anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingIntrinsicValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5EquityIncentivePlanDetailsLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingIntrinsicValue" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm" xlink:href="anik-20140930.xsd#anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5EquityIncentivePlanDetailsLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTermRange" xlink:href="anik-20140930.xsd#anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTermRange"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note5EquityIncentivePlanDetailsLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTermRange" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note6EarningsPerShareDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note8IntangibleAssetsandGoodwillDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note10CommitmentsandContingenciesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProductWarrantyAccrual" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProductWarrantyAccrual"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_ProductWarrantyAccrual" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProductWarrantyExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProductWarrantyExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_ProductWarrantyExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note11MitekMonoviscAgreementDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="Note11MitekMonoviscAgreementDetailsTable" xlink:href="anik-20140930.xsd#anik_Note11MitekMonoviscAgreementDetailsTable"/>
    <loc xlink:type="locator" xlink:label="Note11MitekMonoviscAgreementDetailsLineItems" xlink:href="anik-20140930.xsd#anik_Note11MitekMonoviscAgreementDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueDisclosureAbstract" xlink:to="Note11MitekMonoviscAgreementDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note11MitekMonoviscAgreementDetailsTable" xlink:to="us-gaap_DeferredRevenueArrangementTypeAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="MiltekMONOVISCAgreementMember" xlink:href="anik-20140930.xsd#anik_MiltekMONOVISCAgreementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="MiltekMONOVISCAgreementMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="us-gaap_DeferredRevenueArrangementTypeDomain" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note11MitekMonoviscAgreementDetailsTable" xlink:to="Note11MitekMonoviscAgreementDetailsLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="ContractTermYears" xlink:href="anik-20140930.xsd#anik_ContractTermYears"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note11MitekMonoviscAgreementDetailsLineItems" xlink:to="ContractTermYears" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note11MitekMonoviscAgreementDetailsLineItems" xlink:to="us-gaap_DeferredRevenue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueRevenueRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueRevenueRecognized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note11MitekMonoviscAgreementDetailsLineItems" xlink:to="us-gaap_DeferredRevenueRevenueRecognized" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note11MitekMonoviscAgreementDetailsLineItems" xlink:to="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note12IncomeTaxesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="Note12IncomeTaxesDetailsTable" xlink:href="anik-20140930.xsd#anik_Note12IncomeTaxesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="Note12IncomeTaxesDetailsLineItems" xlink:href="anik-20140930.xsd#anik_Note12IncomeTaxesDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="Note12IncomeTaxesDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TaxPeriodAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note12IncomeTaxesDetailsTable" xlink:to="us-gaap_TaxPeriodAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarliestTaxYearMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarliestTaxYearMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxPeriodAxis" xlink:to="us-gaap_EarliestTaxYearMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TaxPeriodDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxPeriodAxis" xlink:to="us-gaap_TaxPeriodDomain" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note12IncomeTaxesDetailsTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DomesticCountryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_DomesticCountryMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCountryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_ForeignCountryMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note12IncomeTaxesDetailsTable" xlink:to="us-gaap_IncomeTaxAuthorityNameAxis" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InternalRevenueServiceIRSMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_InternalRevenueServiceIRSMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MinistryOfEconomicAffairsAndFinanceItalyMember" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MinistryOfEconomicAffairsAndFinanceItalyMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_MinistryOfEconomicAffairsAndFinanceItalyMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_IncomeTaxAuthorityNameDomain" order="2.0"/>
    <loc xlink:type="locator" xlink:label="RevenueComponentsAxis" xlink:href="anik-20140930.xsd#anik_RevenueComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note12IncomeTaxesDetailsTable" xlink:to="RevenueComponentsAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MilestoneAndContractRevenueMember" xlink:href="anik-20140930.xsd#anik_MilestoneAndContractRevenueMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueComponentsAxis" xlink:to="MilestoneAndContractRevenueMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RevenueComponentsDomain" xlink:href="anik-20140930.xsd#anik_RevenueComponentsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueComponentsAxis" xlink:to="RevenueComponentsDomain" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note12IncomeTaxesDetailsTable" xlink:to="Note12IncomeTaxesDetailsLineItems" order="5.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note12IncomeTaxesDetailsLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note12IncomeTaxesDetailsLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContractsRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ContractsRevenue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note12IncomeTaxesDetailsLineItems" xlink:to="us-gaap_ContractsRevenue" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OpenTaxYear" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OpenTaxYear"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note12IncomeTaxesDetailsLineItems" xlink:to="us-gaap_OpenTaxYear" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note13SegmentandGeographicInformationDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NumberOfReportableSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_NumberOfReportableSegments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/Note14RestructuringCreditsDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="Note14RestructuringCreditsDetailsTable" xlink:href="anik-20140930.xsd#anik_Note14RestructuringCreditsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="Note14RestructuringCreditsDetailsLineItems" xlink:href="anik-20140930.xsd#anik_Note14RestructuringCreditsDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="Note14RestructuringCreditsDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestructuringCostAndReserveAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note14RestructuringCreditsDetailsTable" xlink:to="us-gaap_RestructuringCostAndReserveAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="NonCashTerminationAndImpairmentOfIPRDProjectMember" xlink:href="anik-20140930.xsd#anik_NonCashTerminationAndImpairmentOfIPRDProjectMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringCostAndReserveAxis" xlink:to="NonCashTerminationAndImpairmentOfIPRDProjectMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NoncashDisposalOfPropertyAndEquipmentMember" xlink:href="anik-20140930.xsd#anik_NoncashDisposalOfPropertyAndEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringCostAndReserveAxis" xlink:to="NoncashDisposalOfPropertyAndEquipmentMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DisposalOfInventoryMember" xlink:href="anik-20140930.xsd#anik_DisposalOfInventoryMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringCostAndReserveAxis" xlink:to="DisposalOfInventoryMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TypeOfRestructuringDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringCostAndReserveAxis" xlink:to="us-gaap_TypeOfRestructuringDomain" order="3.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note14RestructuringCreditsDetailsTable" xlink:to="Note14RestructuringCreditsDetailsLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note14RestructuringCreditsDetailsLineItems" xlink:to="us-gaap_RestructuringCostsAndAssetImpairmentCharges" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="RestructuringCredit" xlink:href="anik-20140930.xsd#anik_RestructuringCredit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Note14RestructuringCreditsDetailsLineItems" xlink:to="RestructuringCredit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anikatherapeutics.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="DocumentAndEntityInformationAbstract" xlink:href="anik-20140930.xsd#anik_DocumentAndEntityInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityRegistrantName" order="1.0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentType" order="2.0"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_CurrentFiscalYearEndDate" order="3.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityCommonStockSharesOutstanding" order="4.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityPublicFloat" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityPublicFloat" order="5.0"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_AmendmentFlag" order="6.0"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentDescription" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_AmendmentDescription" order="7.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityCentralIndexKey" order="8.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityCurrentReportingStatus" order="9.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityVoluntaryFilers" order="10.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityFilerCategory" order="11.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="12.0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentPeriodEndDate" order="13.0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentFiscalYearFocus" order="14.0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentFiscalPeriodFocus" order="15.0"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EGFBG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 8 -  Intangible Assets and Goodwill (Details) - Intangible Assets (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsLineItems', window );"><strong>Note 8 - Intangible Assets and Goodwill (Details) - Intangible Assets [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_IntangibleAssetsGrossCarryingAmount', window );">Gross Value</a></td>
        <td class="nump">$ 28,902,686<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_IntangibleAssetsTranslationAdjustments', window );">Currency Translation Adjustment</a></td>
        <td class="num">(3,015,503)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_IntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
        <td class="num">(9,853,239)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Book Value</a></td>
        <td class="nump">16,033,944<span></span></td>
        <td class="nump">18,998,409<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Developed Technology Rights [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsLineItems', window );"><strong>Note 8 - Intangible Assets and Goodwill (Details) - Intangible Assets [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_IntangibleAssetsGrossCarryingAmount', window );">Gross Value</a></td>
        <td class="nump">16,700,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_IntangibleAssetsTranslationAdjustments', window );">Currency Translation Adjustment</a></td>
        <td class="num">(1,828,214)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_IntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
        <td class="num">(4,779,123)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Book Value</a></td>
        <td class="nump">10,092,663<span></span></td>
        <td class="nump">11,753,003<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">15 years<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">In Process Research and Development [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsLineItems', window );"><strong>Note 8 - Intangible Assets and Goodwill (Details) - Intangible Assets [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_IntangibleAssetsGrossCarryingAmount', window );">Gross Value</a></td>
        <td class="nump">5,502,686<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_IntangibleAssetsTranslationAdjustments', window );">Currency Translation Adjustment</a></td>
        <td class="num">(638,426)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Book Value</a></td>
        <td class="nump">4,864,260<span></span></td>
        <td class="nump">5,286,127<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Distribution Rights [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsLineItems', window );"><strong>Note 8 - Intangible Assets and Goodwill (Details) - Intangible Assets [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_IntangibleAssetsGrossCarryingAmount', window );">Gross Value</a></td>
        <td class="nump">4,700,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_IntangibleAssetsTranslationAdjustments', window );">Currency Translation Adjustment</a></td>
        <td class="num">(440,953)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_IntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
        <td class="num">(4,084,944)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Book Value</a></td>
        <td class="nump">174,103<span></span></td>
        <td class="nump">863,655<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">5 years<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Patents [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsLineItems', window );"><strong>Note 8 - Intangible Assets and Goodwill (Details) - Intangible Assets [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_IntangibleAssetsGrossCarryingAmount', window );">Gross Value</a></td>
        <td class="nump">1,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_IntangibleAssetsTranslationAdjustments', window );">Currency Translation Adjustment</a></td>
        <td class="num">(107,910)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_IntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
        <td class="num">(271,208)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Book Value</a></td>
        <td class="nump">620,882<span></span></td>
        <td class="nump">719,574<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">16 years<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Elevess Trade Name [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsLineItems', window );"><strong>Note 8 - Intangible Assets and Goodwill (Details) - Intangible Assets [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_IntangibleAssetsGrossCarryingAmount', window );">Gross Value</a></td>
        <td class="nump">1,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_IntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
        <td class="num">(717,964)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Book Value</a></td>
        <td class="nump">$ 282,036<span></span></td>
        <td class="nump">$ 376,050<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">9 years<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anik_IntangibleAssetsAccumulatedAmortization">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents intangible assets accumulated amortization.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>anik_IntangibleAssetsAccumulatedAmortization</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>anik_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anik_IntangibleAssetsGrossCarryingAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the gross carrying amount of intangible assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>anik_IntangibleAssetsGrossCarryingAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>anik_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anik_IntangibleAssetsTranslationAdjustments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents intangible assets translation adjustments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>anik_IntangibleAssetsTranslationAdjustments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>anik_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anik_Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>anik_Note8IntangibleAssetsandGoodwillDetailsIntangibleAssetsLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>anik_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FiniteLivedIntangibleAssetUsefulLife</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 45<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph ((a)(1),(b))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IntangibleAssetsNetExcludingGoodwill</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EN4AE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 14 - Restructuring Credits (Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="3">3 Months Ended</th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_Note14RestructuringCreditsDetailsLineItems', window );"><strong>Note 14 - Restructuring Credits (Details) [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Restructuring Costs and Asset Impairment Charges</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 2,500,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_RestructuringCredit', window );">Restructuring Credit</a></td>
        <td class="nump">196,084<span></span></td>
        <td class="nump">196,084<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">442,869<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Non-Cash Termination And Impairment Of IPR&amp;D [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_Note14RestructuringCreditsDetailsLineItems', window );"><strong>Note 14 - Restructuring Credits (Details) [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Restructuring Costs and Asset Impairment Charges</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,200,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Noncash Disposal of Property and Equipment [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_Note14RestructuringCreditsDetailsLineItems', window );"><strong>Note 14 - Restructuring Credits (Details) [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Restructuring Costs and Asset Impairment Charges</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">300,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Disposal of inventory [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_Note14RestructuringCreditsDetailsLineItems', window );"><strong>Note 14 - Restructuring Credits (Details) [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Restructuring Costs and Asset Impairment Charges</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 100,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anik_Note14RestructuringCreditsDetailsLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>anik_Note14RestructuringCreditsDetailsLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>anik_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anik_RestructuringCredit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of credit associated with exit or disposal activities during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>anik_RestructuringCredit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>anik_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan and expenses resulting from the write-down of assets. Excludes expenses related to a business combination, a discontinued operation or an asset retirement obligation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RestructuringCostsAndAssetImpairmentCharges</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>14
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0`!@`(````(0!NR'4D#`(``#@>```3``@"6T-O;G1E;G1?5'EP97-=
M+GAM;""B!`(HH``"````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M``````````````````````````````````````#,F4MNVS`41><%N@>!T\*B
M^6F:%I8SZ&?8!FBZ`$9ZM@1+)$$RJ;W[4G(2%('KP(B!WHD%2^2[1QR<@>[B
M:COTQ3V%V#E;,5'.64&V=DUGUQ7[=?-M=LF*F(QM3.\L56Q'D5TMW[Y9W.P\
MQ2+OMK%B;4K^$^>Q;FDPL72>;'ZR<F$P*?\-:^Y-O3%KXG(^O^"ULXELFJ5Q
M!ELNOM#*W/6I^+K-M_<D@?K(BL_[A6-6Q8SW?5>;E$GYO6V>I<P>$LJ\<UH3
MV\['=QF#\8,)XY-_!SSL^Y&/)G0-%=<FI.]FR!A\V_/?+FQNG=N4QX<<H'2K
M55=3X^J[(9]`&7T@T\26*`U].5W+P73VD?M(_K0X\NDBS@PROM\T^$0."<*A
M0#@T",=[$(X+$(X/(!R7(!P?03C$'`4$Q:@"1:D"Q:D"1:H"Q:H"1:L"Q:L"
M1:P"Q:P2Q:P2Q:P2Q:P2Q:P2Q:P2Q:P2Q:P2Q:P2Q:P2Q:P*Q:P*Q:P*Q:P*
MQ:P*Q:P*Q:P*Q:P*Q:P*Q:P*Q:P:Q:P:Q:P:Q:P:Q:P:Q:P:Q:P:Q:P:Q:P:
MQ:SZ?YDUY5Z.^/3[>I5-8UXHAF+:]13/_#%W/_2EY-8$:GZFD!O,LP/\/?L8
M1^[WKH/S,3>=@4X_A<<J<]P]\WD0A=314YEYJ!1\2LPMZ>F!SUI)&GO8AIH#
MV7SJ?9=_````__\#`%!+`P04``8`"````"$`M54P(_4```!,`@``"P`(`E]R
M96QS+RYR96QS(*($`BB@``(`````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M`````````````````````````````````````````````(R2ST[#,`S&[TB\
M0^3[ZFY("*&ENTQ(NR%4'L`D[A^UC:,D0/?VA`."2F/;T?;GSS];WN[F:50?
M'&(O3L.Z*$&Q,V)[UVIXK9]6#Z!B(F=I%,<:CAQA5]W>;%]XI)2;8M?[J+*+
MBQJZE/PC8C0=3Q0+\>QRI9$P4<IA:-&3&:AEW)3E/8:_'E`M/-7!:@@'>P>J
M/OH\^;*W-$UO>"_F?6*73HQ`GA,[RW;E0V8+J<_;J)I"RTF#%?.<TQ')^R)C
M`YXFVEQ/]/^V.'$B2XG02.#S/-^*<T#KZX$NGVBI^+W./.*GA.%-9/AAP<4/
M5%\```#__P,`4$L#!!0`!@`(````(0!+1T5B-P(``'T=```:``@!>&PO7W)E
M;',O=V]R:V)O;VLN>&UL+G)E;',@H@0!**```0``````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M``````````````````"\F4]KVT`4Q.^%?@>Q]WB][ZV<I$3.)11R;=,/(*RU
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ME`B'30-A')O&01QA5W6!55W855U@55=V8BE,+,].+(\3B^TZ#KJ.8T_'P>DH
M.\\5YKEGY[F'>5[.FN>QK<?0?$UC?@427V/BXC1*"/IL$`Q;QE#%CCT:!V4C
ML\KF'<U"8`T4=@T46`.5;<@*#5G954=AU?'LJN-AU?'LJN-AU6'30)ARUNR,
MZ73(K\"G-SE_CI$%LY4"A>+8GN>@YSFVYSGH><(V&8$FHW3I0.TH>ULKW->>
M_3SEX?.4L/-28%[Z65WO'>7&PR<&-@V$80MGTHV]^&BZ_@T``/__`P!02P,$
M%``&``@````A`**:F*DX!```>@\```\```!X;"]W;W)K8F]O:RYX;6R4EUU/
MXSH0AN]7VO\0Y7ZWS4=30)05+-VS7(#0@<->6B:9MA:)W6,[M/S[G;@0QM21
MZ%7KI'F9>>>9&7+Z8]O4T3-H(Y2<Q<GW<1R!+%4EY'(6_W?_Z]M1'!G+9<5K
M)6$6OX")?YQ]_7*Z4?KI4:FG"`6DF<4K:]<GHY$I5]!P\UVM0>*=A=(-MWC4
MRY%9:^"560'8IAZEXW$Q:KB0\4[A1']&0RT6HH1+5;8-2+L3T5!SB^&;E5B;
M^.QT(6IXV&44\?7ZAC<8][:.HYH;.Z^$A6H63_"H-N!=T.WZHA4UWCW.QED\
M.NN3O-51!0O>UO8>TWM31[_2/$V+[I>=%0\"-N;]H>X8;?\(6:E-]U.T]J4_
M91C`QMWZ(RJ[POOC\;B_]AO$<F7?+J+\B.@[!_'ON,](NO3>'&'GLF)S:85]
M85=RY[Y06,+.]2O,+(DC?2+PB[ZJDBYPJO)3R0JD@8KA-Z-J47$TBUWPFLL2
MB$I*5-+#5#"`/IB,R#B_/Q',G<68&AI,3E3R3P;SJD*#0?-[9R8?96Z4!9:P
M&VY;#4PMV$5KA`1C2#83+'"OX*"@Z3B%%+TTPG0"MQH,(NS(I2*T0--@&!F[
MYOH)+'^L@=U!V6IA!;;ENZ\36I^CH$C.?G&AV0.O6V#7P`WFU;64)T/K<QR4
MF;#Y_^T.MA*?%L_`;A$6&@LM3S(.JA1LSK7$D6/8+6AVM^*:%GA"2Y/L4>N<
MG2+NSQB!TA^L*$A1DCU6W;-'^"R.N*7H##TW!JQA./'8/S2-*=79@]7I'+/S
MLM0M=LQ\B^//^#7!0=K3D>QQZ@22,39>TPCK*N%BP$:TW8SL>V9R3'4&0$W8
M-8ZY)W:MI'H6IF3G2PU^UQ24UB2,:Y*B,Z5J@-WSK9=-03%-PIPF&=*Y[%+9
MN0EJJ?EZ)4J234%)3<*H)CG[%P>U;DML/H2$_=2`4YR26E!2DS"JR83=P*8K
MD6H[3Y<,AP#N-4W#H;#BP/XP'UV1!MJ/W5,=2FP:)G:P`^E0*BB^:1C?@1[T
M`Z+XIF%\0UV(A7_$S=G35U"*TS#%7BLZ`1\="G`:!GBP(ZDW4TKP;@OO#=S]
MEMP/:$I93@]DV0N(PIP>!C,C)D\IS6F8YH%-PBZ)3D8-PL,A-%.=*>V*[$":
MT9.>GHP:A(=00$,T>P'1]LK"-`_JT(IE7F9AG(-M<8GKER;F!11F>E#'"XCV
M>Q:>RGY_=9&(VG3KCP9$^ST+,SW89%[):,-G8:8'A9#C]]K3ML_"4`\*89EZ
MH9Q2C8<01(&VW_E$==#W?B'G8:H'%S*M64ZIQD,HH&1H(WM"M._S,-8?5C)[
M+3_-BS*=AYD>7,VT]#F%&@_!O(9V/"U]3J'&PT%"7NDIU7F8ZJ'_%ICG-*4Z
M#U,]*.1Y1*G.'=4C1RJ^GY6\+O'%L?OHWKP<J:.WU^:SOP```/__`P!02P,$
M%``&``@````A`-K$&$E;!P``6!X``!@```!X;"]W;W)K<VAE971S+W-H965T
M-"YX;6R<F=N.HT80AN\CY1TL[L>F3S2,QA,MATTB)5(4Y7#-V'@&K6TL8'9V
MWS[5-(:N8LS8N=EDS$?1?U=U]0_]\-.WPW[QM:B;LCJN/;;TO45QW%3;\OB\
M]O[^Z_-=Z"V:-C]N\WUU+-;>]Z+Q?GK\\8>'MZK^TKP41;N`",=F[;VT[>E^
MM6HV+\4A;Y;5J3C"E5U5'_(6_JR?5\VI+O)M=]-AO^*^'ZP.>7GT;(3[^IH8
MU6Y7;HJTVKP>BF-K@]3%/F]A_,U+>6K.T0Z;:\(=\OK+Z^EN4QU.$.*IW)?M
M]RZHMSAL[G]]/E9U_K0'W=^8S#?GV-T?D_"'<E-73;5KEQ!N90<ZU1RMHA5$
M>GS8EJ#`3/NB+G9K[Q.[SX3OK1X?N@GZIRS>&N?_%\U+]?9S76Y_*X\%S#;D
MR63@J:J^&/37K?D);EY-[O[<9>"/>K$M=OGKOOVS>ONE*)]?6DBW`D5&V/WV
M>UHT&YA1"+/DRD3:5'L8`/R[.)2F-&!&\F_=?]_*;?NR]D2P5-H7#/#%4]&T
MGTL3TEML7INV.OQK(=:'LD%X'P3NZ(,PON2A8BKX.,K*CJ@3F.9M_OA05V\+
MJ!IX9G/*30VR>XALE,%,]N,8M%Z2"AI-D$\FRMK3W@)N;R`_7Q^U>EA]A2G=
M]$C\#A)@)#DC9@)-V/3\PQB6X5NR,V&R!XH&63!9KJSW$W4>O8'-Z,_/C>T/
M$'N0P_%SDRFA-4;2*4*"9%/""8+DB%OD&'CM0?!A]#K$8XLM$G:9XBS2"BH1
M(XF+,.US(23)5^HB2JM(A%K@*!E"F`H5E^.#D$2))9X+<3YSYB8B-<(CB"VB
M.JFASQBIH,2]K@7SHW%\M@A=@$LM`QF15&<(X5*J4`ZC0")AA5U?E@;&XD)_
M"-N-+;:(%<>YKY3D)`.)BS"ME92"5$/J(B$7TA>:/"AS$25"'H5\K`8D,;A%
MHH&AX3BE&I+\Q!:!&1ZJF726Y$,B_9#(Y@@D#WK<]1DT,,D@J:[8(C:#2G,9
M^F3J$T0(R&!`\^<23$D&RY`\)D-(H(3O.RE&`HUG<3:$^?5G8"*0U%]L$2N0
M15$4!F3U)(@(&"Q2,OK4)0(6^%J22<I<0OD\BO2%%1C=(L_`1-X8UJY`BUAY
MTH>E3U=7XA*"A6$0D!:5N@1CTF<B(DB&$%^)0`;C)*'\,=B]KT]@1Q.)9'W%
M/6,UWK$H\)WVULU"\C&2]LC,0LYP%"EYZ$P5%FGV_:NKE%F7X.Z(X=B];!Y[
MIJ]3IH,(VBGNM@EBH))#%A`D18B`-NF'FG2T##,00P1B7!-8I[$(U^NTA@+I
M'`/W.BW3Z_1ABCDC_21A+J-U$'"ZKZ<(D9%0D9S4+&(XASEEX5C76*?Q"=?K
MM*X"Z20:8F89JS.*G`GN*]:]?B<XY!)G.T416"#$./8N1(:`.P:95F,Y8'G&
M(%POS]H))(\\.V:6&=(8!<QY>"_19;0&`Z=(-:0H#*11JY#VKPPQ8#("+<78
M!;%.8Q.NUVE-A:LS(GT]-F]9T(*M3@FO2V(JTT4XE"OL,C25+@(M&/99,::J
MSZ;+A$QJ'E[JL,8L7*_26@NDDG2$F%G&J@S`;4]=`$)D!%9!D9)/$2)\Y1LG
MAV<B0PSL,]QGZI),XQD<F=<Y<F:=!I([/J";ZKAG9.?)I2"SD0R7+UJ^=$#,
MJ^8D0C9<?B\"KEAC'&X7:>T&$DEF.F:N);EC@8XB:MP2Q$0L@+<+G*\4$7?0
M/P,PZ)C)$*-\S=A8_UBL<1&WB[7>`XDEPXR9ZT\ZL6K:<5WF?;$NT8F%`J5B
M769.++_)!W4T?A.)2(>(>P:ZZL57D8^1]&,DFT501OE-/JBCL=F+R*X7]TS4
MK4U_Z;RMVTV%7!?D_A1=YTM_+$7;9M%U^&0Z%C,6!N5V>ZER<Q<12+:\N&?Z
MG5/"CJ?I.V>"&0%K3DHB),4,V/$@$J.87JP=3_\LH82$37@H:"SX)@?$K7N!
M?X=2C,AV$/?,;+G:,#-(^G&4;!;!(HTC<1K0_,LE-S3))BFWN&>&<ATFMZ]6
M&^)\F28H1;>SY>3##KKN+YV6@'49[^#HNFZK-%]MJ3Y297'/]!6DP'F!RZ0B
M7>?"P!O`+D&8E,:!UQO:H#/,R$##][QQ/%CP31:(7V&!>F;.`B'D?0N$D`L6
M"#'S%HC_+PO4W47JEFQC<<]<LD##Y7%]3S)JC=:%"-EL!)S+_V6!^!46J&=L
M3B]8(,2\ZPH0<<$"(6;6%1C[</M*M:9CU@)QUYA<L$"(>5\LC@(K>6J!4)0Y
ML>8@QQ4[WVX[&I<MHQ\CXQZR)P>P*3(>D$TO00CLKF+R-3)%"'R"@(^1]+N\
M.<\SW=$^B<''(,V=+RFV@NV!G3W/.A3U<Y$4^WVSV%2OYC!.@(<9?AT."C]Q
M<\Y#?H_9/9P^37]/X6"Q^WTUW`#G>J?\N?@]KY_+8[/8%SMXE+_4T(1K>S)H
M_VBK4W>Z]E2U<*+7_>\+G.`6<*[E+P'>555[_L.<7@UGPH__`0``__\#`%!+
M`P04``8`"````"$`-ER#LL`"````!P``&0```'AL+W=O<FMS:&5E=',O<VAE
M970S."YX;6R,E5UOFS`4AN\G[3]8OB]@"/E`(543TFW2)DW3/JX=,&`5,+*=
MIOWW.\:!AK"UO0G8>?WXO.?8A_7M4UVA1R85%TV,B>-AQ)I49+PI8OSKY_W-
M$B.E:9/12C0LQL],X=O-QP_KDY`/JF1,(R`T*L:EUFWDNBHM64V5(UK6P#^Y
MD#75,)2%JUK):-8MJBO7][RY6U/>8$N(Y'L8(L]YRA*1'FO6:`N1K*(:XE<E
M;U5/J]/WX&HJ'X[M32KJ%A`'7G']W$$QJM/H2]$(20\5^'XB,YKV[&XPP=<\
ME4*)7#N`<VV@4\\K=^4":;/..#@P:4>2Y3&^(]%^AMW-NLO/;\Y.ZN(=J5*<
M/DF>?>4-@V1#F4P!#D(\&.F7S$S!8G>R^KXKP'>),I;38Z5_B--GQHM20[5#
M,&1\1=ESPE0*"06,XX>&E(H*`H!?5'-S,B`A]*E[GGBFRQ@'<R=<>`$!.3HP
MI>^Y06*4'I46]1\K(F>4A?AG"*PX0XCO^,N0A/.W*:Z-J#.84$TW:RE."`X-
M[*E::HX@B8#<.[-Q#%[_9Q4\&LB=H<1X@1&X4%">Q\W,GZ_=1\AI>M9LIYK%
ME6372TP&#3?I)UZX9$S=]PI3/K`T^()L7?KZ=Z7Z\(W8A-_ON[43P![\^.-]
M=U/%8C&6)%/)%60_55Q`1G:"L1U3I@".\>NVS"+07;KPE^,@MU8SN]"$8\7N
M347RIF+_FF+D$P)Y?]F,.,:0Q*%*,_^J"%NK679G,B3+^6IU96\D\$FPO"(D
MEP(2K@)_[HT1T'E,''8/$H;A8O5RL*T[VUGLQ:N9+-B.595"J3B:KA%`=,/L
MT-#N?',>K^:W)();,IU/H`%V\^ZP`!I02POVC<J"-PI5+(>M/&<!MUS:%F8'
M6K1=&S@(#:VG>RWA2\/@_GD.B',A=#\PMVSX=FW^`@``__\#`%!+`P04``8`
M"````"$`;TX$02<&``#='```&0```'AL+W=O<FMS:&5E=',O<VAE970S.2YX
M;6R4F=MNHT@0AN]7VG=`W(^A#YRB.*/8H]D=:4=:K?9P33"VT1AC`9G,O/U6
M=[4Q?0B&7"1Q\E'^NZJK_L8\?OQ1G[SO9=M5S7GMDU7H>^6Y:';5^;#V__G[
M\X?4][H^/^_R4W,NU_[/LO,_/OWZR^-;TW[KCF79>Q#AW*W]8]]?'H*@*XYE
MG7>KYE*>X3_[IJWS'EZVAZ"[M&6^DQ?5IX"&81S4>77V,<)#.R=&L]]71?FI
M*5[K\MQCD+8\Y3WH[X[5I;M&JXLYX>J\_?9Z^5`T]05"O%2GJO\I@_I>73Q\
M.9R;-G\YP;I_$)X7U]CRA16^KHJVZ9I]OX)P`0JUUYP%60"1GAYW%:Q`I-UK
MR_W:?R8/6Q[ZP=.C3-"_5?G6C7[WNF/S]EM;[?ZHSB5D&^HD*O#2--\$^F4G
M_@07!];5GV4%_FR]7;G/7T_]7\W;[V5U./90[@A6)!;VL/OYJ>P*R"B$6=%(
M1"J:$PB`[UY=B:T!&<E_R)]OU:X_KGT6KZ(D9`1P[Z7L^L^5".E[Q6O7-_5_
M"!$5"H-0%01^JB`D6G$:)>F2*$Q%@9_7*/'L*`&N2Z;I4][G3X]M\^;!W@/E
MW247.YD\0.1K?G`U0\;>2QAD2@1Y%E'6?N)[D(L.JOS]B=/T,?@.E2D4LT$&
MO@\,T8FM37":#4P`B@?9D,JQ;'<YK^H$+-2)\@JY&_S#6`H=WD826YM@X8!H
M2B!I8R4B@?S=#795)"Z"K33*!1_%1Y'(\!$3#0I0Y!2A:80@8XW3V1+PVH<$
M#'6BS'CG#3*IK#1-LY#&:6R(0P2^#V%N031QD*SYX@2LB^/,V$8;9"(I[@,+
M212%S!"'R`QQ\1)Q`C;%&1MK@XP2EZ41H^RVQ;&LB,P0!_TV/W,"-L49:=D@
M@^)('#*6<6YD3D/2+$MY>-.OU558J#%9&,SOZ<TG+C)5&A(VR+CS@QF<(C2-
MF:WQ?O.*B^XU+S)3&J<(32.!I(T3.9U`2>L9M-M70==")Z'X,@JM&/<2=(%B
M;H\J?4<@3OGQ?+%;F""DVH2D-*7$V`9;Q<P1**;Y?($X^W6!9AL3A)1`GB09
MH48W;14S1Z"8Y/,%XMS7!1IOOB$(J1*'84;CV&"V.D.2B(6C2:G7&%:Q0*&@
MC4W(K10BY$X/]C&Q$3[R(EVAX2/"B._/&W$6-)1R9EC91D&32F<["C$L9=Z!
M05YU;^@H:%+G;',AB]Q%TD;%1Y62Y=PH"/<DN++CU*`0]Q+T>AO^<F?JN(S%
M/#@0A%13QRSEU-@*6X7,T6=XRQU]:`=W>AHAU,?3&.194WN,1#2-"4V&P:[E
MCRZR%4D;];4Z6D'NY&!'NY!;CG6!BVR%NFSEMG3<@`J:%(AQW(BN3UC`:&C/
M:V2*Q@'3>3@7VT=_!;E%J$1B'#>BZUQD+M0V%_O\H""U$9W'!X7,T0?,.(_3
MC4(%K6]$^_B@(-7('(ZHD>E]"IFCSS"6._I<AF):G_CL`!9QU1>FW#YH*V:.
M0,-1[@A$!YB>-!0A%$@23D;G`K7_QD0:LSAZY_:.+O(12>OEI?:<P9L0=VJ4
M/!OA[/:)A-X@BYR$NISD=@ND!@U"DPJG$%V?X20S!PTZP9U!@]"DSBE$TRE.
M6_,;6=)&I:T3@X+4/I2W*:;C*<2]!%W?(D-A+D,Q3PP*4HU,0K@-L/3--A1F
M&,IT'TM:SQ]GYJ!1D-)'$T+#6Q-@IRAD3OX6&0FSC80S8PIO%(3Z8A"7&BO8
M:D1"LBBYW0?JU845+-A]@M:S9\\9AI`[-2I[-@)VXSYQL45&(FE=(>?6_D,C
MF50XA>@9-'QDWIQA:`33<T9!DSHQCAO1=2YR%(9.,/8[^T"CH,DY8SO*.X['
M%OF)I(TZVWV,9J'Z."%)%M_:0.W$V7["##^Y,V=P_H_SY^ACA*X?"-/0O(?>
MRC==^TBP)`ZC=[H$G@8MZ&-)Z]FS^UA![JV%V7,@?'3NP/V'3YGP\4E=MH=R
M6YY.G5<TK^()$H$/G(>_#D^WGJE\/C7\`QXN7?)#^35O#]6Y\T[E'BX-5PET
M:8N/I_!%WUSDPYF7IH?'2O+7(SQ&+.'Q1;@">-\T_?6%>``V/)A\^A\``/__
M`P!02P,$%``&``@````A`*>Q=^+!`@``&@<``!D```!X;"]W;W)K<VAE971S
M+W-H965T-#`N>&ULE)5=;YLP%(;O)^T_6+XO7^$S"JF:5-TJK=(T[>/:`0-6
M`2/;:=I_OV.<4"!=E-V0`*]?GO,><UC=OC8U>J%",MZFV+4<C&B;\9RU98I_
M_7RXB3&2BK0YJ7E+4_Q&);Y=?_ZT.G#Q+"M*%0*'5J:X4JI;VK;,*MH0:?&.
MMG"GX*(A"DY%:<M.4)+WBYK:]APGM!O"6FP<EN(:#UX4+*/W/-LWM%7&1-":
M*."7%>ODR:W)KK%KB'C>=S<9;SJPV+&:J;?>%*,F6SZ6+1=D5T/=KZY/LI-W
M?W)FW[!,<,D+98&=;4#/:T[LQ`:G]2IG4(&.'0E:I/C.76Y#;*]7?3Z_&3W(
MT7\D*W[X(EC^C;44PH8VZ0;L.'_6TL=<7X+%]MGJA[X!WP7*:4'VM?K!#U\I
M*RL%W0Z@(%W7,G^[IS*#0,'&\@+ME/$:`."(&J9W!@1"7OO?`\M5E>)%:`61
MLW!!CG94J@>F+3'*]E+QYH\1N4<K8^(=319`?[P?6+X71/$5+K8AZ@N\)XJL
M5X(?$&P:>*;LB-Z"[A*<=64+R,=P#+7^JU2H49O<:9<41QC!<@GM>5G[_F)E
MOT"FV5&S,1HX#IHHG$JVYQ)W4-@`/%!#%F/JC_MP@M-B#:?[HFDWYL*8Q!L>
MTRNVEQ03$(AL#'**[S*07@0QCY+P?7]*L#$:?Z0)IHKM)<6$$4S&C)?9M#C%
M4/_0)2^<LQE-W/<Y681.',\4VXD"MD*<O"LF;+#]KV?3XCG;+)6-T00]VTT8
MQ$&<S'*;*"+?#9)WQ80M_!\V+9ZSQ=,G;XS&Y!9'CN<E,WJ88=KE8X5A,S/*
MO,(-%27=TKJ6*.-[/7]<J'NX.HS&.Z^?;L,-&$T=*>D3$25K):II`4L=*X)D
MA!ENYD3QKA\0.ZY@*/5_*_@&47B''`O$!>?J=*+'Y_!56_\%``#__P,`4$L#
M!!0`!@`(````(0""1MS]^0(``*$(```9````>&PO=V]R:W-H965T<R]S:&5E
M=#0Q+GAM;)266V^;,!B&[R?M/R#?EX,Y1TFJ)E6W2ILT33M<.V""5<#(=IKV
MW^\SS@&<K4MOVA`>OWZ^SS9D?OO2-LXS%9+Q;H$"UT<.[0I>LFZ[0#]_/-QD
MR)&*="5I>$<7Z)5*=+O\^&&^Y^))UI0J!Q(ZN4"U4OW,\V11TY9(E_>T@SL5
M%RU1<"FVGNP%)>4PJ&T\[/N)UQ+6(9,P$]=D\*IB!;WGQ:ZEG3(A@C9$@;^L
M62^/:6UQ35Q+Q-.NOREXVT/$AC5,O0ZAR&F+V>.VXX)L&JC[)8A(<<P>+B[B
M6U8(+GFE7(CSC.AES;F7>Y"TG)<,*M!M=P2M%N@NF*USY"WG0W]^,;J7H\^.
MK/G^DV#E%]91:#8LDUZ`#>=/&GTL]5<PV+L8_3`LP#?AE+0BNT9]Y_O/E&UK
M!:L=0T&ZKEGY>D]E`0V%&!?'.JG@#0C`7Z=E>F=`0\C+\'_/2E4O4)BX<>J'
M`>#.ADKUP'0D<HJ=5+S];:#@$&5"\"$D!/O#?>SB+`[BY/\IGC$:"KPGBBSG
M@N\=V#0PI^R)WH+!#))U92'TY^^504EZS)T>-`P%6L)J/"^C*)Y[S]#"XL"L
M+AD\)=:71.B?$`_\3I)0^ECR;3D-0Q'(&<DEI]RA@)5AHA%CZ:_?(B9N,-'U
M;AI>(,@^N>'4FGEEF&QH*\XBC,-H:K^>$JD?1.F)F+A!@=>[:=AVL_MFF'AP
MRQ,,&_@T\=#8]1C(,IS$9V!B!MO^>C,-VV;GBLV*&L:8A1F.<&B938$0C]0G
M9LE[S#1LFV73B5>&,6;ZJ,86L!X#2>!'^1F8F*7O,=.P;99;9H8Q9D&0^];]
M]?@^CI+P'U[Z)3=ZA+Q].C5L>67G4V_6TC#&*\IQ/)K8[+(QD"9)&ISWZ:1C
M^7O,-&R98?ML&L:<S1C$DMS>9A,B#M,LLT^`><N8AW!/MO0K$5O62:>A%3P5
M?#>%G2K,.\9<*-X/#]L-5_!N&#[6\%.`PI/8=P&N.%?'"_T6._VX6/X!``#_
M_P,`4$L#!!0`!@`(````(0"W4(1&H0(``-L&```9````>&PO=V]R:W-H965T
M<R]S:&5E=#,W+GAM;)2576^;,!2&[R?M/UB^+Q_F(R0*J9I4W2JMTC3MX]H!
M$ZP"1K;3M/]^QW::`MFZ[";!\/CE?8^/S?+ZN6W0$Y.*BR['H1=@Q+I"E+S;
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MX3/CNUK#:B<0R.1:E"^W3!504)#Q2&*4"M&``?A%+3>=`06AS_;_P$M=YSA*
MO6061"'@:,N4ON-&$J-BK[1H?SDH/$HY$7(4B<#]\3GQ2):$2?IO%=\YL@%O
MJ::KI10'!$T#[U0]-2T8+D#9)(N@/G].!I',G!LSR4X%6L%J/*UB$B_])RAA
M<636YPP9$YMS(@I.B`_^3B8A^M#D^^8,#"$P&IA+3KHVP-HQ\8"9$)OWB)$W
M>-'EW@R<8]`^>2-D4I:U8S);UC2+HS@.Q^XW0R*9DS3X6]T@X.7>##SU%HW?
MO'9,8KV1B"1I.AL3FS$19"1ZTQC5#1K_<F\&GGJ;-IQCG#>H613%V<3;D"`S
MV#6#VH^\I?_CS<!3;Y-N6CO&K6D8)1F)DW1B;H0$\WDZR]Y4G#MW/KGMV],=
M>Z!RQSN%&E9!/P7>#`)*=SJY@1:]W:9;H>%4L9<U?$08[.'``[@20K\.S/EW
M^BRM?@,``/__`P!02P,$%``&``@````A`#"3@"%3`P``N`D``!D```!X;"]W
M;W)K<VAE971S+W-H965T,S8N>&ULE);;CMHP$(;O*_4=HMPOP3D'`:N%L.U*
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M[`<TVT2VLYPW^?E%R4GT?EOBP$Z?.,V_T(I`LJ%,J@!;QIX5^I2K)=CLC'8_
M-@7XQJV<[/"QD-_9Z3.A^X.$:@=@2/F:Y6\I$1DD%&0F;J"4,E9``/!IE51U
M!B0$OS;?)YK+P\+VPDD033T$N+4E0CY2)6E;V5%(5O[6$#I+:1'W+`([SB+(
MG;AQ@(+PMHJC(VH,IECBY9RSDP5-`_<4-58MB&:@W#K3<71>_V45/"J1!Z6R
ML"/;`A<"RO.R]%UW[KQ`3K,SLQHS46@BZQ91&52Z:;MPT47FEDU+J/*!I<X7
M9*OOZ^^5:L-7L`J_O>]*+X!VYV?@9CTFHL@,+1TC`Y'-F.B)&'8\TXXJDP=M
M?-V6V@1<SX7O>F:0*\WX/28PB?5-(KU);*X1AD\(I%^V]_E4FQ8V)/-2+31(
M]4HS0=.;R(^".(H'K;0V$"^,7=]/S%RD!N*';IAX@X1N#,0+/-_S_$[%\`J/
M6]_K]5HJV*REBP:W7FD&`NCR,*SE32*]26RN$8:_\'_\*7A8PTO>FM-@I1E=
MPS`*I\D`6/<!Y$9A@`8G3-HG8G@:I@.)31]`R$L"_Y)#PQT<=OWJO:]3U::A
MRXN^=JF9<Z<&ON?'T0!9&XB?!'$2#I#40`(_3%QO<#[!P%3!M(]$&'EQ=.EW
M[55/1#TP2L+W9$V*0E@9.ZIIY\'3U*UV@_C!5>?H8'V%9G"ZC]=3&-S-NM-M
M@,%9XSWYBOF>5L(JR`YN-9U$T'=<CUY](5G=C*\MDS`RFY\'>$,B,#>F$X!W
MC,GV0DV'[IUK^0<``/__`P!02P,$%``&``@````A`'$`44J_`@``^`8``!D`
M``!X;"]W;W)K<VAE971S+W-H965T,S4N>&ULE)5=;YLP%(;O)^T_6+XO7X&0
MHI"J">E6J9.F:1_7#ABP"AC93M/^^QWCP`*L:W>3!.<]C\][SK%9WSS7%7JB
M0C+>Q-BU'(QHD_*,-46,?WR_NUIA)!5I,E+QAL;XA4I\L_GX87WBXE&6E"H$
MA$;&N%2JC6Q;IB6MB;1X2QOX)^>B)@H>16'+5E"2=4%U97N.L[1KPAIL")%X
M#X/G.4MIPM-C31ME(()61$'^LF2M[&EU^AY<3<3CL;U*>=T"XL`JIEXZ*$9U
M&MT7#1?D4('O9]<G:<_N'F;XFJ6"2YXK"W"V273N^=J^MH&T66<,'.BR(T'S
M&-^ZT=[']F;=U><GHR=Y\1O)DI\^"98]L(9"L:%-N@$'SA^U]#[32Q!LSZ+O
MN@9\%2BC.3E6ZAL_?::L*!5T.P!#VE>4O214IE!0P%A>H$DIKR`!^$0UTY,!
M!2'/W?>)9:J,\6)I!:&S<$&.#E2J.Z:1&*5'J7C]RXC<,\I`O#,$(LX0U[.\
M5>`&R[<IMLFH,Y@0139KP4\(A@;VE"W1(^A&0.Z=F3P&KZ]9!8\:<JLI,0XQ
M`A<2VO.T\3UG;3]!3=.S9CO7A,NQ9-=+=`4U-^D7_G#=<<B^5^CV@:7!%U3K
MTM??.]6GK\4Z_7[?K5D`]N#'&^^[FRO"<"Q)YI()9#]77$!&=A;_8T>+8<0N
MLW>"<7);H_$O-!/%[DU%\J9B_R_%R!\D<MDN/8;^JP>L;YL.BC$4<>B2[TWF
M8VLT03>3KN==+R==VAF!WPDF(YN,@MU5Z$UJ!'>.SL#05RLO7`U5-N[,C6(.
M7$U%07>TJB1*^5'?%@O8=%@=+K);3\_A9'WK1G`ZYNL)7'S=NCT$P,73DH)^
M(:)@C405S6$KQPJAG,)<7>9!\;8[_@>NX,KI?I;PAJ%P[AP+Q#GGJG_0IVMX
M9VU^`P``__\#`%!+`P04``8`"````"$`>SY+@1H#```O"0``&0```'AL+W=O
M<FMS:&5E=',O<VAE970S,2YX;6R<5EUOVC`4?9^T_V#YO?F$!!"A*D3=*FW2
M-.WCV20.L9K$D6U*^^]W'9,4#*5T/,2Q?7Q\[KD7._/;Y[I"3U1(QIL$^XZ'
M$6TRGK-FD^#?O^YO)AA)19J<5+RA"7ZA$M\N/G^:[[AXE"6E"@%#(Q-<*M7.
M7%=F):V)='A+&Y@IN*B)@J[8N+(5E.3=HKIR`\^+W)JP!AN&F;B&@Q<%RVC*
MLVU-&V5(!*V(`OVR9*WLV>KL&KJ:B,=M>Y/QN@6*-:N8>NE(,:JSV<.FX8*L
M*XC[V1^1K.?N.B?T-<L$E[Q0#M"Y1NAIS%-WZ@+38IXSB$#;C@0M$GSGS](8
MNXMYY\\?1G?RX!W)DN^^")9_8PT%LR%-.@%KSA\U]"'70[#8/5E]WR7@AT`Y
M+<BV4C_Y[BMEFU)!ML<0D(YKEK^D5&9@*-`XP5@S9;P"`?!$-=.5`8:0YZ[=
ML5R5"0XC9QQ[H0]PM*92W3--B5&VE8K7?PW(WU,9DF!/`NV>Q`^<8#+VQ]$'
M6,(]"[3_+V6T)X&V)P'ME^-PC2>=Q2E19#$7?(>@;&&E;(G^$_@S(.R]-4X,
M;K]E-KBL2>XT2X)CC,!'"07RM`CC\=Q]@JQF>\SR%!,<(U8&`<^!Q4*DIXC0
M&TA<"&F("_)DQQ5"Y9VOF3X,O4B'H6M(Q[6T!U9FX%!B&$>#@FY1>@X3#Y@C
ME5`'MLK1FY7=J]2+H(8/;`KCR<!OA!L,)'2PTDK'ZEU$>@EQ%`5L<QC%98\U
M.,'@T:`LC*>6>H.9=(7D3^'G1Q9D=009G8.DAY"QU_V&?8[T@^/7Z]=@2__D
MM0:-^P8SZO1'4UOZQ=FTGWWUYS5S1ZJCCZC68%NU/[AA5!N,47T31%9)K2Y/
MI_WTN[KAE+C>;0VV=5N'PM)@#JHE\JR$K(X@NEI.('"!Z9T,R_EJ,1>4.3UK
M*C9T1:M*HHQO]>430+:'T>%>O`OT86*-+_T9G"SZRALFX+YJR89^)V+#&HDJ
M6@"EY\10#<+<>*:C>-N=V6NNX*;J7DOX,*%P6'D.@`O.5=_1&PR?.HM_````
M__\#`%!+`P04``8`"````"$`)M(I.F0$``!7%```&0```'AL+W=O<FMS:&5E
M=',O<VAE970S,BYX;6R<F-N.HS@0AN]'VG=`W$_`D`.)DHPF:?7N2#/2:+2'
M:P).@AHPPG2G^^VW[*+3V&$+LKGH#LGGXG?]=A7Q^LMKD3LOO):9*#<NF_BN
MP\M$I%EYVKA__?GX.7(=V<1E&N>BY!OWC4OWR_:W3^N+J)_DF?/&@0BEW+CG
MIJE6GB>3,R]B.1$5+^&;HZB+N('+^N3)JN9QJ@<5N1?X_MPKXJQT,<*J'A-#
M'(]9PA]$\ESPLL$@-<_C!O3+<U;)]VA%,B9<$==/S]7G1!05A#AD>=:\Z:"N
M4R2K;Z=2U/$AAWF_LFF<O,?6%S?ABRRIA13'9@+A/!1Z.^>EM_0@TG:=9C`#
ME7:GYL>-^Y6M]L'"];9KG:"_,WZ1G?>./(O+[W66?L]*#MD&GY0#!R&>%/HM
M51_!8.]F]*-VX&?MI/P8/^?-+W'Y@V>G<P-VSV!&:F*K].V!RP0R"F$FP4Q%
M2D0.`N"O4V1J:4!&XE?]_Y*ES7GCAO/);.&'#'#GP&7SF*F0KI,\RT84_R#$
MVE`8)&B#A*"^_3Z8!-&,S>;#43Q4I"?X$#?Q=EV+BP.K!NXIJUBM0;:"R&IF
MT_^<&4Q)C?FJ!NFA0$NPXV4;1N':>X$4)BVSNV4"D]C?$J%_13S0=Q4)4[]?
MI!H$B7:=CLCI-;Z>R`Z9:8>9F<2>(@R-<*.NQOZE\9Y`!6]<B/VAS<X?(I'.
M+EO":^Y_9$>KWR/2K][0!DA7VSB3U2!+8V1E9X=,OP+42!&&1EAT]VM4@X8\
M1H;22!&&QKFID?98P5;^;(\1F:''TUZ/$>E7;VA;W*--P9:V:&ZN_!TR_7=&
M;RG"T*;ZX-U%1@T:\A892B-%&!J7ID;:6P5;^;.]183T%I%^]88V!AW+3F`(
MG]$B]2A+9;2P7&ZA?A%H,XF8.O]?-\%&`-7LHQI&=J5F")$Z*<34J:IZ9T$.
MY!%[0+=:L\72SB-"Z/=TJ?KR/#*9/>LRX328SV<^NS*F0E7;.PI5R1[A.':$
MKM(PLE3L&-4V6L<IQ-0)AM@Z1SP_J%%#>YLA1#I.(:9.J[T,.(X=P<BCO;_5
M\Q_,`0V?^?IU];)-X^C&PN[J+)JV-_;-@J0Z1ZN/0LST6=UEW!,$PP8!BXG:
MV%07:752B*G3ZC0#-F-SH&U&AK1Y=(]A=S4935LV+ZUGP%T+D;MD=)\)>OK,
M\&[6HX9V<PM1.DG$L#FP^@QMLZ;-/-[6[Q8BZ[?!T/4[4*7^[OJM1YE*PX7]
M7-9"9";5W>&'7&?C?3RYFYE4E=[2.<)Q[`_TQ@X0ZA>!&YM$3)T0IJMSP'%%
M6WFTZW>`#!K.^A^^6Z9_"J:^N_J+^KUNZUO83V8MU'_S-G^C&TQ@-9AQ!5R/
M&MS95!=I=5*(F4>KT0SXC(V!+.!P+J1RC3^D^_MTB_1G&N7AT1">G%3QB?^(
MZU-62B?G1^AM_F0!3M1X,(07C:CT"<E!-'"@H]^>X0"/P_&)/P'X*$3S?J&.
MGJY'@MM_`0``__\#`%!+`P04``8`"````"$`O3/?D5P'``!8*@``&0```'AL
M+W=O<FMS:&5E=',O<VAE970S,RYX;6R<FEF3HD@0Q]\W8K^#X?LH"(@8;6\,
M<A\1&QM[/-.*+3$J!M#3,]]^LRA0*W$J[7[Q2'Z55%7^ZR"IIS]^'`^C[WE5
M%^5I-58GRGB4GS;EMCB]KL;__.U]68Q'=9.=MMFA/.6K\<^\'O_Q_/MO3^]E
M]:W>YWDS`@^G>C7>-\UY.9W6FWU^S.I)><Y/<&575L>L@;_5Z[0^5WFV;0L=
M#].9HLRGQZPXC;F'9?6(CW*W*S:Y4V[>COFIX4ZJ_)`U4/]Z7YSKWMMQ\XB[
M8U9]>SM_V93',[AX*0Y%\[-U.AX=-\OP]516V<L!VOU#U;--[[O],W!_+#95
M69>[9@+NIKRBPS9;4VL*GIZ?M@6T@'7[J,IWJ_%7=9FJUGCZ_-1VT+]%_E[?
M_![5^_+=KXIM4IQRZ&V($XO`2UE^8VBX928H/!V4]MH(_%F-MODN>SLT?Y7O
M05Z\[AL(MP$M8@U;;G\Z>;V!'@4WDYG!/&W*`U0`/D?'@DD#>B3[T7Z_%]MF
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MO,9#`E<MZ6_\RZJE/0%5FT(0+Y$$>0F1O#^!]`%C-`M8WT"[-UQO/$/!&1*F
M*2+.$$%.W"&!G7@<@69>`HB<^"01D$1($A%)Q$-",Q6Q2Y(A@UJ3R@@APC`\
MA0BSL:K!@B./-"LE1!H;UMC@8(.+#1XWW,9(LU"[_`>8X!ZCB3T8/L!$#S#Q
M/<80[Y7<8]`DE=YCK@-!B!BLA$+$Y)%BM!`I;%AC@X,-+C9XW,"7>S:E^M@0
M](;K>-,L7>R7L&?ZZ2+"AA@;$FQ(;PQ")\'B)7328[)FI4#^-[.$9BW$6MN<
M@?M>9A(4[S5)."3ADH1'$CY)!"01DD1$$C%))"21R@@A\+!)^T3@6:G5&";-
M2U`URT*!Y\RBVX@HAHF4L1:`^6*NH$G'N054U9IK<[28NR)AS*T9JH7'"8G\
M?)((2"(DB8@D8I)(2"*5$4+889<X"/N<7,98*3'LNH+66ILS1AMV4\&7U_RR
M)![.K0,55C0=W<$E77@DX9-$0!(A240D$9-$0A*IC!""SM(5^#F##CHKA8..
MQJ'-&4E4UR3AD(1+$EY/L(<?)!N?7^/"U!20ICA?!;?7+6V.5JE0XCKJKUVG
M0U0Z)HF$)%(9(<39NA-G'58$^<Z'E<)Q1MM)FS.R.).$0Q(N27@DX0\)':\O
MP9!!80M)(AH2@_O$0P;=)QD2NH*V?^D]YKIB"@)0828?C'1:`6TQ+`%45;N#
M^#C2(5$YG.,[1"(3A_;BTEX\&O%I)*"1D$8B&HEI)*&15(J(,F!IBH]/^"K/
M;MSN[B!I)\Z6=@=)8KRF$><.HBO7Y[@V_^3>@9`H/1KQ:22@D9!&(AJ):22A
MD52*B$)@Z8U/"(%G140AH%V\S5*JL&Y(A4`B3N>%SRHS0S<U98&V\J[`Z(IE
M++3K_-=*Q:,KX]-(0",AC40T$M-(0B.I%!%UP-(FMSJ0[PA8+GJP)4!1L3N(
M1TXU#17%9"T""T4W380X(J*9\!B'5C]70&:6-IOKJ"9>ATB4Z--(0",AC40T
M$M-(0B.I%!&##QTC!/^Q'(_*BJ%-@8KVSG8'2;I^32,.C;@TXM&(3R,!C80T
M$M%(W"'=^-$TTT323V@GJ1015<`R0[=3`%,!_1#(WH8.5("?`CM(J@)98JI[
MW<01WB'P(*98@PT!Z<2CJ^+32$`C(8U$-!+32$(CJ1015<`215@%[`TFL2#P
M_)*P(5#Q,Z+*(:O-`*G:Q$!Z7G>`1"8.Y<.E?7@TXM-(0",AC40T$M-(0B.I
M%!$EP-)&6`(/3`0\VR1*`*WGMLHAGON=J8N[#XFRM%4W$]!NW.Y6$C%Y-.+3
M2$`C(8U$-!+32$(CJ101A<#R2E@(#\P%/!TE"@$-=5N5Y:S:(*]IQ+F#Z"IZ
M!'3O0`CQ:,2GD8!&0AJ):"2FD81&4BDB"H%EF+`0'L@:\<24*(1!NF"8O4+1
M6<,!+^)!TKF#Z.I@=T#Z\>[X0;7Q:22@D9!&(AJ):22A$7:`[M?]RX7`#\CQ
MLTG'O'K-U_GA4(\VY1L[_,96](OU<C#OJ\[.KR"[K2[A'-'0[JA+."PTM/OJ
M$H[[#.T)._AWQV[/EO:]^ZYG2W@_/_3CS);PFGYH=V=+>%L/]NFE`7"N[YR]
MYFE6O1:G>G3(=]!T9<(FQ(J?#.1_FO+<GMQZ*1LXT=?^W,,)SAQ>[RL3@'=E
MV?1_V`TN9T*?_P<``/__`P!02P,$%``&``@````A`'5!@+BS`P``0`T``!D`
M``!X;"]W;W)K<VAE971S+W-H965T,S0N>&ULE%==CZ)*$'V_R?X'TN\#-(*(
M43<C[.QNLIML-OOQC-`J&:`)W8XS__Y6T8HT[H#ZH'R<.M0Y54V7BX^O16Z\
ML%IDO%P2:MK$8&7"TZS<+<GO7T\/,V((&9=IG/.2+<D;$^3CZL-_BR.OG\6>
M,6D`0RF69"]E-;<LD>Q9$0N35ZR$.UM>%[&$TWIGB:IF<=H$%;GEV/;4*N*L
M)(IA7M_"P;?;+&$13PX%*Z4BJ5D>2\A?[+-*G-F*Y!:Z(JZ?#]5#PHL**#99
MGLFWAI0813+_NBMY'6]RT/U*W3@Y<S<G5_1%EM1<\*TT@<Y2B5YK#JS``J;5
M(LU``=INU&R[)(]T'E&'6*M%8]"?C!U%Y]@0>W[\7&?IMZQDX#;4"2NPX?P9
MH5]3O`3!UE7T4U.!'[61LFU\R.5/?OS"LMU>0KD]4(3"YNE;Q$0"C@*-Z7C(
ME/`<$H!OH\BP-<"1^+7Y/6:IW"_)9&IZOCVA`#<V3,BG#"F)D1R$Y,5?!:(G
M*D7BG$C@]T1"/=-U/']V#\ODQ.)>6!S3F7G4FX[G8BE=C4U1+./5HN9'`WH/
M,A=5C)U,Y\",_KB@3*EI'7O/,'`*21Z194E\8D"X@"J_K%PZ6U@O4)GDA%DK
M#'RW&'^J0\)K&JHCHC,":PX*6AE@;5?&O\M[SA;!F"V6&]-?JPO=U!S]N>$H
M(KI&^'Y+HN4*A>SFBI;[[[;D.6<,@N;KN.?2H.57,A0&JM@Z[.F(<!01#2$T
M%?"8KHIAQQ&\)&!1FQD-)GIN:X7QG:9];-.;.#.[\^E+N0\>]>&^%W0_ET[4
M1$)9;A>)X+Y(MR=282"9U@C7[AD1WH")AC&:AND]&A#<U]!S?JTPYT+I`L.A
MF]$[-[5TX25RN^4(UM.=!)=2JE6A,%W+>X+"440TA-"RQ[FA]SH=7]L8-+:V
M%69(Q2@B&D)H*@)=Q?#:1K!>`QKT7I]KA3FU##6=[M*#XT\/O8"P%T#UU7H=
M$&D!4Y-VWAQPZ'YZN*PR32J%D:);L6&M#5H7.PDNKWG5<"?04*W&(=$@1)>`
MF^+=34?55CJ\HYQ`@U(4SP`D&F31I>`NVI$R4@VUY^K;2J^3UC!=8G^VO3>9
MZ<UWW7MW1^`$VWF&;^K-9]/K[E,#JYK$"E;O6,CR7!@)/^`PBGM@>[4=E!^;
M.;EW/<0!NAF!VQLPOU;QCGV/ZUU6"B-G6Z"T37P/U6H"5B>25\W\M^$2)M?F
M<`__5!A,1+#]$F/+N3R?X+S5_O=9_0\``/__`P!02P,$%``&``@````A``*E
MC_]P`@``QP4``!D```!X;"]W;W)K<VAE971S+W-H965T-#(N>&ULC%1;;YLP
M%'Z?M/]@^;T8"&G2**1*5W6KM$G3M,NS8PY@!6-D.TW[[W>,$R]=LRDO@.'S
M=SD^A^7ML^K($Q@K=5_2+$DI@5[H2O9-27]\?[B:4V(=[RO>Z1Y*^@*6WJ[>
MOUONM=G:%L`19.AM25OGA@5C5K2@N$WT`#U^J;51W.'2-,P.!G@U;E(=R]/T
MFBDN>QH8%N82#EW74L"]%CL%O0LD!CKNT+]MY6"/;$I<0J>XV>Z&*Z'5@!0;
MV4GW,I)2HL3BL>FUX9L.<S]G!1='[G'QAEY)8;35M4N0C@6C;S/?L!N&3*ME
M)3&!+SLQ4)=TG2WNII2MEF-]?DK8VY-G8EN]_VAD]5GV@,7&8_('L-%ZZZ&/
ME7^%F]F;W0_C`7PUI(*:[SKW3>\_@6Q:AZ<]Q4`^UZ)ZN0<KL*!(D^2C#:$[
M-(!7HJ3O#"P(?Q[O>UFYMJ23ZV0Z2R<9PLD&K'N0GI(2L;-.JU\!E'E3D20_
MD.#]0))-DR*?SN87L+#@:`QXSQU?+8W>$VP:U+0#]RV8+9#YF"SXB%G_%17M
M>9*U9RGIC!),8?%XGE9%,5NR)ZRI.&#N`@:O$9-%!$,WT1+:.+5TOLA'90_V
MRKY2WLI=>'$JDY^7F;R6\<DGV!G_E_.;$'<2(I__X0\.`J8XP4S/.T#(Y4$]
MN*28+I:O*.:1-R@'S'P\@#1^>U5<[+?+-3WX;\V;R!LT`^:\9ABHT&\*3`,?
MH.LL$7KGAR5#G_%MG.-U/HYB_(!S-/`&OG#3R-Z2#FK<FB8SU#5A$L/"Z6'L
MYHUV.$'C8XL_3,">2!,$UUJ[X\+/>OP%KWX#``#__P,`4$L#!!0`!@`(````
M(0`8%G9R+`,```X*```9````>&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;)16
M76^;,!1]G[3_8/F]?`5"&H54#:A;I4V:IGT\.V""5<#(=IKVW^\:!P2DHVD>
M0B#'AW/.O?BRN7NI2O1,A62\CK!K.1C1.N49JP\1_OWKX6:%D52DSDC):QKA
M5RKQW?;SI\V)BR=94*H0,-0RPH52S=JV95K0BDB+-[2&?W(N*J+@5!QLV0A*
MLG915=J>XRSMBK`:&X:UN(:#YSE+:<+38T5K94@$+8D"_;)@C>S8JO0:NHJ(
MIV-SD_*J`8H]*YEZ;4DQJM+UXZ'F@NQ+\/WB^B3MN-N3"_J*I8)+GBL+Z&PC
M]-+SK7UK`]-VDS%PH&-'@N81OG?7R0K;VTV;SQ]&3W+P&\F"G[X(EGUC-86P
MH4RZ`'O.GS3T,=.78+%]L?JA+<`/@3*:DV.I?O+35\H.A8)J!V!(^UIGKPF5
M*00*-)87:*:4ER``OE'%=&=`(.2E/9Y8IHH(+Y96$#H+%^!H3Z5Z8)H2H_0H
M%:_^&I![IC(DWID$CF<2-[!\+PA7'V%9G%G@V+$`X942_/-B./:+K_5AFTS:
MB!.BR'8C^`E!VX)KV1#]$+AK(-;9+J!")HD^[?^%#2EKDGO-$N$0(U@NH4&>
MMW[@;.QGJ&IZQNP,!KX'&'>,B2]YPN48DG00W3'@H3<".0Z-O-T<G5X-UGIU
MLV@#.W-A+,X;WSF^Q"S"B<GD$N,'BYYG)!AZ8"BX2WY>N%X48;C+($2_YS=>
M#`:*V6.",2)^%Y',(48NX#8?=Z$709\-%/K!1./.8.9<O(M(YA`C%[`/#%W,
MUT"#IS68=.G.8(;J_<7$87R)F2"2.<1(__(C^C5XJC\<=\C.8%;MH^P%COZ,
M$;%!#!U.U<\A1NIAWQBF?]V3H!=-7:S&&G<&,Z,Q?A>1&$1@DH#!/TQBY$*_
M;;RQD\[WDEXT=7$[<6$P<RX,PE3+%&M2+1C/^CX&X8:3@AH;9OZ:X5!1<:`Q
M+4N)4G[4L]6#`/JK_=B_]_06.KD>P^M`.SSM_@\8QPTYT.]$'%@M44ESH'2L
M$!I<F(%N3A1OVI&TYPH&<?NS@/<N"ENT8P$XYUQU)WH`]&]RVW\```#__P,`
M4$L#!!0`!@`(````(0!I7N<\!00``!80```9````>&PO=V]R:W-H965T<R]S
M:&5E=#0T+GAM;)2748^;.!#'WT^Z[X!X+\1`((F25$M@VTIW4E6U=\\$G`0M
M8(2=S>ZWOS%."#9[=OJ27>`W?_R?,3"S_OQ65]8K[FA)FHV-G)EMX28G1=D<
M-_:OG\^?%K9%6=84644:O+'?,;4_;__\8WTAW0L]8<PL4&CHQCXQUJY<E^8G
M7&?4(2UNX,J!='7&X+`[NK3M<%;T077E>K-9Z-99V=A"8=4]HD$.AS+'"<G/
M-6Z8$.EPE3%8/SV5+;VIU?DC<G76O9S;3SFI6Y#8EU7)WGM1VZKSU;=C0[IL
M7X'O-Q1D^4V[/YC(UV7>$4H.S`$Y5RQTZGGI+EU0VJZ+$ASPM%L=/FSL)[1*
M46"[VW6?H']*?*&C_RUZ(I<O75G\5388L@UUXA78$_+"T6\%/P7![B3ZN:_`
M]\XJ\"$[5^P'N7S%Y?'$H-QS<,2-K8KW!-,<,@HRCC?G2CFI8`'P:]4EWQJ0
MD>RM_WLI"W;:V'[HS*.9CP"W]IBRYY)+VE9^IHS4_PH(7:6$B'<5@8BK"/(<
M;S%'\]"LXHH5]0:3C&7;=4<N%NP:N"=M,[X'T0J4;\[$.@:O_V<5/'*1)ZZR
ML2/;`A<4ZO.Z#<+9VGV%G.97)IXR42@CNQO",\AUD]N)NRZ20](;P<L'E@9?
MD*VQKX\K=5L^A_GR;_>-Q0G0'OQX\GUW4R**9"29(HI(.B5&(I(=7[;#R^3#
M-M;;XD'`C5P$H9*_6##!B)G+-G9&(C$2J8Z0?,)"'B\;AS<V)'&H4A`J*8X%
MLQ![$AXW?Z[Z&Q->%(5HN90SD(P)M%A$7N`K(ND86:`@\A;WA4@&X1D;&WRL
MD#Q(->K+BXP%$WF]TYD3R)=WRF5?>?02]?I"CD_5Z_?-+MD+I_8""-7O4QZD
MVE/6'PL&TCS46BG!SD@D1B+5$9)/>-7]?AEYD.EY%(S.IY%(C$2J(R2?O(,9
M?1[T=>2P6D>E2K%@=/Z,1#(E@E#9S^F4N:]$<KB4'?(',C2^67F0ZO3^1/3?
MKE@P.J=&(C$2J8Z0?"(P-2[E8V^>/LJT9Z^0SJH92<Q(JD5DM[PO>'CC(M%%
MR%^2^WX1];Q"6I="1X,D'Z@$H?JR_0"ZKT;VR5N(D<\'JRH:#]FO\M6+D8`T
M9G9F)#$CJ1:1W?(^XO?=BNX#?H=OQ[0/0KH6I=\`.S.2F)%4B\AN(?5CM_J7
M+\P_DW=2-.G!!:2MJ1%)KK<23947A'-HFR9;6"<C;(IQ2TPC->Z.>(>KBEHY
M.?-1RH=&9C@[C'E/'F_2E?,Q6L'H,#V?\+&0GW>'`)C*VNR(_\ZZ8]E0J\('
MN-7,B:!'Z<1<)PX8:?O9:$\8S&/]OR>8OS$,)3,'X`,A[';`;S!,]-O_````
M__\#`%!+`P04``8`"````"$`*O#0<AL,``!`<0``#0```'AL+W-T>6QE<RYX
M;6SL76V/XL@1_AXI_\'R)E%.RBQ@S`!SPYQVV'&RTF9SNILHD7)19,#,^-8O
MQ)C=F8ORWU/5?JO&V&Y#FYZ1<NAVP-!53SU575W=[9?K[YY\3_OB1%LW#&;Z
MX&U?UYQ@&:[<X&&F__7>NICHVC:V@Y7MA8$STY^=K?[=S:]_=;V-GSWGQT?'
MB340$6QG^F,<;ZYZO>WRT?'M[=MPXP3PS3J,?#N&C]%#;[N)''NUQ4:^US/Z
M_<N>;[N!GDBX\I<B0GP[^KS;7"Q#?V/'[L+UW/B9R=(U?WGUX2$((WOA`=2G
M@6DO,]GL0TF\[RZC<!NNX[<@KA>NU^[2*:.<]J8]D'1S'>Q\RX^WVC+<!?%,
M-_)#6O+-A]5,O]2UQ.1YN`(0O_OW+HR__4WRY\T?WKSI_^N;;__Q@[/ZYT^_
M+W_WTS=Z+U-#9((/ZF6^[=>*A:\3R;W4@IOK=1@00PR@"=FZ^AR$7P,+OX-@
M`//P9S?7VU^T+[8'1P8(;QEZ8:3%X&6PCQT);-])?C&W/7<1N?BSM>V[WG-R
MV,`#+##2W_DNN`D/]A(-Y]6S0#2931.$P=DTQ"/4)A],LO%@O4WVSP=LXG2-
MFG6=PA^GBUE1;Y<T7>6X*'%XBJ[<5T1/]+"8Z98%.630[R.MU&$=*9O.^Z#O
M;,HN1V>S;&@-K;%4R[A8+/L-%0XMF50V*+3>C=^?C4[YRJJL2]/PN7H`=CBY
M++K0=6OZ]]C"USGBY,P#6C<>8U*YI,^Z7I$;[UW?V6J?G*_:#Z%O!T@L'=38
MK[DQF0L\^>)SUS>*/JVTX,*L45<+EAA96V#1];R\,AR.L':"(S?74*3&3A18
M\$%+W]\_;Z!R"J">1OI[R>\:?OT0V<\#@]4/8@VVH>>N$,7#G-5KZ7@YO[RS
MYG=,+T$FBJ)"J&7-QQT(O;N=SN4CG4^GLH4:%KPD"WTWPI=DH1;\-Y?&:9HQ
M35D@<WE:[.+\JO]V/)U.)X/+R60R-8<#TV0D+]*(=H.5\^3@E$L:364$(T`P
M'4ZFEP8`Z9L3INJL"(8`8#P:34:#J6'"_RQ%=X]`-J<C7;57"0)%7B4(%'F5
ME?@]"9D_[2FPVJ&XKQ($BKQ*$"CRZEAR!AXK]RI!H,BK!($BK[*%*8E]%581
M%?=5@D"15PD"15Z55GRF&7BJW*L$@2*O$@3G]FHVK9K?W5ELF:)<F4FKCU-=
M6,2WU\5FC3!/7831"K9[LCV,`<Y4DV,WUYZSCF%&&KD/C_@W#C?P[R*,8]@<
MN;E>N?9#&-@>O.UE+;*_-2UA^PAVBF9Z_.@N/X,R;G4BX291T96&/.N9.)LP
MQV9_;(Z,RV3")DFU[ZS<G5^V+M=],"Z!1N2VV7#"89`K2<.A6"'KH1=2]PFV
M8*YFGA9L`#&1A81@"QDV%JO%HC:2%F(VD@:"-I(6HC9"USG4N3(F5^$.=B[W
M'6Q9DWX_69@3U5,OD``_$#&'09`V93X;FQQ@M+%-6ULAOY3ZQJV!+U8='["T
MH479SH8&!ZQL:"%J(Q\WF7<YX?G2!:;G`TCV^.9^?AP,4)0TS/#L)<$T/^&&
M0;)E()SN>'-+>O9,D:5'V`S"+F!K-RP>HT2XS7%^S,0WTMIL=UH70)FQ=#SO
M1QSX_[[.:PU8OKNY?EJ3$QO@;!/<^<?S)O`MK)&G;Y.Z(OD`'%<U@O,6*AII
M]F;C/7_:^0LGLM@I*$P%.VJ!GN+3+2N(BL_O//<A\!VV`*DG8KZ/PMA9QNP4
M&;9W4(5G6(%GD`H2P7.*?K-"/_`DS,<I^F&!ZZ`_@!>E^B&XA/7+C`<\&2@-
M:G`!#>HZ/#(1P#)&A@"<H`(!GKR4<@#AJ0(!3`\S!!"@!0*`4Q,5I_2#`<EF
M$`.%2M#?E4K(,9F5G,H.K:Q*OZ"_QDJ+2[\GT4SR+01Z03-\J`%PDLJJ%*LJ
MQ1"W0T\K*(`/-118,.K*&?)@`2&/.^"@`*",$))T.4"0!NH8D1>5).>"3E%&
M;B76(20H,!6IA@!PE$`@CA@H&G\'%(.B$9A&@Z(AF$+@QN#Z+"&U3U!/<".D
M(@R`1TFO*/+U@!LQSD@#@:`J0Y)H,%2E2(I!58XL7&&H2I$$@JH,23VA*D52
M#*IR)'&%JA1)(``C2C(D]82J%$DQJ,J1A2N&JE(D@:`J0Q)/##M.D3VZ;)HL
MHI+UT_'PJ/53[6G=N)`ZJ)HT@=^SYLGL*9DY@B_87(I,I?%R,3M;.]4>P\C]
M!2:9>-G8$A93G4C'RPQC=TF/?(WLS;WS!%/19'_K:5V]U@M(LO6-_6#D$59B
M*O3#2K:NM5$NG9\3L)Q.1*/EN*[2N"Z_%QC\VG9C@#1B8`L+JD$@URD&Z2$@
MJ8M@SU5-$PR2RC%05\&`*98K+&`.DT]#-CNAM^(<2RJ6QHY#B#A#JI"J[;7R
MC#-(94X>R([V-A$F7?FAK-@*$.EOP_WI)%\H\)W?8@O`C:F`XL-S2EK6$1VC
M:V2*C.PT,S4P=7AL/YD_=H;-RR*0NO=4>/L+"2\K^CI`UQA]9+#@HH_#@CL6
MXE1E2\1==-RJSM(`MWUO.<H(J>%Y!M)/Q<LE<[@5R0L/D@:XKR1(&JRH&P(Z
M#6HZ.ZRL0<I!+<+Z4;BS-8Y6*?#_A1L=$*K8P*W;NO%`O;_*<<;WBQ>`4!:'
MK>*;%KO<F-EJA*]<SSNF5A,:TDOP1-+&$?,'N2-B"34?A#R^HT)2<+Y3Q3$_
MEI3@MB?Y*"->&^FGXN4ZWLLOFQK@OI(@:;!">L\\,4B@+R[8Z6?IZ?=UPZU0
M.A;,%$)5W%&)0@AE6K3!!0:]TLZ3$+3RP"\2GT>EK3JLP-`ZVZ6HJJ)*+/(Q
M>#)?(ABZK.0..E$(5`,S77H+\:7GQL/;H@N6XTHZ"E21!PTMU+A1NL2-2'SS
ME4:;R&JW)RN.FH_U+O%5TLJ-"*^&UGK4YZ/UN&`]"I^D/:B&%?6CH-$)3[;@
M\$K@I@6*)+00#D6R+'4FGENA_//S;AN[Z^>7NQ=1+J@TO/]9LGM]_-@'R;ZN
MUCMEU#D^EW><=+JA4FH4GM!-,%-V7U*T<RZI2;M(BZW6I#K&0E-T.=#:=-0N
MF*+H7OZ4,<]PR;T(2U,T#/5LVG/&6K#LUAPHN^MYPUQ2'&E'M789_\&PY";`
M%'1]>E8+FH8$Z>EPN*@7!F"`ND&/3A"J<C4<YP$>)K6RLCF4$-FIQ7`R,;DU
M`W]CAOS48PWO%@U/M^C_5KO0WBVQT,PW6W&K;;%S/;B1'"X5X6GA2RB=0O\V
M.9B>R%LG*]^),'"F262!6]K*RLL7`R\5(+(@7MO*RJ-B"-8267#7BM:RX/*-
MQ(%P(VA.%IRLV187-$EE\=R/!+DW#_F17?)$^`*317!1684?,2$066!R6UF%
M'\%Q5!:8W%96X4=`2&29H*2MK,*/X`4J"\*MK:S<CR8XCL@:"7)_>="/?*SB
M]0DBN*BLPH]\K`X%8Y7**OS(QRJ:W!97X4>02O@RX8NVL@H_\GG"%,P3U,;"
MCSSW(T'N]S,J'_&&8,0G4@K?P3O"$=:.(APE4@JO\5$^%(SR1$KA+SZ^3<'X
M3J04G@)YQ"(3OA"W*/?1D&?7%&3WUEYE69</&!QG1&#`PPJ6.P^>3Q7BTZW8
M]3>X]48,PJLMA20].LO/VAQNIY0+XOL##J,B@NZ>-IX=V'$8/6MXS4TNCG?Z
M2%#<'\,PYXB78,!'$4!_@F>!P6/&-.`E88B/8;S>HHV8O"_P].`%^&W$0.L$
M#1]_>+IB&S'0.A'#)U6LGT3$?`@VN]Q#?"[%H5M$Q$<W^.RL^,CA&38`I(BD
M3\XNCNP\_O@N90@2\PEOPI7+X%-$\CR.[(YA:?WY">ZYE9&(<Q'2=["&%@'^
MEUU,:,161(@AF)?NW1CNR9AU8DX$PA+!<1_"=7"YB+V,(BCC;W848&_ANNY>
MC%985%Q5"-7_ZJFX(1OC/<:GY;%;M>7S`2!JY:SMG1??YU_.].+]G]G=3B&8
MTE]][WX)8R9BIA?O/^)M9*$7P^P2TLW'+=R:%/YJN\B=Z?^YNQU/W]]9QL6D
M?SNY,(?.Z&(ZNGU_,3+GM^_?6].^T9__%RC#1PM>P;/I3GAT'WO$(%Q7.#"O
MMAX\X"]*C4W!_U@<F^GD0P*?W3L28,,6<69$;YL_^O#F?P```/__`P!02P,$
M%``&``@````A`$/WCSO2.```%;D``!0```!X;"]S:&%R9613=')I;F=S+GAM
M;,R=ZVX<1[+GOR^P[U`0-"L::-*\7SP>'U"DY,,YN@U)V1@,]D.SNTBVU>SF
M]$42!_MAL-B76&`7,,[GQ3Z$]TWF2?;WC\BLJLZJ:K5LSYPY\!F(75F9D9%Q
MC\BHK__EX]TP>Y]/IH/QZ'>/MC8V'V7YJ#?N#T8WOWOT]O+Y^N&C;#KKCOK=
MX7B4_^[10SY]]"_?_.?_]/5T.LMX=S3]W:/;V>S^JR^_G/9N\[ON=&-\GX]X
M<CV>W'5G_#FY^7)Z/\F[_>EMGL_NAE]N;V[N?WG7'8P>9;WQ?#1CW<-MUIF/
M!G^>YR?^T][FYJ-OOIX.OOEZ]LWIN#>_RT>S['C4SYZ-9H/90W8V\@6`^^LO
M9]]\_:6&^O"C[.5X-+N=,K2?]].G%_G]1K:SV<FV-[=VTX>O>S,>;C4_+,``
M'0U@9'\ZOIK.)MW>[+^FTSY)?PB;.,]O!GJ%K;WJWN7IJ"?'H\&[;G9YFT^Z
M]_E\-NA-.VR\MY$.+""[?+BOS[*UN?Z'](V3^60BC#X?3'O=8?;'O#L1NK+3
M[JP^P?KZUO;ZSE8Z1]C$R?CN;CS*+F;CWKM.=G';G>33[/5\9F0#':6O'7.4
M?3O.Y\-N[>F3Z^YP6@,A+@7($\`]XV`_9O^6/Z1S/]GD_PZ/#G=W#M)'<8JP
M\?/\?CR9`1Z`=V?S:3K\R1_SVF]ABN_&P_EHUIT\@+TAK%-[]=4X_2F\:>.S
M$W!\,Y[4@3_N]7(FY''?IVZ9YOM\.%Q_-QI_`.MY=PIC]K.SZ72>3](7"L)X
MDT\&8U%M\Q$7XZKT\!RVJV^NB6W2U\-JS1/\82>%\F3,>8ZF[()_3<?#0=]0
M\+0[[(YZ.22%W)AF:V]'W7E_`'*^X-\7I]GC+]*)3O->P;[U5<+)=Z=3IOLJ
M??>D.[W-Q-D]_2/_\WSPOCO,1[,:!EYV)^_R6?=JF&?3O#>?#&:#.JEPE))C
MTVR2]W)F8G0G&^6S;'S-3]-\\AXFX=^/]W;W.[M[>[;RX[VCG<[F]D[6G7&P
M][/\[BJ?%++*AK##\*L+J9V.IKO/>[/!^WQ8(ZFST7NV,)XT0/AFDM]W!_UL
M@+B_R[-9]V-]%U%*&*O`X_W\.D=N+'\I3IQ_1!%,V::0.IXAQ%*47XYG,#,H
M-%'DYY*.>3-!GTP0^)I%IW(OT=$1BGKCZ2P=_B*?3K_*NCT4QGQH5-3/[SF#
M07?6H"E>C$<WZ[-\<L?.[L?3`>?5"NP9+#^Z&>C8'5([SW3];\?C_H?!<)C^
M[EMMWF+$\G#0O1H,C9QJU%G0TWWW0<24SL_SR9R#B4A/GY_&DYOD4,2\]CY:
MI:""K&6-Q>.J0)LN]EJ'G6$P!.0N&5H]@4!;+1`6.X!2LSACC>"EC`8SD8@?
M90]+`"&/30,+9&NOQK,\V]JL"8XG/_WXTX_I-DRCW8Z'?63\__OWO_WW__.W
M__'O1H*SA]KY0/0!_*GKP<<;FUL@<I(A1>;Y;[.MSO;>9@?ME$U=0W;GLUL8
M\R]Y'T(:QU\'$N-]I\)2A?YZ`B$HZQ8@,8N`L`W*K=W.(4]W]Q!0,"-_;A\>
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ML-T(S2O[#)$N+ZOM1>>ZEEG#MC'[HZ:LB?(3S`J99O?+X3O'BNM.>K?9?^G>
MW?\6`P+[:VS&24I6%YCKM@_4$$@?AC>Z_;O!R-P_V6[I2TP_FX`>[$N`[6%T
M89VD@WRK,I`XRLJ>TG'A/*\GX[LLC,;0KH_"%&+9:!*N!11]T6CIA#FO<OSP
M/+[2:$5RT.\'"C!D#%TZ\A4&\L`LD12VMR,B"$-IR^P&*9TQ66E\%Y8URZ<O
M/@>ZP<TH6)F]ATSN]A334/!T^S_,IV8MI*\%S)HATUO@#8<O6Y,*J0FUI]WI
MH&=V?AA6R+\:F95[75%@^MP?V,VM',0N49ON32[%)O>[+A9LV@LS-FIPG@Z&
M<TTBC^23D,;!O\[2BY*F^;1;',)%"68.V_/A^,-*KJ&-OK;153:`:1`E@_<M
M5G=!']-L-D;@('MZ"*,JWOA=6#2O$9'Q?M`'KU</D<^6+W!:<4Y,N'7O%)7X
M2Z.W8H;#^E57CK)H$O'H9!SX-*7A1;[KC^=7L^OY4,Z1N:;+AP^"Y_B0#OLV
MLA_>L<1DLT]SB9%^A;B['LPRPW?^,9_T!E-[Q4PH$"0>K$FADUO<+&QU,7DA
MV'P1PU`T_;'G:SS58-6DX+\);F\4_QUW34LO%`U3>B[-FSNK.$OI_&+KE6@A
M?3$E4!W`U*3Z$@)],T<#01`ZB+M5XA+01"_/^U,_E.G2,ZQ.#F5S&*D;GNZA
M<?-K<Q'L8/0%_U_?4CI%BH;KP8@@D)3;,C0L[&IE4GN)_KV;WRGVD7T8S&YE
MU6NE*$XSY[7NA^ZD7Z/3-RCFWN#>?)&'8%8I0G)5BTDT8J5I7RDNGGWD<&&&
M3"'!;'!W+ZL'X$1?Z5AH$@T))<`W1G]F*GTBE&7(;AHHA_.*X/1(CI`90Q8_
M3!==^CY1WO8W7YDCGJT3]\;$,?I].L?:(WR3+G)*B!IEJU&7^<=9]G1(H'E)
ML+V<\;7+#X1,]J?RU5ITOGRA#82&./Q//X+QC6QM-K[)S4H0`66*($WG5]-!
M?]!5T*V3_>VO_\O>[OSMK_\[8Z!^D`KLCA[L)_[\D,=_S:?V+ZPD?A[/)[SS
M1;0LF>NN.YI?0P.@(D8W[NXD5LTR0D65B8)HO<+HS#8SOT*_S10I'(\ZV:W,
M*7$5IV0B<;*A1`,$Q"C9Y:P`QIT#H+G;!^(8D_$(\Z;;(VRX!H3_>BP`B<5E
M(YUB=SA$[>%Y3V2S=K*KP5AJ"AVEH-G]>`B;3(!GSI*SV\EX?G.+%V-(N1KW
M'S:RTSEQR+$AT7-!FN+^]@&;"C83I)J2+)/]'4228?E?C[/[8?=!6!&?H$.5
M4YF,61=^`+ZYA5)EU6NZ\7!\8W-<ST>&#YT:IGS7<%C!DRTZG%]-&&T6(S-,
MQ]<`;1CU4_AA/"#<U+&-**TURR6RC*9UX-&.9PMZ=D/`&#1=QRE`G^&#K<LR
M%>PFS8&]-\?O$48T0O0EWL:9F-820)P<L7.CJFQ@)/@#!VTVRV#Z;AJ-1*:R
M$QDI&,9D`@^40A2W(^'$HZQW^!I"."X-/ACC^AC)HF;^V1L2@K?#Y>1&XQF1
M..)MR/?9N!,I5<)0%I!FCT#)\(>DM#JA"2+2%OT>Y1^R8G%;$XDS?F^H!J$$
M91$BQ.[`Y2A[ES\HG#`=CT;YL%,])!TK^@D0+2LS*%.#CMMB>QU#1.28XD3S
MC[AAD1D$4V0!/QL!C=4A,(S)M:^W&Q<;V7."O;;"Z61^DQU7_#G`%8,\/S4.
ML3%RD^2(3/(;1:9E^MCOW7M6(TC(`V)`$_?067B:?>"H(TEZ9!B<CK.;R1BL
ME;C]VU__YS2["L*S1ADF:+<1M'(?#.E80%-.R$!(96T4@-EI/NU-!F:A&92-
M;R^5JHUOI.M=L@W9HT:Y.H%YS/%P4C&*P;_*I%#0F^"+_&*,9[@0\W@_1`FE
MWN(>H<'R$6=)GD,YBX0B[^>3Z5Q2`I0*FQ,QVT\_^E3E$8E1>7I19'H,'85F
MAK[O$`5R)M<TCD._>'9B<ELS2?BPO4F_I)Y@?FNS4*Q,"#%Y"`T@0'FNU(^]
MJQG?CHR_S/?!TV$!T9Y6,(&=-2+$&161P@1A03O[!D66F1XS8!/EM<$C(@+K
MX7A</LD*BZ1[Y0FZ*K9SR0.T0=YWZ!Z(D:S+$E@XQ/`B3BN9/0DL0NS$0/IN
ME:+XLI#I:]P=F@7ATQ^#-@X[""7V";?T"UM!F3?C)SOXST:ZV/O,!>3X'C.1
M\X424,"XW))O)NVG^<^D5Y"A6+.!7,8@.%UA*<BB\4C:])HM4D<AZ1#T:B5H
M07AW1#YP.E4N&C*^[@XFO&2,84?/="&QNH#^DF0LZ14V)UJ!G.^Q3"1U6+J>
M@W0EAP"9#R$6ADBHEQ$E-S:8!_6>>[0.`S)?)T"!<83P)@<]S233^PV3&V>1
M7MX)8E?&:_#89<,P[<^9K"81+P-/_.HR9XHY,X3<D"54NXCWP?H/P<(H54?`
ML8GM[F@TYW#+`ZD(M6L"#:[V#<O'/O3<ZA:D#XELW?WT(\4=_U:@7=P6T%M+
M%#L_5H[NUSLV[$0Q8J3%`32(T6`F$U(8*M'9Q96A4S`D][LG*6?F*8\CZ)*+
M$?:??HRE.!O9"=ZG6`:9"3$X*65$2^;*])72'C89XK0/K@?,S5*<`"O@XKF0
M%P_).@GOWU=4H>&'G7R`]LG'E=Y6P!-P(55)DM8(ZIB]A0"G7K[K]LU>T:9;
M&+`X92''O+5%.I\./F;&,Y%9?C\G^!V+EGQ?;*0W`],D'K$446,L)T>V->K2
M"QB46)0C;UZM=HW\+39`,`$VK.Q>T[:!J[&\*F\AR!#;B^R995$P;?KQ]L:>
MXOI#O6A651=DL2<,8$C'D>T.K4Y1HJ`Z;6`8AI51`2`92O'$LUZ*C(405$&$
MG\![H.0II5J!])K0MT`\-?15N`XZ]HVI\@`\&`661Q%)MEF&MYT)UHX3-6<3
MN&-VBS<O9TY,VL_17X8CN)`"/61R%VM:_,JA(8RD=12E-X+JWMQ@KS(*P>\<
MM,!_+>3=),YJ7/-*$8`=#--*/4UI97V=U/0U!P$NYO=83^9OM!??G4`\'8JN
M("%E64-5C^N8QK67FK6-;Z30'GL4MUY\J-Q2.KA,;:1/%&J==C+%CR`]0JKI
M@!?D(!1D:!_Q'),@?>L[522D/RZ:F9=BO3E619ED25]XG/ZPMKU_F/Y62SP\
M[8[>X<,2X[Z6?L"$8V>A^"9]>3W]X1)9%"T42(\H"^Y@!407)!#UW(NR-+=;
M(D&80M@8VR'X*=;$"?#X:1]81.(PA?&DA&2@E&`&6V+,ZKDPY^&@#]026*F`
M3-UC;,\@':KJW0.>HD^X$0:LZ";)SO?=P5#%/.NHJ'6+Q<H,MX%=8B@L`N/*
MJ/,B$M_>?#$3QC2\HV04N%2"PH`SR8RR0IA*W0$:%O#2B@C7;44F+<I2_]FK
MPYI9>!<6%I5E1E;92R,<]V+3\ZL,*_F9V%QKW6S;"TN">957/@D*!TS$"?6'
MQB,&@%E`G`=15\A0Z2&1B4M2_LEY?"B-/%7V<4B6WS!!'\/I6/8J,I0@M1H[
MR4X%=R@10F/&#(:L)"VM(Y/=;D/<OX(.9Q_DO7I07X5$%'00;18E%3$Y%IG?
MF8^NN!6P-8UV>(G!:S5M4)MBU0+"`AS(&%1H>E`BNRR0ZT-$PW5)BG>58T:4
M.INM4PE)@*\<=<O?RI$_=&"7`0&V@@$\T%896IVPW*&P.AC=4[*1A2Q"Y@,%
M4ODVTT/Q<"C<-,"IA'&T@Z'2?5]E:R^4F\^VOLC&5ZJ\%,O%66/8[\]SU%'?
M"<!"8V972$.JV-/1@;BAF,Q"D59"JN.-R",Z]MNXT/87V91(CTDX,1^;F#0L
M7:CE"E0Y03X&]XD#F7''"M+,_M=O.38"K[Z;G<5%YJ/*+`%CG+=C77,:G5-<
M.%/6;B(+-Q`+DJ\;CR>XS'XX4=)"O*&XP;T]JHXKA!<LH.*D81YSNVMSB`(K
M,":K0^J%.'35S+*JC[@CYV\\:.]?XW!7)@D;-5'<S[%E],8"96QDKYE9@M&C
MTD[=[L;&#;K4Y-0Y9P?+**14?8MBN"8&+TNU9$Y=*O45F"@(OPCD!J*T,_5_
M;T<54A)V5N#5C<,VY=(^?=!*35.:IC$9V(>[A+?`!>%L3!I.?]["2_=27;@0
M9JCM"6Y/E%!27N8`6]AN,($WD8%$@(,$HXJU3Q2Y$R"O$$6`/M!&9'"%WC&,
M20K(ZNAD#X,<7QVJ("49X@U68Y--")@W'G$C"AN4?FH_V`FO0%>FB$JQM41Y
M5A6;:--C`AQ@^LZIK)JW.MKTR1]<WKV1PI.\2Y\?X]+AN[]T\9<^E7(X*Z3A
ML4G#=$PA==,'%Q79:)7"Z8#7I90^,]F?#@A3;]>LR\K4Z3MO*W(C?;9TE9W:
M*B\QJAZB^"2#5,\-.]H2*5*K5O`:HT;*2"'\Z<<FE-=+EG_ZL17M-:S6WWXE
MEVP/>TY^$KQ&9%@:#SIXPTV,%*;2A)/<DF0J"E+.@R<N=P?NNE`14BA<>=,-
MR?)VJ^^73KS$.EQI8Q5Y+IMB("^Y9J^PY<48@G2S_Z*,3KQQ@#BA7$O6B^0K
MBCA[.NSVWJU?]"@V8%:)7\]#W8W[^9"<4FD]L80D%BPJT\3GQC(+EE*1T+C!
MLIRMFP,CX5@$W*JZ8FIE8"[**W*,%?(N9EEU)QX8ROKX4`'B7QK,55`'<P8Z
M&LH0=$O-L-I7'%-(L3UDMH<V3'FYT+JV*,`,7650U8T]/:C8)G6.L[`T_+OL
M=F!Y[2:E^'-4`]8^D>T%;9(.>Q9CF^_'0\X6HZM61%4,&8(5XOZ*?M:K"8M1
M%IM1%L6T5KK>*T+LV;)-50G:C1WHZ?'.T69G[^#0U-/CG?W#SO[FCCC9:&5)
MF5D1+3.Z^/S8_B(Y2*[)8D3<2.47(J0,3Y8^?PG[5F?K:+^SL[_ET//GWG[G
M:/OHL^#_.=F$Q>M6'</%JN`C%91X=5&B`+C=CHJ>-O:NL6$3YAT94)TQB\4?
MP_LX(!P^&<([7#?RZXIR+>"Q\#_ALA+S_!-O<B!HFFP=O(4/<AD.["J()-O6
MSE%G>Y?+*[K=$DOWG&VA)70@7HL868KB%\N.122;U(H0X;><ES+QPJ`YMDBV
MI4;/+XZGEGR%JFKC%.+R#.KYQ5L?9G+GTQM8(/*08*DGQQ8`Y6+,_EZFA0HL
MR:.QRWL6]!*VJB+ZZ9@J,]'OJ;E[JI!H1VN-=%<#B@S"`3>0A*4J5`&,+*?.
M8?R0(Y!^M947":;C2XN@4LR4:^NIN[S"P14A+<+MH:;/3"K.5G6$LN3YFW`U
ME=`PXGQB220L:)6Y"[VF3\"HG7*-SBD94JTM&H@A&MY,VQ5%N#K6E?@)MXEB
MVH64$[*.##(:^CJWJC<Y'EX3@WUD,7FVQ98\A$$M"Z5EC%&4*-Q\LBC\X"X:
M4[&<4G%X2R$$;VU!`NB:I(3#=*Q;D*P3BUAPR`TS5)HLZ.0V#5RQ52AYH_1%
MM6A4M91)/,`/>IUDS56L60&]&!D#<F3!H*BBXF;,-:7ZV1B+U%G,''?)`@"V
MPIF/MAY$\'AW8[M(*.E`[6ZI@J6],;$871RH804IB()VS(_&HW6AD[\6Z*`3
M_FPRZE2,<7%\;J*DC;1+3@I<%D($5<O:3@W+3B<E+U"RW6P^),:5Q':Q!2/U
M+L+9+P&LQTL`(9_)OG<V-IT-:CB]A,0=*U@O&'>ZJ>`14%Y;V+,I56TLLAU(
M6<8&,4M9/R^;22E].[''VWN=W0.N.!\>N=[>[6P>[74.=W92B6_9&O:=!%A;
M*WNKX/TR<]45W^.M@\X>4$L6/=[J[!R@_8YV/4[`WX>;NYV#@_!XNW.TL]W9
MWSU*-W%:FM#$DF!1XBO$,!!6(%S7Z!?#4-V>!<Z(73)21:38%2AH:'M"R9S8
M;`M$'1SLBI!):,0K'Q4B1O=&.9HMG)^E[^Y4;&,Q-6J>E3^<P[V$G9/JYVH=
M6A,1155\M+//\1T4QH#`MD4K5],JBF0)^4L*@I(&\@F9X1J]%X10>#R/MW8V
M]G:5V'>\Z*RR(GTI@STE^41^;&]M'$8!X@?=P&>4YY&3DQR3@-<M-)5O*/"H
M#>PS@UGR&]DKW5;C)^F5<-%!8=<:?HC>-&R;D5X'4UIL<IUNJ2J1A;=.;H$X
MKN4]HRII.JEH7Q"K().'*S*]YKB!*-B3<])#!8MS$6*2V2]<$J'V9&C3ARU$
M15.E#;-]/;CM%G"P7'UR'#T51(>`=GG9V6JWJ.[U>\[NEVKE\"_RCI$-+/!7
MV$@;WF!D80V+(T83SDFEW(_'\N5;Z(0\>>VQEO`D;*U*ET$*NIF]:#UDP<H,
MBETDH%R"_.U2^U;*^!KLE@5[1?0!5*79HN,ETD(JA5BX5</42,P$`]802A8;
M+4`BDB\,BQ*4C9;PSK[".^&"<_8&;KE0:"!U*>LCEF3IF@8OB\%\8O4)+7_4
M6NBKZ7VW1\NA>YA`_3(>?2,-%HX+F2CK#<T39RLXW^REI.CR^.(DV]ZGZ8]O
ME"7TWQO^9_`E;8/^(D5(&Z+-1_S5HQ+:G)D[%M_2+Y/G,+L/N334OZ)&^'R,
M+:>GUUWJ6!["#/KA2YMX]DT=+[75_TXKQWQ.:4Z2)K<N3EQD,;Y%A9!5LW@)
M8MM0;(T2&O"Y8:7#O88GLE5\(I03[&IA"LTY0M&$S'&1U1&U,[A07.$*?2S+
MC2*^N-=8ENQ7WT)1E/>WJUJ?XZ>XD#L$X69C$UW\!T,K]I7T+7?6%["*K]X3
M>07_2*KJ9BTP`F5:T*!B@,6]OBW<[EE1KV$>,2("^YS<R"@JRKXJD^F7P/IR
M9O,'O.34Z$.QXR7,R_*@\F74E"!?N!*D'QP2R6]&2*;+O<%CN<YD6/N5DF)2
M?`*_>X;`T70CS^E"%T491G7W6/B^:C1R%Z1W'1T%<U5:@3VU^[A"O*$:,FV@
M"X6@M)E?:#AJ5Q@R,>U<E[^7M>CCHNY/A?"K-*ZW?+@)\C)/KAV1J^8.B<>7
M47?DVK#YZQA(%WYV?8W_(?.E(-`R&5H+JEY40T($^_$;W'Y2F"&=.K)G4/<D
M=:U0M@'8%<#TL&$P9H!V:QM;?/_`#.BMK</.P?9>M"LLG%45';_HT!<M?=^M
MK3`JZ]'+?9FH+0YA"2%B,W25YA8V?%<XBY5:S#I*W!%&<JS'DUH(0A$M(S=0
M/HR1UH"R11P@%HHB[;9PTLY&S`V56#\\[&P31@XGVHKHE8,G._]<^%1GH#HO
MOU*J[`!;ZJR]PU9\](!2*JXPMJ>]FH<O,:3B"[J9A>&GBP/1Y2C2(35NC;75
MZG*8,N=Y]P.N`G(;153CW._'DW?K:!"3XO5;FL]QBZSRYH9+4;67+=69+E>%
M7\)3+BGB($A]:G?<4[:H""+:Q7_P*^S'JUS&1BS\X-4R<G4]F$QG@$N$WOZE
MBX:N%3>R9"<F+BA9K8"/\5+T39,APZ6WLE@6Z4;5WGCB9%K>R10LBL]PL[)?
M\\:,7@Z-7HHV8L=>123MU-8V+/YN,)Z5'<C"JRO1U6?,L838#G$HZFQ0!VG9
M;L[L1@37!"SJ&L.0!`<1Y%X"+?JMWU'*+C8F&^1&%6_SI_Z#(OTM,93W7+\=
MSU794*`;VT:57`)0-*HN;>SI$EE[@H36K9?<(YP0DB3P\BEBU,4R+I6^$KR)
M!*\M"[$L7NA#SJL9@^?_!!,UAD7GAT"J*N@L`I0M$X<ME(S).Z$QC6:MM*4Q
M])V].;=^-:>6):F!">#$D:T(W+Q1BL]HX:`;:%5(X55=&,@_@"FW`%45AP^$
M*2<L4V$K!"(I[!:JA9K@&L<N`7?GG/Z`6G\_=L6XP\W2[`.UN_GZ^/IZC>M-
MTE#=*S:"R2HWQ2:<LN>WJ#6N`.K2;N1_U[!*D',!P\B"2PZ`.D(G!^12JENG
MX<L*!?BVO!3,ND#H?#@;)QU!HWLA@XG%1A!40\H@F=VNY@RYP5QV*%.\1DB(
MM"5R"]@%F:I($P)M@Y4I,9S5GP\R9:E>V0DC7N_,>H,)=;SRY;QNQV[9R&((
M4K-'X;#5:X:25?A)4(0-*`XD=%R1@ICKP!1:5A\9542R8C'-`G4NSN$HM1X9
MR&<+HA&$0W)C&JB6H+(;RB:HE]7&61#C$TP2<-)%#Y!(G569>B%*CHK491[&
M5%@*@A+X`M/JFD5"15S--D5U-K?0RD/A_,/=(S76*_8N5U64I>!*7XU3F5G9
MP#)C499%U(1W1<H%1+8&+,5S515K<;S5M?.W$PJYO9(ZU98G=G6I5RLEN%1A
ML=OXZ2O'1?N:VI.R&KSVJ"*'TF>Z9_!T/'Z7_O[6A=F+P74MDG3J?;$XUEEQ
M#3M]?8V(^C969+T?\YKB[$>=K>V=])VSPA*!.E;MQ+6VOW/8V=W>KT\6Q5SZ
M!`U+X)C[IG"'"6/$U_1V<%^S<-9V=S<[1WLU.-G!YN%NYVAW-YWZ#3P#IZ<_
MKVUM'G2.MC9KOV\?T$-RLW;%XMD0#$OB3G3O;-301GKM@&S&T7X-@#4R,5M[
MG;W-.M!'G<.]G<[VSE$*Q:6$2;P4%,6J2]Y8D5#1677]HL3=XSU\L_VCD`/:
MVR:_<GA@DE#L^BM4E9@/],O!W.JH'R]A0[,92/OL[>UU#H[V"U!K+@WRY--W
M6ZLQ_9JH.2EEOI!1B/-"\$73I0#BYT4MS$VK1"OJYTR94_KC2WF(+6W5%:Q(
MQS_U^^'<UXZM9-(19:0!W;K8IZUR+SI]:VU_[["S=U@CSK6#79U9[?<"#DX'
M*SV=[I5\N2-L\^/01/=9J,U)!U*[*$WI-J0-QD]:$AAGB-]/#2\:'<5%7E3:
M@E;M^"4V>'RU#;[X/'#BS_`*[<9MNNT7\G8,]LC:<8%TY`G52'9!`IG952R3
MRH-TS)O)^!IYA1QEQ#7%)NF`\RC.O3BAX7&U,6+3$HU5Q:]TREN;'#,FV4*/
MX!/(&K+P'L'I<DL'K^;8KS[%DK-?.DD*M!RM<-L7XTUV#O$!2U=BADNN,-N]
M/!XJIU0]BO9P<XB&[S,23-3=%*8@1K>W`^)^5.GL>L@!IBVN5H=QF6H]_7*?
M5*7<'NI7<H\H!B-5^2N++M(M`NN3"AZW4L,4+KXCB+)98;-QA'4%R/JTY+-`
MW+5J6/$%WM/Q!VTK$_=*&48U>N<J@2E@_8B>HM<*?JERA4"!4T,]HI?N@C#3
MK$1`R<-KM.<\-:RIXPQ[T>0TZXEW%NP."GV1B+[*]ZGB/QZ+W[N5MW6G>T-@
MUPZM.(VNFEZ:IP$RY"QB4X<[?S*D+?1`A&-\;5E<%0S9X:JFDFXY5DLB=UN.
M%[\-NP/RU7:_:T#=(!`'K`1B"50A,!BE5T*B6W^!IQNL.0PFQ8C#4O'P+7Y9
M5":/\IOA0'QEF&<.FV\<&J;8PA5D),ZX=5+2KG$8PO33XKJ5KLYQ/]6*J6@L
M-5!?3[E`UHW(D8>,LJ9AEKYRSZ.RF%7A</,=N\YO=*D^646H;*@WOKM2#Q-.
MRY/8.HO:>NXXB;HJTZ+IAA0Z@3C]V.1<!%JW&$$X[=!:JLM5:[\W*6?%ZC2Z
M!#TN*^RJV_F*Z08]53DG$45XZKLRIK*3GMH=Q)JE\7J4_7Z."WA@'SLA-?IM
M/OK+`XQY,I[<C\E5:_O>@\(]-JB&+&BDQ.JFP9G^7+Q"[)8S)')"91[76*$=
M#2I^AM9>XDW!C#B;,S`\S?-W(N0Y3;!,A(C*NG<T7'&%:T4&YJFBA@;YM:.&
MP[H/D`7*+"17E"#T@S(YT/>N36YW4Z&QD>UUMG8IJ=G>51:R%&Z"XN7K5Z^_
M.[LX^>G_BB3JV]-^[,JND@K<#&P8HC/QVY<1@@0`ZKY*"#1ZK[-S1.'HWM9/
M/Q()J**X!`ZL:"@=D?H%D(T@FMAY:2V*_8RI-XIGK!FJT\=SME9FU-;;X:,3
MA@/U.N/8B#@8;X0)C'V&W0]3"K<;2<(6X.+@8"IN=S:ZG^0_T#T,:2#QQ?E7
M)W-2K<"\%3[1X_Q5D(U34RSZ$&@EM)^[6COD3(NX]CI#5?>$ED:IGKUD7$%E
M4*G4%*'C\5!!(\@FAA!=8R`X7;TH"PJ-\4*0W8'"0JL?C,8):TLL*Z"-L81H
M/!Z2TJ5CGIT&-`?=2SP;E6@PF-#E]OH*"D;J_J=5DO4'U]R[IWF/%#[GP6G,
M%@58T59)-A[<*PSCL?#)&Z.)3R[(O*&.)682*%Y%R0-C,`(0*Q*HA!41WS(3
MRR@@"\7&0@U],A1E;8C?O3+#;@O#[B61PW>Z":%^T[WL.`K4]-B*3TF<*]A&
M0`GJBBTFV_,S2]]:8KFM"M49S?;CUUVH_N+[+L)])"_.CT,458'A+MB[GG$_
M?-T*A=!_W"60U"IT2-&-+*P>I%F)$XO_6@C^-'\S?\@N'O#MH"@??X$&X(Q>
MBD"@0.P&*^ZP/F>0@+_R>@))WG<U!K.2RV(;@#RFH(Q0KKZR@'()*?LH3,43
MVI1US[NL[(X`GY=Z4K0WOZ>`&TW#5TAB"=KC;:(4_ET*9EC`DK0`ZE+ENW3"
M(8YH&B*=HT_'2IF$1IJ*GOKWS"PD#9=C&BE!9+D%$VUP%XU%(L57@^ACRK-I
MB&*VK=^N#ODA8IM7*OG6,80>?ZJNM``IWGM@U6C*F`PWOGJO%X248([J`S"^
M0+B/[TQ!WFNA$EAOI+NTZF`]:`8XQ.K59U/ZT!:U[-CRNM3B;.AFN+"=XE0E
M['TO$&AU*T%!&)E%U5,Q+Q8V&!&DP#0;*#T#"8OF#97W%*"`@O07^4:AXU#_
MG19\$DUSFO)S++H^N/%6EGK&;G40OJQ>FA1INRXYS",V9'JD.N1/Z&]44&RD
M8R@7PXTXMEFMAA-=2H>Q*V6#C/#N?_@6L3<@`K-<SG8C\B/P[<RTPA&:8BK.
ML:LR5VQ3E2!&X-B;U3P'C&!G*D4A::QS*<OW%VA`-E`#$43:JA&TFP&!$`+C
MUD%1B+#,3L2SLQY5)JPKE3\>^[+"A1AZ<X.G[!N&F7L,+FG_L.=?]:N0O8DA
M6#WTT`WV''9IE)8"Q=IY81[J?DEE+`F,&5]SZ`19N%1\;F`:]U'/8@U9$U%O
M1X45ERL4UB()J^P#DA.749LH-U5_M1SB7EG#[&3]*70&D=Q<H5[S&ES9JI\H
M\EX7<^A*5`_AE,]64ZTMXY<HU?*-^NIOXO<FO-1Q4.G6'JK[=\DH8&O'SZX1
MCCX\V.[L[NP5;LK/BJJF94%%RLLM'Q7ZJ=C>.A"(K78W?V.GNG/XFXWLTU!O
MDPO9Y^+CD;WT^!#GY8!/,&W_(J!W/A?HG?T`],%O%E]U?PQLJQ915B?_&8FP
M9YFJ&('.`2J#6^U&G94WP;V8$2JQ[6.J86#$):J?KUAU\5K(OCUB+\99:>U8
M;1LZ\<&<C[=W._M[.J]#X:&4<<[#'HHKA#I>\,+5+$D:$TUNURGA$B(#=M)1
M.E$1STUD4[=*)JO:`0>(")Y9:5A"X#O8QG7LZ+4Z5=K\%A^#.FUFJZJ-LM7O
MK(`6CA7YQT8Y#0VS&ZE>"1#'LFV_PB`T]M7=U;H/A9-$GNH]NOV^MQY8=DFZ
ML`!R0,=B"I4*QC/^`1PATX&(I(!M@*,R".$*-&5A'`85`'T+Z=)F0\PV6+"O
M0)XH%."%ZC)*$\),"GP0K`H?!6%\:'!8$X:7;.$D1%+E02M*%"F>]6;S"=$K
M0-96[4`U,3%OWYZJ,:=VNR_&:FV,JB5B2Q+>/>/K9A06:*D*G4B,L"*:5GI1
MH3+=&(H]O_./E*2'`!:8QNZ!DLPNUGOA+H:^6FGG370GQ(HI-+ZA!%!GKPAM
M441F&]"KYFV`MMA6:`P62S#`+T4`KT%I_,UN8LJ780;K]VXSW6-8R.HI9OSD
M#H3`L_,+.TGW='E79D:Z%\-@1+#.W;!I*U%CC*.9$W-I@'#SZ%>`L%(+0841
MXFXD_P5"KD)9'&GJE)XU%T>!+%C-HW&!*4O/V7:G1:`CX2@2(ZRHT+P9#2`-
M"E)++PZN.XUG37R)T(T9.&3>"/2\D[]&[&QDCI(%T30@=CMS\AEGA`'T&2:C
MV^LY)!Z+P`,(*OTOK&0CMU!VE0@Y6?4:6W9753S;$Y[`3FB38O[O<_?8B&);
M#9Z\BY!#\*`![(SHZWN(>4[+-.Y%NOE.[-G9O7@..0A+<P-4E-L()OM!.K!%
MV[`Q+%5GU$34<*0*>N-A<V-4BF0^FKF8\C7E>7@SOK+R29&O\0=S`-A'\\VO
MF@1KC7FH>^9%?N/%2!#[M_F8P-@]G=:PSD0`1C8IH<4WBJY!2S*8];'54,D2
M^XS&Q#LU>?G3CW$^L>9JT$KP1;)6@%M.B]_]\0."U-DEHF#JB'!&<-?%[&R7
M5:I:DG:$R.`*F%#L(G?,\F!Z_V=UGJ]M$2M.V@(0W3]$_`:MPEWK\?Q>H7UV
M$2\)I&=C(96K\'V*6F;T%-^A_JW+B_G$/F91F^O^%FX9\K&,],EW:I6&@JA_
M@MI;$E6`ORE)BL^NN!@R?2H'$=SK&G.7+]0@FJR0#-_=[QB'.;Q#AI#]LRQJ
MD_BR(PB52@%&Q/TVW=*YXSO]^4T5PO1AA0!?A+W5RJ47<AKI!+])?WC&%U+J
M'V!_90%*]<D\Q]8H/^IWHOAK/4&^.$C(/@]5H,>E4=(>IESI]16Y>'&N%GA1
M7(7(XJBV%U41M9'40/1D*T($,<H*N4@!S.P:*"8X7QK*19)JZL@'UD(B[IC*
MSW%V"=6C;\P0BBZ`Y@I2P>)U$/.5OX:2LWO.WC<)/K1/.2@2YV$_78#C%!`>
M7N\-@VHR/SF47PQY3@F5HE8>K&KVV4O_CH<"'L?]]Y+??9ED"-N'^`9Z/C`_
M"L:%SA7W.;"C2CL;=?)[ON&C=OWA\]UNV4T6Z()\EGRGD$;@%C*5]ZS<D^"+
MO;9AA?AYD(I9R#]1J:%@UNP"GS\*T$(E+2XH&JN44%)W2N>)PG+5%56LPL6[
MZ];?+PVHE2V],;+<@8C"H$KW+<N9@2XZ<9^B@3:*G``V_3UBM6S^L%5I_B";
M)IE+T6&K*D7N%9:QP(CC*KN'-$%_42<M\2V[NI,]WMS8B<$5,YSBRP%@U`M&
M"63`#+R$<"2=K$64N+S7:;@KPCQ;J\X3[R'@`6`+25L1E0Z\M'B&1C35+54\
M&-2=9&BUB;X[C%A\OG.FU+NA0E;5UR74ME>E&\W=)R(H-F7*Q?7=03.-^UB]
MF2AZM"D?[^YN=P[WCZ+.750#BUWN:_;03A)A2.4M+%CU4LPBX`*CG,R_0,"+
M$%K6G.,)B'G@30](6$R`X^+^:&LTH*88SA=8]E@9^;IJ?A8:ZJ1P7Z"MO'@!
MK*</SX.T?^J?3ZQ9`4$+U`N!%VD[G?9Y%*PGV$"8[>GSDZ9*JA/UDT*L^;W-
M-=3&E7*3)EJ^2&>@<K6SM5,O7-VBY':O/MCJ*=.?GX<RP.(#.V<8:+U9.HR*
MX<V]AI6VZT6N]`8[J/WZRE2R6AWJ*C>GISH]T?6%Y88:/O=W6OD@$@R>O`:*
M7,T99A1VP5<FH=2G]P.\M?3K<RL"@)JUKT#`R;NN8I\7&=2F#5"HK892]AFJ
MXXNG?M_#NRXT#G][;PT/UAX=7[Q]](651VBI=2ET/""ID*(Y&VZ'7?I<^''M
MDB_E]+*#K<,OOJJB5&QV81T@GQ)UZ6<40SJ6OM<58"E?:7B3'`C>8WE^'@RU
MH@K<I*[Z%#`+-1#HP$MKBX3V#]]:.;;60A)@9$2=H<\E<;E9DN,=>8L&)H"[
M[>-ZKIHK78IM!=B_6,$;+P&9GECA&GT:87?HPR6X/8%D_&,OGAQ9`,!F-P"F
M`0`7+ZJ$I9R,[D\:'DSH8EV\7._B)*7M;JHYU\6``%CXSLP((F.Z,NJ(3!:4
M\OJ@9"'6RB2\#59YO2&&V>P&IY;")9G[X5]+TX-$BC$F7H86MEHY>[MY5_W4
M39%?8WTMZEN5O'=4$T7`$+)R!=0B7:&X:V+3AL'I]N*%D1*O:*:P8)&CLY6D
M#PN:-+BZ,Z_6]T7<D'!XXFTBATE+UP_)/GXRY'CZ#X`,<9*<ZROK[E:4O@QW
M,Q]X_@ZDE78=6S"`Q`\JEROJG1-S;U]W9-3JO2O!H#@CTP#?G2ZFA%7B'#P)
MZ4'&AYMI\5REM'$RD4.4&2J.\J&P;G7#1J8UQ(3.!EB16E/$J.:Z(F!>4N13
MD2^(#0"<SID!H5"*A$U:'3T*'I=W6SN)Y:6>XCN9AS+2C4?VI@F2S2-BE&P6
M&8!N]A.(2=0BJ^FG0D!002W1T".7*ON;I._BDN>>TQ4"'YF147`S;Y$^U_3^
MM6;+'C*GK\-T6-/LT<B/KTY0_>*04.+IW?G==J-FB3VKU!ZQ1)V7,['-6E;(
M:C;^LX^L^(R!%7U*'0"1J1"Z`YZ2\@Q*#M4J;&Q6^-A^U!>?F)<2"O_PJQ.6
M@E4U8(@Z<281LPOD2.B9>T0JW_$J#,WB=]2T&Q6[DE(!*RKR$$DYAZC77OSB
MJ\O2PJT+N=-]'!MKZN,T[&%E(V/)HG\B.CZVC.\JE'QHE!P1P>ECXG!RH$54
M_YH]6<P#48T0TC,WGDQ;\:<9_/:'V);8E*B662",9R+%AP4&.)1?H'"E)#_A
M%S[DB+`E#&E5`S`N;_:KZQ<.CTB*.8UNPQRQZV;Q\4J+?7][?/RF2AF'D:%L
M!D2&OBJG8I[25_'J3H,]@.[T::7$W1"V`C))VX4=QF%.V,64A8S6+O'[D$#$
MIY#@7DN(4D7.VN0FZ14O1:V29_\!XG29*B'F`B*>C*_U!.0N'DDIV3#V53M&
MO[[*9]CTNK.4IBL'EX%S5\/-6%]$I!51%`=8*((`:L/<G+8E.BH4I'4J%-2\
M['1QW0769OV$L2/>Z6P*_M#<]O4S#]5Q`GP<38WN)0+BR"]TS"VGZ21F'_&5
M(*I+C55EQ>YBY*&IK+!0@H!3RK)#R>ZTA#`JO%5U6_V6KUG\K9^;RM8N93+4
M6S!33L+W/\R<N"@_`?HG&XW=&C]'7?^FM!R,)9_&:5WPN?I_?Z=KKAT^QV(W
MUD.[_[ZX`M47/F2!,0UEK`A):U/W5CAH4$ZP2=>":<QGUCNY#E@I6.]NI]/M
MQ?R`U_X1FHX![D%B8)_';].L"&1S:[*5(,2J4N'=M.QHU@E=JUQN4[T*["O"
MD;3U6`F`L]`P@EO?)Z&H:\75/MT48B4`GDN'Y-D+-#ZN!<KJ#-,5H53^>%:V
M0@B$1>SSI4G=$TF-%=!3)8IO0P^%%5XSWFNZ8+?2SBRVPJ:J%^96Q"UY@U4R
M9"N!$5-7YX795,FQX=A10AM2<9\&KHK':-3JS(*]@4EVYH4$S%IF*8A=':MR
M856,;[6F'%;:\&*$B[_4A$_[O'RX-[&@B-&JL+1^@3I;.T6^#H8T>UA[>W&:
M/:Z%E<[P2^@A@+&/<I^/D-)8`:CSR0>L]'C=K/ZIO7T5@K=>5R64LE%\4//K
MY&.#(%]XM@J1&`$KOF@)HQ&'D-D<`G%R-_[TTAI[-ZN!5?;^IQ=D0,AQT,>]
M-LD;8A<3238%*%$`"RJ>&-,/>%ORE])M8+ZW;Z,DM56WL41Y%D?8\C7'MJ-]
M>Z&`&^4N)K'>X*_.[#;6Q?RJ3_F-"IFF))>NE"I'[[EKUX;K$P+N?O&0^=!:
MIS`J,9CE9_-+-K7LS([C%R`)5"W[Y&-FWWA,3Z[\)&3VPK[LEPXHK83TR:M/
M&AZ5PRJG$<("92-FSKAK.*$1H+R9%J[\U==9ALT23MTST.?@.EG\?E8DA^R_
M9;\J.:VR9HK\]G>V"S($3@03'Q!RTS)[3J5>NP!9<<;/I?U5IDTW]QE0&W$L
ML3D+$FPA+E,]_MD;-S#C(:<PU0:&;SSHZP)?%"A/WVKXU$+;`K[\\3VNG+KG
M*V1W[E_T65.CP_8U7F)ZW=%GNVWBEQ2P+7N^,@J7\<TQU49X@AA/51->H8HB
M;/K,>QVD*&H=?ZP+XS<6GS.;I]TU*)R";WD#08([Z3J,:XC6YF:-7VR=NMOU
M*RS_S+M#5D79:UD-'DEI!2[[^T+EZ8WO/)L0\)'B_LFN=Q&O_;YEOZ<_QR0C
M.M*3'6W(XSO!8]P4^\:!P8$47:`%,^A>A=Q5"++RX81_^(*=:.PH:A'@$.NE
M@#S9:4:4(<#<U>KV*I3[]*$<$AQ:0TB@BN-1W_B^RO;.]<\^4E"$V3D]&SDM
M6\$4GA6U*_16-;\]A?)-3)]:->R"PYS%^6HX]F'X&N$#Q>[3G7,E3677X0)7
M9"?;#)KZ$_QDZ;?E&+$AGX61UV4[YE?SNROXZS\$C._#%S&.E5B_R2->,9U)
M&0JB4V[.\(TM1:F]56G-SS`L_KUQM)Q4_B$@)*@ZCY\TB#D<ZA@N24FE9/QD
MWYDMVS[:)J7X4*M+^-G`)PN?2[_45J=SBWU:(7WP2O;N*J8&[7TJ(:FWBF41
M:'SF"=.\^@EK1;RJ82US3OR7JD2(AH"+TG]6N+)E]H$AKRWL%HVT=&?')#9B
MM^&J7T;)AOJD$FO6]Y<D9^;X=K*80&A3@`X?:5[W6E>"B;`.G$I6H1K>JZ^1
M@K[*.TNJH0VT6G0PX@F88A10(8$6T[8ZI+V(TU9:)3)8+-ZR7/!#BW.H!0%3
M%'W^RMHV53,W`R7V0V2Q!9JM;?D^K4&97V?M903OL5FJ.B^5\!V&4'5K!(70
MX_QNSC"HNHK)&M*H]5%?Q.;.C64+Q,NB!6(4'FWNP9.MO69Y=X85+8."()A"
M<M;>PYB`'/=P;&6&K3[':6QF6'%C6@%H6=^[I[0[K$^V@IY(<13[%(+Y?IZ]
M4F%LZ]I'S7O_.?1Q4C;4.R'C:KU1S4R35"IBV"WTNMK+GV#CYL!WP;CUMG-M
MHB,&PH/+QAD<7RF_VIO50H:&J4\W._MT\!5:L_L,WX,[O+@'[Y%7KW2LC6OQ
M*QVP9<TZJC`1][6.'K4+T@7I=`CZ-`6-MY8*&B*C1'^]!'LK)53B,L7#6N'@
MIR%*I_NL'2^57:'&AK3CY*Z3_1'>K]E@I[$_0<@JI,"DSVLU-0WN7DQ05!RQ
MCB+R.)+$L2A_]V^-),,:)G),I'?'J^?=?):??&\9UD(BY9+;BX$DL[5065OS
M`)Y9L9_NB%;>.D?ZFQ-*T'_H(2#S3W7S)44O%@B=J<B*:#D=4$&G1/U.50)'
M?-L>'L_!&@'MA^H(]"B7!HF_1EQ&CWZ-RX_MH29"^:-BQ12D)U3!U$A\*9S/
M0PFN]M`(ID);R!WK,/:,8AD:NM%LY_J:S+4'\CV07-S9:!7S]-\X2N$M"4M:
M+;H&!4;:YHH#I16MV"N=]Y55_*Z:#XS2N3:+N[BH#D\#AL(`NX)78\:?MR1F
M9!2FD0S(N<6?B)QQB:Q%7<4$9&.*<JDC$*=O0=[BM;2"9%/LG"*8H-ZV,[H(
M%]5:![PN;JRU#BFOKK4.^3717B9?2<2$ZV\MR/>K<RT()%)3N2G7,FCAKEGK
M]ORF4NMCCW$6=_7:SL*1M"1!'#F@C=:J*G0[)8359U\FNBVXSV5*$G]D6Q6<
M=/%B/D:FBP&A$3]FFBXLI5`D[]MMNW0,$=%U2_%*J9+9-7^5^%]U^M?7E>M`
M[0@=V0TC;.SB%A!<1;@)&2]1IGCT)\WSXM7BXD_K0:^.X_3>H=F1\&E(_'+%
M;9G>785&/KG"LF,.W9G3DRG"VNC$XF1Z1@1M9U!LJ'J8PGUZ]R404WV>+Z?3
MV3?_7P````#__P,`4$L#!!0`!@`(````(0`Z"I%8]@(``#P)```8````>&PO
M=V]R:W-H965T<R]S:&5E=#,N>&ULE););MLP$(;O!?H.@N[1+GF!Y2!2D+9`
M"Q1%ES,M4181211(.D[>OD/2=D)Z2>R#;9G__/IF.-1X<?O<=\X39IS0(7=#
M+W`=/%2T)L,Z=__\?KB9N@X7:*A11P><NR^8N[?+SY\66\H>>8NQ<,!AX+G;
M"C'.?9]7+>X1]^B(!UAI*.N1@$NV]OG(,*I54-_Y41!D?H_(X&J'.?N(!VT:
M4N%[6FUZ/`AMPG"'!/#SEHQ\[]97'['K$7O<C#<5[4>P6)&.B!=EZCI]-?^V
M'BA#JP[R?@X35.V]U<61?4\J1CEMA`=VO@8]SGGFSWQP6BYJ`AG(LCL,-[E[
M%\[+,'#]Y4(5Z"_!6_[FN\-;NOW"2/V=#!BJ#?LD=V!%Z:.4?JOE3Q#L'T4_
MJ!WXR9P:-VC3B5]T^Q63=2M@NU/(2"8VKU_N,:^@HF#C1:ETJF@'`/#N]$2V
M!E0$/:O/+:E%F[MQYJ63(`Y![JPP%P]$6KI.M>&"]O^T*-Q9:9-H9Q(#_6X]
M\J)I&J;9^RZ^)E()WB.!E@M&MPYT#=R3CTCV8#@'9YE9<C8S2$G&W,D@%0IJ
M#MOQM,S2A?\$%:QVDN)8$IF*\E@1!P>)#W@'1LC<9HQA#T]7?\\H@W(7WE\9
MLX.]2J/0DJE*($VR)+62*`W!+`ZB^.!@`$+AK@>401;@Y&"O`;5DI@`#+PC-
MY?+LL@&7F'"7JR;%%M34O&NA):F"@OX-X&4JRDL*`PT:[6W=+J-)L84V,V]<
M:$FBZV6NE:?7#)SL&API-G$F5AT*+3F-<WK-P)F8./)HOM_V,LC"LMJFT)*S
M775VV8"3H^W-<^/RUDFQ!64]#0HMT5T5RYZ"E[6#%R4&W.P:."FVX%Z/N3Z'
M6K)K^60:!$EJ24I3$DWA:?%Z<`PX&%17E$ZI+;S$+$RQTUSDLS0G`?7\T^-A
M1&O\`[$U&;C3X09Z+_`F<(:8GG[Z0M!1C8$5%3"UU-<6_J5@F!&!!^*&4K&_
MD//U\+]G^1\``/__`P!02P,$%``&``@````A`+*6=SL6!@```AD``!@```!X
M;"]W;W)K<VAE971S+W-H965T,BYX;6R46=MNVS@0?5]@_T'0>VS>105QBDI%
M=PML@<5B+\^*+<=";,N0E*;]^QUJ:(ND8E=*@,1.#H>'9X9S*/KAP_?#/OI6
M-FU5'U<Q79`X*H_K>E,=GU?Q/W]_OM-QU';%<5/LZV.YBG^4;?SA\==?'M[J
MYJ7=E647081CNXIW77>Z7R[;]:X\%.VB/I5'^,^V;@Y%!V^;YV5[:LIBTP\Z
M[)>,$+4\%-4QQ@CWS908]79;K<M/]?KU4!X[#-*4^Z(#_NVN.K7G:(?UE'"'
MHGEY/=VMZ\,)0CQ5^ZK[T0>-H\/Z_LOSL6Z*ISVL^SL5Q?H<NW\S"G^HUDW=
MUMMN`>&62'2\YG29+B'2X\.F@A48V:.FW*[BC_0^YS)>/C[T`OU;E6^M\SIJ
M=_7;;TVU^:,ZEJ`VY,EDX*FN7PSTR\;\"08O1Z,_]QGXLXDVY;9XW7=_U6^_
ME]7SKH-T2UB16=C]YL>GLEV#HA!FP7H:ZWH/!.!G=*A,:8`BQ??^]UNUZ7:K
MF*N%3`BG`(^>RK;[7)F0<;1^;;OZ\!^"J"%U"<)L$`[L[?_9U"!+)-2O[U/1
M%8\/3?T60='`E.VI,"5([R&P61@'>=Y?&)`Q8SZ:0?U00+>0C6^/+'U8?@,!
MUQ:2O0/Q$?D8P<D%L@1Z%XZP<)?C;6X&#&N(HPLW3B]A>_H90H0#D3XBOX7P
MJ,$\TZD9\"J&V`,UYD^<(43WFB8T21A-A0_)78CB\$75%=U@A=/)&7!`COLS
M9PB1/3F:PI<BP\R]M#E"X.=EB8.TGG!0]BXW4W?JIW5G!@4<`W4RA"!'1FA"
M2#HP0(XNA.J$*RT&B$=2^21O%YX!!^2&L%AX"+$"<JF9D,K7./<@!"1.]!#%
M(Y?,(6?``;E@Y@PA9W*"RR1`Y(B8D%QC>TY3N:V;`0?4$E^4#"%(3<F4B+#L
M;@`\S=(YQ`PX(*8#8@BQFE&F51KLF=Q%:.`NA[5YS"@4_W3->G3`;=2!3<15
M;,D!-RF5#+9+;@,A*!4RI8F^QC"PBMM9I=C>W6879BVS&)Q<<IY`N0_%CIO5
MQS!!N6"#QKZ$IFM/+CN*/=XC&!J%Q2#!.P9S<\Z"EIW[(.C7B4CH`/(ISO(+
M>C8,<PHPQIO9OR`AS@A72@QJ6,5PU!F3<IW086$^'=.NIRN&S=U3;%BG)8@8
MG%RE9%QP`4`/6]FG%AC$3ZIM[`RA+IDYKPW[01'.4S':#AY&IZD69-A7/L%9
MYD#'[A!.GED,:J<3PMC(NCP(T.?:.1[X]&;9`QW[@^.)-K6>06@IT@1:L=\0
M<QL(UT"E(H)J?:WZ9MD$Q1X/Q7TY6HC`H#*+@1*[8$;]!,.\#_$5G&46=.P6
M8FBD5D'7#"A5B0Q%SFT8U(\E*4^O[5TVRS!ZM&\8(C0SB\&Y)9-\[&8^1/+D
M:G+9++?HT0&]8=^A>A9C2XMIYUS4`W(?H`DTZTMU>IEELXRB1_O<9%#VF<6\
M7U66'?H-TD]@=SO'*Y_=+(]@9X]P2G[8;U8YUQ'`,`1U+-2R<R$ITTR2(8I/
MSS3PR9[!##H0+_0,BT%E4@&)#2HS]Q"4<BZ=YNFSFV4;YN$[9#?4C!7/M00X
M024!(+=!D#X#QTO%->EF608;6T;HIIG%X-R:2_@>YK:9Q3"V[E)XVE&#Z_G:
M!98Q[2Z`C:U#!DTWLQAO>P2].[^-\8G.,@XV-@[G$&Z3?,L5K(ZW(#Z]P#B,
MC@E4T>TC#!L;2+@/,HNYK2/&N8+QB)J+'G<K3R/:CPJV=-BK+0:+C@I-R%!S
M*&>`8-IY<O))SC(2/G[L<&Y',-D68W>$(M`1=;BI?0P!$-S5O>\F/'"3:=NF
M'^6KJ(8)+%'7,NXX/#P*Y^',ZNAAJ$I3]\+#5W*6L?"QL:BP<UL,*IDF1">*
M!'L_]S!*22T8&>+X!(U93+86;M"!@D$:,XNQ=:B`HI!CAAC(@KA47%Q/=N`O
M$Y,]]AFG"=MD(P:O_NB5XS7<<9LU6]"5XS7>8N,M[ZEX+K\6S7-U;*-]N85.
M1!:F%S5XAXUONOK4W^8^U1W</?<O=_!90PE/G&0!X&U==^<WYI;\\NG%X_\`
M``#__P,`4$L#!!0`!@`(````(0#[8J5ME`8``*<;```3````>&PO=&AE;64O
M=&AE;64Q+GAM;.Q93V_;-A2_#]AW('1O;2>V&P=UBMBQFZU-&\1NAQYIF998
M4Z)`TDE]&]KC@`'#NF&7`;OM,&PKT`*[=)\F6X>M`_H5]DA*LAC+2](&&];5
MAT0B?WS_W^,C=?7:@XBA0R(DY7';JUVN>HC$/A_3.&A[=X;]2QL>D@K'8\QX
M3-K>G$COVM;[[UW%FRHD$4&P/I:;N.V%2B6;E8KT81C+RSPA,<Q-N(BP@E<1
M5,8"'P'=B%76JM5F)<(T]E",(R![>S*A/D%#3=+;RHCW&+S&2NH!GXF!)DV<
M%08[GM8T0LYEEPETB%G;`SYC?C0D#Y2'&)8*)MI>U?R\RM;5"MY,%S&U8FUA
M7=_\TG7I@O%TS?`4P2AG6NO76U=V<OH&P-0RKM?K=7NUG)X!8-\'3:TL19KU
M_D:MD]$L@.SC,NUNM5&MN_@"_?4EF5N=3J?12F6Q1`W(/M:7\!O59GU[S<$;
MD,4WEO#USG:WVW3P!F3QS25\_TJK67?Q!A0R&D^7T-JA_7Y*/8=,.-LMA6\`
M?*.:PA<HB(8\NC2+"8_5JEB+\'TN^@#00(85C9&:)V2"?8CB+HY&@F+-`&\2
M7)BQ0[Y<&M*\D/0%353;^S#!D!$+>J^>?__J^5/TZOF3XX?/CA_^=/SHT?'#
M'RTM9^$NCH/BPI???O;GUQ^C/YY^\_+Q%^5X6<3_^L,GO_S\>3D0,F@AT8LO
MG_SV[,F+KS[]_;O')?!M@4=%^)!&1*);Y`@=\`AT,X9Q)2<C<;X5PQ!39P4.
M@78)Z9X*'>"M.69EN`YQC7=70/$H`UZ?W7=D'81BIF@)YQMAY`#W.&<=+DH-
M<$/S*EAX.(N#<N9B5L0=8'Q8QKN+8\>UO5D"53,+2L?VW9`X8NXS'"L<D)@H
MI.?XE)`2[>Y1ZMAUC_J"2SY1Z!Y%'4Q+33*D(R>0%HMV:01^F9?I#*YV;+-W
M%W4X*]-ZAQRZ2$@(S$J$'Q+FF/$ZGBD<E9$<XH@5#7X3J[!,R,%<^$5<3RKP
M=$`81[TQD;)LS6T!^A:<?@-#O2IU^QZ;1RY2*#HMHWD3<UY$[O!I-\114H8=
MT#@L8C^04PA1C/:Y*H/O<3=#]#OX`<<KW7V7$L?=IQ>".S1P1%H$B)Z9B1)?
M7B?<B=_!G$TP,54&2KI3J2,:_UW99A3JMN7PKFRWO6W8Q,J29_=$L5Z%^P^6
MZ!T\B_<)9,7R%O6N0K^KT-Y;7Z%7Y?+%U^5%*88JK1L2VVN;SCM:V7A/*&,#
M-6?DIC2]MX0-:-R'0;W.'#I)?A!+0GC4F0P,'%P@L%F#!%<?414.0IQ`WU[S
M-)%`IJ0#B1(NX;QHADMI:SST_LJ>-AOZ'&(KA\1JCX_M\+H>SHX;.1DC56#.
MM!FC=4W@K,S6KZ1$0;?785;30IV96\V(9HJBPRU769O8G,O!Y+EJ,)A;$SH;
M!/T06+D)QW[-&LX[F)&QMKOU4>86XX6+=)$,\9BD/M)Z+_NH9IR4Q<J2(EH/
M&PSZ['B*U0K<6IKL&W`[BY.*[.HKV&7>>Q,O91&\\!)0.YF.+"XF)XO14=MK
M-=8:'O)QTO8F<%2&QR@!KTO=3&(6P'V3KX0-^U.3V63YPINM3#$W"6IP^V'M
MOJ2P4P<2(=4.EJ$-#3.5A@"+-2<K_UH#S'I1"I14H[-)L;X!P?"O20%V=%U+
M)A/BJZ*S"R/:=O8U+:5\IH@8A.,C-&(S<8#!_3I409\QE7#C82J"?H'K.6UM
M,^46YS3IBI=B!F?',4M"G)9;G:)9)ENX*4BY#.:M(![H5BJ[4>[\JIB4OR!5
MBF'\/U-%[R=P!;$^UA[PX7988*0SI>UQH4(.52@)J=\7T#B8V@'1`E>\,`U!
M!7?4YK\@A_J_S3E+PZ0UG"35`0V0H+`?J5`0L@]ER43?*<1JZ=YE2;*4D(FH
M@K@RL6*/R"%A0UT#FWIO]U`(H6ZJ25H&#.YD_+GO:0:-`MWD%//-J63YWFMS
MX)_N?&PR@U)N'38-36;_7,2\/5CLJG:]69[MO45%],2BS:IG60',"EM!*TW[
MUQ3AG%NMK5A+&J\U,N'`B\L:PV#>$"5PD83T']C_J/"9_>"A-]0A/X#:BN#[
MA28&80-1?<DV'D@72#LX@L;)#MI@TJ2L:=/625LMVZPON-/-^9XPMI;L+/X^
MI['SYLQEY^3B11H[M;!C:SNVTM3@V9,I"D.3["!C'&.^E!4_9O'1?7#T#GPV
MF#$E33#!IRJ!H8<>F#R`Y+<<S=*MOP```/__`P!02P,$%``&``@````A`%6"
M$TJ6`P``G0P``!D```!X;"]W;W)K<VAE971S+W-H965T-#DN>&ULE%?;CMHP
M$'VOU'^(\@Z)<P&"@&JWJVTKM5)5]?)L$H=8F\21;9;=O^_8#ME<R!)>@(3C
M<^;,#)-A\^FER*UGP@5EY=9&<]>V2!FSA):'K?WG]^-L95M"XC+!.2O)UGXE
MPOZT^_AA<V+\262$2`L82K&U,RFKM>.(.",%%G-6D1*^21DOL(1+?G!$Q0E.
M]*$B=SS773@%IJ5M&-9\"@=+4QJ3!Q8?"U)*0\))CB7$+S):B3-;$4^A*S!_
M.E:SF!454.QI3N6K)K6M(EY_.Y2,XWT.OE]0@.,SM[X8T!<TYDRP5,Z!SC&!
M#CU'3N0`TVZ34'"@TFYQDF[M.[2^1Y'M[#8Z07\I.8G69TMD[/2%T^0[+0ED
M&^JD*K!G[$E!OR7J%AQV!J<?=05^<BLA*3[F\A<[?27TD$DH=PB.E+%U\OI`
M1`P9!9JY%RJFF.40`+Q:!56M`1G!+_K]1!.9;6U_,0^7KH\`;NV)D(]44=I6
M?!22%?\,"-54AL2K2>"])D'A//#"Y6H"BV,BT@8?L,2[#6<G"[H&-$6%50^B
M-3"?G9DX&J]C5L&C(KE3+%M[:5O@0D!]GG=!%&Z<9\AI7&/N#09>&PQJ$`Y$
MTX0$8;1#NISDL[("*V65=!7*O;G1EO$NR_A=&>4\&*WI64X=@NJU3`31HN$W
M$1A,T,*\I:)C%"#3C2KPU@9W3?J":-E3-IB5+H`7+/Q5\WU'%UQ.UU7@KJ[O
M^PVO<6PPH=:=(12&(X87MP@K<%^X;]A@&N%ET`36,0R-.=VP`G=UAXDV&*.+
M4.1&EW75_&_]N-[O9`7NZ[X5T"3:8":T5M15GM;<ZM"UYC:8"1$@F++3S6MT
MWWV_VC7(I-U#R[&T(S5J)N==H[O2PPZO0>=.<Y'O7BXYNFEZ:71?>V#;C+1&
M.QR3[DVT]]L-F3'U_D"I076CNZ$WTNA(39Y6QE6_^=``5T(P\ZH;PIN":7E-
M#:.Y-?A&IHMZ(O>#N#[1]:EK75^#I@1QTXQ#PR$W'#8UJ&[[:+0&-TTY-!QS
M%[J^/>=F"):-D::_:="AX:3S_4'3GT>=6B9FR!N9[+#U=6I^I>',].HVW$#9
M@,Q3%/FK_J_-;(EFB2H(/Y#/),^%%;.CV@`1/`2;N\UV>N?I_;+Y`I;#"A_(
M#\P/M!163E(XZLZ7T,'<K)?F0K)*KVA[)F$MU!\S^!M`8-%QYP!.&9/G"[7`
M-G\L=O\!``#__P,`4$L#!!0`!@`(````(0"2KOT9]0,``%00```9````>&PO
M=V]R:W-H965T<R]S:&5E=#0X+GAM;)R876^;,!2&[R?M/R#NQU<@(5&2J02Z
M3=JD:=K'-0$G006,;*=I__V.,:$8.CM=+T@@CU^?]QP#QUU_?*I*XQ$16N!Z
M8[J68QJHSG!>U,>-^>OG_8?0-"A+ZSPM<8TVYC.BYL?M^W?K"R8/](00,T"A
MIAOSQ%BSLFV:G5"54@LWJ(9?#IA4*8-3<K1I0U":MX.JTO8<9VY7:5&;0F%%
M;M'`AT.1H1AGYPK53(@05*8,XJ>GHJ%7M2J[1:Y*R<.Y^9#AJ@&)?5$6[+D5
M-8TJ6WTYUIBD^Q)\/[E^FEVUVY.)?%5D!%-\8!;(V2+0J>>EO;1!:;O."W#`
MTVX0=-B8=^XJ<7W3WJ[;!/TNT(4.OAOTA"^?2)%_+6H$V88Z\0KL,7[@Z)><
M7X+!]F3T?5N![\3(T2$]E^P'OGQ&Q?'$H-P!..+&5OESC&@&&049RPNX4H9+
M"`".1E7PI0$929_:STN1L]/&G,VM8.',7,"-/:+LON"2II&=*</5'P&YG900
M\3H1'Z+O?O<L+PS<8/X&%9BO#04^KRJ!Y7O!(KPA%EOX:M,4IRS=K@F^&+#V
M('+:I'PENRM0ON9'N.DS]J^$0::XR!U7V9@+TX!<4*CRX]8/%VO[$2J3=4PT
M919S&=E=$5X'KAN/+R3B`AS[B=Q>PP9+O2_(^=#7Z_6^AL]A'OYUWDA<&$[C
M]=.TD>VFQ&)D.)XB?AC*,LF4&<A(AF:R(5ZH&=P.:F-\$'"#=/GA4@XA$@RL
MS3ZE@4SLM$2L)1(5(?F$0(:%N\TG'[0Q(9F]!W_IR"XBP:A\:HE8$&&[PKW`
MX7_R+(E*0_()-]O0I[J.'![[>UGX[8J,!!.TL;G+N1/Z<F@['1`+0)&A9"CA
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M"\'\AUL^:OQ@&C^`8?/%(:5;+1)W*J(Q<E]=P"H1859LXL3NI$+DB':H+*F1
MX3/?H'G0V/17^\WCG<>;]M'UR%W!S@&NV_T/L*=KTB/ZEI)C45.C1`>0=*P%
M-#1$[`K%"<--NR?:8P:[N?;K"7;O"#8CC@7P`6-V/>$3]/\/V/X%``#__P,`
M4$L#!!0`!@`(````(0!37DP9D`0``&82```9````>&PO=V]R:W-H965T<R]S
M:&5E=#0W+GAM;)28;6^K-AB&OT_:?T!\/P$;#"1*<E1>NAUIDZ9I+Y\)<1)4
MP!'0IOWW>XP)P68U5*K:`A<WOI\78[/]_EX6QANMFYQ5.Q.M;-.@5<:.>77>
MF7__]?PM,(VF3:MC6K"*[LP/VIC?]S__M+VQ^J6Y4-H:H%`U._/2MM>-9379
MA99ILV)76L&5$ZO+M(7#^FPUUYJFQ^ZFLK"P;7M6F>:5*10V]1(-=CKE&8U9
M]EK2JA4B-2W2%L;?7/)K<U<KLR5R95J_O%Z_9:R\@L0A+_+VHQ,UC3+;_#A7
MK$X/!?A^1VZ:W;6[@XE\F6<U:]BI78&<)08Z];RVUA8H[;?''!SPL!LU/>W,
M)[1)D&]:^VT7H']R>FM&_QO-A=U^J?/C;WE%(=J0)YZ!`V,O'/UQY*?@9FMR
M]W.7@3]JXTA/Z6O1_LENO]+\?&DAW00<<6.;XT=,FPPB"C(K3+A2Q@H8`/PV
MRIR7!D0D?>_^WO)C>]F9CK<BONT@P(T#;=KGG$N:1O;:M*S\5T"HEQ(BN!>!
M.WH1A%<X((AX\RJ6&%%G,$[;=+^MV<V`JH%G-M>4UR#:@#)WYD!\Q#@&KY]9
M!8]<Y(FK[$S?-.#V!O+SMG<#M+7>(*99SX13QO=D)+HC/()<-[Z?>.@JJLF=
MX.D#2X,OB-;8U_]GZCY\#O/AWY\;BA.@/?C!RE"GA._+2#Q%%)%D2HQ$)#O.
M5^QP&-(X&KV#B#RX4##NB%&(:):(9XE$1TC^8"#+T\7AG0G!&[+C!DIH0\$$
M72UB;!/B8D<.031&D.\3UW4"&8G'2(`=UW9\6T:2,4*<`*\#_"AKR2.TUW*/
M'%8]*@9"P?BX,ZDT1J2[&.LN)I]<E+QX7_'"8=6+*X<Q%`P$<\BI6H^S1#Q+
M)#I"\@=3V?)<<7BNWP2C\S=+Q+-$HB,D?WQE,IKV]=,CA]7\J?TF&")*,7`)
M09XR'T82XKH!";!2M/$8\?':(3Y6'I2,$1=C@ASGDWY;?\4CAU6/:K\)IN\W
M>Q4H-1RIUY6AQ^KUM=P#B7+=?\Q&4NX0O)^7)Z^C56=*;X4]I"O/>22>1Q(M
M(KOD;_;%)8K$.@#>-\/\,7WG]9#6I=#1(/&\2J)%9)=\";#<I5@PZ-]\2$!]
M*_J!ZR*U4&7$(Q[\R+482PC!OFO[2K,F"H(]#STJ6G;)UP'+78I5@^Q2[44D
MH*$9[4>S=$O':`(\QM:O+54%)02)JO#P+YN#8OF".4ZK[:@\.40"TE1A-(_$
M\TBB1627?%6P/(5B#0$1UK6C@+0N9Y&8[\,@H!J51(O(+OD"8;E+L9R0"U69
M]$,D(+$210$B@:L@D8QX"*V]1ZWUQ3I6<9%CD]%.H4,22<5S"`I&'2N[Y,N$
MY2[%HD)V.6E'`6G:404F[:@"RCN*;_!YHH='H$<8A3NQ?1>[VY+69QK1HFB,
MC+WRK;D#2Y/A[/#9X`GS39]R/D0;V(I.S\?\,P,_;PTWP"[_FI[I[VE]SJO&
M*.@)'F6O?"C*6GPG$`<MNW9[[0-K87_?_7N![SD4-KGV"N`38^W]@#]@^$*T
M_P\``/__`P!02P,$%``&``@````A`,'7HS;D!```B10``!D```!X;"]W;W)K
M<VAE971S+W-H965T-#8N>&ULE)A=CZLV$(;O*_4_(.Y/P(#YB)(<;8!MCW0J
M554_K@EQ$K2`(R";W7_?,28$FQZ;WNQNV,>#WYD7,YG-UX^J--Y)TQ:TWIIH
M99L&J7-Z+.KSUOSKS]<OH6FT758?LY+69&M^DM;\NOOYI\V=-F_MA9#.@`AU
MNS4O77==6U:;7TB5M2MZ)37\YT2;*NO@8W.VVFM#LF._J"HMQ[9]J\J*VN01
MULV2&/1T*G*2T/Q6D;KC01I29AWLO[T4U_81K<J7A*NRYNUV_9+3Z@HA#D59
M=)]]4-.H\O6W<TV;[%""[@_D9?DC=O]A%KXJ\H:V]-2M()S%-SK7'%F1!9%V
MFV,!"EC:C8:<MN8+6J<H,JW=ID_0WP6YMY._C?9"[[\TQ?%[41/(-M2)5>!`
MZ1M#OQW9)5ALS5:_]A7XO3&.Y)3=RNX/>O^5%.=+!^7&H(@)6Q\_$]+FD%$(
MLW(PBY33$C8`/XVJ8-:`C&0?_>][<>PN6]/U5SBP702X<2!M]UJPD*:1W]J.
M5O]P"`VA>!!G"`(KAB#(63DA1MC71['XCGJ!2=9ENTU#[P:X!N[97C/F0;2&
MR$R9"_GA^QBU_D@J:&1!7EB4K1F8!BQOH3[O.R]P-]8[Y#0?F/V<"7P1B1\(
MRR"+FSPN/.,B<4GZ(%CY0-*H"[(UU?7?E7ILG\%L^X_[[OD%B#WJ<<3[QG,B
M"$0DF2-2D'1.3(((<EQ1SJ-,:EEL$91SHL(+/'&3>\YX$P:+1*PE$BV1J@A!
M)VQD>=D8O#4AB6.5O$#:_9XS8>])!T4!AF=.$CA%4&`[KNM)QDRF"`YPY(:R
MO5,!03C$CO>\D:`1'K/E&ADL:Y1VM^<,;&#,@Y2%6$LD6B)5$8(^7]2WS*ML
MD<ZKG%'IU!*)EDA5A*`3CKOE=62P7$>I2GO.X-ZK*`RC:.:R6$"<T+6Q+[DA
MF2)>&&#;F1PJ_;&:"HCM.[;K1N-#(6AD'<SD]:`^;Q@L:Y0.Q3UG5#74$HF6
M2%6$H"\2]2WS*END\RIG5#JU1*(E4A4AZ$3P3E]>R)Z6*RF[=8"X73T;N5@B
M8H%P_""8>54@X%2-9"(5"&3[OF?_P*J(M0*+O=K3LL1P?`CZYV0_0*HJZI%$
MCZ1*1"PDZQDF*I<Y%O%.`U[#XRMBW@H,D%(MCZ-`$GV45(F(:EGC,%&K/G\0
M;S/4#<$`#:>LAYU(?MO'(H)<W_$D9R0"XN$0>9%T#J<"XD88(_?9?(DJ(9__
M0R6C9><^GXG!N1Q2%"I&6B31(ZD2$56R!F)2RX7.Y6V'QKFJWJ1/2,R^KD'6
M%`E)]$BJ1$2UK(V8J-4XES<=&N=RB#O7]7WD2JZ,T91`GH/]R6'9YR$1$#AQ
MIZ;LB50@G!"%GOU\B8L:61^Q7"/O.@2-H2V?N!Q2E"E&6B31(ZD2$56R9F*B
M<J%O>0NB\:VJ3QE\JT42I$52)2*J92W%1*W&M[P!$6HZ^PH&DQGVZ/'O8"'&
MMBU5/18(.&]=A)^6&WP[#>*XX3P*FP`][P-?\[P(/V<07"2?\/`!2$6:,XE)
M6;9&3F]L>N-"YSU>'2=++PZ;"TC7]V@-TXKY]81-HMAU:UP`@Z!K=B:_9<VY
MJ%NC)">XE;T*X$!J^"B)?^CHM1_''&@'(Z#^SPN,_`C,0>P5P"=*N\<'=H-Q
MB+C[%P``__\#`%!+`P04``8`"````"$`S0#8,%H"``!+!0``&0```'AL+W=O
M<FMS:&5E=',O<VAE970T-2YX;6R45-N.VC`0?:_4?[#\OG$"8=E%A!44T:[4
ME:JJEV?C3!*+.(YL<_O[CF,(5&PE^I+$SIDSY\R,/7TYJ)KLP%BIFXPF44P)
M-$+GLBDS^O/'ZN&)$NMXD_-:-Y#1(UCZ,OOX8;K79F,K`$>0H;$9K9QK)XQ9
M48'B-M(M-/BGT$9QATM3,ML:X'D7I&HVB.-'IKAL:&"8F'LX=%%(`4LMM@H:
M%T@,U-RA?EO)UI[9E+B'3G&SV;8/0JL6*=:REN[8D5*BQ.2U;+3AZQI]'Y*4
MBS-WM[BA5U(8;77A(J1C0>BMYV?VS)!I-LTE.O!E)P:*C,Z3R2*E;#;MZO-+
MPMY>?1-;Z?UG(_.OL@$L-K;)-V"M]<9#7W._A<'L)GK5->";(3D4?%N[[WK_
M!619.>SV"`UY7Y/\N`0KL*!($PU&GDGH&@7@DRCI)P,+P@_=>R]S5V5T^!B-
MQO$P03A9@W4KZ2DI$5OKM/H=0,F)*I`,3B3X/I$DHR@=C,9/=["PH*@SN.2.
MSZ9&[PD.#>:T+?<CF$R0^>PLZ.B]_LLJ>O0D<\^2T3$EZ,)B>W:S=)Q,V0YK
M*DZ81<#@L\=<$`S5]))0QK6D]XM\SNS!/K,ONI>R"!O7:0:]D+_2#/\GC0=C
MUZ[$#^.+_)`Y8-(KS.C]S`BYWZ`'9Q1=]65+QQ='(7/`I%WA+ZJ"VS#4H><*
M3`F?H*XM$7KK!S;!F'ZW/TOS07<<^A\XRRTOX8V;4C:6U%!@:!R-<7A-.`UA
MX73;3=1:.YSB[K/"2PNP+W&$X$)K=U[X\]9?@[,_````__\#`%!+`P04``8`
M"````"$`N7<&G<@#``"3#0``&````'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;)2776^C.!2&[U>:_X"XGX#)1YLH9-10=7>D'6FT.[-[[8"3H`)FL-.T_W[.
MP03\T53DA@3R\OKQ\3GVR?K+:UEX+ZP1.:]BGTQ"WV-5RK.\.L3^SQ]/G^]]
M3TA:9;3@%8O]-R;\+YM/?ZS/O'D61\:D!PZ5B/VCE/4J"$1Z9"45$UZS"G[9
M\Z:D$FZ;0R#JAM&L?:DL@B@,%T%)\\I7#JMFC`??[_.4/?+T5+)**I.&%50"
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MNEDW_.Q!G@*PJ"EF/5F!X?OA@#B@]@'%L7\'"Q;[`M;D91.N@Q>(>MHIMDH!
MUUY!3$5R4>#"`4,/`E,8#X)B!,%U0K*M>J"/&UGCNHIIKS!`(`HZ"";*%'+T
MX\C@2Z#3YCWKW16A4LPTQ=Q4)!\I#$(PT0D_)D-Q[,/L^Q59F.-NE4(GNS,5
MB:L8V`TR2.+Q9"@VR>[-<;=*H9,M347B*JZ0+6XA0[%)1NQ$5Q(=C=B9[DJN
ML$%!Z5$;EW'XDL5HI?Q6273&`:!-RD0IYFTID]D\G(5DR%MC9?'P'+U/H-AB
M&XI-E8.2Z&S:R`K.E0SX!MOR%C846VR#K6)3$H/-JIG$E0PF!AN!K6-\X%JU
M16<5X[;3&'A6X23O:*[QX7X\>F&)VKWUW818);GM-#I?9%5/\H[F&A_NV^/Y
MU"ZO\T5666[QL(0,,/BLRDG>T5SCPUU[/)_:XPT^NS*(>PZX\7,UU_A@GC?P
MH=K,OVC8$%1U$*59M)O&C"R)$SPE@&M_Y%R#N^F\P';-AAN,.SCW0(CLVNU\
MQO#==&I`S^OP.<7K'@J14[RN9IBFVEQ4RZL:N9(U!Y:PHA!>RD_8PA)8FOYI
MWY-WS7+_`W2W-3VP;[0YY)7P"K:'5\,)-J*-ZH_5C>1UVR;NN(2^MOUZA#\_
M#-JN<`+B/>?R<H--7?]W:O,;``#__P,`4$L#!!0`!@`(````(0``6P#,?P(`
M`"T'```9````>&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;)Q578_:,!!\K]3_
M8/F=."%``!%.A]"U)[72J>K'LW$<8A''D6V.NW_?=0PI!-KF[H7$879V9G>S
M6=R]R!(]<VV$JE(<!2%&O&(J$]4VQ3^^/PRF&!E+JXR6JN(I?N4&WRT_?E@<
ME-Z9@G.+@*$R*2ZLK>>$&%9P24V@:E[!/[G2DEHXZBTQM>8T:X)D289A."&2
MB@I[AKGNPZ'R7#"^5FPO>64]B>8EM:#?%*(V)S;)^M!)JG?[>L"4K(%B(TIA
M7QM2C"2;/VXKI>FF!-\OT8BR$W=SN**7@FEE5&X#H"->Z+7G&9D18%HN,@$.
M7-F1YGF*[Z/Y:HK)<M'4YZ?@!W-VCTRA#I^TR+Z(BD.QH4VN`1NE=@[ZF+E'
M$$RNHA^:!CQIE/&<[DO[31T^<[$M+'1[#(:<KWGVNN:&04&!)AB.'1-3)0B`
M7R2%FPPH"'UIK@>1V2+%\208)V$<`1QMN+$/PE%BQ/;&*OG+@Z(CE2<9'DG@
M>B2)QL%H.$ZF/5B(5]087%-+EPNM#@B&!G*:FKH1C.;`[)S%4)_;SL"2B[EW
M04THH`UTXWD93Y(%>882LB-F=0LS:S$$TK<:(.^YAG_G=N!N[FG+V^A;W<`D
M88NYR!U?YN[GWP6E&++\\9]$+;_7X#&C,\RX15PH`,BY^WX*7!!TZHP]3H8M
MOU?@,3T4P`R^78$+ZM8@[BCPF%DS(</@+_XG[\GN@KK91YWL'M/#?_(>!2[H
M?QWPF!X*W'?BS6^A"^K6H-L!C_$=&%RWP&\\OQ!JNN5?J=Z*RJ"2YS#:89!`
M![7?=_Y@5=V\?!ME84\UMP5\ECALA3``<*Z4/1W<1FT_=,O?````__\#`%!+
M`P04``8`"````"$`KIK3M4P/```[2```&0```'AL+W=O<FMS:&5E=',O<VAE
M970R."YX;6RLG-MRVS@2AN^W:M_!Y?NQ15*D)%:<J>A`D13/UNY>*[(<JV);
M+DF9S+S]-@0T&T#32NSD)G8^=/\`V``(M"!_^//OI\>+OS;[PW;W?'/I7/4N
M+S;/Z]W=]OG+S>5_EM$?P\N+PW'U?+=ZW#UO;B[_V1PN__SX[W]]^+[;?ST\
M;#;'"U!X/MQ</AR/+^'U]6']L'E:':YV+YMG*+G?[9]61_CO_LOUX66_6=V=
MG)X>K]U>+[A^6FV?+Z5"N/\9C=W]_7:]F>[6WYXVST<ILM\\KH[0_L/#]N6`
M:D_KGY%[6NV_?GOY8[U[>@&)S]O'[?&?D^CEQ=,Z3+X\[_:KSX_0[[^=_FJ-
MVJ?_,/FG[7J_.^SNCU<@=RT;ROL\NAY=@]+'#W=;Z(%X[!?[S?W-Y2<G7'K.
MY?7'#Z<']-_MYOM!^_WB\+#[/M]O[[+M\P:>-L1)1.#S;O=5F"9W`H'S-?..
M3A&H]A=WF_O5M\=CL_L>;[9?'HX0;A]Z)#H6WOTSW1S6\$1!YLKUA=)Z]P@-
M@'\OGK9B:,`36?U]^OE]>W=\N+GT@BM_T/,<,+_XO#D<HZV0O+Q8?SL<=T__
MDT:G'K4BKA*!GTK$@?'UD\Z><H:?Z.Q>]5U_,'Q+$_I*!7ZBRM70]_O!</#S
M_0#+T\.`GTID>#5P>B/O#1J!TH"?[V_(0(G`SW<W9*0TX*?2\-X<6`?&HQP>
M8F#*T+MO5VD'&?SR[OXX.,K$+TK%>7N,'1QOXI?W-P;'F_-+`T[,5/E\?V7(
M.3A<Q"^J2^^(-4Q9V1;X1:F\(]8X[!P:=S\]B:[EXG1:ZZ:KX^KCA_WN^P6\
M0&#<'%Y6XG7DA"X,15SEY)K4KGNO+7NPW@F53T+FYA(>$JQH!UBK__KH!>Z'
MZ[]@?5TKFS&W<4R+"5J(Q53(3FTPLT%D@[D-8ALD-DAML+!!9H/<!H4-2AM4
M-JAMT-C@U@9+#5Q#`-LHPKS]'5$4,B**^/S'""BL5E`G:($N4QO,;!#98&Z#
MV`:)#5(;+&R0V2"W06&#T@:5#6H;-#:XM<%2`T;(8(W\'2$3,K"ST"=>SYI6
M8VDC%O=V=OK6S&M-VC@R,F,D8F3.2,Q(PDC*R(*1C)&<D8*1DI&*D9J1AI%;
M1I8Z,0(+KZW?$5@A`XLR5-,&S0L\,VQC970NLJU)&UE&9HQ$C,P9B1E)&$D9
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M9E`5&;83;](2&M5>;V#&:-H:80MGBHQ:H:BU(2''M\(RET:P5Q>/PAD.1Z/A
MP+*)6R&L+&&5I:W-F<H69F7NT.OY06#V+&N%L+*<55:T-F<J*XW*^I!>Z+D#
MZS%6K1!65K/*FM;F3&6W9F6]P.UYWLCLV;(5@LJ,,21R?/JIZ?P8$M;F&)+$
M==O03UI";?9Z0[,]T]8(.S]3Q&N%(F8SE\0;G`9,'^:Y;^W^8N:3,-V4V2P,
M73<8#-C(8#XYTRV836GHCKSAR-:MF$_-=!MF<VOH.KT@Z/?L@.M.1L#AR/V&
M@`MK,^"*:(M&2_2`6^V9MD9MP!71%@UF,Y<$5XB^[X[ZUIR-F5/"A%-FLS"%
M'3CB]ZTAFC&GG`D7S*8TA/O^T.F/K!97S*EFP@VSN36$O9'O.Y[U0EKJ3D;,
M18KN#4$_F9M15TB?YX2TN-N[M"E9M8%'I$UU1+2,S!52D]T+`L>S(A1SKP01
M::>(2'MA:CN02`[L"91QMQP1B1>(2+PTQ6'6LT!5W*M&1-H-(M*^-;7=H3/L
MVZ_GI>%F#@.1=-$7>YDB>^.VWY&I&SC/843'B+1%@9`^.JP-\I2L4&N&2%L7
M%/)(?HYH='H50!*_U[/.!S&:D%?"M5-NM4`DM6%M\!S?>GEG:$/B.1<ON%6)
M2(J[WI"WO$(;$J^Y>,.M;A%)<?AXIC^R-UU+M#F)F\-#)'A^?7C(-)$Q/"0R
M%@^)/#H:3$56!]XUFM4,$0VU2*$^#,+V;,AWEFCEGH:'ZXP&/CP-<P\2HY'\
MG$ID:1->84I69RI<H)6LT!GT7,^S7U49&E&%.:^P(*LS%99H)2OT!SXL-/;F
MN4(CJK#F%39D=:;"6[12%3K^T'?[UB-=HM&I0G-PB2S3N<&UW+W`*^>'V7F5
MK#*32=:+<"QR36+;`B.J'2363G%"-KCT3#F:<11Q-.<HYBCA*.5HP5'&4<Y1
MP5')4<51S5'#T2U'2P.9T1:9)SW:YX\5X@,R:YN)B!:("4=3A3P]T*Z]!YF1
M%88ZXFC.4<Q1PE'*T8*CC*.<HX*CDJ.*HYJCQD!F>$3Z2`_/^S8",@D%HP`?
MZUA\5BD"J4>-H:FR\OIR=699H!D9H'+$T9RCF*.$HY2CA4):PS.RZL[4Y&2`
MK2PX*CFJ.*HY:@QDAD]DA/3P_6!VR022$2>)]'P>=%V$3D-31/IBZ[K60CHC
M*WP,$4=S1/)^B7C9QHAT><_.""9DA?(I1PM$]*;+$.GRK/4Y6:%\P5&)B%I?
M(=+E6>MKLD+YQD!F7$66!N,J;L>\;UJJ7(\^+2728CL1UP#L<"NDI]T].Y<Z
M0\=^.^LCCN:(*!XQHK/R"5GA`TLY6B`B^0S16?F<K%"^X*A$1/(5HK/R-5FA
M?&,@,]PB1Z.'^P?36*9TC&DL40!+;+O/@<.*N<^=B)$$H0XH8E-$-)YGB&CI
MCA"1U5PAN+B!'8P1T6DE4<BEYY=RJX5"6KLR1%1CCHC:52`BJU(AK5T5(FI7
MK9#6KL:P,L,CTBEO"(_*ONC33J)`/ZMXCI4.FHA+,!`>EQRGB/1M#3ODS)25
MRI!`*@!R0H%U4(U("@,V1T05QH@HU9"@>B!/V-86.R4/?>A9M2_0BJK*$)WM
M6XZURU2OT^\/_:%K90\*DL*^E8BHP@H1]:U&==4WZQ33D$=WWXQA(JX:O6&8
MG,S-W)I"/HP#;19;R:X).M+,FR*B$3Y3"'Z</E,9#/M]^XT:<;<Y(A*/$9%X
MHA!,'R%N-3`E![T;]HA`*ZHI0T0UY5B3ZD8`']7XUKPIN%N)B,0K1"1>H[CL
MAI6H;LBANQMF\$4N3%\CWO7&A@<J5@!]95?(6#K<H97BFB@K?>E`1(O]#)'X
M*%!\S@9'=_O@'J$-N<T1T52*$9%5@DA-)?/5DV*I^=9D8T+V7^M&1HXXM7-$
MJAN!XXP">T5`&VI@B8BZ42$BJQJ1[`8;$ZJ!KW7#'!.PLOV&,2%4K#$A40"O
M\W:=8!O:">3/3HXT!Z8*N;"_:QWYZP2MAJ=AXKH]N!GM6A_'1FA$-^OFO,*8
M6R6(5%+5SM:F6*ZWT7/82&&=R[H<6>=RM)*=<P8#O]^W/T\HT(@Z5RH$;P0<
MAQ6WJA&]TKD&RU_KG#E^X$1Q=OS\7*8,9A,;0`K15FJ"5H2F"EDY%6NFS<@*
M'TS$T9RCF*.$HY2C!4<91SE'!4<E1Q5'-4>-@<RPP>)P-FP_=:?*%2K6M%>(
M0C1!*T)3A5[/J9`!!4PJ@P^B.;>*.4HX2CE:*`3G793/R.J5G`H9H$_!4<E1
MQ5'-46,@,WPB3:6_R<\?QL077^PX2:0?LI65AJ:(]+0!6\1G9(6/(>)HCHC.
M03$B79YE)1*R0OF4HP4B.L5EB'1YUOJ<K%"^X*A$1*VO$.GRK/4U6:%\8R`S
MKGJN3!SVWK=#XRDTE^7+)AQ-$<%,:U^]/*="5MBCB*,Y(HI'C.BL?$)6*)]R
MM$!$\AFBL_(Y6:%\P5&)B.0K1&?E:[)"^<9`9KA%#NL-TUB86\NM1#_(J8B]
M%#AJN8LI(AK/,T2T`D:(R&JND+;'B!'1J251"#:J^!A2;K502&M7AHAJS!%1
MNPI$9%4JI+6K0D3MJA72VM485F9X1"KJ#>&1F2OC8"21<3#B.1576L';&A_6
M%!'L(-N9R/:),V6E<BH#=^3Y`]?*#T0DA>IS1%1AC(CR#@FJJ\.2=<Q(R8.:
MV+$'9GW+NAQ9WW*L75V?@W7;\3QVJE;JU.H2U:EO%2*RJE%=]FU@90<:\NCN
MFSE,1$KL#<-$9M",82+1CW(JRI%V]U-7(1KA,X4@,2`V+;X[@#LWUG8XXFYS
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M-OLOF\GF\?%PL=Y]$W_QH"^:WF+\<PQ>^`G$X>5NE<#%HE#<>N$E\"<</IU>
MALP#'#KLQVX(WZ?D.F.HH%._'WZ"ZTP=#OT0ON;%.9S>0K&EYR5PB`O%>:RK
M)("2+A\XK(5B!\]]X,P6BN-75TD`)5T^D&*"DJYN0AHC%*D$K@:I`_#I*AE#
M"\:=]4R@1!S*N!H<PT-QHNXJ":"DRP>.VZ$X@W$?.'5#J[O4X(`&)5T^<&,A
M%!]C<S6XN!"*.PA=)0,HZ?*!"PJA^-2:^\`]A5!<.>@J&4!)EP]<JX*2KF<-
M5W="<7V&J\%U&?#I*AE#"\:=]4R@1%Q$X&IP]204MTBZ2@90TN4#5TQ"<>^`
M^\!-$VAUEQI<2H"2+I^Q'\)7%;E6Y(?P_4#."S^$+^5Q/@Y"^&(<YU$0PE?;
M.$^#$+Z<QGD1A/#U,LZ;((0OB`&_;E<>^-,M+ZLOFWRU_[)]/EP\;NYAH>N=
M;GGOY1]_D?\YJAN7GW='^*,ML%6"Y`C\D9X-W,WI74$RZWZW.^)_1`7MG_WY
M^'\```#__P,`4$L#!!0`!@`(````(0"7@K;1$`@``-0D```9````>&PO=V]R
M:W-H965T<R]S:&5E=#$Q+GAM;*R:6W/B.A:%WZ=J_@/%^P%\X5I)3H6++V"#
M<9V9>2;@!%<#3F&GT_WO9\N6+$N+Z0DS_1*'SUO+EI:V+,E^^//'^=3ZGESS
M-+L\MHU.K]U*+OOLD%[>'MO_^,OY8]1NY<7N<MB=LDORV/Z9Y.T_G_[^MX?/
M[/HM/R9)T2*%2_[8/A;%^Z3;S??'Y+S+.]E[<J$SK]GUO"OHY_6MF[]?D]VA
M+'0^=<U>;]`][])+NU*87+^BD;V^IOMDGNT_SLFEJ$2NR6E7T/WGQ_0]%VKG
M_5?DSKOKMX_W/_;9^9TD7M)36OPL1=NM\W[BOUVRZ^[E1/7^8=B[O=`N?X#\
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MJP-/![X.ECI8Z2#00:B#M0XV.HATL-5!W`!=LJ?VB'KU[_"(R3"/1.M.!6B8
MIADB(D21N0X6.G!TX.K`TX&O@Z4.5CH(=!#J8*V#C0XB'6QU$#>`8@@-%;_#
M$";SV*:_C:3IJPY,JQB#[J0.TD)F=4CM$I`%$`>("\0#X@-9`ED!"8"$0-9`
M-D`B(%L@<9,HIM%@_3M,8S(T6-)E:D/,WD!SC0?]RK4ZI'8-R`*(`\0%X@'Q
M@2R!K(`$0$(@:R`;(!&0+9"X2137:`:BN'9[^B8>0RRZ-$<TZI237OE,TFR:
MU2>;7@YK+Y4;H4?\'3?"HM4;X<2LA]\9D#F0!1`'B`O$`^(#60)9`0F`A$#6
M0#9`(B!;('&3*`U/DPJEX=D,Q>QWR+L[YRA,2/6$$^I\C5P>U?Z7<Y!9'23Z
MU!S(`H@#Q`7B`?&!+(&L@`1`0B!K(!L@$9`MD+A)%)MH[JC8].M$9=&J%YPT
M\@/(',@"B`/$!>(!\8$L@:R`!$!"(&L@&R`1D"V0N$F4AJ?UTAT-SZ+5AN=$
M38*QE@1U4)T$0!9`'"`N$`^(#V0)9`4D`!("60/9`(F`;('$3:)XP5:B=YA1
MAJMN"-3(`T1S1`M$#B(7D8?(1[1$M$(4(`H1K1%M$$6(MHAB!:E>L.44+FT[
M;.NC.*;[;].,1GT*NC%2631=X`O;:E%&\SW1\Z<&1]56#UNGS@0:U%%SCBPE
MKXR>FE<+&27D'40N(@^1CVB):,41;5F(*P8RJO$<-+3%>2BC1,$UH@VB"-$6
M4:P@U4BV#/O_C:P6<XJ1',FFF+&%%AL?)9IS-*BFD&;/T/8U%C)`-(R#R$5E
M3T95&R:&I?8.7P8(Y26B%2H',HHK:_<<R@"AO$:T0>5(1MV^YZT,$,JQ@E1K
MV6I-M]8<L!W96VE)N,Y+OLYKYB5']*24TSG#5-MTQE9NS.%QW?_G`I6[T67:
M+S@R*],->]@?#4=:1CA8SA5(JGL"275?4[<&(].VM4?N$LNM!)+J@4!2/=34
M[8$Y&%M:UUICN8U`4CT22*IO-76K;]F6I76O6"FG.LY6>DW';XR^39M9N/:$
MK)!)F=JP6:O?S.!1LG_,!9*/U@5'EDQW!Z-<@:26)Y#4\E%KB5$K@:16()#4
M"E%KC5$;@:16))#4VJ)6K$2I]K`E<=.>:C_XWH<F4]%<JU"?IDX-U[1^,V,O
M:/3DK)`EN^""1UGC:E$_'/3&FI`C0F0I%[4]C/(%JK0-<SCH&]JVP5+$2/$5
MB@<8%0I4B8]LT](WR=<B1&IO4#O"J*U`_,8-:]RWM9W"6,24XJKO;/FM^V[2
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M1H\^B2B_:H`S0SI3OKF#,R/Q&85VAKZO>"X33^-3]MT%\U#GYH3>=]W@UH3>
MJ2!_MB?/5&T\,;4GM)U_@P\FM,E[@U/=;E:-:G93?SRA#1C4H17WA"UX\0PM
M<*G.M\[0XF["%FM8AA9GI';K#"VN)FRQA&5H<437*<]TZ]:E;TK>=V])N+N^
MI9>\=4I>R?Y>.;I>JZ]2JA\%'V5?LH*^)BD'W"-]/930]D*/;7:_9EDA?M"E
MN_7W2$__!@``__\#`%!+`P04``8`"````"$`+Z8\VQX&``"S%P``&0```'AL
M+W=O<FMS:&5E=',O<VAE970Q,BYX;6RLF&V/HS80Q]]7ZG>(>'\!#'D`)3EM
M>$:M5%77]C5+2((VA`C8V[MO?V-L`_;DTMOVWBR;'^.QY^^Q/7CS\4MUF7TN
MFK:LKUO-G!O:K+CF]:&\GK;:7Y_"#VMMUG;9]9!=ZFNQU;X6K?9Q]^LOF[>Z
M>6G/1='-P,.UW6KGKKNYNM[FYZ+*VGE]*Z[PYE@W5=;!S^:DM[>FR`Y]H^JB
M$\-8ZE567C7FP6U^Q$=]/)9YX=?Y:U5<.^:D*2Y9!^-OS^6M%=ZJ_$?<55GS
M\GK[D-?5#5P\EY>R^]H[U695[B:G:]UDSQ>(^XMI9[GPW?]`[JLR;^JV/G9S
M<*>S@>*8'=W1P=-N<R@A`BK[K"F.6^W)=%-SJ>F[32_0WV7QUD[^G[7G^BUJ
MRL-OY;4`M6&>Z`P\U_4+-4T.%$%C';4.^QGXHYD=BF/V>NG^K-_BHCR=.YCN
M!41$`W,/7_VBS4%1<#,G"^HIKR\P`/@[JTJ:&J!(]J5_OI6'[KS5+&.^,@W'
M6H&7YZ+MPI*ZU&;Y:]O5U3_,R.2NF!/"G<!3.+'FIFTLH<M'[2S>#IZ\'8%_
M'W1D\P;PY`WL.5DOS,6_]03CZ,.$I^AI$N:#'I>\X6IL:([Z/&@("ZSO$9[O
M&ZK#&\+S?4,U(7G87-(L8O-$'@Y69\G0YY:?==ENT]1O,UBP,-WM+:/+WW2I
M6Y%5+-XAS[Z79I!?U,L3=;/50#K(H!;6QN<=,5<;_3/D<\YM]MC&E"T\84&3
ME[KU51"H(%1!I()8!8D*T@G0099!&TCRGZ$-=4.U$5'M!9B(I0@A+$037P6!
M"D(51"J(59"H()T`20A8JC]#".H&=ATI2=9RY'MF8\)(ADQ:R";>8#*H@TB`
M2(A(A$B,2()(.B622+!3_0R1J!M8C-#-(``Q'5F"/3=ZI-)@,JB$2(!(B$B$
M2(Q(@D@Z)9)*L"U+*MT_O<2V0JU[,400>TZ,?H]1=AAO>#EJ9XW9(XT#=OMW
MC(-:R^/@A`RKVD/$1R1`)$0D0B1&)$$DG1(I4-B3WQ$HM98#Y00F=,Q'8LCY
MZ`U&8IY\1`)$0D0B1&)$$D32*9%BIZ7O]'![G&S46HZ=D\DD(^(C$B`2(A(A
M$B.2()).B10H5!#O")1:RX$R8K%:CYZ\'B(^(S:(/22"Z2@G>#`8B40($8F0
MZWBP&5T3HKA.!B/A.IT220Y:R$AZL*IF3@O=[ESF+_L:8H!C_TY"6+"S\)J&
M>I%UZAW#$381"B.?(]MAA9!AVO)R"48#$4N(480]QZ-57V(9IB5[3D8#X3F5
MD"P3+7Q^?'V8K$Z"HTGXW@L$B3DD!2%$'I0GK)RAH2_0M*&Y4*()N!5AN_UR
M;5NVK:1%.'H2HXH$&ON+!7K87R+WMW#(TK"4K2X=/4%_LIRT?'J'G*S:DN1D
MB$S/=4(453Q:'$%>P@>4B-@7:-RI`HZL%4M"BRR62^6\#'&S2*#1>2S0Z#Q1
MG1MK8BG#3*5FLE"TAIH*]=^6)Z_$QI'N:=5$5^QTE@E15I\GK,;T\#FRUH.D
M@4!L$4/>69:M%*NAL!F;1=AYC*T2@?@.L8*/6G75I,*F=R[K1ZNK_Z\?K]&F
M^C&TA(4^6<YC!=7OBY[)K*3\8\B>-KRSG+D5Z5/2M!9K8B^6\F81<N_@2F1W
MA#N,1ZMQI*C#1%CQ#@W'6:[62CBI,.H[E'6F]>0CG3_5M^\=(W`?,IPCO"R=
M"LW1N*0\>I5#<W=$/D8!1B%&$48Q1@E&J81D+6B!.=7BSM$YC9G7H].8.8(D
MF"27,OT>W*#U,MC#]/L8!1B%&$48Q1@E&-%KO'$03`9V+<>N3JJB.15><;FT
ML[Q^I5=NL./L-@-F]X%[<RDN!)4W<%/XU$^SPO?T!I'&K7+BPJ?Y'6ZY\#F*
M^9/M/D$(^,7>=N'+[`Z'D=ZU7[E07-^Q7[M0B][AY@(BZ"\?U1`<=P^%"&[B
M.:YW]X7ON%`[X@907;FT6L)O(L>E-1-^$3LNU(IW.+BBY1&\T8?QPI7I+3L5
MOV?-J;RVLTMQA/F%&T18G@V[=&4_.K[VG^L.+DO[;>`,E^,%%,_&'(R/==V)
M'[2#X;I]]PT``/__`P!02P,$%``&``@````A`.5WLK:H$````%<``!D```!X
M;"]W;W)K<VAE971S+W-H965T,3,N>&ULK)S9<MM(LH;O)V+>0:'[D0AP$<FP
M/6$N6+COVYTLT1:C)5$ATNWNMS]90"43E3\.6W1,7[3HKW(I5&4E:@'PZ;]_
MO3Q?_;E]/^SVKY^OO9O"]=7V]6'_N'O]\?EZ/@O^4[V^.ASO7Q_OG_>OV\_7
M?V\/U__]\N]_??JU?__C\+3='J_(PNOA\_73\?A6O[T]/#QM7^X/-_NW[2N5
M?-^_O]P?Z9_O/VX/;^_;^\=$Z>7YUB\4*K<O][O7Z]1"_?TC-O;?O^\>MJW]
MP\^7[>LQ-?*^?;X_4OT/3[NW`UM[>?B(N9?[]S]^OOWG8?_R1B:^[9YWQ[\3
MH]=7+P_U^,?K_OW^VS-=]U]>Z?Z!;2?_`/,ONX?W_6'__7A#YF[3BN(UUVYK
MMV3IRZ?''5V!:?:K]^WWS]=?O?JF6+F^_?(I::#%;OOKD/E]=7C:_PK?=X^]
MW>N66IOZR?3`M_W^#R,:/QI$RK>@'20],'J_>MQ^O__Y?)SL?T7;W8^G(W5W
MF:[(7%C]\>_6]O!`+4IF;ORRL?2P?Z8*T/^O7G8F-*A%[O]*_O[:/1Z?/E\7
M*S?ENT+1(_&K;]O#,=@9D]=7#S\/Q_W+,A7RK*G4B&^-%*GV:.2,8LDJTE^K
M6+HI^>6[:N+]C"+5+:DV_;6*?N&F6BZ7*M4[8F<T*U:3_G)=;^Z\0JWX#WIW
M5H_^LD>Z[#..:(0E5:2_EUU;S2K27_9$G5<M>^6*Z9,S+CT*G[0W31S9GOC0
MU7FG.*`?[/7\]7G<Z^;'95?H4:"D]92(H?[[V#5RS'@2-,6/72,'C1D?'[Q&
MCA9/PN6#$>IQP)@?[.V#,>IQ['B9&#C?&SYWO?EQ66_XW/?FQX4U]3D(?.D-
MP\X$J8GAI//-#^O.JWUL\/K<'^8'5S77W6V:YY*TV;H_WG_Y]+[_=47W(KK&
MP]N]N;-Y=6.%$V9:XU,*_?\R**5.8^6K,?/YFKJ6DN.!TOZ?7WS_[M/MGY2J
M'ZQ,`V4\5Z+)$B8O&[,M#=H:!!J$&D0:Q!IT-.AJT-.@K\%`@Z$&(PW&&DPT
MF&HPTV"NP4*#I08K#=8:;#+@EL+D%"L46?^+6#%F3*QP+S<89()'!09+L$I+
M@[8&@0:A!I$&L08=#;H:]#3H:S#08*C!2(.Q!A,-IAK,-)AKL-!@J<%*@[4&
MFPQP`H-N6Q`814J\^;,NSAE&B^973LZHNAW?2&7,+?646,JN2/,D<@H.(&T@
M`9`02`0D!M(!T@72`](',@`R!#(",@8R`3(%,@,R![(`L@2R`K(&LLD2)V;H
M!@DQ8V8B%]YXC!FZ=Y&;4X#X?LT-D885.A=%)Y%3%`%I`PF`A$`B(#&0#I`N
MD!Z0/I`!D"&0$9`QD`F0*9`9D#F0!9`ED!60-9!-ECA11`'C1-'YC&.DDV#A
M3FY80KE*PJ=8<,.GF0I5LN'C%V7NXE2(IE`75,A(NQ6RQ#_='9M`6D#:0`(@
M(9`(2`RD`Z0+I`>D#V0`9`AD!&0,9`)D"F0&9`YD`60)9`5D#623)4X@T%S8
M"00SL?;+-Q1+%V8X8\B-$4MH4&2"UE=!>Q+B6&\!:0,)@(1`(B`QD`Z0+I`>
MD#Z0`9`AD!&0,9`)D"F0&9`YD`60)9`5D#60398X86,V(K/KL?,)S4B[L6%)
M)G\`:0%I`PF`A$`B(#&0#I`ND!Z0/I`!D"&0$9`QD`F0*9`9D#F0!9`ED!60
M-9!-ECB!0%L=%P2"D78#P1(W2115DC@)G9($D#:0`$@()`(2`^D`Z0+I`>D#
M&0`9`AD!&0.9`)D"F0&9`UD`60)9`5D#V62)$QMF8_."X$C$W>A@E,D3B%J(
MVH@"1"&B"%&,J(.HBZB'J(]H@&B(:(1HC&B":(IHAFB.:(%HB6B%:(UHXR`W
M1LPNSL?O)&;'6V401FX**:D4(E*G'(*HC2A`%"**$,6(.HBZB'J(^H@&B(:(
M1HC&B":(IHAFB.:(%HB6B%:(UH@V#G+#QNSQ7!`V1ERE%HNRJ050RVSI&$61
M:B,*$(6((D0QH@ZB+J(>HCZB`:(AHA&B,:()HBFB&:(YH@6B):(5HC6BC8/<
M&#&;.MD820\-;LR1X?%I]_!'8T\+$THH.9/7(AT.V",#NS54/"UU&V8;QP1%
M>IQJ3@":C)(S8WLHD$H5LZ$#*+"*&:D0;44L54C.+$I>S5/KJ%@D.+]U$'41
M]1#U$0T0#1&-$(T131!-+:+S.J[]3*3,,4W)JQ35=ME<)%AI@6B):(5HC6CC
M(#>PS#Y/-K!R`HB.R4X19,15\K&H=+K>ICD8):FB!%6+$>6@S`I:;2RW18J;
M(4`4,A+S$2,*RHSYBGOCC$6*S7<0=1FE#RN8(=%CY)I7G=@7*38_0#1D).9'
MC!SS)=GN2@;A6*38_`31E)$TSHS16?-SD6+S"T1+1E+[%2/7O!K4:Y%B\QL'
MN5%I]O\NB,ITNY"BG&TWS+ZV"=1L5*;(B4J+LGD-4&!M.7D-;$4BE0U!=2(;
MBQ17M8.HRT@ZL<?(&4`EM6_:%RDV/T`T9"3F1XRRYKTRA"`TSD04V>.4D9B?
M,3IK?BY2;&N!:,E(S*\823^N$6T<Y,:;V5/,QMOOW5[MSF0V#"W*AF&*G#"T
M2*3:YG$/DT(%!8A"1M(4$2-*P9E,J`[Y8I'BENX@ZC(2\SV+*G*-?40#1$.T
M-4*I,:()HBG:FJ'4'-$"T1)MK1A)VZ\1;1SD1I/9:LQ&TS_<4^W.I#1IPSRQ
M8[(7;55))Y;T5A)+U4YIK\4HJ^B5E6+;2M&#.F8^XE7N"N8_]V89B"D.D9"1
M.(P8G748LT.:H&:N1ZUK._FVU!RARU)2B1ZCLY7HYU="F1_DVU)20Y:22HP8
MG:W$F"MAF[Y0J/F5BNJ?B9CBII\R$H<S1F<=SI5#[ZY<+!24PX688H=+1N)P
MQ:AZBK>U164_C2353!M'PQTC5.M+QH@15_/.%)EGO3(QI:9\33.$2-&7P=5B
M)#>+MD7%N^0RRN6"7ZDJ2P&JA8S$>,1(C,=LG#)ZIJ)J8M`119'RRJI!NRPE
M'GN,Q&,_SZ-75AX'J#AD).9'C,3\F,VGK56J5DI^166/":I-&8GQ&2,Q/G>-
ME_UJQ=./M2U0;<E(C*\8B?&U167GYEA2-\>-H^A&K=D?OB"SV^UDJ53#/$^)
MF5VM))HL)8.OQ4@&7]LBF\9+^5G\Y(]'=LB6Q'C$2(S';-Q)V675S1U1/!NU
MMA+BL2>*7*]^OD<U!1V(XAF/0Y82CR-&<HUC]FB3\5W)TYEQ@EI31F)[QDAL
MSUW;U4JQH@?S`K66C,3VBI'87EMDLZ[*$1M'P0E?\V3N!>&;B+M)UR)*I]+Z
M?EFM]9HBQ9W;8B2#L6V13;I>,@=1\16@6LA(!E7$2(S';-Q)NGHBU!%%N1Q,
MNBPE'GN,Q&,_WZ.:XPQ$\8S'(4N)QQ$C\3AFCVD>KOB%:E7UQ`2UIHS$]HR1
MV)Z[MN^\6OE.7<H"M9:,Q/:*D=A>6T19.)U^NA//C:/AQJ\Y,<FFW]]:IOG&
MB@IKBVBR(+=H/5Z;K"B#LV51409GFU$MO;K\L$[]9=1"-!ZQ)3$>6U3*/CT%
M=_8.*G;1?`^E^GGF_;*:"0U$45H+1LT0/8Y$D?/"F%':6G[5+Q25NPF+2#-,
MT?8,I>:,4MO%NTI!W[\6+"*VEVA[Q4BDUA;9%*SNWQM'P0UAFJ[^#T+86%$A
MG*(*19:$L*_N#4TS6U;388M*645<,K)4.M'WJ[6\*3(+R7Y!B`XCD9*:@L.8
MI=P[C9K#=EC*K;RZZBY6HI>OJ-9%?99R*Z'FBP.6.EN)(59BE*^H*C%F*;O&
MJA2*Q5I))>,)"TG33]'A3*3.-/V<I:S#:JU6+154B"]82!PNT>&*43;[IR&8
MOI*8[&QO'"EWN%#+GQTNL_T;C8/<<Z_,L869K^CQ8I'4K,E2@EJ(VH@"1"&B
M"%&,J(.HBZB'J(]H@&B(:(1HC&B":(IHAFB.:(%HB6B%:(UHXR`W=LPI5':V
M<'X;SKP_IF/$(F>Y6%8CH<F*LEW80M1&%"`*$46(8D0=1%U$/41]1`-$0T0C
M1&-$$T131#-$<T0+1$M$*T1K1!L'N6%CSC@N")OT2"1[]F1>*S21)'FDB:B%
MJ(TH0!0BBA#%B#J(NHAZB/J(!HB&B$:(QH@FB*:(9HCFB!:(EHA6B-:(-@YR
M8\2<SEP0(^EACA,C%CFI1>^B-<WKH2:2LJD%4!NE`D0AH@A1C*B#J(NHAZB/
M:(!HB&B$:(QH@FB*:(9HCFB!:(EHA6B-:.,@-VPN.QCR\6"(43:U6"E!+91J
M(PH0A8@B1#&B#J(NHAZB/J(!HB&B$:(QH@FB*:(9HCFB!:(EHA6B-:*-@]P8
M,0<6%Z26]'S#22TIH@-FF>3K]4+3/PGQ4KQE48GB25:0%;7_VA8I5@P0A6@^
M$JFL>;78B46*S7<<Y+:5V5>^H*WL-K3L3C7\%&4.XYN(6A:IEE%[;6V1XJH'
MB$(T'XE4MF64^5BDV'S'04[+F%>!+VB91-S=3[`HVS*(6A8Y+4-/]+D[>FV1
MXJH'B$(T'XF4M`R8CT6*S7<<Y+8,#0NG97YK#]$,+K58L,AIL%0J@UI6JF3W
MNPJ>6LBW18`O)D`46D1_6"H2J>1;$&`Y%@'6Z3C(;2:S2O_XT*)GHZ`]4E21
MN4O32F50BY$\3]9F)`]0!HQ$*K2(#COX:B)&LDT76T3[<2S5<:3<:]:;#><7
MC$7<5+#([&=D4JCJXB9+21YJ,<HJPIY8VTK9$Y-:L4([_LIX();XBD-&XB]B
M=-9?K/R52L5J3?GKB"7RYS:G63UG0^CW1II=@TOE&_105!)L=`O+M++:]&NR
ME`1(RZ+,MGO;(F=#G9[(<!-8((KB$7:\0_08B2+W1ISO46]LBF*^1[>E]9+U
M]UH:5[+%%)D]EDQ+J_W/IDCQ1;8L^H=-999*-QJK=P7ZCH#JQH!E9`2'Z"\2
M*:DHC)^8I<[XZ[!,XL]M9;/R.A?/']N+I(U/2)46R12^R5*"6HC:B`)$(:((
M48RH@ZB+J(>HCVB`:(AHA&B,:()HBFB&:(YH@6B):(5HC<A\9B_IVJ33TMA)
M/YN7?O_I9?O^8]O</C\?KA[V/\TG\9(CT!-.O]?7\._J9GU`8TF7%"O\*3]=
MXM%'_M)W.*#$IY*D0KK$+Y*?)*U"28E*DOLVE)2I)+D+0PG5C5:^.;4F8[FV
M2"%7GBX_]^JK=7IU-\=^K4ZO;>9PKT!7GGR[4-655B=U,X-"'5JDU,UZ(Z^D
M1B5Y?FB26C?SS1R=HD<E>7[HFXQ?<_O$=&..I09U8JX\=6%>#WXMU;]2,&*5
M&G2!C=PJT8JPWLPMH85AW:SQT!HMC*@DKU%H85`W<_P<'6H4,Z/%$GIUH6X>
M[<42>H.A;EY&R"LI4TE>0-(3P5229XW>8:B;QW[1&KW*0.V?5T(OA=3-X]"H
M0^^&U,UK'GDE92K)JQL]14TE>=;H[9"Z>50:K=%+(G7SOD=>29E*\OS0$]94
MDF>MY17KYGTMM$;O9Y%.7@F]QD2MDU?2H+HU<OW0JT#U9FX)O1%$-<BK&[W?
M4S=/MN?5K50W;^SDE92I)*\-Z(%X*DFLW9[R`'U_].W^Q[9___YC]WJX>MY^
MIV1<2-ZF>T^_8)K^XVA/%[_MC_3ET>2@\8F^-+NE=X(*YKLBW_?[(_^#*G5[
M^G;ME_\3````__\#`%!+`P04``8`"````"$`=V]^BWP&``#=&0``&0```'AL
M+W=O<FMS:&5E=',O<VAE970Q-"YX;6RLF5V/HS84AN\K]3\@[C<!)WPJ234)
MWVJEJMJVUPPA"9HD1,#L[/[['H.-L4]V--GNS;)Y.'ZQ7Q^;@V?UV]?+6?M2
M-FU57]>Z.3-TK;P6];ZZ'M?ZWY^C3ZZNM5U^W>?G^EJN]6]EJ_^V^?67U5O=
MO+2GLNPT4+BV:_W4=3=_/F^+4WG)VUE]*Z]PYU`WE[R#G\UQWMZ:,M_WC2[G
M.3$,>W[)JZL^*/C-1S3JPZ$JRJ`N7B_EM1M$FO*<=]#_]E3=6JYV*3XB=\F;
ME]?;IZ*^W$#BN3I7W;=>5-<NA9\>KW63/Y]AW%_-95YP[?X'DK]415.W]:&;
M@=Q\Z"@>LS?WYJ"T6>TK&`&U76O*PUI_,OW,=/7Y9M4;]$]5OK63_VOMJ7Z+
MFVK_>W4MP6V8)SH#SW7]0D/3/470>(Y:1_T,_-EH^_*0OYZ[O^JWI*R.IPZF
MVX(1T8'Y^V]!V1;@*,C,B$65BOH,'8!_M4M%4P,<R;_VU[=JWYW6^L*>68ZQ
M,"%<>R[;+JJHI*X5KVU77_X=@DPF-8@0)@)7)D+(S%P:]@,:"Z8!5Z9A6C/B
M6J;UB,J2J<"5J\Q<RUK:KO/QX4!D[PE<F8CSN`@LL%X$KC_>$X^)P/7AGLR'
MF>X3)\B[?+-JZC<-5B/,97O+Z=HV?1,2CJ?,,,%C$GTOAR!YJ,H3E5GKCJY!
M>K20^%\VQ/96\R^0K`6+V>(84X[8\0B:F50V4$&H@D@%L0H2%:0JR"9@#K:,
MWD`&_PQOJ`SUAH]JR\'$+,4('L&;!"H(51"I(%9!HH)4!=D$2$;`,OP91E`9
MV%*F2>(8\LBW0XP)/1DSR9)#=F/(Z`XB(2(1(C$B"2(I(MF42";!+O,S3*(R
ML!CA,:,!Q%$6RI8%O>?2&#*ZA$B(2(1(C$B"2(I(-B622["-2B[=?S7Q;85&
M]V;P06P9,?H]1MEA=N/-J7=D3!^I(_9#':'1<D<8(>.RWB$2(!(B$B$2(Y(@
MDB*238DT4-B4'W"<1LL#'8@M[>W.8C2UWZAW8Q"?J`"1$)$(D1B1!)$4D6Q*
MI+'3PG;Z=GL_VVBT/'9&)I.,2(!(B$B$2(Q(@DB*2#8ETD"A)GA@H#1:'NA`
MEDN1S2Q&D(#%@-GCSF1ZRLX4CD$\$2)$8B2=C#%"FCA+.<?2,8A+9U,BV4$K
M&<F/H:R9T;JO.U7%R[:&,<![_TY"+&!K844-59%]ZH77^M0HALR)4SS*&RHA
MPU2&$HH`/I8(HQ@K)R*JK[$,4UF(J0C@RIF$9)MHY?/Q]6$.A1*\F[CVEB-(
MS#$IB*.^L7F4-S8,.)HV-"UE-"&+(L-V3]PE(0O%RT@H\5[%'(GG)1R]^[Q4
M?9X#4^?(:9@))7B>;">MGQZP<RBW)#L'1*8O=N+8<@]VM#J"O"1B'@*.Q$X5
M,K1PAE>E3>`S3A:*<*N8(Z&=<"2T4UG;=8EM*=J9U$JVB990#]C$*B[1HRVM
MCNC"G$XF<92)VO$HD04!1_TW>+_(0X98BBU<LB1*%D:X5<R1T$XX$MJIJKT@
MZA1D4BO9)EI#/6`3*[FF-@U(R2973H(=;%PHF\:&?$F%+(IE$_T,MQ2AB`N)
M/(DY$IU*.!)1J:QMF\;24[0SJ95L$RWZ'K")U8BB1UMZ0H*S2:TM>928\8`C
M,>,A0RR;3-,S%)T(-XHY$M()1T(ZE:7)TEX@D\:!H)V)5H=3DW[L?<AJS*EW
M`Y)3S%4^ZG8FBQ(-`X[$6S/DR.HWK*5'+'6$$0\1K6*.A';"D8A*.1JT'=MV
M3&57S7A(WTI.,5I?_G_WABH5%CQ?5%MS0!;4,>+M2=#;DS44Z1&PA@3NC`WO
MO#V'AL3M#;7`3]M#>QN+$<<3,1,WQ?.2#STOY5'L>=;"<5WT6I@^3W89=O-W
M7?Y<W[Y7L\'1XEBT41FE:&-(;#D[^NJ@40(%&(4811C%&"48I1C1HV#1B<&+
MX6AW.*&[E,VQW)7G<ZL5]2L]M@6#-ZL1CV?*3_TH%+ZE9\TTU51.?#CGN<,7
M/IQM8/ZT])^@H_C&=NG#9_X=;OOP,7J'.SY\J-WAK@_?-7>X"3?N/]GSMU#4
MXB8[S]_=O1%X/GR'X`:!:?BT\L9W8L^G]3>^D7@^?'?<X2!%2VVX,Q\MA\/U
M6WXL_\B;8W5MM7-Y@%DT^L^09CB>'WYT++6?ZPZ.U?LL/\&?44HX`S5FL*L?
MZKKC/^@#QC_,;/X#``#__P,`4$L#!!0`!@`(````(0!H*;^C:`D```(M```9
M````>&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;*R:76_B/!;'[U?:[X"X'R`)
MH8#:/AKR:FE76JWVY9JA:8L&2$4RTYEOO\>Q'?OXGX="M7,QE)_/.?%YL7T2
M<O_'K^-A]+,Z-_OZ]#`.)K/QJ#KMZJ?]Z>5A_.]_Y5^6XU'3;D]/VT-]JA[&
MOZMF_,?C7_]R_UZ?OS>O5=6.R,*I>1B_MNW;>CIM=J_5<=M,ZK?J1"//]?FX
M;>GK^67:O)VK[5.G=#Q,P]EL,3UN]Z>QLK`^7V.C?G[>[ZJTWOTX5J=6&3E7
MAVU+\V]>]V^-L7;<76/NN#U___'V95<?W\C$M_UAW_[NC(Y'Q]U:O)SJ\_;;
M@?S^%<RW.V.[^P+FC_O=N6[JYW9"YJ9JHNCS:KJ:DJ7'^Z<]>2##/CI7SP_C
MK\%:1'?CZ>-]%Z#_[*OWQOE[U+S6[\5Y__2W_:FB:%.>9`:^U?5W*2J>)"+E
M*6CG70;^<1X]5<_;'X?VG_5[6>U?7EM*=TP>2<?63[_3JME11,G,)(REI5U]
MH`G0_Z/C7I8&163[J_M\WS^UKP_C:#&)[V910.*C;U73YGMI<CS:_6C:^OA?
M)11H4\I(J(U$-'LT<D%QKA7I4RL&RTFXC(-X(2]_09-&NWG3I]&,)\LXGB^6
M=Y<U%UJ3/K5FN)@$\]E'5[S3>O1YXQ5IK75SI4^C>:67*ZU)GT;SLI=3E=ZN
M6M)MNWV\/]?O(UJ"E,#F;2L7=+`F:Z9,5(3[POFSNJ&"D4:^2BL/8XH`E41#
MQ?[S,5C&]].?5*`[+;,9D.$2B9&0U2C-IC[(?)#[H/!!Z0/A@"D%H8\$%>O_
M(1+2BHR$\6%C@`U-Z+EM)(Q*ZH/,![D/"A^4/A`.8&[3VO3=GM-"&=XG3+ZE
M$NT(+-\+[M9&R01TW;XHO))(>I'>=2`9D!Q(`:0$(ES"`D![C!\`N5'>N`*D
M%5I#=)7>VV!YYX5$"UT*22_2AP1(!B0'4@`I@0B7L)"0^VY(+M>"%.X\-S/>
M:#+K-@(_Y_V@&ZAE'R@V#]J*KY^'%.;ST"3L%V,")`62`<F!%$!*(,(ES"O:
M)EVOY)8;QA.*RXTE)^UPAS6AO#I%N.ICVVVJ22]D\I4"R8#D0`H@)1#A$A8#
MV68ZQ\[E"I/"W%%-G,P"28%D0'(@!9`2B'`)\XH.T.N]DL+<*T4BU4/)`S#1
MQ-TP@M6,)S3MA4Q",R`YD`)("42XA#D:4#]ZO:>=-'=5(]=7@[BS@>>LE>J]
M190C*A"5B`1#W&79-S@EJSJEB6PJV]?][ONFIC5',@.E'-%&J/LDU7S0,6%F
MOPDT<K*N433O-M!P%LS]("@=$C!F,JMC4&XLVV:DL%*R1R/+$;=<6@%C1C#$
M0T*I<D,RX#IUZ[WO4MJK`HVHSNR&M?+[(]E"D&(<=.$()N&*_\N^>!JIT2!%
M:S?V3N/,2!F[T?(#N[G6"&VN"HV"59^*TMB]>'5AI2C2/*RR57$J[8.PZL;&
M+2F%0M:,K+Q4)[)7H;"2E$EUJE$L"_;GXVP21^%RYOSSSO+,R-LZS-%J@:BT
MBA<2)*P4A$BV+M>'2#<ZUM--H%`L5V]_R[+RUEEBI6R(M.*B"Y&GD!F%11_3
MW"!W%?87-V9+(T5-@YV/7['"2D%`9%MU?4"DM+<4%?)JQDMX(AMCOV84,C7#
M]Y-,*\1NA8"-`LV65O%B0/3%._-\$<GVZ_J`Z&;-K1"W?U.=4P`H190ARA$5
MB$I$@B'NGVRMKO=/-V*N?PJQ$U@CMG&MO/NZ-.BE3/5FB')$!:(2D6"(NRS[
MKNM=UEV:Z[)"S&6-N,O0=/12UF5`>0"H0%0B$@QQEV4'YKC\N:9#M7&TFYK9
M;^BXZC8`>Y`E&EUH.I0.:SH`Y<:RN]WU4G_6=/0"9H+"SH80"TEX4^O92?.=
MSB"ZJ-UJH>G04GW3$<0?-`>IT6"EY&_AF9&ZONG0&F[3P8W04TKGC*8_Y]D7
M[[`OC<;%R0DCI29W-^%F9X%KER=%-J1.G5YN6<@5__C1R#M^/"\2*V4*)=7(
M'#\?MBQ&WCF0T&J!J#2*?6]TQRO"VR:%D<>C*:0DW!`L*>U5L$(?-"_=9:AM
M5D_WN^>I!@TW+W;41#<WR%G-!EFSI4&#9H4=A:4L.]#KJT;UJ^XV)LM%M2/N
M4O:;%BME_$HU,E7C-2UFU*V1_DK&1H%F2Z.H:X2;%69TH")D0WA](%3[R`*A
MD?-`)`24(LH0Y8@*1"4BP1#?'F2;YO@GC[&(?NH@?.,S+ZGBKP:-R%]G/_=N
M]A*C:'.:(LH0Y8@*1"4BP1`/QTV]:8B]J4%NNK$W1:D,48ZH0%0B$@QQ_V2'
MZ*6;#M*;<ZT:35;G&O%<VZ?'JD\/>RFS6%-$&:(<48&H1"08XK&03:$3BP].
M1M5",I<U<G,-*`T!98AR1`6B$I%@B/LG>S?'OT\_S0Y5$\A<UXAGVW^>;13=
ME=TKF@+(4"I'5"`J$0F&6#2BFYK33IH?[08YV4:4(LH0Y8@*1"4BP1#WS^OS
M/IUMN@?S]W&#W&S32R/\$$VLE$EMBBA#E",J$)6(!$,\&C<U<A$V<@:YV=92
M%J4HE2'*$16(2D2"(>Z?UY]]_MB.L'<SB*?;N_-.K)1-M[9EUWN&4CFB`E&)
M2##$PT%3=;>ZRULYW2=#A6MD<YL8*8M21!FB'%&!J$0D&.+^#71IG_IA,L(F
M3:.8CJF^20MGWG/[Q$K9;"M;I&A0AE(YH@)1B4@PQ*-Q4Y,689-FD$UM@BA%
ME"'*$16(2D2"(>[?0)/VN9Z<7F.#2N\[,#?=_NV\4;0K.464(<H1%8A*1/*-
MNVZJW155.-0;=.J=J&-U?JF2ZG!H1KOZAWP[CE;+XWV/U:M[FVA.[^YU)F`D
MII'NSAA&%C32_2P`(W?F34!_)%RN9>=%A0\C*QKI?G+R1Z(96>M>#801^<9A
M]\`/1D(:Z<H41B(:Z9X;^B,TM<&9!>0G/;4>FC-%C6X1AT8H:G2W-#1"UN@^
M8VB$HD9=-X[0@\QU1H\/<:2@$?E@$4?H9<RO@_Y3R`8C1@$;E)?A&K(_7W^E
MTL,+;R@F@R$AOP?=)J\'[:S6&_KI&B^0D,M#'B<!U<FP1A!0_(:\IE^/26=H
M9!/<T?6'ZB&A$?E(?V!F`960TIGVQ45OH+YM7ZJ_;\\O^U,S.E3/M`9GW8_L
M9_4.J_K2UF_4-]-[J'5+[YYV?[[2N\85O3-!OUJ.1\]UW9HO=.EI__;RX_\`
M``#__P,`4$L#!!0`!@`(````(0!;X].ML@T``)Y$```8````>&PO=V]R:W-H
M965T<R]S:&5E=#DN>&ULK)Q9<QLW%H7?IVK^@TKO$<558I?EE+GTOE=FYIFF
M*(ME2521M)W\^[GHQN4%<#J,Y"0/H?SAX`*-@UU-??CU]^>GB^^;_6&[>[F[
M[%]=7UYL7M:[^^W+E[O+__SF_W)[>7$XKE[N5T^[E\W=Y1^;P^6O'__]KP\_
M=ONOA\?-YGA!$5X.=Y>/Q^.KU^L=UH^;Y]7A:O>Z>:&4A]W^>76D?^Z_]`ZO
M^\WJOLGT_-0;7%]/>L^K[<ME&\';OR7&[N%AN]XL=NMOSYN78QMDOWE:':G^
MA\?MZX&C/:_?$NYYM?_Z[?67]>[YE4)\WCYMCW\T02\OGM=>].5EMU]]?J+G
M_KT_6JTY=O,/"/^\7>]WA]W#\8K"]=J*XC-/>],>1?KXX7Y+3Z":_6*_>;B[
M_-3WZN'PLO?Q0]-`_]UN?AR,GR\.C[L?P7Y[GVY?-M3:Y)-RX/-N]U5)HWN%
M*',/<ON-`^7^XG[SL/KV=*QW/\+-]LOCD>P>TQ.I!_/N_UAL#FMJ40IS-1BK
M2.O=$U6`_G_QO%5=@UID]7OS^6-[?WR\NQSVKV['X]'D]H;"?-X<COY6Q;R\
M6'\[''?/_VM5?1VKC3+04894?1UE<C6^N1[VJ=!S&4<Z(WWJC&.C]#,E4MBF
MWO2I,PYNWI9SHG/>2,[IU>!VW!]/_J*R-&::,NGS?96=ZHST^<[*]JE#M/Z0
M`9SWC=7MLROJA_=5N$]&ML6*HV]MWSY[JKKA>ZO,YO3IAW=6F?QLJRS&GN][
M??93_?"VBO;:T=,,QL7JN/KX8;_[<4$S'+ES>%VI^;+OJ7`\#-L>?!J8?S8N
M:4"J*)]4F+M+>@`:<0>:3+Y_[(^G'WK?:0)8:\VL0V,KYJQ0HUV%7;A@Z0+?
M!8$+0A=$+HA=D+@@=4'F@MP%A0M*%U0NJ`W0(WM.'M$H^"<\4F&41]RZ,P9B
MVL`QA!6<9>&"I0M\%P0N"%T0N2!V0>*"U`69"W(7%"XH75"YH#:`90C-+?^$
M(2H,+5OFH)E<VP[,6HV:"$\C:VQ+YB?)R24@2R`^D`!(""0"$@-)@*1`,B`Y
MD`)(":0"4IO$,HUF]W_"-!6&)DLJYF1(?]*W+9EIT3G73I*3:T"60'P@`9`0
M2`0D!I(`28%D0'(@!9`22`6D-HGE&JV$EFO=VT->AI2Z,8<;=:;)=;,FC6R;
MYJ=$TTN9`ZV*T+K^CHHHM5T130:GZ7<.9`%D"<0'$@`)@41`8B`)D!1(!B0'
M4@`I@51`:I-8#4^;"JOAU0YE>*L.!7I__N9-BHIDFZ()]3YC,`^=7G(2<:=:
M`%D"\8$$0$(@$9`82`(D!9(!R8$40$H@%9#:))9/M'FT?#H_4I7:]D(38X``
M60!9`O&!!$!"(!&0&$@")`62`<F!%$!*(!60VB16P]/A[!T-K]1VPVMB#P)W
MJCR)3H,`R!*(#R0`$@*)@,1`$B`ID`Q(#J0`4@*I@-0FL;Q0Q]YWF-'(;3<8
M&>,`T0+1$I&/*$`4(HH0Q8@21"FB#%&.J$!4(JH0U1:RO5#G*?-L>WY&ZK?'
M+]K9<1>?,;*'AKO_%A5G7"!:(O(1!8A"1!&B&%&"*$64(<H1%8A*1!6BVD*V
M/>IT]0Y[VL.898]&YE`!M%!G)S7CB6J)R$<4(`H118AB1`FB%%&&*$=4("H1
M58AJ"]E>J%/3.[S0ARQSJ+1H-#J-GKDZ(U'##]L;U_8^1R/3"T`^9Q15P$AB
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MMI#MJ3JFOL-3?:HU/6V1Y6F+C(9?J%\CV(XM$?F(`HV,6"&KZ.1FF.C<SD>B
MXF:($248/A65$?[&.41GHN+P.:("PY>B,L,[TWPE*@Y?6\@V49UAWV&B/O*:
M)K;(,K%%1L,O^EHE/7Z)R$<4:&3$"EE%(<7$&^>V.!(5-T.,*,'PJ:C,\,XA
M,!,5A\\1%1B^%)49WIGU*U%Q^-I"MHGJ/&R:^'-KHCY5F]ZVR/*V188?"_6[
M,C5`)Z<Y;XG(1Q1H9,0*646G2L-;YTXY$A6W3HPHP?"I1N/F]_'-@I`ARA$5
M&*O4:&17U5D0*E%Q56L+V4:JP_3?-U(?R4TC-2*GC&9UYKUY7ZNF)R,7&@VL
ML39V9K0EJV[;97>J?A,_<5K"9Y'\UBW``D-1&35U"XQ81166YQD[@RAFE928
M8(FIJ,Q8SB-FK#KWB#F+I,`""RQ%=:;`BE5G'[%F55.BU9<&[O6+.RG\MGO]
MLXVRL15KPM@[98T&LN&=,Y(NMV`DJJ5&0YDH?%0%C"16R$AB11@K1E7"2&*E
MC"16AK%R5!6,)%;)2&)5&*NV5+9'[[N6&>"U#"-K8-\Z:^&<5<;`9B0;U:5&
M],%3E8^J@)'$"AE)K$@C^N!8,:H21A(K922Q,HWH@V/EJ"H82:R2D<2J-*(/
MCE5;*ML>=5UB3L?G3RTT(-0Z2&=7CCW32'T8\Y2SJY^S2C(N&$G/6FHTO&DF
MV?YH.IU.KAVG?<P7,)+H(2.)'KTE>HSY$D82/64DT3..3EMYHQV<^3K'C`4C
M"5\RDO#5F\+75D;;:'7Q8AKMSI5ONE08M-<WEO\:6<-S[.S8YYQ1NNY"HZ%T
MW26C:>/_^+KYSSY^^JR1;`$&#U$5:32B1>//#8HQ8X+A4U1EC,[4/6>-U+W`
MX"6J*HW.U[VV,MKNJ^N4O^]^>RECN=\BU>^D46^=S>Q\H%72Q1<:C6B^EXSN
M)FC)JD$[(=!\T#4AM-$I%$]*`188<JBS!4:LT@5VSD`QBZ3`!`M,177F"3-6
MM05V=OF<-5)>@>65HCI37L4J&K5&NSO35,VJID2[)ZG;GW,]Z8U[KO82R>I*
M&LFD-U>_]5?+C:`%HB4B'U&`*$04(8H1)8A21!FB'%&!J$14(:HM9'NDKI-,
MC_YB46]OGRPO](64W+7.!RTR3K(+1F+/$I&/*&`D'3ID9$TD$V<9B43%0SU&
ME"!*$66(<D0%HA)1A:BVD&V/NB@R[?FYI;B];K)<:Y%YEZ%.M32"+-<T,ET#
MY'-&406,3-=T1IJ!93:9.+-)Q!FE-\6($D0IH@Q1CJA`5"*J$-46LEU35T"F
M:W\QJ)3<V2FWR+*G198]6L7W^Y.A<X>Q')P4/`A\1(%&1NB0593?<,NYQ(A$
MQ>%C1`F'E]O.5%1&>+C?%Q6'SQ$5&+X4E1G>O=\7%8>O+61[JFZ#WN&IOCR2
M;<QLT"++TQ89#;]@E336$I&/*-#(B!6RBD:>8:+31R)1<3/$B!(,GXK*"'_K
M7@V+BL/GB`H,7XK*"'_C3/.5J#A\;2'+Q*%["W1^8#9R>V!J9)JHD='P"U89
M)B+R$048*V259>*M<VB.1,7-$"-*,'PJ*K.571-%Q>%S1`6&+T5EAG=F_4I4
M'+ZVD&VB>TWT4VLBV>5.NAI9WK8JR]L6F??[G-&XR4,4:&3$"EE%TX`,T%OG
MLC42%;=.C"C1B#Y8E:(J0Y0C*C2B#XY5BLJHZHVS(%2BXHRUA6PCU0V1.:7^
MG)$JBC-(-;(6KQMGWIO3*PI-1N.>02.ULHL?<-)D57OY/1P-)I/QM7..]5DD
ME]\!%AB*ZDR!$:NL;@+W^ZR2$A,L,175F1(S5IU[Q)Q%4F"!!9:B.E-@Q:JS
MCUBS"N_WZ0NIY_O2V\Z:31BG,^E+*]G=SEDE:(%HB<A'%"`*$46(8D0)HA11
MABA'5"`J$56(U%>#FV'5-$X[WMNO^K;?+GS>[+]LYINGI\/%>O=-?8UWHEY$
M.N'V.\:S_L!3;Z71+.*F#,:>.L]VI`R'_,5D-\_$JYNYV>4W7MUT)9??>G5S
M[^;RJ5<WLX7+^]=4V^:WJ)!"7Y:F-QVQMK1'I>?H*H4V/I3250ZMIO2$7>70
M]$PI7>70M[4_=;:CJEA'O6;4\)UZU;@=^D\C[Q-9C@\X&WEU<XISFH2.`YY:
MK#`'G0H\M<'O2IE22E>3T/[%4UN1CCS4)&IMPQ0Z,7AJB<.4&:7,.E/FE#+O
M3%E0BM^90N<J3ZWZ6`X=KSQU4NI*F5)*UY/21M!3>[J.//2D:D>`*?2B$[G<
M-5CH[1E*Z1H4]$H&I70-"_H=/Z5TU7HVF'@S6C6Q!G07Y,T[4^A*R%-7!YB'
M[GP\=8.`*73U0[VSJ];A@&K=F8=>+_/4RP\8C=XR\]0+8UTI$TKI*H?>AZ&4
MKKK1VQ24TE4.O8'FJ5<FL)P9I<PZ4^:4,N],65"*>GT$H]%[>IYZBP13Z'4]
M3[UYUY4RH92N)Z47BRBEZTGIM11*Z2IGUA_2\W2->GKGEYZG*V5!*>H54:P;
MO=M+S].50J_X4D_LFG7"/DT[;9[>:>*AOP[QNOJRR5;[+]N7P\73YH&6G>OF
M)=E]^_<EVG\<]3L`GW='^K,0M`V@;[W3WP'9T&N1UU=TO_RPVQWY'U3=WNDO
MBWS\/P```/__`P!02P,$%``&``@````A`/R$G)U8!P``$R```!@```!X;"]W
M;W)K<VAE971S+W-H965T."YX;6RLF5USHD@4AN^W:O^#Y?VH^!6@DDQ%$5!1
MT9K=O2:(D8J*!>1C_OV>!DY#]V%8L[MS,9K'TV]_O-VGN^'^^^?YU'H/XB2,
M+@]MI=-KMX*+'^W#R\M#^X\?YC>UW4I2[[+W3M$E>&C_#)+V]\???[O_B.+7
MY!@$:0L4+LE#^YBF5[W;3?QC</:23G0-+O#+(8K/7@I_QB_=Y!H'WCXK=#YU
M^[W>N'OVPDL[5]#C6S2BPR'T`R/RW\[!)<U%XN#DI=#^Y!A>$U0[^[?(G;WX
M]>WZS8_.5Y!X#D]A^C,3;;?.OCY_N42Q]WR"?G\J0\]'[>P/(G\._3A*HD/:
M`;ENWE#:9ZVK=4'I\7X?0@_8L+?BX/#0?E+TG3)L=Q_OLP'Z,PP^DLKW5G*,
M/JPXW#OA)8#1!I^8`\]1],I"YWN&H'"7E#8S!]RXM0\.WMLIW44?=A"^'%.P
M>P0]8AW3]S^-(/%A1$&FTQ\Q)3\Z00/@_]8Y9%,#1L3[S#X_PGUZ?&@/QIW1
M76^@0'CK.4A2,V22[9;_EJ31^:\\2"FD<I%^(3*`UE.1AH+#HB!\%@6''678
M&[.Z&XK!KUFCX;,HIFB=87]TIV:M;B@Y+DK>\9+]WFTE8<%D=<+G5YJJ%<7@
MLRAVUU%'H^%8O6ONHP)3(7<&QKXH>FM;%32$??E*:Q5P,*^TM%*[Q1&8XD7!
MTLK!;0/+9FM>9VGGS1U%/Q7X\J6.P@3(*RUGPJUS2,&IP+[<YDPW7W79(C:\
MU'N\CZ./%F1&\#:Y>BS/*CJ3P^6;3V&^H'^UGF$A,Y4G)O/0AJ[`4DT@";T_
M*D/EOOL.B<,O8B8U,6+$%"-8EF"RA@QF,C!E8,G`EL%<!@L9+&7@R&`E@[4,
M-C)P9;"5P:X"NF`/]PC6T/_A$9-A'N'H3A"4IO4E0S`"BQ@RF,G`E($E`UL&
M<QDL9+"4@2.#E0S6,MC(P)7!5@:["A`,@=Q$#!E`NJS?\W"-L%*PNPEK1!KP
M21[#LB9?2"/)$Q["32%D1HA)B$6(3<B<D`4A2T(<0E:$K`G9$.(2LB5D5R6"
M1[`-$(]8IO]B8F,RD!NA&FZ(,AR(EDR*H";7>`AWC9`9(28A%B$V(7-"%H0L
M"7$(61&R)F1#B$O(EI!=E0BN@4&":\TKBD5GYN"@3@K2R[8@R:8I_['JY9![
M*30$MO,O-(1%BPTI2)]GVRDA!B$S0DQ"+$)L0N:$+`A9$N(0LB)D3<B&$)>0
M+2&[*A$&'LX0PL#G!Y(..ZRFQ]!_G43Y;:!F9@S`]?PXPD1$/PHR+OT@Q,@)
M)')V?ADJFB)EYQD/P/EF$F(18A,R)V1!R)(0AY`5(6M"-H2XA&P)V56)8`\<
M$05[:FR`NQ/ZP*)%'W(RR*]O[(PW)<0HB)ASI6UPQH.X%X18!<FOG:PRF\=4
M4\`=3P'9[)GS()1>$+(DT@Z/:9!>\2"47A.R(=(NCZE(CWIBJ[<\"*5W52*8
M"'=!P<1_M<:8B.AM3JK>$F(4!#:`RGXZ%KLRXT'8%9,0BTC;/*8JK8K2<QZ$
MT@M"ED3:X3%5:4V47O$@E%X3LB'2+H^I2(^DJ].6!Z'TKDH$;]FU73"W>85F
MX:*-B&#ZE!Z-I%PXQ2B-9U0#D5A0VH5G150_3[/*4-,T92R-I5E*88\M1&6%
M-J+&"N=8H9+E];$FU;4H5;"N):*R+@=18UVKLJ[JV)5GC"S!K.NUI`RWP:BR
M$2ZBQD9LL1&5$1[WI'2Q*Z6@U^(,8O=0^DS@BUNPDM]FX>2,HSHI4+]Z3E9&
MTN*?8E19T$"4/<;,AG"&B.TU[X^C7O9/7)`FQI3%+$2EN(VHC)HC@D-*905(
MV\0"H\J"2T2EO(.HC%HA:I1?8U19<(.HE'<1E5%;1`U#L\.8K)CH/KOT_G?W
MF8J45@JD\@DQ9?=<%E7.<*-`?3B`5(:>Y)"\8%_-W%<@A=3ED"*H?.)AT0KM
MFRJ<8Y3VJQQ"ZEK2NAQ4:>S<"J,@Q5>&@.007F,UBN20/*HRPB[*-S9BBU&5
M$:[)(;P-)(>P>WG3+/H17<'X?WIDPN[=\C0J4.5FA5$E,BB:46129%%D4S2G
M:$'1DB*'HA5%:XHV%+D4;2G:"4A<Z>P6+GO4'W7@IO7%AR3LX;ML4X&$@]Y(
M.HU-L6"9O0R*9A29%%D4V13-*5I0M*3(H6A%T9JB#44N15N*V%N[;%0K.3I_
M"Y<_P#\'\4LP#4ZGI.5';^P-6Y]=@#G.7_]-QCK<M6%YREP9P'O!;",AOPSQ
MC:'TBZ/I<*2E6AM5AX,MY:ZJPQVDAFLZG%\IAU>53]D:ENJ=L%>8-?&3O@Z/
M:*G.!+I6U[.GH?X$@UI3`'I<QXT['6["-?&J/JGKP%35IW7<4'6S;B`,38>;
M#=6W5!WN-Y3;J@Y7T1JNZ7"-H7RIZG"9H=Q1=;AW`N_RD897LE?O)5AY\4MX
M25JGX``3JI>=^>+\I6[^1UKD[><HA9>Q60H_PLOW`"[7/98Y#E&4XA^L`OXZ
M__%O````__\#`%!+`P04``8`"````"$`_UA9^FD#``"Y"@``&````'AL+W=O
M<FMS:&5E=',O<VAE970W+GAM;*Q676^;,!1]G[3_@'AO@)!/E*1*J+I5VJ1I
MVL>S`R98!8QLIVG__>XUX,:$5:G4EQ`NQ\?'YU[[>G7[7!;.$Q62\6KM!B/?
M=6B5\)15A[7[^]?]S<)UI")52@I>T;7[0J5[N_G\:77BXE'FE"H'&"JY=G.E
MZLCS9)+3DL@1KVD%7S(N2J+@51P\60M*4CVH++RQ[\^\DK#*;1@B<0T'SS*6
MT#N>'$M:J89$T((HT"]S5LN.K4RNH2N)>#S6-PDO:Z#8LX*I%TWJ.F42/1PJ
M+LB^@'4_!Q.2=-SZY8*^9(G@DF=J!'1>(_1RS4MOZ0'39I4R6`':[@B:K=UM
M$,5!X'J;E3;H#Z,G>?;?D3D_?1$L_<8J"FY#GC`#>\X?$?J08@@&>Q>C[W4&
M?@@GI1DY%NHG/WVE[)`K2/<45H0+B]*7.RH3<!1H1N,I,B6\``'PZY0,2P,<
M(<_Z>6*IRM=N.!M-YWX8`-S94ZGN&5*Z3G*4BI=_&Y!>D2$9MR3P;$FFH_%B
M&DQG2/+&P+`=",^!V2\'>HUZ;<8=462S$OSD0(6!/ED3K-<@`K+.A8;!^/(_
M6\`/)-DBR]J=NPZL6$(NGS9!.%UY3^!_TF)V`Q@;$7<(3!O(,QK!G0_0B"RH
M$5.)HG==X%7TN">H0_0%@5$?(`A9H&HLTWQ;P:[!!"#$.-OS-3:0OLK)AZA$
M%B@.6^:L)[,%O2730/HRH=#/S1S>?UVA(5BK,5EL([ZNNGX"S<=7^X)P;L1;
M539[CPX$VSK:R-C45WP>L6:"?7*^8MQSXV6(QTR[Y:_>=\ADRV@CX+8IF"!<
MF!7KRH\-J)\+;&YGI\';N4"P/7D;.?/@/&)YL+1G:LX=*+)W'CQ(8VMH([8!
MRYX!!M0W((`^<KT#&FU/WX7./+!"E@G0WZS9="4$L]'\_96@J7I2FO,4F]IK
M+4QZ)PSV6&VA[G&-NJ9G-FVBI.)`8UH4TDGX$?LA'$:;E0DWS7H7^-"M=<.]
M^&+Z>.\+-/BM=JD7W^$`W$7]^#B*!_%A!&?@)7X[B;:PN,L/NTD43X;BLPCV
M[`!^'L&.&8@OHG@Q%%]&\1+CGED!7!QJ<J#?B3BP2CH%S<!(7^=9-%>/YD7Q
M&@R&ZP-7<&70?W.X(E)H5_X(\IAQKKH7G,!<.C?_````__\#`%!+`P04``8`
M"````"$`ZTT3K28#``!R"0``&````'AL+W=O<FMS:&5E=',O<VAE970V+GAM
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M0KI`YW5"S_>\\E8>,&W7.84=*-L=3HH-V@5QND+>=JW]^4/)28S^.Z)DIR^<
MYM]H0\!L2)-*P)ZQ!P6]SU4()GMGL^]T`GYP)R<%/E;R)SM])?102LCV'#:D
M]A7GS[=$9&`HT+CA7#%EK`(!\.O45%4&&(*?]/-$<UEN4!2XX7(>S!>`=_9$
MR#NJ.)&3'85D]=\.%?1<'4O8L\"S9UF\BH]Z/#R'51?N_-J/`K7H^4)>IUJ;
M<(LEWJXY.SE06"!+M%B5:1`#V;#[CL'X\3\[P`=%LE,L&W2-'-BH@!0^;H-P
MM?8>P?>LQR07,#8B'1`J72#/:`13/D"C8E$:50J5Z&0(O(@.)X(&Q%00&/4!
M@A0+5,O8M,BW%20=)@`AQMFY#4D-9*IR]B$J%0L4ARTSL#4D/>@UF08RE0GU
M.C;S\KD;"DV!M1J3Q3[B=U5GZTK-RQ?[@N@ERU:5P8%[NPX%MG7TD=#45SJ.
M6"O!.1FOI,_<8NY>@]IWGCO%9,OH(^"V*9@@BB:V&-`T%ZJGC6Z#UW.AP/;B
M?63DP3AB>;"R5](>S/05^UX/%),MHX_8'LPF'AB0\:!K$=WM6!-^("FI*N%D
M[*BN_T!5F`F;UK33FYW$$VA9^GZ?QL,XO8B/8CC&(&2"W\WBG6Y]DW@RB]/9
M!7RRB*'JSGF2ZSC5%]^49QFGRTOX5=]R/3,!6EZ+#^0[Y@?:"*<B!7CBZYKE
M7=/L!I*UX!7T/2:AU^F_)7S;$+AP?1<*O&!,#@/EO/E:VOX#``#__P,`4$L#
M!!0`!@`(````(0#J*,]\D`8``,<:```8````>&PO=V]R:W-H965T<R]S:&5E
M=#4N>&ULG%G;CIM($'U?:?\!\6Z[;S0P&D\4B+(;:5=:K?;RS&`\1C'&`B:3
M_/U64VWH;FS&[#PD8\^A.'6JND[3/'[X7AV];T73EO5IZ],U\;WBE->[\O2R
M]?_^Z_,J\KVVRTZ[[%B?BJW_HVC]#T\___3X5C=?VT-1=!Y$.+5;_]!UYX?-
MILT/196UZ_I<G.`O^[JIL@X^-B^;]MP4V:Z_J#IN&"%R4V7ER<<(#\T],>K]
MOLR+3W7^6A6G#H,TQ3'K@'][*,_M)5J5WQ.NRIJOK^=57E=G"/%<'LON1Q_4
M]ZK\X<O+J6ZRYR/D_9V*++_$[C],PE=EWM1MO>_6$&Z#1*<YQYMX`Y&>'G<E
M9*!D]YIBO_4_TH>4A_[FZ;$7Z)^R>&N-W[WV4+_]TI2[W\I3`6I#G50%GNOZ
MJX)^V:FOX.+-Y.K/?07^:+Q=L<]>C]V?]=NO1?ERZ*#<`62D$GO8_?A4M#DH
M"F'6+%"1\OH(!.!?KRI5:X`BV??^_[=RUQVV/I?K("2<`MQ[+MKN<ZE"^E[^
MVG9U]2^"J`Z%09@.PH&]_CM;LRB@@7P_R@89]0E^RKKLZ;&IWSSH&KAG>\Y4
M#]('B'S)#'D,N=Y*%7)403ZJ*%L_]#W(HH7Z?'NBA#YNOH&FN<8D5S`V(KT@
M5"F`WL`1,C<Y7E?]0D6!%155!<4MP2\@]L"-.?>=(L)P@%A,0*'[F2@P5-JX
M,27.K1/$"`,3#'?NZ:=S"(L;!+F?FP)O?4A\$"5VZX60J*\F)P'A@G"'FPFA
M/&:$!F."%CEH<Y.<:C-Q<P%=2JDN<@5T*"2(`2)#(JZ`<PB+H[0YSK>9`ML"
M4B)L>1+$!*A@$$HA'(U3!Q&+<(QA<8.E9>HWSTV!76Z.*@EBD!NEL>32Y68C
M`AFS>,C/XJ9<SA@A\]P4V.4FA[BX8A$S5U-$('LF2!P-$2QF\1)F"NPR&\<`
M,D.,OB\CC#B`U`10&43&DK&84?"@^T7KT2ZW,6?DID%SLFD(\E\)P;C1D38_
M-8N-HJH%RX'S?'$I3G!SK%`R=HWFB2!-(F9<AL3))=6!-`96#HW&]K2)JN&]
MG"B.?&LV4S(TD2:*H%E!YR`V3S7'#9[O"(E3'Z(/8XW240'-#T%:)!H)(B;]
M2$V,D#*,^%@/FR#DN8"@0ML=R=T10Q&C^3%5:38IM(7A@A,9C'%L@FJ0&PK>
MV9(X_FTE1Y/22B((F=*("Z/;>D2J=GN0+R("3H6X)>,B%Z%3&Q$3<H@!H89>
M&!72[$P?88&(Q[%D2[C(1NC41\086"MGNL0JCEG$'/ZI#J/%94*&MZ1;9"1T
MZB3"Z:Y$8W0'QA%8F+.(4ALB!8,6'.:`+=XB-Z%3.S%:1HMGNL4*S"0*A+._
M274<G0*C`8&?ZP39(D_IT?8*IM2Y>Z)!>/<P#"EQM_6I#9$RN&7&S+&4^0G8
MHVUZQMX2]=,8K0V5(65.`JD-X2$'S`WUU"A?/%X8&H`]7L8]G.:)(.3)`L88
M#T<6/2;5@1!#0QK$-+ZQ3M@B*^G1SBZ:.@,DT:"Y&3,+L18*4S/=4/*=0J,#
MV`JZ.\(^Y&7\KD"9.*9RE$=+B)%$O]^^M48<$WF'VS7S<$>@>O@&:YC5SG8/
M$LFQ`+9TB]R#3=V#4G<&:I!>).H9C4]ZS[2/%>.WMZW,,9#[/+B_RE[+\,@Q
M+$.]2"PG803ZGT^'C0EB<4#DF(LMY"(O8>@EL*X&BZ5L["!-$$&S=9Z#V/P<
M,[E3R*FI4.8X6L),5Z$\!--S!E)J05C,F32\R>*I]OSF6KZ/9W^54_#)<X`&
M86->?PRP('-/`=SQECMI7GE<<;<O21]Z&#T2]H:Q8<`X>33F>FO8>BHKN'LV
M<C0.:S:Z%I=HT/6;:WX81\\`:.W;FPCNF,N=2N)CADW4Z;JD#WU14C"P:_<X
M++4@3,0RNK4;XY#O`B$5VFE(-LY@7.!]R`N_%>6P'7*&5&I!N(S"<4C895YD
M,_R*S3#7`C4(:Q@)'L.!G#U"4PL")AF%L7&J8Q-TC.;.,E\Q'.;Z(3?=1'+X
MH7*423>DB1&"R%#</'+]7Y8#;P.F!7>M48/PB#.D8<CH9%1:&"E(`%OT,0YJ
MBN\-\%B]*IJ7(BV.Q];+ZU?U3H#!?F3X=GA?\9&I$VKG^P3>8_2'_IOA#_`:
MX9R]%+]GS4MY:KUCL8>09!U"RS3X(@(_=/6Y/\Q_KCMX@=#_>H`71@6<@),U
M@/=UW5T^J//UX174TW\```#__P,`4$L#!!0`!@`(````(0#NBH^\OP8``+,:
M```9````>&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;*R9VV[B2!"&[U?:=T"^
M'\!'P$JR"A@?P*#5:@_7CC'!&L#(=B8S;[_5[J.[O"@9[4T,7ZK_:O]=W>XV
M#[]]OYQ'WXJZ*:OKHV&.I\:HN.;5H;R^/AI__1E^F1NCILVNA^Q<78M'XT?1
M&+\]_?K+PWM5?VU.1=&.0.':/!JGMKWYDTF3GXI+UHRK6W&%_QRK^I*U\+5^
MG32WNL@.7:/+>6)-I][DDI57@RKX]4<TJN.QS(N@RM\NQ;6E(G5QSEKH?W,J
M;PU7N^0?D;MD]=>WVY>\NMQ`XJ4\E^V/3M0877(_>;U6=?9RAOO^;CI9SK6[
M+TC^4N9UU53'=@QR$]I1?,^+R6("2D\/AQ+N@-@^JHOCH_%L^GO3-B9/#YU!
M?Y?%>Z-\'C6GZCVJRT-:7@MP&\:)C,!+57TEH<F!(&@\0:W#;@1^KT>'XIB]
MG=L_JO>X*%]/+0RW"W=$;LP__`B*)@='069LN40IK\[0`?@[NI2D-,"1['MW
M?2\/[>G1L+VQ.YO:)H2/7HJF#4LB:8SRMZ:M+O_0()-)41&+B<"5B5CN>.ZZ
MCC>??5S%82IPY2JR)W>R0X;N%N#*VBWN]M9C\7`5>4QGZI$;OI,&9DR7!JZB
MF;S'.PVA-UU#N+*&\[%CN;-Y9_&=AB94`QT<4A;4>.N#3?F0F'),S,\/"50N
MZP%\8#WPQM;<-=W.K@_6A\F'EGQ@,J8<V_LJ$UJQW00(LC9[>JBK]Q&L*E"3
MS2TC:Y3I$V%>^M11,1G^:R[`)"`JST3FT9@9(RCS!B;PMR?;<Q\FWV#2Y2QF
MB6/,?L2*1Y`91F0#':QU$.H@TD&L@T0'&QUL=9#J8*>#O0(F8*WP%RKG__"7
MR!!_N3-+#J3AEF8FC^!-`AVL=1#J(-)!K(-$!QL=;'60ZF"G@[T">F;"_$%F
MVC"MA]=I7IND%:S(:FU:T[Y92QI#YKDH8*U\5R)$&(K(&I$0D0B1&)$$D0TB
M6T121':([%72\Q;F/O*6/`,_N1`0&5A+((TPTO8\S6T6=,]M$2+<1F2-2(A(
MA$B,2(+(!I$M(BDB.T3V*NFY#<8.N#TF#_KV5.9?EQ7=+PQ4M@W+*UUTB4CG
M-?=HR0C=6)`5=,6()U:.@!(;NB9'R-**?2V"N'2(2(1(C$B"R`:1+2(I(CM$
M]BKI60L[DIZU`Q;")H5[2*+['C+B",=6E-C2U8`2!W8QBH=:E:]%D/`0D8A)
MTTTE&;!8Q*C2B_X$2D00E]X@LD72J8B1TI8^\CL1Q*7W*NDY#8_[3SA-HOM.
M,Z(X38GJ-"4.7!2G9WT[UB*(]SE$)*)$D8Y%C")M:P^&1`1QZ0TB6R2=HI@=
M(GN5]&PEITIU2W:_@$ETWU9&%%LI4>X]H$2S=:[9*H+XO8>(1$@Z%C&JK=I.
M+Q%!7'J#R!9)IRAFA\A>)3U;X>30LY7N=#^YY!*1OMN,*&Y3HKI-B=L=0KNE
M>XU(B$B$=&)*'+C(R6!K^[Y$!`EK$=E2HG0Q13$[1/8JZ5E+SE@];^^7;!?>
M=Y$A;]&='1S3L[4E;\4;+<2Z''`$0R[\,%U;JV(694T[:<N<337I4.IPRR*.
M9+:8H[O9$BW;PM*2;:0,3[;E2"9+.;J;;*<E<SQ;F\)[J0/9^F-&3BP?7V9,
M>L"A;V&Z&EXR9*G;.-O6[%_QJ.[U#3O542UHR"U8LR@;GC5B*&W;Z0]ER+74
MC*:K[5TB'B4SQAS)C,EP1DUK(QO*?J&,6QXE,Z8<R8R[X8S:KF$O&PYG[`\B
M.-$;Q)]:U,BQ1UO5.%+KS[:UY^Z*1\G"#1BRY\K84GD'%@EE;+5*#65#&86<
MCG#&6#;DU90PI&5$,Y'V"[IZ)^,69TQQQMU@1D?;3.QEP^&,_;$E1S5U@O[<
MV+(#GRS-)3F<P7#/Z(+HF`M3>X2L6(0E&P4,.3!UQ2`.K+54VK&ZM=:<NOKR
M%TH=/EH1SA;+J#O9$A[%LMESS>\-#Y`[]RU.ELJH.\EV/(HE,Q?Z8X2\H2:^
M@D5BK:5OG.D+MTM1OQ:KXGQN1GGU1MXF=X\D@>FK[GCNPU8(!'2^\#?=--/X
MUO/A:8[C4\^'YS7F\"K]N5N3-)TE><4^$+^T?'@=@W66M@_O$C!_=OQG,`+_
M8^GX<!S&/'!].,MAOO3\Y=`-K#Q_-<0#SP^[4ZYV8\',A],`U@_F/FQG!_C"
MA[T8YI'GPXX,\]CSX?`UP&<^'!6`3T2'X">#6_9:[++ZM;PVHW-QA"*8=CO0
MFO[H0+^TU0UV1_##0=7"CP7=QQ/\.%3`\7`ZAG/OL:I:_H4D$#\W/?T+``#_
M_P,`4$L#!!0`!@`(````(0`E.=G*;@,``*4*```9````>&PO=V]R:W-H965T
M<R]S:&5E=#$U+GAM;*Q6VXZ;,!!]K]1_0+POMY"$H"2KA-6VE5JIJGIY=L`$
M:P$CV]GL_GW'!EP,:;2I^A+"<'Q\?&;L\?K^I2JM9\PXH?7&]AW/MG"=THS4
MQXW]X_OC761;7*`Z0R6M\<9^Q=R^W[Y_MSY3]L0+C(4%##7?V(403>RZ/"UP
MA;A#&US#EYRR"@EX94>7-PRC3`VJ2C?PO(5;(5+;+4/,WL)!\YRD^(&FIPK7
MHB5AN$0"]/."-+QGJ]*WT%6(/9V:NY16#5`<2$G$JR*UK2J-/QUKRM"AA'6_
M^"%*>V[U,J&O2,HHI[EP@,YMA4[7O')7+C!MUQF!%4C;+8;SC;WSX\3W;7>[
M5@;])/C,!_\M7M#S!T:RSZ3&X#;D26;@0.F3A'[*9`@&NY/1CRH#7YF5X1R=
M2O&-GC]B<BP$I'L.*Y(+B[/7!\Q3<!1HG&`NF5):@@#XM2HB2P,<02_J>2:9
M*#;V;.',E][,![AUP%P\$DEI6^F)"UK]:D%J19HDZ$C@V9&$CA]Z"TEQ9=BL
M&P;/"W-/![JM=F7%`Q)HNV;T;$%]@3K>(%FM?@QDO0<M@W;E;Z:`&Y)D)UDV
M]M*V8+T<,OF\#2)_[3Z#^VF'V4\Q(T32(V320)[6"-[\!XV216J4B92B]WU@
M(-J4G/2(L2`P:BQH!N5WN7!ZC^0@*!'#H\"<<-]B?)A7&SDW(8F&C$6%4U&R
MFF_,I&2!6C!ESDP-^PYT3::&C&6"I*%WUSV38*5&)ZV+>*K(?,\4ENBO?_P+
MHE"#C*I:W")$@DTA7230]90,(\9,L"^&2Y9[+(@\!\3>F!Q)9*KH(N"V+I@@
M&I>,!HUS(3O98/-?SX4$FY-WD8$%PXAAP<J<25D0K/[!`DEDJN@BI@4+G7.U
MUQ,-&EO@P[Y]NP<*;4[?AP8N&"'#!FAGQFSJN/5@']U8"(IGI*,]/7W3A^7(
MAWY@J#JC.F3;_M@VA0JS(TYP67(KI2?9^^`LVJYUN&W,>]^#SJR:Z^2+[MFC
M+]#,=\JB47PO!T@QXW@0P_%[(3Z+X0B<QG=AO(/%33_LPSA1JQU/L(AAQU[`
M+^-$-8DQ/HJ3Z!)^%4-U`8^K!\`EH4%'_`6Q(ZFY5>(<C/2<)6QXUEXSVA=!
M&S`8K@I4P/5`_2W@.HBA.:G3(:=4]"]R`GW!W/X&``#__P,`4$L#!!0`!@`(
M````(0#J@L]R9P,``+,*```9````>&PO=V]R:W-H965T<R]S:&5E=#$W+GAM
M;*Q676^;,!1]G[3_@'AO^`A-`DI2)53=)FW2-.WCV0$GL0H8V4[3_OO=:\##
MD%6IU)<0+L?'YQY?^WIY]UP6SA,5DO%JY083WW5HE?&<58>5^^OGP\W"=:0B
M54X*7M&5^T*E>[?^^&%YYN)1'BE5#C!4<N4>E:H3SY/9D99$3GA-*_BRYZ(D
M"E[%P9.UH"37@\K""WU_YI6$56[#D(AK./A^SS)ZS[-322O5D`A:$`7ZY9'5
MLF,KLVOH2B(>3_5-QLL:*':L8.I%D[I.F25?#A479%=`WL]!1+*.6[^,Z$N6
M"2[Y7DV`SFN$CG..O=@#IO4R9Y`!VNX(NE^YFR!)@\#UUDMMT&]&S[+WWY%'
M?OXD6/Z5513<AG7"%=AQ_HC0+SF&8+`W&OV@5^"[<'*Z)Z="_>#GSY0=C@J6
M^Q8RPL22_.6>R@P<!9I)>(M,&2]``/PZ)</2`$?(LWZ>6:Z.*W<:3H+(GP':
MV5&I'A@RNDYVDHJ7?QJ,3LAPA"T'/%N.`/Z^,F#:#H!G-^EL<COWIP'..A[H
M-:*U!_=$D?52\+,#A06Z9$VP3(,$R+KD&P9CQ__<`!N09(,L*W?N.I"IA"5\
M6H?Q=.D]@>U9B]F.,8&-2#L$KA;(,QK!BG?0B"RH$5<016^[0$_T0%"'&`H"
MH]Y!$+)`L5BF1;:";8/!8C#.WMJ0U$"&*J-W48DL4!RVS(&&;0MZ3::!#&5"
MO?;-O+SMND)#L%9C5K&-^+KJ@G!@COGZS[\PGAF056:SMPA!L"VDC82FP-)^
MQ)H)-DH_9=QT813B\=)NW:LW'C+9,MH(V&TJ)HSG)F-=^JD!#1<#FUKO.'A]
M,1!L3]Y&>A[T(Y8'L3V3/GC"^>3M%B"1K:*-V!8L!A88T-""`#K(]1YHM#U]
M%^JY8(4L&Z"S6;-I'X)H,G^[$9IJ(*4Y4@/;BGA@13<PTGU2G[Q-MVPZ14G%
M@::T**23\1-V0CB/UDL3;MKT-O"A3^M6._IB.OC@"[3VC79I$-_B`!0SC(=)
M>A$_3>`8'.,W4;*!Y,8?ME&2ZFR'$\P2V+47\/,$]LR%^"))%Y?B<9+&&/?,
M!'!EJ,F!?B/BP"KI%'0/1OIZG45SZ6A>%*_!8+@Y<`6W!?WW")=#"AW+Q]VQ
MYUQU+SB!N6ZN_P(``/__`P!02P,$%``&``@````A`&*?U`2D!0``I18``!D`
M``!X;"]W;W)K<VAE971S+W-H965T,C0N>&ULK)A9CZ,X%(7?1YK_@'COL).`
MDK0J"]G(JEF>*4(25"&.@.KJ_O=SC;$#OM6CZE:]5"4?QR?&APL7][]^SZ[*
MMR0O4G(;J$9'5Y7D%I-C>CL/U+__"K[T5*4HH]LQNI);,E!_)(7Z=?CG'_TW
MDK\4ER0I%7"X%0/U4I9W7].*^))D4=$A]^0&1TXDSZ(2ON9GK;CG272L!F57
MS=1U5\NB]*8R!S__B`<YG=(XF9#X-4MN)3/)DVM4POR+2WHON%L6?\0NB_*7
MU_N7F&1WL'A.KVGYHS)5E2SV%^<;R:/G*YSW=\..8NY=?4'V61KGI""GL@-V
M&ILH/F=/\S1P&O:/*9P!778E3TX#]<GP#X:N:L-^M4#_I,E;T?BL%!?R-LO3
M8YC>$EAMR(DF\$S("Y4NCA3!8`V-#JH$=KER3$[1Z[4\D+=YDIXO)<3MP!G1
M$_.//R9)$<.*@DW'=*A33*XP`?BK9"F]-&!%HN\#U80?3H_E9:!:;L?IZI8!
M<N4Y*<H@I9:J$K\6)<G^92*CMF(FH*Q,X']MTNMT#=VSNA_W\&H/^/_;'H95
MF]`/O^_2Y2[PX5==-+:^55R3J(R&_9R\*5`#L(+%/:(59?@&5!\/BBVKB.YG
MR4%DU.6)V@Q4F!B$4L#E]FUH.59?^P:72%QK1EACM!5CKJ#7`[6=R&`J@T`&
M,QG,9;"0P5(&*QF$,EC+8".#K0QV,MC+X-``&L0C,H(B^(R,J`W-B*_NB(-'
M:*84"%?P(1,93&40R&`F@[D,%C)8RF`E@U`&:QEL9+"5P4X&>QD<&J`5")3Q
M9P1";>#&UB@:4W?:"8R8QH"9B,J2)&,A$2DA,D4D0&2&R!R1!2)+1%:(A(BL
M$=D@LD5DA\@>D4.3M$*S/R<T:@,W2_@9$8CEV%)JM>C_4A,2D1HB4T0"1&:(
MS!%9(+)$9(5(B,@:D0TB6T1VB.P1.31)*S5X4K]3:AWZ!"\O:?PR(JP->*>Q
ML.`YQ)Y.U*3*C*_UJ":L7Z"/FG%-7'%[G#!BP=1$TJ:AMY.>"A&W#A"9(3)'
M9('($I$5(\9CBJ'0-*<H/5770L2GN$%DB\@.D3TBAR9II>9^1FK4I)U:31X+
M,$9DPHBK5TV(J1M2:4[%<;X:`2(SY#H7&MK:@*O4VRS$<>ZZ1&2%7$.AJ5VE
MN:[%<>ZZ062+7'="\_Y<]^(X=STT22M':.A0]9DN;=E_TLGSBJ,#V]G5!%K,
M1C7)_48M\AY%*(;QR4X9,5G`AMUU>MV>=,D':-0,.<^19M%VMMR>:=M>N]Z7
M:-0*.8=(LVX[VZ[I>I9T"6W0J"URWB'-ONT,3;=M6=)E=&B.:L5+W[:;S?\[
M-U&(FF=*U>U,&3&;CSE3+HUQ+;(>F8IA(E-&K$=A!T@S0SYSI%D@GR72K)!/
MB#1KY+-!FBWRV2'-'OD<FII6%O""V<J"O8C]XH..FK0C8L2!?XVRDRZ0<3VL
M47:,6#T1VK0F7G5?=;NN[DDN`1HS0[YSI%FT?`VSZSJ&*]4<&K1"QB'2K%O&
M/=NT=&G"&S1FBWQW2+-O^1J&Y3FVU)$?FH-:(<.6"T[9A/K\>"]36;0SKI%4
MA]*DQES5*,0:V8\V:,J16>5L.+9E][J25<!%CW$S[#['J@5'M;OM.3W/E=R7
M7/1P7V'W$*O6'(FYNYYI==L7TX:+'NY;[+[#JCU'?.YNU^IUI<?#@8LJ=Q8]
MVR-CFRY9DI^3<7*]%DI,7NG^%[S9#?L"B\VY)Y-6GL1'=-/N/6[Z\*KZCM[R
MX74(\R?;?X*)X@,CVX=.'/.)XT,[BGGH^-`#8CYQ?>BJ,)^[/O1%F(>N#YT-
MYCO7A]X$N"96`C8)[]$Y64?Y.;T5RC4YP2+JU6TR9]N,[$M)[K"XL%5(2M@>
MK#Y>8#LX@59?[T#[<B*DY%_H#X@-YN%_````__\#`%!+`P04``8`"````"$`
M`?W+:M,$```I$0``&0```'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6RL6-N.
MJS84?:_4?T"\GP#FD@0E.<J-2]1*5=7+,T.<!`W@")C)S-]W&V,'VVDU<SHO
MP[!87K:7M_>VL_C^5I7&*V[:@M1+TYG8IH'KG!R+^KPT__PC^C8SC;;+ZF-6
MDAHOS7?<FM]7/_^TN)'FN;U@W!F@4+=+\])UU]"RVOR"JZR=D"NNX<N)-%76
MP6MSMMIK@[-CWZ@J+63;@55E16TRA;#YB`8YG8H<[TC^4N&Z8R(-+K,.QM]>
MBFO+U:K\(W)5UCR_7+_EI+J"Q%-1%MU[+VH:51ZFYYHTV5,)\WYSO"SGVOV+
M)E\5>4-:<NHF(&>Q@>ISGEMS"Y16BV,!,Z"V&PT^+<VU$QX<V[16B]Z@OPI\
M:T?_&^V%W.*F./Y2U!C<AG6B*_!$R#.EID<*06-+:QWU*_!;8QSQ*7LIN]_)
M+<'%^=+!<OLP(SJQ\/B^PVT.CH+,!/E4*2<E#`#^&E5!0P,<R=[ZYZTX=I>E
MZ083?VJ[#M"-)]QV44$E32-_:3M2_<U(SB#%1-`@`L]!Q/$^W!B8_0C@R1M/
M9K[O!;/IQT<`S%X$GH/(;#)U[+G["0W8$KT&/']\(/-!!)Z?'8C%EJ9?Z5W6
M9:M%0VX&;!\PO[UF=#,Z(<22P=>8K8A8]7];=%AMJK*F,DMS:AJPGBU$ZNO*
M]?V%]0K1E0^<C<YQ9,:6,V@H4=F="NQ5(%*!6`42%4A5X#`"++!%>`,A]Q7>
M4!GJ#9_5A@-WLY!B!&?P)CL5V*M`I`*Q"B0JD*K`801(1KA?8P25@1PP"A+D
MS.29;QC'@9&(2%+B:"LHPAT-V6M(I"&QAB0:DFK(88Q()D&.^8IHH3*P&:$;
M88#K!XI+`^F_7!(4X9*&[#4DTI!80Q(-237D,$8DER")2BX]KB4\K5!V;P:?
MQ(8A+JL1-$=L-63'$&^<C9RYDFOV@L2E(PV)->E$<.ZK@Y`BG0H2ESZ,$<F.
M0+&#I=\)K2S=I<B?-X05R`<VN9!F6?*E(K)+#!F[I"$[AGCS/ELCV_'D&-N+
M[WP6D8;$FFHB.+0&@*HKJZ;B.U<]C!')&UB_3X0*9<LF#`B47+&3$%(S[4":
MB^R\>]#,\95I[!D)V;UYP<QS/4^)@DCH\)G&6E^)X-R'J/652GWY<Q38KBV[
M>A`ZT)?D(3V*C\O[@SB"LQ@/),J6/60(&B<:A!0SM@/)O7LHFO&Y[QGB3EFT
MN<@/@JD\B4AK%&O"B<9)%6%[AEQE?(=Q(\D=.$A)[OS0[J,BLFD#`MV.`D_9
M7MN!-`H\AK@S8>-^0-@6A0AS74^IEY'6*-:$$XV32L)H&B!?W1B'<2/)-'I*
M_/^N]2JR;0,4P'%LY)M:_0<6&D7;`'GCAMHVVG,6ZD/0<?T9\M3"&G'2O;[$
M>H?)G74?J=9AREE#A_9\'DQGRG3H_8V&#XQ=;%UV'V.G]`HW9[S%9=D:.7FA
M=RTX&:P6`A87P36B`@J^H1?$1S@*X:SW@.^&<+[1\;47KF&@^H>-%T*I?X#[
MX29X@&_]</L(W_DAE%]=9Q>$4'5T//9#J#TZGO@AU-H'>!!"G0'<$@[!1?6:
MG?&O67,NZM8H\0G,M?O*V["K+GOIR!5,AQLGZ>"*VO][@9\D,!P][`F4Z1,A
M'7^A'8@?.5;_````__\#`%!+`P04``8`"````"$`772==ZT,``!(.@``&0``
M`'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6RLF]ER(KD2AN]/Q'D'!_=CJ!6H
M:/>$68M]7^]HC-M$&^,`>GKF[2=%*96ES#IT>^;,Q>#^2/V24JG44L6GW_\\
MO-[]L3N=]\>WAYQS7\C=[=ZVQZ?]V]>'W&S:^*V4NSM?-F]/F]?CV^XA]]?N
MG/O]\W__\^G'\?3M_++;7>Y`X>W\D'NY7-ZC?/Z\?=D=-N?[X_ON#;YY/IX.
MFPO\\_0U?WX_[39/UT*'U[Q;*(3YPV;_EDL4HM.O:!R?G_?;7>VX_7[8O5T2
MD=/N=7.!]I]?]N]G5#ML?T7NL#E]^_[^V_9X>`>)+_O7_>6OJVCN[K"-6E_?
MCJ?-EU?H]Y^.O]FB]O4?0OZPWYZ.Y^/SY1[D\DE#99_+^7(>E#Y_>MI##Y3;
M[TZ[YX?<HQ.M72^7__SIZJ#Y?O?CG/K[[OQR_-$\[9^Z^[<=>!O&28W`E^/Q
MFS)M/2D$A?.B=.,Z`L/3W=/N>?/]]3(^_HAW^Z\O%QCN`'JD.A8]_57;G;?@
M49"Y=P.EM#V^0@/@_W>'O0H-\,CFS^OGC_W3Y>4AYX7W0;'@.6!^]V5WOC3V
M2C)WM_U^OAP/B\3(T5*)B*M%X!-%"O>E(/##4O'757RM`I]:Q?FX"%1W[0]\
M:I'2?=$IE+T/-"34&O!I&O)1E\#\NK8#/HT&>>2&+\NZ('R:#OAN4"Q=!^1&
M00=B)QE*%41ZF&@H;Y7$\7-H`/^!ZQT/&P!_9+3]%X/)P3A0?\A^_*H*#J*3
M'D4:@5^5*6*?X`_3IX\&E(M#H_XP7?IP8UR<K.J/?]X8G")J@AL5MQ0X0?CS
M.9]/\L<U'=4VE\WG3Z?CCSO(\="D\_M&K1A.Y(+/,1$E<6=2T__*3)"2E,JC
MDGG(@;,AZ9PAG?[QV0N*G_)_0`K<:IN*M'%LBRI:J'RG9&L<U#EH<-#D(.:@
MQ4&;@PX'70YZ'/0Y&'`PY&#$P9B#"0=3#F8<S#E8<+#D8,7!.@7R$"8F5B#-
M_#]B1<FH6,%1KB"@X'%98*`%%JEQ4.>@P4&3@YB#%@=M#CH<=#GH<=#G8,#!
MD(,1!V,.)AQ,.9AQ,.=@P<&2@Q4'ZQ2P`@,6#A$8'N3,[-T,Y@Q5"O8MJ9SA
MNB5[X"N)C5K@3&();).J,3'!(4A=D(8@34%B05J"M`7I"-(5I"=(7Y"!($-!
M1H*,!9D(,A5D)LA<D(4@2T%6@JS3Q(H9V"6(F%$[X`\N/$H&UBZHQ@2(%_`H
MTD:WHLB8F"@2I"Y(0Y"F(+$@+4':@G0$Z0K2$Z0OR$"0H2`C0<:"3`29"C(3
M9"[(0I"E("M!UFEB11$$3$84W:M3P^5EO_U6.2:GH(Q,Y,$V)=F\*)%K#.'8
M5S1)CDMJ)U+5)#2K5BTAGFM(79"&($VA$VN;PG77Y#MEARU^+6.`S6L+TA&D
M*TA/D+X@`T&&@HP$&0LR20ALXK'-4V.C-H>^$WIE.X_/C`$6F0NR$&0IR$J0
M=9I8T0/[72MZ,J($MM88)LK:#A--?-/+:D(\"IR:)NG<XWIL#:L;(^Q[0Y"F
MD(XU2><^UPMMM[:,$4JW!>EHDEPTJ'#O&AM*JRX?L9XQ0NF^(`,A/30V*6F?
MG01&Q@BEQX),-"%?3XW-#>F9,4+IN2`+3<@A2V.3EF8S=66,4'J=)E;HP5'I
M`Z&GK.W0TR05>@E)AYXFJ0PE2$.0IM")C4VJ[QX[W;6,$?:]+4A'2'>-34K:
M+]@AW#-&*-T79""DA\:&I)V`QYDQ0NFQ(!,A/34V-Z1GQ@BEYX(LA/12V*P$
M6:>)%53J=E@>YC^X&BH1.]8T2<5:0M*QI@G9U`5I"-(4.K&Q(=>Z'MO/M8P1
MNK8M2$=(=Q,27F]UKPM_3Y"^(`.A,Q0V(T'&@DR$SE38S`29"[(0.DM-R/4K
M0=9I8H4,W%=:(7-["536=FQH`OIF_^WZGCV!J]JH;-;)6D8Q)V#%ZHD17+ZI
M+8,3%@OJ/UNZ880P%)JBLMC84!M%92U=&=Q]I#KBV[6U,Y788MX1#>AF%F.]
M[64V@&GW,Y68T4`T8)A9C#5@I!N@W5THE-TP9#9C(X3NGHC*IL:&/"G</;,K
M<XJ!5RBPRN9&""M;B,J6PF:5D,!-HH;Y9IVVMR:"NH?_P$RXFMM302/7VNKY
M;#]612M*0S5$J85:(Z]X[440%-RPQ)0:LE@3$8G'B$B\A>*P.4G%.EO0VU20
MK)R`^;.#5E1C%Q'5V,NJT>$7Q'U9<("(Y(>(2'Z$\HFW_%+HNR%+%&-9;(*(
MQ*>(2'QFBP=N*71<YJNY++9`1.)+1"2^TBB``VYJ*-AZM[8*VE&K[FK32_[M
M_.TD5[MP78)3JH+(SN#L<%9%JU0*1U0R6G6-=,;V,Q.V+-9$1.(Q(A)OH;B5
MH0,VS&TJ2`[-B%KM!ZJQ2P71-;WL&MD6LD\%;]0X0"NJ<8B(^CC"&G4.+OH.
M3XIC66J"B+2GB$A[9FN70B_DDWDN2RT0D?82$6FO--))E^6(M57`#E_(E1\)
M7V7.DFZ"X%D]>=\-V,&LJBZ0H2!8X>#6$-%DK&NDDZYSW6ZP^&K(8DU$)!XC
M(O$6BEM)EV]YVE20NI,1OJ([72J(/>QEU\BV-'TJ>*/&`5I1'X>(J(\CK#')
MPZ%;*)782(QEJ0DBTIXB(NV9K5UTRD&1=64N2RT0D?82$6FO-((LG.PT[5W?
MVBIAQZ^ZWDZGW^3QZ0=/7.KVFH>U1E96YO.UB@5I<M8T\FARUA&5D]YEAW52
M7ZI84XK'J$3B+8U\V#V9!4RL[&U9L"/EN]*JER7O!FPGU*>"Z4:P-#20-0ZI
M(,Z:$:+$6V[)+?`KM3&:D!LF4GLJK6:($FVO&!;X^C5'$])>2.TE(K):::13
M,%N_UU8!.X35W?J_#V%]0T_SK*+>`X&H#JWUVF6#4M565F9."OKI@N(`4=<%
M_62?[Y;*F5MD(X7CVY05QBAUL\(66L%,,9$.+_C8N:*-5K86ZW5'-J*;79`=
MB7IH93>"[1?[:'6S$0/9B&%V0=:($5KI(U98\+RRSY+Q&(WH>G8B*YR2%3E5
MC/4,K72%I7*YY!=8B,_1B"I<R`J7B-+9/PD2CQY6K"TK>[JHAPFWILOT^`X[
ME)\]^U9/.I.43_WV`M:E"EK!<F]"CH52E6PPQ&L2U25J2-24*):H)5%;HHY$
M78EZ$O4E&D@TE&@DT5BBB413B682S25:2+24:"71VD)V?*DG!NGX^LF!+GG`
M`.D=1[^BWIR#T(++60H:/CNK9(3E:AKY<+ML@LT-V6FG3E98L"%14\K'9)66
M9ZFE158HW[:0[2MU$8Z^4F?DG_@JN3>W?*6OTBEG5!V!:AHQS["=;9VLL.D-
MB9I2/B:KM&>8?(NL4+YM(=LSZK[W`YY1YNQ<E:#4%7_5$:BFD>49>()MKXEU
MLL*F-R1J2OF8K,@S0KY%5BC?MI#M&74!F/;,/]NQZVO$]+1+D.4P@6I.@GR]
MNRPX;-FLDP%VIB%14Z-493%9J3.,*Y1;9(#*;0M9;E)OO%INNCVUKN9V`&D4
MTF.)JD0U1/2DM8Z(EN,&(K)J:@0]P-[$B&A3W-+(I?G=MJSL/D/&_$B?E3GK
M<X+L&^"0#7$56J,*IK>\B-(+O=@&U;65OI\H>R&<KYEX@Y30+TU$%*PQHIOU
MM5A]ON^5RJR^-BE!?;8[U27%OYYIRI?<RQI!.DHM5'Q?A`4I0&H:I0ZY=8VL
MXRL\]K`36(,*4HWB5J8I:XRI((Y&*[M&?HR@@MDUVIY6A_=_[^GD"B"]/*I;
MM212J17P(,+V3I6LL),UC7YRA$.K9%M?*A9<M\R&L8$V-(.;LKZ8K*BA8OZT
MT.I&?6VTN=:7>#GY$4_RUOQA=_JZJ^Y>7\]WV^-W]0,=7[U'9G#RZZ&*'\$K
M:^`-QA^=('J$&N0WL-6/U*Y0?@-[J4CE>_D-;*DBM3O*^J8(WUS?L&8M@"45
MOKEF2/%-&;[)J@=^"_5X/2ZQ$A7XC=3539R[\-NIC%95O`A>!Y6M??2C1SAP
MR2]@*QM5,IL$^]>HFOD-;&,CM2.5:K"-@V^RG`+;&/@FRRFP7L,W64Z9A!$\
MTI>U3,,(WB?*X,4(WO_(X*4('O)+O@@C>-0O^3*,X&&^Y)TP@E<>).^&$;R5
ME<&+$;Q%D\%+$;P$(?D@C.!5",F'802O9F7P8@2OTF3P4@0O1TA>"R)X6U+R
M.(C@]4+)IS!?LG@%0B9+OPH!D\5K$"Y9O`FS+HO',.>R^AO#C,OJ;PSS[:J3
M-[,$?L?WOOFZZVU.7_=OY[O7W3.DD<+USOB4_!(P^<=%WR1\.5[@%WS72X47
M^,7F#M[/*]S#_<'S\7C!?X"#\N8WH)__!@``__\#`%!+`P04``8`"````"$`
M%.(,IHL%``"?%```&0```'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6RL6-F.
MHS@4?1]I_@'QWB&8-2A)J[*P1#/2:#3+,T6<!%4($5"5ZK_O:[R`[4RKTE,O
M17%R[K%]?&U?//_Z7IV--]RT97U9F/9D:AKX4M3[\G)<F'__%7\)3:/M\LL^
M/]<7O#"_X=;\NOSUE_FM;E[:$\:=`0J7=F&>NNX:659;G'"5MY/ZBB_PRZ%N
MJKR#U^9HM=<&Y_L^J#I;:#KUK2HO+R95B)J/:-2'0UG@35V\5OC249$&G_,.
M^M^>RFO+U:KB(W)5WKR\7K\4=74%B>?R7';?>E'3J(HH.U[J)G\^P[C?;3<O
MN';_HLE79='4;7WH)B!GT8[J8YY9,PN4EO-]"2,@MAL-/BS,)SO:V8YI+>>]
M0?^4^-:._C?:4WU+FG+_6WG!X#;,$YF!Y[I^(=1L3R`(MK3HN)^!/QICCP_Y
MZ[G[L[ZEN#R>.IAN#T9$!A;MOVUP6X"C(#-!'E$JZC-T`/X:54E2`QS)W_OG
MK=QWIX7I^!,OF#HVT(UGW'9Q221-HWAMN[KZEY)L)D5%$!.!)Q-!:&*[4_\!
M#9=IP)-IV)/0\UP_##[>$6#VHX$G$PD>%X&ET8O`\^=[,F,B\'RX)Q:=HW[*
M-WF7+^=-?3-@'<$LM-><K$H[LB%5^&33J1'3_U^S#]-.5)Z(S,(,3`,FMH64
M?5LZ_G1NO4&:%8RSTCFVS%AS!LDI(KM1@:T*Q"J0J$"J`ID*[$:`!;8(;R#W
M/L,;(D.\X:-:<6`P"RE&<`8/V:C`5@5B%4A4(%6!3`5V(T`RPOD<(X@,;`:C
M)$&!FB248T-/1"9YBCF"(MS1D*V&Q!J2:$BJ(9F&[,:(9!+L,I^1+40&%B,T
M(PQP?&6AK!CI1RX)BG!)0[8:$FM(HB&IAF0:LALCDDNPC4HNW3]4^+9"V+T9
M?!`KBKBN6$UKQAF0#>.,=R-[IEBX%20N'6M(HDFG@C/,#@I<.4$S0>+2NS$B
MV>$K=M#M=T+.I^Y4%B^KFIZ4=VQR8)NEFR\1D5VBR-@EQAFYQ#BS?K=&4UL9
MQ5;\SD<1:TBBJ::"0\X`4'44;\3O7'4W1B1O8/X>2!7"EDU@")RY8B6A0-U,
M&&DF\FES)\SVE&%L*0E-J7FABY"C^!<+'3[21&LK%9RABUI;F=)6`%,5R*[N
MA`ZT)7E(:O+Q\7XGCZ"@XHE$V+*'%$'CC08%OMSZFI'ZDI2>VR*,CWU+$2?H
M#9OY"*I!62768A)--]4XF:0;ALCW%-W=.$;R!NJH![PA;-D;AH#^*+^4F5DS
MTBB_1)CPAB(LF9P0N4A)MUB+233=5.-DBJZ#5,]WXQC)&U(*/F!.3Y?=89"2
M.J$\Z6O.&N4.AY!8DEL&L>SQX!O`4X1B/2KAT*"=<FC0SF1MWYZZ,T5[)T7)
M-I'2\>/KRZ:5)OUXZU?*BD-R%LU4FUC@*(V&0)%'#&*)9-NSJ:(3ZT$)AP;I
ME$.AF(%,ED:N[V@FL2[V0;))I*P<F_13AQPI"94%R"`YQ4*EHEQSUI`&&PX-
MI^&60V0S?%NZ,^2I(XPY98A*.#1HIQP:6!F'J';@^X&M;*$[3NFC9/=(P?G_
MW6-EZ]#1%2DQP5`/]H!A_T+J^<A8]I`>&P8A.'1$H'9J;3DK[`WUP$]_IFYK
MG#-\&R5Z>^G`^D%[&6>Q]CPG"$/U*."<OCWJ,KT%H9_$%6Z.>(W/Y]8HZE=R
MPP$!R[F`Q?7+4[]_*/B*7,N0%:/B*((/JSNX$\''A(X_N=$3M*O_L'(CJ*OO
MX%ZT\N_@:R]:W\,W7@2UKJZS\2,H\70\\2(H]'0\]2(H;._@?@1%'>"6<`*N
MAZ[Y$?^>-\?RTAIG?`!SIWV9V]`+)OK2U5<P'2Z)Z@XNAOI_3W`1B.$N8#J!
MFOA0UQU_(0V(J\7E=P```/__`P!02P,$%``&``@````A`'#S0VCW`@``-`@`
M`!D```!X;"]W;W)K<VAE971S+W-H965T,38N>&ULK%7;;IPP$'VOU'^P_!YN
MR][0LM%"E#92(U55+\]>,&`%,+*]V>3O.S:7+)!&B=2793V<.9PY,PR[ZZ>J
M1(]42,;K$+N6@Q&M$YZR.@_QKY^W5QN,I")U2DI>TQ`_4XFO]Y\_[<Y</,B"
M4H6`H98A+I1J`MN624$K(BW>T!KN9%Q41,%1Y+9L!"6I2:I*VW.<E5T15N.6
M(1#OX>!9QA)ZPY-316O5D@A:$@7Z9<$:V;-5R7OH*B(>3LU5PJL&*(ZL9.K9
MD&)4)<%=7G-!CB74_>3Z).FYS6%&7[%$<,DS90&=W0J=U[RUMS8P[7<I@PJT
M[4C0+,0'-XC7V-[OC#^_&3W+B_](%OS\1;#T&ZLIF`UMT@TX<OZ@H7>I#D&R
M/<N^-0WX+E!*,W(JU0]^_DI97BCH]A(*TG4%Z?,-E0D8"C26M]1,"2]!`/RB
MBNG)`$/(D[F>6:J*$"]6UG+M+%R`HR.5ZI9I2HR2DU2\^M."W(ZJ)?$Z$KAV
M)$O+]Y;KC2%Y(W'1)<+UE:?/$^U6O3'CABBRWPE^1C!@H$\V1(^K&P!9[T++
M,/CR+UO`#TURT"PA7F,$%4MHY>/>VVQV]B/XGW28:(YQQXBX1^BV@;Q!([CS
M'S1J%JU1MU*+COK`A>B)H!XQ%01&304M8`!?'YW>(YT$0S+R:#M^8-1B7'CN
M8.1R#(D'R%24/Q>EY_F#G=0L,`LCF5MGK"'J0&_)'"!3F2#ITKNW/=-@HV9H
M6A=QS)"YTPD:[K[XYVU?0*.I6GU$B`:/A701;YBG^#(R>A*\%Y<EZW?,=[86
MX#_8'$TT5M%%P.UA8+RM-VX7;%&3YFNIK;!V*[:+H*(BIS$M2XD2?M(;;P/F
M#M%A&1],J9-X!$O:K+1IW`OB5_&+`"88=$SP!S\XF%=S$H_\(#:ZI_%5`'[/
M>:)U]]&PAP18V@W)Z3T1.:LE*FD&)3K6&F9%M&N_/2C>@+>PNKF"=6W^%O!U
MIK`J'`O`&>>J/V@CA^_]_B\```#__P,`4$L#!!0`!@`(````(0#%Y@X!608`
M`+<9```9````>&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;*Q96V_J.!!^7VG_
M0Y3W$@R$2P0<-?=(N])JM9?G-!B(2@A*TLOY]SN.+_&%ME!M'QKX///9,Q[/
M3,SZQWMULEYQTY;U>6.CT=BV\+FH=^7YL+'__BM^6-I6V^7G77ZJSWAC_\2M
M_6/[ZR_KM[IY;H\8=Q8PG-N-?>RZB^<X;7'$5=Z.Z@L^P\B^;JJ\@Z_-P6DO
M#<YWO5)U<B;C\=RI\O)L4P:ON86CWN_+`H=U\5+A<T=)&GS*.UA_>RPO+6>K
MBEOHJKQY?KD\%'5U`8JG\E1V/WM2VZH*+SN<ZR9_.H'=[VB6%YR[_V+05V71
MU&V][T9`Y]"%FC:OG)4#3-OUK@0+B-NM!N\W]B/R,K2TG>VZ=]`_)7YKI<]6
M>ZS?DJ;<_5:>,7@;]HGLP%-=/Q/1;$<@4'8,[;C?@3\::X?W^<NI^[-^2W%Y
M.':PW2Y81`SS=C]#W!;@4:`935S"5-0G6`#\MZJ2A`9X)'_OGV_EKCMN[.E\
MY"[&4P3BUA-NN[@DE+95O+1=7?U+A1"CHB031@)/1H)6H]G$72SO89DR%G@R
M%O?NE<P8!SP9Q_S^A8#AO4_@^>V%+!@'/+_-`6>T7P<\OV_,BI'`\]Z%.#16
M^M`+\R[?KIOZS8+S#-'07G*2'9`'O#SF:(2(*/PH""'Z",DC8=G8X""(KQ9.
MSNMVZJ*U\PK17C`9WY31)`(N04*;T(8Z$.E`K`.)#J0ZD$F``TX0GH"(_Q\\
M05B()[@-/@<&UTQ4QP1<@JN$.A#I0*P#B0ZD.I!)@&(V'%'=[-F'28?O-U&"
M]"+M-UK.5;-\*H-@7A$4KBH2"!%ANH%$!A(;2&(@J8%D,J(X`/*+[@"2=>\\
M`80%SA#,(JR=NMI.^TSH,Y<($>$2`XD,)#:0Q$!2`\ED1'$)F"^[Y'H!XK%`
MA'O+^8I]BDQI82$'.6"(;#A:C=5H"(40)XH,)#:0Q$!2`\ED1#%T?H^A1%@U
ME"*RH0Q1#=7R7"B$A*$&$AM(8B"I@60RHA@*J5G>49KF1PMP3'<LBV>_IHW!
ME9V>0CJG29YPJ/8S1-IHBDQG?0V8C-%,VV,Q+DPWD)BQ#CDT$3*DL@#K5&5-
MQ3AGS61$<01IEJ5Z=\5@:):XQ418M9@A4"G%,4<K[9@'5,A%O1/0:+)2_Z('
M32%D"DK4N`O5R$ACG2Z_8(VIPF38G80B:"6J4WK+S)D0`O<JS@0WW.Y,(JPZ
MDR(3.6>BE;:W@1#B>QM2Q"6!^;H=C]SI9#F6_K0B$S'QF3`Z-B@3`TF%EK31
M^I9D0DAW#(+F_W;/]-*J:QCDD@/*6RJTTDY3,$@)YW!HWGM'4XB&4:X0<T@Z
M;ARB+QDD@:<<@@0SK,?PQR!E.(1T73>?.T1[-*BF?)D^@[1@T?8Z&*2X8L@@
M'B[:H>*C4G28'(D)I8/BIPZAAK@]O7)T2%]TAT.(M!8A%)*+3\\);9F21U9:
M7Q8.4MQ'D0G%)I284&I"F0*I)I,6[/888`V;'`,44DQFD&JR7G!)6P;N`\<,
M)AM0;$HE)I2:4*9`JLFDQ9),_E;=1:Q/DSW!H"&W!TSJX](["`Q.H#2@PZ&8
M3R:G`R'U0?DUF3,%4EU"FC'))9]78-*)ZX'/($B^0RHR:C!3%$48N5^4RY!K
M**&DI[B(2_'B_G499AIR'59)YB,DE2_X.(L>M"J8<HU/%Y=Q*;JXQ4BE'2.9
M5]T4TCC>OBFTS82PYV'C(PIIZ5FS(ABDN&+(()Z>OZSF7%X.63$W9TW,B5*N
M*-J&A1H16IK,N/R5U$V:R]N=15M1Q5D4^JJX"REN5H@8]$%Q%Z-<(>8*\FDV
M:%,N=94V&T:!5HT:TAC>[@C6?<I10R$M:HRB+J2X72%<PY*TP*-&+^IL5(X1
M@R-A'#`YITT_I25WO_VD4D30NUQZH5;AYH`#?#JU5E&_D'M:"*'M6L#T$AGR
MM!=!=H0YM9$$1DC>-$?@XOFQ+UV:AD\NI*_(^Q,/KGM,'G_JP36(B3_.O$<P
MSASP8477%N2[GC^_(A^X'KQKFSS!W(-7TROXPHOZT-0,2Q8>O,&9\CZ:>#X]
M29I&`".D]3!U`@164QU'*,&U^24_X-_SYE">6^N$][!=X_Y]N*$7[_1+5U]@
M&^'RO.[@PKS_>(0?2#"TQ/#B85O[NN[X%YC:$3^Y;/\#``#__P,`4$L#!!0`
M!@`(````(0!IWGUP.08``*,9```9````>&PO=V]R:W-H965T<R]S:&5E=#(Q
M+GAM;*R969.B.A3'WV_5_0X4[U>,+"K5.M7N"ZYUEV<:4:D6L8#NGOGV]P1(
M3'(8JWMJYF'0GR?_+/_D)*2?OGV/+]I[F&91<NWII-'4M?`:)(?H>NKI__P]
M^:NC:UGN7P_^);F&/?U'F.G?^G_^\?21I*_9.0QS#12N64\_Y_G--8PL.(>Q
MGS626WB%7XY)&OLY?$U/1G9+0_]0%(HO1JO9=(S8CZYZJ>"FG]%(CL<H"$=)
M\!:'U[P42<.+GT/[LW-TRYA:''Q&+O;3U[?;7T$2WT#B);I$^8]"5-?BP)V?
MKDGJOUR@W]^)Y0=,N_B"Y.,H2),L.>8-D#/*AN(^=XVN`4K]IT,$/:##KJ7A
ML:<_$W=/FKK1?RH&Z-\H_,B$SUIV3CZF:73PHFL(HPT^40=>DN25ALX/%$%A
M`Y6>%`YL4^T0'OVW2[Y//F9A=#KG8+<-/:(=<P\_1F$6P(B"3*-E4Z4@N4`#
MX'\MCNC4@!'QOQ?/C^B0GWNZZ33L=M,D$*Z]A%D^B:BDK@5O69[$_Y5!I)(J
M15J5"#PKD9;3Z-BVY73:GU>Q*A5X5BKDZR)07=$?>%8BG4:;-+OF%QH":Z/0
M@.>O-Z1;B<"S$C&_/*Z$#2S]@%4>.$+,JGKZ@0]$JV,3VZ'&/BK*?"!W(T#D
M40F'508??GW$2)O)P`?>YD^:9Y3SNE@F(S_W^T]I\J%![H&9F]U\FLF(2\!1
MMD#*_O`E\[,5`TN%JCQ3F9X.#8/%D,$R?^^;5OO)>(>E&50Q`QQ#Y(@ABZ#K
MD,J.5#!6P40%4Q7,5#!7P4(%2Q5X*EBI8*V"C0JV*MBI8"\``^SA'L'L_AT>
M41GJ$1O=`0-WTUJ*(2R"%1FI8*R"B0JF*IBI8*Z"A0J6*O!4L%+!6@4;%6Q5
ML%/!7@"2(;#>D2$F[$WUNPI;([04[!_"&B&6,N"#,H;F,[Z0;,43'L)-062,
MR`21*2(S1.:(+!!9(N(ALD)DC<@&D2TB.T3V(I$\@NR,/*([_Q<3&Y6!W`C5
M<$-,JR-;,JB"'KG&0[AKB(P1F2`R162&R!R1!2)+1#Q$5HBL$=D@LD5DA\A>
M)))K8%"-:PUZ.LG/4?`Z2,K35LU*,V';*3<C*E)XQL9Z4!&'Y[XA(J.2P#*F
MNY=%ND19FV,>P&0GB$P1F2$R1V2!R!(1#Y$5(FM$-HAL$=DALA>)9`\<8"1[
M:FR`XQ/S@4;+/I3$+(_'=(<?(C*JB+CBB*4DP3$/XEX@,JU(>:RGE<UXS'TQ
M$_68,N=!3'J!R!))>SSF@?2*!S'I-2(;)+WE,8*TW913T(X',>F]2"03X90F
MF5@>^;ZXQJB([&U)1&\1&54$EC_/IL1RY*Z,>1#KR@21*9*>\1A16DG4<Q[$
MI!>(+)&TQV-$Z:[<ZA4/8M)K1#9(>LMC!&E;.1;O>!"3WHM$\I;>6XC'^<<+
ME$;+)E8$'G>#;"41#JN@+L^FH]IBICQ"XS*H52988G6[7>(HHSCA0JRK4U39
MC,>(;50JFU>5D2*;.UVEG@778/4L43T>CWE0SXK7(P99<L_7M4I*2MN@!FQK
MBRD=W54-$$;5:2K)8<^%H+?2=(&W;VFZ_%(JH"+R+"I)2SP/P8NU/"C#*LB\
MSZ**6)R,*T*WE/>^W2S^R3(35&B*A&<H9EX1R)'"/%=>6!>HV!))>RAF]1GI
M-2JV0=);%+.KR(/AV(N%)*OAENTW>%VHR&8SU.&V#1D2,D2%6I"YA!%7)O.8
M174*PPFDB)H<P8+N;[)37.'L'O6@PCF+ZOXD3[#?[W4M<5W>/>I!72L6!18)
M0Z#F"A8E#Y2:+'`CMO4%E1'>L2AAA'&^8$%%K\M95-ZPEE='<9B>PF%XN61:
MD+S1V],BJ7-<7NUZ;1>V0,@X"M\X+FR$F&\=%\XL-;SMPGZ'.5P=/[=J^(!>
M*=?QE@LO]%AG8+KP%HGYL^4^PT#@'P:6"R\PF(]L%T[.F`\<=U#7@:'C#NOX
MR'$G=0,Q:KMP$L+Z4\>%\Q#F,\>%HVL-;[MP[,%\Z;AP^,'<<UPXIP(WN)-P
M17[S3^'*3T_1-=,NX1$F0;,X0J;E)7OY)4]ND"S@HCS)X7*\^'B&/X:$<!AO
M-N`MXY@D.?M"*^!_7NG_#P``__\#`%!+`P04``8`"````"$`=:."IZ$1```F
M60``&0```'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6RLG-MRV[BRAN]WU7X'
ME^^7+9(Z5Y)5D2B>Q+.TU[IV;"5QC6VY+&4R\_:[(:+5!'Y:L3RY&6<^-GX`
M[`8(-"%^^/=?CP\7?VY>=O?;IX^7SE7O\F+S=+N]NW_Z]O'R_];!O\:7%[O]
MS=/=S</V:?/Q\N_-[O+?G_[W?S[\W+[\L?N^V>PO2.%I]_'R^W[_/+V^WMU^
MWSS>[*ZVSYLGNO)U^_)XLZ?_??EVO7M^V=S<'0H]/ER[O=[P^O'F_NFR49B^
MO$5C^_7K_>W&W][^>-P\[1N1E\W#S9[:O_M^_[QCM<?;M\@]WKS\\>/Y7[?;
MQV>2^'+_<+__^R!Z>?%X.XV_/6U?;KX\4+__<OHWMZQ]^!^0?[R_?=GNME_W
M5R1WW304^SRYGER3TJ</=_?4`W7;+UXV7S]>?G:FZ[YS>?WIP^$&_>=^\W/7
M^O?%[OOV9_AR?Y?>/VWH;I.?E`>^;+=_*-/X3B$J?`VE@X,'RI>+N\W7FQ\/
M^WK[,]K<?_N^)W</J$>J8].[O_W-[I;N*,E<N0.E=+M]H`;0?R\>[U5HT!VY
M^>OP]^?]W?[[QTMO>#48]3R'S"^^;';[X%Y)7E[<_MCMMX__;8P./3J*N%J$
M_FH1A^+KC84]79C^<@N<*Z??&Y[1@+[6H+_<@*OQ8-`?CD=O[P59'FX%_=4B
MXZN1TYMX9V@,M0;]?7]#1EJ$_KZ[(1.M07^UAG>V6QV*QB8X5%@VCG?/5SF&
M&/WCW?UQ.,;4/[2*<[Z/'8XV]8_W-X;CS?E'`:?&:7-__TG(.1PNZA^Z2^_P
M-0W8IBWT#ZWR#E]SV#D2=V\>1-?-U'28Z?R;_<VG#R_;GQ?T^*"XV3W?J(>1
M,W4I%'F.:V:DXZSWVJ1'LYU2^:QD/E[23:+Y;$<S]9^?O%[OP_6?-+O>:IL9
MVCBFQ9PMU%2J9'T;+&P0V""T062#V`:)#98V2&V0V2"W06&#T@:5#6H;K&RP
M;H%K<N#1BS1N?X<7E8SR(M__&0-QJVNYC"VXB&^#A0T"&X0VB&P0VR"QP=(&
MJ0TR&^0V*&Q0VJ"R06V#E0W6+6"XC.;(W^$R)4/K"F/@6<-JUMBHR?TX.@>6
M&X\F1S\"60`)@(1`(B`QD`3($D@*)`.2`RF`E$`J(#60%9!UFQB.I<?6[W"L
MDJ%)F:HY.LWK6:-OIHU.>?9H<O0LD`60`$@()`(2`TF`+(&D0#(@.9`"2`FD
M`E(#60%9MXGA65I)&)[MW@?P(U%9'QS(-WZF"3UE6R[UK)'8:=0_&AD-HI7P
M&0U2UF:#-'&/$_X<B`]D`20`$@*)@,1`$B!+("F0#$@.I`!2`JF`U$!60-9M
M8CB'%D-G.$=9F\[1A**Q%2WVO'TTXB#S@2R`!$!"(!&0&$@"9`DD!9(!R8$4
M0$H@%9`:R`K(NDT,?ZFL37LE?'IT*VO37YJT!A,0'\@"2``D!!(!B8$D0)9`
M4B`9D!Q(`:0$4@&I@:R`K-O$<`YM><YPCK(VG:.).9B&QUGUL-N8'XV.@PG(
M`D@`)`02`8F!)$"60%(@&9`<2`&D!%(!J8&L@*S;Q/"72F^<X;"#N>DQ1JWQ
MA,A'M$`4(`H118AB1`FB):(4488H1U0@*A%5B&I$*T1K`YD>4WO+]OS79`*N
M5()N__W^]H_9EIY#9-0Q+WJTX]=Y@&:'2LM6'D,SIT%>D]94V_HY(A_10B-G
M>-0*V*H]CEW'2C2$8L6-B!#%B!)$2T0IHDRC5E-SL9+GM^M86[-"K+BI):(*
M48UHA6AM(-/=:E_ZS]W=[&X-=S?(<#<@7VU&:8IN62TT:MW#0*-A[Y!1<GN.
MK(,/X1:*`=^^"%&,RHE8J5P5*5O+\*48L'***$/E7*RTLM7F0@Q8N414H7(M
M5MUM7HD!*Z\-9`:`VL"V`Z!C7--;@N/`UOO=]L#6:'P<GW.U755/7GJ.MQ:M
M(_,YZXL5MW/!:'+4"ABUM9R!Y:=06U'J4MT49SR>3,8CRR@2*:XP9B05)HQ.
M5KBT*G3'7F\PM%82J4AQA1DCJ3!G=++"PJRP3V]=>N[(NJ6E2'&%%2.IL&9T
MLL*552&]+.IYWL3TX5JDJ$(SL-3^^8S`4N;6H[]!;OO1?T3MP!J;C?+5*P/2
M:A5<,)*X#1B)?*B1-SI$49^F@X&UTXJP5,Q(M!-&HKTTM=WA:(3A`NW.6$BT
M<T:B79C:$V\\L;5++%4Q$NV:D6BO3&VG-QSV>Q`%[8:;4:#R&&=$@4Y[2)-F
MZ@U.,Y=P2,\%M:/`:I0O5EQPP4C&0L!(9J]0(YY+^@-WTK=&=H3%8D8BGC`2
M\:4E[GA#MV_%;XK%,D8BGC,2\<(4[P_&3G]BM;S$8A4C$:\9B?C*%/<F@X'C
M60^UM5',#`25(#DC$'0^I1T(#6J-ZCDM$O1`;P6"O0[TQ4H"01<4^0"M0HWT
M=.`-AXYGN2K"4C$CT4X8R;!:FMI.WQT,[6&58K&,D8CGC$2\,,5I/@!/E5BJ
M8B3:-2/17IG:[M@9]WO68VAM%#/#0.5=VF'PONV%SMY(2V?JS:P]31Q1.SJL
MI;>/!1>,9#P$&GDR'D)&D\/#@HY"].Q7G1&;2*D8M1.T6C)JM&F2\)R!=9-3
MMA'Q#,5SM"H8->*N-\:6EVPCXA6*UVBU8M2(TQ&7_L1>K*W9YB!NA@<M27Y#
M>"@5:RW1(&/R:)`G^TI?+5CMA8-&$FJ!MJ(C1Q)7'2O2IF#?/82'ZTQ&`[H;
MYDHE$BF>FF)N@U28B-6)"I=LU53HC'JNY]G/K92-9!>>886Y6)VHL&"KIL+!
M:$`3C;WF+ME(*JRPPEJL3E2X8BM=H3,8#]R^=4O7;'2HT`PNE:8Z-?>LM\^O
MI3;:6R"=[1('S=11#!5P,DW.$?F(%H@"1"&B"%&,*$&T1)0BRA#EB`I$):(*
M48UHA6AM(,.3ZH2*X<G3F]:#N3D?,**%J^Q0[>$Y%RL>GCZB!:(`48@H0A0C
M2A`M$:6(,D0YH@)1B:A"5"-:(5H;R'2B2@BVA^,OG(@I15>CUK!#Y"-:(`H0
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M]NSW'`NQXAX%B$)&XH^(T4GY6*Q8/D&T9"3R*:.3\IE8L7R.J&`D\B6CD_*5
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MT(!2`ZU1;.6/YZXN*"//9R01OM"(]E*'MYNC<;]O/U$#+!8R$O&(D8C'+.XT
M(6%FJ!(IT.X&1`1T(Y6"[,:,:]+=&-(+TX$U;G(L5C"2;I2,I!L5BS?=L%X&
MU5*@NQNF\W^5*'K3&1@7\T0:&5.'.[;.K<RUE3%U-%JTR.";N6`K]6Y>O?&F
M;)B="PO81HJ%C&0H18S$*F:DAY(=$\?6=-_,PZ&,)6M(32DCJ2ECI+LQ=)S)
M$&:$8WW<^X*+B7C)2,0K1DTW(":.LMW=,&+"LU-.[UK%'53,3)1&0QI!QWD"
M%K1S+BACP-=(36O'@O@X8:OQ(4Q<MT<_V72M@Q$!&\E/?D*L,$*KF)%^3V&_
M`$GX>KN-GF//'EA7VE40.I>Q5=,Y9S0:]/OV*[J<C:1S!598HE7%Z)7.U7S]
MM<Z9\6-GN^SX>5ORF1;[AP2*Q/V,D3P)YXA\1`M$`:(0480H1I0@6B)*$66(
M<D0%HA)1A:A&M$*T-I#I297#>OO20&6QK)=1C&3Q.T?D:Z3^',<WG!Q<B!7/
MC0&B$%&$*$:4(%HB2A%EB')$!:(2486H-I#I'MJZ&^ZQ!]J;'MZ>4K$F:HW:
M7@/DZX*O9\'$0!S6R+2S8&@5(8H1)8B6&K6S8&+U2A9,#+B5.:("48FH0E0;
MR'0?;<4-]YW>G]$]`S\UB`8P-WVNK5K(9T2W7D:7G4=:B!5K!8A"1K)SC1BU
MY2&/%(L5RR>(EHRD0RFCMCPL&C*Q8OD<4<%(6E\R:LM#ZRNQ8OG:0*9?56:J
M/6N^;U@V^:WV/LN#E-<<D<_H9*)G(5;<HP!1R$C\$3$Z*1^+%<LGB):,1#YE
M=%(^$RN6SQ$5C$2^9'12OA(KEJ\-9+K[O"P8'<*`8?RF+)@NV,HV^8PDGA>,
M9.H.&(E5J%$KVQ0QDGUFK%$KVY2@U5*C5KM21E)CQDC:E3,2JT*C5KM*1M*N
M2J-6NVK#RG2/RF&U1^,O9EEE;CT-&V1L93$+1EDL5;"]E6747M;`RGZAK706
M;.1.O,'(M3(Z@4AQ1(:,9'T<,9+U<:P1W1_U^!M;&\-$2LBSH6/7`GU+NPI"
MWS*N79\RIGG;\3P[#R)2W+>"D?2M9"1]JUB]Z=O(2CC54J*[;V:8J+3.&6&B
MLT#2P!D=F%,!\(LLF+9J1;C/2")\H9'.@@W<$1T\M%(%`18+&<G6.6(DXC&+
M-^DCRQN)%.B^:TW&@ZVDII21U)1Q34T6;."Z=*[4BL`<BQ6,1+QD).(5BS?=
ML-^9UU*BNQ^F]U5^I.W]]SVRFRR+\<AND#%W8!K,T^D9B2:?D:1X%HR:_%'?
MH9]AV+^*"-A&BH6,1#QB)%8QHV8L66]@$KYJ/C8AN0'=2*4@C^V,4=.-H3=P
MQG9LYVPC#2P823=*1F)5,6JZ89]RJOGR:_TP@J+_6_)@!Q7S@:+1+_)@7%!&
M@:_1+_)@;-6DBL:NU^]Y(ROS&K"1I(I"K#!"JYC1*ZFBA*_3(^.XV\`G"M:5
M=A7$)PI;-9T;>&-W,G:M.2QG(^E<@166:%4Q>J5S-5]_K7-F_/R>/)@Z?&NM
M2!C)LW".R$>T0!0@"A%%B&)$":(EHA11ABA'5"`J$56(:D0K1.K#BH<;?;BK
MC2>;#R4VGP][W+Q\V\PW#P^[B]OM#_41Q(&:98ZX^4+CS.E-U6^.:;J#*Q.Z
M<AC-]A67RM"SOJ.,2Q]\;-:Y=AF/KC2[?/M*__B12.L*?3WR\Z%S%I]1@<,>
MR>8N5=[5*H^J[N"?^]//=!,[NM&GSU9V\>&4OB;283^:TE<K.OAX2A],Z.!T
M9[MN+.43IFJ3B24HK3!5&8*N*P.ZTE6&T@=3M:?$,I1%F*J$0->5`5WI*D-)
M3[K2=7LIL395R2U42^F*2BCAE1FU8-99#V6$IBI-@&4H,315.9ZN*P.ZTE6&
M$D!3E17`,I0'HE9WJ5'*@*YTE:%33U-U%`;5Z/#35)UCZKI"_NDL0X><INKD
M"Y:ALTY3=6RIZPKYI[,,'<VD*YW^<<D_S3[/&C!TY([*=/J'6C#KK(?.K4WG
MG5?H^-I4G43#5M-))[K2U5,ZIC959Y>P#)U6HU9WJ='!)KK258:^9#!5WRE`
M-?HNP51]%@"OT&<`:#;INC)S7%+KNJ/TL_>I^AD[JM'/UJF>KBOTL_.I^ADY
MEJ&?C5,+#E>NCPZBK]0^WWS;9#<OW^Z?=A</FZ\T@?<.WWIX:;YSV_S/7O\P
MXLMV3]^GI74;?2"2OD>\H?-^O2O*OWW=;O?\/U3U]?$+QY_^7P````#__P,`
M4$L#!!0`!@`(````(0`^5;'M*@@``!\D```9````>&PO=V]R:W-H965T<R]S
M:&5E=#$Y+GAM;*R:VW+B.!"&[[=JWX'B?@`?@.!*,A4P/MNUM36[>^V`$UP#
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M<P%JPSR1&7BNJJ_$--P3!(VGJ+77S<`?]6A?O.1OQ_;/ZCTHRM=#"],]AQ&1
M@3G['V[1[$!1<#,QY\33KCI"!^#OZ%22U`!%\N_=];W<MX>'L;68S)<SRP#S
MT7/1M%Y)7(Y'N[>FK4[_4".#N:).3.;$@MYC)U<:VJPA7%G#Y61IS%;6$H)?
M:0=WNU[#E;4S%Q/;G"_ONFY?:;E@+>'*6DK#O=)NR=K!];8APD+KN@K7FX:X
M8NW@RH=H?D@;`W*(3BE))CH='QNCT2<#_'/;*`V>`N2?F\9I0-+0[HKL^>AD
M&CQ_R#\?&>J49G^WF-R\S1_OZ^I]!#L4#+BYY&2_,QSBC"\CFA']POK9NH(%
M1;P\$3</8\@16#(-;`;?'BUC=3_]!@MXQVS6V,90+3;<@JQ6XM;5P58'G@Y\
M'00Z"'40Z2#60:*#5`>9!*8@;:\O9,7_H2]Q0_3ERJPY$(*;FIC<@C=Q=;#5
M@:<#7P>!#D(=1#J(=9#H(-5!)@%%3%@H2$P+%OOPGL]SD[2"W5W.37.FBK6F
M-F0-]PD\5TTVO4DO*");1#Q$?$0"1$)$(D1B1!)$4D0RF2C:PMI'VI+GZ8T;
M`7$#>PF$Z86T3&V=KYG1-;5[DUYM1+:(>(CXB`2(A(A$B,2()(BDB&0R4=0&
M816UKV<PL>Y$Y6*L&9EU6ZUA:ZG:WY4G0>P/2D_@/'!#3XBUVA-&S'YKVB#B
M(K)%Q$/$1R1`)$0D0B1&)$$D1223B2(8/.04P<@3<P[;_XT+A;A1E60$<D9:
M.I8VM;T13P47D2TB'B(^(@$B(2(1(C$B"2(I(IE,%'%)=28?1ZZO"V*M:LB(
ME(V(N(AL$?$0\1$)$`D1B1")$4D021')9*((!J?D&P0CUJI@C*A)I^\GO5&?
M=(AL$?$0\1$)$`D1B1")$4D021')9*)H2`J'&T3LS%45.9+R#B,7HRU&'D8^
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M.JA8D@SFG:YR;\5E\$1#CGR&)/>!L)+<6UH1%`HK[BO"*,;N$VR58I0I2%69
ME`>RRK^V7;,B0TYQAF3Q*9+4<4E1">+/N]>[W=:_Q<C#R&=(\A4P9,.C72P7
M2U0ZG?M06`FE:2>@(4<Q=I_@ABE&F8)4I4D1(2O]']LUJSED22E:K+I"SS86
MEK9+;@S62(S$Y4C>O8VY5DELF16\HR>OZTQC.=-<>\(/%\GG2$0+.+H:+=2B
MK4PM6"3<\&`Q1R)8PM'58*D6S%Y8VMK.A!^(ILX9J4UNF#-6RLAS1I$)CT(I
M*37Y-P:S$@U=CL0I<LN0!9,L^=+.YYYH**R,N?;`\[F5B!AP)"*&PQ$U7Y%H
M>"5BS*U$Q(0C$3$=CJ@=-C+1<#BB.HF0'\HD_MH61[QHSQ>&Y/RS+.WYO#&8
ME4A<ER%+'(RV#-E0?4ASJV6J)QH*JX&Y11$#T9`OJ'`X(EJ)U!=T]4K$F/DR
MQ!@3'#$=C&AK!XY,-!R.J,XMJ>/D!?IK<\NJ09&::Q@*F>XEW1!M8V5H#Y(-
MLS!%(Y<A&RJ5?A(']EKJVC:[O=:8S?7MSQ-^^&SY.%H@K*Y$"[D5BV;=:7I'
MW$"<^&,<+!%65X*EW(H%,U;Z8R3C%ETT92KAV7-]*K]4EY\5CE*9T[E1URE'
M8IO98.1BM,7(P\C'*,`HQ"C"*,8HP2C%B'R[WFU/W1BIKO3;<OH%WZFH7XM-
M<3PVHUWU1KX)-Q>0?CVF7].O%PZ\ZH2<T_G2@;=T`_S.@9=1`WSEP`N6`6[,
M'/+J8."."7=@#/@.'*`=<A8>NC.'.UTEJ?47ZD"''.%P&R@'H0=#=^`G"D^=
M>)JO-?QTH4M6G8.C07O+@>]5<.0G&_P/#7!M._#5`&X`KS(@\F!H&,1Z<!!0
MOCN;P3M0Q3L>E+1#<2RX,]1E*(W@SG#?YG!G2$:H\!UR.,=QH-"'Z1KJ`52B
M<*?KP;17&7Z><<E?BS2O7\MS,SH6+Y"TL^XU4DU_X$$_M&Q7>*Y:^&%&MT$<
MX(<X!;Q:F$W@8/]252W_`)V:]C_M>?P7``#__P,`4$L#!!0`!@`(````(0";
M5)*G&0L``",T```9````>&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;*R;77/:
MNA:&[\_,^0\,]SM@OO$DV5,^;(.-;3S[['U-B9,P!9P!VK3__BQ96EZ2EC=-
MTO:BD$>O7LE:DBS)YO;/[X=]XUM^.N^*XUW3N6DW&_EQ6SSLCD]WS?_]Y?TQ
M:C;.E\WQ8;,OCOE=\T=^;OYY_]__W+X6IR_GYSR_-,#A>+YK/E\N+VZK==X^
MYX?-^:9XR8^0\EB<#IL+_'EZ:IU?3OGFH<QTV+<Z[?:@==CLCDWIX)[>XE$\
M/NZV^:S8?CWDQXLT.>7[S07J?W[>O9S1[;!]B]UA<_KR]>6/;7%X`8O/N_WN
M\J,T;38.6W?Q="Q.F\][N.[O3F^S1>_R#V9_V&U/Q;EXO-R`74M6E%_SN#5N
M@=/][<,.KD`T>^.4/]XU/SENUNDV6_>W90/]O<M?S]KWQOFY>/5/NX=H=\RA
MM2%.(@*?B^*+D"X>!(+,+9;;*R.0GAH/^>/FZ_Z2%:]!OGMZOD"X^W!%XL+<
MAQ^S_+R%%@6;FTY?.&V+/50`_F\<=J)K0(MLOI>?K[N'R_-=LSNXZ0_;70?D
MC<_Y^>+MA&6SL?UZOA2'?Z3(45;2I*-,X%.9=`8WHWZ_-Q@-W^[24R[PJ5R<
M]YM`<>7UP*<R&=T,G?:X^XZ*P-@H/>#SXQ49*Q/X_'!%'&Q8\>7C57&ZJB[B
MR\<K,T`7^/(+E1FB#7RI;-[8XUJR]Y:#8;:Y;.YO3\5K`V88Z)_GEXV8KQS7
M@;CA,)"=MAH8_S8N8$`(ET_"YJX)%8,N?X;!_.V^VQO?MK[!`-PJS81K'%,Q
M1848;<)V9H.Y#3P;^#8(;+"PP=(&H0TB&ZQL$-L@L4%J@[4-,@VT(#Q5C*`/
M_XX8"1L1(VS="0(*6L<*""HPR\P&<QMX-O!M$-A@88.E#4(;1#98V2"V06*#
MU`9K&V0:,`("L\'O"(BP@=N&-FB<0=N,P$1JQ#16C:R^*9E6DBI*C,P9\1CQ
M&0D863"R9"1D)&)DQ4C,2,)(RLB:D4PG1M#@[O@[@B9L8+*$8JJ`=/MVU)3H
M6M0J214U1N:,>(SXC`2,+!A9,A(R$C&R8B1F)&$D963-2*83(VJP'#&B5K\\
MP]N04)?!P4:=2-+K5;/>5)*N7(B5=QE%.I5FSHC'B,]\@DI#7<,9#,S1NJA$
M6,4E(R$C$2,K1F)&$D921M:,9#HQ8@'+%R,6<JUP(Q:(E^?=]LNDD`O>FAAU
M84T@5PK"Q`R1)'J()-%#I(@6(D8\1GSF$R@"W:T:O<Y@:(6H$E4A8B1D)&)D
MQ4C,2,)(RLB:D4PG1HA@!6:$J"84L#W!6`BU&0M)]%A(HL=":83-M_N>,W:L
M5<.\$F#[>8SXS#90&EB#:J$96:&I1&B]9"14UG+3)@9X5&DTZZ%5ZU4E0NN8
MD819IY5&M[;NT.M*A-:93HP`PN6_(X!";090$CV`DN@!5!IJH#DC'B,^\PF4
M!JY%BYBUZE]4(KSV)2,ALXXJC68][)J=856)T#IF)&'6::71K:U9>EV)T#K3
MB1$QV*>^(V)";49,$CUBDN@14QHM8HQXC/C,)U`:(V)#:_&RJ$1X[4M&0F8=
M51J]67M6Q"H16L>,),PZK32ZM35IKRL16F<Z,2+FP&&1$;(/W<A*%S.4"NFQ
M5$@/)JH&M-[@R./(YUX!JN!::0P.K7WU@E38.$N.0FX?*=0OC]+*^_>*HYBC
MA'NE"O7,JEH3_)I46-7,0&8@Q8Z9GUZ\<T7BR'TW+.FQR`DB&/1:LUI3VQ15
MXRKC3*&.,<+ZUL0U1]5(WD+'G5'?&5@MX:&(-NP^+S`@E593N\`%JHRV[UM#
M:(DJ*C'D)4:DNE+B"E77+C%&$168\`)34ETI<(VJJY>8H:HLT>Q+8K-_K2_]
M5;S`:/_I09@\,S`ZDT0=6KQ.Q7X>;@/R?%L==3'57*FZ-%%XF)&\?$34?0-$
MI%IPKR57A8C(*T)$7BON%7-5@HB\4D3DM>9>F:$R8R0V]WJ,KB]OQ2;=NMDB
M,@;VR+H#3E&E#VSE-:K&^ERI.K23]#`CJ7Q$Y!4@(M6">RVY*D1$7A$B\EIQ
MKYBK$D3DE2(BKS7WR@R5&1ZQBW]'>-2FGSK(Q)$(AHH^U*V5^A15E'&&B'K6
M7*'NL)QDG=YX/!ZTK4A[/)^/B-P#1.2^>(O[DN<+$9%[A(C<5^@.^SRZ_]CS
M=<PS)HC(/D5$]NLWV6=&1C/0XHA`#_3'%E#RH`'Z$]UW%3*&9]]:G$_%8SHQ
MKJGKSA3J4M>=(QJ7\>^WRW_F>M1##67SN7G`50N%>K"2_/<`+7G&D-M'7+5"
M=*7N,6JH[@DW3[EJK=#UNF=&1C/ZXO3AUZ,OSS",Z$MDCOZ1M9B=.DI%W6:F
M4`_NSEHTV*I+9NQUY(0`\T'=A*!$-*G[O,#@304N4*4*K)V!EBBB`D->8$2J
M*U>X0I4LL+;+QZBA\A)>7DJJ*^6M4:4?ACOV-)6AJBS1[$GB&.1:3WKCFDO8
M6#LQB8R=F$3&3DRB(;7%W&'(X\A72/,*$!FW+G;Z2RJ<\Y8<A1Q%'*TXBCE*
M.$HY6G.4&<@,FS@+N1:V-QT$BZ?-=M0D,J(FD=;2,Y6Q2S>T.4<>1SXB"G>`
MZ/J!,*DH:JI>]&`AY*J(HQ5',4<)1RE':XXR`YE1@YV1$;6?+)Z%W!I4$AGA
MD<@(CU+A^?"@:^V;YW#C%M8].L[R./(5TJP#5$';TSQO;YP7I*)HJ1+I7AFB
M/54BHHR:/3LG)A7:QQPEW#XEE6YOGQ63"NTS`QDQ[=@G6==C6LK-F"JDQU0A
MK>%GJ*+&FG/D<>1SKP!5,-%J0;3ZR()4V`Q+CD)N'Y%*LQ_9!Y&D0ON8HX3;
MIZ32[(?6"G5-*K3/#&0&T3[%^DD0^7$5;$'+`463T50A(XA*I0>1(0^]2.5S
MKP!51A!'UD9M02ILAB5'(;>/2*6W,@NBJCT='\64$4M,N'U**MW>.@Y;DPJ]
M,@.9013'-[]\3Q1+7VO25<@8H%)EQ%:B'AT5S3$C(8\C7R'-*T`5S)DT0$?6
M:GI!*FR=)4<AMX^X:L51S%'"O5)2:54=6B>I:U)A53,#F8&TSY@^M+>%DST6
MR.H$2:^K->]-,:.VMU7H)V?*J)('KMU>9S#HMZV]DX<B&C$^+S`@E593=J:,
M*J.;V(O_):JHQ)"7&)'J2HDK5%V[Q!A%5&#""TQ)=:7`-:JN7J)X2UG$&N(#
MW4OV)?G6L7S1\I"?GO)IOM^?&]OBJWBCN-^#'6B%Y>O.L#IPQ8T>+.R43AO>
MA"Z?P+`4\8YTN9IE*1U(*1?(5@J\5OVICD_`JLYI(HQJ:C7INEFY`[?]>^!?
MES#IN?"6#[\\6(BY8IK@*;`><\72JB8%FD3<K^M2'$BINQ"8=R"EKAQ8J[EB
M<N%N$TB9U*9,(65:FS*#%#'1<C=8T;IBON4IL+!UE[57"JLE5RQ\:O)T'$BI
MNU*8P"&EKIQTZ,*;!]PK';GP?+N&0Y^L:W]XE@>]I:Y6$V?H3F`/PKVFD#*M
M39E!BMBN\3RPSW;%KHVGP'8;:E!W+;"E@Y2Z/.'0%<\XN5DT=.%=CQH^<N&-
M@AH._;*N6>!Q*738NA*2H2L>B7*KB6BNNH2I:*VZA)EHK+H$7[1574(P=.$M
M&5YV,'+A78P:#IVQ[O+@83/TTKH2)GUW4BXSK,E@VG>G=7S6=^%M+5ZRWW?A
MG2W.@[X+;Z75\($+KT(!;U4%PT\T7C9/^6IS>MH=SXU]_@@3;KM\(GR2/_*0
M?US4T[S/Q05^G`%[(GCU'7Z,D\/K0NT;.%]^+(H+_B$*J'[><_]_````__\#
M`%!+`P04``8`"````"$`GHE*BV0#``"Z"@``&0```'AL+W=O<FMS:&5E=',O
M<VAE970R,"YX;6RL5MMNHS`0?5]I_P'QW@"!W%"2*J'J;J6MM%KMY=D!$ZP"
M1K;3M'^_8P,N-MFJ7?4EQ./Q\9DS8X_7UT]5Z3QBQ@FM-VXP\5T'URG-2'W<
MN+]^WEXM78<+5&>HI#7>N,^8N]?;SY_69\H>>(&Q<`"AYANW$**)/8^G!:X0
MG]`&US"34U8A`4-V]'C#,,K4HJKTIKX_]RI$:K=%B-E;,&B>DQ3?T/14X5JT
M(`R72`!_7I"&]VA5^A:X"K&'4W.5TJH!B`,IB7A6H*Y3I?'=L:8,'4J(^RF(
M4-ICJ\$(OB(IHYSF8@)P7DMT'//*6WF`M%UG!"*0LCL,YQMW%\1)$+C>=JT$
M^DWPF0_^.[R@YR^,9-](C4%MR)/,P('2!^EZETD3+/9&JV]5!KXS)\,Y.I7B
M!SU_Q>18"$CW#"*2@<79\PWF*2@*,)/I3"*EM`0"\.M41)8&*(*>U/=,,E%L
MW'`^F2W\,`!WYX"YN"42TG72$Q>T^M,ZJ8@TR+0#@6\',GO!>&5=V*V#[X7-
MQPN]EKS2X@8)M%TS>G:@P(`>;Y`LUR`&L%Z$%D'+\B]50`X)LI,H&W?A.A`P
MAU0^;L,H6'N/('_:^>S'/I9'TGO(K`$]S1'$^0".$D5RE)F4I/>]X87TU*2<
M]!XV(1#J`PA)%"B:@6A!Z)L,]JU/`$2TLC/3)=$N-LOH0UA*%"B.(<TPLH3:
M=TZOT=0N-DTX+$,Q+Q^_OM"DLV*CL]A9?%5U@2V.GGW1+XQ"K:!19O/W$)'.
M)I'.,M4%E@PMQDYP4(8ART,W7?H3(/O.<R>!3!:=!=36!1-&D0Y857ZBG>Q<
MR-XVN`U>SX5T-C?O+`,)AA9#@I6YD[IW%LO_D$`"F2PZBRF!71C:R98@@$;R
M=@V4M[E];QJH8)@,&:#!&;NI4I@O)HOWUX*"LJBT-VI@2C&WJJ%?&*EVJ2[>
MMFFVC:+"[(@37);<2>E)-D2XCK9K;6Z[]3[PH5VKCCN:T8W<FH$.OU,J6?:]
M7"#)V/9I#%?R!7L8PRTXMN^B>`?!C2?V49RH:.T-YC$<V@O^BQC.S`7[,DZ6
ME^RK.%E)NZ<W@)=#@X[X'K$CJ;E3XAR$]%6>6?OV:`>"-B`PO!^H@#>#^EO`
M&Q%#PU(71$ZIZ`=R`_WJW/X%``#__P,`4$L#!!0`!@`(````(0`'-72[,0$`
M`$`"```1``@!9&]C4')O<',O8V]R92YX;6P@H@0!**```0``````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M``````````````````````````"<D4%+PS`8AN^"_Z'DWJ;9QABAS4!E)P>"
M%<5;3+YUP28-2;3KOS?KNCK1D\?POGGR?%^*]4$WR2<XKUI3(I+E*`$C6JE,
M7:*G:I.N4.(#-Y(WK8$2]>#1FEU?%<)2T3IX<*T%%Q3X))*,I\*6:!^"I1A[
ML0?-?18;)H:[UFD>XM'5V'+QSFO`LSQ?8@V!2QXX/@)3.Q'1B)1B0MH/UPP`
M*3`TH,$$CTE&\'<W@-/^SPM#<M'4*O0VSC3J7K*E.(53^^#55.RZ+NOF@T;T
M)_AE>_\XC)HJ<]R5`,2.^VFX#]NXRIT">=.SPYMK$N_W!?Z=%5(,=E0XX`%D
M$M^C)[MS\CR_O:LVB,URLD@)2?-E10@E*[K(7PM\;HWWV034H\"_B6<`&[Q_
M_CG[`@``__\#`%!+`P04``8`"````"$`T-M6,6(#``"%#```$``(`61O8U!R
M;W!S+V%P<"YX;6P@H@0!**```0``````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M``````"<5]]OTS`0?D?B?ZCRSM)T96Q3FJG;"D.BHV)E/)X\Y]I:2^U@.Z7C
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MJGR![O-L(JP_`+E_MHNY0=$B;@%MN@A#G<-(>^(+/NJVV\KL(M_6<&6HT=IA
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M=0ZD9QKDED_"Z`VFO`NKN,"I82072G-(=,3R`XWO[1E['ALOE=?8AEK""C!0
MQTL%_C5-PG4^D(9K/?"U,Y,&KGD7KO<!%[;W/3X-U_M`&M8EP-E!O5S3).61
ML2Z!-'O3#>KXJG#UQ./3L$(+D,;Z'/]'GC[O<T#0;4V\"SM9`ZRQHS7DLS];
M-UP'@'$G+<`S>SH#/+,^`9[9$QTB@/D`P%X]>_>]/VYXGY1^=%_+J;FFF]#F
M"KO_,FV^YCE=[C;[SR_2&[J]VJ(.<K6@3S7F&YN7&_6%^[[]J\B2_E'WN$MW
MZ9UW:?S\_Y#]`@``__\#`%!+`0(M`!0`!@`(````(0!NR'4D#`(``#@>```3
M``````````````````````!;0V]N=&5N=%]4>7!E<UTN>&UL4$L!`BT`%``&
M``@````A`+55,"/U````3`(```L`````````````````100``%]R96QS+RYR
M96QS4$L!`BT`%``&``@````A`$M'16(W`@``?1T``!H`````````````````
M:P<``'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L!`BT`%``&``@````A
M`**:F*DX!```>@\```\`````````````````X@H``'AL+W=O<FMB;V]K+GAM
M;%!+`0(M`!0`!@`(````(0#:Q!A)6P<``%@>```8`````````````````$</
M``!X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"+0`4``8`"````"$`-ER#
MLL`"````!P``&0````````````````#8%@``>&PO=V]R:W-H965T<R]S:&5E
M=#,X+GAM;%!+`0(M`!0`!@`(````(0!O3@1!)P8``-T<```9````````````
M`````,\9``!X;"]W;W)K<VAE971S+W-H965T,SDN>&UL4$L!`BT`%``&``@`
M```A`*>Q=^+!`@``&@<``!D`````````````````+2```'AL+W=O<FMS:&5E
M=',O<VAE970T,"YX;6Q02P$"+0`4``8`"````"$`@D;<_?D"``"A"```&0``
M```````````````E(P``>&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+`0(M
M`!0`!@`(````(0"W4(1&H0(``-L&```9`````````````````%4F``!X;"]W
M;W)K<VAE971S+W-H965T,S<N>&UL4$L!`BT`%``&``@````A`#"3@"%3`P``
MN`D``!D`````````````````+2D``'AL+W=O<FMS:&5E=',O<VAE970S-BYX
M;6Q02P$"+0`4``8`"````"$`<0!12K\"``#X!@``&0````````````````"W
M+```>&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+`0(M`!0`!@`(````(0![
M/DN!&@,``"\)```9`````````````````*TO``!X;"]W;W)K<VAE971S+W-H
M965T,S$N>&UL4$L!`BT`%``&``@````A`";2*3ID!```5Q0``!D`````````
M````````_C(``'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"+0`4``8`
M"````"$`O3/?D5P'``!8*@``&0````````````````"9-P``>&PO=V]R:W-H
M965T<R]S:&5E=#,S+GAM;%!+`0(M`!0`!@`(````(0!U08"XLP,``$`-```9
M`````````````````"P_``!X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L!
M`BT`%``&``@````A``*EC_]P`@``QP4``!D`````````````````%D,``'AL
M+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"+0`4``8`"````"$`&!9V<BP#
M```."@``&0````````````````"]10``>&PO=V]R:W-H965T<R]S:&5E=#0S
M+GAM;%!+`0(M`!0`!@`(````(0!I7N<\!00``!80```9````````````````
M`"!)``!X;"]W;W)K<VAE971S+W-H965T-#0N>&UL4$L!`BT`%``&``@````A
M`"KPT'(;#```0'$```T`````````````````7$T``'AL+W-T>6QE<RYX;6Q0
M2P$"+0`4``8`"````"$`0_>/.](X```5N0``%`````````````````"B60``
M>&PO<VAA<F5D4W1R:6YG<RYX;6Q02P$"+0`4``8`"````"$`.@J16/8"```\
M"0``&`````````````````"FD@``>&PO=V]R:W-H965T<R]S:&5E=#,N>&UL
M4$L!`BT`%``&``@````A`+*6=SL6!@```AD``!@`````````````````TI4`
M`'AL+W=O<FMS:&5E=',O<VAE970R+GAM;%!+`0(M`!0`!@`(````(0#[8J5M
ME`8``*<;```3`````````````````!Z<``!X;"]T:&5M92]T:&5M93$N>&UL
M4$L!`BT`%``&``@````A`%6"$TJ6`P``G0P``!D`````````````````XZ(`
M`'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6Q02P$"+0`4``8`"````"$`DJ[]
M&?4#``!4$```&0````````````````"PI@``>&PO=V]R:W-H965T<R]S:&5E
M=#0X+GAM;%!+`0(M`!0`!@`(````(0!37DP9D`0``&82```9````````````
M`````-RJ``!X;"]W;W)K<VAE971S+W-H965T-#<N>&UL4$L!`BT`%``&``@`
M```A`,'7HS;D!```B10``!D`````````````````HZ\``'AL+W=O<FMS:&5E
M=',O<VAE970T-BYX;6Q02P$"+0`4``8`"````"$`S0#8,%H"``!+!0``&0``
M``````````````"^M```>&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+`0(M
M`!0`!@`(````(0"Y=P:=R`,``),-```8`````````````````$^W``!X;"]W
M;W)K<VAE971S+W-H965T,2YX;6Q02P$"+0`4``8`"````"$``%L`S'\"```M
M!P``&0````````````````!-NP``>&PO=V]R:W-H965T<R]S:&5E=#,P+GAM
M;%!+`0(M`!0`!@`(````(0"NFM.U3`\``#M(```9``````````````````.^
M``!X;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L!`BT`%``&``@````A`)>"
MMM$0"```U"0``!D`````````````````ALT``'AL+W=O<FMS:&5E=',O<VAE
M970Q,2YX;6Q02P$"+0`4``8`"````"$`+Z8\VQX&``"S%P``&0``````````
M``````#-U0``>&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+`0(M`!0`!@`(
M````(0#E=[*VJ!````!7```9`````````````````"+<``!X;"]W;W)K<VAE
M971S+W-H965T,3,N>&UL4$L!`BT`%``&``@````A`'=O?HM\!@``W1D``!D`
M`````````````````>T``'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"
M+0`4``8`"````"$`:"F_HV@)```"+0``&0````````````````"T\P``>&PO
M=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+`0(M`!0`!@`(````(0!;X].ML@T`
M`)Y$```8`````````````````%/]``!X;"]W;W)K<VAE971S+W-H965T.2YX
M;6Q02P$"+0`4``8`"````"$`_(2<G5@'```3(```&``````````````````[
M"P$`>&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L!`BT`%``&``@````A`/]8
M6?II`P``N0H``!@`````````````````R1(!`'AL+W=O<FMS:&5E=',O<VAE
M970W+GAM;%!+`0(M`!0`!@`(````(0#K31.M)@,``'()```8````````````
M`````&@6`0!X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"+0`4``8`"```
M`"$`ZBC/?)`&``#'&@``&`````````````````#$&0$`>&PO=V]R:W-H965T
M<R]S:&5E=#4N>&UL4$L!`BT`%``&``@````A`.Z*C[R_!@``LQH``!D`````
M````````````BB`!`'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"+0`4
M``8`"````"$`)3G9RFX#``"E"@``&0````````````````"`)P$`>&PO=V]R
M:W-H965T<R]S:&5E=#$U+GAM;%!+`0(M`!0`!@`(````(0#J@L]R9P,``+,*
M```9`````````````````"4K`0!X;"]W;W)K<VAE971S+W-H965T,3<N>&UL
M4$L!`BT`%``&``@````A`&*?U`2D!0``I18``!D`````````````````PRX!
M`'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"+0`4``8`"````"$``?W+
M:M,$```I$0``&0````````````````">-`$`>&PO=V]R:W-H965T<R]S:&5E
M=#(U+GAM;%!+`0(M`!0`!@`(````(0!==)UWK0P``$@Z```9````````````
M`````*@Y`0!X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L!`BT`%``&``@`
M```A`!3B#*:+!0``GQ0``!D`````````````````C$8!`'AL+W=O<FMS:&5E
M=',O<VAE970R-RYX;6Q02P$"+0`4``8`"````"$`</-#:/<"```T"```&0``
M``````````````!.3`$`>&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+`0(M
M`!0`!@`(````(0#%Y@X!608``+<9```9`````````````````'Q/`0!X;"]W
M;W)K<VAE971S+W-H965T,C,N>&UL4$L!`BT`%``&``@````A`&G>?7`Y!@``
MHQD``!D`````````````````#%8!`'AL+W=O<FMS:&5E=',O<VAE970R,2YX
M;6Q02P$"+0`4``8`"````"$`=:."IZ$1```F60``&0````````````````!\
M7`$`>&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+`0(M`!0`!@`(````(0`^
M5;'M*@@``!\D```9`````````````````%1N`0!X;"]W;W)K<VAE971S+W-H
M965T,3DN>&UL4$L!`BT`%``&``@````A`)M4DJ<9"P``(S0``!D`````````
M````````M78!`'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"+0`4``8`
M"````"$`GHE*BV0#``"Z"@``&0`````````````````%@@$`>&PO=V]R:W-H
M965T<R]S:&5E=#(P+GAM;%!+`0(M`!0`!@`(````(0`'-72[,0$``$`"```1
M`````````````````*"%`0!D;V-0<F]P<R]C;W)E+GAM;%!+`0(M`!0`!@`(
M````(0#0VU8Q8@,``(4,```0``````````````````B(`0!D;V-0<F]P<R]A
<<'`N>&UL4$L%!@`````Z`#H`R`\``*",`0``````
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EWRAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 13 - Segment and Geographic Information (Details) - Product Revenue by Product Group (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="2">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueGoodsNet', window );">Product Revenue</a></td>
        <td class="nump">$ 21,975,312<span></span></td>
        <td class="nump">$ 17,023,346<span></span></td>
        <td class="nump">$ 57,593,873<span></span></td>
        <td class="nump">$ 51,585,242<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Orthobiologics [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueGoodsNet', window );">Product Revenue</a></td>
        <td class="nump">18,899,873<span></span></td>
        <td class="nump">12,830,566<span></span></td>
        <td class="nump">48,750,277<span></span></td>
        <td class="nump">40,620,339<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Dermal [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueGoodsNet', window );">Product Revenue</a></td>
        <td class="nump">401,355<span></span></td>
        <td class="nump">267,766<span></span></td>
        <td class="nump">938,966<span></span></td>
        <td class="nump">1,066,409<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Surgical [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueGoodsNet', window );">Product Revenue</a></td>
        <td class="nump">1,452,946<span></span></td>
        <td class="nump">1,136,248<span></span></td>
        <td class="nump">4,581,496<span></span></td>
        <td class="nump">3,955,134<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Ophthalmic [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueGoodsNet', window );">Product Revenue</a></td>
        <td class="nump">366,138<span></span></td>
        <td class="nump">1,425,609<span></span></td>
        <td class="nump">938,134<span></span></td>
        <td class="nump">2,818,407<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Veterinary [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueGoodsNet', window );">Product Revenue</a></td>
        <td class="nump">$ 855,000<span></span></td>
        <td class="nump">$ 1,363,157<span></span></td>
        <td class="nump">$ 2,385,000<span></span></td>
        <td class="nump">$ 3,124,953<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueGoodsNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.1(a))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SalesRevenueGoodsNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SegmentReportingInformationLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E2MAI">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 5 - Equity Incentive Plan (Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="2">9 Months Ended</th>
        <th class="th" colspan="1">3 Months Ended</th>
        <th class="th" colspan="2">9 Months Ended</th>
        <th class="th" colspan="1">3 Months Ended</th>
        <th class="th" colspan="1">9 Months Ended</th>
        <th class="th" colspan="1">3 Months Ended</th>
        <th class="th" colspan="2">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2014

</div>
          <div>Restricted Stock [Member]</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2014

</div>
          <div>Restricted Stock [Member]</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2014

</div>
          <div>Restricted Stock Units (RSUs) [Member]

</div>
          <div>Board of Directors [Member]</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2014

</div>
          <div>Restricted Stock Units (RSUs) [Member]</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2014

</div>
          <div>Restricted Stock Units (RSUs) [Member]</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2014

</div>
          <div>Stock Appreciation Rights (SARs) [Member]</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2014

</div>
          <div>Minimum [Member]</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2014

</div>
          <div>Maximum [Member]</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_Note5EquityIncentivePlanDetailsLineItems', window );"><strong>Note 5 - Equity Incentive Plan (Details) [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Allocated Share-based Compensation Expense</a></td>
        <td class="nump">$ 390,578<span></span></td>
        <td class="nump">$ 368,603<span></span></td>
        <td class="nump">$ 1,196,361<span></span></td>
        <td class="nump">$ 1,156,929<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)</a></td>
        <td class="nump">7,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">139,240<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in Shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="nump">30,700<span></span></td>
        <td class="nump">9,365<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">4 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">4 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">1 year<span></span></td>
        <td class="text">4 years<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized</a></td>
        <td class="nump">4,200,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">4,200,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">3 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriodTotalIntrinsicValue', window );">SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriodTotalIntrinsicValue</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">25,473,089<span></span></td>
        <td class="nump">4,095,833<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from Stock Options Exercised</a></td>
        <td class="nump">17,513<span></span></td>
        <td class="nump">1,804,773<span></span></td>
        <td class="nump">1,379,294<span></span></td>
        <td class="nump">2,932,649<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Stock Repurchased and Retired During Period, Shares (in Shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">133,774<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingNumber', window );">ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingNumber (in Shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">936,097<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsWeightedAverageExercisePrice', window );">ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsWeightedAverageExercisePrice (in Dollars per share)</a></td>
        <td class="nump">$ 13.54<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 13.54<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingIntrinsicValue', window );">ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingIntrinsicValue</a></td>
        <td class="nump">$ 21,800,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 21,800,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm', window );">ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">6 years 292 days<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTermRange', window );">ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTermRange</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">10 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anik_Note5EquityIncentivePlanDetailsLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>anik_Note5EquityIncentivePlanDetailsLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>anik_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTermRange">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents share based compensation arrangement by share based payment award contractual term range.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTermRange</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>anik_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anik_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriodTotalIntrinsicValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents share-based compensation arrangement by share-based payment award, options, and stock appreciation rights, exercises in period, total intrinsic value.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>anik_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriodTotalIntrinsicValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>anik_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingIntrinsicValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents share based compensation arrangement by share based payment award, options and stock appreciation rights, outstanding, intrinsic value.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingIntrinsicValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>anik_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingNumber">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents share based compensation arrangement by share based payment award options and stock appreciation rights outstanding number.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingNumber</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>anik_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents share based compensation arrangement by share based payment award options and stock appreciation rights outstanding weighted average remaining contractual term.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>anik_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents share based compensation arrangement by share based payment award options and stock appreciation rights weighted average exercise price.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>anik_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>anik_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 14.F)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (h)(1)(i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 14<br><br> -Section F<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AllocatedShareBasedCompensationExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Unrecognized cost of unvested share-based compensation awards.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow associated with the amount received from holders exercising their stock options. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (j)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromStockOptionsExercised</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(iii)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Gross number of share options (or share units) granted during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares that have been repurchased and retired during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	word-wrap: break-word;
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 7 - Inventories (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory, Current [Table Text Block]</a></td>
        <td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
      <tr style="vertical-align: bottom">
        <td style="font-weight: bold">
          &#160;
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" nowrap="nowrap" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            September 30,
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            2014
          </p>
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" nowrap="nowrap" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            December 31,
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            2013
          </p>
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="width: 78%; text-align: left">
          Raw materials
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          6,843,441
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          5,926,030
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left">
          Work-in-process
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          2,325,667
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          2,308,233
        </td>
        <td style="text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; padding-bottom: 1.1pt">
          Finished goods
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          4,413,348
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          2,762,522
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; padding-bottom: 2.75pt; padding-left: 10pt">
          Total
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          13,582,456
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          10,996,785
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
      </tr>
    </table><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InventoryDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 2<br><br> -Paragraph 6<br><br> -Subparagraph a,b,c<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfInventoryCurrentTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EFG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 10 - Commitments and Contingencies (Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrual', window );">Product Warranty Accrual</a></td>
        <td class="nump">$ 0<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyExpense', window );">Product Warranty Expense</a></td>
        <td class="nump">$ 0<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommitmentsAndContingenciesDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrual">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 210<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.9-03.15(5))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 15<br><br> -Subparagraph 5<br><br> -Article 9<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 460<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -Subparagraph ((c)(5))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6398077&amp;loc=d3e12565-110249<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProductWarrantyAccrual</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The expense charged against earnings for the period pertaining to standard and extended warranties on the entity's goods and services granted to customers.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 460<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -Subparagraph ((c)(3,4))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6398077&amp;loc=d3e12565-110249<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProductWarrantyExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E6EAC">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Note 7 - Inventories (Details) - Inventories (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_InventoriesAbstract', window );"><strong>Inventories [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials</a></td>
        <td class="nump">$ 6,843,441<span></span></td>
        <td class="nump">$ 5,926,030<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work-in-process</a></td>
        <td class="nump">2,325,667<span></span></td>
        <td class="nump">2,308,233<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
        <td class="nump">4,413,348<span></span></td>
        <td class="nump">2,762,522<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total</a></td>
        <td class="nump">$ 13,582,456<span></span></td>
        <td class="nump">$ 10,996,785<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anik_InventoriesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>anik_InventoriesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>anik_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 6<br><br> -Subparagraph a<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.6(a)(1))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InventoryFinishedGoods</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.6(a))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 330<br><br> -SubTopic 10<br><br> -Section 35<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6386567&amp;loc=d3e3927-108312<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InventoryNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 6<br><br> -Subparagraph a<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.6(a)(4))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InventoryRawMaterials</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 6<br><br> -Subparagraph a<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.6(a)(3))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InventoryWorkInProcess</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ENOAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 13 - Segment and Geographic Information (Details) - Product Revenue by Geographic Location (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="2">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_GeographicLocationAbstract', window );"><strong>Geographic Location:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Total Revenue</a></td>
        <td class="nump">$ 22,055,423<span></span></td>
        <td class="nump">$ 17,754,438<span></span></td>
        <td class="nump">$ 82,340,370<span></span></td>
        <td class="nump">$ 53,829,826<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_PercentageOfNetRevenue', window );">Percentage of Revenue</a></td>
        <td class="nump">100.00%<span></span></td>
        <td class="nump">100.00%<span></span></td>
        <td class="nump">100.00%<span></span></td>
        <td class="nump">100.00%<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">United States [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_GeographicLocationAbstract', window );"><strong>Geographic Location:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Total Revenue</a></td>
        <td class="nump">18,455,167<span></span></td>
        <td class="nump">14,485,821<span></span></td>
        <td class="nump">72,935,722<span></span></td>
        <td class="nump">42,251,336<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_PercentageOfNetRevenue', window );">Percentage of Revenue</a></td>
        <td class="nump">84.00%<span></span></td>
        <td class="nump">82.00%<span></span></td>
        <td class="nump">89.00%<span></span></td>
        <td class="nump">78.00%<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Europe [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_GeographicLocationAbstract', window );"><strong>Geographic Location:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Total Revenue</a></td>
        <td class="nump">1,784,414<span></span></td>
        <td class="nump">1,656,656<span></span></td>
        <td class="nump">5,274,071<span></span></td>
        <td class="nump">5,226,619<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_PercentageOfNetRevenue', window );">Percentage of Revenue</a></td>
        <td class="nump">8.00%<span></span></td>
        <td class="nump">9.00%<span></span></td>
        <td class="nump">6.00%<span></span></td>
        <td class="nump">10.00%<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Other location [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_GeographicLocationAbstract', window );"><strong>Geographic Location:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Total Revenue</a></td>
        <td class="nump">$ 1,815,842<span></span></td>
        <td class="nump">$ 1,611,961<span></span></td>
        <td class="nump">$ 4,130,577<span></span></td>
        <td class="nump">$ 6,351,871<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_PercentageOfNetRevenue', window );">Percentage of Revenue</a></td>
        <td class="nump">8.00%<span></span></td>
        <td class="nump">9.00%<span></span></td>
        <td class="nump">5.00%<span></span></td>
        <td class="nump">12.00%<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anik_GeographicLocationAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>anik_GeographicLocationAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>anik_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anik_PercentageOfNetRevenue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the percentage of net revenue.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>anik_PercentageOfNetRevenue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>anik_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SalesRevenueNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 4 - Fair Value Measurements<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Disclosures [Text Block]</a></td>
        <td class="text"><table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
      <tr style="vertical-align: top">
        <td style="width: 6%">
          <b>4.</b>
        </td>
        <td style="width: 94%">
          <b>Fair Value Measurements</b>
        </td>
      </tr>
    </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">
      Fair value is an exit price, representing the amount that would be received from the sale of an asset or paid to transfer a liability in an orderly transaction between market participants based on assumptions that market participants would use in pricing an asset or liability. As a basis for classifying the fair value measurements, a three-tier fair value hierarchy, which classifies the fair value measurements based on the inputs used in measuring fair value, was established as follows: (Level 1) observable inputs such as quoted prices in active markets for identical assets or liabilities; (Level 2) significant other observable inputs that are observable either directly or indirectly; and (Level 3) significant unobservable inputs in which there is little or no market data, which requires the Company to develop its own assumptions. This hierarchy requires the Company to use observable market data, when available, and to minimize the use of unobservable inputs when determining
      fair value. On a recurring basis, the Company records its marketable securities at fair value.
    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">
      The Company&#8217;s investments are all classified within Level 1 and Level 2 of the fair value hierarchy. The Company&#8217;s investments classified within Level 1 of the fair value hierarchy are valued using quoted market prices. The Company&#8217;s investments classified within Level 2 of the fair value hierarchy are valued based on matrix pricing compiled by third party pricing vendors, using observable market inputs such as interest rates, yield curves, and credit risk.
    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">
      The fair value hierarchy of the Company&#8217;s cash equivalents and marketable securities at fair value is as follows:
    </p><br/><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
      <tr style="vertical-align: bottom">
        <td style="text-align: left; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="11" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Fair Value Measurements at Reporting
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Date Using
          </p>
        </td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="text-align: left; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" nowrap="nowrap" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          September 30, 2014
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" nowrap="nowrap" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Quoted Prices in
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Active Markets
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            for Identical Assets
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            (Level 1)
          </p>
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" nowrap="nowrap" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Significant Other
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Observable Inputs
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            (Level 2)
          </p>
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" nowrap="nowrap" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Significant
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Unobservable
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Inputs
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            (Level 3)
          </p>
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="width: 56%; text-align: left; padding-bottom: 2.75pt">
          Money market funds
        </td>
        <td style="width: 1%; padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="width: 1%; border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="width: 8%; border-bottom: Black 2.75pt double; text-align: right">
          49,285,168
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left; width: 1%">
          &#160;
        </td>
        <td style="width: 1%; padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="width: 1%; border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="width: 8%; border-bottom: Black 2.75pt double; text-align: right">
          -
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left; width: 1%">
          &#160;
        </td>
        <td style="width: 1%; padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="width: 1%; border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="width: 8%; border-bottom: Black 2.75pt double; text-align: right">
          49,285,168
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left; width: 1%">
          &#160;
        </td>
        <td style="width: 1%; padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="width: 1%; border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="width: 8%; border-bottom: Black 2.75pt double; text-align: right">
          -
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left; width: 1%">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left">
          Marketable securities:
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left">
          United States Treasury securities
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          14,999,600
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          14,999,600
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          -
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          -
        </td>
        <td style="text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; padding-bottom: 1.1pt">
          Bank certificates of deposit
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          5,000,000
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          -
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          5,000,000
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          -
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; padding-bottom: 2.75pt">
          Total marketable securities
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          19,999,600
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          14,999,600
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          5,000,000
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          -
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
      </tr>
    </table><br/><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
      <tr style="vertical-align: bottom">
        <td style="text-align: left">
          &#160;
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="11" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          Fair Value Measurements at Reporting<br />
          Date Using
        </td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="text-align: left">
          &#160;
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" nowrap="nowrap" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          December 31, 2013
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" nowrap="nowrap" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          Quoted Prices in<br />
          Active Markets<br />
          &#160;for Identical Assets&#160;<br />
          &#160;(Level 1)
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" nowrap="nowrap" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          Significant Other<br />
          Observable Inputs&#160;<br />
          (Level 2)
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" nowrap="nowrap" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Significant
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Unobservable
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Inputs
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            (Level 3)
          </p>
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="width: 56%; text-align: left; padding-bottom: 2.75pt">
          Money market funds
        </td>
        <td style="width: 1%; padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="width: 1%; border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="width: 8%; border-bottom: Black 2.75pt double; text-align: right">
          34,266,501
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left; width: 1%">
          &#160;
        </td>
        <td style="width: 1%; padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="width: 1%; border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="width: 8%; border-bottom: Black 2.75pt double; text-align: right">
          -
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left; width: 1%">
          &#160;
        </td>
        <td style="width: 1%; padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="width: 1%; border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="width: 8%; border-bottom: Black 2.75pt double; text-align: right">
          34,266,501
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left; width: 1%">
          &#160;
        </td>
        <td style="width: 1%; padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="width: 1%; border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="width: 8%; border-bottom: Black 2.75pt double; text-align: right">
          -
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left; width: 1%">
          &#160;
        </td>
      </tr>
    </table><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueDisclosuresAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 21<br><br> -URI http://asc.fasb.org/extlink&amp;oid=35750535&amp;loc=d3e13537-108611<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 10<br><br> -URI http://asc.fasb.org/extlink&amp;oid=35750535&amp;loc=d3e13433-108611<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6957238&amp;loc=d3e14064-108612<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 30<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6957238&amp;loc=d3e14172-108612<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 16<br><br> -URI http://asc.fasb.org/extlink&amp;oid=35750535&amp;loc=d3e13504-108611<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueDisclosuresTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>23
<FILENAME>Financial_Report.xls
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xls
M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O
M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y
M/2(M+2TM/5].97AT4&%R=%]B834Q-S$Q,U\P9#(W7S0S-C%?83=B85\Q,&$V
M,V$S.#4T,F,B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7
M96(@4&%G92P@86QS;R!K;F]W;B!A<R!A(%=E8B!!<F-H:79E(&9I;&4N("!)
M9B!Y;W4@87)E('-E96EN9R!T:&ES(&UE<W-A9V4L('EO=7(@8G)O=W-E<B!O
M<B!E9&ET;W(@9&]E<VXG="!S=7!P;W)T(%=E8B!!<F-H:79E(&9I;&5S+B`@
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M;V9T+6-O;3IO9F9I8V4Z97AC96PB('AM;&YS/3-$(FAT='`Z+R]W=W<N=S,N
M;W)G+U12+U)%0RUH=&UL-#`B/@T*/&AE860^#0H\;65T82!N86UE/3-$(D5X
M8V5L(%=O<FMB;V]K($9R86UE<V5T(CX-"@T*/&UE=&$@;F%M93TS1%!R;V=)
M9"!C;VYT96YT/3-$17AC96PN4VAE970^#0H\;&EN:R!R96P],T1&:6QE+4QI
M<W0@:')E9CTS1")7;W)K<VAE971S+V9I;&5L:7-T+GAM;"(^#0H-"CPA+2U;
M:68@9W1E(&US;R`Y73X\>&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX
M.D5X8V5L5V]R:W-H965T<SX-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^1&]C=6UE;G1?06YD7T5N=&ET>5]);F9O<FUA=&EO/"]X.DYA
M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T
M<R]3:&5E=#`Q+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0V]N9&5N<V5D7T-O
M;G-O;&ED871E9%]"86QA;F-E/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T
M4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`R+FAT;6PB+SX-"B`@
M(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*
M("`@(#QX.DYA;64^0V]N9&5N<V5D7T-O;G-O;&ED871E9%]"86QA;F-E,3PO
M>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS
M:&5E=',O4VAE970P,RYH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^
M#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/D-O;F1E;G-E
M9%]#;VYS;VQI9&%T961?4W1A=&5M93PO>#I.86UE/@T*("`@(#QX.E=O<FMS
M:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970P-"YH=&UL(B\^
M#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E
M=#X-"B`@("`\>#I.86UE/D-O;F1E;G-E9%]#;VYS;VQI9&%T961?4W1A=&5M
M93$\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7
M;W)K<VAE971S+U-H965T,#4N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H
M965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y.;W1E
M7S%?3F%T=7)E7V]F7T)U<VEN97-S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H
M965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`V+FAT;6PB+SX-
M"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T
M/@T*("`@(#QX.DYA;64^3F]T95\R7T)A<VES7V]F7U!R97-E;G1A=&EO;CPO
M>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS
M:&5E=',O4VAE970P-RYH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^
M#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/DYO=&5?,U]-
M87)K971A8FQE7U-E8W5R:71I97,\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE
M9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,#@N:'1M;"(O/@T*
M("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^
M#0H@("`@/'@Z3F%M93Y.;W1E7S1?1F%I<E]686QU95]-96%S=7)E;65N=',\
M+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K
M<VAE971S+U-H965T,#DN:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T
M/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y.;W1E7S5?
M17%U:71Y7TEN8V5N=&EV95]0;&%N/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H
M965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#$P+FAT;6PB+SX-
M"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T
M/@T*("`@(#QX.DYA;64^3F]T95\V7T5A<FYI;F=S7U!E<E]3:&%R93PO>#I.
M86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E
M=',O4VAE970Q,2YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@
M("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/DYO=&5?-U]);G9E
M;G1O<FEE<SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F
M/3-$(E=O<FMS:&5E=',O4VAE970Q,BYH=&UL(B\^#0H@("`\+W@Z17AC96Q7
M;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE
M/DYO=&5?.%]);G1A;F=I8FQE7T%S<V5T<U]A;F1?1SPO>#I.86UE/@T*("`@
M(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970Q
M,RYH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E
M;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/DYO=&5?.5]!8V-R=65D7T5X<&5N
M<V5S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B
M5V]R:W-H965T<R]3:&5E=#$T+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS
M:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^3F]T
M95\Q,%]#;VUM:71M96YT<U]A;F1?0V]N=&EN/"]X.DYA;64^#0H@("`@/'@Z
M5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#$U+FAT
M;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R
M:W-H965T/@T*("`@(#QX.DYA;64^3F]T95\Q,5]-:71E:U]-;VYO=FES8U]!
M9W)E96UE/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968]
M,T0B5V]R:W-H965T<R]3:&5E=#$V+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O
M<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^
M3F]T95\Q,E]);F-O;65?5&%X97,\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE
M9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,3<N:'1M;"(O/@T*
M("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^
M#0H@("`@/'@Z3F%M93Y.;W1E7S$S7U-E9VUE;G1?86YD7T=E;V=R87!H:6,\
M+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K
M<VAE971S+U-H965T,3@N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T
M/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y.;W1E7S$T
M7U)E<W1R=6-T=7)I;F=?0W)E9&ET<SPO>#I.86UE/@T*("`@(#QX.E=O<FMS
M:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970Q.2YH=&UL(B\^
M#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E
M=#X-"B`@("`\>#I.86UE/DYO=&5?,35?3F5W7T%C8V]U;G1I;F=?4W1A;F1A
M<CPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O
M<FMS:&5E=',O4VAE970R,"YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE
M970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/DYO=&5?
M,U]-87)K971A8FQE7U-E8W5R:71I97-?5#PO>#I.86UE/@T*("`@(#QX.E=O
M<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970R,2YH=&UL
M(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS
M:&5E=#X-"B`@("`\>#I.86UE/DYO=&5?-%]&86ER7U9A;'5E7TUE87-U<F5M
M96YT<S$\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS
M1")7;W)K<VAE971S+U-H965T,C(N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R
M:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y.
M;W1E7S5?17%U:71Y7TEN8V5N=&EV95]0;&%N7U0\+W@Z3F%M93X-"B`@("`\
M>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,C,N
M:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7
M;W)K<VAE970^#0H@("`@/'@Z3F%M93Y.;W1E7S9?16%R;FEN9W-?4&5R7U-H
M87)E7U1A8FP\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E
M9CTS1")7;W)K<VAE971S+U-H965T,C0N:'1M;"(O/@T*("`@/"]X.D5X8V5L
M5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M
M93Y.;W1E7S=?26YV96YT;W)I97-?5&%B;&5S/"]X.DYA;64^#0H@("`@/'@Z
M5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#(U+FAT
M;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R
M:W-H965T/@T*("`@(#QX.DYA;64^3F]T95\X7TEN=&%N9VEB;&5?07-S971S
M7V%N9%]',3PO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F
M/3-$(E=O<FMS:&5E=',O4VAE970R-BYH=&UL(B\^#0H@("`\+W@Z17AC96Q7
M;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE
M/DYO=&5?.5]!8V-R=65D7T5X<&5N<V5S7U1A8FQE<SPO>#I.86UE/@T*("`@
M(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970R
M-RYH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E
M;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/DYO=&5?,3-?4V5G;65N=%]A;F1?
M1V5O9W)A<&AI8S$\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@
M2%)E9CTS1")7;W)K<VAE971S+U-H965T,C@N:'1M;"(O/@T*("`@/"]X.D5X
M8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z
M3F%M93Y.;W1E7S$T7U)E<W1R=6-T=7)I;F=?0W)E9&ET<U\\+W@Z3F%M93X-
M"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H
M965T,CDN:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z
M17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y.;W1E7S)?0F%S:7-?;V9?
M4')E<V5N=&%T:6]N7T0\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R
M8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,S`N:'1M;"(O/@T*("`@/"]X
M.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@
M/'@Z3F%M93Y.;W1E7S-?36%R:V5T86)L95]396-U<FET:65S7T0\+W@Z3F%M
M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S
M+U-H965T,S$N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@
M/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y.;W1E7S1?1F%I<E]6
M86QU95]-96%S=7)E;65N=',R/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T
M4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#,R+FAT;6PB+SX-"B`@
M(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*
M("`@(#QX.DYA;64^3F]T95\U7T5Q=6ET>5]);F-E;G1I=F5?4&QA;E]$/"]X
M.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H
M965T<R]3:&5E=#,S+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^3F]T95\U7T5Q
M=6ET>5]);F-E;G1I=F5?4&QA;E]$,3PO>#I.86UE/@T*("`@(#QX.E=O<FMS
M:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970S-"YH=&UL(B\^
M#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E
M=#X-"B`@("`\>#I.86UE/DYO=&5?-E]%87)N:6YG<U]097)?4VAA<F5?1&5T
M83PO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O
M<FMS:&5E=',O4VAE970S-2YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE
M970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/DYO=&5?
M-E]%87)N:6YG<U]097)?4VAA<F5?1&5T83$\+W@Z3F%M93X-"B`@("`\>#I7
M;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,S8N:'1M
M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K
M<VAE970^#0H@("`@/'@Z3F%M93Y.;W1E7S=?26YV96YT;W)I97-?1&5T86EL
M<U]);G8\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS
M1")7;W)K<VAE971S+U-H965T,S<N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R
M:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y.
M;W1E7SA?26YT86YG:6)L95]!<W-E='-?86YD7T<R/"]X.DYA;64^#0H@("`@
M/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#,X
M+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L
M5V]R:W-H965T/@T*("`@(#QX.DYA;64^3F]T95\X7TEN=&%N9VEB;&5?07-S
M971S7V%N9%]',SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(
M4F5F/3-$(E=O<FMS:&5E=',O4VAE970S.2YH=&UL(B\^#0H@("`\+W@Z17AC
M96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.
M86UE/DYO=&5?.%]);G1A;F=I8FQE7T%S<V5T<U]A;F1?1S0\+W@Z3F%M93X-
M"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H
M965T-#`N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z
M17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y.;W1E7SE?06-C<G5E9%]%
M>'!E;G-E<U]$971A:6P\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R
M8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T-#$N:'1M;"(O/@T*("`@/"]X
M.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@
M/'@Z3F%M93Y.;W1E7S$P7T-O;6UI=&UE;G1S7V%N9%]#;VYT:6XQ/"]X.DYA
M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T
M<R]3:&5E=#0R+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^3F]T95\Q,5]-:71E
M:U]-;VYO=FES8U]!9W)E96UE,3PO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E
M=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970T,RYH=&UL(B\^#0H@
M("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@("`\>#I.86UE/DYO=&5?,3)?26YC;VUE7U1A>&5S7T1E=&%I;',\+W@Z
M3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE
M971S+U-H965T-#0N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*
M("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y.;W1E7S$S7U-E
M9VUE;G1?86YD7T=E;V=R87!H:6,R/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H
M965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#0U+FAT;6PB+SX-
M"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T
M/@T*("`@(#QX.DYA;64^3F]T95\Q,U]396=M96YT7V%N9%]'96]G<F%P:&EC
M,SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O
M<FMS:&5E=',O4VAE970T-BYH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE
M970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/DYO=&5?
M,3-?4V5G;65N=%]A;F1?1V5O9W)A<&AI8S0\+W@Z3F%M93X-"B`@("`\>#I7
M;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T-#<N:'1M
M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K
M<VAE970^#0H@("`@/'@Z3F%M93Y.;W1E7S$T7U)E<W1R=6-T=7)I;F=?0W)E
M9&ET<U\Q/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968]
M,T0B5V]R:W-H965T<R]3:&5E=#0X+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O
M<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^
M3F]T95\Q-%]297-T<G5C='5R:6YG7T-R961I='-?,CPO>#I.86UE/@T*("`@
M(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970T
M.2YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@(#PO>#I%>&-E
M;%=O<FMS:&5E=',^#0H@(#QX.E-T>6QE<VAE970@2%)E9CTS1")7;W)K<VAE
M971S+W)E<&]R="YC<W,B+SX-"B`@/'@Z06-T:79E4VAE970^,#PO>#I!8W1I
M=F53:&5E=#X-"B`@/'@Z4')O=&5C=%-T<G5C='5R93Y&86QS93PO>#I0<F]T
M96-T4W1R=6-T=7)E/@T*("`\>#I0<F]T96-T5VEN9&]W<SY&86QS93PO>#I0
M<F]T96-T5VEN9&]W<SX-"B`\+W@Z17AC96Q7;W)K8F]O:SX-"CPO>&UL/CPA
M6V5N9&EF72TM/@T*/"]H96%D/@T*("`\8F]D>3X-"B`@(#QP/E1H:7,@<&%G
M92!S:&]U;&0@8F4@;W!E;F5D('=I=&@@36EC<F]S;V9T($5X8V5L(%A0(&]R
M(&YE=V5R+CPO<#X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE
M>'1087)T7V)A-3$W,3$S7S!D,C=?-#,V,5]A-V)A7S$P838S83,X-30R8PT*
M0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]B834Q-S$Q,U\P9#(W7S0S
M-C%?83=B85\Q,&$V,V$S.#4T,F,O5V]R:W-H965T<R]3:&5E=#`Q+FAT;6P-
M"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-
M"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-
M"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#
M;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F
M+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W
M+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^
M/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@
M:60],T1)1#!%3D=!13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY$;V-U;65N
M="!!;F0@16YT:71Y($EN9F]R;6%T:6]N/&)R/CPO<W1R;VYG/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CD@36]N=&AS($5N
M9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^
M/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/E-E<"X@,S`L(#(P,30\8G(^/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@^3V-T+B`S,2P@,C`Q-#QB<CX\+W1H/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY$;V-U;65N="!A;F0@16YT:71Y
M($EN9F]R;6%T:6]N(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%;G1I='D@4F5G:7-T<F%N="!.86UE
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG06YI:V$@5&AE<F%P
M975T:6-S+"!);F,N/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^1&]C=6UE;G0@5'EP93PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)S$P+5$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#=7)R96YT($9I<V-A;"!996%R($5N
M9"!$871E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG+2TQ,BTS
M,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D5N=&ET>2!#;VUM;VX@4W1O8VLL(%-H87)E<R!/=71S=&%N9&EN9SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$T+#4P-"PP,30\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%M
M96YD;65N="!&;&%G/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M9F%L<V4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y%;G1I='D@0V5N=')A;"!);F1E>"!+97D\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<P,#`P.#DX-#,W/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^16YT:71Y($-U<G)E
M;G0@4F5P;W)T:6YG(%-T871U<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)UEE<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D5N=&ET>2!6;VQU;G1A<GD@1FEL97)S/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG3F\\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%;G1I='D@1FEL97(@0V%T
M96=O<GD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B=!8V-E;&5R
M871E9"!&:6QE<CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D5N=&ET>2!796QL+6MN;W=N(%-E87-O;F5D($ES<W5E
M<CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)TYO/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&]C=6UE
M;G0@4&5R:6]D($5N9"!$871E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#Y397`@,S`L#0H)"3(P,30\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$;V-U;65N="!&:7-C86P@665A<B!&
M;V-U<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)S(P,30\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$
M;V-U;65N="!&:7-C86P@4&5R:6]D($9O8W5S/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG43,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM
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M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q
M=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R
M<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C
M/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO
M<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$
M<F5P;W)T(&ED/3-$240P15%104<^#0H@("`@("`\='(^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0Q/CQS=')O;F<^
M0V]N9&5N<V5D($-O;G-O;&ED871E9"!"86QA;F-E(%-H965T<R`H56YA=61I
M=&5D*2`H55-$("0I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/E-E<"X@,S`L(#(P,30\8G(^/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY#=7)R96YT(&%S<V5T<SH\+W-T
M<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#87-H
M(&%N9"!C87-H(&5Q=6EV86QE;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XD(#<Q+#<W,BPQ.30\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XD(#8S+#,S,RPQ-C`\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DUA<FME=&%B;&4@
M<V5C=7)I=&EE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3DL
M.3DY+#8P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D%C8V]U;G1S(')E8V5I=F%B;&4L(&YE="!O9B!R97-E<G9E
M<R!O9B`D-30V+#0U-2!A;F0@)#4Y,RPP,C,@870@4V5P=&5M8F5R(#,P+"`R
M,#$T(&%N9"!$96-E;6)E<B`S,2P@,C`Q,RP@<F5S<&5C=&EV96QY/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,"PQ-S`L,#DU/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3@L-S,V+#@T
M-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^26YV96YT;W)I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C$S+#4X,BPT-38\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ,"PY.38L-S@U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F5P86ED(&EN8V]M92!T87AE<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PS-#,L-3<V/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0W5R
M<F5N="!P;W)T:6]N(&1E9F5R<F5D(&EN8V]M92!T87AE<SPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^-C4Y+#`T,#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8U.2PP-#`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R97!A:60@
M97AP96YS97,@86YD(&]T:&5R/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XQ+#$R."PV.3,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XX-C4L.34W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F5U/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5&]T86P@8W5R<F5N="!A<W-E=',\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$R."PV-34L-C4T/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.30L
M-3DQ+#<X-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^4')O<&5R='D@86YD(&5Q=6EP;65N="P@870@8V]S=#PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-3,L,S<Y+#DV-3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4R+#0Q,RPT
M,C,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/DQE<W,Z(&%C8W5M=6QA=&5D(&1E<')E8VEA=&EO;CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XH,C$L,S0S+#,R,BD\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q.2PT-S0L-S$R*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M#0H@("`@("`@(#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S(L
M,#,V+#8T,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C,R+#DS."PW,3$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/DQO;F<M=&5R;2!D97!O<VET<R!A;F0@;W1H
M97(\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8Y+#`U-#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8Y+#`X
M,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^26YT86YG:6)L92!A<W-E=',L(&YE=#PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,38L,#,S+#DT-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$X+#DY."PT,#D\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D=O;V1W:6QL/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX+#<P,BPR.34\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XY+#0T,RPX
M.30\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;W4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y4;W1A;"!A<W-E=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$X-2PT.3<L-3DP/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,34V+#`T,2PX.#$\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^0W5R<F5N="!L
M:6%B:6QI=&EE<SH\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y!8V-O=6YT<R!P87EA8FQE/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ+#$V-RPU-#4\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#<Y,RPY,3$\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%C8W)U960@97AP
M96YS97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4L,C4S+#8Y
M,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C4L-3,W+#@X,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^1&5F97)R960@<F5V96YU93PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,3(L.#@U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,3@P+#0S,SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^26YC;VUE('1A>&5S('!A
M>6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW-S`L,C<V
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F]U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^5&]T86P@8W5R<F5N="!L:6%B:6QI=&EE<SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^-BPT,S0L,3(S/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.2PR.#(L-3`Q/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/=&AE<B!L;VYG
M+71E<FT@;&EA8FEL:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/CDT."PX-3@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ+#$S,RPU-#0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/DQO;F<M=&5R;2!D969E<G)E9"!R979E
M;G5E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU-BPU-S,\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#`U
M-"PY-#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D1E9F5R<F5D('1A>"!L:6%B:6QI='D\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C@L,S4S+#4S,3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<L.3,V+#@V-#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]M;6ET;65N
M=',@86YD(&-O;G1I;F=E;F-I97,@*$YO=&4@,3`I/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M/'-T<F]N9SY3=&]C:VAO;&1E<G/B@)D@97%U:71Y.CPO<W1R;VYG/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R969E<G)E9"!S=&]C
M:RP@)"XP,2!P87(@=F%L=64[(#$L,C4P+#`P,"!S:&%R97,@875T:&]R:7IE
M9"P@;F\@<VAA<F5S(&ES<W5E9"!A;F0@;W5T<W1A;F1I;F<@870@4V5P=&5M
M8F5R(#,P+"`R,#$T(&%N9"!$96-E;6)E<B`S,2P@,C`Q,RP@<F5S<&5C=&EV
M96QY/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB
M<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^0V]M;6]N('-T;V-K+"`D+C`Q('!A<B!V86QU
M93L@,S`L,#`P+#`P,"!S:&%R97,@875T:&]R:7IE9"P@,30L.#`P+#0U,R!A
M;F0@,30L,C@Y+#,P."!S:&%R97,@:7-S=65D(&%N9"!O=71S=&%N9&EN9R!A
M="!397!T96UB97(@,S`L(#(P,30@86YD($1E8V5M8F5R(#,Q+"`R,#$S+"!R
M97-P96-T:79E;'D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$T
M."PP,#0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XQ-#(L.#DS/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y!9&1I=&EO;F%L('!A:60M:6XM8V%P:71A;#PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-S8L,#8T+#,X,SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<P+#8P-BPP
M,S$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D%C8W5M=6QA=&5D(&]T:&5R(&-O;7!R96AE;G-I=F4@;&]S<SPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,RPU.34L-#@W*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$L-CDY+#`Y
M-2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/E)E=&%I;F5D(&5A<FYI;F=S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XY-RPP.#<L-C`U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^-C8L-3@T+#(P,CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E=3X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1O=&%L('-T;V-K:&]L
M9&5R<^*`F2!E<75I='D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C$V.2PW,#0L-3`U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,3,U+#8S-"PP,S$\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;W4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!,:6%B:6QI=&EE<R!A
M;F0@4W1O8VMH;VQD97)SXH"9($5Q=6ET>3PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^)"`Q.#4L-#DW+#4Y,#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,34V+#`T,2PX.#$\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B
M;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7V)A-3$W,3$S7S!D
M,C=?-#,V,5]A-V)A7S$P838S83,X-30R8PT*0V]N=&5N="U,;V-A=&EO;CH@
M9FEL93HO+R]#.B]B834Q-S$Q,U\P9#(W7S0S-C%?83=B85\Q,&$V,V$S.#4T
M,F,O5V]R:W-H965T<R]3:&5E=#`S+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M
M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X
M="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D
M/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N
M=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS
M1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO
M=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-
M"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%5T]!0SX-"B`@
M("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@
M<F]W<W!A;CTS1#$^/'-T<F]N9SY#;VYD96YS960@0V]N<V]L:61A=&5D($)A
M;&%N8V4@4VAE971S("A5;F%U9&ET960I("A087)E;G1H971I8V%L<RD@*%53
M1"`D*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y397`N(#,P+"`R,#$T/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/D1E8RX@,S$L(#(P,3,\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D%C8V]U;G1S(')E8V5I=F%B;&4L(&YE="!O9B!R97-E<G9E
M<R`H:6X@1&]L;&%R<RD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/B0@-30V+#0U-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/B0@-3DS+#`R,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^4')E9F5R<F5D('-T;V-K+"!P87(@=F%L
M=64@*&EN($1O;&QA<G,@<&5R('-H87)E*3PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^)"`P+C`Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^)"`P+C`Q/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F5F97)R960@<W1O8VLL('-H
M87)E<R!A=71H;W)I>F5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XQ+#(U,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ+#(U,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R969E<G)E9"!S=&]C:RP@<VAA<F5S
M(&ES<W5E9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C`\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R
M969E<G)E9"!S=&]C:RP@<VAA<F5S(&]U='-T86YD:6YG/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]M;6]N('-T;V-K+"!P87(@=F%L
M=64@*&EN($1O;&QA<G,@<&5R('-H87)E*3PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^)"`P+C`Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^)"`P+C`Q/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM;VX@<W1O8VLL('-H87)E
M<R!A=71H;W)I>F5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS
M,"PP,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,S`L,#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^0V]M;6]N('-T;V-K+"!S:&%R97,@:7-S
M=65D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-"PX,#`L-#4S
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,30L,C@Y+#,P.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^0V]M;6]N('-T;V-K+'-H87)E<R!O=71S=&%N9&EN9SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,30L.#`P+#0U,SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$T+#(X
M.2PS,#@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T
M86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T
M7V)A-3$W,3$S7S!D,C=?-#,V,5]A-V)A7S$P838S83,X-30R8PT*0V]N=&5N
M="U,;V-A=&EO;CH@9FEL93HO+R]#.B]B834Q-S$Q,U\P9#(W7S0S-C%?83=B
M85\Q,&$V,V$S.#4T,F,O5V]R:W-H965T<R]3:&5E=#`T+FAT;6P-"D-O;G1E
M;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E
M;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT
M;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT
M+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS
M8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J
M($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D
M/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)
M1#!%0TA"1SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@
M8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY#;VYD96YS960@0V]N
M<V]L:61A=&5D(%-T871E;65N=',@;V8@3W!E<F%T:6]N<R!A;F0@0V]M<')E
M:&5N<VEV92!);F-O;64@*%5N875D:71E9"D@*%531"`D*3QB<CX\+W-T<F]N
M9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,CXS
M($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O
M;'-P86X],T0R/CD@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/E-E<"X@,S`L(#(P
M,30\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^4V5P+B`S,"P@
M,C`Q,SQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y397`N(#,P
M+"`R,#$T/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/E-E<"X@
M,S`L(#(P,3,\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E!R;V1U8W0@<F5V96YU93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^)"`R,2PY-S4L,S$R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`Q-RPP,C,L,S0V/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`U-RPU.3,L.#<S/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`U,2PU
M.#4L,C0R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y,:6-E;G-I;F<L(&UI;&5S=&]N92!A;F0@8V]N=')A8W0@<F5V
M96YU93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.#`L,3$Q/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-S,Q
M+#`Y,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C(T+#<T-BPT.3<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XR+#(T-"PU.#0\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R974^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!R979E;G5E/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,BPP-34L-#(S/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3<L-S4T+#0S
M.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C@R+#,T,"PS-S`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XU,RPX,CDL.#(V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D]P97)A=&EN9R!E>'!E
M;G-E<SH\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D-O<W0@;V8@<')O9'5C="!R979E;G5E/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XU+#<R-"PX,#`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU+#,W-RPU-C@\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-2PT,3@L-S,R
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,38L-3,P+#`W,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^4F5S96%R8V@@)F%M<#L@9&5V96QO<&UE;G0\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L.3DY+#@V-SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L-C$X+#`Q,CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8L
M,38P+#<T,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C4L,#(Y+#DW-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^4V5L;&EN9RP@9V5N97)A;"`F86UP.R!A9&UI
M;FES=')A=&EV93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-"PP
M-#0L-3,X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,RPQ.#@L-C8Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,3$L-#`Q+#,Y.3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$P+#4S-BPT-C(\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)E<W1R=6-T
M=7)I;F<@8W)E9&ET<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH
M,3DV+#`X-"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M/B@Q.38L,#@T*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M/B@T-#(L.#8Y*3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E=3X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1O=&%L(&]P97)A=&EN9R!E
M>'!E;G-E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3$L-S8Y
M+#(P-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/CDL.3@X+#$V-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C,R+#DX,"PX-S$\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XS,2PV-3,L-C,W/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F]U/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^26YC;VUE(&9R
M;VT@;W!E<F%T:6]N<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,3`L,C@V+#(Q.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C<L-S8V+#(W,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C0Y+#,U.2PT.3D\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,BPQ-S8L,3@Y/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y);G1E
M<F5S="!I;F-O;64@*&5X<&5N<V4I+"!N970\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/CDL.3,W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;3XH,S(L.#$V*3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$V+#,S.3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$P."PW-34I/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F]U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^26YC
M;VUE(&)E9F]R92!I;F-O;64@=&%X97,\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C$P+#(Y-BPQ-34\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XW+#<S,RPT-3<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT.2PS-S4L.#,X/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C(L,#8W
M+#0S-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^4')O=FES:6]N(&9O<B!I;F-O;64@=&%X97,\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C0L,3(U+#,U-3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L-S<V+#$Y.3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$X+#@W,BPT
M,S4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XX+#$T-RPR.#(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;W4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y.970@:6YC;VUE/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XV+#$W,"PX,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XT+#DU-RPR-3@\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS,"PU,#,L-#`S/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3,L.3(P
M+#$U,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^56YR96%L:7IE9"!G86EN(&]N('-E8W5R:71I97,L(&YE="!O9B!T
M87@\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0S,3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT,S$\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y&
M;W)E:6=N(&-U<G)E;F-Y('1R86YS;&%T:6]N(&%D:G5S=&UE;G0\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$L-C<Y+#DV."D\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XY,38L-#<T/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,2PX
M.38L.#(S*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C4P-RPQ,3D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R974^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!O=&AE<B!C;VUP<F5H96YS:79E(&EN
M8V]M92`H;&]S<RD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$L
M-C<Y+#4S-RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XY,38L-#<T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XH,2PX.38L,SDR*3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4P-RPQ,3D\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^0F%S
M:6,@;F5T(&EN8V]M92!P97(@<VAA<F4Z/"]S=')O;F<^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.970@:6YC;VUE("AI;B!$;VQL
M87)S('!E<B!S:&%R92D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/B0@,"XT,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/B0@,"XS-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/B0@,BXP.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/B0@,2XP,SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F%S:6,@=V5I9VAT960@879E
M<F%G92!C;VUM;VX@<VAA<F5S(&]U='-T86YD:6YG("AI;B!3:&%R97,I/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-"PW-3@L-S@Q/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3,L-C@R
M+#0T.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$T+#8R-BPY,S,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ,RPU,S0L,S,T/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D1I;'5T960@;F5T
M(&EN8V]M92!P97(@<VAA<F4Z/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y.970@:6YC;VUE("AI;B!$;VQL87)S('!E
M<B!S:&%R92D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,"XT
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M)"`P+C,S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^)"`Q+CDW/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^)"`P+CDU/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y$:6QU=&5D('=E:6=H=&5D(&%V97)A9V4@
M8V]M;6]N('-H87)E<R!O=71S=&%N9&EN9R`H:6X@4VAA<F5S*3PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,34L-#,T+#@W-3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$T+#DU."PY-C4\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M-2PT-CDL,C,W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,30L-C<S+#@W.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^3F5T(&EN8V]M93PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^-BPQ-S`L.#`P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-"PY-3<L,C4X/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S`L-3`S+#0P
M,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C$S+#DR,"PQ-3(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E5N<F5A;&EZ960@9V%I;B!O;B!S96-U<FET:65S+"!N
M970@;V8@=&%X/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT,S$\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M-#,Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^1F]R96EG;B!C=7)R96YC>2!T<F%N<VQA=&EO;B!A9&IU<W1M96YT
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q+#8W.2PY-C@I/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.3$V
M+#0W-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6T^*#$L.#DV+#@R,RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XU,#<L,3$Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F5U/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5&]T86P@;W1H97(@8V]M<')E:&5N
M<VEV92!I;F-O;64@*&QO<W,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M/B@Q+#8W.2PU,S<I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^.3$V+#0W-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6T^*#$L.#DV+#,Y,BD\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU,#<L,3$Y/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F]U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]M
M<')E:&5N<VEV92!I;F-O;64\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/B0@-"PT.3$L,C8S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`U+#@W,RPW,S(\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#(X+#8P-RPP,3$\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$T+#0R
M-RPR-S$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T
M86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T
M7V)A-3$W,3$S7S!D,C=?-#,V,5]A-V)A7S$P838S83,X-30R8PT*0V]N=&5N
M="U,;V-A=&EO;CH@9FEL93HO+R]#.B]B834Q-S$Q,U\P9#(W7S0S-C%?83=B
M85\Q,&$V,V$S.#4T,F,O5V]R:W-H965T<R]3:&5E=#`U+FAT;6P-"D-O;G1E
M;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E
M;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT
M;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT
M+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS
M8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J
M($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D
M/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)
M1#!%0U)!1SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@
M8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY#;VYD96YS960@0V]N
M<V]L:61A=&5D(%-T871E;65N=',@;V8@0V%S:"!&;&]W<R`H56YA=61I=&5D
M*2`H55-$("0I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H(&-O;'-P86X],T0R/CD@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/E-E
M<"X@,S`L(#(P,30\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M4V5P+B`S,"P@,C`Q,SQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^/'-T<F]N9SY#87-H(&9L;W=S(&9R;VT@;W!E<F%T:6YG(&%C=&EV
M:71I97,Z/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^3F5T(&EN8V]M93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^)"`S,"PU,#,L-#`S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`Q,RPY,C`L,34R/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D%D:G5S=&UE
M;G1S('1O(')E8V]N8VEL92!N970@:6YC;VUE('1O(&YE="!C87-H('!R;W9I
M9&5D(&)Y(&]P97)A=&EN9R!A8W1I=FET:65S.CPO<W1R;VYG/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1E<')E8VEA=&EO;B!A;F0@
M86UO<G1I>F%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS
M+#4W-BPT-#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XS+#4W.2PT-S0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/E-T;V-K+6)A<V5D(&-O;7!E;G-A=&EO;B!E
M>'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#$Y-BPS
M-C$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XQ+#$U-BPY,CD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E!R;W9I<VEO;B!F;W(@9&]U8G1F=6P@86-C;W5N=',\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR-"PP.3@\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R;W9I
M<VEO;B!F;W(@:6YV96YT;W)Y/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XR,C`L,C`W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,38U+#@P,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^1V%I;B!O;B!S86QE(&]F(&%S<V5T<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#0T,BPS-#$I/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y487@@
M8F5N969I="!F<F]M(&5X97)C:7-E(&]F('-T;V-K(&]P=&EO;G,\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#DL,C,V+#<P."D\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@W-C0L,3@Q*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M/'-T<F]N9SY#:&%N9V5S(&EN(&]P97)A=&EN9R!A<W-E=',@86YD(&QI86)I
M;&ET:65S.CPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D%C8V]U;G1S(')E8V5I=F%B;&4\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6T^*#$L.#0P+#0P-RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XT+#8V-RPX,SD\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DEN=F5N=&]R:65S
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R+#DR,RPV,C@I/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,RPT
M,S`L-C4U*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^4')E<&%I9"!E>'!E;G-E<RP@;W1H97(@8W5R<F5N="!A;F0@
M;&]N9RUT97)M(&%S<V5T<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,3@S+#0X,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C4S,2PT-#D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/DQO;F<M=&5R;2!D97!O<VET<R!A;F0@;W1H
M97(\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR-2PT.3<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%C
M8V]U;G1S('!A>6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^
M*#DY,BPX,C(I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,3(T+#8W.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^06-C<G5E9"!E>'!E;G-E<SPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XH.3@Y+#(Y,2D\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@V-#(L-#,P*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&5F97)R
M960@<F5V96YU93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,BPP
M-S@L-30S*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^*#(L,34P+#`P,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/DEN8V]M92!T87AE<SPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^-RPW-S$L,#`Q/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-S8V+#4Y.#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W1H97(@;&]N
M9RUT97)M(&QI86)I;&ET:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M/B@Q-C<L,3(S*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6T^*#,W,RPW,3(I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F]U/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T(&-A<V@@<')O=FED960@8GD@
M;W!E<F%T:6YG(&%C=&EV:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C(U+#(R,BPS-S(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XQ-RPQ-3DL,3DY/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D-A<V@@9FQO
M=W,@9G)O;2!I;G9E<W1I;F<@86-T:79I=&EE<SH\+W-T<F]N9SX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0=7)C:&%S92!O9B!M87)K
M971A8FQE('-E8W5R:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6T^*#$Y+#DY.2PQ-CDI/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^4')O8V5E9',@9G)O;2!S86QE(&]F(&%S<V5T
M<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4S,"PX-C4\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!U
M<F-H87-E(&]F('!R;W!E<G1Y(&%N9"!E<75I<&UE;G0\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6T^*#DR,"PQ,S(I/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,C,U+#@P,RD\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R974^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.970@8V%S
M:"!P<F]V:61E9"!B>2`H=7-E9"!I;BD@:6YV97-T:6YG(&%C=&EV:71I97,\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#(P+#DQ.2PS,#$I/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,CDU
M+#`V,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^/'-T<F]N9SY#87-H(&9L;W=S(&9R;VT@9FEN86YC:6YG(&%C=&EV
M:71I97,Z/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^4')O8V5E9',@9G)O;2!E>&5R8VES92!O9B!S=&]C:R!O<'1I;VYS
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#,W.2PR.30\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#DS
M,BPV-#D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/E1A>"!B96YE9FET(&9R;VT@97AE<F-I<V4@;V8@<W1O8VL@;W!T
M:6]N<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.2PR,S8L-S`X
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M-S8T+#$X,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^36EN:6UU;2!T87@@=VET:&AO;&1I;F<@;VX@<VAA<F4@8F%S
M960@87=A<F1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@V+#,T
M."PY,#`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^4')I;F-I<&%L('!A>6UE;G1S(&]N(&1E8G0\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q+#(P,"PP,#`I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F5U/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T(&-A<V@@
M<')O=FED960@8GD@9FEN86YC:6YG(&%C=&EV:71I97,\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C0L,C8W+#$P,CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L-#DV+#@S,#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17AC:&%N
M9V4@<F%T92!I;7!A8W0@;VX@8V%S:#PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;3XH,3,Q+#$S.2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XS-BPX-S`\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R974^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y);F-R96%S92!I;B!C87-H(&%N
M9"!C87-H(&5Q=6EV86QE;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XX+#0S.2PP,S0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ.2PY.#<L.38Q/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#87-H(&%N9"!C87-H(&5Q=6EV
M86QE;G1S(&%T(&)E9VEN;FEN9R!O9B!P97)I;V0\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C8S+#,S,RPQ-C`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT-"PP-C<L-#<W/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#87-H(&%N
M9"!C87-H(&5Q=6EV86QE;G1S(&%T(&5N9"!O9B!P97)I;V0\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-S$L-S<R+#$Y-#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-C0L,#4U+#0S
M.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE
M/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?8F$U
M,3<Q,3-?,&0R-U\T,S8Q7V$W8F%?,3!A-C-A,S@U-#)C#0I#;VYT96YT+4QO
M8V%T:6]N.B!F:6QE.B\O+T,Z+V)A-3$W,3$S7S!D,C=?-#,V,5]A-V)A7S$P
M838S83,X-30R8R]7;W)K<VAE971S+U-H965T,#8N:'1M;`T*0V]N=&5N="U4
M<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4
M>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-
M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP
M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP
M="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@
M3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@
M(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5-
M13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A
M;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY.;W1E(#$@+2!.871U<F4@;V8@
M0G5S:6YE<W,\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@@8V]L<W!A;CTS1#$^.2!-;VYT:',@16YD960\+W1H/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^4V5P
M+B`S,"P@,C`Q-#QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^/'-T<F]N9SY$:7-C;&]S=7)E(%1E>'0@0FQO8VL@6T%B<W1R86-T73PO
M<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F%T
M=7)E(&]F($]P97)A=&EO;G,@6U1E>'0@0FQO8VM=/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'1A8FQE(&-E;&QS<&%C:6YG/3-$,"!C96QL
M<&%D9&EN9STS1#`@<W1Y;&4],T0G=VED=&@Z(#$P,"4[(&9O;G0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&)O<F1E<BUC;VQL87!S
M93H@8V]L;&%P<V4G/B`@("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC
M86PM86QI9VXZ('1O<"<^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I
M9'1H.B`V)2<^("`-"B`@("`@("`@("`\8CXQ+CPO8CX@(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@.30E)SX@
M("`-"B`@("`@("`@("`\8CY.871U<F4@;V8@0G5S:6YE<W,\+V(^("`@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@/"]T86)L
M93X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UI;F1E;G0Z(#`N-6EN
M)SX@("`@#0H@("`@("!!;FEK82!4:&5R87!E=71I8W,L)B,Q-C`[26YC+B`H
M=&]G971H97(@=VET:"!I=',@<W5B<VED:6%R:65S+"`F(S@R,C`[06YI:V$L
M)B,X,C(Q.R!T:&4@)B,X,C(P.T-O;7!A;GDL)B,X,C(Q.R`F(S@R,C`[=V4L
M)B,X,C(Q.R`F(S@R,C`[=7,L)B,X,C(Q.R!O<B`F(S@R,C`[;W5R)B,X,C(Q
M.RD@9&5V96QO<',L(&UA;G5F86-T=7)E<R!A;F0@8V]M;65R8VEA;&EZ97,@
M=&AE<F%P975T:6,@<')O9'5C=',@9F]R('1I<W-U92!P<F]T96-T:6]N+"!H
M96%L:6YG(&%N9"!R97!A:7(N(%1H97-E('!R;V1U8W1S(&%R92!B87-E9"!O
M;B!H>6%L=7)O;FEC(&%C:60@*"8C.#(R,#M(028C.#(R,3LI+"!A(&YA='5R
M86QL>2!O8V-U<G)I;F<L(&)I;V-O;7!A=&EB;&4@<&]L>6UE<B!F;W5N9"!T
M:')O=6=H;W5T('1H92!B;V1Y+B!$=64@=&\@:71S('5N:7%U92!B:6]P:'ES
M:6-A;"!A;F0@8FEO8VAE;6EC86P@<')O<&5R=&EE<RP@2$$@<&QA>7,@86X@
M:6UP;W)T86YT(')O;&4@:6X@82!N=6UB97(@;V8@<&AY<VEO;&]G:6-A;"!F
M=6YC=&EO;G,@<W5C:"!A<R!T:&4@<')O=&5C=&EO;B!A;F0@;'5B<FEC871I
M;VX@;V8@<V]F="!T:7-S=65S(&%N9"!J;VEN=',L('1H92!M86EN=&5N86YC
M92!O9B!T:&4@<W1R=6-T=7)A;"!I;G1E9W)I='D@;V8@=&ES<W5E<RP@86YD
M('1H92!T<F%N<W!O<G0@;V8@;6]L96-U;&5S('1O(&%N9"!W:71H:6X@8V5L
M;',N("`@#0H@("`@/"]P/CQB<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P<'0@,#L@
M=&5X="UI;F1E;G0Z(#`N-6EN)SX@("`@#0H@("`@("!4:&4@0V]M<&%N>2!I
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M($-O;7!A;GDF(S@R,3<[<R!B=7-I;F5S<RX@("`-"B`@("`\+W`^/&)R+SX\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-
M"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7V)A-3$W
M,3$S7S!D,C=?-#,V,5]A-V)A7S$P838S83,X-30R8PT*0V]N=&5N="U,;V-A
M=&EO;CH@9FEL93HO+R]#.B]B834Q-S$Q,U\P9#(W7S0S-C%?83=B85\Q,&$V
M,V$S.#4T,F,O5V]R:W-H965T<R]3:&5E=#`W+FAT;6P-"D-O;G1E;G0M5')A
M;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP
M93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@
M(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@
M8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@
M='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO
M="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\
M8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%344^
M#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X]
M,T0Q(')O=W-P86X],T0R/CQS=')O;F<^3F]T92`R("T@0F%S:7,@;V8@4')E
M<V5N=&%T:6]N/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H(&-O;'-P86X],T0Q/CD@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/E-E
M<"X@,S`L(#(P,30\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/CQS=')O;F<^1&ES8VQO<W5R92!497AT($)L;V-K(%M!8G-T<F%C=%T\
M+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D)U
M<VEN97-S($1E<V-R:7!T:6]N(&%N9"!"87-I<R!O9B!0<F5S96YT871I;VX@
M6U1E>'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'1A8FQE(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@<W1Y;&4]
M,T0G=VED=&@Z(#$P,"4[(&9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68[(&)O<F1E<BUC;VQL87!S93H@8V]L;&%P<V4G/B`@#0H@
M("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ('1O<"<^("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`V)2<^("`-"B`@("`@("`@
M("`\8CXR+CPO8CX@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=W:61T:#H@.30E)SX@("`-"B`@("`@("`@("`\8CY"87-I
M<R!O9B!0<F5S96YT871I;VX\+V(^(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`\+W1R/B`@(`T*("`@(#PO=&%B;&4^/&)R+SX\<"!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G
M:6XZ(#!P="`P.R!T97AT+6EN9&5N=#H@,"XU:6XG/B`@(`T*("`@("`@5&AE
M(&%C8V]M<&%N>6EN9R!U;F%U9&ET960@8V]N9&5N<V5D(&-O;G-O;&ED871E
M9"!F:6YA;F-I86P@<W1A=&5M96YT<R!A;F0@<F5L871E9"!N;W1E<R!H879E
M(&)E96X@<')E<&%R960@8GD@=&AE($-O;7!A;GD@<'5R<W5A;G0@=&\@=&AE
M(')U;&5S)B,Q-C`[86YD(')E9W5L871I;VYS(&]F('1H92!396-U<FET:65S
M(&%N9"!%>&-H86YG92!#;VUM:7-S:6]N("AT:&4@)B,X,C(P.U-%0R8C.#(R
M,3LI(&%N9"!I;B!A8V-O<F1A;F-E('=I=&@@86-C;W5N=&EN9R!P<FEN8VEP
M;&5S(&=E;F5R86QL>2!A8V-E<'1E9"!I;B!T:&4@56YI=&5D(%-T871E<R`H
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M<W1A=&5M96YT<R!C;VYT86EN(&%L;"!A9&IU<W1M96YT<R`H8V]N<VES=&EN
M9R!O;FQY(&]F(&YO<FUA;"!R96-U<G)I;F<@861J=7-T;65N=',I(&YE8V5S
M<V%R>2!T;R!F86ER;'D@<W1A=&4@=&AE(&-O;F1E;G-E9"!C;VYS;VQI9&%T
M960@9FEN86YC:6%L('!O<VET:6]N(&]F('1H92!#;VUP86YY(&%S(&]F(%-E
M<'1E;6)E<B`S,"P@,C`Q-"P@=&AE(')E<W5L=',@;V8@:71S(`T*("`@("`@
M;W!E<F%T:6]N<R!F;W(@=&AE('1H<F5E(&%N9"!N:6YE+6UO;G1H('!E<FEO
M9',@96YD960@4V5P=&5M8F5R(#,P+"`R,#$T(&%N9"`R,#$S+"!A;F0@8V%S
M:"!F;&]W<R!F;W(@=&AE(&YI;F4M;6]N=&@@<&5R:6]D<R!E;F1E9"!397!T
M96UB97(@,S`L(#(P,30@86YD(#(P,3,N(`T*("`@(#PO<#X\8G(O/CQP('-T
M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68[(&UA<F=I;CH@,#L@=&5X="UI;F1E;G0Z(#`N-6EN)SX@("`@(`T*("`@
M("`@5&AE(&%C8V]M<&%N>6EN9R!U;F%U9&ET960@8V]N9&5N<V5D(&-O;G-O
M;&ED871E9"!F:6YA;F-I86P@<W1A=&5M96YT<R!A;F0@<F5L871E9"!N;W1E
M<R!S:&]U;&0@8F4@<F5A9"!I;B!C;VYJ=6YC=&EO;B!W:71H('1H92!#;VUP
M86YY)B,X,C$W.W,@86YN=6%L(&9I;F%N8VEA;"!S=&%T96UE;G1S(&9I;&5D
M('=I=&@@:71S($%N;G5A;"!297!O<G0@;VX@1F]R;28C,38P.S$P+4L@9F]R
M('1H92!Y96%R(&5N9&5D($1E8V5M8F5R(#,Q+"`R,#$S+B!4:&4@<F5S=6QT
M<R!O9B!O<&5R871I;VYS(&9O<B!T:&4@=&AR964@86YD(&YI;F4M;6]N=&@@
M<&5R:6]D<R!E;F1E9"!397!T96UB97(@,S`L(#(P,30@87)E(&YO="!N96-E
M<W-A<FEL>2!I;F1I8V%T:79E(&]F('1H92!R97-U;'1S('1O(&)E(&5X<&5C
M=&5D(&9O<B!T:&4@>65A<B!E;F1I;F<@1&5C96UB97(F(S$V,#LS,2P@,C`Q
M-"X@0V5R=&%I;B!P<FEO<B!P97)I;V0@86UO=6YT<R!H879E(&)E96X@<F5C
M;&%S<VEF:65D('1O(&-O;F9O<FT@=&\@=&AE(&-U<G)E;G0@<&5R:6]D('!R
M97-E;G1A=&EO;BX@5&AE<F4@=V%S(&YO(&EM<&%C="!O;B!O<&5R871I;F<@
M:6YC;VUE+B`@(`T*("`@(#PO<#X\8G(O/CQP('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@=&5X="UI;F1E;G0Z(#`N-6EN.R!M87)G:6XZ(#`G/B`@("`@
M#0H@("`@("!!(')E=FES:6]N('=A<R!M861E(&]N('1H92!C;VYD96YS960@
M8V]N<V]L:61A=&5D('-T871E;65N="!O9B!C87-H(&9L;W=S(&9O<B!T:&4@
M<VEX(&UO;G1H<R!E;F1E9"!*=6YE(#,P+"`R,#$T('1O(&-O<G)E8W1L>2!R
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M;W!T:6]N<R!F;W(@=&AE('-I>"!M;VYT:',@96YD960@2G5N92`S,"P@,C`Q
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M;G1S+B`@(`T*("`@(#PO<#X\8G(O/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-
M"BTM+2TM+3U?3F5X=%!A<G1?8F$U,3<Q,3-?,&0R-U\T,S8Q7V$W8F%?,3!A
M-C-A,S@U-#)C#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+V)A-3$W
M,3$S7S!D,C=?-#,V,5]A-V)A7S$P838S83,X-30R8R]7;W)K<VAE971S+U-H
M965T,#@N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D
M+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970]
M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T
M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@
M8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T
M('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@
M*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S
M<STS1')E<&]R="!I9#TS1$E$,$5-13X-"B`@("`@(#QT<CX-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N
M9SY.;W1E(#,@+2!-87)K971A8FQE(%-E8W5R:71I97,\8G(^/"]S=')O;F<^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^.2!-
M;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^4V5P+B`S,"P@,C`Q-#QB<CX\+W1H/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY$:7-C;&]S=7)E
M(%1E>'0@0FQO8VL@4W5P<&QE;65N="!;06)S=')A8W1=/"]S=')O;F<^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#87-H+"!#87-H($5Q
M=6EV86QE;G1S+"!A;F0@36%R:V5T86)L92!396-U<FET:65S(%M497AT($)L
M;V-K73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQT86)L92!C
M96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('-T>6QE/3-$)W=I9'1H
M.B`Q,#`E.R!F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!B;W)D97(M8V]L;&%P<V4Z(&-O;&QA<'-E)SX@("`-"B`@("`@(#QT
M<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P)SX@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=VED=&@Z(#8E)SX@(`T*("`@("`@("`@(#QB/C,N
M/"]B/B`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W=I9'1H.B`Y-"4G/B`@(`T*("`@("`@("`@(#QP('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I
M;CH@,"<^("`@("`-"B`@("`@("`@("`@(#QB/DUA<FME=&%B;&4@4V5C=7)I
M=&EE<SPO8CX@("`-"B`@("`@("`@("`\+W`^(`T*("`@("`@("`@(#QP('-T
M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68[(&UA<F=I;CH@,"<^("`@("`-"B`@("`@("`@("`@(#QB/CPO8CX@(`T*
M("`@("`@("`@(#PO<#X@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO
M='(^("`@#0H@("`@/"]T86)L93X\8G(O/CQT86)L92!C96QL<&%D9&EN9STS
M1#`@8V5L;'-P86-I;F<],T0P('-T>6QE/3-$)V)O<F1E<BUC;VQL87!S93H@
M8V]L;&%P<V4[('=I9'1H.B`Q,#`E.R!F;VYT.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF)SX@("`@#0H@("`@("`\='(@<W1Y;&4],T0G
M=F5R=&EC86PM86QI9VXZ(&)O='1O;2<^("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=F;VYT+7=E:6=H=#H@8F]L9"<^("`@("`-"B`@("`@("`@("`F(S$V
M,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)V9O;G0M=V5I9VAT.B!B;VQD.R!P861D:6YG+6)O='1O;3H@,2XQ<'0G/B`@
M(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@8V]L<W!A;CTS1#$U('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B
M;VQD.R!T97AT+6%L:6=N.B!C96YT97([(&)O<F1E<BUB;W1T;VTZ($)L86-K
M(#$N,7!T('-O;&ED)SX@(`T*("`@("`@("`@(%-E<'1E;6)E<B`S,"P@,C`Q
M-"`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@/"]T<CX@("`-"B`@
M("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M)SX@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD)SX@("`@
M(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O;&0[('!A9&1I;F<M
M8F]T=&]M.B`Q+C%P="<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!C;VQS<&%N/3-$,R!S='EL93TS
M1"=F;VYT+7=E:6=H=#H@8F]L9#L@=&5X="UA;&EG;CH@8V5N=&5R.R!B;W)D
M97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9"<^(`T*("`@("`@("`@(#QP
M('-T>6QE/3-$)VUA<F=I;BUT;W`Z(#`[(&UA<F=I;BUB;W1T;VTZ(#`G/B`@
M("`@#0H@("`@("`@("`@("!!;6]R=&EZ960@(`T*("`@("`@("`@(#PO<#X@
M#0H@("`@("`@("`@/'`@<W1Y;&4],T0G;6%R9VEN+71O<#H@,#L@;6%R9VEN
M+6)O='1O;3H@,"<^("`@("`-"B`@("`@("`@("`@($-O<W0@(`T*("`@("`@
M("`@(#PO<#X@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!P861D:6YG+6)O='1O;3H@,2XQ
M<'0G/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@8V]L<W!A;CTS1#,@<W1Y;&4],T0G9F]N="UW96EG
M:'0Z(&)O;&0[('1E>'0M86QI9VXZ(&-E;G1E<CL@8F]R9&5R+6)O='1O;3H@
M0FQA8VL@,2XQ<'0@<V]L:60G/B`-"B`@("`@("`@("`\<"!S='EL93TS1"=M
M87)G:6XM=&]P.B`P.R!M87)G:6XM8F]T=&]M.B`P)SX@("`@(`T*("`@("`@
M("`@("`@56YR96%L:7IE9"`@(`T*("`@("`@("`@(#PO<#X@#0H@("`@("`@
M("`@/'`@<W1Y;&4],T0G;6%R9VEN+71O<#H@,#L@;6%R9VEN+6)O='1O;3H@
M,"<^("`@("`-"B`@("`@("`@("`@($=A:6YS+"!.970@;V8@5&%X("`@("`-
M"B`@("`@("`@("`\+W`^(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@<&%D9&EN9RUB;W1T
M;VTZ(#$N,7!T)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)V9O
M;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97([(&)O<F1E<BUB
M;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED)SX@#0H@("`@("`@("`@/'`@<W1Y
M;&4],T0G;6%R9VEN+71O<#H@,#L@;6%R9VEN+6)O='1O;3H@,"<^("`@("`-
M"B`@("`@("`@("`@(%5N<F5A;&EZ960@("`-"B`@("`@("`@("`\+W`^(`T*
M("`@("`@("`@(#QP('-T>6QE/3-$)VUA<F=I;BUT;W`Z(#`[(&UA<F=I;BUB
M;W1T;VTZ(#`G/B`@("`@#0H@("`@("`@("`@("!,;W-S97,L($YE="!O9B!4
M87@@#0H@("`@("`@("`@/"]P/B`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O;&0[('!A9&1I;F<M
M8F]T=&]M.B`Q+C%P="<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!C;VQS<&%N/3-$,R!S='EL93TS
M1"=F;VYT+7=E:6=H=#H@8F]L9#L@=&5X="UA;&EG;CH@8V5N=&5R.R!B;W)D
M97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9"<^(`T*("`@("`@("`@(#QP
M('-T>6QE/3-$)VUA<F=I;BUT;W`Z(#`[(&UA<F=I;BUB;W1T;VTZ(#`G/B`@
M("`@#0H@("`@("`@("`@("!&86ER("`-"B`@("`@("`@("`\+W`^(`T*("`@
M("`@("`@(#QP('-T>6QE/3-$)VUA<F=I;BUT;W`Z(#`[(&UA<F=I;BUB;W1T
M;VTZ(#`G/B`@("`@#0H@("`@("`@("`@("!686QU92`@(`T*("`@("`@("`@
M(#PO<#X@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@
M("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C
M:V=R;W5N9"UC;VQO<CH@<F=B*#(P-"PR,S@L,C4U*2<^("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=VED=&@Z(#4V)3L@=&5X="UA;&EG;CH@;&5F="<^
M(`T*("`@("`@("`@(%5N:71E9"!3=&%T97,@5')E87-U<GD@<V5C=7)I=&EE
M<R`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G=VED=&@Z(#$E)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!T
M97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@("0@(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@."4[
M('1E>'0M86QI9VXZ(')I9VAT)SX@#0H@("`@("`@("`@,30L.3DY+#$V.2`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED
M=&@Z(#$E.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@("8C
M,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G=VED=&@Z(#$E)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!T
M97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@("0@(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@."4[
M('1E>'0M86QI9VXZ(')I9VAT)SX@#0H@("`@("`@("`@-CDY("`@(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@
M,24[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W
M:61T:#H@,24G/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[('1E>'0M
M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@)"`@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`X)3L@=&5X
M="UA;&EG;CH@<FEG:'0G/B`-"B`@("`@("`@("`H,C8X("`@("`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E
M.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@("D@(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@
M,24G/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[('1E>'0M86QI9VXZ
M(&QE9G0G/B`@("`@#0H@("`@("`@("`@)"`@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`X)3L@=&5X="UA;&EG
M;CH@<FEG:'0G/B`-"B`@("`@("`@("`Q-"PY.3DL-C`P(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[('1E
M>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`\+W1R/B`@(`T*("`@("`@/'1R('-T
M>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L
M;W(Z(%=H:71E)SX@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(&QE9G0[('!A9&1I;F<M8F]T=&]M.B`Q+C%P="<^("`-"B`@("`@("`@
M("!"86YK(&-E<G1I9FEC871E<R!O9B!D97!O<VET("`@(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O
M;3H@,2XQ<'0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ
M($)L86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!L969T)SX@("`-"B`@
M("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED
M.R!T97AT+6%L:6=N.B!R:6=H="<^("`@(`T*("`@("`@("`@(#4L,#`P+#`P
M,"`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT+6%L
M:6=N.B!L969T)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M
M.B`Q+C%P="<^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@
M0FQA8VL@,2XQ<'0@<V]L:60[('1E>'0M86QI9VXZ(&QE9G0G/B`@(`T*("`@
M("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60[
M('1E>'0M86QI9VXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@+2`@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB
M;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!L969T)SX@
M("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`Q+C%P="<^("`@
M(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@
M<V]L:60[('1E>'0M86QI9VXZ(&QE9G0G/B`@(`T*("`@("`@("`@("8C,38P
M.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60[('1E>'0M86QI9VXZ
M(')I9VAT)SX@("`@#0H@("`@("`@("`@+2`@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K
M(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!L969T)SX@("`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`Q+C%P="<^("`@(`T*("`@("`@("`@
M("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60[('1E>'0M
M86QI9VXZ(&QE9G0G/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O
M;3H@0FQA8VL@,2XQ<'0@<V]L:60[('1E>'0M86QI9VXZ(')I9VAT)SX@("`@
M#0H@("`@("`@("`@-2PP,#`L,#`P("`@("`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@
M,2XQ<'0@<V]L:60[('1E>'0M86QI9VXZ(&QE9G0G/B`@(`T*("`@("`@("`@
M("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@/"]T<CX@("`-
M"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B
M86-K9W)O=6YD+6-O;&]R.B!R9V(H,C`T+#(S."PR-34I)SX@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!P861D:6YG+6)O
M='1O;3H@,BXW-7!T)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T
M=&]M.B`R+C<U<'0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T
M=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T)SX@
M("`@(`T*("`@("`@("`@("0@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C<U<'0@
M9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^(`T*("`@("`@("`@(#$Y+#DY
M.2PQ-CD@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[('1E>'0M
M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O
M='1O;3H@,BXW-7!T)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@;&5F="<^
M("`@("`-"B`@("`@("`@("`D("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T
M(&1O=6)L93L@=&5X="UA;&EG;CH@<FEG:'0G/B`-"B`@("`@("`@("`V.3D@
M("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[('1E>'0M86QI
M9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O
M;3H@,BXW-7!T)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O
M;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@;&5F="<^("`@
M("`-"B`@("`@("`@("`D("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O
M=6)L93L@=&5X="UA;&EG;CH@<FEG:'0G/B`-"B`@("`@("`@("`H,C8X("`@
M("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG
M;CH@;&5F="<^("`@("`-"B`@("`@("`@("`I("`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#(N
M-S5P="<^("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L
M86-K(#(N-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@
M("`@("`@("`@)"`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[
M('1E>'0M86QI9VXZ(')I9VAT)SX@#0H@("`@("`@("`@,3DL.3DY+#8P,"`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@
M;&5F="<^("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@/"]T86)L93X\8G(O/CQP('-T
M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68[(&UA<F=I;CH@,#L@=&5X="UI;F1E;G0Z(#`N-6EN)SX@("`@#0H@("`@
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M+"!N970@;V8@<F5L871E9"!I;F-O;64@=&%X97,N("`@(`T*("`@(#PO<#X\
M8G(O/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A
M8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?
M8F$U,3<Q,3-?,&0R-U\T,S8Q7V$W8F%?,3!A-C-A,S@U-#)C#0I#;VYT96YT
M+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+V)A-3$W,3$S7S!D,C=?-#,V,5]A-V)A
M7S$P838S83,X-30R8R]7;W)K<VAE971S+U-H965T,#DN:'1M;`T*0V]N=&5N
M="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N
M="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M
M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M
M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C
M<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@
M1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^
M#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$
M,$5-13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L
M<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY.;W1E(#0@+2!&86ER(%9A
M;'5E($UE87-U<F5M96YT<SQB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XY($UO;G1H<R!%;F1E9#PO=&@^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y397`N(#,P+"`R,#$T/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#X\<W1R;VYG/D9A:7(@5F%L=64@1&ES8VQO<W5R97,@6T%B
M<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^1F%I<B!686QU92!$:7-C;&]S=7)E<R!;5&5X="!";&]C:UT\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\=&%B;&4@8V5L;'-P86-I
M;F<],T0P(&-E;&QP861D:6YG/3-$,"!S='EL93TS1"=W:61T:#H@,3`P)3L@
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@8F]R
M9&5R+6-O;&QA<'-E.B!C;VQL87!S92<^(`T*("`@("`@/'1R('-T>6QE/3-$
M)W9E<G1I8V%L+6%L:6=N.B!T;W`G/B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=W:61T:#H@-B4G/B`@#0H@("`@("`@("`@/&(^-"X\+V(^("`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z
M(#DT)2<^("`@#0H@("`@("`@("`@/&(^1F%I<B!686QU92!-96%S=7)E;65N
M=',\+V(^("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@
M#0H@("`@/"]T86)L93X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UI
M;F1E;G0Z(#`N-6EN)SX@("`@#0H@("`@("!&86ER('9A;'5E(&ES(&%N(&5X
M:70@<')I8V4L(')E<')E<V5N=&EN9R!T:&4@86UO=6YT('1H870@=V]U;&0@
M8F4@<F5C96EV960@9G)O;2!T:&4@<V%L92!O9B!A;B!A<W-E="!O<B!P86ED
M('1O('1R86YS9F5R(&$@;&EA8FEL:71Y(&EN(&%N(&]R9&5R;'D@=')A;G-A
M8W1I;VX@8F5T=V5E;B!M87)K970@<&%R=&EC:7!A;G1S(&)A<V5D(&]N(&%S
M<W5M<'1I;VYS('1H870@;6%R:V5T('!A<G1I8VEP86YT<R!W;W5L9"!U<V4@
M:6X@<')I8VEN9R!A;B!A<W-E="!O<B!L:6%B:6QI='DN($%S(&$@8F%S:7,@
M9F]R(&-L87-S:69Y:6YG('1H92!F86ER('9A;'5E(&UE87-U<F5M96YT<RP@
M82!T:')E92UT:65R(&9A:7(@=F%L=64@:&EE<F%R8VAY+"!W:&EC:"!C;&%S
M<VEF:65S('1H92!F86ER('9A;'5E(&UE87-U<F5M96YT<R!B87-E9"!O;B!T
M:&4@:6YP=71S('5S960@:6X@;65A<W5R:6YG(&9A:7(@=F%L=64L('=A<R!E
M<W1A8FQI<VAE9"!A<R!F;VQL;W=S.B`H3&5V96P@,2D@;V)S97)V86)L92!I
M;G!U=',@<W5C:"!A<R!Q=6]T960@<')I8V5S(&EN(&%C=&EV92!M87)K971S
M(&9O<B!I9&5N=&EC86P@87-S971S(&]R(&QI86)I;&ET:65S.R`H3&5V96P@
M,BD@<VEG;FEF:6-A;G0@;W1H97(@;V)S97)V86)L92!I;G!U=',@=&AA="!A
M<F4@;V)S97)V86)L92!E:71H97(@9&ER96-T;'D@;W(@:6YD:7)E8W1L>3L@
M86YD("A,979E;"`S*2!S:6=N:69I8V%N="!U;F]B<V5R=F%B;&4@:6YP=71S
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M92!I;G!U=',@=VAE;B!D971E<FUI;FEN9R`-"B`@("`@(&9A:7(@=F%L=64N
M($]N(&$@<F5C=7)R:6YG(&)A<VES+"!T:&4@0V]M<&%N>2!R96-O<F1S(&ET
M<R!M87)K971A8FQE('-E8W5R:71I97,@870@9F%I<B!V86QU92X@#0H@("`@
M/"]P/CQB<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6EN9&5N=#H@,"XU
M:6XG/B`@("`@#0H@("`@("!4:&4@0V]M<&%N>28C.#(Q-SMS(&EN=F5S=&UE
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M;G9E<W1M96YT<R!C;&%S<VEF:65D('=I=&AI;B!,979E;"`R(&]F('1H92!F
M86ER('9A;'5E(&AI97)A<F-H>2!A<F4@=F%L=65D(&)A<V5D(&]N(&UA=')I
M>"!P<FEC:6YG(&-O;7!I;&5D(&)Y('1H:7)D('!A<G1Y('!R:6-I;F<@=F5N
M9&]R<RP@=7-I;F<@;V)S97)V86)L92!M87)K970@:6YP=71S('-U8V@@87,@
M:6YT97)E<W0@<F%T97,L('EI96QD(&-U<G9E<RP@86YD(&-R961I="!R:7-K
M+B`@(`T*("`@(#PO<#X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UI
M;F1E;G0Z(#`N-6EN)SX@("`@(`T*("`@("`@5&AE(&9A:7(@=F%L=64@:&EE
M<F%R8VAY(&]F('1H92!#;VUP86YY)B,X,C$W.W,@8V%S:"!E<75I=F%L96YT
M<R!A;F0@;6%R:V5T86)L92!S96-U<FET:65S(&%T(&9A:7(@=F%L=64@:7,@
M87,@9F]L;&]W<SH@("`@(`T*("`@(#PO<#X\8G(O/CQT86)L92!C96QL<&%D
M9&EN9STS1#`@8V5L;'-P86-I;F<],T0P('-T>6QE/3-$)V)O<F1E<BUC;VQL
M87!S93H@8V]L;&%P<V4[('=I9'1H.B`Q,#`E.R!F;VYT.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@("`@(`T*("`@("`@/'1R('-T
M>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VTG/B`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#L@<&%D9&EN9RUB;W1T;VTZ
M(#$N,7!T)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O;&0[
M('!A9&1I;F<M8F]T=&]M.B`Q+C%P="<^("`@#0H@("`@("`@("`@)B,Q-C`[
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!C;VQS<&%N/3-$
M,R!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@=&5X="UA;&EG;CH@8V5N
M=&5R.R!P861D:6YG+6)O='1O;3H@,2XQ<'0G/B`@("`@#0H@("`@("`@("`@
M)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@<&%D9&EN9RUB;W1T;VTZ(#$N,7!T
M)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D(&-O;'-P86X],T0Q,2!S='EL93TS1"=F;VYT+7=E:6=H
M=#H@8F]L9#L@=&5X="UA;&EG;CH@8V5N=&5R.R!B;W)D97(M8F]T=&]M.B!"
M;&%C:R`Q+C%P="!S;VQI9"<^("`-"B`@("`@("`@("`\<"!S='EL93TS1"=M
M87)G:6XM=&]P.B`P.R!M87)G:6XM8F]T=&]M.B`P)SX@("`@(`T*("`@("`@
M("`@("`@1F%I<B!686QU92!-96%S=7)E;65N=',@870@4F5P;W)T:6YG("`@
M(`T*("`@("`@("`@(#PO<#X@#0H@("`@("`@("`@/'`@<W1Y;&4],T0G;6%R
M9VEN+71O<#H@,#L@;6%R9VEN+6)O='1O;3H@,"<^("`@("`-"B`@("`@("`@
M("`@($1A=&4@57-I;F<@("`-"B`@("`@("`@("`\+W`^(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`\+W1R/B`@(`T*("`@("`@/'1R('-T>6QE/3-$
M)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VTG/B`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@;&5F=#L@<&%D9&EN9RUB;W1T;VTZ(#$N,7!T
M)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O;&0[('!A9&1I
M;F<M8F]T=&]M.B`Q+C%P="<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!C;VQS<&%N/3-$,R!N;W=R
M87`],T1N;W=R87`@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O;&0[('1E>'0M
M86QI9VXZ(&-E;G1E<CL@8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L
M:60G/B`@#0H@("`@("`@("`@4V5P=&5M8F5R(#,P+"`R,#$T("`@(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=F;VYT+7=E
M:6=H=#H@8F]L9#L@<&%D9&EN9RUB;W1T;VTZ(#$N,7!T)SX@("`-"B`@("`@
M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M(&-O;'-P86X],T0S(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=F;VYT+7=E
M:6=H=#H@8F]L9#L@=&5X="UA;&EG;CH@8V5N=&5R.R!B;W)D97(M8F]T=&]M
M.B!";&%C:R`Q+C%P="!S;VQI9"<^("`-"B`@("`@("`@("`\<"!S='EL93TS
M1"=M87)G:6XM=&]P.B`P.R!M87)G:6XM8F]T=&]M.B`P)SX@("`@(`T*("`@
M("`@("`@("`@475O=&5D(%!R:6-E<R!I;B`@("`-"B`@("`@("`@("`\+W`^
M(`T*("`@("`@("`@(#QP('-T>6QE/3-$)VUA<F=I;BUT;W`Z(#`[(&UA<F=I
M;BUB;W1T;VTZ(#`G/B`@("`@#0H@("`@("`@("`@("!!8W1I=F4@36%R:V5T
M<R`@#0H@("`@("`@("`@/"]P/B`-"B`@("`@("`@("`\<"!S='EL93TS1"=M
M87)G:6XM=&]P.B`P.R!M87)G:6XM8F]T=&]M.B`P)SX@("`@(`T*("`@("`@
M("`@("`@9F]R($ED96YT:6-A;"!!<W-E=',@("`-"B`@("`@("`@("`\+W`^
M(`T*("`@("`@("`@(#QP('-T>6QE/3-$)VUA<F=I;BUT;W`Z(#`[(&UA<F=I
M;BUB;W1T;VTZ(#`G/B`@("`@#0H@("`@("`@("`@("`H3&5V96P@,2D@(`T*
M("`@("`@("`@(#PO<#X@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!P861D:6YG+6)O='1O
M;3H@,2XQ<'0G/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@8V]L<W!A;CTS1#,@;F]W<F%P/3-$;F]W
M<F%P('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C
M96YT97([(&)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED)SX@(`T*
M("`@("`@("`@(#QP('-T>6QE/3-$)VUA<F=I;BUT;W`Z(#`[(&UA<F=I;BUB
M;W1T;VTZ(#`G/B`@("`@#0H@("`@("`@("`@("!3:6=N:69I8V%N="!/=&AE
M<B`@("`@#0H@("`@("`@("`@/"]P/B`-"B`@("`@("`@("`\<"!S='EL93TS
M1"=M87)G:6XM=&]P.B`P.R!M87)G:6XM8F]T=&]M.B`P)SX@("`@(`T*("`@
M("`@("`@("`@3V)S97)V86)L92!);G!U=',@("`@(`T*("`@("`@("`@(#PO
M<#X@#0H@("`@("`@("`@/'`@<W1Y;&4],T0G;6%R9VEN+71O<#H@,#L@;6%R
M9VEN+6)O='1O;3H@,"<^("`@("`-"B`@("`@("`@("`@("A,979E;"`R*2`@
M#0H@("`@("`@("`@/"]P/B`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O;&0[('!A9&1I;F<M8F]T
M=&]M.B`Q+C%P="<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9"!C;VQS<&%N/3-$,R!N;W=R87`],T1N
M;W=R87`@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O;&0[('1E>'0M86QI9VXZ
M(&-E;G1E<CL@8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60G/B`@
M#0H@("`@("`@("`@/'`@<W1Y;&4],T0G;6%R9VEN+71O<#H@,#L@;6%R9VEN
M+6)O='1O;3H@,"<^("`@("`-"B`@("`@("`@("`@(%-I9VYI9FEC86YT("`@
M(`T*("`@("`@("`@(#PO<#X@#0H@("`@("`@("`@/'`@<W1Y;&4],T0G;6%R
M9VEN+71O<#H@,#L@;6%R9VEN+6)O='1O;3H@,"<^("`@("`-"B`@("`@("`@
M("`@(%5N;V)S97)V86)L92`@("`@#0H@("`@("`@("`@/"]P/B`-"B`@("`@
M("`@("`\<"!S='EL93TS1"=M87)G:6XM=&]P.B`P.R!M87)G:6XM8F]T=&]M
M.B`P)SX@("`@(`T*("`@("`@("`@("`@26YP=71S("`@(`T*("`@("`@("`@
M(#PO<#X@#0H@("`@("`@("`@/'`@<W1Y;&4],T0G;6%R9VEN+71O<#H@,#L@
M;6%R9VEN+6)O='1O;3H@,"<^("`@("`-"B`@("`@("`@("`@("A,979E;"`S
M*2`@#0H@("`@("`@("`@/"]P/B`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@/"]T<CX@("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG
M;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B!R9V(H,C`T+#(S."PR-34I
M)SX@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@-38E.R!T97AT
M+6%L:6=N.B!L969T.R!P861D:6YG+6)O='1O;3H@,BXW-7!T)SX@("`@(`T*
M("`@("`@("`@($UO;F5Y(&UA<FME="!F=6YD<R`@("`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!P861D
M:6YG+6)O='1O;3H@,BXW-7!T)SX@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@
M,24[(&)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[('1E>'0M
M86QI9VXZ(&QE9G0G/B`-"B`@("`@("`@("`D("`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#@E.R!B;W)D97(M
M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H
M="<^("`-"B`@("`@("`@("`T.2PR.#4L,38X(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C
M:R`R+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T.R!W:61T:#H@,24G
M/B`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@<&%D9&EN9RUB;W1T;VTZ
M(#(N-S5P="<^(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!B;W)D97(M
M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T
M)SX@#0H@("`@("`@("`@)"`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W=I9'1H.B`X)3L@8F]R9&5R+6)O='1O;3H@0FQA
M8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@<FEG:'0G/B`@#0H@("`@
M("`@("`@+2`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[('1E
M>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)2<^(`T*("`@("`@("`@("8C,38P
M.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M=VED=&@Z(#$E.R!P861D:6YG+6)O='1O;3H@,BXW-7!T)SX@#0H@("`@("`@
M("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=W:61T:#H@,24[(&)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P
M="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G/B`-"B`@("`@("`@("`D("`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED
M=&@Z(#@E.R!B;W)D97(M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T
M97AT+6%L:6=N.B!R:6=H="<^("`-"B`@("`@("`@("`T.2PR.#4L,38X(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D
M97(M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!L
M969T.R!W:61T:#H@,24G/B`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@
M<&%D9&EN9RUB;W1T;VTZ(#(N-S5P="<^(`T*("`@("`@("`@("8C,38P.R`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED
M=&@Z(#$E.R!B;W)D97(M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T
M97AT+6%L:6=N.B!L969T)SX@#0H@("`@("`@("`@)"`@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`X)3L@8F]R
M9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@
M<FEG:'0G/B`@#0H@("`@("`@("`@+2`@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N
M-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)2<^(`T*
M("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M/"]T<CX@("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@
M8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B!7:&ET92<^("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@("`@("`@
M("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9#X@
M("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@
M("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^("`@("`-"B`@("`@
M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F
M(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D/B`@("`-
M"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@
M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@
M("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@("8C,38P
M.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0^("`@(`T*("`@
M("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@
M("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/B`@("`@#0H@("`@("`@("`@)B,Q
M-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9#X@("`@#0H@("`@("`@
M("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@("`@("`@("`@)B,Q
M-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=T97AT+6%L:6=N.B!R:6=H="<^("`@("`-"B`@("`@("`@("`F(S$V,#L@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@("`\='(@<W1Y
M;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO
M<CH@<F=B*#(P-"PR,S@L,C4U*2<^("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@($UA<FME=&%B
M;&4@<V5C=7)I=&EE<SH@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^
M("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/B`@("`@
M#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@("`@
M("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9#X@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@
M#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^("`@("`-"B`@
M("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D/B`@
M("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@
M("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX@("`@(`T*("`@("`@
M("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@("8C
M,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0^("`@(`T*
M("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@
M("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/B`@("`@#0H@("`@("`@("`@
M)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@("`@("`@("`@)B,Q-C`[
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\+W1R/B`@(`T*("`@("`@
M/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U
M;F0M8V]L;W(Z(%=H:71E)SX@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("!5;FET960@4W1A=&5S
M(%1R96%S=7)Y('-E8W5R:71I97,@("`@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT
M)SX@("`@(`T*("`@("`@("`@(#$T+#DY.2PV,#`@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G
M/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT
M)SX@("`@(`T*("`@("`@("`@(#$T+#DY.2PV,#`@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G
M/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT
M)SX@("`@(`T*("`@("`@("`@("T@(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@
M("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9#X@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@
M("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^("`@("`-
M"B`@("`@("`@("`M("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@
M("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@/"]T<CX@("`-
M"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B
M86-K9W)O=6YD+6-O;&]R.B!R9V(H,C`T+#(S."PR-34I)SX@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!P861D:6YG+6)O
M='1O;3H@,2XQ<'0G/B`@#0H@("`@("`@("`@0F%N:R!C97)T:69I8V%T97,@
M;V8@9&5P;W-I="`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#$N,7!T)SX@("`@#0H@("`@
M("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9#L@
M=&5X="UA;&EG;CH@;&5F="<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M
M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9#L@=&5X="UA;&EG;CH@<FEG:'0G
M/B`@("`-"B`@("`@("`@("`U+#`P,"PP,#`@("`@(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!"
M;&%C:R`Q+C%P="!S;VQI9#L@=&5X="UA;&EG;CH@;&5F="<^("`@#0H@("`@
M("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,2XQ<'0G/B`@("`-"B`@("`@
M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T
M97AT+6%L:6=N.B!L969T)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB
M;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!R:6=H="<^
M("`@(`T*("`@("`@("`@("T@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S
M;VQI9#L@=&5X="UA;&EG;CH@;&5F="<^("`@#0H@("`@("`@("`@)B,Q-C`[
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P
M861D:6YG+6)O='1O;3H@,2XQ<'0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O
M<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!L
M969T)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K
M(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!R:6=H="<^("`@(`T*("`@("`@
M("`@(#4L,#`P+#`P,"`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O
M;&ED.R!T97AT+6%L:6=N.B!L969T)SX@("`-"B`@("`@("`@("`F(S$V,#L@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A
M9&1I;F<M8F]T=&]M.B`Q+C%P="<^("`@(`T*("`@("`@("`@("8C,38P.R`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60[('1E>'0M86QI9VXZ(&QE
M9G0G/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@
M,2XQ<'0@<V]L:60[('1E>'0M86QI9VXZ(')I9VAT)SX@("`@#0H@("`@("`@
M("`@+2`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT+6%L
M:6=N.B!L969T)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@("`\='(@<W1Y;&4],T0G
M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@5VAI
M=&4G/B`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F
M=#L@<&%D9&EN9RUB;W1T;VTZ(#(N-S5P="<^("`@#0H@("`@("`@("`@5&]T
M86P@;6%R:V5T86)L92!S96-U<FET:65S("`@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R+C<U
M<'0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C
M:R`R+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@
M("`@("`@("0@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T
M97AT+6%L:6=N.B!R:6=H="<^(`T*("`@("`@("`@(#$Y+#DY.2PV,#`@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E
M<BUB;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE
M9G0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,BXW
M-7!T)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA
M8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@
M("`@("`@("`D("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@
M=&5X="UA;&EG;CH@<FEG:'0G/B`-"B`@("`@("`@("`Q-"PY.3DL-C`P(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D
M97(M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!L
M969T)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#(N
M-S5P="<^("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L
M86-K(#(N-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@
M("`@("`@("`@)"`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[
M('1E>'0M86QI9VXZ(')I9VAT)SX@#0H@("`@("`@("`@-2PP,#`L,#`P("`@
M("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG
M;CH@;&5F="<^("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M
M.B`R+C<U<'0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M
M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T)SX@("`@
M(`T*("`@("`@("`@("0@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U
M8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^(`T*("`@("`@("`@("T@(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M
M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T
M)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@/"]T<CX@("`-"B`@("`\+W1A8FQE/CQB<B\^/'1A8FQE(&-E
M;&QP861D:6YG/3-$,"!C96QL<W!A8VEN9STS1#`@<W1Y;&4],T0G8F]R9&5R
M+6-O;&QA<'-E.B!C;VQL87!S93L@=VED=&@Z(#$P,"4[(&9O;G0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`@("`-"B`@("`@(#QT
M<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M)SX@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@
M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!P861D:6YG+6)O='1O;3H@
M,2XQ<'0G/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@8V]L<W!A;CTS1#,@<W1Y;&4],T0G9F]N="UW
M96EG:'0Z(&)O;&0[('1E>'0M86QI9VXZ(&-E;G1E<CL@<&%D9&EN9RUB;W1T
M;VTZ(#$N,7!T)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G9F]N="UW96EG:'0Z
M(&)O;&0[('!A9&1I;F<M8F]T=&]M.B`Q+C%P="<^("`@#0H@("`@("`@("`@
M)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!C;VQS
M<&%N/3-$,3$@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O;&0[('1E>'0M86QI
M9VXZ(&-E;G1E<CL@8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60G
M/B`@#0H@("`@("`@("`@1F%I<B!686QU92!-96%S=7)E;65N=',@870@4F5P
M;W)T:6YG/&)R("\^("`@(`T*("`@("`@("`@($1A=&4@57-I;F<@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@("`\='(@<W1Y
M;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;2<^("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@("`@("`@("`@
M)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@<&%D9&EN9RUB;W1T;VTZ(#$N,7!T
M)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D(&-O;'-P86X],T0S(&YO=W)A<#TS1&YO=W)A<"!S='EL
M93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@=&5X="UA;&EG;CH@8V5N=&5R.R!B
M;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9"<^("`-"B`@("`@("`@
M("!$96-E;6)E<B`S,2P@,C`Q,R`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@<&%D9&EN
M9RUB;W1T;VTZ(#$N,7!T)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0S(&YO=W)A
M<#TS1&YO=W)A<"!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@=&5X="UA
M;&EG;CH@8V5N=&5R.R!B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI
M9"<^("`-"B`@("`@("`@("!1=6]T960@4')I8V5S(&EN/&)R("\^("`@(`T*
M("`@("`@("`@($%C=&EV92!-87)K971S/&)R("\^("`-"B`@("`@("`@("`F
M(S$V,#MF;W(@261E;G1I8V%L($%S<V5T<R8C,38P.SQB<B`O/B`@(`T*("`@
M("`@("`@("8C,38P.RA,979E;"`Q*2`@("`@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!P
M861D:6YG+6)O='1O;3H@,2XQ<'0G/B`@(`T*("`@("`@("`@("8C,38P.R`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@8V]L<W!A;CTS1#,@
M;F]W<F%P/3-$;F]W<F%P('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T
M97AT+6%L:6=N.B!C96YT97([(&)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T
M('-O;&ED)SX@(`T*("`@("`@("`@(%-I9VYI9FEC86YT($]T:&5R/&)R("\^
M("`@("`-"B`@("`@("`@("!/8G-E<G9A8FQE($EN<'5T<R8C,38P.SQB<B`O
M/B`@("`@#0H@("`@("`@("`@*$QE=F5L(#(I("`@("`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O
M;&0[('!A9&1I;F<M8F]T=&]M.B`Q+C%P="<^("`@#0H@("`@("`@("`@)B,Q
M-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!C;VQS<&%N
M/3-$,R!N;W=R87`],T1N;W=R87`@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O
M;&0[('1E>'0M86QI9VXZ(&-E;G1E<CL@8F]R9&5R+6)O='1O;3H@0FQA8VL@
M,2XQ<'0@<V]L:60G/B`@#0H@("`@("`@("`@/'`@<W1Y;&4],T0G;6%R9VEN
M+71O<#H@,#L@;6%R9VEN+6)O='1O;3H@,"<^("`@("`-"B`@("`@("`@("`@
M(%-I9VYI9FEC86YT("`@(`T*("`@("`@("`@(#PO<#X@#0H@("`@("`@("`@
M/'`@<W1Y;&4],T0G;6%R9VEN+71O<#H@,#L@;6%R9VEN+6)O='1O;3H@,"<^
M("`@("`-"B`@("`@("`@("`@(%5N;V)S97)V86)L92`@("`@#0H@("`@("`@
M("`@/"]P/B`-"B`@("`@("`@("`\<"!S='EL93TS1"=M87)G:6XM=&]P.B`P
M.R!M87)G:6XM8F]T=&]M.B`P)SX@("`@(`T*("`@("`@("`@("`@26YP=71S
M("`@(`T*("`@("`@("`@(#PO<#X@#0H@("`@("`@("`@/'`@<W1Y;&4],T0G
M;6%R9VEN+71O<#H@,#L@;6%R9VEN+6)O='1O;3H@,"<^("`@("`-"B`@("`@
M("`@("`@("A,979E;"`S*2`@#0H@("`@("`@("`@/"]P/B`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@/"]T<CX@("`-"B`@("`@(#QT<B!S='EL93TS
M1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B!R
M9V(H,C`T+#(S."PR-34I)SX@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W
M:61T:#H@-38E.R!T97AT+6%L:6=N.B!L969T.R!P861D:6YG+6)O='1O;3H@
M,BXW-7!T)SX@("`@(`T*("`@("`@("`@($UO;F5Y(&UA<FME="!F=6YD<R`@
M("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M=VED=&@Z(#$E.R!P861D:6YG+6)O='1O;3H@,BXW-7!T)SX@#0H@("`@("`@
M("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=W:61T:#H@,24[(&)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P
M="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G/B`-"B`@("`@("`@("`D("`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED
M=&@Z(#@E.R!B;W)D97(M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T
M97AT+6%L:6=N.B!R:6=H="<^("`-"B`@("`@("`@("`S-"PR-C8L-3`Q(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D
M97(M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!L
M969T.R!W:61T:#H@,24G/B`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@
M<&%D9&EN9RUB;W1T;VTZ(#(N-S5P="<^(`T*("`@("`@("`@("8C,38P.R`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED
M=&@Z(#$E.R!B;W)D97(M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T
M97AT+6%L:6=N.B!L969T)SX@#0H@("`@("`@("`@)"`@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`X)3L@8F]R
M9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@
M<FEG:'0G/B`@#0H@("`@("`@("`@+2`@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N
M-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)2<^(`T*
M("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!P861D:6YG+6)O='1O;3H@,BXW
M-7!T)SX@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[(&)O<F1E<BUB;W1T
M;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G/B`-
M"B`@("`@("`@("`D("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=VED=&@Z(#@E.R!B;W)D97(M8F]T=&]M.B!";&%C:R`R
M+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^("`-"B`@("`@("`@
M("`S-"PR-C8L-3`Q(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE
M.R!T97AT+6%L:6=N.B!L969T.R!W:61T:#H@,24G/B`-"B`@("`@("`@("`F
M(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W=I9'1H.B`Q)3L@<&%D9&EN9RUB;W1T;VTZ(#(N-S5P="<^(`T*("`@
M("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!B;W)D97(M8F]T=&]M.B!";&%C:R`R
M+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T)SX@#0H@("`@("`@("`@
M)"`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)W=I9'1H.B`X)3L@8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L
M93L@=&5X="UA;&EG;CH@<FEG:'0G/B`@#0H@("`@("`@("`@+2`@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB
M;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[
M('=I9'1H.B`Q)2<^(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@/"]T<CX@("`-"B`@("`\+W1A8FQE/CQB<B\^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@
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M('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\
M:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O
M;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y
M<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@
M4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O
M9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14U%/@T*
M("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$
M,2!R;W=S<&%N/3-$,CX\<W1R;VYG/DYO=&4@-2`M($5Q=6ET>2!);F-E;G1I
M=F4@4&QA;CQB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:"!C;VQS<&%N/3-$,3XY($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y397`N
M(#,P+"`R,#$T/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#X\<W1R;VYG/D1I<V-L;W-U<F4@;V8@0V]M<&5N<V%T:6]N(%)E;&%T960@
M0V]S=',L(%-H87)E+6)A<V5D(%!A>6UE;G1S(%M!8G-T<F%C=%T\+W-T<F]N
M9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1I<V-L;W-U
M<F4@;V8@0V]M<&5N<V%T:6]N(%)E;&%T960@0V]S=',L(%-H87)E+6)A<V5D
M(%!A>6UE;G1S(%M497AT($)L;V-K73PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQT86)L92!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<]
M,T0P('-T>6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!B;W)D97(M8V]L;&%P<V4Z(&-O;&QA
M<'-E)SX@("`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N
M.B!T;W`G/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@-B4G
M/B`@#0H@("`@("`@("`@/&(^-2X\+V(^("`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#DT)2<^("`@#0H@("`@
M("`@("`@/&(^17%U:71Y($EN8V5N=&EV92!0;&%N/"]B/B`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@/"]T<CX@("`-"B`@("`\+W1A8FQE/CQB<B\^
M/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6EN9&5N=#H@,"XU:6XG/B`@("`-
M"B`@("`@(%1H92!#;VUP86YY(&5S=&EM871E<R!T:&4@9F%I<B!V86QU92!O
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M960@4V5P=&5M8F5R(#,P+"`R,#$T(&%N9"`R,#$S+"!R97-P96-T:79E;'DL
M('=A<R!E<W1I;6%T960@;VX@=&AE(&=R86YT(&1A=&4@=7-I;F<@=&AE($)L
M86-K+5-C:&]L97,@;W!T:6]N+7!R:6-I;F<@;6]D96P@=VET:"!T:&4@9F]L
M;&]W:6YG(&%S<W5M<'1I;VYS.B`@(`T*("`@(#PO<#X\8G(O/CQT86)L92!B
M;W)D97(],T0P(&-E;&QP861D:6YG/3-$,"!C96QL<W!A8VEN9STS1#`@<W1Y
M;&4],T0G=VED=&@Z(#$P,"4[(&)O<F1E<BUC;VQL87!S93H@8V]L;&%P<V4[
M(&9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`-
M"B`@("`@(#QT<CX@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G9F]N="UW96EG
M:'0Z(&)O;&0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9"!C;VQS<&%N/3-$-R!S='EL93TS1"=T
M97AT+6%L:6=N.B!C96YT97(G/B`@(`T*("`@("`@("`@(#QP('-T>6QE/3-$
M)VUA<F=I;BUT;W`Z(#`[(&UA<F=I;BUB;W1T;VTZ(#`G/B`@("`@#0H@("`@
M("`@("`@("`\8CY4:')E92!-;VYT:',@16YD960\+V(^("`@("`-"B`@("`@
M("`@("`\+W`^(`T*("`@("`@("`@(#QP('-T>6QE/3-$)VUA<F=I;BUT;W`Z
M(#`[(&UA<F=I;BUB;W1T;VTZ(#`G/B`@("`@#0H@("`@("`@("`@("`\8CY3
M97!T96UB97(@,S`L/"]B/B`@("`@#0H@("`@("`@("`@/"]P/B`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@/"]T<CX@("`-"B`@("`@(#QT<CX@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#$N,7!T)SX@
M("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!C;VQS<&%N/3-$,R!S='EL93TS1"=T97AT+6%L:6=N.B!C
M96YT97([(&)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED)SX@(`T*
M("`@("`@("`@(#QB/C(P,30\+V(^("`@(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@=&5X
M="UA;&EG;CH@8V5N=&5R.R!P861D:6YG+6)O='1O;3H@,2XQ<'0G/B`@(`T*
M("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@8V]L<W!A;CTS1#,@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R
M.R!B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9"<^("`-"B`@("`@
M("`@("`\8CXR,#$S/"]B/B`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@/"]T<CX@("`-"B`@("`@(#QT<B!S='EL93TS1"=B86-K9W)O=6YD+6-O
M;&]R.B!R9V(H,C`T+#(S."PR-34I)SX@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G=VED=&@Z(#<Q)2<^("`@#0H@("`@("`@("`@4FES:R!F<F5E(&EN
M=&5R97-T(')A=&4@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W=I9'1H.B`S)3L@=&5X="UA;&EG;CH@8V5N=&5R)SX@
M(`T*("`@("`@("`@(#$N,S`E(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=W:61T:#H@-R4[('1E>'0M86QI9VXZ(&-E;G1E
M<B<^("`-"B`@("`@("`@("`M("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R.R!W:61T:#H@
M,R4G/B`@#0H@("`@("`@("`@,2XS.24@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!W:61T
M:#H@,R4G/B`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`S)2<^("`-"B`@("`@
M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W=I9'1H.B`W)3L@=&5X="UA;&EG;CH@8V5N=&5R)SX@(`T*
M("`@("`@("`@("T@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([('=I9'1H.B`S)2<^("`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@/"]T<CX@("`-"B`@("`@(#QT
M<B!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B!7:&ET92<^("`@(`T*("`@
M("`@("`\=&0^("`@(`T*("`@("`@("`@($5X<&5C=&5D('9O;&%T:6QI='D@
M("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9#X@("`@#0H@
M("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97(G/B`-"B`@("`@("`@
M("`U,RXR."4@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=T97AT+6%L:6=N.B!C96YT97(G/B`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0^("`@(`T*("`@("`@("`@
M("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R)SX@#0H@("`@("`@("`@+2`@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(&-E;G1E<B<^(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\
M+W1R/B`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!T
M;W`[(&)A8VMG<F]U;F0M8V]L;W(Z(')G8B@R,#0L,C,X+#(U-2DG/B`-"B`@
M("`@("`@/'1D/B`@("`-"B`@("`@("`@("!%>'!E8W1E9"!L:79E<R`H>65A
M<G,I("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D/B`@("`-
M"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^(`T*("`@("`@
M("`@(#0@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=T97AT+6%L:6=N.B!C96YT97(G/B`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/B`@
M("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9#X@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C
M96YT97(G/B`-"B`@("`@("`@("`M("`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R)SX@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@("`\='(@
M<W1Y;&4],T0G8F%C:V=R;W5N9"UC;VQO<CH@5VAI=&4G/B`@("`-"B`@("`@
M("`@/'1D/B`@("`-"B`@("`@("`@("!%>'!E8W1E9"!D:79I9&5N9"!Y:65L
M9"`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0^("`@(`T*
M("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R)SX@#0H@("`@("`@
M("`@,"XP,"4@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9#X@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9#X@("`@#0H@("`@("`@("`@
M)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=T97AT+6%L:6=N.B!C96YT97(G/B`-"B`@("`@("`@("`M("`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@8V5N=&5R)SX@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO
M='(^("`@#0H@("`@/"]T86)L93X\8G(O/CQT86)L92!B;W)D97(],T0P(&-E
M;&QP861D:6YG/3-$,"!C96QL<W!A8VEN9STS1#`@<W1Y;&4],T0G=VED=&@Z
M(#$P,"4[(&)O<F1E<BUC;VQL87!S93H@8V]L;&%P<V4[(&9O;G0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`@("`@#0H@("`@("`\
M='(^("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD
M)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@8V]L<W!A;CTS1#<^(`T*("`@("`@("`@(#QP('-T
M>6QE/3-$)VUA<F=I;BUT;W`Z(#`[(&UA<F=I;BUB;W1T;VTZ(#`[('1E>'0M
M86QI9VXZ(&-E;G1E<B<^("`@("`-"B`@("`@("`@("`@(#QB/DYI;F4@36]N
M=&AS($5N9&5D/"]B/B`@("`-"B`@("`@("`@("`\+W`^(`T*("`@("`@("`@
M(#QP('-T>6QE/3-$)VUA<F=I;BUT;W`Z(#`[(&UA<F=I;BUB;W1T;VTZ(#`[
M('1E>'0M86QI9VXZ(&-E;G1E<B<^("`@("`-"B`@("`@("`@("`@(#QB/E-E
M<'1E;6)E<B`S,"P\+V(^("`@("`-"B`@("`@("`@("`\+W`^(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`\+W1R/B`@(`T*("`@("`@/'1R/B`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,2XQ<'0G/B`@
M("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E
M;G1E<CL@8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60G/B`@#0H@
M("`@("`@("`@/&(^,C`Q-#PO8CX@("`@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT
M+6%L:6=N.B!C96YT97([('!A9&1I;F<M8F]T=&]M.B`Q+C%P="<^("`@#0H@
M("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!C;VQS<&%N/3-$,R!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([
M(&)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED)SX@(`T*("`@("`@
M("`@(#QB/C(P,3,\+V(^("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`\+W1R/B`@(`T*("`@("`@/'1R('-T>6QE/3-$)V)A8VMG<F]U;F0M8V]L
M;W(Z(')G8B@R,#0L,C,X+#(U-2DG/B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=W:61T:#H@-S$E)SX@("`-"B`@("`@("`@("!2:7-K(&9R964@:6YT
M97)E<W0@<F%T92`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=VED=&@Z(#,E.R!T97AT+6%L:6=N.B!C96YT97(G/B`@
M#0H@("`@("`@("`@,2XQ-B4@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W=I9'1H.B`W)3L@=&5X="UA;&EG;CH@8V5N=&5R
M)SX@(`T*("`@("`@("`@("T@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([('=I9'1H.B`S
M)2<^("`-"B`@("`@("`@("`Q+C,Y)2`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0[('=I9'1H
M.B`S)2<^(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#,E.R!T97AT+6%L:6=N
M.B!C96YT97(G/B`@#0H@("`@("`@("`@,"XV,24@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`W)3L@=&5X="UA
M;&EG;CH@8V5N=&5R)SX@(`T*("`@("`@("`@("T@(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT
M97([('=I9'1H.B`S)2<^("`-"B`@("`@("`@("`P+C<P)2`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@/"]T<CX@("`-"B`@("`@(#QT<B!S='EL93TS
M1"=B86-K9W)O=6YD+6-O;&]R.B!7:&ET92<^("`@(`T*("`@("`@("`\=&0^
M("`@(`T*("`@("`@("`@($5X<&5C=&5D('9O;&%T:6QI='D@("`@(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9#X@("`@#0H@("`@("`@("`@
M)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=T97AT+6%L:6=N.B!C96YT97(G/B`-"B`@("`@("`@("`U,RXR."4@
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T
M97AT+6%L:6=N.B!C96YT97(G/B`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0^("`@(`T*("`@("`@("`@("8C,38P.R`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@8V5N=&5R)SX@#0H@("`@("`@("`@-3<N-C`E("`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@8V5N=&5R)SX@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^
M("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ('1O<#L@
M8F%C:V=R;W5N9"UC;VQO<CH@<F=B*#(P-"PR,S@L,C4U*2<^(`T*("`@("`@
M("`\=&0^("`@(`T*("`@("`@("`@($5X<&5C=&5D(&QI=F5S("AY96%R<RD@
M("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0^("`@(`T*("`@
M("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R)SX@#0H@("`@("`@("`@
M-"`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)W1E>'0M86QI9VXZ(&-E;G1E<B<^(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^("`@("`-
M"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E
M<B<^(`T*("`@("`@("`@(#0@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97(G/B`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@/"]T<CX@("`-"B`@("`@(#QT<B!S='EL
M93TS1"=B86-K9W)O=6YD+6-O;&]R.B!7:&ET92<^("`@(`T*("`@("`@("`\
M=&0^("`@(`T*("`@("`@("`@($5X<&5C=&5D(&1I=FED96YD('EI96QD("`@
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9#X@("`@#0H@("`@
M("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97(G/B`-"B`@("`@("`@("`P
M+C`P)2`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G=&5X="UA;&EG;CH@8V5N=&5R)SX@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D/B`@("`-"B`@("`@("`@("`F(S$V
M,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)W1E>'0M86QI9VXZ(&-E;G1E<B<^(`T*("`@("`@("`@(#`N,#`E(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L
M:6=N.B!C96YT97(G/B`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@/"]T
M<CX@("`-"B`@("`\+W1A8FQE/CQB<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T
M97AT+6EN9&5N=#H@,"XU:6XG/B`@("`-"B`@("`@(%1H92!#;VUP86YY(')E
M8V]R9&5D("0S.3`L-3<X(&%N9"`D,S8X+#8P,R!O9B!S:&%R92UB87-E9"!C
M;VUP96YS871I;VX@97AP96YS92!F;W(@=&AE('1H<F5E+6UO;G1H('!E<FEO
M9',@96YD960@4V5P=&5M8F5R(#,P+"`R,#$T(&%N9"`R,#$S+"!R97-P96-T
M:79E;'DL(&9O<B!E<75I='D@8V]M<&5N<V%T:6]N(&%W87)D<RX@5&AE($-O
M;7!A;GD@<F5C;W)D960@)#$L,3DV+#,V,2!A;F0@)#$L,34V+#DR.2!O9B!S
M:&%R92UB87-E9"!C;VUP96YS871I;VX@97AP96YS92!F;W(@=&AE(&YI;F4M
M;6]N=&@@<&5R:6]D<R!E;F1E9"!397!T96UB97(@,S`L(#(P,30@86YD(#(P
M,3,L(')E<W!E8W1I=F5L>2P@9F]R(&5Q=6ET>2!C;VUP96YS871I;VX@87=A
M<F1S+B!4:&4@0V]M<&%N>2!P<F5S96YT<R!T:&4@97AP96YS97,@<F5L871E
M9"!T;R!S=&]C:RUB87-E9"!C;VUP96YS871I;VX@87=A<F1S(&EN('1H92!S
M86UE(&5X<&5N<V4@;&EN92!I=&5M<R!A<R!C87-H(&-O;7!E;G-A=&EO;B!P
M86ED('1O('1H92!R97-P96-T:79E(')E8VEP:65N=',N("`@(`T*("`@(#PO
M<#X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UI;F1E;G0Z(#`N-6EN
M)SX@("`@(`T*("`@("`@5&AE<F4@=V5R92`W+#`P,"!A;F0@,3,Y+#(T,"!S
M=&]C:R!O<'1I;VYS(&=R86YT960@=6YD97(@=&AE(%!L86X@9'5R:6YG('1H
M92!T:')E92!A;F0@;FEN92UM;VYT:"!P97)I;V1S(&5N9&5D(%-E<'1E;6)E
M<B`S,"P@,C`Q-"P@<F5S<&5C=&EV96QY+B!4:&5R92!W97)E(&YO(%)E<W1R
M:6-T960@4W1O8VL@07=A<F1S("@F(S@R,C`[4E-!<R8C.#(R,3LI(&]R(%)E
M<W1R:6-T960@4W1O8VL@56YI=',@*"8C.#(R,#M24U5S)B,X,C(Q.RD@9W)A
M;G1E9"!U;F1E<B!T:&4@4&QA;B!D=7)I;F<@=&AE('1H<F5E+6UO;G1H('!E
M<FEO9"!E;F1E9"!397!T96UB97(@,S`L(#(P,30N(%1H97)E('=E<F4@.2PS
M-C4@4E-5<R!G<F%N=&5D('1O(&UE;6)E<G,@;V8@=&AE($-O;7!A;GDF(S@R
M,3<[<R!";V%R9"!O9B!$:7)E8W1O<G,@=6YD97(@=&AE(%!L86X@9'5R:6YG
M('1H92!N:6YE+6UO;G1H('!E<FEO9"!E;F1E9"!397!T96UB97(@,S`L(#(P
M,30N(%1H97)E('=E<F4@,S`L-S`P(%)307,@9W)A;G1E9"!T;R!#;VUP86YY
M(&5M<&QO>65E<R!U;F1E<B!T:&4@4&QA;B!D=7)I;F<@=&AE(&YI;F4M;6]N
M=&@@<&5R:6]D(&5N9&5D(%-E<'1E;6)E<B`S,"P@,C`Q-"X@5&AE('-T;V-K
M(&]P=&EO;G,L(%)307,@86YD(%)357,@9W)A;G1E9"!T;R!E;7!L;WEE97,@
M86YD(&1I<F5C=&]R<R!B96-O;64@97AE<F-I<V%B;&4@;W(@=F5S="!R871A
M8FQY(&]V97(@9F]U<B!Y96%R<R!F<F]M('1H92!D871E(&]F(&=R86YT+B`@
M("`@#0H@("`@/"]P/CQB<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6EN
M9&5N=#H@,"XU:6XG/B`@("`@#0H@("`@("!!('!O<G1I;VX@;V8@=&AE('-T
M;V-K(&]P=&EO;G,@9W)A;G1E9"!D=7)I;F<@=&AE(&YI;F4M;6]N=&@@<&5R
M:6]D(&5N9&5D(%-E<'1E;6)E<B`S,"P@,C`Q-"!C;VYT86EN960@8V5R=&%I
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M97)F;W)M86YC92!G;V%L<RX@("`-"B`@("`\+W`^/&)R+SX\<"!S='EL93TS
M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M
M87)G:6XZ(#`[('1E>'0M:6YD96YT.B`P+C5I;B<^("`@("`-"B`@("`@($%S
M(&]F(%-E<'1E;6)E<B`S,"P@,C`Q-"P@=&AE<F4@=V%S(&%P<')O>&EM871E
M;'D@)#0N,B!M:6QL:6]N(&]F('1O=&%L('5N<F5C;V=N:7IE9"!C;VUP96YS
M871I;VX@8V]S="!R96QA=&5D('1O(&YO;BUV97-T960@<W1O8VL@;W!T:6]N
M<RP@<W1O8VL@87!P<F5C:6%T:6]N(')I9VAT<R`H)B,X,C(P.U-!4G,F(S@R
M,C$[*2P@4E-!<R!A;F0@4E-5<R!G<F%N=&5D('5N9&5R('1H92!#;VUP86YY
M)B,X,C$W.W,@:6YC96YT:79E(%!L86YS+B!4:&ES(&-O<W0@:7,@97AP96-T
M960@=&\@8F4@<F5C;V=N:7IE9"!O=F5R(&$@=V5I9VAT960M879E<F%G92!P
M97)I;V0@;V8@,RXP('EE87)S+B`@("`@#0H@("`@/"]P/CQB<B\^/'`@<W1Y
M;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9CL@;6%R9VEN.B`P.R!T97AT+6EN9&5N=#H@,"XU:6XG/B`@("`@#0H@("`@
M("!4:&4@=&]T86P@:6YT<FEN<VEC('9A;'5E(&]F('-T;V-K(&]P=&EO;G,@
M86YD(%-!4G,@97AE<F-I<V5D(&1U<FEN9R!T:&4@;FEN92UM;VYT:"!P97)I
M;V1S(&5N9&5D(%-E<'1E;6)E<B`S,"P@,C`Q-"!A;F0@,C`Q,R!W87,@)#(U
M+#0W,RPP.#D@86YD("0T+#`Y-2PX,S,L(')E<W!E8W1I=F5L>2X@0V%S:"!R
M96-E:79E9"!F<F]M('1H92!E>&5R8VES92!O9B!S=&]C:R!O<'1I;VYS(&1U
M<FEN9R!T:&4@=&AR964@86YD(&YI;F4M;6]N=&@@<&5R:6]D<R!E;F1E9"!3
M97!T96UB97(@,S`L(#(P,30@86YD(#(P,3,@=V5R92`D,3<L-3$S(&%N9"`D
M,2PS-SDL,CDT+"!A;F0@)#$L.#`T+#<W,R!A;F0@)#(L.3,R+#8T.2P@<F5S
M<&5C=&EV96QY+B!$=7)I;F<@=&AE('-E8V]N9"!Q=6%R=&5R(&]F(#(P,30L
M('1H92!#;VUP86YY(&%C<75I<F5D(&%N9"!S=6)S97%U96YT;'D@<F5T:7)E
M9"`Q,S,L-S<T(&-O;6UO;B!S:&%R97,@<F5L871E9"!T;R!A;B!E;7!L;WEE
M92!305)S(&5X97)C:7-E+"!T;R!M965T(&UI;FEM=6T@<W1A='5T;W)Y('1A
M>"!W:71H:&]L9&EN9R!R97%U:7)E;65N=',N("`-"B`@("`\+W`^/&)R+SX\
M<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[('1E>'0M
M:6YD96YT.B`P+C5I;B<^(`T*("`@("`@5&AE<F4@=V5R92`Y,S8L,#DW(&]P
M=&EO;G,@86YD(%-!4G,@;W5T<W1A;F1I;F<@=6YD97(@=&AE($-O;7!A;GDF
M(S@R,3<[<R!I;F-E;G1I=F4@4&QA;G,@87,@;V8@4V5P=&5M8F5R(#,P+"`R
M,#$T('=I=&@@82!W96EG:'1E9"UA=F5R86=E(&5X97)C:7-E('!R:6-E(&]F
M("0Q,RXU-"!P97(@<VAA<F4L(&%N(&%G9W)E9V%T92!I;G1R:6YS:6,@=F%L
M=64@;V8@87!P<F]X:6UA=&5L>2`D,C$N."!M:6QL:6]N+"!A;F0@82!W96EG
M:'1E9"UA=F5R86=E(')E;6%I;FEN9R!C;VYT<F%C='5A;"!T97)M(&]F(#8N
M."!Y96%R<RX@3F]N92!O9B!T:&4@;W!T:6]N<R!O<B!305)S(&]U='-T86YD
M:6YG(&%T(%-E<'1E;6)E<B`S,"P@,C`Q-"!O<B`R,#$S+"!R97-P96-T:79E
M;'DL(&AA9"!C87-H+7-E='1L96UE;G0@9F5A='5R97,N("`@("`-"B`@("`\
M+W`^/&)R+SX\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M:6YD96YT.B`P+C5I
M;B<^("`@("`-"B`@("`@(%1H92!#;VUP86YY(&UA>2!S871I<V9Y('1H92!A
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M=&EM97,@8V]N=&%I;B!P97)F;W)M86YC92!C;VYD:71I;VYS+B8C,38P.R`@
M#0H@("`@/"]P/CQB<B\^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM
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M:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV
M/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T
M/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$
M4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R
M:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P
M;W)T(&ED/3-$240P14U%/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/DYO=&4@
M-B`M($5A<FYI;F=S(%!E<B!3:&%R93QB<CX\+W-T<F]N9SX\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XY($UO;G1H<R!%;F1E
M9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y397`N(#,P+"`R,#$T/&)R/CPO=&@^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D5A<FYI;F=S(%!E<B!3:&%R92!;
M06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y%87)N:6YG<R!097(@4VAA<F4@6U1E>'0@0FQO8VM=/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'1A8FQE(&-E;&QS<&%C:6YG
M/3-$,"!C96QL<&%D9&EN9STS1#`@<W1Y;&4],T0G=VED=&@Z(#$P,"4[(&9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&)O<F1E
M<BUC;VQL87!S93H@8V]L;&%P<V4G/B`@#0H@("`@("`\='(@<W1Y;&4],T0G
M=F5R=&EC86PM86QI9VXZ('1O<"<^("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W=I9'1H.B`V)2<^("`-"B`@("`@("`@("`\8CXV+CPO8CX@(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@
M.30E)SX@("`-"B`@("`@("`@("`\8CY%87)N:6YG<R!097(@4VAA<F4\+V(^
M("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@
M/"]T86)L93X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UI;F1E;G0Z
M(#`N-6EN)SX@("`@#0H@("`@("!4:&4@0V]M<&%N>2!R97!O<G1S(&5A<FYI
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M+"!U;F5X97)C:7-E9"`F(S@R,C`[:6XM=&AE+6UO;F5Y)B,X,C(Q.R!S=&]C
M:R!O<'1I;VYS(&%R92!A<W-U;65D('1O(&)E(&5X97)C:7-E9"!A="!T:&4@
M8F5G:6YN:6YG(&]F('1H92!P97)I;V0@;W(@870@:7-S=6%N8V4L(&EF(&QA
M=&5R+B!4:&4@87-S=6UE9"!P<F]C965D<R!A<F4@=&AE;B!U<V5D('1O('!U
M<F-H87-E(&-O;6UO;B!S:&%R97,@870@=&AE(&%V97)A9V4@;6%R:V5T('!R
M:6-E(&1U<FEN9R!T:&4@<&5R:6]D+B`@("`-"B`@("`\+W`^/&)R+SX\<"!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!M87)G:6XZ(#`[('1E>'0M:6YD96YT.B`P+C5I;B<^("`@("`-"B`@
M("`@($)A<VEC(&%N9"!D:6QU=&5D(&5A<FYI;F=S('!E<B!S:&%R92!F;W(@
M=&AE('1H<F5E(&%N9"!N:6YE+6UO;G1H('!E<FEO9',@96YD960@4V5P=&5M
M8F5R(#,P+"`R,#$T(&%N9"`R,#$S(&%R92!A<R!F;VQL;W=S.B8C,38P.R`@
M("`@#0H@("`@/"]P/CQB<B\^/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C96QL
M<W!A8VEN9STS1#`@<W1Y;&4],T0G8F]R9&5R+6-O;&QA<'-E.B!C;VQL87!S
M93L@=VED=&@Z(#$P,"4[(&9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68G/B`@("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC
M86PM86QI9VXZ(&)O='1O;2<^("`@#0H@("`@("`@(#QT9#X@("`@#0H@("`@
M("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@<&%D9&EN9RUB;W1T;VTZ
M(#$N,7!T)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0W('-T>6QE/3-$)V9O;G0M
M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97([(&)O<F1E<BUB;W1T
M;VTZ($)L86-K(#$N,7!T('-O;&ED)SX@#0H@("`@("`@("`@5&AR964@36]N
M=&AS($5N9&5D(%-E<'1E;6)E<B`S,"P@("`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O;&0[('!A
M9&1I;F<M8F]T=&]M.B`Q+C%P="<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!C;VQS<&%N/3-$-R!S
M='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@=&5X="UA;&EG;CH@8V5N=&5R
M.R!B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9"<^(`T*("`@("`@
M("`@($YI;F4@36]N=&AS($5N9&5D(%-E<'1E;6)E<B`S,"P@(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`\+W1R/B`@(`T*("`@("`@/'1R('-T>6QE
M/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VTG/B`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O;&0G/B`@("`@#0H@("`@("`@("`@
M)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@<&%D9&EN9RUB;W1T;VTZ(#$N,7!T
M)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)V9O;G0M=V5I9VAT
M.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97([(&)O<F1E<BUB;W1T;VTZ($)L
M86-K(#$N,7!T('-O;&ED)SX@#0H@("`@("`@("`@,C`Q-"`@("`@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V9O;G0M=V5I
M9VAT.B!B;VQD.R!P861D:6YG+6)O='1O;3H@,2XQ<'0G/B`@(`T*("`@("`@
M("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M8V]L<W!A;CTS1#,@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O;&0[('1E>'0M
M86QI9VXZ(&-E;G1E<CL@8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L
M:60G/B`-"B`@("`@("`@("`R,#$S("`@("`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O;&0[('!A
M9&1I;F<M8F]T=&]M.B`Q+C%P="<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!C;VQS<&%N/3-$,R!S
M='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@=&5X="UA;&EG;CH@8V5N=&5R
M.R!B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9"<^(`T*("`@("`@
M("`@(#(P,30@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@<&%D9&EN9RUB;W1T;VTZ
M(#$N,7!T)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)V9O;G0M
M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97([(&)O<F1E<BUB;W1T
M;VTZ($)L86-K(#$N,7!T('-O;&ED)SX@#0H@("`@("`@("`@,C`Q,R`@("`@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@("`\
M='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N
M9"UC;VQO<CH@<F=B*#(P-"PR,S@L,C4U*2<^("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G=VED=&@Z(#4V)3L@=&5X="UA;&EG;CH@;&5F="<^(`T*("`@
M("`@("`@(%-H87)E<R!U<V5D(&EN('1H92!C86QC=6QA=&EO;B!O9B!B87-I
M8R!E87)N:6YG<R!P97(@<VAA<F4@("`@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)2<^("`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@
M("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W=I9'1H.B`X)3L@=&5X="UA;&EG;CH@<FEG:'0G/B`-
M"B`@("`@("`@("`Q-"PW-3@L-S@Q(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[('1E>'0M86QI9VXZ(&QE
M9G0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24G/B`@#0H@("`@
M("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=W:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@
M#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=W:61T:#H@."4[('1E>'0M86QI9VXZ(')I9VAT
M)SX@#0H@("`@("`@("`@,3,L-C@R+#0T.2`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!T97AT+6%L:6=N
M.B!L969T)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E)SX@(`T*
M("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!T97AT+6%L:6=N.B!L969T)SX@
M("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#@E.R!T97AT+6%L:6=N.B!R
M:6=H="<^(`T*("`@("`@("`@(#$T+#8R-BPY,S,@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA
M;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)2<^
M("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F
M="<^("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`X)3L@=&5X="UA;&EG
M;CH@<FEG:'0G/B`-"B`@("`@("`@("`Q,RPU,S0L,S,T(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[('1E
M>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`\+W1R/B`@(`T*("`@("`@/'1R('-T
M>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L
M;W(Z(%=H:71E)SX@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("!%9F9E8W0@;V8@9&EL=71I=F4@
M<V5C=7)I=&EE<SH@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-
M"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX@("`@(`T*("`@
M("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@
M("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0^("`@
M(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@
M("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/B`@("`@#0H@("`@("`@
M("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@("`@("`@("`@)B,Q
M-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9#X@("`@#0H@
M("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@("`@("`@
M("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^("`@("`-"B`@("`@("`@("`F
M(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D/B`@("`-"B`@("`@
M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F
M(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("8C,38P
M.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@/"]T<CX@("`-"B`@("`@(#QT<B!S
M='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O
M;&]R.B!R9V(H,C`T+#(S."PR-34I)SX@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=T97AT+6%L:6=N.B!L969T.R!P861D:6YG+6)O='1O;3H@,2XQ<'0[
M('!A9&1I;F<M;&5F=#H@,3!P="<^("`-"B`@("`@("`@("!3=&]C:R!O<'1I
M;VYS+"!305)S+"!A;F0@4E-!<R`@("`@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`Q+C%P="<^
M("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ
M<'0@<V]L:60[('1E>'0M86QI9VXZ(&QE9G0G/B`@(`T*("`@("`@("`@("8C
M,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60[('1E>'0M86QI
M9VXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@-C<V+#`Y-"`@(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T
M=&]M.B!";&%C:R`Q+C%P="!S;VQI9#L@=&5X="UA;&EG;CH@;&5F="<^("`@
M#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,2XQ<'0G/B`@("`-
M"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O
M;&ED.R!T97AT+6%L:6=N.B!L969T)SX@("`-"B`@("`@("`@("`F(S$V,#L@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O
M<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!R
M:6=H="<^("`@(`T*("`@("`@("`@(#$L,C<V+#4Q-B`@("`@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T
M;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!L969T)SX@("`-
M"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`Q+C%P="<^("`@(`T*
M("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L
M:60[('1E>'0M86QI9VXZ(&QE9G0G/B`@(`T*("`@("`@("`@("8C,38P.R`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60[('1E>'0M86QI9VXZ(')I
M9VAT)SX@("`@#0H@("`@("`@("`@.#0R+#,P-"`@(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!"
M;&%C:R`Q+C%P="!S;VQI9#L@=&5X="UA;&EG;CH@;&5F="<^("`@#0H@("`@
M("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,2XQ<'0G/B`@("`-"B`@("`@
M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T
M97AT+6%L:6=N.B!L969T)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB
M;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!R:6=H="<^
M("`@(`T*("`@("`@("`@(#$L,3,Y+#4T-2`@("`@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L
M86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!L969T)SX@("`-"B`@("`@
M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^
M("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O
M;3L@8F%C:V=R;W5N9"UC;VQO<CH@5VAI=&4G/B`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#L@<&%D9&EN9RUB;W1T;VTZ(#(N
M-S5P="<^("`@#0H@("`@("`@("`@1&EL=71E9"!S:&%R97,@=7-E9"!I;B!T
M:&4@8V%L8W5L871I;VX@;V8@96%R;FEN9W,@<&5R('-H87)E(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O
M='1O;3H@,BXW-7!T)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@;&5F="<^
M("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N
M-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT)SX@#0H@("`@("`@("`@
M,34L-#,T+#@W-2`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@
M=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I
M;F<M8F]T=&]M.B`R+C<U<'0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D
M97(M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!L
M969T)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA
M8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@<FEG:'0G/B`-"B`@("`@
M("`@("`Q-"PY-3@L.38U(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U
M8FQE.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@("8C,38P
M.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M<&%D9&EN9RUB;W1T;VTZ(#(N-S5P="<^("`@("`-"B`@("`@("`@("`F(S$V
M,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[('1E>'0M86QI
M9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M
M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^(`T*
M("`@("`@("`@(#$U+#0V.2PR,S<@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P
M="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@
M)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=P861D:6YG+6)O='1O;3H@,BXW-7!T)SX@("`@(`T*("`@("`@("`@
M("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X
M="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB
M;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT
M)SX@#0H@("`@("`@("`@,30L-C<S+#@W.2`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@
M,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@
M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^
M("`@#0H@("`@/"]T86)L93X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X
M="UI;F1E;G0Z(#`N-6EN)SX@("`@#0H@("`@("!%<75I='D@87=A<F1S(&]F
M(#$R,BPY-C<@86YD(#$Q."PW,C4@<VAA<F5S('=E<F4@;W5T<W1A;F1I;F<@
M9F]R('1H92!T:')E92!A;F0@;FEN92UM;VYT:"!P97)I;V1S(&5N9&5D(%-E
M<'1E;6)E<B`S,"P@,C`Q-"P@<F5S<&5C=&EV96QY+"!A;F0@=V5R92!N;W0@
M:6YC;'5D960@:6X@=&AE(&-O;7!U=&%T:6]N(&]F(&1I;'5T960@96%R;FEN
M9W,@<&5R('-H87)E(&)E8V%U<V4@=&AE(&%W87)D<R8C.#(Q-SL@:6UP86-T
M(&]N(&5A<FYI;F=S('!E<B!S:&%R92!W87,@86YT:2UD:6QU=&EV92X@5&AE
M<F4@=V5R92!N;R!A;G1I+61I;'5T:79E(&5Q=6ET>2!A=V%R9',@9F]R('1H
M92!T:')E92!M;VYT:"!P97)I;V0@96YD960@4V5P=&5M8F5R(#,P+"`R,#$S
M+B!%<75I='D@87=A<F1S(&]F(#@X+#(W."!S:&%R97,@=V5R92!O=71S=&%N
M9&EN9R!F;W(@=&AE(&YI;F4M;6]N=&@@<&5R:6]D(&5N9&5D(%-E<'1E;6)E
M<B`S,"P@,C`Q,RP@86YD('=E<F4@;F]T(&EN8VQU9&5D(&EN('1H92!C;VUP
M=71A=&EO;B!O9B!D:6QU=&5D(&5A<FYI;F=S('!E<B!S:&%R92!B96-A=7-E
M('1H92!A=V%R9',F(S@R,3<[(&EM<&%C="!O;B!E87)N:6YG<R!P97(@<VAA
M<F4@=V%S(&%N=&DM9&EL=71I=F4N)B,Q-C`[)B,Q-C`[)B,Q-C`[("`-"B`@
M("`\+W`^/&)R+SX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE
M>'1087)T7V)A-3$W,3$S7S!D,C=?-#,V,5]A-V)A7S$P838S83,X-30R8PT*
M0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]B834Q-S$Q,U\P9#(W7S0S
M-C%?83=B85\Q,&$V,V$S.#4T,F,O5V]R:W-H965T<R]3:&5E=#$R+FAT;6P-
M"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-
M"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-
M"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#
M;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F
M+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W
M+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^
M/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@
M:60],T1)1#!%344^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^3F]T92`W("T@
M26YV96YT;W)I97,\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@@8V]L<W!A;CTS1#$^.2!-;VYT:',@16YD960\+W1H/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M4V5P+B`S,"P@,C`Q-#QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^/'-T<F]N9SY);G9E;G1O<GD@1&ES8VQO<W5R92!;06)S=')A8W1=
M/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y)
M;G9E;G1O<GD@1&ES8VQO<W5R92!;5&5X="!";&]C:UT\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\=&%B;&4@8V5L;'-P86-I;F<],T0P(&-E
M;&QP861D:6YG/3-$,"!S='EL93TS1"=W:61T:#H@,3`P)3L@9F]N=#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@8F]R9&5R+6-O;&QA
M<'-E.B!C;VQL87!S92<^("`@("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T
M:6-A;"UA;&EG;CH@=&]P)SX@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M=VED=&@Z(#8E)SX@(`T*("`@("`@("`@(#QB/C<N/"]B/B`@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Y-"4G
M/B`@(`T*("`@("`@("`@(#QB/DEN=F5N=&]R:65S/"]B/B`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@/"]T<CX@("`-"B`@("`\+W1A8FQE/CQB<B\^
M/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6EN9&5N=#H@,"XU:6XG/B`@("`-
M"B`@("`@($EN=F5N=&]R:65S(&-O;G-I<W0@;V8@=&AE(&9O;&QO=VEN9SH@
M("`@#0H@("`@/"]P/CQB<B\^/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C96QL
M<W!A8VEN9STS1#`@<W1Y;&4],T0G8F]R9&5R+6-O;&QA<'-E.B!C;VQL87!S
M93L@=VED=&@Z(#$P,"4[(&9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68G/B`@("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC
M86PM86QI9VXZ(&)O='1O;2<^("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=F
M;VYT+7=E:6=H=#H@8F]L9"<^("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V9O;G0M
M=V5I9VAT.B!B;VQD.R!P861D:6YG+6)O='1O;3H@,2XQ<'0G/B`@(`T*("`@
M("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@8V]L<W!A;CTS1#,@;F]W<F%P/3-$;F]W<F%P('-T>6QE/3-$)V9O;G0M
M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97([(&)O<F1E<BUB;W1T
M;VTZ($)L86-K(#$N,7!T('-O;&ED)SX@(`T*("`@("`@("`@(#QP('-T>6QE
M/3-$)VUA<F=I;BUT;W`Z(#`[(&UA<F=I;BUB;W1T;VTZ(#`G/B`@("`@#0H@
M("`@("`@("`@("!397!T96UB97(@,S`L(`T*("`@("`@("`@(#PO<#X@#0H@
M("`@("`@("`@/'`@<W1Y;&4],T0G;6%R9VEN+71O<#H@,#L@;6%R9VEN+6)O
M='1O;3H@,"<^("`@("`-"B`@("`@("`@("`@(#(P,30@(`T*("`@("`@("`@
M(#PO<#X@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!P861D:6YG+6)O='1O;3H@,2XQ<'0G
M/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@8V]L<W!A;CTS1#,@;F]W<F%P/3-$;F]W<F%P('-T>6QE
M/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97([(&)O
M<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED)SX@(`T*("`@("`@("`@
M(#QP('-T>6QE/3-$)VUA<F=I;BUT;W`Z(#`[(&UA<F=I;BUB;W1T;VTZ(#`G
M/B`@("`@#0H@("`@("`@("`@("!$96-E;6)E<B`S,2P@("`@(`T*("`@("`@
M("`@(#PO<#X@#0H@("`@("`@("`@/'`@<W1Y;&4],T0G;6%R9VEN+71O<#H@
M,#L@;6%R9VEN+6)O='1O;3H@,"<^("`@("`-"B`@("`@("`@("`@(#(P,3,@
M(`T*("`@("`@("`@(#PO<#X@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M(#PO='(^("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ
M(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@<F=B*#(P-"PR,S@L,C4U*2<^
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#<X)3L@=&5X="UA
M;&EG;CH@;&5F="<^(`T*("`@("`@("`@(%)A=R!M871E<FEA;',@("`@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H
M.B`Q)2<^("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG
M;CH@;&5F="<^("`@("`-"B`@("`@("`@("`D("`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#@E.R!T97AT+6%L
M:6=N.B!R:6=H="<^(`T*("`@("`@("`@(#8L.#0S+#0T,2`@("`@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q
M)3L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@("`F(S$V,#L@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I
M9'1H.B`Q)2<^("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA
M;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@("`D("`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#@E.R!T97AT
M+6%L:6=N.B!R:6=H="<^(`T*("`@("`@("`@(#4L.3(V+#`S,"`@("`@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H
M.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@("`F(S$V
M,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@
M("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R
M;W5N9"UC;VQO<CH@5VAI=&4G/B`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@(%=O<FLM:6XM<')O
M8V5S<R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0^("`@(`T*
M("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@
M("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/B`@("`@#0H@("`@("`@("`@
M,BPS,C4L-C8W("`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@
M("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0^("`@
M(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@
M("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/B`@("`@#0H@("`@("`@
M("`@,BPS,#@L,C,S("`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@
M("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@/"]T<CX@
M("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M
M.R!B86-K9W)O=6YD+6-O;&]R.B!R9V(H,C`T+#(S."PR-34I)SX@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!P861D:6YG
M+6)O='1O;3H@,2XQ<'0G/B`@#0H@("`@("`@("`@1FEN:7-H960@9V]O9',@
M("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=P861D:6YG+6)O='1O;3H@,2XQ<'0G/B`@("`-"B`@("`@("`@("`F(S$V
M,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N
M.B!L969T)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L
M86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!R:6=H="<^("`@(`T*("`@
M("`@("`@(#0L-#$S+#,T."`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T
M('-O;&ED.R!T97AT+6%L:6=N.B!L969T)SX@("`-"B`@("`@("`@("`F(S$V
M,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)W!A9&1I;F<M8F]T=&]M.B`Q+C%P="<^("`@(`T*("`@("`@("`@("8C,38P
M.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60[('1E>'0M86QI9VXZ
M(&QE9G0G/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA
M8VL@,2XQ<'0@<V]L:60[('1E>'0M86QI9VXZ(')I9VAT)SX@("`@#0H@("`@
M("`@("`@,BPW-C(L-3(R("`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@
M<V]L:60[('1E>'0M86QI9VXZ(&QE9G0G/B`@(`T*("`@("`@("`@("8C,38P
M.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@/"]T<CX@("`-"B`@("`@
M(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O
M=6YD+6-O;&]R.B!7:&ET92<^("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T
M97AT+6%L:6=N.B!L969T.R!P861D:6YG+6)O='1O;3H@,BXW-7!T.R!P861D
M:6YG+6QE9G0Z(#$P<'0G/B`@(`T*("`@("`@("`@(%1O=&%L(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O
M='1O;3H@,BXW-7!T)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@;&5F="<^
M("`@("`-"B`@("`@("`@("`D("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T
M(&1O=6)L93L@=&5X="UA;&EG;CH@<FEG:'0G/B`-"B`@("`@("`@("`Q,RPU
M.#(L-#4V(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T97AT
M+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB
M;W1T;VTZ(#(N-S5P="<^("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB
M;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G
M/B`@("`@#0H@("`@("`@("`@)"`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P
M="!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT)SX@#0H@("`@("`@("`@,3`L
M.3DV+#<X-2`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X
M="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@/"]T86)L93X\
M8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UI;F1E;G0Z(#`N-6EN)SX@
M("`@#0H@("`@("!);G9E;G1O<FEE<R!A<F4@<W1A=&5D(&%T('1H92!L;W=E
M<B!O9B!C;W-T(&]R(&UA<FME="P@=VET:"!C;W-T(&)E:6YG(&1E=&5R;6EN
M960@=7-I;F<@=&AE(&9I<G-T+6EN+"!F:7)S="UO=70@;65T:&]D+B!7;W)K
M+6EN+7!R;V-E<W,@86YD(&9I;FES:&5D(&=O;V1S(&EN=F5N=&]R:65S(&EN
M8VQU9&4@;6%T97)I86QS+"!L86)O<BP@86YD(&UA;G5F86-T=7)I;F<@;W9E
M<FAE860N("`-"B`@("`\+W`^/&)R+SX\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*
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M/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT
M='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[
M(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP
M="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT
M("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA
M<W,],T1R97!O<G0@:60],T1)1#!%344^#0H@("`@("`\='(^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O
M;F<^3F]T92`X("T@26YT86YG:6)L92!!<W-E=',@86YD($=O;V1W:6QL/&)R
M/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P
M86X],T0Q/CD@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/E-E<"X@,S`L(#(P,30\
M8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^
M1V]O9'=I;&P@86YD($EN=&%N9VEB;&4@07-S971S($1I<V-L;W-U<F4@6T%B
M<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^1V]O9'=I;&P@86YD($EN=&%N9VEB;&4@07-S971S($1I<V-L;W-U
M<F4@6U1E>'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'1A8FQE(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@<W1Y
M;&4],T0G=VED=&@Z(#$P,"4[(&9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68[(&)O<F1E<BUC;VQL87!S93H@8V]L;&%P<V4G/B`@
M(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!T;W`G/B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@-B4G/B`@#0H@("`@
M("`@("`@/&(^."XF(S$V,#LF(S$V,#L\+V(^("`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#DT)3L@=&5X="UA
M;&EG;CH@:G5S=&EF>2<^("`@(`T*("`@("`@("`@(#QB/DEN=&%N9VEB;&4@
M07-S971S(&%N9"!';V]D=VEL;#PO8CX@("`@(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`\+W1R/B`@(`T*("`@(#PO=&%B;&4^/&)R+SX\<"!S='EL
M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M.R!M87)G:6XZ(#`[('1E>'0M:6YD96YT.B`P+C5I;B<^("`@(`T*("`@("`@
M26X@8V]N;F5C=&EO;B!W:71H('1H92!A8W%U:7-I=&EO;B!O9B!!;FEK82!4
M:&5R87!E=71I8W,@4RYR+FPN("@F(S@R,C`[06YI:V$@4RYR+FPN)B,X,C(Q
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M(&9O<B!A8F%N9&]N960@<')O:F5C=',N)B,Q-C`[56YT:6P@<W5C:"!D971E
M<FUI;F%T:6]N(&ES(&UA9&4L('1H97D@87)E(&YO="!A;6]R=&EZ960N)B,Q
M-C`[(`T*("`@(#PO<#X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UI
M;F1E;G0Z(#`N-6EN)SX@("`@(`T*("`@("`@5&AE($-O;7!A;GD@<F5V:65W
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M;6%T960@9F%I<B!V86QU92X@(`T*("`@(#PO<#X\8G(O/CQP('-T>6QE/3-$
M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA
M<F=I;CH@,#L@=&5X="UI;F1E;G0Z(#`N-6EN)SX@("`@(`T*("`@("`@26YT
M86YG:6)L92!A<W-E=',@87,@;V8@4V5P=&5M8F5R(#,P+"`R,#$T(&%N9"!$
M96-E;6)E<B`S,2P@,C`Q,R!C;VYS:7-T(&]F('1H92!F;VQL;W=I;F<Z("`-
M"B`@("`\+W`^/&)R+SX\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C
M:6YG/3-$,"!S='EL93TS1"=B;W)D97(M8V]L;&%P<V4Z(&-O;&QA<'-E.R!W
M:61T:#H@,3`P)3L@9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9B<^("`@("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA
M;&EG;CH@8F]T=&]M)SX@("`-"B`@("`@("`@/'1D/B`@("`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!P861D:6YG+6)O='1O;3H@,2XQ
M<'0G/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@8V]L<W!A;CTS1#,@<W1Y;&4],T0G9F]N="UW96EG
M:'0Z(&)O;&0[('1E>'0M86QI9VXZ(&-E;G1E<B<^("`-"B`@("`@("`@("`F
M(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!P861D:6YG+6)O='1O;3H@,2XQ<'0G
M/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@8V]L<W!A;CTS1#$Q('-T>6QE/3-$)V9O;G0M=V5I9VAT
M.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97([(&)O<F1E<BUB;W1T;VTZ($)L
M86-K(#$N,7!T('-O;&ED)SX@(`T*("`@("`@("`@(%-E<'1E;6)E<B`S,"P@
M,C`Q-"`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G9F]N="UW96EG:'0Z(&)O;&0[('!A9&1I;F<M8F]T=&]M.B`Q+C%P
M="<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!C;VQS<&%N/3-$-R!S='EL93TS1"=F;VYT+7=E:6=H
M=#H@8F]L9#L@=&5X="UA;&EG;CH@8V5N=&5R.R!B;W)D97(M8F]T=&]M.B!"
M;&%C:R`Q+C%P="!S;VQI9"<^(`T*("`@("`@("`@($1E8V5M8F5R(#,Q+"`R
M,#$S("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@
M("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;2<^("`@
M#0H@("`@("`@(#QT9#X@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=F;VYT+7=E:6=H
M=#H@8F]L9#L@<&%D9&EN9RUB;W1T;VTZ(#$N,7!T)SX@("`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&-O
M;'-P86X],T0S('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L
M:6=N.B!C96YT97([(&)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED
M)SX@#0H@("`@("`@("`@1W)O<W,@5F%L=64@(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@
M<&%D9&EN9RUB;W1T;VTZ(#$N,7!T)SX@("`-"B`@("`@("`@("`F(S$V,#L@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0S
M('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT
M97([(&)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED)SX@#0H@("`@
M("`@("`@/'`@<W1Y;&4],T0G;6%R9VEN+71O<#H@,#L@;6%R9VEN+6)O='1O
M;3H@,"<^("`@("`-"B`@("`@("`@("`@($-U<G)E;F-Y(`T*("`@("`@("`@
M(#PO<#X@#0H@("`@("`@("`@/'`@<W1Y;&4],T0G;6%R9VEN+71O<#H@,#L@
M;6%R9VEN+6)O='1O;3H@,"<^("`@("`-"B`@("`@("`@("`@(%1R86YS;&%T
M:6]N("`@(`T*("`@("`@("`@(#PO<#X@#0H@("`@("`@("`@/'`@<W1Y;&4]
M,T0G;6%R9VEN+71O<#H@,#L@;6%R9VEN+6)O='1O;3H@,"<^("`@("`-"B`@
M("`@("`@("`@($%D:G5S=&UE;G0@("`-"B`@("`@("`@("`\+W`^(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=F;VYT+7=E
M:6=H=#H@8F]L9#L@<&%D9&EN9RUB;W1T;VTZ(#$N,7!T)SX@("`-"B`@("`@
M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M(&-O;'-P86X],T0S('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT
M+6%L:6=N.B!C96YT97([(&)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O
M;&ED)SX@#0H@("`@("`@("`@/'`@<W1Y;&4],T0G;6%R9VEN+71O<#H@,#L@
M;6%R9VEN+6)O='1O;3H@,"<^("`@("`-"B`@("`@("`@("`@($%C8W5M=6QA
M=&5D("`@(`T*("`@("`@("`@(#PO<#X@#0H@("`@("`@("`@/'`@<W1Y;&4]
M,T0G;6%R9VEN+71O<#H@,#L@;6%R9VEN+6)O='1O;3H@,"<^("`@("`-"B`@
M("`@("`@("`@($%M;W)T:7IA=&EO;B`@("`@#0H@("`@("`@("`@/"]P/B`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G9F]N
M="UW96EG:'0Z(&)O;&0[('!A9&1I;F<M8F]T=&]M.B`Q+C%P="<^("`@#0H@
M("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!C;VQS<&%N/3-$,R!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@
M=&5X="UA;&EG;CH@8V5N=&5R.R!B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P
M="!S;VQI9"<^(`T*("`@("`@("`@(#QP('-T>6QE/3-$)VUA<F=I;BUT;W`Z
M(#`[(&UA<F=I;BUB;W1T;VTZ(#`G/B`@("`@#0H@("`@("`@("`@("!.970@
M0F]O:R`-"B`@("`@("`@("`\+W`^(`T*("`@("`@("`@(#QP('-T>6QE/3-$
M)VUA<F=I;BUT;W`Z(#`[(&UA<F=I;BUB;W1T;VTZ(#`G/B`@("`@#0H@("`@
M("`@("`@("!686QU92`@(`T*("`@("`@("`@(#PO<#X@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B
M;VQD.R!P861D:6YG+6)O='1O;3H@,2XQ<'0G/B`@(`T*("`@("`@("`@("8C
M,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@8V]L<W!A
M;CTS1#,@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O;&0[('1E>'0M86QI9VXZ
M(&-E;G1E<CL@8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60G/B`-
M"B`@("`@("`@("`\<"!S='EL93TS1"=M87)G:6XM=&]P.B`P.R!M87)G:6XM
M8F]T=&]M.B`P)SX@("`@(`T*("`@("`@("`@("`@3F5T($)O;VL@#0H@("`@
M("`@("`@/"]P/B`-"B`@("`@("`@("`\<"!S='EL93TS1"=M87)G:6XM=&]P
M.B`P.R!M87)G:6XM8F]T=&]M.B`P)SX@("`@(`T*("`@("`@("`@("`@5F%L
M=64@("`-"B`@("`@("`@("`\+W`^(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@<&%D9&EN
M9RUB;W1T;VTZ(#$N,7!T)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0S('-T>6QE
M/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97([(&)O
M<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED)SX@#0H@("`@("`@("`@
M57-E9G5L($QI9F4@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\+W1R
M/B`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T
M;VT[(&)A8VMG<F]U;F0M8V]L;W(Z(')G8B@R,#0L,C,X+#(U-2DG/B`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`S-"4[('1E>'0M86QI9VXZ
M(&QE9G0G/B`-"B`@("`@("`@("!$979E;&]P960@=&5C:&YO;&]G>2`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z
M(#$E)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!T97AT+6%L:6=N
M.B!L969T)SX@("`@(`T*("`@("`@("`@("0@(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@."4[('1E>'0M86QI
M9VXZ(')I9VAT)SX@#0H@("`@("`@("`@,38L-S`P+#`P,"`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!T
M97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z
M(#$E)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!T97AT+6%L:6=N
M.B!L969T)SX@("`@(`T*("`@("`@("`@("0@(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@."4[('1E>'0M86QI
M9VXZ(')I9VAT)SX@#0H@("`@("`@("`@*#$L.#(X+#(Q-"`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!T
M97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@("D@(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24G
M/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[('1E>'0M86QI9VXZ(&QE
M9G0G/B`@("`@#0H@("`@("`@("`@)"`@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`X)3L@=&5X="UA;&EG;CH@
M<FEG:'0G/B`-"B`@("`@("`@("`H-"PW-SDL,3(S(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[('1E>'0M
M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@*2`@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)2<^("`-
M"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^
M("`@("`-"B`@("`@("`@("`D("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#@E.R!T97AT+6%L:6=N.B!R:6=H
M="<^(`T*("`@("`@("`@(#$P+#`Y,BPV-C,@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG
M;CH@;&5F="<^("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)2<^("`-
M"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^
M("`@("`-"B`@("`@("`@("`D("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#@E.R!T97AT+6%L:6=N.B!R:6=H
M="<^(`T*("`@("`@("`@(#$Q+#<U,RPP,#,@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG
M;CH@;&5F="<^("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)2<^("`-
M"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^
M("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`X)3L@=&5X="UA;&EG;CH@
M8V5N=&5R)SX@(`T*("`@("`@("`@(#$U("`@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG
M;CH@;&5F="<^("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@("`\='(@<W1Y;&4],T0G
M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@5VAI
M=&4G/B`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F
M="<^("`@(`T*("`@("`@("`@($EN+7!R;V-E<W,@<F5S96%R8V@@)F%M<#L@
M9&5V96QO<&UE;G0@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9#X@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@
M#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^("`@("`-"B`@
M("`@("`@("`U+#4P,BPV.#8@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@
M("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9#X@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@
M("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^("`@("`-
M"B`@("`@("`@("`H-C,X+#0R-B`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*
M("`@("`@("`@("D@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9#X@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@
M#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^("`@("`-"B`@
M("`@("`@("`M("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@("8C
M,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0^("`@(`T*
M("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@
M("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/B`@("`@#0H@("`@("`@("`@
M-"PX-C0L,C8P("`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@
M("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0^("`@
M(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@
M("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/B`@("`@#0H@("`@("`@
M("`@-2PR.#8L,3(W("`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@
M("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0^
M("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*
M("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R)SX@#0H@("`@("`@
M("`@26YD969I;FET92`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@
M("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@/"]T<CX@("`-
M"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B
M86-K9W)O=6YD+6-O;&]R.B!R9V(H,C`T+#(S."PR-34I)SX@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@("`@
M("`@("`@1&ES=')I8G5T;W(@<F5L871I;VYS:&EP<R`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0^("`@(`T*("`@("`@("`@("8C,38P.R`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@<FEG:'0G/B`@("`@#0H@("`@("`@("`@-"PW,#`L,#`P("`@("`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0^("`@(`T*("`@("`@("`@("8C,38P
M.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@<FEG:'0G/B`@("`@#0H@("`@("`@("`@*#0T,"PY-3,@("`@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`I("`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0^("`@(`T*("`@("`@("`@("8C,38P.R`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@<FEG:'0G/B`@("`@#0H@("`@("`@("`@*#0L,#@T+#DT-"`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@;&5F="<^("`@(`T*("`@("`@("`@("D@(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9#X@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L
M:6=N.B!L969T)SX@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R
M:6=H="<^("`@("`-"B`@("`@("`@("`Q-S0L,3`S("`@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE
M9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I
M9VAT)SX@("`@(`T*("`@("`@("`@(#@V,RPV-34@("`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F
M="<^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@;&5F="<^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N
M=&5R)SX@#0H@("`@("`@("`@-2`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@
M("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO
M='(^("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O
M='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@5VAI=&4G/B`@(`T*("`@("`@("`\
M=&0^("`@(`T*("`@("`@("`@(%!A=&5N=',@("`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@
M<FEG:'0G/B`@("`@#0H@("`@("`@("`@,2PP,#`L,#`P("`@("`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@;&5F="<^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0^("`@(`T*("`@("`@("`@("8C,38P.R`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@<FEG:'0G/B`@("`@#0H@("`@("`@("`@*#$P-RPY,3`@("`@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`I("`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@
M<FEG:'0G/B`@("`@#0H@("`@("`@("`@*#(W,2PR,#@@("`@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(&QE9G0G/B`@("`-"B`@("`@("`@("`I("`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@;&5F="<^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG
M:'0G/B`@("`@#0H@("`@("`@("`@-C(P+#@X,B`@(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T
M)SX@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9#X@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N
M.B!L969T)SX@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H
M="<^("`@("`-"B`@("`@("`@("`W,3DL-3<T("`@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G
M/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E
M<B<^(`T*("`@("`@("`@(#$V("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@
M("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO
M='(^("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O
M='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@<F=B*#(P-"PR,S@L,C4U*2<^("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#L@<&%D
M9&EN9RUB;W1T;VTZ(#$N,7!T)SX@(`T*("`@("`@("`@($5L979E<W,@=')A
M9&4@;F%M92`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#$N,7!T)SX@("`@#0H@("`@("`@
M("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9#L@=&5X
M="UA;&EG;CH@;&5F="<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T
M=&]M.B!";&%C:R`Q+C%P="!S;VQI9#L@=&5X="UA;&EG;CH@<FEG:'0G/B`@
M("`-"B`@("`@("`@("`Q+#`P,"PP,#`@("`@(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C
M:R`Q+C%P="!S;VQI9#L@=&5X="UA;&EG;CH@;&5F="<^("`@#0H@("`@("`@
M("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=P861D:6YG+6)O='1O;3H@,2XQ<'0G/B`@("`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT
M+6%L:6=N.B!L969T)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T
M;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!R:6=H="<^("`@
M(`T*("`@("`@("`@("T@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI
M9#L@=&5X="UA;&EG;CH@;&5F="<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D
M:6YG+6)O='1O;3H@,2XQ<'0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E
M<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!L969T
M)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N
M,7!T('-O;&ED.R!T97AT+6%L:6=N.B!R:6=H="<^("`@(`T*("`@("`@("`@
M("@W,3<L.38T("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9#L@
M=&5X="UA;&EG;CH@;&5F="<^("`@#0H@("`@("`@("`@*2`@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T
M=&]M.B`Q+C%P="<^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O
M;3H@0FQA8VL@,2XQ<'0@<V]L:60[('1E>'0M86QI9VXZ(&QE9G0G/B`@(`T*
M("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L
M:60[('1E>'0M86QI9VXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@,C@R+#`S
M-B`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9#L@=&5X="UA;&EG
M;CH@;&5F="<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@
M,2XQ<'0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L
M86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!L969T)SX@("`-"B`@("`@
M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T
M97AT+6%L:6=N.B!R:6=H="<^("`@(`T*("`@("`@("`@(#,W-BPP-3`@("`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60[('1E>'0M86QI9VXZ(&QE
M9G0G/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#$N,7!T
M)SX@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,2XQ<'0[
M('1E>'0M86QI9VXZ(&QE9G0G/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG
M+6)O='1O;3H@,2XQ<'0[('1E>'0M86QI9VXZ(&-E;G1E<B<^("`@(`T*("`@
M("`@("`@(#D@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=P861D:6YG+6)O='1O;3H@,2XQ<'0[('1E>'0M86QI9VXZ(&QE
M9G0G/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`\+W1R/B`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L
M+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z(%=H:71E)SX@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R+C<U<'0[
M('!A9&1I;F<M;&5F=#H@,3!P="<^("`@("`-"B`@("`@("`@("!4;W1A;"`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D
M9&EN9RUB;W1T;VTZ(#(N-S5P="<^("`@("`-"B`@("`@("`@("`F(S$V,#L@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O
M<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ
M(&QE9G0G/B`@("`@#0H@("`@("`@("`@)"`@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K
M(#(N-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT)SX@#0H@("`@("`@
M("`@,C@L.3`R+#8X-B`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L
M93L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@("`F(S$V,#L@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A
M9&1I;F<M8F]T=&]M.B`R+C<U<'0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B
M;W)D97(M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N
M.B!L969T)SX@("`@(`T*("`@("`@("`@("0@(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C
M:R`R+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^(`T*("`@("`@
M("`@("@S+#`Q-2PU,#,@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B
M;&4[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@*2`@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I
M;F<M8F]T=&]M.B`R+C<U<'0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D
M97(M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!L
M969T)SX@("`@(`T*("`@("`@("`@("0@(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R
M+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^(`T*("`@("`@("`@
M("@Y+#@U,RPR,SD@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[
M('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@*2`@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M
M8F]T=&]M.B`R+C<U<'0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M
M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T
M)SX@("`@(`T*("`@("`@("`@("0@(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C<U
M<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^(`T*("`@("`@("`@(#$V
M+#`S,RPY-#0@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[('1E
M>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG
M+6)O='1O;3H@,BXW-7!T)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@;&5F
M="<^("`@("`-"B`@("`@("`@("`D("`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW
M-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@<FEG:'0G/B`-"B`@("`@("`@("`Q
M."PY.3@L-#`Y(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T
M97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN
M9RUB;W1T;VTZ(#(N-S5P="<^("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I
M;F<M8F]T=&]M.B`R+C<U<'0[('1E>'0M86QI9VXZ(&QE9G0G/B`@(`T*("`@
M("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#(N-S5P=#L@=&5X="UA;&EG
M;CH@<FEG:'0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M
M.B`R+C<U<'0[('1E>'0M86QI9VXZ(&QE9G0G/B`@(`T*("`@("`@("`@("8C
M,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@/"]T<CX@("`-"B`@
M("`\+W1A8FQE/CQB<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6EN9&5N
M=#H@,"XU:6XG/B`@("`-"B`@("`@(%1H92!A9V=R96=A=&4@86UO<G1I>F%T
M:6]N(&5X<&5N<V4@<F5L871E9"!T;R!I;G1A;F=I8FQE(&%S<V5T<R!W87,@
M)#4Q."PV.3D@86YD("0U,C$L,S@W(&9O<B!T:&4@=&AR964M;6]N=&@@<&5R
M:6]D<R!E;F1E9"!397!T96UB97(@,S`L(#(P,30@86YD(#(P,3,L(')E<W!E
M8W1I=F5L>2X@5&AE(&%G9W)E9V%T92!A;6]R=&EZ871I;VX@97AP96YS92!R
M96QA=&5D('1O(&EN=&%N9VEB;&4@87-S971S('=A<R`D,2PU.3,L,C8P(&%N
M9"`D,2PU-34L-SDV(&9O<B!T:&4@;FEN92UM;VYT:"!P97)I;V1S(&5N9&5D
M(%-E<'1E;6)E<B`S,"P@,C`Q-"!A;F0@,C`Q,RP@<F5S<&5C=&EV96QY+B`@
M(`T*("`@(#PO<#X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UI;F1E
M;G0Z(#`N-6EN)SX@("`@(`T*("`@("`@0VAA;F=E<R!I;B!T:&4@8V%R<GEI
M;F<@=F%L=64@;V8@9V]O9'=I;&P@9F]R('1H92!T:')E92!A;F0@;FEN92UM
M;VYT:"!P97)I;V1S(&5N9&5D(%-E<'1E;6)E<B`S,"P@,C`Q-"!W97)E(&%S
M(&9O;&QO=W,Z("`-"B`@("`\+W`^/&)R+SX\=&%B;&4@8V5L;'!A9&1I;F<]
M,T0P(&-E;&QS<&%C:6YG/3-$,"!S='EL93TS1"=B;W)D97(M8V]L;&%P<V4Z
M(&-O;&QA<'-E.R!W:61T:#H@,3`P)3L@9F]N=#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9B<^("`@("`-"B`@("`@(#QT<B!S='EL93TS
M1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M)SX@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!P861D:6YG+6)O='1O;3H@,2XQ
M<'0G/B`@(`T*("`@("`@("`@($=O;V1W:6QL("`@(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L
M9#L@<&%D9&EN9RUB;W1T;VTZ(#$N,7!T)SX@("`-"B`@("`@("`@("`F(S$V
M,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&-O;'-P86X]
M,T0S(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L
M9#L@=&5X="UA;&EG;CH@8V5N=&5R.R!B;W)D97(M8F]T=&]M.B!";&%C:R`Q
M+C%P="!S;VQI9"<^("`-"B`@("`@("`@("`\<"!S='EL93TS1"=M87)G:6XM
M=&]P.B`P.R!M87)G:6XM8F]T=&]M.B`P)SX@("`@(`T*("`@("`@("`@("`@
M5&AR964@("`-"B`@("`@("`@("`\+W`^(`T*("`@("`@("`@(#QP('-T>6QE
M/3-$)VUA<F=I;BUT;W`Z(#`[(&UA<F=I;BUB;W1T;VTZ(#`G/B`@("`@#0H@
M("`@("`@("`@("!-;VYT:',@16YD960@("`@(`T*("`@("`@("`@(#PO<#X@
M#0H@("`@("`@("`@/'`@<W1Y;&4],T0G;6%R9VEN+71O<#H@,#L@;6%R9VEN
M+6)O='1O;3H@,"<^("`@("`-"B`@("`@("`@("`@(%-E<'1E;6)E<B`S,"P@
M#0H@("`@("`@("`@/"]P/B`-"B`@("`@("`@("`\<"!S='EL93TS1"=M87)G
M:6XM=&]P.B`P.R!M87)G:6XM8F]T=&]M.B`P)SX@("`@(`T*("`@("`@("`@
M("`@,C`Q-"`@#0H@("`@("`@("`@/"]P/B`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O;&0[('!A
M9&1I;F<M8F]T=&]M.B`Q+C%P="<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!C;VQS<&%N/3-$,R!N
M;W=R87`],T1N;W=R87`@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O;&0[('1E
M>'0M86QI9VXZ(&-E;G1E<CL@8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@
M<V]L:60G/B`@#0H@("`@("`@("`@/'`@<W1Y;&4],T0G;6%R9VEN+71O<#H@
M,#L@;6%R9VEN+6)O='1O;3H@,"<^("`@("`-"B`@("`@("`@("`@($YI;F4@
M(`T*("`@("`@("`@(#PO<#X@#0H@("`@("`@("`@/'`@<W1Y;&4],T0G;6%R
M9VEN+71O<#H@,#L@;6%R9VEN+6)O='1O;3H@,"<^("`@("`-"B`@("`@("`@
M("`@($UO;G1H<R!%;F1E9"`@("`@#0H@("`@("`@("`@/"]P/B`-"B`@("`@
M("`@("`\<"!S='EL93TS1"=M87)G:6XM=&]P.B`P.R!M87)G:6XM8F]T=&]M
M.B`P)SX@("`@(`T*("`@("`@("`@("`@4V5P=&5M8F5R(#,P+"`-"B`@("`@
M("`@("`\+W`^(`T*("`@("`@("`@(#QP('-T>6QE/3-$)VUA<F=I;BUT;W`Z
M(#`[(&UA<F=I;BUB;W1T;VTZ(#`G/B`@("`@#0H@("`@("`@("`@("`R,#$T
M("`-"B`@("`@("`@("`\+W`^(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`\+W1R/B`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N
M.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z(')G8B@R,#0L,C,X+#(U-2DG
M/B`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD
M)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O;&0G/B`@
M("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@=&5X="UA
M;&EG;CH@;&5F="<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@
M8F]L9#L@=&5X="UA;&EG;CH@<FEG:'0G/B`@("`-"B`@("`@("`@("`F(S$V
M,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!L969T)SX@("`-"B`@
M("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@
M("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX@("`@(`T*
M("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@
M("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@/"]T<CX@
M("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M
M.R!B86-K9W)O=6YD+6-O;&]R.B!7:&ET92<^("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=W:61T:#H@-S@E.R!T97AT+6%L:6=N.B!L969T)SX@#0H@("`@
M("`@("`@0F%L86YC92P@8F5G:6YN:6YG("`@(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24G/B`@#0H@("`@
M("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=W:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@
M#0H@("`@("`@("`@)"`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W=I9'1H.B`X)3L@=&5X="UA;&EG;CH@<FEG:'0G/B`-
M"B`@("`@("`@("`Y+#,V,"PX.#0@("`@(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[('1E>'0M86QI9VXZ
M(&QE9G0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24G/B`@#0H@
M("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=W:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G/B`@
M("`@#0H@("`@("`@("`@)"`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W=I9'1H.B`X)3L@=&5X="UA;&EG;CH@<FEG:'0G
M/B`-"B`@("`@("`@("`Y+#0T,RPX.30@("`@(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[('1E>'0M86QI
M9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`\+W1R/B`@(`T*("`@("`@/'1R('-T>6QE/3-$
M)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z(')G
M8B@R,#0L,C,X+#(U-2DG/B`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(&QE9G0[('!A9&1I;F<M8F]T=&]M.B`Q+C%P="<^("`-"B`@
M("`@("`@("!%9F9E8W0@;V8@9F]R96EG;B!C=7)R96YC>2!A9&IU<W1M96YT
M<R`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G<&%D9&EN9RUB;W1T;VTZ(#$N,7!T)SX@("`@#0H@("`@("`@("`@)B,Q
M-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9#L@=&5X="UA;&EG
M;CH@;&5F="<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!"
M;&%C:R`Q+C%P="!S;VQI9#L@=&5X="UA;&EG;CH@<FEG:'0G/B`@("`-"B`@
M("`@("`@("`H-C4X+#4X.2`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@
M<V]L:60[('1E>'0M86QI9VXZ(&QE9G0G/B`@(`T*("`@("`@("`@("D@(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D
M:6YG+6)O='1O;3H@,2XQ<'0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E
M<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!L969T
M)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N
M,7!T('-O;&ED.R!T97AT+6%L:6=N.B!R:6=H="<^("`@(`T*("`@("`@("`@
M("@W-#$L-3DY("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9#L@
M=&5X="UA;&EG;CH@;&5F="<^("`@#0H@("`@("`@("`@*2`@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@("`\='(@<W1Y;&4]
M,T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@
M5VAI=&4G/B`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T
M;VTZ(#(N-S5P="<^("`@("`-"B`@("`@("`@("!"86QA;F-E+"!E;F1I;F<@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A
M9&1I;F<M8F]T=&]M.B`R+C<U<'0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B
M;W)D97(M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N
M.B!L969T)SX@("`@(`T*("`@("`@("`@("0@(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C
M:R`R+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^(`T*("`@("`@
M("`@(#@L-S`R+#(Y-2`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P="!D
M;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@)B,Q
M-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=P861D:6YG+6)O='1O;3H@,BXW-7!T)SX@("`@(`T*("`@("`@("`@("8C
M,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA
M;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@("`D("`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@
M0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@<FEG:'0G/B`-"B`@
M("`@("`@("`X+#<P,BPR.34@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C<U
M<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@
M("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@/"]T<CX@("`-
M"B`@("`\+W1A8FQE/CQB<B\^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM
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M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q
M=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R
M<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C
M/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO
M<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$
M<F5P;W)T(&ED/3-$240P14U%/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/DYO
M=&4@.2`M($%C8W)U960@17AP96YS97,\8G(^/"]S=')O;F<^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^.2!-;VYT:',@16YD
M960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@^4V5P+B`S,"P@,C`Q-#QB<CX\+W1H/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY087EA8FQE<R!A;F0@06-C<G5A
M;',@6T%B<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^06-C;W5N=',@4&%Y86)L92!A;F0@06-C<G5E9"!,:6%B
M:6QI=&EE<R!$:7-C;&]S=7)E(%M497AT($)L;V-K73PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQT86)L92!C96QL<W!A8VEN9STS1#`@8V5L
M;'!A9&1I;F<],T0P('-T>6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!B;W)D97(M8V]L;&%P
M<V4Z(&-O;&QA<'-E)SX@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L
M+6%L:6=N.B!T;W`G/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T
M:#H@-B4G/B`@#0H@("`@("`@("`@/&(^.2X\+V(^("`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#DT)2<^("`@
M#0H@("`@("`@("`@/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P)SX@("`@(`T*("`@("`@
M("`@("`@/&(^06-C<G5E9"!%>'!E;G-E<SPO8CX@("`-"B`@("`@("`@("`\
M+W`^(`T*("`@("`@("`@(#QP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^("`@("`-"B`@
M("`@("`@("`\+W`^(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\+W1R
M/B`@(`T*("`@(#PO=&%B;&4^/&)R+SX\<"!S='EL93TS1"=F;VYT.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`@,"`P
M(#`N-6EN)SX@("`@#0H@("`@("!!8V-R=65D(&5X<&5N<V5S(&-O;G-I<W0@
M;V8@=&AE(&9O;&QO=VEN9SH@("`@#0H@("`@/"]P/CQB<B\^/'1A8FQE(&-E
M;&QP861D:6YG/3-$,"!C96QL<W!A8VEN9STS1#`@<W1Y;&4],T0G8F]R9&5R
M+6-O;&QA<'-E.B!C;VQL87!S93L@=VED=&@Z(#$P,"4[(&9O;G0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`@("`@#0H@("`@("`\
M='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;2<^("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!P861D:6YG+6)O
M='1O;3H@,2XQ<'0G/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O
M;3H@,2XQ<'0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0S(&YO=W)A<#TS1&YO
M=W)A<"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([(&)O<F1E<BUB;W1T
M;VTZ($)L86-K(#$N,7!T('-O;&ED)SX@("`-"B`@("`@("`@("`\<"!S='EL
M93TS1"=M87)G:6XM=&]P.B`P.R!M87)G:6XM8F]T=&]M.B`P)SX@("`@(`T*
M("`@("`@("`@("`@/&(^4V5P=&5M8F5R(#,P+#PO8CX@("`@(`T*("`@("`@
M("`@(#PO<#X@#0H@("`@("`@("`@/'`@<W1Y;&4],T0G;6%R9VEN+71O<#H@
M,#L@;6%R9VEN+6)O='1O;3H@,"<^("`@("`-"B`@("`@("`@("`@(#QB/C(P
M,30\+V(^(`T*("`@("`@("`@(#PO<#X@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`Q+C%P="<^
M("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@8V]L<W!A;CTS1#,@;F]W<F%P/3-$;F]W<F%P('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B;W)D97(M8F]T=&]M.B!";&%C:R`Q
M+C%P="!S;VQI9"<^("`-"B`@("`@("`@("`\<"!S='EL93TS1"=M87)G:6XM
M=&]P.B`P.R!M87)G:6XM8F]T=&]M.B`P.R!T97AT+6%L:6=N.B!C96YT97(G
M/B`@("`@#0H@("`@("`@("`@("`\8CY$96-E;6)E<B8C,38P.S,Q+#PO8CX@
M("`-"B`@("`@("`@("`\+W`^(`T*("`@("`@("`@(#QP('-T>6QE/3-$)VUA
M<F=I;BUT;W`Z(#`[(&UA<F=I;BUB;W1T;VTZ(#`[('1E>'0M86QI9VXZ(&-E
M;G1E<B<^("`@("`-"B`@("`@("`@("`@(#QB/C(P,3,\+V(^(`T*("`@("`@
M("`@(#PO<#X@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@
M#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@
M8F%C:V=R;W5N9"UC;VQO<CH@<F=B*#(P-"PR,S@L,C4U*2<^("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#<X)3L@=&5X="UA;&EG;CH@;&5F
M="<^(`T*("`@("`@("`@($QA8F]R(&%N9"!R96QA=&5D(&5X<&5N<V5S("`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED
M=&@Z(#$E)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!T97AT+6%L
M:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@("0@(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@."4[('1E>'0M
M86QI9VXZ(')I9VAT)SX@#0H@("`@("`@("`@,BPX-#(L,C,T("`@("`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z
M(#$E.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@("8C,38P
M.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M=VED=&@Z(#$E)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!T97AT
M+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@("0@(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@."4[('1E
M>'0M86QI9VXZ(')I9VAT)SX@#0H@("`@("`@("`@,BPX-S`L,30W("`@("`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED
M=&@Z(#$E.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@("8C
M,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@/"]T<CX@("`-"B`@
M("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K
M9W)O=6YD+6-O;&]R.B!7:&ET92<^("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@("`@("`@("`@0VQI;FEC86P@
M=')I86P@8V]S=',@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-
M"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX@("`@(`T*("`@
M("`@("`@(#DV,BPP,S$@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@
M("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0^
M("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*
M("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/B`@("`@#0H@("`@
M("`@("`@.#@R+#8U,2`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@("`@("`@
M("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\+W1R/B`@
M(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[
M(&)A8VMG<F]U;F0M8V]L;W(Z(')G8B@R,#0L,C,X+#(U-2DG/B`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@
M("`@("`@("!0<F]F97-S:6]N86P@9F5E<R`@(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9#X@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L
M:6=N.B!L969T)SX@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R
M:6=H="<^("`@("`-"B`@("`@("`@("`S.#(L-#(S("`@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE
M9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I
M9VAT)SX@("`@(`T*("`@("`@("`@(#,X,RPR,S$@("`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F
M="<^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@/"]T<CX@("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A
M;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B!7:&ET92<^("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@
M#0H@("`@("`@("`@4F5S96%R8V@@9W)A;G1S(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9#X@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L
M:6=N.B!L969T)SX@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R
M:6=H="<^("`@("`-"B`@("`@("`@("`U-C(L-34X("`@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE
M9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I
M9VAT)SX@("`@(`T*("`@("`@("`@(#8Q,"PT.3@@("`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F
M="<^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@/"]T<CX@("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A
M;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B!R9V(H,C`T+#(S
M."PR-34I)SX@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N
M.B!L969T)SX@("`@#0H@("`@("`@("`@4F5S=')U8W1U<FEN9R!C;W-T<R`@
M("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D/B`@("`-"B`@
M("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@(#$Q
M+#DP.2`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D/B`@("`-"B`@("`@
M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F
M(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@(#(T+#8S
M."`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@("`\='(@
M<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC
M;VQO<CH@5VAI=&4G/B`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@;&5F=#L@<&%D9&EN9RUB;W1T;VTZ(#$N,7!T)SX@(`T*("`@("`@
M("`@($]T:&5R(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=P861D:6YG+6)O='1O;3H@,2XQ<'0G/B`@("`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT
M+6%L:6=N.B!L969T)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T
M;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!R:6=H="<^("`@
M(`T*("`@("`@("`@(#0Y,BPU,S@@("`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ
M<'0@<V]L:60[('1E>'0M86QI9VXZ(&QE9G0G/B`@(`T*("`@("`@("`@("8C
M,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G<&%D9&EN9RUB;W1T;VTZ(#$N,7!T)SX@("`@#0H@("`@("`@("`@)B,Q
M-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9#L@=&5X="UA;&EG
M;CH@;&5F="<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!"
M;&%C:R`Q+C%P="!S;VQI9#L@=&5X="UA;&EG;CH@<FEG:'0G/B`@("`-"B`@
M("`@("`@("`W-C8L-S$V("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O
M;&ED.R!T97AT+6%L:6=N.B!L969T)SX@("`-"B`@("`@("`@("`F(S$V,#L@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@("`\
M='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N
M9"UC;VQO<CH@<F=B*#(P-"PR,S@L,C4U*2<^("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#L@<&%D9&EN9RUB;W1T;VTZ(#(N
M-S5P=#L@<&%D9&EN9RUL969T.B`Q,'!T)SX@("`-"B`@("`@("`@("!4;W1A
M;"`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M<&%D9&EN9RUB;W1T;VTZ(#(N-S5P="<^("`@("`-"B`@("`@("`@("`F(S$V
M,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[('1E>'0M86QI
M9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@)"`@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L
M86-K(#(N-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT)SX@#0H@("`@
M("`@("`@-2PR-3,L-CDS("`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T
M(&1O=6)L93L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@("`F
M(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W!A9&1I;F<M8F]T=&]M.B`R+C<U<'0G/B`@("`@#0H@("`@("`@("`@
M)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T97AT
M+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@("0@(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M
M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^(`T*
M("`@("`@("`@(#4L-3,W+#@X,2`@("`@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N
M-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@
M("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\+W1R/B`@
M(`T*("`@(#PO=&%B;&4^/&)R+SX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM
M+2TM+2T]7TYE>'1087)T7V)A-3$W,3$S7S!D,C=?-#,V,5]A-V)A7S$P838S
M83,X-30R8PT*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]B834Q-S$Q
M,U\P9#(W7S0S-C%?83=B85\Q,&$V,V$S.#4T,F,O5V]R:W-H965T<R]3:&5E
M=#$U+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP
M<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U
M<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M
M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H
M87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S
M<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO
M/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,]
M,T1R97!O<G0@:60],T1)1#!%344^#0H@("`@("`\='(^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^
M3F]T92`Q,"`M($-O;6UI=&UE;G1S(&%N9"!#;VYT:6YG96YC:65S/&)R/CPO
M<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X]
M,T0Q/CD@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/E-E<"X@,S`L(#(P,30\8G(^
M/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^0V]M
M;6ET;65N=',@86YD($-O;G1I;F=E;F-I97,@1&ES8VQO<W5R92!;06)S=')A
M8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y#;VUM:71M96YT<R!A;F0@0V]N=&EN9V5N8VEE<R!$:7-C;&]S=7)E(%M4
M97AT($)L;V-K73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQT
M86)L92!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('-T>6QE/3-$
M)W=I9'1H.B`Q,#`E.R!F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF.R!B;W)D97(M8V]L;&%P<V4Z(&-O;&QA<'-E)SX@("`-"B`@
M("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P)SX@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#8E)SX@(`T*("`@("`@("`@
M(#QB/C$P+CPO8CX@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=VED=&@Z(#DT)2<^("`@#0H@("`@("`@("`@/&(^0V]M
M;6ET;65N=',@86YD($-O;G1I;F=E;F-I97,\+V(^("`@(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`\+W1R/B`@(`T*("`@(#PO=&%B;&4^/&)R+SX\
M<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M:6YD96YT.B`P+C5I;B<^("`@(`T*
M("`@("`@26X@8V5R=&%I;B!O9B!I=',@8V]N=')A8W1S+"!T:&4@0V]M<&%N
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M0V]M<&%N>2`-"B`@("`@(&AA<R!N;R!A8V-R=65D('=A<G)A;G1I97,@86YD
M(&AA<R!N;R!H:7-T;W)Y(&]F(&-L86EM<R!P86ED+B`@#0H@("`@/"]P/CQB
M<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6EN9&5N=#H@,"XU:6XG/B`@
M("`@#0H@("`@("!/;B!*=6QY(#<L(#(P,3`L($=E;GIY;64@0V]R<&]R871I
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M-2PQ-#,L-S(T(&%N9"`U+#,Y.2PS-3$F(S$V,#MI9B!T:&4@0V]M<&%N>2!M
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M.#(Q-SMS(&-L86EM<RX@3VX@36%R8V@@,3`L(#(P,30L('1H92!$:7-T<FEC
M="!#;W5R="!G<F%N=&5D('1H92!M;W1I;VX@=&\@9&ES;6ES<R!W:71H('!R
M96IU9&EC92!A;&P@;V8@1V5N>GEM928C.#(Q-SMS(&-L86EM<R!A9V%I;G-T
M('1H92!#;VUP86YY(&%N9"!T:&4@8V%S92!W87,@=&5R;6EN871E9"X@(`T*
M("`@(#PO<#X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UI;F1E;G0Z
M(#`N-6EN)SX@("`@(`T*("`@("`@5&AE($-O;7!A;GD@:7,@86QS;R!I;G9O
M;'9E9"!I;B!V87)I;W5S(&]T:&5R(&QE9V%L('!R;V-E961I;F=S(&%R:7-I
M;F<@:6X@=&AE(&YO<FUA;"!C;W5R<V4@;V8@8G5S:6YE<W,N)B,Q-C`[06QT
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M(')E<W5L=',@;V8@;W!E<F%T:6]N<R!O<B!C87-H(&9L;W<N)B,Q-C`[(`T*
M("`@(#PO<#X\8G(O/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?
M3F5X=%!A<G1?8F$U,3<Q,3-?,&0R-U\T,S8Q7V$W8F%?,3!A-C-A,S@U-#)C
M#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+V)A-3$W,3$S7S!D,C=?
M-#,V,5]A-V)A7S$P838S83,X-30R8R]7;W)K<VAE971S+U-H965T,38N:'1M
M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L
M90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI
M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS
M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU
M=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H
M;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP
M=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R
M="!I9#TS1$E$,$5-13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY.;W1E(#$Q
M("T@36ET96L@36]N;W9I<V,@06=R965M96YT/&)R/CPO<W1R;VYG/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CD@36]N=&AS
M($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H/E-E<"X@,S`L(#(P,30\8G(^/"]T:#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^1&5F97)R960@4F5V96YU
M92!$:7-C;&]S=7)E(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1E9F5R<F5D(%)E=F5N=64@1&ES8VQO
M<W5R92!;5&5X="!";&]C:UT\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\=&%B;&4@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!S
M='EL93TS1"=W:61T:#H@,3`P)3L@9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9CL@8F]R9&5R+6-O;&QA<'-E.B!C;VQL87!S92<^
M(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!T;W`G/B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@-B4G/B`@#0H@("`@
M("`@("`@/&(^,3$N/"]B/B`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=W:61T:#H@.30E)SX@("`-"B`@("`@("`@("`\
M8CY-:71E:R!-;VYO=FES8R!!9W)E96UE;G0\+V(^("`@(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`\+W1R/B`@(`T*("`@(#PO=&%B;&4^/&)R+SX\
M<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M:6YD96YT.B`P+C5I;B<^("`@(`T*
M("`@("`@26X@1&5C96UB97(@,C`Q,2P@=&AE($-O;7!A;GD@96YT97)E9"!I
M;G1O(&$@9FEF=&5E;BUY96%R(&QI8V5N<VEN9R!A9W)E96UE;G0@*'1H92`F
M(S@R,C`[36ET96L@34].3U9)4T,@06=R965M96YT)B,X,C(Q.RD@=VET:"!$
M95!U>2!3>6YT:&5S($UI=&5K(%-P;W)T<R!-961I8VEN92P@82!D:79I<VEO
M;B!O9B!$95!U>2!/<G1H;W!A961I8W,L($EN8RXL('1O(&5X8VQU<VEV96QY
M(&UA<FME="!-3TY/5DE30R!I;B!T:&4@52Y3+B!4:&4@0V]M<&%N>2!R96-E
M:79E9"!A;B!U<&9R;VYT('!A>6UE;G0@;V8@)#(L-3`P+#`P,"!I;B!$96-E
M;6)E<B`R,#$Q+B!4:&ES(&YO;BUR969U;F1A8FQE('5P9G)O;G0@<&%Y;65N
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M,C`P+#`P,"!W:&EC:"!R97!R97-E;G1S('1H92!R96UA:6YI;F<@8F%L86YC
M92!O9B!D969E<G)E9"!R979E;G5E(')E;&%T:6YG('1O('1H92!I;FET:6%L
M("`@#0H@("`@("`D,BPU,#`L,#`P('!A>6UE;G0@:6X@86-C;W)D86YC92!W
M:71H(&-U<G)E;G0@9V5N97)A;&QY(&%C8V5P=&5D('!R:6YC:7!L97,@;VX@
M<F5V96YU92!R96-O9VYI=&EO;BX@26X@=&AE(&9I<G-T('%U87)T97(@;V8@
M,C`Q-"P@=&AE($-O;7!A;GD@86QS;R!R96-E:79E9"!A(&UI;&5S=&]N92!P
M87EM96YT(&]F("0Q-RPU,#`L,#`P(&%S(&$@<F5S=6QT(&]F(&%C:&EE=FEN
M9R!&1$$@87!P<F]V86P@9F]R($U/3D]625-#(&%N9"!R97-O;'9I;F<@=&AE
M('!A=&5N="!L:71I9V%T:6]N('=I=&@@1V5N>GEM92X@5&AI<R!M:6QE<W1O
M;F4@<&%Y;65N="!W87,@9G5L;'D@<F5C;V=N:7IE9"!A<R!R979E;G5E(&1U
M<FEN9R!T:&4@=&AR964@;6]N=&AS(&5N9&5D($UA<F-H(#,Q+"`R,#$T+B!/
M;B!!<')I;"`Q-2P@,C`Q-"!T:&4@9FER<W0@52Y3+B!C;VUM97)C:6%L('-A
M;&4@;V8@34].3U9)4T,@=V%S(&UA9&4@8GD@;W5R(&-O;6UE<F-I86P@<&%R
M=&YE<BP@1&50=7D@4WEN=&AE<R!-:71E:R!3<&]R=',@365D:6-I;F4N(%5N
M9&5R('1H92!T97)M<R!O9B!T:&4@36ET96L@34].3U9)4T,@06=R965M96YT
M+"!T:&4@0V]M<&%N>2!E87)N960@86YD(&-O;&QE8W1E9"!A(&UI;&5S=&]N
M92!P87EM96YT(&]F("0U(&UI;&QI;VXL('=H:6-H('=A<R!F=6QL>2!R96-O
M9VYI>F5D(&%S(')E=F5N=64@:6X@=&AE('-E8V]N9"!Q=6%R=&5R(&]F(#(P
M,30N("`@(`T*("`@(#PO<#X\8G(O/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-
M"BTM+2TM+3U?3F5X=%!A<G1?8F$U,3<Q,3-?,&0R-U\T,S8Q7V$W8F%?,3!A
M-C-A,S@U-#)C#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+V)A-3$W
M,3$S7S!D,C=?-#,V,5]A-V)A7S$P838S83,X-30R8R]7;W)K<VAE971S+U-H
M965T,3<N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D
M+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970]
M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T
M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@
M8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T
M('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@
M*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S
M<STS1')E<&]R="!I9#TS1$E$,$5-13X-"B`@("`@(#QT<CX-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N
M9SY.;W1E(#$R("T@26YC;VUE(%1A>&5S/&)R/CPO<W1R;VYG/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CD@36]N=&AS($5N
M9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/E-E<"X@,S`L(#(P,30\8G(^/"]T:#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^26YC;VUE(%1A>"!$:7-C;&]S
M=7)E(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/DEN8V]M92!487@@1&ES8VQO<W5R92!;5&5X="!";&]C
M:UT\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\=&%B;&4@8V5L
M;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!S='EL93TS1"=W:61T:#H@
M,3`P)3L@9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9CL@8F]R9&5R+6-O;&QA<'-E.B!C;VQL87!S92<^("`@("`-"B`@("`@(#QT
M<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P)SX@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=VED=&@Z(#8E)SX@(`T*("`@("`@("`@(#QB/C$R
M+CPO8CX@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G=VED=&@Z(#DT)2<^("`@#0H@("`@("`@("`@/&(^26YC;VUE(%1A
M>&5S/"]B/B`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@
M#0H@("`@/"]T86)L93X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UI
M;F1E;G0Z(#`N-6EN)SX@("`@#0H@("`@("!0<F]V:7-I;VYS(&9O<B!I;F-O
M;64@=&%X97,@=V5R92`D-"PQ,C4L,S4U(&%N9"`D,3@L.#<R+#0S-2!F;W(@
M=&AE('1H<F5E(&%N9"!N:6YE+6UO;G1H('!E<FEO9',@96YD960@4V5P=&5M
M8F5R(#,P+"`R,#$T+"!R97-P96-T:79E;'DL(&)A<V5D(&]N(&5F9F5C=&EV
M92!T87@@<F%T97,@;V8@-#`E(&%N9"`S."4N(%!R;W9I<VEO;G,@9F]R(&EN
M8V]M92!T87AE<R!W97)E("0R+#<W-BPQ.3D@86YD("0X+#$T-RPR.#(@9F]R
M('1H92!T:')E92!A;F0@;FEN92UM;VYT:"!P97)I;V1S(&5N9&5D(%-E<'1E
M;6)E<B`S,"P@,C`Q,RP@<F5S<&5C=&EV96QY+"!B87-E9"!O;B!E9F9E8W1I
M=F4@=&%X(')A=&5S(&]F(#,V)2!A;F0@,S<E+"!R97-P96-T:79E;'DN(%1H
M92!I;F-R96%S92!I;B!I;F-O;64@=&%X97,@;W9E<B!T:&4@=&AR964M;6]N
M=&@@<&5R:6]D(&5N9&5D(%-E<'1E;6)E<B`S,"P@,C`Q-"!W87,@<')I;6%R
M:6QY(&1U92!T;R!I;F-R96%S960@;F5T(&EN8V]M92X@5&AE(&EN8W)E87-E
M(&EN(&EN8V]M92!T87AE<R!O=F5R('1H92!N:6YE+6UO;G1H('!E<FEO9"!E
M;F1E9"!397!T96UB97(@,S`L(#(P,30@=V%S('!R:6UA<FEL>2!D=64@=&\@
M:6YC<F5A<V5D(&YE="!I;F-O;64L('=H:6-H(')E9FQE8W1E9"`D,C0L-C4R
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M('1O('1H92!S86UE('!E<FEO9',@96YD960@:6X@,C`Q,RP@=V%S(&1R:79E
M;B!P<FEM87)I;'D@8GD@=&AE('5N879A:6QA8FEL:71Y(&]F('1H92!F961E
M<F%L(%(F86UP.T0@=&%X(&-R961I="!I;B`@("`@#0H@("`@("`R,#$T+"!D
M=64@=&\@:71S(&5X<&ER871I;VX@;VX@1&5C96UB97(@,S$L(#(P,3,L(&%N
M9"!A(')E;&%T:79E(&1E8W)E87-E('1O(&]U<B!E<W1I;6%T960@<')O9'5C
M=&EO;B!A8W1I=FET:65S(&1E9'5C=&EO;BX@("`@(`T*("`@(#PO<#X\8G(O
M/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UI;F1E;G0Z(#`N-6EN)SX@("`@
M(`T*("`@("`@5&AE($-O;7!A;GD@9FEL97,@:6YC;VUE('1A>"!R971U<FYS
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M9FEL:6YG<R!R96QA=&4N($]U<B!F:6QI;F=S(&9R;VT@,C`Q,2!T:')O=6=H
M('1H92!P<F5S96YT('1A>"!Y96%R(')E;6%I;B!S=6)J96-T('1O(&5X86UI
M;F%T:6]N(&)Y('1H92!)4E,@86YD(&]T:&5R('1A>&EN9R!A=71H;W)I=&EE
M<R!F;W(@52Y3+B!F961E<F%L(&%N9"!S=&%T92!T87@@<'5R<&]S97,N($]U
M<B!F:6QI;F=S(&9R;VT@,C`P.2!T:')O=6=H('1H92!P<F5S96YT('1A>"!Y
M96%R(')E;6%I;B!S=6)J96-T('1O(&5X86UI;F%T:6]N(&)Y('1H92!A<'!R
M;W!R:6%T92!G;W9E<FYM96YT86P@875T:&]R:71I97,@:6X@271A;'DN("`@
M("`-"B`@("`\+W`^/&)R+SX\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M:6YD
M96YT.B`P+C5I;B<^("`@("`-"B`@("`@($EN(&-O;FYE8W1I;VX@=VET:"!T
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M<B`S,"P@,C`Q-"!O<B!$96-E;6)E<B`S,2P@,C`Q,RXF(S$V,#L@(`T*("`@
M(#PO<#X\8G(O/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X
M=%!A<G1?8F$U,3<Q,3-?,&0R-U\T,S8Q7V$W8F%?,3!A-C-A,S@U-#)C#0I#
M;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+V)A-3$W,3$S7S!D,C=?-#,V
M,5]A-V)A7S$P838S83,X-30R8R]7;W)K<VAE971S+U-H965T,3@N:'1M;`T*
M0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*
M0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*
M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O
M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M
M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N
M:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\
M+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I
M9#TS1$E$,$5-13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY.;W1E(#$S("T@
M4V5G;65N="!A;F0@1V5O9W)A<&AI8R!);F9O<FUA=&EO;CQB<CX\+W-T<F]N
M9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XY
M($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y397`N(#,P+"`R,#$T/&)R/CPO=&@^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E-E9VUE;G0@
M4F5P;W)T:6YG(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/E-E9VUE;G0@4F5P;W)T:6YG($1I<V-L;W-U
M<F4@6U1E>'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'1A8FQE(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!W:61T:#H@,3`P)3L@8F]R9&5R+6-O
M;&QA<'-E.B!C;VQL87!S92<^("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T
M:6-A;"UA;&EG;CH@=&]P)SX@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M=VED=&@Z(#8E)SX@(`T*("`@("`@("`@(#QP('-T>6QE/3-$)V9O;G0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^
M("`@("`-"B`@("`@("`@("`@(#QB/B8C,38P.S$S+CPO8CX@("`@(`T*("`@
M("`@("`@(#PO<#X@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W=I9'1H.B`Y-"4G/B`@(`T*("`@("`@("`@(#QP('-T>6QE
M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[
M(&UA<F=I;CH@,"<^("`@("`-"B`@("`@("`@("`@(#QB/B8C,38P.U-E9VUE
M;G0@86YD($=E;V=R87!H:6,@26YF;W)M871I;VX\+V(^(`T*("`@("`@("`@
M(#PO<#X@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@
M("`@/"]T86)L93X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UI;F1E
M;G0Z(#`N-6EN)SX@("`@#0H@("`@("!4:&4@0V]M<&%N>2!H87,@;VYE(')E
M<&]R=&%B;&4@;W!E<F%T:6YG('-E9VUE;G0L('1H92!R97-U;'1S(&]F('=H
M:6-H(&%R92!D:7-C;&]S960@:6X@=&AE(&%C8V]M<&%N>6EN9R!U;F%U9&ET
M960@8V]N9&5N<V5D(&-O;G-O;&ED871E9"!F:6YA;F-I86P@<W1A=&5M96YT
M<RX@#0H@("`@/"]P/CQB<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6EN
M9&5N=#H@,"XU:6XG/B`@("`@#0H@("`@("!0<F]D=6-T(')E=F5N=64@8GD@
M<')O9'5C="!G<F]U<"!I<R!A<R!F;VQL;W=S.B`@("`-"B`@("`\+W`^/&)R
M+SX\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!S='EL
M93TS1"=B;W)D97(M8V]L;&%P<V4Z(&-O;&QA<'-E.R!W:61T:#H@,3`P)3L@
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^("`@
M("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M
M)SX@("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)V9O;G0M
M=V5I9VAT.B!B;VQD)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G9F]N="UW96EG:'0Z
M(&)O;&0[('!A9&1I;F<M8F]T=&]M.B`Q+C%P="<^("`@#0H@("`@("`@("`@
M)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!C;VQS
M<&%N/3-$-R!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@=&5X="UA;&EG
M;CH@8V5N=&5R.R!B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9"<^
M(`T*("`@("`@("`@(%1H<F5E($UO;G1H<R!%;F1E9"!397!T96UB97(@,S`L
M("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)V9O;G0M=V5I9VAT.B!B;VQD.R!P861D:6YG+6)O='1O;3H@,2XQ<'0G/B`@
M(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@8V]L<W!A;CTS1#<@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O
M;&0[('1E>'0M86QI9VXZ(&-E;G1E<CL@8F]R9&5R+6)O='1O;3H@0FQA8VL@
M,2XQ<'0@<V]L:60G/B`-"B`@("`@("`@("!.:6YE($UO;G1H<R!%;F1E9"!3
M97!T96UB97(@,S`L("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@/"]T
M<CX@("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T
M=&]M)SX@("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)V9O
M;G0M=V5I9VAT.B!B;VQD)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G9F]N="UW96EG
M:'0Z(&)O;&0[('!A9&1I;F<M8F]T=&]M.B`Q+C%P="<^("`@#0H@("`@("`@
M("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!C
M;VQS<&%N/3-$,R!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@=&5X="UA
M;&EG;CH@8V5N=&5R.R!B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI
M9"<^(`T*("`@("`@("`@(#(P,30@("`@(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@<&%D
M9&EN9RUB;W1T;VTZ(#$N,7!T)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0S('-T
M>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97([
M(&)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED)SX@#0H@("`@("`@
M("`@,C`Q,R`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!P861D:6YG+6)O='1O;3H@
M,2XQ<'0G/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@8V]L<W!A;CTS1#,@<W1Y;&4],T0G9F]N="UW
M96EG:'0Z(&)O;&0[('1E>'0M86QI9VXZ(&-E;G1E<CL@8F]R9&5R+6)O='1O
M;3H@0FQA8VL@,2XQ<'0@<V]L:60G/B`-"B`@("`@("`@("`R,#$T("`@("`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G9F]N
M="UW96EG:'0Z(&)O;&0[('!A9&1I;F<M8F]T=&]M.B`Q+C%P="<^("`@#0H@
M("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!C;VQS<&%N/3-$,R!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@
M=&5X="UA;&EG;CH@8V5N=&5R.R!B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P
M="!S;VQI9"<^(`T*("`@("`@("`@(#(P,3,@("`@(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`\+W1R/B`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E
M<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z(')G8B@R
M,#0L,C,X+#(U-2DG/B`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H
M.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@("`F(S$V
M,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)W=I9'1H.B`U-"4[('1E>'0M86QI9VXZ(&QE9G0G/B`-"B`@("`@("`@("!/
M<G1H;V)I;VQO9VEC<R`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^
M("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)2<^("`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@
M("`@("`@("`D("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G=VED=&@Z(#@E.R!T97AT+6%L:6=N.B!R:6=H="<^(`T*("`@
M("`@("`@(#$X+#@Y.2PX-S,@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^
M("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)2<^("`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@
M("`@("`@("`D("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G=VED=&@Z(#@E.R!T97AT+6%L:6=N.B!R:6=H="<^(`T*("`@
M("`@("`@(#$R+#@S,"PU-C8@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^
M("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)2<^("`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@
M("`@("`@("`D("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G=VED=&@Z(#@E.R!T97AT+6%L:6=N.B!R:6=H="<^(`T*("`@
M("`@("`@(#0X+#<U,"PR-S<@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^
M("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)2<^("`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@
M("`@("`@("`D("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G=VED=&@Z(#@E.R!T97AT+6%L:6=N.B!R:6=H="<^(`T*("`@
M("`@("`@(#0P+#8R,"PS,SD@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^
M("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@(#PO='(^("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM
M86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@5VAI=&4G/B`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*
M("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@
M("`@($1E<FUA;"`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F
M(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D/B`@("`-
M"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@
M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@
M(#0P,2PS-34@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@("8C
M,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0^("`@(`T*
M("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@
M("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/B`@("`@#0H@("`@("`@("`@
M,C8W+#<V-B`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@("`@("`@("`@)B,Q
M-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9#X@("`@#0H@
M("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@("`@("`@
M("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^("`@("`-"B`@("`@("`@("`Y
M,S@L.38V("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V
M,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D/B`@("`-"B`@
M("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@(#$L
M,#8V+#0P.2`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F
M(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@
M("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C
M:V=R;W5N9"UC;VQO<CH@<F=B*#(P-"PR,S@L,C4U*2<^("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@
M("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@(%-U
M<F=I8V%L("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@("`@("`@("`@)B,Q
M-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9#X@("`@#0H@
M("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@("`@("`@
M("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^("`@("`-"B`@("`@("`@("`Q
M+#0U,BPY-#8@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@("`@("`@("`@
M)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9#X@("`@
M#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@("`@
M("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^("`@("`-"B`@("`@("`@
M("`Q+#$S-BPR-#@@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@("`@("`@
M("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9#X@
M("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@
M("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^("`@("`-"B`@("`@
M("`@("`T+#4X,2PT.38@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@("`@
M("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9#X@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@
M#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^("`@("`-"B`@
M("`@("`@("`S+#DU-2PQ,S0@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@
M("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\
M+W1R/B`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B
M;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z(%=H:71E)SX@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("!/<&AT
M:&%L;6EC(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@("`@("`@("`@)B,Q-C`[
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9#X@("`@#0H@("`@
M("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@("`@("`@("`@
M)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=T97AT+6%L:6=N.B!R:6=H="<^("`@("`-"B`@("`@("`@("`S-C8L
M,3,X("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D/B`@("`-"B`@("`@
M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F
M(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@(#$L-#(U
M+#8P.2`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V
M,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D/B`@("`-"B`@
M("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@(#DS
M."PQ,S0@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@("8C,38P
M.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0^("`@(`T*("`@
M("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@
M("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/B`@("`@#0H@("`@("`@("`@,BPX
M,3@L-#`W("`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@("8C
M,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@/"]T<CX@("`-"B`@
M("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K
M9W)O=6YD+6-O;&]R.B!R9V(H,C`T+#(S."PR-34I)SX@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,2XQ<'0[('1E>'0M86QI
M9VXZ(&QE9G0G/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@
M,2XQ<'0[('1E>'0M86QI9VXZ(&QE9G0G/B`@#0H@("`@("`@("`@5F5T97)I
M;F%R>2`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G<&%D9&EN9RUB;W1T;VTZ(#$N,7!T.R!T97AT+6%L:6=N.B!L969T)SX@
M(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#$N,7!T)SX@("`@
M#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S
M;VQI9#L@=&5X="UA;&EG;CH@;&5F="<^("`@#0H@("`@("`@("`@)B,Q-C`[
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B
M;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9#L@=&5X="UA;&EG;CH@
M<FEG:'0G/B`@("`-"B`@("`@("`@("`X-34L,#`P("`@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ
M($)L86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!L969T)SX@("`-"B`@
M("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`Q+C%P="<^("`@(`T*("`@
M("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60[
M('1E>'0M86QI9VXZ(&QE9G0G/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60[('1E>'0M86QI9VXZ(')I9VAT
M)SX@("`@#0H@("`@("`@("`@,2PS-C,L,34W("`@("`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@
M0FQA8VL@,2XQ<'0@<V]L:60[('1E>'0M86QI9VXZ(&QE9G0G/B`@(`T*("`@
M("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#$N,7!T)SX@("`@#0H@("`@
M("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9#L@
M=&5X="UA;&EG;CH@;&5F="<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M
M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9#L@=&5X="UA;&EG;CH@<FEG:'0G
M/B`@("`-"B`@("`@("`@("`R+#,X-2PP,#`@("`@(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!"
M;&%C:R`Q+C%P="!S;VQI9#L@=&5X="UA;&EG;CH@;&5F="<^("`@#0H@("`@
M("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,2XQ<'0G/B`@("`-"B`@("`@
M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T
M97AT+6%L:6=N.B!L969T)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB
M;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!R:6=H="<^
M("`@(`T*("`@("`@("`@(#,L,3(T+#DU,R`@("`@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L
M86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!L969T)SX@("`-"B`@("`@
M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^
M("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O
M;3L@8F%C:V=R;W5N9"UC;VQO<CH@5VAI=&4G/B`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#(N-S5P=#L@=&5X="UA;&EG;CH@
M;&5F="<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,BXW
M-7!T.R!T97AT+6%L:6=N.B!R:6=H="<^("`@(`T*("`@("`@("`@("8C,38P
M.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M<&%D9&EN9RUB;W1T;VTZ(#(N-S5P=#L@=&5X="UA;&EG;CH@;&5F="<^("`@
M#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,BXW-7!T)SX@("`@
M(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T
M(&1O=6)L93L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@("`D
M("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG
M;CH@<FEG:'0G/B`-"B`@("`@("`@("`R,2PY-S4L,S$R(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M
M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T)SX@("`@
M(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#(N-S5P="<^("`@
M("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P
M="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@
M)"`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[('1E>'0M86QI
M9VXZ(')I9VAT)SX@#0H@("`@("`@("`@,3<L,#(S+#,T-B`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O
M;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@;&5F="<^("`@
M("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R+C<U<'0G/B`@
M("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C<U
M<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@
M("0@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T97AT+6%L
M:6=N.B!R:6=H="<^(`T*("`@("`@("`@(#4W+#4Y,RPX-S,@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T
M;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G/B`@
M("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,BXW-7!T)SX@
M("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW
M-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@
M("`D("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA
M;&EG;CH@<FEG:'0G/B`-"B`@("`@("`@("`U,2PU.#4L,C0R(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T
M=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T)SX@
M("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@/"]T<CX@("`-"B`@("`\+W1A8FQE/CQB<B\^/'`@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R
M9VEN.B`P.R!T97AT+6EN9&5N=#H@,"XU:6XG/B`@("`-"B`@("`@(%1O=&%L
M(')E=F5N=64@8GD@9V5O9W)A<&AI8R!L;V-A=&EO;B!A;F0@87,@82!P97)C
M96YT86=E(&]F(&]V97)A;&P@=&]T86P@<F5V96YU92P@9F]R('1H92!T:')E
M92!A;F0@;FEN92UM;VYT:"!P97)I;V1S(&5N9&5D(%-E<'1E;6)E<B`S,"P@
M,C`Q-"!A;F0@,C`Q,R!A<F4@87,@9F]L;&]W<SL@#0H@("`@/"]P/CQB<B\^
M/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C96QL<W!A8VEN9STS1#`@<W1Y;&4]
M,T0G8F]R9&5R+6-O;&QA<'-E.B!C;VQL87!S93L@=VED=&@Z(#$P,"4[(&9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`@("`@
M#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;2<^
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9"<^
M("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD)SX@("`@
M(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@8V]L<W!A;CTS1#$U('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B
M;VQD.R!T97AT+6%L:6=N.B!C96YT97(G/B`@(`T*("`@("`@("`@(%1H<F5E
M($UO;G1H<R!%;F1E9"!397!T96UB97(@,S`L("`@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R
M=&EC86PM86QI9VXZ(&)O='1O;2<^("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=F;VYT+7=E:6=H=#H@8F]L9"<^("`@("`-"B`@("`@("`@("`F(S$V,#L@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V9O
M;G0M=V5I9VAT.B!B;VQD.R!P861D:6YG+6)O='1O;3H@,2XQ<'0G/B`@(`T*
M("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@8V]L<W!A;CTS1#<@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O;&0[
M('1E>'0M86QI9VXZ(&-E;G1E<CL@8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ
M<'0@<V]L:60G/B`-"B`@("`@("`@("`R,#$T("`@("`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O
M;&0[('!A9&1I;F<M8F]T=&]M.B`Q+C%P="<^("`@#0H@("`@("`@("`@)B,Q
M-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!C;VQS<&%N
M/3-$-R!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@=&5X="UA;&EG;CH@
M8V5N=&5R.R!B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9"<^(`T*
M("`@("`@("`@(#(P,3,@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`\+W1R/B`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N
M.B!B;W1T;VTG/B`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G9F]N="UW96EG
M:'0Z(&)O;&0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@
M8F]L9#L@<&%D9&EN9RUB;W1T;VTZ(#$N,7!T)SX@("`-"B`@("`@("`@("`F
M(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&-O;'-P
M86X],T0S('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N
M.B!C96YT97([(&)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED)SX@
M#0H@("`@("`@("`@/'`@<W1Y;&4],T0G;6%R9VEN+71O<#H@,#L@;6%R9VEN
M+6)O='1O;3H@,"<^("`@("`-"B`@("`@("`@("`@(%1O=&%L("`@#0H@("`@
M("`@("`@/"]P/B`-"B`@("`@("`@("`\<"!S='EL93TS1"=M87)G:6XM=&]P
M.B`P.R!M87)G:6XM8F]T=&]M.B`P)SX@("`@(`T*("`@("`@("`@("`@4F5V
M96YU92`@("`@#0H@("`@("`@("`@/"]P/B`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O;&0[('!A
M9&1I;F<M8F]T=&]M.B`Q+C%P="<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!C;VQS<&%N/3-$,R!S
M='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@=&5X="UA;&EG;CH@8V5N=&5R
M.R!B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9"<^(`T*("`@("`@
M("`@(#QP('-T>6QE/3-$)VUA<F=I;BUT;W`Z(#`[(&UA<F=I;BUB;W1T;VTZ
M(#`G/B`@("`@#0H@("`@("`@("`@("!097)C96YT86=E(&]F(`T*("`@("`@
M("`@(#PO<#X@#0H@("`@("`@("`@/'`@<W1Y;&4],T0G;6%R9VEN+71O<#H@
M,#L@;6%R9VEN+6)O='1O;3H@,"<^("`@("`-"B`@("`@("`@("`@(%)E=F5N
M=64@("`@(`T*("`@("`@("`@(#PO<#X@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!P861D
M:6YG+6)O='1O;3H@,2XQ<'0G/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@8V]L<W!A;CTS1#,@<W1Y
M;&4],T0G9F]N="UW96EG:'0Z(&)O;&0[('1E>'0M86QI9VXZ(&-E;G1E<CL@
M8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60G/B`-"B`@("`@("`@
M("`\<"!S='EL93TS1"=M87)G:6XM=&]P.B`P.R!M87)G:6XM8F]T=&]M.B`P
M)SX@("`@(`T*("`@("`@("`@("`@5&]T86P@("`-"B`@("`@("`@("`\+W`^
M(`T*("`@("`@("`@(#QP('-T>6QE/3-$)VUA<F=I;BUT;W`Z(#`[(&UA<F=I
M;BUB;W1T;VTZ(#`G/B`@("`@#0H@("`@("`@("`@("!2979E;G5E("`@("`-
M"B`@("`@("`@("`\+W`^(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@<&%D9&EN9RUB;W1T
M;VTZ(#$N,7!T)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)V9O
M;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97([(&)O<F1E<BUB
M;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED)SX@#0H@("`@("`@("`@/'`@<W1Y
M;&4],T0G;6%R9VEN+71O<#H@,#L@;6%R9VEN+6)O='1O;3H@,"<^("`@("`-
M"B`@("`@("`@("`@(%!E<F-E;G1A9V4@;V8@#0H@("`@("`@("`@/"]P/B`-
M"B`@("`@("`@("`\<"!S='EL93TS1"=M87)G:6XM=&]P.B`P.R!M87)G:6XM
M8F]T=&]M.B`P)SX@("`@(`T*("`@("`@("`@("`@4F5V96YU92`@("`@#0H@
M("`@("`@("`@/"]P/B`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@/"]T
M<CX@("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T
M=&]M.R!B86-K9W)O=6YD+6-O;&]R.B!R9V(H,C`T+#(S."PR-34I)SX@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@=&5X
M="UA;&EG;CH@;&5F="<^("`@#0H@("`@("`@("`@1V5O9W)A<&AI8R!,;V-A
M=&EO;CH@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)V9O;G0M=V5I9VAT.B!B;VQD)SX@("`@(`T*("`@("`@("`@("8C,38P
M.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M9F]N="UW96EG:'0Z(&)O;&0[('1E>'0M86QI9VXZ(&QE9G0G/B`@(`T*("`@
M("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O;&0[('1E>'0M86QI9VXZ(')I
M9VAT)SX@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@
M=&5X="UA;&EG;CH@;&5F="<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9#X@("`@#0H@("`@("`@("`@
M)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@("`@("`@("`@)B,Q-C`[
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T
M97AT+6%L:6=N.B!R:6=H="<^("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V9O;G0M=V5I9VAT
M.B!B;VQD)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O
M;&0[('1E>'0M86QI9VXZ(&QE9G0G/B`@(`T*("`@("`@("`@("8C,38P.R`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G9F]N
M="UW96EG:'0Z(&)O;&0[('1E>'0M86QI9VXZ(')I9VAT)SX@("`@#0H@("`@
M("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@=&5X="UA;&EG;CH@;&5F
M="<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9#X@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N
M.B!L969T)SX@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H
M="<^("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@
M("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@(#PO='(^("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI
M9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@5VAI=&4G/B`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#4V)3L@=&5X="UA;&EG;CH@;&5F
M=#L@<&%D9&EN9RUL969T.B`Q,'!T)SX@#0H@("`@("`@("`@56YI=&5D(%-T
M871E<R`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G=VED=&@Z(#$E)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E
M.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@("0@(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@
M."4[('1E>'0M86QI9VXZ(')I9VAT)SX@#0H@("`@("`@("`@,3@L-#4U+#$V
M-R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M=VED=&@Z(#$E.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@
M("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G=VED=&@Z(#$E)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E
M.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED
M=&@Z(#@E.R!T97AT+6%L:6=N.B!R:6=H="<^(`T*("`@("`@("`@(#@T("`@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I
M9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@("`E
M("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M=VED=&@Z(#$E)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!T97AT
M+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@("0@(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@."4[('1E
M>'0M86QI9VXZ(')I9VAT)SX@#0H@("`@("`@("`@,30L-#@U+#@R,2`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z
M(#$E.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@("8C,38P
M.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M=VED=&@Z(#$E)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!T97AT
M+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#@E
M.R!T97AT+6%L:6=N.B!R:6=H="<^(`T*("`@("`@("`@(#@R("`@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q
M)3L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@("`E("`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@/"]T<CX@("`-"B`@("`@(#QT<B!S
M='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O
M;&]R.B!R9V(H,C`T+#(S."PR-34I)SX@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=T97AT+6%L:6=N.B!L969T.R!P861D:6YG+6QE9G0Z(#$P<'0G/B`@
M("`-"B`@("`@("`@("!%=7)O<&4@(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9#X@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L
M969T)SX@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^
M("`@("`-"B`@("`@("`@("`Q+#<X-"PT,30@("`@(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T
M)SX@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9#X@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N
M.B!L969T)SX@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H
M="<^("`@("`-"B`@("`@("`@("`X("`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*
M("`@("`@("`@("4@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9#X@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@
M#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^("`@("`-"B`@
M("`@("`@("`Q+#8U-BPV-38@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@
M("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9#X@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@
M("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^("`@("`-
M"B`@("`@("`@("`Y("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@
M("4@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\+W1R/B`@(`T*("`@
M("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG
M<F]U;F0M8V]L;W(Z(%=H:71E)SX@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F<M8F]T=&]M.B`Q+C%P=#L@<&%D
M9&EN9RUL969T.B`Q,'!T)SX@(`T*("`@("`@("`@($]T:&5R(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O
M='1O;3H@,2XQ<'0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T
M;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!L969T)SX@("`-
M"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O
M;&ED.R!T97AT+6%L:6=N.B!R:6=H="<^("`@(`T*("`@("`@("`@(#$L.#$U
M+#@T,B`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT
M+6%L:6=N.B!L969T)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T
M=&]M.B`Q+C%P="<^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O
M;3H@0FQA8VL@,2XQ<'0@<V]L:60[('1E>'0M86QI9VXZ(&QE9G0G/B`@(`T*
M("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L
M:60[('1E>'0M86QI9VXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@."`@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E
M<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!L969T
M)SX@("`-"B`@("`@("`@("`E("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#$N,7!T)SX@("`@
M#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S
M;VQI9#L@=&5X="UA;&EG;CH@;&5F="<^("`@#0H@("`@("`@("`@)B,Q-C`[
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B
M;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9#L@=&5X="UA;&EG;CH@
M<FEG:'0G/B`@("`-"B`@("`@("`@("`Q+#8Q,2PY-C$@("`@(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T
M=&]M.B!";&%C:R`Q+C%P="!S;VQI9#L@=&5X="UA;&EG;CH@;&5F="<^("`@
M#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,2XQ<'0G/B`@("`-
M"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O
M;&ED.R!T97AT+6%L:6=N.B!L969T)SX@("`-"B`@("`@("`@("`F(S$V,#L@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O
M<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!R
M:6=H="<^("`@(`T*("`@("`@("`@(#D@(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q
M+C%P="!S;VQI9#L@=&5X="UA;&EG;CH@;&5F="<^("`@#0H@("`@("`@("`@
M)2`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@
M("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R
M;W5N9"UC;VQO<CH@<F=B*#(P-"PR,S@L,C4U*2<^("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#L@<&%D9&EN9RUB;W1T;VTZ
M(#(N-S5P=#L@<&%D9&EN9RUL969T.B`R,'!T)SX@("`-"B`@("`@("`@("!4
M;W1A;"`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G<&%D9&EN9RUB;W1T;VTZ(#(N-S5P="<^("`@("`-"B`@("`@("`@("`F
M(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[('1E>'0M
M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@)"`@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ
M($)L86-K(#(N-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT)SX@#0H@
M("`@("`@("`@,C(L,#4U+#0R,R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T
M(&1O=6)L93L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@("`F
M(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W!A9&1I;F<M8F]T=&]M.B`R+C<U<'0G/B`@("`@#0H@("`@("`@("`@
M)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T97AT
M+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@<FEG:'0G
M/B`-"B`@("`@("`@("`Q,#`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P
M="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@
M)2`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)W!A9&1I;F<M8F]T=&]M.B`R+C<U<'0G/B`@("`@#0H@("`@("`@("`@)B,Q
M-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T97AT+6%L
M:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@("0@(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!"
M;&%C:R`R+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^(`T*("`@
M("`@("`@(#$W+#<U-"PT,S@@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P="!D
M;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@)B,Q
M-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=P861D:6YG+6)O='1O;3H@,BXW-7!T)SX@("`@(`T*("`@("`@("`@("8C
M,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA
M;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T
M;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT)SX@
M#0H@("`@("`@("`@,3`P("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C<U<'0@
M9&]U8FQE.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@("4@
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\+W1R/B`@(`T*("`@(#PO
M=&%B;&4^/&)R+SX\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG
M/3-$,"!S='EL93TS1"=B;W)D97(M8V]L;&%P<V4Z(&-O;&QA<'-E.R!W:61T
M:#H@,3`P)3L@9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^("`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N
M.B!B;W1T;VTG/B`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G9F]N="UW96EG
M:'0Z(&)O;&0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@
M8F]L9"<^("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0Q-2!S='EL93TS1"=F;VYT
M+7=E:6=H=#H@8F]L9#L@=&5X="UA;&EG;CH@8V5N=&5R)SX@("`-"B`@("`@
M("`@("!.:6YE($UO;G1H<R!%;F1E9"!397!T96UB97(@,S`L("`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@/"]T<CX@("`-"B`@("`@(#QT<B!S='EL
M93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M)SX@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD)SX@("`@(`T*("`@("`@("`@
M("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G9F]N="UW96EG:'0Z(&)O;&0[('!A9&1I;F<M8F]T=&]M.B`Q+C%P
M="<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!C;VQS<&%N/3-$-R!S='EL93TS1"=F;VYT+7=E:6=H
M=#H@8F]L9#L@=&5X="UA;&EG;CH@8V5N=&5R.R!B;W)D97(M8F]T=&]M.B!"
M;&%C:R`Q+C%P="!S;VQI9"<^(`T*("`@("`@("`@(#(P,30@("`@(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=F;VYT+7=E
M:6=H=#H@8F]L9#L@<&%D9&EN9RUB;W1T;VTZ(#$N,7!T)SX@("`-"B`@("`@
M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M(&-O;'-P86X],T0W('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT
M+6%L:6=N.B!C96YT97([(&)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O
M;&ED)SX@#0H@("`@("`@("`@,C`Q,R`@("`@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@(#PO='(^("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC
M86PM86QI9VXZ(&)O='1O;2<^("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=F
M;VYT+7=E:6=H=#H@8F]L9"<^("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V9O;G0M
M=V5I9VAT.B!B;VQD.R!P861D:6YG+6)O='1O;3H@,2XQ<'0G/B`@(`T*("`@
M("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@8V]L<W!A;CTS1#,@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O;&0[('1E
M>'0M86QI9VXZ(&-E;G1E<CL@8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@
M<V]L:60G/B`-"B`@("`@("`@("`\<"!S='EL93TS1"=M87)G:6XM=&]P.B`P
M.R!M87)G:6XM8F]T=&]M.B`P)SX@("`@(`T*("`@("`@("`@("`@5&]T86P@
M("`-"B`@("`@("`@("`\+W`^(`T*("`@("`@("`@(#QP('-T>6QE/3-$)VUA
M<F=I;BUT;W`Z(#`[(&UA<F=I;BUB;W1T;VTZ(#`G/B`@("`@#0H@("`@("`@
M("`@("!2979E;G5E("`@("`-"B`@("`@("`@("`\+W`^(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@
M8F]L9#L@<&%D9&EN9RUB;W1T;VTZ(#$N,7!T)SX@("`-"B`@("`@("`@("`F
M(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&-O;'-P
M86X],T0S('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N
M.B!C96YT97([(&)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED)SX@
M#0H@("`@("`@("`@/'`@<W1Y;&4],T0G;6%R9VEN+71O<#H@,#L@;6%R9VEN
M+6)O='1O;3H@,"<^("`@("`-"B`@("`@("`@("`@(%!E<F-E;G1A9V4@;V8@
M#0H@("`@("`@("`@/"]P/B`-"B`@("`@("`@("`\<"!S='EL93TS1"=M87)G
M:6XM=&]P.B`P.R!M87)G:6XM8F]T=&]M.B`P)SX@("`@(`T*("`@("`@("`@
M("`@4F5V96YU92`@("`@#0H@("`@("`@("`@/"]P/B`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O
M;&0[('!A9&1I;F<M8F]T=&]M.B`Q+C%P="<^("`@#0H@("`@("`@("`@)B,Q
M-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!C;VQS<&%N
M/3-$,R!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@=&5X="UA;&EG;CH@
M8V5N=&5R.R!B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9"<^(`T*
M("`@("`@("`@(#QP('-T>6QE/3-$)VUA<F=I;BUT;W`Z(#`[(&UA<F=I;BUB
M;W1T;VTZ(#`G/B`@("`@#0H@("`@("`@("`@("!4;W1A;"`@(`T*("`@("`@
M("`@(#PO<#X@#0H@("`@("`@("`@/'`@<W1Y;&4],T0G;6%R9VEN+71O<#H@
M,#L@;6%R9VEN+6)O='1O;3H@,"<^("`@("`-"B`@("`@("`@("`@(%)E=F5N
M=64@("`@(`T*("`@("`@("`@(#PO<#X@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!P861D
M:6YG+6)O='1O;3H@,2XQ<'0G/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@8V]L<W!A;CTS1#,@<W1Y
M;&4],T0G9F]N="UW96EG:'0Z(&)O;&0[('1E>'0M86QI9VXZ(&-E;G1E<CL@
M8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60G/B`-"B`@("`@("`@
M("`\<"!S='EL93TS1"=M87)G:6XM=&]P.B`P.R!M87)G:6XM8F]T=&]M.B`P
M)SX@("`@(`T*("`@("`@("`@("`@4&5R8V5N=&%G92!O9B`-"B`@("`@("`@
M("`\+W`^(`T*("`@("`@("`@(#QP('-T>6QE/3-$)VUA<F=I;BUT;W`Z(#`[
M(&UA<F=I;BUB;W1T;VTZ(#`G/B`@("`@#0H@("`@("`@("`@("!2979E;G5E
M("`@("`-"B`@("`@("`@("`\+W`^(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`\+W1R/B`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L
M:6=N.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z(')G8B@R,#0L,C,X+#(U
M-2DG/B`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B
M;VQD.R!T97AT+6%L:6=N.B!L969T)SX@("`-"B`@("`@("`@("!'96]G<F%P
M:&EC($QO8V%T:6]N.B`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O;&0G/B`@("`@#0H@("`@("`@
M("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@=&5X="UA;&EG;CH@;&5F="<^
M("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@=&5X="UA
M;&EG;CH@<FEG:'0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V9O;G0M=V5I9VAT
M.B!B;VQD.R!T97AT+6%L:6=N.B!L969T)SX@("`-"B`@("`@("`@("`F(S$V
M,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D/B`@("`-"B`@
M("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("8C
M,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@("8C,38P.R`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G9F]N
M="UW96EG:'0Z(&)O;&0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=F;VYT+7=E
M:6=H=#H@8F]L9#L@=&5X="UA;&EG;CH@;&5F="<^("`@#0H@("`@("`@("`@
M)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@=&5X="UA;&EG;CH@<FEG:'0G/B`@
M("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L
M:6=N.B!L969T)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D/B`@("`-"B`@("`@("`@("`F(S$V,#L@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@
M;&5F="<^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@/"]T<CX@("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T
M:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B!7:&ET92<^
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@-38E.R!T97AT+6%L
M:6=N.B!L969T.R!P861D:6YG+6QE9G0Z(#$P<'0G/B`-"B`@("`@("`@("!5
M;FET960@4W1A=&5S("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=W:61T:#H@,24G/B`@#0H@("`@("`@("`@)B,Q-C`[
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W
M:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@
M)"`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)W=I9'1H.B`X)3L@=&5X="UA;&EG;CH@<FEG:'0G/B`-"B`@("`@("`@("`W
M,BPY,S4L-S(R(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=W:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@
M("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=W:61T:#H@,24G/B`@#0H@("`@("`@("`@)B,Q-C`[
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W
M:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@
M)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=W:61T:#H@."4[('1E>'0M86QI9VXZ(')I9VAT)SX@#0H@("`@("`@
M("`@.#D@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G=VED=&@Z(#$E.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@
M("`@("`@("4@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=W:61T:#H@,24G/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@
M,24[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@)"`@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H
M.B`X)3L@=&5X="UA;&EG;CH@<FEG:'0G/B`-"B`@("`@("`@("`T,BPR-3$L
M,S,V(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=W:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@
M("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=W:61T:#H@,24G/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@
M,24[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W
M:61T:#H@."4[('1E>'0M86QI9VXZ(')I9VAT)SX@#0H@("`@("`@("`@-S@@
M("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M=VED=&@Z(#$E.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@
M("4@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\+W1R/B`@(`T*("`@
M("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG
M<F]U;F0M8V]L;W(Z(')G8B@R,#0L,C,X+#(U-2DG/B`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F<M;&5F=#H@
M,3!P="<^("`@(`T*("`@("`@("`@($5U<F]P92`@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(')I9VAT)SX@("`@(`T*("`@("`@("`@(#4L,C<T+#`W,2`@("`@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D/B`@("`-"B`@("`@("`@("`F(S$V,#L@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@(#8@(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T
M)SX@("`@#0H@("`@("`@("`@)2`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE
M9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX@
M("`@(`T*("`@("`@("`@(#4L,C(V+#8Q.2`@("`@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G
M/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT
M)SX@("`@(`T*("`@("`@("`@(#$P("`@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-
M"B`@("`@("`@("`E("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@/"]T
M<CX@("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T
M=&]M.R!B86-K9W)O=6YD+6-O;&]R.B!7:&ET92<^("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!P861D:6YG+6)O='1O;3H@
M,2XQ<'0[('!A9&1I;F<M;&5F=#H@,3!P="<^("`-"B`@("`@("`@("!/=&AE
M<B`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M<&%D9&EN9RUB;W1T;VTZ(#$N,7!T)SX@("`@#0H@("`@("`@("`@)B,Q-C`[
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B
M;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9#L@=&5X="UA;&EG;CH@
M;&5F="<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C
M:R`Q+C%P="!S;VQI9#L@=&5X="UA;&EG;CH@<FEG:'0G/B`@("`-"B`@("`@
M("`@("`T+#$S,"PU-S<@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S
M;VQI9#L@=&5X="UA;&EG;CH@;&5F="<^("`@#0H@("`@("`@("`@)B,Q-C`[
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P
M861D:6YG+6)O='1O;3H@,2XQ<'0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O
M<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!L
M969T)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K
M(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!R:6=H="<^("`@(`T*("`@("`@
M("`@(#4@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9#L@=&5X="UA
M;&EG;CH@;&5F="<^("`@#0H@("`@("`@("`@)2`@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`Q
M+C%P="<^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA
M8VL@,2XQ<'0@<V]L:60[('1E>'0M86QI9VXZ(&QE9G0G/B`@(`T*("`@("`@
M("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60[('1E
M>'0M86QI9VXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@-BPS-3$L.#<Q("`@
M("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60[('1E>'0M86QI9VXZ
M(&QE9G0G/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#$N
M,7!T)SX@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C
M:R`Q+C%P="!S;VQI9#L@=&5X="UA;&EG;CH@;&5F="<^("`@#0H@("`@("`@
M("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9#L@=&5X
M="UA;&EG;CH@<FEG:'0G/B`@("`-"B`@("`@("`@("`Q,B`@(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T
M=&]M.B!";&%C:R`Q+C%P="!S;VQI9#L@=&5X="UA;&EG;CH@;&5F="<^("`@
M#0H@("`@("`@("`@)2`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO
M='(^("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O
M='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@<F=B*#(P-"PR,S@L,C4U*2<^("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#L@<&%D
M9&EN9RUB;W1T;VTZ(#(N-S5P=#L@<&%D9&EN9RUL969T.B`R,'!T)SX@("`-
M"B`@("`@("`@("!4;W1A;"`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#(N-S5P="<^("`@("`-
M"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P="!D
M;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@)"`@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O
M<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ
M(')I9VAT)SX@#0H@("`@("`@("`@.#(L,S0P+#,W,"`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@
M0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-
M"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R+C<U<'0G/B`@("`@
M#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C<U<'0@
M9&]U8FQE.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@("8C
M,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA
M;&EG;CH@<FEG:'0G/B`-"B`@("`@("`@("`Q,#`@("`@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ
M($)L86-K(#(N-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@
M#0H@("`@("`@("`@)2`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R+C<U<'0G/B`@("`@#0H@
M("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U
M8FQE.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@("0@(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D
M97(M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R
M:6=H="<^(`T*("`@("`@("`@(#4S+#@R.2PX,C8@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L
M86-K(#(N-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@
M("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,BXW-7!T)SX@("`@(`T*
M("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O
M=6)L93L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@("`F(S$V
M,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[('1E>'0M86QI
M9VXZ(')I9VAT)SX@#0H@("`@("`@("`@,3`P("`@(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!"
M;&%C:R`R+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*
M("`@("`@("`@("4@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\+W1R
M/B`@(`T*("`@(#PO=&%B;&4^/&)R+SX\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*
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M/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT
M='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[
M(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP
M="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT
M("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA
M<W,],T1R97!O<G0@:60],T1)1#!%344^#0H@("`@("`\='(^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O
M;F<^3F]T92`Q-"`M(%)E<W1R=6-T=7)I;F<@0W)E9&ET<SQB<CX\+W-T<F]N
M9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XY
M($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y397`N(#,P+"`R,#$T/&)R/CPO=&@^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E)E<W1R=6-T
M=7)I;F<@86YD(%)E;&%T960@06-T:79I=&EE<R!;06)S=')A8W1=/"]S=')O
M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y297-T<G5C
M='5R:6YG(&%N9"!296QA=&5D($%C=&EV:71I97,@1&ES8VQO<W5R92!;5&5X
M="!";&]C:UT\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\=&%B
M;&4@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[('=I9'1H.B`Q,#`E.R!B;W)D97(M8V]L;&%P<V4Z
M(&-O;&QA<'-E)SX@("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM
M86QI9VXZ('1O<"<^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H
M.B`V)3L@9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9B<^("`@(`T*("`@("`@("`@(#QB/C$T+CPO8CX@("`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#DT)3L@9F]N
M=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^("`@("`-
M"B`@("`@("`@("`\8CY297-T<G5C='5R:6YG($-R961I=',\+V(^(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`\+W1R/B`@(`T*("`@(#PO=&%B;&4^
M/&)R+SX\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M:6YD96YT.B`P+C5I;B<^
M("`@(`T*("`@("`@26X@1&5C96UB97(@,C`Q,BP@=&AE($-O;7!A;GD@86YN
M;W5N8V5D('1H92!C;&]S=7)E(&]F(&ET<R!T:7-S=64@96YG:6YE97)I;F<@
M9F%C:6QI='D@:6X@06)A;F\@5&5R;64L($ET86QY(&1U92!T;R!T:&4@0V]M
M<&%N>28C.#(Q-SMS(&EN86)I;&ET>2!T;R!M965T('-T<FEC="!R96=U;&%T
M;W)Y('-T86YD87)D<R!E<W1A8FQI<VAE9"!B>2!T:&4@175R;W!E86X@365D
M:6-I;F5S($%G96YC>2`H)B,X,C(P.T5-028C.#(R,3LI(&9O<B!!9'9A;F-E
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M<R!I;B!T:&4@9F]U<G1H('%U87)T97(@;V8@,C`Q,B!O9B!A<'!R;WAI;6%T
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M="P@)#`N,R!M:6QL:6]N('=A<R!R96QA=&5D('1O('1H92!D:7-P;W-A;"!O
M9B!P<F]P97)T>2!A;F0@97%U:7!M96YT+"!A;F0@)#`N,2!M:6QL:6]N('=A
M<R!R96QA=&5D('1O('1H92!D:7-P;W-A;"!O9B!I;G9E;G1O<GDN(%=E(&-O
M;7!L971E9"!T:&4@<F5S=')U8W1U<FEN9R!P;&%N(&%N9"!R96QA=&5D(&%C
M=&EV:71I97,@:6X@,C`Q,RX@0V5R=&%I;B!P<F5V:6]U<VQY(&EM<&%I<F5D
M(&%N9"`@("`@#0H@("`@("!W<FET=&5N+6]F9B!E<75I<&UE;G0@=V%S('-O
M;&0L(')E<W5L=&EN9R!I;B!R97-T<G5C='5R:6YG(&-R961I=',@;V8@)#$Y
M-BPP.#0@86YD("0T-#(L.#8Y(&EN('1H92!T:')E92!A;F0@;FEN92!M;VYT
M:',@96YD960@4V5P=&5M8F5R(#,P+"`R,#$S+"!R97-P96-T:79E;'DN("`-
M"B`@("`\+W`^/&)R+SX\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M:6YD96YT
M.B`P+C5I;B<^("`@("`-"B`@("`@(%1H92!F;VQL;W=I;F<@=&%B;&4@<W5M
M;6%R:7IE<R!R97-T<G5C='5R:6YG(&%C8W)U86P@86-T:79I='D@9F]R('1H
M92!N:6YE+7!E<FEO9"!E;F1E9"!397!T96UB97(@,S`L(#(P,30Z("`@(`T*
M("`@(#PO<#X\8G(O/CQT86)L92!C96QL<&%D9&EN9STS1#`@8V5L;'-P86-I
M;F<],T0P('-T>6QE/3-$)V)O<F1E<BUC;VQL87!S93H@8V]L;&%P<V4[('=I
M9'1H.B`Q,#`E.R!F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF)SX@("`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L
M:6=N.B!B;W1T;VTG/B`@(`T*("`@("`@("`\=&0^("`@(`T*("`@("`@("`@
M("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G9F]N="UW96EG:'0Z(&)O;&0[('!A9&1I;F<M8F]T=&]M.B`Q+C%P
M="<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!C;VQS<&%N/3-$,3$@<W1Y;&4],T0G9F]N="UW96EG
M:'0Z(&)O;&0[('1E>'0M86QI9VXZ(&-E;G1E<CL@8F]R9&5R+6)O='1O;3H@
M0FQA8VL@,2XQ<'0@<V]L:60G/B`@#0H@("`@("`@("`@4F5S=')U8W1U<FEN
M9R!!8V-R=6%L("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@/"]T<CX@
M("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M
M)SX@("`-"B`@("`@("`@/'1D/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V9O;G0M
M=V5I9VAT.B!B;VQD.R!P861D:6YG+6)O='1O;3H@,2XQ<'0G/B`@(`T*("`@
M("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@8V]L<W!A;CTS1#,@;F]W<F%P/3-$;F]W<F%P('-T>6QE/3-$)V9O;G0M
M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97([(&)O<F1E<BUB;W1T
M;VTZ($)L86-K(#$N,7!T('-O;&ED)SX@(`T*("`@("`@("`@(#QP('-T>6QE
M/3-$)VUA<F=I;BUT;W`Z(#`[(&UA<F=I;BUB;W1T;VTZ(#`G/B`@("`@#0H@
M("`@("`@("`@("!%;7!L;WEE92`-"B`@("`@("`@("`\+W`^(`T*("`@("`@
M("`@(#QP('-T>6QE/3-$)VUA<F=I;BUT;W`Z(#`[(&UA<F=I;BUB;W1T;VTZ
M(#`G/B`@("`@#0H@("`@("`@("`@("!3979E<F%N8V4@86YD(`T*("`@("`@
M("`@(#PO<#X@#0H@("`@("`@("`@/'`@<W1Y;&4],T0G;6%R9VEN+71O<#H@
M,#L@;6%R9VEN+6)O='1O;3H@,"<^("`@("`-"B`@("`@("`@("`@(%)E;&%T
M960@0F5N969I=',@("`@#0H@("`@("`@("`@/"]P/B`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O
M;&0[('!A9&1I;F<M8F]T=&]M.B`Q+C%P="<^("`@#0H@("`@("`@("`@)B,Q
M-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!C;VQS<&%N
M/3-$,R!N;W=R87`],T1N;W=R87`@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O
M;&0[('1E>'0M86QI9VXZ(&-E;G1E<CL@8F]R9&5R+6)O='1O;3H@0FQA8VL@
M,2XQ<'0@<V]L:60G/B`@#0H@("`@("`@("`@/'`@<W1Y;&4],T0G;6%R9VEN
M+71O<#H@,#L@;6%R9VEN+6)O='1O;3H@,"<^("`@("`-"B`@("`@("`@("`@
M($%C=&EV:71Y(`T*("`@("`@("`@(#PO<#X@#0H@("`@("`@("`@/'`@<W1Y
M;&4],T0G;6%R9VEN+71O<#H@,#L@;6%R9VEN+6)O='1O;3H@,"<^("`@("`-
M"B`@("`@("`@("`@(%1E<FUI;F%T:6]N(&%N9"`@(`T*("`@("`@("`@(#PO
M<#X@#0H@("`@("`@("`@/'`@<W1Y;&4],T0G;6%R9VEN+71O<#H@,#L@;6%R
M9VEN+6)O='1O;3H@,"<^("`@("`-"B`@("`@("`@("`@($9A8VEL:71Y($-L
M;W-U<F4@("`@#0H@("`@("`@("`@/"]P/B`-"B`@("`@("`@("`\<"!S='EL
M93TS1"=M87)G:6XM=&]P.B`P.R!M87)G:6XM8F]T=&]M.B`P)SX@("`@(`T*
M("`@("`@("`@("`@0V]S=',@("`-"B`@("`@("`@("`\+W`^(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=F;VYT+7=E:6=H
M=#H@8F]L9#L@<&%D9&EN9RUB;W1T;VTZ(#$N,7!T)SX@("`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&-O
M;'-P86X],T0S(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=F;VYT+7=E:6=H
M=#H@8F]L9#L@=&5X="UA;&EG;CH@8V5N=&5R.R!B;W)D97(M8F]T=&]M.B!"
M;&%C:R`Q+C%P="!S;VQI9"<^("`-"B`@("`@("`@("!4;W1A;"`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@/"]T<CX@("`-"B`@("`@(#QT<B!S='EL
M93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R
M.B!R9V(H,C`T+#(S."PR-34I)SX@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=W:61T:#H@-C<E.R!T97AT+6%L:6=N.B!L969T)SX@#0H@("`@("`@("`@
M1&5C96UB97(@,S$L(#(P,3,@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E)SX@(`T*("`@("`@("`@("8C
M,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G=VED=&@Z(#$E.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@
M("`@("0@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=W:61T:#H@."4[('1E>'0M86QI9VXZ(')I9VAT)SX@#0H@("`@("`@
M("`@,C$L-S`Y("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G=VED=&@Z(#$E.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*
M("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E)SX@(`T*("`@("`@("`@("8C,38P
M.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M=VED=&@Z(#$E.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@
M("0@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=W:61T:#H@."4[('1E>'0M86QI9VXZ(')I9VAT)SX@#0H@("`@("`@("`@
M,BPY,CD@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@
M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W=I9'1H.B`Q)2<^("`-"B`@("`@("`@("`F(S$V,#L@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H
M.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@("`D("`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED
M=&@Z(#@E.R!T97AT+6%L:6=N.B!R:6=H="<^(`T*("`@("`@("`@(#(T+#8S
M."`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@
M#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@
M8F%C:V=R;W5N9"UC;VQO<CH@5VAI=&4G/B`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@($-A<V@@
M4')O8V5E9',@*$1I<V)U<G-E;65N=',I("`@("`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@
M<FEG:'0G/B`@("`@#0H@("`@("`@("`@*#$P+#$S,"`@(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L
M969T)SX@("`@#0H@("`@("`@("`@*2`@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT
M)SX@("`@(`T*("`@("`@("`@("@Q+#0R-2`@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@
M("`-"B`@("`@("`@("`I("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^
M("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/B`@("`@
M#0H@("`@("`@("`@*#$Q+#4U-2`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@
M("`@("`@("`@*2`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^
M("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O
M;3L@8F%C:V=R;W5N9"UC;VQO<CH@<F=B*#(P-"PR,S@L,C4U*2<^("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#L@<&%D9&EN
M9RUB;W1T;VTZ(#$N,7!T)SX@(`T*("`@("`@("`@($9O<F5I9VX@17AC:&%N
M9V4@26UP86-T("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,2XQ<'0G/B`@("`-"B`@("`@
M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T
M97AT+6%L:6=N.B!L969T)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB
M;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!R:6=H="<^
M("`@(`T*("`@("`@("`@("@Q+#`U,"`@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N
M,7!T('-O;&ED.R!T97AT+6%L:6=N.B!L969T)SX@("`-"B`@("`@("`@("`I
M("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M<&%D9&EN9RUB;W1T;VTZ(#$N,7!T)SX@("`@#0H@("`@("`@("`@)B,Q-C`[
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B
M;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9#L@=&5X="UA;&EG;CH@
M;&5F="<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C
M:R`Q+C%P="!S;VQI9#L@=&5X="UA;&EG;CH@<FEG:'0G/B`@("`-"B`@("`@
M("`@("`H,3(T("`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60[
M('1E>'0M86QI9VXZ(&QE9G0G/B`@(`T*("`@("`@("`@("D@(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O
M='1O;3H@,2XQ<'0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T
M;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!L969T)SX@("`-
M"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O
M;&ED.R!T97AT+6%L:6=N.B!R:6=H="<^("`@(`T*("`@("`@("`@("@Q+#$W
M-"`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N
M.B!L969T)SX@("`-"B`@("`@("`@("`I("`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@/"]T<CX@("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A
M;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B!7:&ET92<^("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!P861D
M:6YG+6)O='1O;3H@,BXW-7!T)SX@("`-"B`@("`@("`@("!397!T96UB97(@
M,S`L(#(P,30@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R+C<U<'0G/B`@("`@#0H@("`@
M("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE
M.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@("0@(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M
M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H
M="<^(`T*("`@("`@("`@(#$P+#4R.2`@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N
M-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@
M("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=P861D:6YG+6)O='1O;3H@,BXW-7!T)SX@("`@(`T*("`@("`@
M("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@
M=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@("`D("`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@<FEG:'0G
M/B`-"B`@("`@("`@("`Q+#,X,"`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T
M(&1O=6)L93L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@("`F
M(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W!A9&1I;F<M8F]T=&]M.B`R+C<U<'0G/B`@("`@#0H@("`@("`@("`@
M)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T97AT
M+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@("0@(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M
M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^(`T*
M("`@("`@("`@(#$Q+#DP.2`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P="!D
M;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@)B,Q
M-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\+W1R/B`@(`T*("`@
M(#PO=&%B;&4^/&)R+SX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]
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M:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78]
M,T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]
M=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13
M:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I
M<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O
M<G0@:60],T1)1#!%344^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^3F]T92`Q
M-2`M($YE=R!!8V-O=6YT:6YG(%-T86YD87)D<SQB<CX\+W-T<F]N9SX\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XY($UO;G1H
M<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y397`N(#,P+"`R,#$T/&)R/CPO=&@^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D1I<V-L;W-U<F4@5&5X
M="!";&]C:R!;06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y$97-C<FEP=&EO;B!O9B!.97<@06-C;W5N=&EN
M9R!0<F]N;W5N8V5M96YT<R!.;W0@>65T($%D;W!T960@6U1E>'0@0FQO8VM=
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'1A8FQE(&-E;&QS
M<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!W:61T:#H@,3`P)3L@8F]R9&5R+6-O;&QA<'-E.B!C;VQL87!S
M92<^("`@("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@
M=&]P)SX@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#8E.R!F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@("`@
M#0H@("`@("`@("`@/&(^,34N/"]B/B`@(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@.30E.R!F;VYT.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@("`@(`T*("`@("`@
M("`@(#QB/DYE=R!!8V-O=6YT:6YG(%-T86YD87)D<SPO8CX@("`@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@/"]T86)L93X\
M8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68[(&UA<F=I;CH@,'!T(#`[('1E>'0M:6YD96YT.B`P+C5I
M;B<^("`@#0H@("`@("`\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G
M/DEN($IU;F4@,C`Q-"P@=&AE($9I;F%N8VEA;"!!8V-O=6YT:6YG(%-T86YD
M87)D<R!";V%R9"`H)B,X,C(P.T9!4T(F(S@R,C$[*2!I<W-U960@06-C;W5N
M=&EN9R!3=&%N9&%R9',@57!D871E("@B05-5(BD@3F\N/"]F;VYT/B`\9F]N
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M97%U:7-I=&4@<V5R=FEC92!H87,@("`-"B`@("`@(&%L<F5A9'D@8F5E;B!R
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M=#X@("`@#0H@("`@/"]P/CQB<B\^/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P<'0@,#L@
M=&5X="UI;F1E;G0Z(#`N-6EN)SX@("`@#0H@("`@("!);B!-87D@,C`Q-"P@
M=&AE($9!4T(@:7-S=65D($%352!.;RX@,C`Q-"TP.2P@(E)E=F5N=64@9G)O
M;2!#;VYT<F%C=',@=VET:"!#=7-T;VUE<G,N(B!!4U4@,C`Q-"TP.2!S=7!E
M<G-E9&5S('1H92!R979E;G5E(')E8V]G;FET:6]N(')E<75I<F5M96YT<R!I
M;B`B5&]P:6,@-C`U+"!2979E;G5E(%)E8V]G;FET:6]N(B!A;F0@<F5Q=6ER
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M<FEO9',@8F5G:6YN:6YG(&%F=&5R($1E8V5M8F5R(#$U+"`R,#$V+"!W:71H
M(&5A<FQY(&%P<&QI8V%T:6]N(&YO="!P97)M:71T960N(%1H92!#;VUP86YY
M(&ES(&-U<G)E;G1L>2!E=F%L=6%T:6YG('1H92!I;7!A8W0@;V8@=&AI<R!N
M97<@<W1A;F1A<F0@;VX@:71S(&-O;G-O;&ED871E9"!F:6YA;F-I86P@<W1A
M=&5M96YT<RX@("`-"B`@("`\+W`^/&)R+SX\<"!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#!P
M="`P.R!T97AT+6EN9&5N=#H@,"XU:6XG/B`@("`-"B`@("`@(#QF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P="<^26X@07!R:6P@,C`Q-"P@=&AE($9!
M4T(@:7-S=65D($%352!.;RX@,C`Q-"TP."P@(E)E<&]R=&EN9R!O9B!$:7-C
M;VYT:6YU960@3W!E<F%T:6]N<R!A;F0@1&ES8VQO<W5R97,@;V8@1&ES<&]S
M86QS(&]F($-O;7!O;F5N=',@;V8@86X@16YT:71Y+B(@05-5(#(P,30M,#@@
M<')O=FED97,@82!N87)R;W=E<B!D969I;FET:6]N(&]F(&1I<V-O;G1I;G5E
M9"!O<&5R871I;VYS('1H86X@=&AA="!P<F]V:61E9"!U;F1E<B!E>&ES=&EN
M9R!5+E,N($=!05`N($%352`R,#$T+3`X(')E<75I<F5S('1H870@;VYL>2!A
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M:79E;'D@9F]R(&1I<W!O<V%L<R`H;W(@8VQA<W-I9FEC871I;VYS(&%S(&AE
M;&0@9F]R(&1I<W!O<V%L*2!O9B!C;VUP;VYE;G1S(&]F(&%N(&5N=&ET>2!T
M:&%T(&]C8W5R(&EN(&%N;G5A;"!O<B!I;G1E<FEM('!E<FEO9',@8F5G:6YN
M:6YG(&%F=&5R($1E8V5M8F5R(#$U+"`R,#$T+B!4:&4@0V]M<&%N>2!D;V5S
M(&YO="!E>'!E8W0@=&AE(&%D;W!T:6]N(&]F($%352`R,#$T+3`X('1O(`T*
M("`@("`@:&%V92!A(&UA=&5R:6%L(&EM<&%C="!O;B!I=',@8V]N<V]L:61A
M=&5D(&9I;F%N8VEA;"!S=&%T96UE;G1S+CQF;VYT('-T>6QE/3-$)V9O;G0M
M9F%M:6QY.B!!<FEA;"P@2&5L=F5T:6-A+"!386YS+5-E<FEF)SX\+V9O;G0^
M/"]F;VYT/B8C,38P.R`@("`-"B`@("`\+W`^/&)R+SX\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*
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M.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@
M(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T
M97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O
M:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI
M<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\
M=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%344^#0H@("`@("`\='(^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X]
M,T0R/CQS=')O;F<^3F]T92`S("T@36%R:V5T86)L92!396-U<FET:65S("A4
M86)L97,I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H(&-O;'-P86X],T0Q/CD@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/E-E<"X@
M,S`L(#(P,30\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/CQS=')O;F<^1&ES8VQO<W5R92!497AT($)L;V-K(%-U<'!L96UE;G0@6T%B
M<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^36%R:V5T86)L92!396-U<FET:65S(%M486)L92!497AT($)L;V-K
M73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQT86)L92!C96QL
M<&%D9&EN9STS1#`@8V5L;'-P86-I;F<],T0P('-T>6QE/3-$)V)O<F1E<BUC
M;VQL87!S93H@8V]L;&%P<V4[('=I9'1H.B`Q,#`E.R!F;VYT.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@#0H@("`@("`\='(@<W1Y
M;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;2<^("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9"<^("`@("`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!P861D:6YG+6)O='1O;3H@,2XQ
M<'0G/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@8V]L<W!A;CTS1#$U('-T>6QE/3-$)V9O;G0M=V5I
M9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97([(&)O<F1E<BUB;W1T;VTZ
M($)L86-K(#$N,7!T('-O;&ED)SX@(`T*("`@("`@("`@(%-E<'1E;6)E<B`S
M,"P@,C`Q-"`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@/"]T<CX@
M("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M
M)SX@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD
M)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O;&0[('!A
M9&1I;F<M8F]T=&]M.B`Q+C%P="<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!C;VQS<&%N/3-$,R!S
M='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@=&5X="UA;&EG;CH@8V5N=&5R
M.R!B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9"<^(`T*("`@("`@
M("`@(#QP('-T>6QE/3-$)VUA<F=I;BUT;W`Z(#`[(&UA<F=I;BUB;W1T;VTZ
M(#`G/B`@("`@#0H@("`@("`@("`@("!!;6]R=&EZ960@(`T*("`@("`@("`@
M(#PO<#X@#0H@("`@("`@("`@/'`@<W1Y;&4],T0G;6%R9VEN+71O<#H@,#L@
M;6%R9VEN+6)O='1O;3H@,"<^("`@("`-"B`@("`@("`@("`@($-O<W0@(`T*
M("`@("`@("`@(#PO<#X@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!P861D:6YG+6)O='1O
M;3H@,2XQ<'0G/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@8V]L<W!A;CTS1#,@<W1Y;&4],T0G9F]N
M="UW96EG:'0Z(&)O;&0[('1E>'0M86QI9VXZ(&-E;G1E<CL@8F]R9&5R+6)O
M='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60G/B`-"B`@("`@("`@("`\<"!S='EL
M93TS1"=M87)G:6XM=&]P.B`P.R!M87)G:6XM8F]T=&]M.B`P)SX@("`@(`T*
M("`@("`@("`@("`@56YR96%L:7IE9"`@(`T*("`@("`@("`@(#PO<#X@#0H@
M("`@("`@("`@/'`@<W1Y;&4],T0G;6%R9VEN+71O<#H@,#L@;6%R9VEN+6)O
M='1O;3H@,"<^("`@("`-"B`@("`@("`@("`@($=A:6YS+"!.970@;V8@5&%X
M("`@("`-"B`@("`@("`@("`\+W`^(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@<&%D9&EN
M9RUB;W1T;VTZ(#$N,7!T)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0S('-T>6QE
M/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97([(&)O
M<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED)SX@#0H@("`@("`@("`@
M/'`@<W1Y;&4],T0G;6%R9VEN+71O<#H@,#L@;6%R9VEN+6)O='1O;3H@,"<^
M("`@("`-"B`@("`@("`@("`@(%5N<F5A;&EZ960@("`-"B`@("`@("`@("`\
M+W`^(`T*("`@("`@("`@(#QP('-T>6QE/3-$)VUA<F=I;BUT;W`Z(#`[(&UA
M<F=I;BUB;W1T;VTZ(#`G/B`@("`@#0H@("`@("`@("`@("!,;W-S97,L($YE
M="!O9B!487@@#0H@("`@("`@("`@/"]P/B`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O;&0[('!A
M9&1I;F<M8F]T=&]M.B`Q+C%P="<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!C;VQS<&%N/3-$,R!S
M='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@=&5X="UA;&EG;CH@8V5N=&5R
M.R!B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9"<^(`T*("`@("`@
M("`@(#QP('-T>6QE/3-$)VUA<F=I;BUT;W`Z(#`[(&UA<F=I;BUB;W1T;VTZ
M(#`G/B`@("`@#0H@("`@("`@("`@("!&86ER("`-"B`@("`@("`@("`\+W`^
M(`T*("`@("`@("`@(#QP('-T>6QE/3-$)VUA<F=I;BUT;W`Z(#`[(&UA<F=I
M;BUB;W1T;VTZ(#`G/B`@("`@#0H@("`@("`@("`@("!686QU92`@(`T*("`@
M("`@("`@(#PO<#X@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^
M("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O
M;3L@8F%C:V=R;W5N9"UC;VQO<CH@<F=B*#(P-"PR,S@L,C4U*2<^("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#4V)3L@=&5X="UA;&EG;CH@
M;&5F="<^(`T*("`@("`@("`@(%5N:71E9"!3=&%T97,@5')E87-U<GD@<V5C
M=7)I=&EE<R`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G=VED=&@Z(#$E)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z
M(#$E.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@("0@(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T
M:#H@."4[('1E>'0M86QI9VXZ(')I9VAT)SX@#0H@("`@("`@("`@,30L.3DY
M+#$V.2`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G=VED=&@Z(#$E.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@
M("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G=VED=&@Z(#$E)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z
M(#$E.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@("0@(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T
M:#H@."4[('1E>'0M86QI9VXZ(')I9VAT)SX@#0H@("`@("`@("`@-CDY("`@
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W
M:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@
M)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=W:61T:#H@,24G/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[
M('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@)"`@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`X
M)3L@=&5X="UA;&EG;CH@<FEG:'0G/B`-"B`@("`@("`@("`H,C8X("`@("`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED
M=&@Z(#$E.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@("D@
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W
M:61T:#H@,24G/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[('1E>'0M
M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@)"`@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`X)3L@=&5X
M="UA;&EG;CH@<FEG:'0G/B`-"B`@("`@("`@("`Q-"PY.3DL-C`P(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@
M,24[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\+W1R/B`@(`T*("`@("`@
M/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U
M;F0M8V]L;W(Z(%=H:71E)SX@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(&QE9G0[('!A9&1I;F<M8F]T=&]M.B`Q+C%P="<^("`-"B`@
M("`@("`@("!"86YK(&-E<G1I9FEC871E<R!O9B!D97!O<VET("`@(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG
M+6)O='1O;3H@,2XQ<'0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB
M;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!L969T)SX@
M("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T
M('-O;&ED.R!T97AT+6%L:6=N.B!R:6=H="<^("`@(`T*("`@("`@("`@(#4L
M,#`P+#`P,"`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T
M97AT+6%L:6=N.B!L969T)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M
M8F]T=&]M.B`Q+C%P="<^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60[('1E>'0M86QI9VXZ(&QE9G0G/B`@
M(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@
M<V]L:60[('1E>'0M86QI9VXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@+2`@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O
M<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!L
M969T)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`Q+C%P
M="<^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@
M,2XQ<'0@<V]L:60[('1E>'0M86QI9VXZ(&QE9G0G/B`@(`T*("`@("`@("`@
M("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60[('1E>'0M
M86QI9VXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@+2`@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ
M($)L86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!L969T)SX@("`-"B`@
M("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`Q+C%P="<^("`@(`T*("`@
M("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60[
M('1E>'0M86QI9VXZ(&QE9G0G/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60[('1E>'0M86QI9VXZ(')I9VAT
M)SX@("`@#0H@("`@("`@("`@-2PP,#`L,#`P("`@("`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@
M0FQA8VL@,2XQ<'0@<V]L:60[('1E>'0M86QI9VXZ(&QE9G0G/B`@(`T*("`@
M("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@/"]T
M<CX@("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T
M=&]M.R!B86-K9W)O=6YD+6-O;&]R.B!R9V(H,C`T+#(S."PR-34I)SX@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!P861D
M:6YG+6)O='1O;3H@,BXW-7!T)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I
M;F<M8F]T=&]M.B`R+C<U<'0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D
M97(M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!L
M969T)SX@("`@(`T*("`@("`@("`@("0@(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R
M+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^(`T*("`@("`@("`@
M(#$Y+#DY.2PQ-CD@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[
M('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D
M:6YG+6)O='1O;3H@,BXW-7!T)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@
M;&5F="<^("`@("`-"B`@("`@("`@("`D("`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@
M,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@<FEG:'0G/B`-"B`@("`@("`@
M("`V.3D@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[('1E
M>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG
M+6)O='1O;3H@,BXW-7!T)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@;&5F
M="<^("`@("`-"B`@("`@("`@("`D("`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW
M-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@<FEG:'0G/B`-"B`@("`@("`@("`H
M,C8X("`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X
M="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@("`I("`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T
M;VTZ(#(N-S5P="<^("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T
M;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G/B`@
M("`@#0H@("`@("`@("`@)"`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P="!D
M;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT)SX@#0H@("`@("`@("`@,3DL.3DY
M+#8P,"`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA
M;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@/"]T86)L93X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@
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M96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N
M=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP
M93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!2
M96UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D
M>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%344^#0H@
M("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q
M(')O=W-P86X],T0R/CQS=')O;F<^3F]T92`T("T@1F%I<B!686QU92!-96%S
M=7)E;65N=',@*%1A8FQE<RD\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^.2!-;VYT:',@16YD960\+W1H
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^4V5P+B`S,"P@,C`Q-#QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^/'-T<F]N9SY&86ER(%9A;'5E($1I<V-L;W-U<F5S(%M!
M8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D9A:7(@5F%L=64L($%S<V5T<R!-96%S=7)E9"!O;B!296-U<G)I
M;F<@0F%S:7,@6U1A8FQE(%1E>'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C96QL<W!A
M8VEN9STS1#`@<W1Y;&4],T0G8F]R9&5R+6-O;&QA<'-E.B!C;VQL87!S93L@
M=VED=&@Z(#$P,"4[(&9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68G/B`@("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM
M86QI9VXZ(&)O='1O;2<^("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT
M+6%L:6=N.B!L969T.R!P861D:6YG+6)O='1O;3H@,2XQ<'0G/B`@#0H@("`@
M("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@<&%D9&EN9RUB;W1T;VTZ
M(#$N,7!T)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)V9O;G0M
M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97([('!A9&1I;F<M8F]T
M=&]M.B`Q+C%P="<^("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V9O;G0M=V5I9VAT
M.B!B;VQD.R!P861D:6YG+6)O='1O;3H@,2XQ<'0G/B`@(`T*("`@("`@("`@
M("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@8V]L
M<W!A;CTS1#$Q('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L
M:6=N.B!C96YT97([(&)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED
M)SX@(`T*("`@("`@("`@(#QP('-T>6QE/3-$)VUA<F=I;BUT;W`Z(#`[(&UA
M<F=I;BUB;W1T;VTZ(#`G/B`@("`@#0H@("`@("`@("`@("!&86ER(%9A;'5E
M($UE87-U<F5M96YT<R!A="!297!O<G1I;F<@("`@#0H@("`@("`@("`@/"]P
M/B`-"B`@("`@("`@("`\<"!S='EL93TS1"=M87)G:6XM=&]P.B`P.R!M87)G
M:6XM8F]T=&]M.B`P)SX@("`@(`T*("`@("`@("`@("`@1&%T92!5<VEN9R`@
M(`T*("`@("`@("`@(#PO<#X@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M(#PO='(^("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ
M(&)O='1O;2<^("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N
M.B!L969T.R!P861D:6YG+6)O='1O;3H@,2XQ<'0G/B`@#0H@("`@("`@("`@
M)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@<&%D9&EN9RUB;W1T;VTZ(#$N,7!T
M)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D(&-O;'-P86X],T0S(&YO=W)A<#TS1&YO=W)A<"!S='EL
M93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@=&5X="UA;&EG;CH@8V5N=&5R.R!B
M;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9"<^("`-"B`@("`@("`@
M("!397!T96UB97(@,S`L(#(P,30@("`@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!P861D
M:6YG+6)O='1O;3H@,2XQ<'0G/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@8V]L<W!A;CTS1#,@;F]W
M<F%P/3-$;F]W<F%P('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT
M+6%L:6=N.B!C96YT97([(&)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O
M;&ED)SX@(`T*("`@("`@("`@(#QP('-T>6QE/3-$)VUA<F=I;BUT;W`Z(#`[
M(&UA<F=I;BUB;W1T;VTZ(#`G/B`@("`@#0H@("`@("`@("`@("!1=6]T960@
M4')I8V5S(&EN("`@(`T*("`@("`@("`@(#PO<#X@#0H@("`@("`@("`@/'`@
M<W1Y;&4],T0G;6%R9VEN+71O<#H@,#L@;6%R9VEN+6)O='1O;3H@,"<^("`@
M("`-"B`@("`@("`@("`@($%C=&EV92!-87)K971S("`-"B`@("`@("`@("`\
M+W`^(`T*("`@("`@("`@(#QP('-T>6QE/3-$)VUA<F=I;BUT;W`Z(#`[(&UA
M<F=I;BUB;W1T;VTZ(#`G/B`@("`@#0H@("`@("`@("`@("!F;W(@261E;G1I
M8V%L($%S<V5T<R`@(`T*("`@("`@("`@(#PO<#X@#0H@("`@("`@("`@/'`@
M<W1Y;&4],T0G;6%R9VEN+71O<#H@,#L@;6%R9VEN+6)O='1O;3H@,"<^("`@
M("`-"B`@("`@("`@("`@("A,979E;"`Q*2`@#0H@("`@("`@("`@/"]P/B`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G9F]N
M="UW96EG:'0Z(&)O;&0[('!A9&1I;F<M8F]T=&]M.B`Q+C%P="<^("`@#0H@
M("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!C;VQS<&%N/3-$,R!N;W=R87`],T1N;W=R87`@<W1Y;&4],T0G9F]N
M="UW96EG:'0Z(&)O;&0[('1E>'0M86QI9VXZ(&-E;G1E<CL@8F]R9&5R+6)O
M='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60G/B`@#0H@("`@("`@("`@/'`@<W1Y
M;&4],T0G;6%R9VEN+71O<#H@,#L@;6%R9VEN+6)O='1O;3H@,"<^("`@("`-
M"B`@("`@("`@("`@(%-I9VYI9FEC86YT($]T:&5R("`@("`-"B`@("`@("`@
M("`\+W`^(`T*("`@("`@("`@(#QP('-T>6QE/3-$)VUA<F=I;BUT;W`Z(#`[
M(&UA<F=I;BUB;W1T;VTZ(#`G/B`@("`@#0H@("`@("`@("`@("!/8G-E<G9A
M8FQE($EN<'5T<R`@("`@#0H@("`@("`@("`@/"]P/B`-"B`@("`@("`@("`\
M<"!S='EL93TS1"=M87)G:6XM=&]P.B`P.R!M87)G:6XM8F]T=&]M.B`P)SX@
M("`@(`T*("`@("`@("`@("`@*$QE=F5L(#(I("`-"B`@("`@("`@("`\+W`^
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=F
M;VYT+7=E:6=H=#H@8F]L9#L@<&%D9&EN9RUB;W1T;VTZ(#$N,7!T)SX@("`-
M"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D(&-O;'-P86X],T0S(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=F
M;VYT+7=E:6=H=#H@8F]L9#L@=&5X="UA;&EG;CH@8V5N=&5R.R!B;W)D97(M
M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9"<^("`-"B`@("`@("`@("`\<"!S
M='EL93TS1"=M87)G:6XM=&]P.B`P.R!M87)G:6XM8F]T=&]M.B`P)SX@("`@
M(`T*("`@("`@("`@("`@4VEG;FEF:6-A;G0@("`@#0H@("`@("`@("`@/"]P
M/B`-"B`@("`@("`@("`\<"!S='EL93TS1"=M87)G:6XM=&]P.B`P.R!M87)G
M:6XM8F]T=&]M.B`P)SX@("`@(`T*("`@("`@("`@("`@56YO8G-E<G9A8FQE
M("`@("`-"B`@("`@("`@("`\+W`^(`T*("`@("`@("`@(#QP('-T>6QE/3-$
M)VUA<F=I;BUT;W`Z(#`[(&UA<F=I;BUB;W1T;VTZ(#`G/B`@("`@#0H@("`@
M("`@("`@("!);G!U=',@("`@#0H@("`@("`@("`@/"]P/B`-"B`@("`@("`@
M("`\<"!S='EL93TS1"=M87)G:6XM=&]P.B`P.R!M87)G:6XM8F]T=&]M.B`P
M)SX@("`@(`T*("`@("`@("`@("`@*$QE=F5L(#,I("`-"B`@("`@("`@("`\
M+W`^(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\+W1R/B`@(`T*("`@
M("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG
M<F]U;F0M8V]L;W(Z(')G8B@R,#0L,C,X+#(U-2DG/B`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W=I9'1H.B`U-B4[('1E>'0M86QI9VXZ(&QE9G0[('!A
M9&1I;F<M8F]T=&]M.B`R+C<U<'0G/B`@("`@#0H@("`@("`@("`@36]N97D@
M;6%R:V5T(&9U;F1S("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=W:61T:#H@,24[('!A9&1I;F<M8F]T=&]M.B`R+C<U
M<'0G/B`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@8F]R9&5R+6)O='1O
M;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@;&5F="<^(`T*
M("`@("`@("`@("0@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=W:61T:#H@."4[(&)O<F1E<BUB;W1T;VTZ($)L86-K(#(N
M-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT)SX@(`T*("`@("`@("`@
M(#0Y+#(X-2PQ-C@@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[
M('1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)2<^(`T*("`@("`@("`@("8C
M,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G=VED=&@Z(#$E.R!P861D:6YG+6)O='1O;3H@,BXW-7!T)SX@#0H@("`@
M("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=W:61T:#H@,24[(&)O<F1E<BUB;W1T;VTZ($)L86-K(#(N
M-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G/B`-"B`@("`@("`@("`D
M("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M=VED=&@Z(#@E.R!B;W)D97(M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE
M.R!T97AT+6%L:6=N.B!R:6=H="<^("`-"B`@("`@("`@("`M("`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@;&5F=#L@
M=VED=&@Z(#$E)SX@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[('!A9&1I
M;F<M8F]T=&]M.B`R+C<U<'0G/B`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q
M)3L@8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA
M;&EG;CH@;&5F="<^(`T*("`@("`@("`@("0@(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@."4[(&)O<F1E<BUB
M;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT
M)SX@(`T*("`@("`@("`@(#0Y+#(X-2PQ-C@@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K
M(#(N-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)2<^
M(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!P861D:6YG+6)O='1O;3H@
M,BXW-7!T)SX@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[(&)O<F1E<BUB
M;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G
M/B`-"B`@("`@("`@("`D("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=VED=&@Z(#@E.R!B;W)D97(M8F]T=&]M.B!";&%C
M:R`R+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^("`-"B`@("`@
M("`@("`M("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X
M="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E)SX@#0H@("`@("`@("`@)B,Q-C`[
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\+W1R/B`@(`T*("`@("`@
M/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U
M;F0M8V]L;W(Z(%=H:71E)SX@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D/B`@("`-"B`@("`@("`@("`F
M(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0^("`@(`T*("`@("`@("`@("8C,38P
M.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@<FEG:'0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N
M.B!L969T)SX@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9#X@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT
M+6%L:6=N.B!L969T)SX@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N
M.B!R:6=H="<^("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE
M9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I
M9VAT)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^
M("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@/"]T<CX@("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA
M;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B!R9V(H,C`T+#(S."PR
M-34I)SX@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L
M969T)SX@("`@#0H@("`@("`@("`@36%R:V5T86)L92!S96-U<FET:65S.B`@
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9#X@("`@#0H@("`@
M("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@("`@("`@("`@
M)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=T97AT+6%L:6=N.B!R:6=H="<^("`@("`-"B`@("`@("`@("`F(S$V
M,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D/B`@("`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V
M,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)W1E>'0M86QI9VXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0^("`@(`T*("`@("`@("`@("8C
M,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@("8C,38P.R`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@<FEG:'0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L
M:6=N.B!L969T)SX@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9#X@("`@#0H@("`@("`@("`@)B,Q-C`[
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T
M97AT+6%L:6=N.B!L969T)SX@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L
M:6=N.B!R:6=H="<^("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R
M=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@5VAI=&4G
M/B`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^
M("`@(`T*("`@("`@("`@(%5N:71E9"!3=&%T97,@5')E87-U<GD@<V5C=7)I
M=&EE<R`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0^("`@
M(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@
M("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/B`@("`@#0H@("`@("`@
M("`@,30L.3DY+#8P,"`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@
M("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0^("`@
M(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@
M("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/B`@("`@#0H@("`@("`@
M("`@,30L.3DY+#8P,"`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@
M("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0^("`@
M(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@
M("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/B`@("`@#0H@("`@("`@
M("`@+2`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D/B`@("`-"B`@("`@
M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F
M(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("T@(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT
M+6%L:6=N.B!L969T)SX@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`\+W1R/B`@(`T*("`@("`@/'1R('-T>6QE
M/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z
M(')G8B@R,#0L,C,X+#(U-2DG/B`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F<M8F]T=&]M.B`Q+C%P="<^("`-
M"B`@("`@("`@("!"86YK(&-E<G1I9FEC871E<R!O9B!D97!O<VET("`@(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D
M:6YG+6)O='1O;3H@,2XQ<'0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E
M<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!L969T
M)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N
M,7!T('-O;&ED.R!T97AT+6%L:6=N.B!R:6=H="<^("`@(`T*("`@("`@("`@
M(#4L,#`P+#`P,"`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED
M.R!T97AT+6%L:6=N.B!L969T)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I
M;F<M8F]T=&]M.B`Q+C%P="<^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60[('1E>'0M86QI9VXZ(&QE9G0G
M/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ
M<'0@<V]L:60[('1E>'0M86QI9VXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@
M+2`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N
M.B!L969T)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`Q
M+C%P="<^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA
M8VL@,2XQ<'0@<V]L:60[('1E>'0M86QI9VXZ(&QE9G0G/B`@(`T*("`@("`@
M("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60[('1E
M>'0M86QI9VXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@-2PP,#`L,#`P("`@
M("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60[('1E>'0M86QI9VXZ
M(&QE9G0G/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#$N
M,7!T)SX@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C
M:R`Q+C%P="!S;VQI9#L@=&5X="UA;&EG;CH@;&5F="<^("`@#0H@("`@("`@
M("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9#L@=&5X
M="UA;&EG;CH@<FEG:'0G/B`@("`-"B`@("`@("`@("`M("`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O
M;3H@0FQA8VL@,2XQ<'0@<V]L:60[('1E>'0M86QI9VXZ(&QE9G0G/B`@(`T*
M("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M/"]T<CX@("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@
M8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B!7:&ET92<^("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!P861D:6YG+6)O='1O
M;3H@,BXW-7!T)SX@("`-"B`@("`@("`@("!4;W1A;"!M87)K971A8FQE('-E
M8W5R:71I97,@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#(N-S5P="<^("`@("`-"B`@("`@
M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[
M('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@)"`@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB
M;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT
M)SX@#0H@("`@("`@("`@,3DL.3DY+#8P,"`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@
M,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@
M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R+C<U<'0G/B`@("`@#0H@("`@
M("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE
M.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@("0@(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M
M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H
M="<^(`T*("`@("`@("`@(#$T+#DY.2PV,#`@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K
M(#(N-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@
M("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,BXW-7!T)SX@("`@(`T*("`@
M("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L
M93L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@("`D("`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@<FEG
M:'0G/B`-"B`@("`@("`@("`U+#`P,"PP,#`@("`@(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!"
M;&%C:R`R+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*
M("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#(N-S5P="<^("`@("`-
M"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P="!D
M;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@)"`@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O
M<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ
M(')I9VAT)SX@#0H@("`@("`@("`@+2`@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N
M-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@
M("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\+W1R/B`@
M(`T*("`@(#PO=&%B;&4^/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C96QL<W!A
M8VEN9STS1#`@<W1Y;&4],T0G8F]R9&5R+6-O;&QA<'-E.B!C;VQL87!S93L@
M=VED=&@Z(#$P,"4[(&9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68G/B`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L
M:6=N.B!B;W1T;VTG/B`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G9F]N="UW96EG:'0Z
M(&)O;&0[('!A9&1I;F<M8F]T=&]M.B`Q+C%P="<^("`@#0H@("`@("`@("`@
M)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!C;VQS
M<&%N/3-$,R!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@=&5X="UA;&EG
M;CH@8V5N=&5R.R!P861D:6YG+6)O='1O;3H@,2XQ<'0G/B`@("`@#0H@("`@
M("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@<&%D9&EN9RUB;W1T;VTZ
M(#$N,7!T)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0Q,2!S='EL93TS1"=F;VYT
M+7=E:6=H=#H@8F]L9#L@=&5X="UA;&EG;CH@8V5N=&5R.R!B;W)D97(M8F]T
M=&]M.B!";&%C:R`Q+C%P="!S;VQI9"<^("`-"B`@("`@("`@("!&86ER(%9A
M;'5E($UE87-U<F5M96YT<R!A="!297!O<G1I;F<\8G(@+SX@("`@#0H@("`@
M("`@("`@1&%T92!5<VEN9R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M/"]T<CX@("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@
M8F]T=&]M)SX@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD
M.R!P861D:6YG+6)O='1O;3H@,2XQ<'0G/B`@(`T*("`@("`@("`@("8C,38P
M.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@8V]L<W!A;CTS
M1#,@;F]W<F%P/3-$;F]W<F%P('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD
M.R!T97AT+6%L:6=N.B!C96YT97([(&)O<F1E<BUB;W1T;VTZ($)L86-K(#$N
M,7!T('-O;&ED)SX@(`T*("`@("`@("`@($1E8V5M8F5R(#,Q+"`R,#$S("`@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V9O
M;G0M=V5I9VAT.B!B;VQD.R!P861D:6YG+6)O='1O;3H@,2XQ<'0G/B`@(`T*
M("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@8V]L<W!A;CTS1#,@;F]W<F%P/3-$;F]W<F%P('-T>6QE/3-$)V9O
M;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97([(&)O<F1E<BUB
M;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED)SX@(`T*("`@("`@("`@(%%U;W1E
M9"!0<FEC97,@:6X\8G(@+SX@("`@#0H@("`@("`@("`@06-T:79E($UA<FME
M=',\8G(@+SX@(`T*("`@("`@("`@("8C,38P.V9O<B!)9&5N=&EC86P@07-S
M971S)B,Q-C`[/&)R("\^("`@#0H@("`@("`@("`@)B,Q-C`[*$QE=F5L(#$I
M("`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G9F]N="UW96EG:'0Z(&)O;&0[('!A9&1I;F<M8F]T=&]M.B`Q+C%P="<^
M("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!C;VQS<&%N/3-$,R!N;W=R87`],T1N;W=R87`@<W1Y;&4]
M,T0G9F]N="UW96EG:'0Z(&)O;&0[('1E>'0M86QI9VXZ(&-E;G1E<CL@8F]R
M9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60G/B`@#0H@("`@("`@("`@
M4VEG;FEF:6-A;G0@3W1H97(\8G(@+SX@("`@(`T*("`@("`@("`@($]B<V5R
M=F%B;&4@26YP=71S)B,Q-C`[/&)R("\^("`@("`-"B`@("`@("`@("`H3&5V
M96P@,BD@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@<&%D9&EN9RUB;W1T;VTZ(#$N
M,7!T)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0S(&YO=W)A<#TS1&YO=W)A<"!S
M='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@=&5X="UA;&EG;CH@8V5N=&5R
M.R!B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9"<^("`-"B`@("`@
M("`@("`\<"!S='EL93TS1"=M87)G:6XM=&]P.B`P.R!M87)G:6XM8F]T=&]M
M.B`P)SX@("`@(`T*("`@("`@("`@("`@4VEG;FEF:6-A;G0@("`@#0H@("`@
M("`@("`@/"]P/B`-"B`@("`@("`@("`\<"!S='EL93TS1"=M87)G:6XM=&]P
M.B`P.R!M87)G:6XM8F]T=&]M.B`P)SX@("`@(`T*("`@("`@("`@("`@56YO
M8G-E<G9A8FQE("`@("`-"B`@("`@("`@("`\+W`^(`T*("`@("`@("`@(#QP
M('-T>6QE/3-$)VUA<F=I;BUT;W`Z(#`[(&UA<F=I;BUB;W1T;VTZ(#`G/B`@
M("`@#0H@("`@("`@("`@("!);G!U=',@("`@#0H@("`@("`@("`@/"]P/B`-
M"B`@("`@("`@("`\<"!S='EL93TS1"=M87)G:6XM=&]P.B`P.R!M87)G:6XM
M8F]T=&]M.B`P)SX@("`@(`T*("`@("`@("`@("`@*$QE=F5L(#,I("`-"B`@
M("`@("`@("`\+W`^(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\+W1R
M/B`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T
M;VT[(&)A8VMG<F]U;F0M8V]L;W(Z(')G8B@R,#0L,C,X+#(U-2DG/B`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`U-B4[('1E>'0M86QI9VXZ
M(&QE9G0[('!A9&1I;F<M8F]T=&]M.B`R+C<U<'0G/B`@("`@#0H@("`@("`@
M("`@36]N97D@;6%R:V5T(&9U;F1S("`@(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[('!A9&1I;F<M8F]T
M=&]M.B`R+C<U<'0G/B`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@8F]R
M9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@
M;&5F="<^(`T*("`@("`@("`@("0@(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@."4[(&)O<F1E<BUB;W1T;VTZ
M($)L86-K(#(N-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT)SX@(`T*
M("`@("`@("`@(#,T+#(V-BPU,#$@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P
M="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)2<^(`T*("`@
M("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!P861D:6YG+6)O='1O;3H@,BXW-7!T
M)SX@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[(&)O<F1E<BUB;W1T;VTZ
M($)L86-K(#(N-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G/B`-"B`@
M("`@("`@("`D("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G=VED=&@Z(#@E.R!B;W)D97(M8F]T=&]M.B!";&%C:R`R+C<U
M<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^("`-"B`@("`@("`@("`M
M("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG
M;CH@;&5F=#L@=VED=&@Z(#$E)SX@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@
M,24[('!A9&1I;F<M8F]T=&]M.B`R+C<U<'0G/B`-"B`@("`@("`@("`F(S$V
M,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)W=I9'1H.B`Q)3L@8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L
M93L@=&5X="UA;&EG;CH@;&5F="<^(`T*("`@("`@("`@("0@(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@."4[
M(&)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[('1E>'0M86QI
M9VXZ(')I9VAT)SX@(`T*("`@("`@("`@(#,T+#(V-BPU,#$@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T
M;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[('=I
M9'1H.B`Q)2<^(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!P861D:6YG
M+6)O='1O;3H@,BXW-7!T)SX@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[
M(&)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[('1E>'0M86QI
M9VXZ(&QE9G0G/B`-"B`@("`@("`@("`D("`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#@E.R!B;W)D97(M8F]T
M=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^
M("`-"B`@("`@("`@("`M("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O
M=6)L93L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E)SX@#0H@("`@("`@
M("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\+W1R/B`@
M(`T*("`@(#PO=&%B;&4^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM
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M:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV
M/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T
M/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$
M4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R
M:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P
M;W)T(&ED/3-$240P14U%/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/DYO=&4@
M-2`M($5Q=6ET>2!);F-E;G1I=F4@4&QA;B`H5&%B;&5S*3QB<CX\+W-T<F]N
M9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XY
M($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y397`N(#,P+"`R,#$T/&)R/CPO=&@^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D1I<V-L;W-U
M<F4@;V8@0V]M<&5N<V%T:6]N(%)E;&%T960@0V]S=',L(%-H87)E+6)A<V5D
M(%!A>6UE;G1S(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/E-C:&5D=6QE(&]F(%-H87)E+6)A<V5D(%!A
M>6UE;G0@07=A<F0L(%-T;V-K($]P=&EO;G,L(%9A;'5A=&EO;B!!<W-U;7!T
M:6]N<R!;5&%B;&4@5&5X="!";&]C:UT\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\=&%B;&4@8F]R9&5R/3-$,"!C96QL<&%D9&EN9STS1#`@
M8V5L;'-P86-I;F<],T0P('-T>6QE/3-$)W=I9'1H.B`Q,#`E.R!B;W)D97(M
M8V]L;&%P<V4Z(&-O;&QA<'-E.R!F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)SX@#0H@("`@("`\='(^("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD)SX@("`@(`T*("`@("`@("`@
M("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@8V]L
M<W!A;CTS1#<@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R)SX@("`-"B`@
M("`@("`@("`\<"!S='EL93TS1"=M87)G:6XM=&]P.B`P.R!M87)G:6XM8F]T
M=&]M.B`P)SX@("`@(`T*("`@("`@("`@("`@/&(^5&AR964@36]N=&AS($5N
M9&5D/"]B/B`@("`@#0H@("`@("`@("`@/"]P/B`-"B`@("`@("`@("`\<"!S
M='EL93TS1"=M87)G:6XM=&]P.B`P.R!M87)G:6XM8F]T=&]M.B`P)SX@("`@
M(`T*("`@("`@("`@("`@/&(^4V5P=&5M8F5R(#,P+#PO8CX@("`@(`T*("`@
M("`@("`@(#PO<#X@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^
M("`@#0H@("`@("`\='(^("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I
M;F<M8F]T=&]M.B`Q+C%P="<^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@8V]L<W!A;CTS1#,@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R.R!B;W)D97(M8F]T=&]M.B!";&%C
M:R`Q+C%P="!S;VQI9"<^("`-"B`@("`@("`@("`\8CXR,#$T/"]B/B`@("`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G9F]N
M="UW96EG:'0Z(&)O;&0[('1E>'0M86QI9VXZ(&-E;G1E<CL@<&%D9&EN9RUB
M;W1T;VTZ(#$N,7!T)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0S('-T>6QE/3-$
M)W1E>'0M86QI9VXZ(&-E;G1E<CL@8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ
M<'0@<V]L:60G/B`@#0H@("`@("`@("`@/&(^,C`Q,SPO8CX@("`@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@("`\='(@<W1Y
M;&4],T0G8F%C:V=R;W5N9"UC;VQO<CH@<F=B*#(P-"PR,S@L,C4U*2<^("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`W,24G/B`@(`T*("`@
M("`@("`@(%)I<VL@9G)E92!I;G1E<F5S="!R871E("`@(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,R4[('1E
M>'0M86QI9VXZ(&-E;G1E<B<^("`-"B`@("`@("`@("`Q+C,P)2`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#<E
M.R!T97AT+6%L:6=N.B!C96YT97(G/B`@#0H@("`@("`@("`@+2`@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(&-E;G1E<CL@=VED=&@Z(#,E)SX@(`T*("`@("`@("`@(#$N,SDE(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT
M+6%L:6=N.B!R:6=H=#L@=VED=&@Z(#,E)SX@#0H@("`@("`@("`@)B,Q-C`[
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W
M:61T:#H@,R4G/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@-R4[('1E>'0M
M86QI9VXZ(&-E;G1E<B<^("`-"B`@("`@("`@("`M("`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N
M=&5R.R!W:61T:#H@,R4G/B`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M(#PO='(^("`@#0H@("`@("`\='(@<W1Y;&4],T0G8F%C:V=R;W5N9"UC;VQO
M<CH@5VAI=&4G/B`@("`-"B`@("`@("`@/'1D/B`@("`-"B`@("`@("`@("!%
M>'!E8W1E9"!V;VQA=&EL:71Y("`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@
M8V5N=&5R)SX@#0H@("`@("`@("`@-3,N,C@E("`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R
M)SX@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D/B`@("`-"B`@
M("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^
M(`T*("`@("`@("`@("T@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97(G/B`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@/"]T<CX@("`-"B`@("`@(#QT<B!S='EL93TS
M1"=V97)T:6-A;"UA;&EG;CH@=&]P.R!B86-K9W)O=6YD+6-O;&]R.B!R9V(H
M,C`T+#(S."PR-34I)SX@#0H@("`@("`@(#QT9#X@("`@#0H@("`@("`@("`@
M17AP96-T960@;&EV97,@*'EE87)S*2`@(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9#X@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N
M.B!C96YT97(G/B`-"B`@("`@("`@("`T("`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R)SX@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0^("`@(`T*("`@("`@("`@
M("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R)SX@#0H@("`@("`@("`@+2`@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(&-E;G1E<B<^(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\
M+W1R/B`@(`T*("`@("`@/'1R('-T>6QE/3-$)V)A8VMG<F]U;F0M8V]L;W(Z
M(%=H:71E)SX@("`@#0H@("`@("`@(#QT9#X@("`@#0H@("`@("`@("`@17AP
M96-T960@9&EV:61E;F0@>6EE;&0@("`@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(&-E;G1E<B<^(`T*("`@("`@("`@(#`N,#`E(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97(G
M/B`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0^("`@(`T*("`@
M("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R)SX@
M#0H@("`@("`@("`@+2`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`\+W1R/B`@(`T*("`@(#PO=&%B;&4^/'1A8FQE
M(&)O<F1E<CTS1#`@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!S
M='EL93TS1"=W:61T:#H@,3`P)3L@8F]R9&5R+6-O;&QA<'-E.B!C;VQL87!S
M93L@9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^
M("`@(`T*("`@("`@/'1R/B`@#0H@("`@("`@(#QT9"!S='EL93TS1"=F;VYT
M+7=E:6=H=#H@8F]L9"<^("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0W/B`-"B`@
M("`@("`@("`\<"!S='EL93TS1"=M87)G:6XM=&]P.B`P.R!M87)G:6XM8F]T
M=&]M.B`P.R!T97AT+6%L:6=N.B!C96YT97(G/B`@("`@#0H@("`@("`@("`@
M("`\8CY.:6YE($UO;G1H<R!%;F1E9#PO8CX@("`@#0H@("`@("`@("`@/"]P
M/B`-"B`@("`@("`@("`\<"!S='EL93TS1"=M87)G:6XM=&]P.B`P.R!M87)G
M:6XM8F]T=&]M.B`P.R!T97AT+6%L:6=N.B!C96YT97(G/B`@("`@#0H@("`@
M("`@("`@("`\8CY397!T96UB97(@,S`L/"]B/B`@("`@#0H@("`@("`@("`@
M/"]P/B`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@/"]T<CX@("`-"B`@
M("`@(#QT<CX@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T
M;VTZ(#$N,7!T)SX@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9"!C;VQS<&%N/3-$,R!S='EL93TS1"=T
M97AT+6%L:6=N.B!C96YT97([(&)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T
M('-O;&ED)SX@(`T*("`@("`@("`@(#QB/C(P,30\+V(^("`@(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=F;VYT+7=E:6=H
M=#H@8F]L9#L@=&5X="UA;&EG;CH@8V5N=&5R.R!P861D:6YG+6)O='1O;3H@
M,2XQ<'0G/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@8V]L<W!A;CTS1#,@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@8V5N=&5R.R!B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI
M9"<^("`-"B`@("`@("`@("`\8CXR,#$S/"]B/B`@("`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@/"]T<CX@("`-"B`@("`@(#QT<B!S='EL93TS1"=B
M86-K9W)O=6YD+6-O;&]R.B!R9V(H,C`T+#(S."PR-34I)SX@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#<Q)2<^("`@#0H@("`@("`@("`@
M4FES:R!F<F5E(&EN=&5R97-T(')A=&4@("`@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`S)3L@=&5X="UA;&EG
M;CH@8V5N=&5R)SX@(`T*("`@("`@("`@(#$N,38E(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@-R4[('1E>'0M
M86QI9VXZ(&-E;G1E<B<^("`-"B`@("`@("`@("`M("`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N
M=&5R.R!W:61T:#H@,R4G/B`@#0H@("`@("`@("`@,2XS.24@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(')I9VAT.R!W:61T:#H@,R4G/B`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`S
M)3L@=&5X="UA;&EG;CH@8V5N=&5R)SX@(`T*("`@("`@("`@(#`N-C$E(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T
M:#H@-R4[('1E>'0M86QI9VXZ(&-E;G1E<B<^("`-"B`@("`@("`@("`M("`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@8V5N=&5R.R!W:61T:#H@,R4G/B`@#0H@("`@("`@("`@,"XW
M,"4@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@
M("`\='(@<W1Y;&4],T0G8F%C:V=R;W5N9"UC;VQO<CH@5VAI=&4G/B`@("`-
M"B`@("`@("`@/'1D/B`@("`-"B`@("`@("`@("!%>'!E8W1E9"!V;VQA=&EL
M:71Y("`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0^("`@
M(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R)SX@#0H@("`@
M("`@("`@-3,N,C@E("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R)SX@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D/B`@("`-"B`@("`@("`@("`F(S$V,#L@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D/B`@("`-"B`@("`@
M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^(`T*("`@("`@("`@(#4W
M+C8P)2`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`\+W1R/B`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L
M+6%L:6=N.B!T;W`[(&)A8VMG<F]U;F0M8V]L;W(Z(')G8B@R,#0L,C,X+#(U
M-2DG/B`-"B`@("`@("`@/'1D/B`@("`-"B`@("`@("`@("!%>'!E8W1E9"!L
M:79E<R`H>65A<G,I("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^
M(`T*("`@("`@("`@(#0@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97(G/B`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@
M<FEG:'0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9#X@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT
M+6%L:6=N.B!C96YT97(G/B`-"B`@("`@("`@("`T("`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N
M=&5R)SX@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@
M("`@("`\='(@<W1Y;&4],T0G8F%C:V=R;W5N9"UC;VQO<CH@5VAI=&4G/B`@
M("`-"B`@("`@("`@/'1D/B`@("`-"B`@("`@("`@("!%>'!E8W1E9"!D:79I
M9&5N9"!Y:65L9"`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R)SX@
M#0H@("`@("`@("`@,"XP,"4@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9#X@("`@#0H@("`@("`@("`@)B,Q
M-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9#X@("`@#0H@
M("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97(G/B`-"B`@("`@("`@
M("`P+C`P)2`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R)SX@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@(#PO='(^("`@#0H@("`@/"]T86)L93X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*
M/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7V)A-3$W,3$S7S!D,C=?-#,V
M,5]A-V)A7S$P838S83,X-30R8PT*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO
M+R]#.B]B834Q-S$Q,U\P9#(W7S0S-C%?83=B85\Q,&$V,V$S.#4T,F,O5V]R
M:W-H965T<R]3:&5E=#(T+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I
M;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL
M.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@
M(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T
M97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O
M:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI
M<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\
M=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%344^#0H@("`@("`\='(^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X]
M,T0R/CQS=')O;F<^3F]T92`V("T@16%R;FEN9W,@4&5R(%-H87)E("A486)L
M97,I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M(&-O;'-P86X],T0Q/CD@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/E-E<"X@,S`L
M(#(P,30\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS
M=')O;F<^16%R;FEN9W,@4&5R(%-H87)E(%M!8G-T<F%C=%T\+W-T<F]N9SX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-C:&5D=6QE(&]F
M($5A<FYI;F=S(%!E<B!3:&%R92P@0F%S:6,@86YD($1I;'5T960@6U1A8FQE
M(%1E>'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C96QL<W!A8VEN9STS1#`@<W1Y;&4]
M,T0G8F]R9&5R+6-O;&QA<'-E.B!C;VQL87!S93L@=VED=&@Z(#$P,"4[(&9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`@#0H@
M("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;2<^("`@
M#0H@("`@("`@(#QT9#X@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=F;VYT+7=E:6=H
M=#H@8F]L9#L@<&%D9&EN9RUB;W1T;VTZ(#$N,7!T)SX@("`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&-O
M;'-P86X],T0W('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L
M:6=N.B!C96YT97([(&)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED
M)SX@#0H@("`@("`@("`@5&AR964@36]N=&AS($5N9&5D(%-E<'1E;6)E<B`S
M,"P@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G9F]N="UW96EG:'0Z(&)O;&0[('!A9&1I;F<M8F]T=&]M.B`Q+C%P="<^
M("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!C;VQS<&%N/3-$-R!S='EL93TS1"=F;VYT+7=E:6=H=#H@
M8F]L9#L@=&5X="UA;&EG;CH@8V5N=&5R.R!B;W)D97(M8F]T=&]M.B!";&%C
M:R`Q+C%P="!S;VQI9"<^(`T*("`@("`@("`@($YI;F4@36]N=&AS($5N9&5D
M(%-E<'1E;6)E<B`S,"P@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\
M+W1R/B`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B
M;W1T;VTG/B`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G9F]N="UW96EG:'0Z
M(&)O;&0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L
M9#L@<&%D9&EN9RUB;W1T;VTZ(#$N,7!T)SX@("`-"B`@("`@("`@("`F(S$V
M,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&-O;'-P86X]
M,T0S('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C
M96YT97([(&)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED)SX@#0H@
M("`@("`@("`@,C`Q-"`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!P861D:6YG+6)O
M='1O;3H@,2XQ<'0G/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0@8V]L<W!A;CTS1#,@<W1Y;&4],T0G
M9F]N="UW96EG:'0Z(&)O;&0[('1E>'0M86QI9VXZ(&-E;G1E<CL@8F]R9&5R
M+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60G/B`-"B`@("`@("`@("`R,#$S
M("`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G9F]N="UW96EG:'0Z(&)O;&0[('!A9&1I;F<M8F]T=&]M.B`Q+C%P="<^
M("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!C;VQS<&%N/3-$,R!S='EL93TS1"=F;VYT+7=E:6=H=#H@
M8F]L9#L@=&5X="UA;&EG;CH@8V5N=&5R.R!B;W)D97(M8F]T=&]M.B!";&%C
M:R`Q+C%P="!S;VQI9"<^(`T*("`@("`@("`@(#(P,30@("`@(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=F;VYT+7=E:6=H
M=#H@8F]L9#L@<&%D9&EN9RUB;W1T;VTZ(#$N,7!T)SX@("`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&-O
M;'-P86X],T0S('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L
M:6=N.B!C96YT97([(&)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED
M)SX@#0H@("`@("`@("`@,C`Q,R`@("`@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@(#PO='(^("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM
M86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@<F=B*#(P-"PR,S@L
M,C4U*2<^("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#4V)3L@
M=&5X="UA;&EG;CH@;&5F="<^(`T*("`@("`@("`@(%-H87)E<R!U<V5D(&EN
M('1H92!C86QC=6QA=&EO;B!O9B!B87-I8R!E87)N:6YG<R!P97(@<VAA<F4@
M("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)W=I9'1H.B`Q)2<^("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@=&5X
M="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`X
M)3L@=&5X="UA;&EG;CH@<FEG:'0G/B`-"B`@("`@("`@("`Q-"PW-3@L-S@Q
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W
M:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@
M)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=W:61T:#H@,24G/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[
M('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T
M:#H@."4[('1E>'0M86QI9VXZ(')I9VAT)SX@#0H@("`@("`@("`@,3,L-C@R
M+#0T.2`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G=VED=&@Z(#$E.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@
M("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G=VED=&@Z(#$E)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z
M(#$E.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@("8C,38P
M.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M=VED=&@Z(#@E.R!T97AT+6%L:6=N.B!R:6=H="<^(`T*("`@("`@("`@(#$T
M+#8R-BPY,S,@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@
M("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W=I9'1H.B`Q)2<^("`-"B`@("`@("`@("`F(S$V,#L@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I
M9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@("`F
M(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W=I9'1H.B`X)3L@=&5X="UA;&EG;CH@<FEG:'0G/B`-"B`@("`@("`@
M("`Q,RPU,S0L,S,T(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=W:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@
M#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`\+W1R/B`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N
M.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z(%=H:71E)SX@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@
M("`@("!%9F9E8W0@;V8@9&EL=71I=F4@<V5C=7)I=&EE<SH@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D/B`@("`-"B`@("`@("`@("`F(S$V
M,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@;&5F="<^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0^("`@(`T*("`@("`@("`@("8C,38P.R`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@<FEG:'0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L
M969T)SX@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9#X@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L
M:6=N.B!L969T)SX@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R
M:6=H="<^("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G
M/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT
M)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@
M(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@/"]T<CX@("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG
M;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B!R9V(H,C`T+#(S."PR-34I
M)SX@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T
M.R!P861D:6YG+6)O='1O;3H@,2XQ<'0[('!A9&1I;F<M;&5F=#H@,3!P="<^
M("`-"B`@("`@("`@("!3=&]C:R!O<'1I;VYS+"!305)S+"!A;F0@4E-!<R`@
M("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)W!A9&1I;F<M8F]T=&]M.B`Q+C%P="<^("`@(`T*("`@("`@("`@("8C,38P
M.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60[('1E>'0M86QI9VXZ
M(&QE9G0G/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA
M8VL@,2XQ<'0@<V]L:60[('1E>'0M86QI9VXZ(')I9VAT)SX@("`@#0H@("`@
M("`@("`@-C<V+#`Y-"`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI
M9#L@=&5X="UA;&EG;CH@;&5F="<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D
M:6YG+6)O='1O;3H@,2XQ<'0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E
M<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!L969T
M)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N
M,7!T('-O;&ED.R!T97AT+6%L:6=N.B!R:6=H="<^("`@(`T*("`@("`@("`@
M(#$L,C<V+#4Q-B`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED
M.R!T97AT+6%L:6=N.B!L969T)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I
M;F<M8F]T=&]M.B`Q+C%P="<^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60[('1E>'0M86QI9VXZ(&QE9G0G
M/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ
M<'0@<V]L:60[('1E>'0M86QI9VXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@
M.#0R+#,P-"`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9#L@=&5X
M="UA;&EG;CH@;&5F="<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O
M='1O;3H@,2XQ<'0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T
M;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!L969T)SX@("`-
M"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O
M;&ED.R!T97AT+6%L:6=N.B!R:6=H="<^("`@(`T*("`@("`@("`@(#$L,3,Y
M+#4T-2`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT
M+6%L:6=N.B!L969T)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@("`\='(@<W1Y;&4]
M,T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@
M5VAI=&4G/B`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@
M;&5F=#L@<&%D9&EN9RUB;W1T;VTZ(#(N-S5P="<^("`@#0H@("`@("`@("`@
M1&EL=71E9"!S:&%R97,@=7-E9"!I;B!T:&4@8V%L8W5L871I;VX@;V8@96%R
M;FEN9W,@<&5R('-H87)E(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,BXW-7!T)SX@("`@(`T*
M("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O
M=6)L93L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@("`F(S$V
M,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[('1E>'0M86QI
M9VXZ(')I9VAT)SX@#0H@("`@("`@("`@,34L-#,T+#@W-2`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O
M;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@;&5F="<^("`@
M("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R+C<U<'0G/B`@
M("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C<U
M<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@
M("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X
M="UA;&EG;CH@<FEG:'0G/B`-"B`@("`@("`@("`Q-"PY-3@L.38U(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M
M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T
M)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#(N-S5P
M="<^("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K
M(#(N-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@
M("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE
M.R!T97AT+6%L:6=N.B!R:6=H="<^(`T*("`@("`@("`@(#$U+#0V.2PR,S<@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O
M<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ
M(&QE9G0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@
M,BXW-7!T)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@
M0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-
M"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P="!D
M;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT)SX@#0H@("`@("`@("`@,30L-C<S
M+#@W.2`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA
M;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@/"]T86)L93X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@
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M96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N
M=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP
M93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!2
M96UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D
M>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%344^#0H@
M("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q
M(')O=W-P86X],T0R/CQS=')O;F<^3F]T92`W("T@26YV96YT;W)I97,@*%1A
M8FQE<RD\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@@8V]L<W!A;CTS1#$^.2!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^4V5P+B`S
M,"P@,C`Q-#QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M/'-T<F]N9SY);G9E;G1O<GD@1&ES8VQO<W5R92!;06)S=')A8W1=/"]S=')O
M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y38VAE9'5L
M92!O9B!);G9E;G1O<GDL($-U<G)E;G0@6U1A8FQE(%1E>'0@0FQO8VM=/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'1A8FQE(&-E;&QP861D
M:6YG/3-$,"!C96QL<W!A8VEN9STS1#`@<W1Y;&4],T0G8F]R9&5R+6-O;&QA
M<'-E.B!C;VQL87!S93L@=VED=&@Z(#$P,"4[(&9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`@#0H@("`@("`\='(@<W1Y;&4]
M,T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;2<^("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9"<^("`@("`-"B`@("`@("`@("`F
M(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!P861D:6YG+6)O='1O;3H@,2XQ<'0G
M/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@8V]L<W!A;CTS1#,@;F]W<F%P/3-$;F]W<F%P('-T>6QE
M/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97([(&)O
M<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED)SX@(`T*("`@("`@("`@
M(#QP('-T>6QE/3-$)VUA<F=I;BUT;W`Z(#`[(&UA<F=I;BUB;W1T;VTZ(#`G
M/B`@("`@#0H@("`@("`@("`@("!397!T96UB97(@,S`L(`T*("`@("`@("`@
M(#PO<#X@#0H@("`@("`@("`@/'`@<W1Y;&4],T0G;6%R9VEN+71O<#H@,#L@
M;6%R9VEN+6)O='1O;3H@,"<^("`@("`-"B`@("`@("`@("`@(#(P,30@(`T*
M("`@("`@("`@(#PO<#X@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!P861D:6YG+6)O='1O
M;3H@,2XQ<'0G/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@8V]L<W!A;CTS1#,@;F]W<F%P/3-$;F]W
M<F%P('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C
M96YT97([(&)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED)SX@(`T*
M("`@("`@("`@(#QP('-T>6QE/3-$)VUA<F=I;BUT;W`Z(#`[(&UA<F=I;BUB
M;W1T;VTZ(#`G/B`@("`@#0H@("`@("`@("`@("!$96-E;6)E<B`S,2P@("`@
M(`T*("`@("`@("`@(#PO<#X@#0H@("`@("`@("`@/'`@<W1Y;&4],T0G;6%R
M9VEN+71O<#H@,#L@;6%R9VEN+6)O='1O;3H@,"<^("`@("`-"B`@("`@("`@
M("`@(#(P,3,@(`T*("`@("`@("`@(#PO<#X@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@(#PO='(^("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC
M86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@<F=B*#(P-"PR
M,S@L,C4U*2<^("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#<X
M)3L@=&5X="UA;&EG;CH@;&5F="<^(`T*("`@("`@("`@(%)A=R!M871E<FEA
M;',@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W=I9'1H.B`Q)2<^("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@
M=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@("`D("`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#@E
M.R!T97AT+6%L:6=N.B!R:6=H="<^(`T*("`@("`@("`@(#8L.#0S+#0T,2`@
M("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)W=I9'1H.B`Q)2<^("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q
M)3L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@("`D("`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z
M(#@E.R!T97AT+6%L:6=N.B!R:6=H="<^(`T*("`@("`@("`@(#4L.3(V+#`S
M,"`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@
M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^
M("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O
M;3L@8F%C:V=R;W5N9"UC;VQO<CH@5VAI=&4G/B`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@(%=O
M<FLM:6XM<')O8V5S<R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@
M(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/B`@("`@#0H@
M("`@("`@("`@,BPS,C4L-C8W("`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*
M("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^
M("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/B`@("`@
M#0H@("`@("`@("`@,BPS,#@L,C,S("`@("`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@
M(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@/"]T<CX@("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG
M;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B!R9V(H,C`T+#(S."PR-34I
M)SX@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T
M.R!P861D:6YG+6)O='1O;3H@,2XQ<'0G/B`@#0H@("`@("`@("`@1FEN:7-H
M960@9V]O9',@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,2XQ<'0G/B`@("`-"B`@("`@
M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T
M97AT+6%L:6=N.B!L969T)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB
M;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!R:6=H="<^
M("`@(`T*("`@("`@("`@(#0L-#$S+#,T."`@("`@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L
M86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!L969T)SX@("`-"B`@("`@
M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`Q+C%P="<^("`@(`T*("`@("`@
M("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60[('1E
M>'0M86QI9VXZ(&QE9G0G/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60[('1E>'0M86QI9VXZ(')I9VAT)SX@
M("`@#0H@("`@("`@("`@,BPW-C(L-3(R("`@("`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA
M8VL@,2XQ<'0@<V]L:60[('1E>'0M86QI9VXZ(&QE9G0G/B`@(`T*("`@("`@
M("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@/"]T<CX@
M("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M
M.R!B86-K9W)O=6YD+6-O;&]R.B!7:&ET92<^("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!P861D:6YG+6)O='1O;3H@,BXW
M-7!T.R!P861D:6YG+6QE9G0Z(#$P<'0G/B`@(`T*("`@("`@("`@(%1O=&%L
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P
M861D:6YG+6)O='1O;3H@,BXW-7!T)SX@("`@(`T*("`@("`@("`@("8C,38P
M.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG
M;CH@;&5F="<^("`@("`-"B`@("`@("`@("`D("`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA
M8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@<FEG:'0G/B`-"B`@("`@
M("`@("`Q,RPU.#(L-#4V(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U
M8FQE.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@("8C,38P
M.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M<&%D9&EN9RUB;W1T;VTZ(#(N-S5P="<^("`@("`-"B`@("`@("`@("`F(S$V
M,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[('1E>'0M86QI
M9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@)"`@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L
M86-K(#(N-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT)SX@#0H@("`@
M("`@("`@,3`L.3DV+#<X-2`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O
M=6)L93L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@("`F(S$V
M,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@
M/"]T86)L93X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'10
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M/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT
M96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G
M/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS
M/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H
M96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60]
M,T1)1#!%,D8^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L
M(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^3F]T92`X("T@26YT
M86YG:6)L92!!<W-E=',@86YD($=O;V1W:6QL("A486)L97,I/&)R/CPO<W1R
M;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q
M/CD@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/E-E<"X@,S`L(#(P,30\8G(^/"]T
M:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^1V]O9'=I
M;&P@86YD($EN=&%N9VEB;&4@07-S971S($1I<V-L;W-U<F4@6T%B<W1R86-T
M73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M4V-H961U;&4@;V8@1FEN:71E($QI=F5D(&%N9"!);F1E9FEN:71E($QI=F5D
M($EN=&%N9VEB;&4@07-S971S(&)Y($UA:F]R($-L87-S(%M486)L92!497AT
M($)L;V-K73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQT86)L
M92!C96QL<&%D9&EN9STS1#`@8V5L;'-P86-I;F<],T0P('-T>6QE/3-$)V)O
M<F1E<BUC;VQL87!S93H@8V]L;&%P<V4[('=I9'1H.B`Q,#`E.R!F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@("`@(`T*("`@
M("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VTG/B`@(`T*
M("`@("`@("`\=&0^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G9F]N="UW96EG:'0Z
M(&)O;&0[('!A9&1I;F<M8F]T=&]M.B`Q+C%P="<^("`@#0H@("`@("`@("`@
M)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!C;VQS
M<&%N/3-$,R!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@=&5X="UA;&EG
M;CH@8V5N=&5R)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O
M;&0[('!A9&1I;F<M8F]T=&]M.B`Q+C%P="<^("`@#0H@("`@("`@("`@)B,Q
M-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!C;VQS<&%N
M/3-$,3$@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O;&0[('1E>'0M86QI9VXZ
M(&-E;G1E<CL@8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60G/B`@
M#0H@("`@("`@("`@4V5P=&5M8F5R(#,P+"`R,#$T("`@(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@
M8F]L9#L@<&%D9&EN9RUB;W1T;VTZ(#$N,7!T)SX@("`-"B`@("`@("`@("`F
M(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&-O;'-P
M86X],T0W('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N
M.B!C96YT97([(&)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED)SX@
M#0H@("`@("`@("`@1&5C96UB97(@,S$L(#(P,3,@("`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@/"]T<CX@("`-"B`@("`@(#QT<B!S='EL93TS1"=V
M97)T:6-A;"UA;&EG;CH@8F]T=&]M)SX@("`-"B`@("`@("`@/'1D/B`@("`-
M"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!P861D:6YG+6)O
M='1O;3H@,2XQ<'0G/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0@8V]L<W!A;CTS1#,@<W1Y;&4],T0G
M9F]N="UW96EG:'0Z(&)O;&0[('1E>'0M86QI9VXZ(&-E;G1E<CL@8F]R9&5R
M+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60G/B`-"B`@("`@("`@("!'<F]S
M<R!686QU92`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!P861D:6YG+6)O='1O;3H@,2XQ
M<'0G/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@8V]L<W!A;CTS1#,@<W1Y;&4],T0G9F]N="UW96EG
M:'0Z(&)O;&0[('1E>'0M86QI9VXZ(&-E;G1E<CL@8F]R9&5R+6)O='1O;3H@
M0FQA8VL@,2XQ<'0@<V]L:60G/B`-"B`@("`@("`@("`\<"!S='EL93TS1"=M
M87)G:6XM=&]P.B`P.R!M87)G:6XM8F]T=&]M.B`P)SX@("`@(`T*("`@("`@
M("`@("`@0W5R<F5N8WD@#0H@("`@("`@("`@/"]P/B`-"B`@("`@("`@("`\
M<"!S='EL93TS1"=M87)G:6XM=&]P.B`P.R!M87)G:6XM8F]T=&]M.B`P)SX@
M("`@(`T*("`@("`@("`@("`@5')A;G-L871I;VX@("`@#0H@("`@("`@("`@
M/"]P/B`-"B`@("`@("`@("`\<"!S='EL93TS1"=M87)G:6XM=&]P.B`P.R!M
M87)G:6XM8F]T=&]M.B`P)SX@("`@(`T*("`@("`@("`@("`@061J=7-T;65N
M="`@(`T*("`@("`@("`@(#PO<#X@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!P861D:6YG
M+6)O='1O;3H@,2XQ<'0G/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@8V]L<W!A;CTS1#,@<W1Y;&4]
M,T0G9F]N="UW96EG:'0Z(&)O;&0[('1E>'0M86QI9VXZ(&-E;G1E<CL@8F]R
M9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60G/B`-"B`@("`@("`@("`\
M<"!S='EL93TS1"=M87)G:6XM=&]P.B`P.R!M87)G:6XM8F]T=&]M.B`P)SX@
M("`@(`T*("`@("`@("`@("`@06-C=6UU;&%T960@("`@#0H@("`@("`@("`@
M/"]P/B`-"B`@("`@("`@("`\<"!S='EL93TS1"=M87)G:6XM=&]P.B`P.R!M
M87)G:6XM8F]T=&]M.B`P)SX@("`@(`T*("`@("`@("`@("`@06UO<G1I>F%T
M:6]N("`@("`-"B`@("`@("`@("`\+W`^(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@<&%D
M9&EN9RUB;W1T;VTZ(#$N,7!T)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0S('-T
M>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97([
M(&)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED)SX@#0H@("`@("`@
M("`@/'`@<W1Y;&4],T0G;6%R9VEN+71O<#H@,#L@;6%R9VEN+6)O='1O;3H@
M,"<^("`@("`-"B`@("`@("`@("`@($YE="!";V]K(`T*("`@("`@("`@(#PO
M<#X@#0H@("`@("`@("`@/'`@<W1Y;&4],T0G;6%R9VEN+71O<#H@,#L@;6%R
M9VEN+6)O='1O;3H@,"<^("`@("`-"B`@("`@("`@("`@(%9A;'5E("`@#0H@
M("`@("`@("`@/"]P/B`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O;&0[('!A9&1I;F<M8F]T=&]M
M.B`Q+C%P="<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!C;VQS<&%N/3-$,R!S='EL93TS1"=F;VYT
M+7=E:6=H=#H@8F]L9#L@=&5X="UA;&EG;CH@8V5N=&5R.R!B;W)D97(M8F]T
M=&]M.B!";&%C:R`Q+C%P="!S;VQI9"<^(`T*("`@("`@("`@(#QP('-T>6QE
M/3-$)VUA<F=I;BUT;W`Z(#`[(&UA<F=I;BUB;W1T;VTZ(#`G/B`@("`@#0H@
M("`@("`@("`@("!.970@0F]O:R`-"B`@("`@("`@("`\+W`^(`T*("`@("`@
M("`@(#QP('-T>6QE/3-$)VUA<F=I;BUT;W`Z(#`[(&UA<F=I;BUB;W1T;VTZ
M(#`G/B`@("`@#0H@("`@("`@("`@("!686QU92`@(`T*("`@("`@("`@(#PO
M<#X@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)V9O;G0M=V5I9VAT.B!B;VQD.R!P861D:6YG+6)O='1O;3H@,2XQ<'0G/B`@
M(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@8V]L<W!A;CTS1#,@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O
M;&0[('1E>'0M86QI9VXZ(&-E;G1E<CL@8F]R9&5R+6)O='1O;3H@0FQA8VL@
M,2XQ<'0@<V]L:60G/B`-"B`@("`@("`@("!5<V5F=6P@3&EF92`@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@("`\='(@<W1Y
M;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO
M<CH@<F=B*#(P-"PR,S@L,C4U*2<^("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G=VED=&@Z(#,T)3L@=&5X="UA;&EG;CH@;&5F="<^(`T*("`@("`@("`@
M($1E=F5L;W!E9"!T96-H;F]L;V=Y(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24G/B`@#0H@("`@("`@("`@
M)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=W:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@
M("`@("`@)"`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)W=I9'1H.B`X)3L@=&5X="UA;&EG;CH@<FEG:'0G/B`-"B`@("`@
M("`@("`Q-BPW,#`L,#`P(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=W:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G/B`@
M("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24G/B`@#0H@("`@("`@("`@
M)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=W:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@
M("`@("`@)"`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)W=I9'1H.B`X)3L@=&5X="UA;&EG;CH@<FEG:'0G/B`-"B`@("`@
M("`@("`H,2PX,C@L,C$T(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=W:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G/B`@
M("`@#0H@("`@("`@("`@*2`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)2<^("`-"B`@("`@("`@("`F(S$V
M,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@
M("`D("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G=VED=&@Z(#@E.R!T97AT+6%L:6=N.B!R:6=H="<^(`T*("`@("`@("`@
M("@T+#<W.2PQ,C,@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-
M"B`@("`@("`@("`I("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=VED=&@Z(#$E)SX@(`T*("`@("`@("`@("8C,38P.R`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED
M=&@Z(#$E.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@("0@
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W
M:61T:#H@."4[('1E>'0M86QI9VXZ(')I9VAT)SX@#0H@("`@("`@("`@,3`L
M,#DR+#8V,R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G=VED=&@Z(#$E.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@
M("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=VED=&@Z(#$E)SX@(`T*("`@("`@("`@("8C,38P.R`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED
M=&@Z(#$E.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@("0@
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W
M:61T:#H@."4[('1E>'0M86QI9VXZ(')I9VAT)SX@#0H@("`@("`@("`@,3$L
M-S4S+#`P,R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G=VED=&@Z(#$E.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@
M("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=VED=&@Z(#$E)SX@(`T*("`@("`@("`@("8C,38P.R`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED
M=&@Z(#$E.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@("8C
M,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G=VED=&@Z(#@E.R!T97AT+6%L:6=N.B!C96YT97(G/B`@#0H@("`@("`@
M("`@,34@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G=VED=&@Z(#$E.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@
M("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@/"]T
M<CX@("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T
M=&]M.R!B86-K9W)O=6YD+6-O;&]R.B!7:&ET92<^("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@("`@("`@("`@
M26XM<')O8V5S<R!R97-E87)C:"`F86UP.R!D979E;&]P;65N="`@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D/B`@("`-"B`@("`@("`@("`F
M(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@(#4L-3`R+#8X-B`@
M("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D/B`@("`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V
M,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)W1E>'0M86QI9VXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("@V,S@L-#(V
M("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@("`@("`@("`@*2`@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D/B`@("`-"B`@("`@("`@("`F
M(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("T@(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N
M.B!L969T)SX@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9#X@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT
M+6%L:6=N.B!L969T)SX@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N
M.B!R:6=H="<^("`@("`-"B`@("`@("`@("`T+#@V-"PR-C`@("`@(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L
M:6=N.B!L969T)SX@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9#X@("`@#0H@("`@("`@("`@)B,Q-C`[
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T
M97AT+6%L:6=N.B!L969T)SX@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L
M:6=N.B!R:6=H="<^("`@("`-"B`@("`@("`@("`U+#(X-BPQ,C<@("`@(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT
M+6%L:6=N.B!L969T)SX@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9#X@("`@#0H@("`@("`@("`@)B,Q
M-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT
M+6%L:6=N.B!C96YT97(G/B`-"B`@("`@("`@("!);F1E9FEN:71E(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L
M:6=N.B!L969T)SX@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`\+W1R/B`@(`T*("`@("`@/'1R('-T>6QE/3-$
M)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z(')G
M8B@R,#0L,C,X+#(U-2DG/B`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("!$:7-T<FEB=71O<B!R
M96QA=&EO;G-H:7!S(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9#X@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@
M#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^("`@("`-"B`@
M("`@("`@("`T+#<P,"PP,#`@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@
M("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9#X@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@
M("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^("`@("`-
M"B`@("`@("`@("`H-#0P+#DU,R`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*
M("`@("`@("`@("D@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9#X@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@
M#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^("`@("`-"B`@
M("`@("`@("`H-"PP.#0L.30T(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@("`@
M("`@("`@*2`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D/B`@
M("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@
M("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX@("`@(`T*("`@("`@
M("`@(#$W-"PQ,#,@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@
M("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0^("`@
M(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@
M("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/B`@("`@#0H@("`@("`@
M("`@.#8S+#8U-2`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@("`@("`@("`@
M)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9#X@("`@
M#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@("`@
M("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97(G/B`-"B`@("`@("`@("`U
M("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@/"]T<CX@("`-"B`@("`@(#QT<B!S
M='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O
M;&]R.B!7:&ET92<^("`@#0H@("`@("`@(#QT9#X@("`@#0H@("`@("`@("`@
M4&%T96YT<R`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9#X@
M("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@
M("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^("`@("`-"B`@("`@
M("`@("`Q+#`P,"PP,#`@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@("`@
M("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9#X@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@
M#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^("`@("`-"B`@
M("`@("`@("`H,3`W+#DQ,"`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@
M("`@("`@("D@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9#X@
M("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@
M("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^("`@("`-"B`@("`@
M("`@("`H,C<Q+#(P."`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@
M("`@("D@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9#X@("`@
M#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@("`@
M("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^("`@("`-"B`@("`@("`@
M("`V,C`L.#@R("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F
M(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D/B`@("`-
M"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@
M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@
M(#<Q.2PU-S0@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@("8C
M,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0^("`@(`T*
M("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@
M("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R)SX@#0H@("`@("`@("`@,38@
M("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@/"]T<CX@("`-"B`@("`@(#QT<B!S
M='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O
M;&]R.B!R9V(H,C`T+#(S."PR-34I)SX@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=T97AT+6%L:6=N.B!L969T.R!P861D:6YG+6)O='1O;3H@,2XQ<'0G
M/B`@#0H@("`@("`@("`@16QE=F5S<R!T<F%D92!N86UE("`@(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O
M='1O;3H@,2XQ<'0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T
M;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!L969T)SX@("`-
M"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O
M;&ED.R!T97AT+6%L:6=N.B!R:6=H="<^("`@(`T*("`@("`@("`@(#$L,#`P
M+#`P,"`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT
M+6%L:6=N.B!L969T)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T
M=&]M.B`Q+C%P="<^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O
M;3H@0FQA8VL@,2XQ<'0@<V]L:60[('1E>'0M86QI9VXZ(&QE9G0G/B`@(`T*
M("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L
M:60[('1E>'0M86QI9VXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@+2`@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E
M<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!L969T
M)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`Q+C%P="<^
M("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ
M<'0@<V]L:60[('1E>'0M86QI9VXZ(&QE9G0G/B`@(`T*("`@("`@("`@("8C
M,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60[('1E>'0M86QI
M9VXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@*#<Q-RPY-C0@("`@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB
M;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!L969T)SX@
M("`-"B`@("`@("`@("`I("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#$N,7!T)SX@("`@#0H@
M("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI
M9#L@=&5X="UA;&EG;CH@;&5F="<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D
M97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9#L@=&5X="UA;&EG;CH@<FEG
M:'0G/B`@("`-"B`@("`@("`@("`R.#(L,#,V("`@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L
M86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!L969T)SX@("`-"B`@("`@
M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`Q+C%P="<^("`@(`T*("`@("`@
M("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60[('1E
M>'0M86QI9VXZ(&QE9G0G/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60[('1E>'0M86QI9VXZ(')I9VAT)SX@
M("`@#0H@("`@("`@("`@,S<V+#`U,"`@(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q
M+C%P="!S;VQI9#L@=&5X="UA;&EG;CH@;&5F="<^("`@#0H@("`@("`@("`@
M)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=P861D:6YG+6)O='1O;3H@,2XQ<'0G/B`@("`-"B`@("`@("`@("`F
M(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W!A9&1I;F<M8F]T=&]M.B`Q+C%P=#L@=&5X="UA;&EG;CH@;&5F="<^
M("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`Q+C%P=#L@=&5X
M="UA;&EG;CH@8V5N=&5R)SX@("`@#0H@("`@("`@("`@.2`@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T
M=&]M.B`Q+C%P=#L@=&5X="UA;&EG;CH@;&5F="<^("`-"B`@("`@("`@("`F
M(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@
M("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C
M:V=R;W5N9"UC;VQO<CH@5VAI=&4G/B`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G<&%D9&EN9RUB;W1T;VTZ(#(N-S5P=#L@<&%D9&EN9RUL969T.B`Q,'!T
M)SX@("`@(`T*("`@("`@("`@(%1O=&%L(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,BXW-7!T
M)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@
M,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@
M("`@("`D("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X
M="UA;&EG;CH@<FEG:'0G/B`-"B`@("`@("`@("`R."PY,#(L-C@V(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M
M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T
M)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#(N-S5P
M="<^("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K
M(#(N-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@
M("`@("`@)"`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[('1E
M>'0M86QI9VXZ(')I9VAT)SX@#0H@("`@("`@("`@*#,L,#$U+#4P,R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@;&5F
M="<^("`@("`-"B`@("`@("`@("`I("`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#(N-S5P="<^
M("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N
M-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@
M("`@)"`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[('1E>'0M
M86QI9VXZ(')I9VAT)SX@#0H@("`@("`@("`@*#DL.#4S+#(S.2`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@;&5F="<^
M("`@("`-"B`@("`@("`@("`I("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#(N-S5P="<^("`@
M("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P
M="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@
M)"`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[('1E>'0M86QI
M9VXZ(')I9VAT)SX@#0H@("`@("`@("`@,38L,#,S+#DT-"`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O
M;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@;&5F="<^("`@
M("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R+C<U<'0G/B`@
M("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C<U
M<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@
M("0@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T97AT+6%L
M:6=N.B!R:6=H="<^(`T*("`@("`@("`@(#$X+#DY."PT,#D@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T
M;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G/B`@
M("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,BXW-7!T)SX@
M("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#(N-S5P=#L@
M=&5X="UA;&EG;CH@;&5F="<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG
M+6)O='1O;3H@,BXW-7!T.R!T97AT+6%L:6=N.B!R:6=H="<^("`@(`T*("`@
M("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#(N-S5P=#L@=&5X="UA;&EG
M;CH@;&5F="<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`\+W1R/B`@(`T*("`@(#PO=&%B;&4^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y38VAE9'5L
M92!O9B!';V]D=VEL;"!;5&%B;&4@5&5X="!";&]C:UT\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E
M;&QS<&%C:6YG/3-$,"!S='EL93TS1"=B;W)D97(M8V]L;&%P<V4Z(&-O;&QA
M<'-E.R!W:61T:#H@,3`P)3L@9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^("`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I
M8V%L+6%L:6=N.B!B;W1T;VTG/B`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M9F]N="UW96EG:'0Z(&)O;&0[('!A9&1I;F<M8F]T=&]M.B`Q+C%P="<^("`@
M#0H@("`@("`@("`@1V]O9'=I;&P@("`@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!P861D
M:6YG+6)O='1O;3H@,2XQ<'0G/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@8V]L<W!A;CTS1#,@;F]W
M<F%P/3-$;F]W<F%P('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT
M+6%L:6=N.B!C96YT97([(&)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O
M;&ED)SX@(`T*("`@("`@("`@(#QP('-T>6QE/3-$)VUA<F=I;BUT;W`Z(#`[
M(&UA<F=I;BUB;W1T;VTZ(#`G/B`@("`@#0H@("`@("`@("`@("!4:')E92`@
M(`T*("`@("`@("`@(#PO<#X@#0H@("`@("`@("`@/'`@<W1Y;&4],T0G;6%R
M9VEN+71O<#H@,#L@;6%R9VEN+6)O='1O;3H@,"<^("`@("`-"B`@("`@("`@
M("`@($UO;G1H<R!%;F1E9"`@("`@#0H@("`@("`@("`@/"]P/B`-"B`@("`@
M("`@("`\<"!S='EL93TS1"=M87)G:6XM=&]P.B`P.R!M87)G:6XM8F]T=&]M
M.B`P)SX@("`@(`T*("`@("`@("`@("`@4V5P=&5M8F5R(#,P+"`-"B`@("`@
M("`@("`\+W`^(`T*("`@("`@("`@(#QP('-T>6QE/3-$)VUA<F=I;BUT;W`Z
M(#`[(&UA<F=I;BUB;W1T;VTZ(#`G/B`@("`@#0H@("`@("`@("`@("`R,#$T
M("`-"B`@("`@("`@("`\+W`^(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@<&%D9&EN9RUB
M;W1T;VTZ(#$N,7!T)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0S(&YO=W)A<#TS
M1&YO=W)A<"!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@=&5X="UA;&EG
M;CH@8V5N=&5R.R!B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9"<^
M("`-"B`@("`@("`@("`\<"!S='EL93TS1"=M87)G:6XM=&]P.B`P.R!M87)G
M:6XM8F]T=&]M.B`P)SX@("`@(`T*("`@("`@("`@("`@3FEN92`@#0H@("`@
M("`@("`@/"]P/B`-"B`@("`@("`@("`\<"!S='EL93TS1"=M87)G:6XM=&]P
M.B`P.R!M87)G:6XM8F]T=&]M.B`P)SX@("`@(`T*("`@("`@("`@("`@36]N
M=&AS($5N9&5D("`@("`-"B`@("`@("`@("`\+W`^(`T*("`@("`@("`@(#QP
M('-T>6QE/3-$)VUA<F=I;BUT;W`Z(#`[(&UA<F=I;BUB;W1T;VTZ(#`G/B`@
M("`@#0H@("`@("`@("`@("!397!T96UB97(@,S`L(`T*("`@("`@("`@(#PO
M<#X@#0H@("`@("`@("`@/'`@<W1Y;&4],T0G;6%R9VEN+71O<#H@,#L@;6%R
M9VEN+6)O='1O;3H@,"<^("`@("`-"B`@("`@("`@("`@(#(P,30@(`T*("`@
M("`@("`@(#PO<#X@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^
M("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O
M;3L@8F%C:V=R;W5N9"UC;VQO<CH@<F=B*#(P-"PR,S@L,C4U*2<^("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O;&0G/B`@("`@
M#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9"<^("`@("`-"B`@
M("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!L
M969T)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T
M97AT+6%L:6=N.B!R:6=H="<^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G9F]N="UW
M96EG:'0Z(&)O;&0[('1E>'0M86QI9VXZ(&QE9G0G/B`@(`T*("`@("`@("`@
M("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0^("`@
M(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@
M("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/B`@("`@#0H@("`@("`@
M("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@("`@("`@("`@)B,Q
M-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\+W1R/B`@(`T*("`@
M("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG
M<F]U;F0M8V]L;W(Z(%=H:71E)SX@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)W=I9'1H.B`W."4[('1E>'0M86QI9VXZ(&QE9G0G/B`-"B`@("`@("`@("!"
M86QA;F-E+"!B96=I;FYI;F<@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)2<^("`-"B`@("`@("`@("`F
M(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@
M("`@("`D("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G=VED=&@Z(#@E.R!T97AT+6%L:6=N.B!R:6=H="<^(`T*("`@("`@
M("`@(#DL,S8P+#@X-"`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^
M("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)2<^("`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@
M("`@("`@("`D("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G=VED=&@Z(#@E.R!T97AT+6%L:6=N.B!R:6=H="<^(`T*("`@
M("`@("`@(#DL-#0S+#@Y-"`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F
M="<^("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@(#PO='(^("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC
M86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@<F=B*#(P-"PR
M,S@L,C4U*2<^("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@;&5F=#L@<&%D9&EN9RUB;W1T;VTZ(#$N,7!T)SX@(`T*("`@("`@("`@
M($5F9F5C="!O9B!F;W)E:6=N(&-U<G)E;F-Y(&%D:G5S=&UE;G1S("`@(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D
M:6YG+6)O='1O;3H@,2XQ<'0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E
M<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!L969T
M)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N
M,7!T('-O;&ED.R!T97AT+6%L:6=N.B!R:6=H="<^("`@(`T*("`@("`@("`@
M("@V-3@L-3@Y("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9#L@
M=&5X="UA;&EG;CH@;&5F="<^("`@#0H@("`@("`@("`@*2`@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T
M=&]M.B`Q+C%P="<^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O
M;3H@0FQA8VL@,2XQ<'0@<V]L:60[('1E>'0M86QI9VXZ(&QE9G0G/B`@(`T*
M("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L
M:60[('1E>'0M86QI9VXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@*#<T,2PU
M.3D@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT+6%L
M:6=N.B!L969T)SX@("`-"B`@("`@("`@("`I("`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@/"]T<CX@("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T
M:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B!7:&ET92<^
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,BXW
M-7!T)SX@("`@(`T*("`@("`@("`@($)A;&%N8V4L(&5N9&EN9R`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB
M;W1T;VTZ(#(N-S5P="<^("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB
M;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G
M/B`@("`@#0H@("`@("`@("`@)"`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P
M="!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT)SX@#0H@("`@("`@("`@."PW
M,#(L,CDU("`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@
M=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I
M;F<M8F]T=&]M.B`R+C<U<'0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D
M97(M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!L
M969T)SX@("`@(`T*("`@("`@("`@("0@(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R
M+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^(`T*("`@("`@("`@
M(#@L-S`R+#(Y-2`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B
M;&4[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\+W1R/B`@(`T*("`@(#PO
M=&%B;&4^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO
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M=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N
M="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\
M<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO
M*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A
M9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$
M240P14U%/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C
M;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/DYO=&4@.2`M($%C8W)U
M960@17AP96YS97,@*%1A8FQE<RD\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^.2!-;VYT:',@16YD960\
M+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^4V5P+B`S,"P@,C`Q-#QB<CX\+W1H/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^/'-T<F]N9SY087EA8FQE<R!A;F0@06-C<G5A;',@
M6T%B<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^4V-H961U;&4@;V8@06-C<G5E9"!,:6%B:6QI=&EE<R!;5&%B
M;&4@5&5X="!";&]C:UT\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!S='EL
M93TS1"=B;W)D97(M8V]L;&%P<V4Z(&-O;&QA<'-E.R!W:61T:#H@,3`P)3L@
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^("`@
M(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VTG
M/B`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#L@
M<&%D9&EN9RUB;W1T;VTZ(#$N,7!T)SX@(`T*("`@("`@("`@("8C,38P.R`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D
M9&EN9RUB;W1T;VTZ(#$N,7!T)SX@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!C;VQS<&%N/3-$,R!N
M;W=R87`],T1N;W=R87`@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R.R!B
M;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9"<^("`@#0H@("`@("`@
M("`@/'`@<W1Y;&4],T0G;6%R9VEN+71O<#H@,#L@;6%R9VEN+6)O='1O;3H@
M,"<^("`@("`-"B`@("`@("`@("`@(#QB/E-E<'1E;6)E<B`S,"P\+V(^("`@
M("`-"B`@("`@("`@("`\+W`^(`T*("`@("`@("`@(#QP('-T>6QE/3-$)VUA
M<F=I;BUT;W`Z(#`[(&UA<F=I;BUB;W1T;VTZ(#`G/B`@("`@#0H@("`@("`@
M("`@("`\8CXR,#$T/"]B/B`-"B`@("`@("`@("`\+W`^(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O
M;3H@,2XQ<'0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0S(&YO=W)A<#TS1&YO
M=W)A<"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@8F]R9&5R+6)O='1O
M;3H@0FQA8VL@,2XQ<'0@<V]L:60G/B`@#0H@("`@("`@("`@/'`@<W1Y;&4]
M,T0G;6%R9VEN+71O<#H@,#L@;6%R9VEN+6)O='1O;3H@,#L@=&5X="UA;&EG
M;CH@8V5N=&5R)SX@("`@(`T*("`@("`@("`@("`@/&(^1&5C96UB97(F(S$V
M,#LS,2P\+V(^("`@#0H@("`@("`@("`@/"]P/B`-"B`@("`@("`@("`\<"!S
M='EL93TS1"=M87)G:6XM=&]P.B`P.R!M87)G:6XM8F]T=&]M.B`P.R!T97AT
M+6%L:6=N.B!C96YT97(G/B`@("`@#0H@("`@("`@("`@("`\8CXR,#$S/"]B
M/B`-"B`@("`@("`@("`\+W`^(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`\+W1R/B`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N
M.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z(')G8B@R,#0L,C,X+#(U-2DG
M/B`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`W."4[('1E>'0M
M86QI9VXZ(&QE9G0G/B`-"B`@("`@("`@("!,86)O<B!A;F0@<F5L871E9"!E
M>'!E;G-E<R`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)W=I9'1H.B`Q)2<^("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q
M)3L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@("`D("`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z
M(#@E.R!T97AT+6%L:6=N.B!R:6=H="<^(`T*("`@("`@("`@(#(L.#0R+#(S
M-"`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@
M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W=I9'1H.B`Q)2<^("`-"B`@("`@("`@("`F(S$V,#L@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H
M.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@("`D("`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED
M=&@Z(#@E.R!T97AT+6%L:6=N.B!R:6=H="<^(`T*("`@("`@("`@(#(L.#<P
M+#$T-R`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@
M("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO
M='(^("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O
M='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@5VAI=&4G/B`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@
M($-L:6YI8V%L('1R:6%L(&-O<W1S(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9#X@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L
M969T)SX@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^
M("`@("`-"B`@("`@("`@("`Y-C(L,#,Q("`@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@
M("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE
M9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX@
M("`@(`T*("`@("`@("`@(#@X,BPV-3$@("`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@
M(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@/"]T<CX@("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG
M;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B!R9V(H,C`T+#(S."PR-34I
M)SX@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T
M)SX@("`@#0H@("`@("`@("`@4')O9F5S<VEO;F%L(&9E97,@("`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0^("`@(`T*("`@("`@("`@("8C
M,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@("8C,38P.R`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@<FEG:'0G/B`@("`@#0H@("`@("`@("`@,S@R+#0R,R`@(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT
M+6%L:6=N.B!L969T)SX@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9#X@("`@#0H@("`@("`@("`@)B,Q
M-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT
M+6%L:6=N.B!R:6=H="<^("`@("`-"B`@("`@("`@("`S.#,L,C,Q("`@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@("`\='(@<W1Y;&4]
M,T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@
M5VAI=&4G/B`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@
M;&5F="<^("`@(`T*("`@("`@("`@(%)E<V5A<F-H(&=R86YT<R`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0^("`@(`T*("`@("`@("`@("8C
M,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@("8C,38P.R`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@<FEG:'0G/B`@("`@#0H@("`@("`@("`@-38R+#4U."`@(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT
M+6%L:6=N.B!L969T)SX@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9#X@("`@#0H@("`@("`@("`@)B,Q
M-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT
M+6%L:6=N.B!R:6=H="<^("`@("`-"B`@("`@("`@("`V,3`L-#DX("`@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@("`\='(@<W1Y;&4]
M,T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@
M<F=B*#(P-"PR,S@L,C4U*2<^("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@(%)E<W1R=6-T=7)I
M;F<@8V]S=',@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9#X@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@
M#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^("`@("`-"B`@
M("`@("`@("`Q,2PY,#D@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@("`@("`@
M("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9#X@
M("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@
M("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^("`@("`-"B`@("`@
M("`@("`R-"PV,S@@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@("`@("`@("`@
M)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\+W1R/B`@(`T*
M("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A
M8VMG<F]U;F0M8V]L;W(Z(%=H:71E)SX@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F<M8F]T=&]M.B`Q+C%P="<^
M("`-"B`@("`@("`@("!/=&AE<B`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#$N,7!T)SX@("`@
M#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S
M;VQI9#L@=&5X="UA;&EG;CH@;&5F="<^("`@#0H@("`@("`@("`@)B,Q-C`[
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B
M;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9#L@=&5X="UA;&EG;CH@
M<FEG:'0G/B`@("`-"B`@("`@("`@("`T.3(L-3,X("`@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ
M($)L86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!L969T)SX@("`-"B`@
M("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`Q+C%P="<^("`@(`T*("`@
M("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60[
M('1E>'0M86QI9VXZ(&QE9G0G/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60[('1E>'0M86QI9VXZ(')I9VAT
M)SX@("`@#0H@("`@("`@("`@-S8V+#<Q-B`@(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C
M:R`Q+C%P="!S;VQI9#L@=&5X="UA;&EG;CH@;&5F="<^("`@#0H@("`@("`@
M("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\+W1R/B`@
M(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[
M(&)A8VMG<F]U;F0M8V]L;W(Z(')G8B@R,#0L,C,X+#(U-2DG/B`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F<M
M8F]T=&]M.B`R+C<U<'0[('!A9&1I;F<M;&5F=#H@,3!P="<^("`@#0H@("`@
M("`@("`@5&]T86P@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R+C<U<'0G/B`@("`@#0H@("`@
M("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE
M.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@("0@(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M
M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H
M="<^(`T*("`@("`@("`@(#4L,C4S+#8Y,R`@("`@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L
M86-K(#(N-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@
M("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,BXW-7!T)SX@("`@(`T*
M("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O
M=6)L93L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@("`D("`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@
M<FEG:'0G/B`-"B`@("`@("`@("`U+#4S-RPX.#$@("`@(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M
M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T)SX@("`@
M(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@/"]T<CX@("`-"B`@("`\+W1A8FQE/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^
M#0H-"BTM+2TM+3U?3F5X=%!A<G1?8F$U,3<Q,3-?,&0R-U\T,S8Q7V$W8F%?
M,3!A-C-A,S@U-#)C#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+V)A
M-3$W,3$S7S!D,C=?-#,V,5]A-V)A7S$P838S83,X-30R8R]7;W)K<VAE971S
M+U-H965T,C@N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O
M=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S
M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@
M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M
M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R
M:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE
M;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C
M;&%S<STS1')E<&]R="!I9#TS1$E$,$4R1CX-"B`@("`@(#QT<CX-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T
M<F]N9SY.;W1E(#$S("T@4V5G;65N="!A;F0@1V5O9W)A<&AI8R!);F9O<FUA
M=&EO;B`H5&%B;&5S*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XY($UO;G1H<R!%;F1E9#PO=&@^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y397`N(#,P+"`R,#$T/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#X\<W1R;VYG/E-E9VUE;G0@4F5P;W)T:6YG(%M!8G-T<F%C=%T\
M+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-C
M:&5D=6QE(&]F(%-E9VUE;G0@4F5P;W)T:6YG($EN9F]R;6%T:6]N+"!B>2!3
M96=M96YT(%M486)L92!497AT($)L;V-K73PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQT86)L92!C96QL<&%D9&EN9STS1#`@8V5L;'-P86-I
M;F<],T0P('-T>6QE/3-$)V)O<F1E<BUC;VQL87!S93H@8V]L;&%P<V4[('=I
M9'1H.B`Q,#`E.R!F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF)SX@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N
M.B!B;W1T;VTG/B`@(`T*("`@("`@("`\=&0@8V]L<W!A;CTS1#,@<W1Y;&4]
M,T0G9F]N="UW96EG:'0Z(&)O;&0G/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=F;VYT
M+7=E:6=H=#H@8F]L9#L@<&%D9&EN9RUB;W1T;VTZ(#$N,7!T)SX@("`-"B`@
M("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D(&-O;'-P86X],T0W('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T
M97AT+6%L:6=N.B!C96YT97([(&)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T
M('-O;&ED)SX@#0H@("`@("`@("`@5&AR964@36]N=&AS($5N9&5D(%-E<'1E
M;6)E<B`S,"P@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O;&0[('!A9&1I;F<M8F]T=&]M.B`Q
M+C%P="<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!C;VQS<&%N/3-$-R!S='EL93TS1"=F;VYT+7=E
M:6=H=#H@8F]L9#L@=&5X="UA;&EG;CH@8V5N=&5R.R!B;W)D97(M8F]T=&]M
M.B!";&%C:R`Q+C%P="!S;VQI9"<^(`T*("`@("`@("`@($YI;F4@36]N=&AS
M($5N9&5D(%-E<'1E;6)E<B`S,"P@(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`\+W1R/B`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L
M:6=N.B!B;W1T;VTG/B`@(`T*("`@("`@("`\=&0@8V]L<W!A;CTS1#,@<W1Y
M;&4],T0G9F]N="UW96EG:'0Z(&)O;&0G/B`@#0H@("`@("`@("`@)B,Q-C`[
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=F
M;VYT+7=E:6=H=#H@8F]L9#L@<&%D9&EN9RUB;W1T;VTZ(#$N,7!T)SX@("`-
M"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD
M.R!T97AT+6%L:6=N.B!C96YT97([(&)O<F1E<BUB;W1T;VTZ($)L86-K(#$N
M,7!T('-O;&ED)SX@#0H@("`@("`@("`@,C`Q-"`@("`@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B
M;VQD.R!P861D:6YG+6)O='1O;3H@,2XQ<'0G/B`@(`T*("`@("`@("`@("8C
M,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@8V]L<W!A
M;CTS1#,@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O;&0[('1E>'0M86QI9VXZ
M(&-E;G1E<CL@8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60G/B`-
M"B`@("`@("`@("`R,#$S("`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O;&0[('!A9&1I;F<M
M8F]T=&]M.B`Q+C%P="<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!C;VQS<&%N/3-$,R!S='EL93TS
M1"=F;VYT+7=E:6=H=#H@8F]L9#L@=&5X="UA;&EG;CH@8V5N=&5R.R!B;W)D
M97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9"<^(`T*("`@("`@("`@(#(P
M,30@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@<&%D9&EN9RUB;W1T;VTZ(#$N,7!T
M)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)V9O;G0M=V5I9VAT
M.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97([(&)O<F1E<BUB;W1T;VTZ($)L
M86-K(#$N,7!T('-O;&ED)SX@#0H@("`@("`@("`@,C`Q,R`@("`@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@("`\='(@<W1Y
M;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO
M<CH@<F=B*#(P-"PR,S@L,C4U*2<^("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G=VED=&@Z(#$E.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@
M("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G=VED=&@Z(#4T)3L@=&5X="UA;&EG;CH@;&5F="<^(`T*("`@
M("`@("`@($]R=&AO8FEO;&]G:6-S("`@("`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!T97AT+6%L:6=N
M.B!L969T)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E)SX@(`T*
M("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!T97AT+6%L:6=N.B!L969T)SX@
M("`@(`T*("`@("`@("`@("0@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=W:61T:#H@."4[('1E>'0M86QI9VXZ(')I9VAT
M)SX@#0H@("`@("`@("`@,3@L.#DY+#@W,R`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!T97AT+6%L:6=N
M.B!L969T)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E)SX@(`T*
M("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!T97AT+6%L:6=N.B!L969T)SX@
M("`@(`T*("`@("`@("`@("0@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=W:61T:#H@."4[('1E>'0M86QI9VXZ(')I9VAT
M)SX@#0H@("`@("`@("`@,3(L.#,P+#4V-B`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!T97AT+6%L:6=N
M.B!L969T)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E)SX@(`T*
M("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!T97AT+6%L:6=N.B!L969T)SX@
M("`@(`T*("`@("`@("`@("0@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=W:61T:#H@."4[('1E>'0M86QI9VXZ(')I9VAT
M)SX@#0H@("`@("`@("`@-#@L-S4P+#(W-R`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!T97AT+6%L:6=N
M.B!L969T)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E)SX@(`T*
M("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!T97AT+6%L:6=N.B!L969T)SX@
M("`@(`T*("`@("`@("`@("0@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=W:61T:#H@."4[('1E>'0M86QI9VXZ(')I9VAT
M)SX@#0H@("`@("`@("`@-#`L-C(P+#,S.2`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!T97AT+6%L:6=N
M.B!L969T)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@/"]T<CX@("`-"B`@("`@(#QT<B!S='EL93TS1"=V
M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B!7:&ET
M92<^("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T
M)SX@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@
M#0H@("`@("`@("`@1&5R;6%L("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@
M("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@
M(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/B`@("`@#0H@
M("`@("`@("`@-#`Q+#,U-2`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@("`@
M("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9#X@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@
M#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^("`@("`-"B`@
M("`@("`@("`R-C<L-S8V("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@
M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-
M"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX@("`@(`T*("`@
M("`@("`@(#DS."PY-C8@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@
M("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0^
M("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*
M("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/B`@("`@#0H@("`@
M("`@("`@,2PP-C8L-#`Y("`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@
M("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@/"]T
M<CX@("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T
M=&]M.R!B86-K9W)O=6YD+6-O;&]R.B!R9V(H,C`T+#(S."PR-34I)SX@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@
M#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@("`@
M("`@("`@4W5R9VEC86P@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@
M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-
M"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX@("`@(`T*("`@
M("`@("`@(#$L-#4R+#DT-B`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@
M("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@
M("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX@("`@(`T*
M("`@("`@("`@(#$L,3,V+#(T."`@("`@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-
M"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G
M/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX@("`@
M(`T*("`@("`@("`@(#0L-3@Q+#0Y-B`@("`@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@
M("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE
M9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX@
M("`@(`T*("`@("`@("`@(#,L.34U+#$S-"`@("`@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G
M/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@(#PO='(^("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM
M86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@5VAI=&4G/B`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*
M("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@
M("`@($]P:'1H86QM:6,@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D/B`@
M("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@
M("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX@("`@(`T*("`@("`@
M("`@(#,V-BPQ,S@@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@
M("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0^("`@
M(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@
M("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/B`@("`@#0H@("`@("`@
M("`@,2PT,C4L-C`Y("`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@
M("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0^
M("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*
M("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/B`@("`@#0H@("`@
M("`@("`@.3,X+#$S-"`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@("`@("`@
M("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9#X@
M("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@
M("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^("`@("`-"B`@("`@
M("`@("`R+#@Q."PT,#<@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@("`@
M("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\+W1R
M/B`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T
M;VT[(&)A8VMG<F]U;F0M8V]L;W(Z(')G8B@R,#0L,C,X+#(U-2DG/B`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`Q+C%P=#L@
M=&5X="UA;&EG;CH@;&5F="<^("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M
M8F]T=&]M.B`Q+C%P=#L@=&5X="UA;&EG;CH@;&5F="<^("`-"B`@("`@("`@
M("!6971E<FEN87)Y(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,2XQ<'0[('1E>'0M86QI9VXZ
M(&QE9G0G/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,2XQ
M<'0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K
M(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!L969T)SX@("`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT
M+6%L:6=N.B!R:6=H="<^("`@(`T*("`@("`@("`@(#@U-2PP,#`@("`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60[('1E>'0M86QI9VXZ(&QE9G0G
M/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#$N,7!T)SX@
M("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P
M="!S;VQI9#L@=&5X="UA;&EG;CH@;&5F="<^("`@#0H@("`@("`@("`@)B,Q
M-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9#L@=&5X="UA;&EG
M;CH@<FEG:'0G/B`@("`-"B`@("`@("`@("`Q+#,V,RPQ-3<@("`@(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M
M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9#L@=&5X="UA;&EG;CH@;&5F="<^
M("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,2XQ<'0G/B`@
M("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T
M('-O;&ED.R!T97AT+6%L:6=N.B!L969T)SX@("`-"B`@("`@("`@("`F(S$V
M,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N
M.B!R:6=H="<^("`@(`T*("`@("`@("`@(#(L,S@U+#`P,"`@("`@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB
M;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!L969T)SX@
M("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`Q+C%P="<^("`@
M(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@
M<V]L:60[('1E>'0M86QI9VXZ(&QE9G0G/B`@(`T*("`@("`@("`@("8C,38P
M.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60[('1E>'0M86QI9VXZ
M(')I9VAT)SX@("`@#0H@("`@("`@("`@,RPQ,C0L.34S("`@("`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60[('1E>'0M86QI9VXZ(&QE9G0G/B`@
M(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@/"]T<CX@("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG
M;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B!7:&ET92<^("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,BXW-7!T.R!T97AT
M+6%L:6=N.B!L969T)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T
M=&]M.B`R+C<U<'0[('1E>'0M86QI9VXZ(')I9VAT)SX@("`@#0H@("`@("`@
M("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=P861D:6YG+6)O='1O;3H@,BXW-7!T.R!T97AT+6%L:6=N.B!L
M969T)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R+C<U
M<'0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C
M:R`R+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@
M("`@("`@("0@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T
M97AT+6%L:6=N.B!R:6=H="<^(`T*("`@("`@("`@(#(Q+#DW-2PS,3(@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E
M<BUB;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE
M9G0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,BXW
M-7!T)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA
M8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@
M("`@("`@("`D("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@
M=&5X="UA;&EG;CH@<FEG:'0G/B`-"B`@("`@("`@("`Q-RPP,C,L,S0V(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D
M97(M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!L
M969T)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#(N
M-S5P="<^("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L
M86-K(#(N-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@
M("`@("`@("`@)"`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[
M('1E>'0M86QI9VXZ(')I9VAT)SX@#0H@("`@("`@("`@-3<L-3DS+#@W,R`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@
M;&5F="<^("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R
M+C<U<'0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!"
M;&%C:R`R+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*
M("`@("`@("`@("0@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE
M.R!T97AT+6%L:6=N.B!R:6=H="<^(`T*("`@("`@("`@(#4Q+#4X-2PR-#(@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O
M<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ
M(&QE9G0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`\+W1R/B`@(`T*("`@(#PO=&%B;&4^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y38VAE9'5L
M92!O9B!2979E;G5E(&%N9"!/<&5R871I;F<@26YC;VUE(&)Y($=E;V=R87!H
M:6-A;"!!<F5A<R!;5&%B;&4@5&5X="!";&]C:UT\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS
M<&%C:6YG/3-$,"!S='EL93TS1"=B;W)D97(M8V]L;&%P<V4Z(&-O;&QA<'-E
M.R!W:61T:#H@,3`P)3L@9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9B<^("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA
M;&EG;CH@8F]T=&]M)SX@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V9O;G0M
M=V5I9VAT.B!B;VQD)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G9F]N="UW96EG
M:'0Z(&)O;&0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9"!C;VQS<&%N/3-$,34@<W1Y;&4],T0G
M9F]N="UW96EG:'0Z(&)O;&0[('1E>'0M86QI9VXZ(&-E;G1E<B<^("`@#0H@
M("`@("`@("`@5&AR964@36]N=&AS($5N9&5D(%-E<'1E;6)E<B`S,"P@("`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@/"]T<CX@("`-"B`@("`@(#QT
M<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M)SX@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD)SX@("`@(`T*("`@
M("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O;&0[('!A9&1I;F<M8F]T=&]M
M.B`Q+C%P="<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!C;VQS<&%N/3-$-R!S='EL93TS1"=F;VYT
M+7=E:6=H=#H@8F]L9#L@=&5X="UA;&EG;CH@8V5N=&5R.R!B;W)D97(M8F]T
M=&]M.B!";&%C:R`Q+C%P="!S;VQI9"<^(`T*("`@("`@("`@(#(P,30@("`@
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=F
M;VYT+7=E:6=H=#H@8F]L9#L@<&%D9&EN9RUB;W1T;VTZ(#$N,7!T)SX@("`-
M"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D(&-O;'-P86X],T0W('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD
M.R!T97AT+6%L:6=N.B!C96YT97([(&)O<F1E<BUB;W1T;VTZ($)L86-K(#$N
M,7!T('-O;&ED)SX@#0H@("`@("`@("`@,C`Q,R`@("`@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@("`\='(@<W1Y;&4],T0G
M=F5R=&EC86PM86QI9VXZ(&)O='1O;2<^("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=F;VYT+7=E:6=H=#H@8F]L9"<^("`@("`-"B`@("`@("`@("`F(S$V
M,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)V9O;G0M=V5I9VAT.B!B;VQD.R!P861D:6YG+6)O='1O;3H@,2XQ<'0G/B`@
M(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@8V]L<W!A;CTS1#,@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O
M;&0[('1E>'0M86QI9VXZ(&-E;G1E<CL@8F]R9&5R+6)O='1O;3H@0FQA8VL@
M,2XQ<'0@<V]L:60G/B`-"B`@("`@("`@("`\<"!S='EL93TS1"=M87)G:6XM
M=&]P.B`P.R!M87)G:6XM8F]T=&]M.B`P)SX@("`@(`T*("`@("`@("`@("`@
M5&]T86P@("`-"B`@("`@("`@("`\+W`^(`T*("`@("`@("`@(#QP('-T>6QE
M/3-$)VUA<F=I;BUT;W`Z(#`[(&UA<F=I;BUB;W1T;VTZ(#`G/B`@("`@#0H@
M("`@("`@("`@("!2979E;G5E("`@("`-"B`@("`@("`@("`\+W`^(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=F;VYT+7=E
M:6=H=#H@8F]L9#L@<&%D9&EN9RUB;W1T;VTZ(#$N,7!T)SX@("`-"B`@("`@
M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M(&-O;'-P86X],T0S('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT
M+6%L:6=N.B!C96YT97([(&)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O
M;&ED)SX@#0H@("`@("`@("`@/'`@<W1Y;&4],T0G;6%R9VEN+71O<#H@,#L@
M;6%R9VEN+6)O='1O;3H@,"<^("`@("`-"B`@("`@("`@("`@(%!E<F-E;G1A
M9V4@;V8@#0H@("`@("`@("`@/"]P/B`-"B`@("`@("`@("`\<"!S='EL93TS
M1"=M87)G:6XM=&]P.B`P.R!M87)G:6XM8F]T=&]M.B`P)SX@("`@(`T*("`@
M("`@("`@("`@4F5V96YU92`@("`@#0H@("`@("`@("`@/"]P/B`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G9F]N="UW96EG
M:'0Z(&)O;&0[('!A9&1I;F<M8F]T=&]M.B`Q+C%P="<^("`@#0H@("`@("`@
M("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!C
M;VQS<&%N/3-$,R!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@=&5X="UA
M;&EG;CH@8V5N=&5R.R!B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI
M9"<^(`T*("`@("`@("`@(#QP('-T>6QE/3-$)VUA<F=I;BUT;W`Z(#`[(&UA
M<F=I;BUB;W1T;VTZ(#`G/B`@("`@#0H@("`@("`@("`@("!4;W1A;"`@(`T*
M("`@("`@("`@(#PO<#X@#0H@("`@("`@("`@/'`@<W1Y;&4],T0G;6%R9VEN
M+71O<#H@,#L@;6%R9VEN+6)O='1O;3H@,"<^("`@("`-"B`@("`@("`@("`@
M(%)E=F5N=64@("`@(`T*("`@("`@("`@(#PO<#X@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD
M.R!P861D:6YG+6)O='1O;3H@,2XQ<'0G/B`@(`T*("`@("`@("`@("8C,38P
M.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@8V]L<W!A;CTS
M1#,@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O;&0[('1E>'0M86QI9VXZ(&-E
M;G1E<CL@8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60G/B`-"B`@
M("`@("`@("`\<"!S='EL93TS1"=M87)G:6XM=&]P.B`P.R!M87)G:6XM8F]T
M=&]M.B`P)SX@("`@(`T*("`@("`@("`@("`@4&5R8V5N=&%G92!O9B`-"B`@
M("`@("`@("`\+W`^(`T*("`@("`@("`@(#QP('-T>6QE/3-$)VUA<F=I;BUT
M;W`Z(#`[(&UA<F=I;BUB;W1T;VTZ(#`G/B`@("`@#0H@("`@("`@("`@("!2
M979E;G5E("`@("`-"B`@("`@("`@("`\+W`^(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`\+W1R/B`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I
M8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z(')G8B@R,#0L
M,C,X+#(U-2DG/B`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V9O;G0M=V5I
M9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!L969T)SX@("`-"B`@("`@("`@("!'
M96]G<F%P:&EC($QO8V%T:6]N.B`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O;&0G/B`@("`@#0H@
M("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@=&5X="UA;&EG;CH@
M;&5F="<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@
M=&5X="UA;&EG;CH@<FEG:'0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V9O;G0M
M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!L969T)SX@("`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D/B`@
M("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@
M("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX@("`@(`T*("`@("`@
M("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@("8C
M,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G9F]N="UW96EG:'0Z(&)O;&0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=F
M;VYT+7=E:6=H=#H@8F]L9#L@=&5X="UA;&EG;CH@;&5F="<^("`@#0H@("`@
M("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@=&5X="UA;&EG;CH@<FEG
M:'0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T
M97AT+6%L:6=N.B!L969T)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D/B`@("`-"B`@("`@("`@("`F
M(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@/"]T<CX@("`-"B`@("`@(#QT<B!S='EL93TS
M1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B!7
M:&ET92<^("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@-38E.R!T
M97AT+6%L:6=N.B!L969T.R!P861D:6YG+6QE9G0Z(#$P<'0G/B`-"B`@("`@
M("`@("!5;FET960@4W1A=&5S("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24G/B`@#0H@("`@("`@("`@
M)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=W:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@
M("`@("`@)"`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)W=I9'1H.B`X)3L@=&5X="UA;&EG;CH@<FEG:'0G/B`-"B`@("`@
M("`@("`Q."PT-34L,38W(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=W:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G/B`@
M("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24G/B`@#0H@("`@("`@("`@
M)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=W:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@
M("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=W:61T:#H@."4[('1E>'0M86QI9VXZ(')I9VAT)SX@#0H@
M("`@("`@("`@.#0@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!T97AT+6%L:6=N.B!L969T)SX@("`@
M(`T*("`@("`@("`@("4@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=W:61T:#H@,24G/B`@#0H@("`@("`@("`@)B,Q-C`[
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W
M:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@
M)"`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)W=I9'1H.B`X)3L@=&5X="UA;&EG;CH@<FEG:'0G/B`-"B`@("`@("`@("`Q
M-"PT.#4L.#(Q(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=W:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@
M("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=W:61T:#H@,24G/B`@#0H@("`@("`@("`@)B,Q-C`[
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W
M:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@
M)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=W:61T:#H@."4[('1E>'0M86QI9VXZ(')I9VAT)SX@#0H@("`@("`@
M("`@.#(@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G=VED=&@Z(#$E.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@
M("`@("`@("4@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\+W1R/B`@
M(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[
M(&)A8VMG<F]U;F0M8V]L;W(Z(')G8B@R,#0L,C,X+#(U-2DG/B`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F<M
M;&5F=#H@,3!P="<^("`@(`T*("`@("`@("`@($5U<F]P92`@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D/B`@("`-"B`@("`@("`@("`F(S$V
M,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@(#$L-S@T+#0Q-"`@("`@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D/B`@("`-"B`@("`@("`@("`F
M(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@(#@@(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N
M.B!L969T)SX@("`@#0H@("`@("`@("`@)2`@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I
M9VAT)SX@("`@(`T*("`@("`@("`@(#$L-C4V+#8U-B`@("`@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(')I9VAT)SX@("`@(`T*("`@("`@("`@(#D@(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@
M("`@#0H@("`@("`@("`@)2`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M(#PO='(^("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ
M(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@5VAI=&4G/B`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#L@<&%D9&EN9RUB;W1T
M;VTZ(#$N,7!T.R!P861D:6YG+6QE9G0Z(#$P<'0G/B`@#0H@("`@("`@("`@
M3W1H97(@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W!A9&1I;F<M8F]T=&]M.B`Q+C%P="<^("`@(`T*("`@("`@("`@("8C
M,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60[('1E>'0M86QI
M9VXZ(&QE9G0G/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@
M0FQA8VL@,2XQ<'0@<V]L:60[('1E>'0M86QI9VXZ(')I9VAT)SX@("`@#0H@
M("`@("`@("`@,2PX,34L.#0R("`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ
M<'0@<V]L:60[('1E>'0M86QI9VXZ(&QE9G0G/B`@(`T*("`@("`@("`@("8C
M,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G<&%D9&EN9RUB;W1T;VTZ(#$N,7!T)SX@("`@#0H@("`@("`@("`@)B,Q
M-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9#L@=&5X="UA;&EG
M;CH@;&5F="<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!"
M;&%C:R`Q+C%P="!S;VQI9#L@=&5X="UA;&EG;CH@<FEG:'0G/B`@("`-"B`@
M("`@("`@("`X("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60[('1E
M>'0M86QI9VXZ(&QE9G0G/B`@(`T*("`@("`@("`@("4@(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O
M;3H@,2XQ<'0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ
M($)L86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!L969T)SX@("`-"B`@
M("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED
M.R!T97AT+6%L:6=N.B!R:6=H="<^("`@(`T*("`@("`@("`@(#$L-C$Q+#DV
M,2`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT+6%L
M:6=N.B!L969T)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M
M.B`Q+C%P="<^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@
M0FQA8VL@,2XQ<'0@<V]L:60[('1E>'0M86QI9VXZ(&QE9G0G/B`@(`T*("`@
M("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60[
M('1E>'0M86QI9VXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@.2`@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB
M;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!L969T)SX@
M("`-"B`@("`@("`@("`E("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M/"]T<CX@("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@
M8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B!R9V(H,C`T+#(S."PR-34I)SX@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!P
M861D:6YG+6)O='1O;3H@,BXW-7!T.R!P861D:6YG+6QE9G0Z(#(P<'0G/B`@
M(`T*("`@("`@("`@(%1O=&%L(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,BXW-7!T)SX@("`@
M(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T
M(&1O=6)L93L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@("`D
M("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG
M;CH@<FEG:'0G/B`-"B`@("`@("`@("`R,BPP-34L-#(S(`T*("`@("`@("`\
M+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M
M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T)SX@("`@
M(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#(N-S5P="<^("`@
M("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P
M="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@
M)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T97AT
M+6%L:6=N.B!R:6=H="<^(`T*("`@("`@("`@(#$P,"`@("`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O
M;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@;&5F="<^("`@
M("`-"B`@("`@("`@("`E("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#(N-S5P="<^("`@("`-
M"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P="!D
M;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@)"`@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O
M<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ
M(')I9VAT)SX@#0H@("`@("`@("`@,3<L-S4T+#0S."`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@
M0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-
M"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R+C<U<'0G/B`@("`@
M#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C<U<'0@
M9&]U8FQE.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@("8C
M,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA
M;&EG;CH@<FEG:'0G/B`-"B`@("`@("`@("`Q,#`@("`@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ
M($)L86-K(#(N-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@
M#0H@("`@("`@("`@)2`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO
M='(^("`@#0H@("`@/"]T86)L93X\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E
M;&QS<&%C:6YG/3-$,"!S='EL93TS1"=B;W)D97(M8V]L;&%P<V4Z(&-O;&QA
M<'-E.R!W:61T:#H@,3`P)3L@9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC
M86PM86QI9VXZ(&)O='1O;2<^("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=F
M;VYT+7=E:6=H=#H@8F]L9"<^("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V9O;G0M
M=V5I9VAT.B!B;VQD)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@8V]L<W!A;CTS1#$U('-T>6QE
M/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97(G/B`@
M(`T*("`@("`@("`@($YI;F4@36]N=&AS($5N9&5D(%-E<'1E;6)E<B`S,"P@
M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\+W1R/B`@(`T*("`@("`@
M/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VTG/B`@(`T*("`@
M("`@("`\=&0@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O;&0G/B`@("`@#0H@
M("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@<&%D9&EN9RUB;W1T
M;VTZ(#$N,7!T)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0W('-T>6QE/3-$)V9O
M;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97([(&)O<F1E<BUB
M;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED)SX@#0H@("`@("`@("`@,C`Q-"`@
M("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)V9O;G0M=V5I9VAT.B!B;VQD.R!P861D:6YG+6)O='1O;3H@,2XQ<'0G/B`@
M(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@
M("`@("`\=&0@8V]L<W!A;CTS1#<@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O
M;&0[('1E>'0M86QI9VXZ(&-E;G1E<CL@8F]R9&5R+6)O='1O;3H@0FQA8VL@
M,2XQ<'0@<V]L:60G/B`-"B`@("`@("`@("`R,#$S("`@("`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@/"]T<CX@("`-"B`@("`@(#QT<B!S='EL93TS
M1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M)SX@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD)SX@("`@(`T*("`@("`@("`@("8C
M,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G9F]N="UW96EG:'0Z(&)O;&0[('!A9&1I;F<M8F]T=&]M.B`Q+C%P="<^
M("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!C;VQS<&%N/3-$,R!S='EL93TS1"=F;VYT+7=E:6=H=#H@
M8F]L9#L@=&5X="UA;&EG;CH@8V5N=&5R.R!B;W)D97(M8F]T=&]M.B!";&%C
M:R`Q+C%P="!S;VQI9"<^(`T*("`@("`@("`@(#QP('-T>6QE/3-$)VUA<F=I
M;BUT;W`Z(#`[(&UA<F=I;BUB;W1T;VTZ(#`G/B`@("`@#0H@("`@("`@("`@
M("!4;W1A;"`@(`T*("`@("`@("`@(#PO<#X@#0H@("`@("`@("`@/'`@<W1Y
M;&4],T0G;6%R9VEN+71O<#H@,#L@;6%R9VEN+6)O='1O;3H@,"<^("`@("`-
M"B`@("`@("`@("`@(%)E=F5N=64@("`@(`T*("`@("`@("`@(#PO<#X@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V9O;G0M
M=V5I9VAT.B!B;VQD.R!P861D:6YG+6)O='1O;3H@,2XQ<'0G/B`@(`T*("`@
M("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@8V]L<W!A;CTS1#,@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O;&0[('1E
M>'0M86QI9VXZ(&-E;G1E<CL@8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@
M<V]L:60G/B`-"B`@("`@("`@("`\<"!S='EL93TS1"=M87)G:6XM=&]P.B`P
M.R!M87)G:6XM8F]T=&]M.B`P)SX@("`@(`T*("`@("`@("`@("`@4&5R8V5N
M=&%G92!O9B`-"B`@("`@("`@("`\+W`^(`T*("`@("`@("`@(#QP('-T>6QE
M/3-$)VUA<F=I;BUT;W`Z(#`[(&UA<F=I;BUB;W1T;VTZ(#`G/B`@("`@#0H@
M("`@("`@("`@("!2979E;G5E("`@("`-"B`@("`@("`@("`\+W`^(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=F;VYT+7=E
M:6=H=#H@8F]L9#L@<&%D9&EN9RUB;W1T;VTZ(#$N,7!T)SX@("`-"B`@("`@
M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M(&-O;'-P86X],T0S('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT
M+6%L:6=N.B!C96YT97([(&)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O
M;&ED)SX@#0H@("`@("`@("`@/'`@<W1Y;&4],T0G;6%R9VEN+71O<#H@,#L@
M;6%R9VEN+6)O='1O;3H@,"<^("`@("`-"B`@("`@("`@("`@(%1O=&%L("`@
M#0H@("`@("`@("`@/"]P/B`-"B`@("`@("`@("`\<"!S='EL93TS1"=M87)G
M:6XM=&]P.B`P.R!M87)G:6XM8F]T=&]M.B`P)SX@("`@(`T*("`@("`@("`@
M("`@4F5V96YU92`@("`@#0H@("`@("`@("`@/"]P/B`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O
M;&0[('!A9&1I;F<M8F]T=&]M.B`Q+C%P="<^("`@#0H@("`@("`@("`@)B,Q
M-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!C;VQS<&%N
M/3-$,R!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@=&5X="UA;&EG;CH@
M8V5N=&5R.R!B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9"<^(`T*
M("`@("`@("`@(#QP('-T>6QE/3-$)VUA<F=I;BUT;W`Z(#`[(&UA<F=I;BUB
M;W1T;VTZ(#`G/B`@("`@#0H@("`@("`@("`@("!097)C96YT86=E(&]F(`T*
M("`@("`@("`@(#PO<#X@#0H@("`@("`@("`@/'`@<W1Y;&4],T0G;6%R9VEN
M+71O<#H@,#L@;6%R9VEN+6)O='1O;3H@,"<^("`@("`-"B`@("`@("`@("`@
M(%)E=F5N=64@("`@(`T*("`@("`@("`@(#PO<#X@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R
M=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@<F=B*#(P
M-"PR,S@L,C4U*2<^("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G9F]N="UW
M96EG:'0Z(&)O;&0[('1E>'0M86QI9VXZ(&QE9G0G/B`@(`T*("`@("`@("`@
M($=E;V=R87!H:6,@3&]C871I;VXZ(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`@(#QT9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9"<^("`@("`-
M"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N
M.B!L969T)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD
M.R!T97AT+6%L:6=N.B!R:6=H="<^("`@(`T*("`@("`@("`@("8C,38P.R`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G9F]N
M="UW96EG:'0Z(&)O;&0[('1E>'0M86QI9VXZ(&QE9G0G/B`@(`T*("`@("`@
M("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0^
M("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*
M("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/B`@("`@#0H@("`@
M("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@("`@("`@("`@
M)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=F;VYT+7=E:6=H=#H@8F]L9"<^("`@("`-"B`@("`@("`@("`F(S$V
M,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!L969T)SX@("`-"B`@
M("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!R
M:6=H="<^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O;&0[
M('1E>'0M86QI9VXZ(&QE9G0G/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0^("`@(`T*("`@("`@("`@
M("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@("8C,38P
M.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@<FEG:'0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT
M+6%L:6=N.B!L969T)SX@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`\+W1R/B`@(`T*("`@("`@/'1R('-T>6QE
M/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z
M(%=H:71E)SX@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`U-B4[
M('1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F<M;&5F=#H@,3!P="<^(`T*("`@
M("`@("`@(%5N:71E9"!3=&%T97,@("`@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)2<^("`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@
M("`@("`@("`D("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G=VED=&@Z(#@E.R!T97AT+6%L:6=N.B!R:6=H="<^(`T*("`@
M("`@("`@(#<R+#DS-2PW,C(@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^
M("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)2<^("`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@
M("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)W=I9'1H.B`X)3L@=&5X="UA;&EG;CH@<FEG:'0G/B`-
M"B`@("`@("`@("`X.2`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@
M(#QT9"!S='EL93TS1"=W:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G/B`@
M("`@#0H@("`@("`@("`@)2`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)2<^("`-"B`@("`@("`@("`F(S$V
M,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@
M("`D("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G=VED=&@Z(#@E.R!T97AT+6%L:6=N.B!R:6=H="<^(`T*("`@("`@("`@
M(#0R+#(U,2PS,S8@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-
M"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)2<^("`-"B`@("`@("`@("`F(S$V
M,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)W=I9'1H.B`X)3L@=&5X="UA;&EG;CH@<FEG:'0G/B`-"B`@("`@
M("`@("`W."`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=W:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@
M("`@("`@("`@)2`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^
M("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O
M;3L@8F%C:V=R;W5N9"UC;VQO<CH@<F=B*#(P-"PR,S@L,C4U*2<^("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#L@<&%D9&EN
M9RUL969T.B`Q,'!T)SX@("`@#0H@("`@("`@("`@175R;W!E("`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0^("`@(`T*("`@("`@("`@("8C
M,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@("8C,38P.R`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@<FEG:'0G/B`@("`@#0H@("`@("`@("`@-2PR-S0L,#<Q("`@
M("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0^("`@(`T*("`@("`@("`@
M("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@("8C,38P
M.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@<FEG:'0G/B`@("`@#0H@("`@("`@("`@-B`@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`E("`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@
M<FEG:'0G/B`@("`@#0H@("`@("`@("`@-2PR,C8L-C$Y("`@("`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@;&5F="<^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0^("`@(`T*("`@("`@("`@("8C,38P.R`-
M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@;&5F="<^("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@<FEG:'0G/B`@("`@#0H@("`@("`@("`@,3`@("`-"B`@("`@("`@/"]T
M9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F
M="<^("`@(`T*("`@("`@("`@("4@(`T*("`@("`@("`\+W1D/B`@("`@#0H@
M("`@("`\+W1R/B`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L
M:6=N.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z(%=H:71E)SX@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F<M
M8F]T=&]M.B`Q+C%P=#L@<&%D9&EN9RUL969T.B`Q,'!T)SX@(`T*("`@("`@
M("`@($]T:&5R(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=P861D:6YG+6)O='1O;3H@,2XQ<'0G/B`@("`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT
M+6%L:6=N.B!L969T)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T
M;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!R:6=H="<^("`@
M(`T*("`@("`@("`@(#0L,3,P+#4W-R`@("`@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K
M(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!L969T)SX@("`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`Q+C%P="<^("`@(`T*("`@("`@("`@
M("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60[('1E>'0M
M86QI9VXZ(&QE9G0G/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O
M;3H@0FQA8VL@,2XQ<'0@<V]L:60[('1E>'0M86QI9VXZ(')I9VAT)SX@("`@
M#0H@("`@("`@("`@-2`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED
M.R!T97AT+6%L:6=N.B!L969T)SX@("`-"B`@("`@("`@("`E("`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB
M;W1T;VTZ(#$N,7!T)SX@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T
M=&]M.B!";&%C:R`Q+C%P="!S;VQI9#L@=&5X="UA;&EG;CH@;&5F="<^("`@
M#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S
M;VQI9#L@=&5X="UA;&EG;CH@<FEG:'0G/B`@("`-"B`@("`@("`@("`V+#,U
M,2PX-S$@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9#L@=&5X
M="UA;&EG;CH@;&5F="<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O
M='1O;3H@,2XQ<'0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T
M;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!L969T)SX@("`-
M"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O
M;&ED.R!T97AT+6%L:6=N.B!R:6=H="<^("`@(`T*("`@("`@("`@(#$R("`@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O
M<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED.R!T97AT+6%L:6=N.B!L
M969T)SX@("`-"B`@("`@("`@("`E("`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@/"]T<CX@("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA
M;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B!R9V(H,C`T+#(S."PR
M-34I)SX@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L
M969T.R!P861D:6YG+6)O='1O;3H@,BXW-7!T.R!P861D:6YG+6QE9G0Z(#(P
M<'0G/B`@(`T*("`@("`@("`@(%1O=&%L(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,BXW-7!T
M)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@
M,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@
M("`@("`D("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X
M="UA;&EG;CH@<FEG:'0G/B`-"B`@("`@("`@("`X,BPS-#`L,S<P(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M
M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T
M)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#(N-S5P
M="<^("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K
M(#(N-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@
M("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C<U<'0@9&]U8FQE
M.R!T97AT+6%L:6=N.B!R:6=H="<^(`T*("`@("`@("`@(#$P,"`@("`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@;&5F
M="<^("`@("`-"B`@("`@("`@("`E("`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#(N-S5P="<^
M("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N
M-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@
M("`@)"`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[('1E>'0M
M86QI9VXZ(')I9VAT)SX@#0H@("`@("`@("`@-3,L.#(Y+#@R-B`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@;&5F="<^
M("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R+C<U<'0G
M/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R
M+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@
M("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@
M=&5X="UA;&EG;CH@<FEG:'0G/B`-"B`@("`@("`@("`Q,#`@("`@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB
M;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G
M/B`@("`@#0H@("`@("`@("`@)2`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@(#PO='(^("`@#0H@("`@/"]T86)L93X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL
M/@T*#0HM+2TM+2T]7TYE>'1087)T7V)A-3$W,3$S7S!D,C=?-#,V,5]A-V)A
M7S$P838S83,X-30R8PT*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]B
M834Q-S$Q,U\P9#(W7S0S-C%?83=B85\Q,&$V,V$S.#4T,F,O5V]R:W-H965T
M<R]3:&5E=#(Y+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U
M;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R
M<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!
M(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT
M;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C
M<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM
M96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@
M8VQA<W,],T1R97!O<G0@:60],T1)1#!%344^#0H@("`@("`\='(^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS
M=')O;F<^3F]T92`Q-"`M(%)E<W1R=6-T=7)I;F<@0W)E9&ET<R`H5&%B;&5S
M*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C
M;VQS<&%N/3-$,3XY($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y397`N(#,P+"`R
M,#$T/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R
M;VYG/E)E<W1R=6-T=7)I;F<@86YD(%)E;&%T960@06-T:79I=&EE<R!;06)S
M=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y38VAE9'5L92!O9B!297-T<G5C='5R:6YG(%)E<V5R=F4@8GD@5'EP
M92!O9B!#;W-T(%M486)L92!497AT($)L;V-K73PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQT86)L92!C96QL<&%D9&EN9STS1#`@8V5L;'-P
M86-I;F<],T0P('-T>6QE/3-$)V)O<F1E<BUC;VQL87!S93H@8V]L;&%P<V4[
M('=I9'1H.B`Q,#`E.R!F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF)SX@("`-"B`@("`@(#QT<B!S='EL93TS1"=V97)T:6-A;"UA
M;&EG;CH@8F]T=&]M)SX@("`-"B`@("`@("`@/'1D/B`@("`-"B`@("`@("`@
M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!P861D:6YG+6)O='1O;3H@,2XQ
M<'0G/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@
M(`T*("`@("`@("`\=&0@8V]L<W!A;CTS1#$Q('-T>6QE/3-$)V9O;G0M=V5I
M9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97([(&)O<F1E<BUB;W1T;VTZ
M($)L86-K(#$N,7!T('-O;&ED)SX@(`T*("`@("`@("`@(%)E<W1R=6-T=7)I
M;F<@06-C<G5A;"`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^
M("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O
M;2<^("`@#0H@("`@("`@(#QT9#X@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=F;VYT
M+7=E:6=H=#H@8F]L9#L@<&%D9&EN9RUB;W1T;VTZ(#$N,7!T)SX@("`-"B`@
M("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D(&-O;'-P86X],T0S(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=F;VYT
M+7=E:6=H=#H@8F]L9#L@=&5X="UA;&EG;CH@8V5N=&5R.R!B;W)D97(M8F]T
M=&]M.B!";&%C:R`Q+C%P="!S;VQI9"<^("`-"B`@("`@("`@("`\<"!S='EL
M93TS1"=M87)G:6XM=&]P.B`P.R!M87)G:6XM8F]T=&]M.B`P)SX@("`@(`T*
M("`@("`@("`@("`@16UP;&]Y964@#0H@("`@("`@("`@/"]P/B`-"B`@("`@
M("`@("`\<"!S='EL93TS1"=M87)G:6XM=&]P.B`P.R!M87)G:6XM8F]T=&]M
M.B`P)SX@("`@(`T*("`@("`@("`@("`@4V5V97)A;F-E(&%N9"`-"B`@("`@
M("`@("`\+W`^(`T*("`@("`@("`@(#QP('-T>6QE/3-$)VUA<F=I;BUT;W`Z
M(#`[(&UA<F=I;BUB;W1T;VTZ(#`G/B`@("`@#0H@("`@("`@("`@("!296QA
M=&5D($)E;F5F:71S("`@(`T*("`@("`@("`@(#PO<#X@#0H@("`@("`@(#PO
M=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B
M;VQD.R!P861D:6YG+6)O='1O;3H@,2XQ<'0G/B`@(`T*("`@("`@("`@("8C
M,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@8V]L<W!A
M;CTS1#,@;F]W<F%P/3-$;F]W<F%P('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B
M;VQD.R!T97AT+6%L:6=N.B!C96YT97([(&)O<F1E<BUB;W1T;VTZ($)L86-K
M(#$N,7!T('-O;&ED)SX@(`T*("`@("`@("`@(#QP('-T>6QE/3-$)VUA<F=I
M;BUT;W`Z(#`[(&UA<F=I;BUB;W1T;VTZ(#`G/B`@("`@#0H@("`@("`@("`@
M("!!8W1I=FET>2`-"B`@("`@("`@("`\+W`^(`T*("`@("`@("`@(#QP('-T
M>6QE/3-$)VUA<F=I;BUT;W`Z(#`[(&UA<F=I;BUB;W1T;VTZ(#`G/B`@("`@
M#0H@("`@("`@("`@("!497)M:6YA=&EO;B!A;F0@("`-"B`@("`@("`@("`\
M+W`^(`T*("`@("`@("`@(#QP('-T>6QE/3-$)VUA<F=I;BUT;W`Z(#`[(&UA
M<F=I;BUB;W1T;VTZ(#`G/B`@("`@#0H@("`@("`@("`@("!&86-I;&ET>2!#
M;&]S=7)E("`@(`T*("`@("`@("`@(#PO<#X@#0H@("`@("`@("`@/'`@<W1Y
M;&4],T0G;6%R9VEN+71O<#H@,#L@;6%R9VEN+6)O='1O;3H@,"<^("`@("`-
M"B`@("`@("`@("`@($-O<W1S("`@#0H@("`@("`@("`@/"]P/B`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G9F]N="UW96EG
M:'0Z(&)O;&0[('!A9&1I;F<M8F]T=&]M.B`Q+C%P="<^("`@#0H@("`@("`@
M("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!C
M;VQS<&%N/3-$,R!N;W=R87`],T1N;W=R87`@<W1Y;&4],T0G9F]N="UW96EG
M:'0Z(&)O;&0[('1E>'0M86QI9VXZ(&-E;G1E<CL@8F]R9&5R+6)O='1O;3H@
M0FQA8VL@,2XQ<'0@<V]L:60G/B`@#0H@("`@("`@("`@5&]T86P@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@("`\='(@<W1Y
M;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO
M<CH@<F=B*#(P-"PR,S@L,C4U*2<^("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G=VED=&@Z(#8W)3L@=&5X="UA;&EG;CH@;&5F="<^(`T*("`@("`@("`@
M($1E8V5M8F5R(#,Q+"`R,#$S("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)2<^("`-"B`@("`@("`@("`F
M(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE
M/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@
M("`@("`D("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G=VED=&@Z(#@E.R!T97AT+6%L:6=N.B!R:6=H="<^(`T*("`@("`@
M("`@(#(Q+#<P.2`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-
M"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)2<^("`-"B`@("`@("`@("`F(S$V
M,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@
M("`D("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4]
M,T0G=VED=&@Z(#@E.R!T97AT+6%L:6=N.B!R:6=H="<^(`T*("`@("`@("`@
M(#(L.3(Y(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=W:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@
M("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=W:61T:#H@,24G/B`@#0H@("`@("`@("`@)B,Q-C`[(`T*
M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T
M:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@)"`@
M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I
M9'1H.B`X)3L@=&5X="UA;&EG;CH@<FEG:'0G/B`-"B`@("`@("`@("`R-"PV
M,S@@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=W:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@
M("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\+W1R/B`@
M(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[
M(&)A8VMG<F]U;F0M8V]L;W(Z(%=H:71E)SX@("`-"B`@("`@("`@/'1D('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("!#87-H
M(%!R;V-E961S("A$:7-B=7)S96UE;G1S*2`@("`@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@
M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@
M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(')I9VAT)SX@("`@(`T*("`@("`@("`@("@Q,"PQ,S`@("`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@
M;&5F="<^("`@(`T*("`@("`@("`@("D@(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9#X@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N
M.B!L969T)SX@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D
M/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H
M="<^("`@("`-"B`@("`@("`@("`H,2PT,C4@(`T*("`@("`@("`\+W1D/B`@
M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@
M("`@#0H@("`@("`@("`@*2`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@
M("`@/'1D/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^
M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G
M/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX@("`@
M(`T*("`@("`@("`@("@Q,2PU-34@("`-"B`@("`@("`@/"]T9#X@("`@(`T*
M("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F="<^("`@(`T*
M("`@("`@("`@("D@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\+W1R
M/B`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T
M;VT[(&)A8VMG<F]U;F0M8V]L;W(Z(')G8B@R,#0L,C,X+#(U-2DG/B`@("`-
M"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I
M;F<M8F]T=&]M.B`Q+C%P="<^("`-"B`@("`@("`@("!&;W)E:6=N($5X8VAA
M;F=E($EM<&%C="`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#$N,7!T)SX@("`@#0H@("`@
M("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9#L@
M=&5X="UA;&EG;CH@;&5F="<^("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@
M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M
M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9#L@=&5X="UA;&EG;CH@<FEG:'0G
M/B`@("`-"B`@("`@("`@("`H,2PP-3`@(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q
M+C%P="!S;VQI9#L@=&5X="UA;&EG;CH@;&5F="<^("`@#0H@("`@("`@("`@
M*2`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$
M)W!A9&1I;F<M8F]T=&]M.B`Q+C%P="<^("`@(`T*("`@("`@("`@("8C,38P
M.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XQ<'0@<V]L:60[('1E>'0M86QI9VXZ
M(&QE9G0G/B`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@
M("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA
M8VL@,2XQ<'0@<V]L:60[('1E>'0M86QI9VXZ(')I9VAT)SX@("`@#0H@("`@
M("`@("`@*#$R-"`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@
M/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#$N,7!T('-O;&ED
M.R!T97AT+6%L:6=N.B!L969T)SX@("`-"B`@("`@("`@("`I("`-"B`@("`@
M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB
M;W1T;VTZ(#$N,7!T)SX@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@
M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T
M=&]M.B!";&%C:R`Q+C%P="!S;VQI9#L@=&5X="UA;&EG;CH@;&5F="<^("`@
M#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S
M;VQI9#L@=&5X="UA;&EG;CH@<FEG:'0G/B`@("`-"B`@("`@("`@("`H,2PQ
M-S0@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS
M1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q+C%P="!S;VQI9#L@=&5X="UA;&EG
M;CH@;&5F="<^("`@#0H@("`@("`@("`@*2`@#0H@("`@("`@(#PO=&0^("`@
M("`-"B`@("`@(#PO='(^("`@#0H@("`@("`\='(@<W1Y;&4],T0G=F5R=&EC
M86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@5VAI=&4G/B`@
M(`T*("`@("`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#L@<&%D
M9&EN9RUB;W1T;VTZ(#(N-S5P="<^("`@#0H@("`@("`@("`@4V5P=&5M8F5R
M(#,P+"`R,#$T("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT
M9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,BXW-7!T)SX@("`@(`T*("`@
M("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\
M=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L
M93L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@("`D("`-"B`@
M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@<FEG
M:'0G/B`-"B`@("`@("`@("`Q,"PU,CD@(`T*("`@("`@("`\+W1D/B`@("`@
M#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R
M+C<U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@
M("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@
M<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#(N-S5P="<^("`@("`-"B`@("`@
M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[
M('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@)"`@#0H@("`@
M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB
M;W1T;VTZ($)L86-K(#(N-S5P="!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT
M)SX@#0H@("`@("`@("`@,2PS.#`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@
M("`@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-S5P
M="!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@
M)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL
M93TS1"=P861D:6YG+6)O='1O;3H@,BXW-7!T)SX@("`@(`T*("`@("`@("`@
M("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y
M;&4],T0G8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X
M="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@("`D("`-"B`@("`@("`@
M/"]T9#X@("`@(`T*("`@("`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O
M;3H@0FQA8VL@,BXW-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@<FEG:'0G/B`-
M"B`@("`@("`@("`Q,2PY,#D@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@
M("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`R+C<U<'0@
M9&]U8FQE.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@("8C
M,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@/"]T<CX@("`-"B`@
M("`\+W1A8FQE/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X
M=%!A<G1?8F$U,3<Q,3-?,&0R-U\T,S8Q7V$W8F%?,3!A-C-A,S@U-#)C#0I#
M;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+V)A-3$W,3$S7S!D,C=?-#,V
M,5]A-V)A7S$P838S83,X-30R8R]7;W)K<VAE971S+U-H965T,S`N:'1M;`T*
M0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*
M0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*
M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O
M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M
M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N
M:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\
M+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I
M9#TS1$E$,$5.24%#/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/DYO=&4@,B`M
M($)A<VES(&]F(%!R97-E;G1A=&EO;B`H1&5T86EL<RD@*%531"`D*3QB<CY)
M;B!-:6QL:6]N<RP@=6YL97-S(&]T:&5R=VES92!S<&5C:69I960\+W-T<F]N
M9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XV
M($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$T/&)R/CPO=&@^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y);F-R96%S92!T;R!#87-H
M(%!R;W9I9&5D(&)Y($9I;F%N8VEN9R!!8W1I=FET:65S(%M-96UB97)=/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/DYO=&4@
M,B`M($)A<VES(&]F(%!R97-E;G1A=&EO;B`H1&5T86EL<RD@6TQI;F4@271E
M;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y0<FEO<B!097)I;V0@4F5C;&%S<VEF:6-A=&EO;B!!9&IU<W1M96YT/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#(N-3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&5C<F5A<V4@
M=&\@0V%S:"!0<F]V:61E9"!B>2!/<&5R871I;F<@06-T:79I=&EE<R!;365M
M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N
M9SY.;W1E(#(@+2!"87-I<R!O9B!0<F5S96YT871I;VX@*$1E=&%I;',I(%M,
M:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^4')I;W(@4&5R:6]D(%)E8VQA<W-I9FEC871I;VX@061J=7-T
M;65N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@R+C4I/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@
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M('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\
M:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O
M;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y
M<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@
M4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O
M9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14%+04,^
M#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X]
M,T0Q(')O=W-P86X],T0Q/CQS=')O;F<^3F]T92`S("T@36%R:V5T86)L92!3
M96-U<FET:65S("A$971A:6QS*2`M($UA<FME=&%B;&4@4V5C=7)I=&EE<R`H
M55-$("0I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/E-E<"X@,S`L(#(P,30\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^4V5P+B`S,"P@,C`Q-#QB<CY54R!3=&%T97,@86YD(%!O;&ET:6-A
M;"!3=6)D:79I<VEO;G,@1&5B="!396-U<FET:65S(%M-96UB97)=/&)R/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^
M0V5R=&EF:6-A=&5S(&]F($1E<&]S:70@6TUE;6)E<ET\8G(^/"]T:#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^3F]T92`S("T@36%R
M:V5T86)L92!396-U<FET:65S("A$971A:6QS*2`M($UA<FME=&%B;&4@4V5C
M=7)I=&EE<R!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^06UO<G1I>F5D($-O<W0\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,3DL.3DY+#$V.3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,30L.3DY+#$V
M.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/B0@-2PP,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y5;G)E86QI>F5D($=A:6YS/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XV.3D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XV.3D\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y5;G)E86QI>F5D($QO<W-E<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,C8X*3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#(V."D\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y&86ER
M(%9A;'5E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$Y+#DY
M.2PV,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XD(#$T+#DY.2PV,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XD(#4L,#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT
M;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?8F$U,3<Q,3-?,&0R-U\T,S8Q7V$W
M8F%?,3!A-C-A,S@U-#)C#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z
M+V)A-3$W,3$S7S!D,C=?-#,V,5]A-V)A7S$P838S83,X-30R8R]7;W)K<VAE
M971S+U-H965T,S(N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@
M<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H
M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%
M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O
M:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A
M<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O
M;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L
M92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$4U5D%'/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$
M,3X\<W1R;VYG/DYO=&4@-"`M($9A:7(@5F%L=64@365A<W5R96UE;G1S("A$
M971A:6QS*2`M($9A:7(@5F%L=64@;V8@1FEN86YC:6%L($EN<W1R=6UE;G1S
M("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^4V5P+B`S,"P@,C`Q-#QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:#Y$96,N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#X\<W1R;VYG/DYO=&4@-"`M($9A:7(@5F%L=64@365A
M<W5R96UE;G1S("A$971A:6QS*2`M($9A:7(@5F%L=64@;V8@1FEN86YC:6%L
M($EN<W1R=6UE;G1S(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DUA<FME=&%B;&4@<V5C=7)I=&EE
M<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q.2PY.3DL-C`P
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^1F%I<B!686QU92P@26YP=71S+"!,979E;"`Q(%M-96UB97)=('P@55,@
M4W1A=&5S(&%N9"!0;VQI=&EC86P@4W5B9&EV:7-I;VYS($1E8G0@4V5C=7)I
M=&EE<R!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/CQS=')O;F<^3F]T92`T("T@1F%I<B!686QU92!-96%S=7)E;65N=',@
M*$1E=&%I;',I("T@1F%I<B!686QU92!O9B!&:6YA;F-I86P@26YS=')U;65N
M=',@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^36%R:V5T86)L92!S96-U<FET:65S/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-"PY.3DL-C`P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1F%I<B!686QU
M92P@26YP=71S+"!,979E;"`Q(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY.;W1E(#0@+2!&86ER(%9A;'5E
M($UE87-U<F5M96YT<R`H1&5T86EL<RD@+2!&86ER(%9A;'5E(&]F($9I;F%N
M8VEA;"!);G-T<G5M96YT<R!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y-87)K971A8FQE('-E8W5R
M:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$T+#DY.2PV
M,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y&86ER(%9A;'5E+"!);G!U=',L($QE=F5L(#(@6TUE;6)E<ET@?"!-
M;VYE>2!-87)K970@1G5N9',@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/DYO=&4@-"`M($9A:7(@5F%L=64@
M365A<W5R96UE;G1S("A$971A:6QS*2`M($9A:7(@5F%L=64@;V8@1FEN86YC
M:6%L($EN<W1R=6UE;G1S(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DUO;F5Y(&UA<FME="!F=6YD
M<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#DL,C@U+#$V.#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,T
M+#(V-BPU,#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D9A:7(@5F%L=64L($EN<'5T<RP@3&5V96P@,B!;365M8F5R
M72!\($-E<G1I9FEC871E<R!O9B!$97!O<VET(%M-96UB97)=/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY.;W1E(#0@+2!&
M86ER(%9A;'5E($UE87-U<F5M96YT<R`H1&5T86EL<RD@+2!&86ER(%9A;'5E
M(&]F($9I;F%N8VEA;"!);G-T<G5M96YT<R!;3&EN92!)=&5M<UT\+W-T<F]N
M9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y-87)K971A
M8FQE('-E8W5R:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C4L,#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D9A:7(@5F%L=64L($EN<'5T<RP@3&5V96P@,B!;365M
M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O
M;F<^3F]T92`T("T@1F%I<B!686QU92!-96%S=7)E;65N=',@*$1E=&%I;',I
M("T@1F%I<B!686QU92!O9B!&:6YA;F-I86P@26YS=')U;65N=',@6TQI;F4@
M271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^36%R:V5T86)L92!S96-U<FET:65S/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XU+#`P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y-;VYE>2!-87)K970@1G5N9',@
M6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\
M<W1R;VYG/DYO=&4@-"`M($9A:7(@5F%L=64@365A<W5R96UE;G1S("A$971A
M:6QS*2`M($9A:7(@5F%L=64@;V8@1FEN86YC:6%L($EN<W1R=6UE;G1S(%M,
M:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/DUO;F5Y(&UA<FME="!F=6YD<SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^-#DL,C@U+#$V.#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,T+#(V-BPU,#$\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E53(%-T871E
M<R!A;F0@4&]L:71I8V%L(%-U8F1I=FES:6]N<R!$96)T(%-E8W5R:71I97,@
M6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\
M<W1R;VYG/DYO=&4@-"`M($9A:7(@5F%L=64@365A<W5R96UE;G1S("A$971A
M:6QS*2`M($9A:7(@5F%L=64@;V8@1FEN86YC:6%L($EN<W1R=6UE;G1S(%M,
M:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/DUA<FME=&%B;&4@<V5C=7)I=&EE<SPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,30L.3DY+#8P,#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-E<G1I9FEC871E<R!O
M9B!$97!O<VET(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^/'-T<F]N9SY.;W1E(#0@+2!&86ER(%9A;'5E($UE87-U<F5M
M96YT<R`H1&5T86EL<RD@+2!&86ER(%9A;'5E(&]F($9I;F%N8VEA;"!);G-T
M<G5M96YT<R!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y-87)K971A8FQE('-E8W5R:71I97,\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-2PP,#`L,#`P/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\
M+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?8F$U,3<Q,3-?
M,&0R-U\T,S8Q7V$W8F%?,3!A-C-A,S@U-#)C#0I#;VYT96YT+4QO8V%T:6]N
M.B!F:6QE.B\O+T,Z+V)A-3$W,3$S7S!D,C=?-#,V,5]A-V)A7S$P838S83,X
M-30R8R]7;W)K<VAE971S+U-H965T,S,N:'1M;`T*0V]N=&5N="U4<F%N<V9E
M<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T
M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE
M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT
M96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E
M/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E
M;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y
M/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$4R34%)/@T*
M("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$
M,2!R;W=S<&%N/3-$,CX\<W1R;VYG/DYO=&4@-2`M($5Q=6ET>2!);F-E;G1I
M=F4@4&QA;B`H1&5T86EL<RD@*%531"`D*3QB<CX\+W-T<F]N9SX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,CXS($UO;G1H<R!%
M;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0R
M/CD@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@
M8V]L<W!A;CTS1#$^,R!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:"!C;VQS<&%N/3-$,CXY($UO;G1H<R!%;F1E9#PO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C,@36]N=&AS($5N
M9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^
M.2!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C
M;VQS<&%N/3-$,3XS($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H(&-O;'-P86X],T0R/CD@36]N=&AS($5N9&5D/"]T:#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M/E-E<"X@,S`L(#(P,30\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^4V5P+B`S,"P@,C`Q,SQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y397`N(#,P+"`R,#$T/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H/E-E<"X@,S`L(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^4V5P+B`S,"P@,C`Q-#QB<CY297-T<FEC=&5D(%-T;V-K(%M-
M96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/E-E<"X@
M,S`L(#(P,30\8G(^4F5S=')I8W1E9"!3=&]C:R!;365M8F5R73QB<CX\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y397`N(#,P+"`R,#$T/&)R/E)E
M<W1R:6-T960@4W1O8VL@56YI=',@*%)357,I(%M-96UB97)=/&)R/D)O87)D
M(&]F($1I<F5C=&]R<R!;365M8F5R73QB<CX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y397`N(#,P+"`R,#$T/&)R/E)E<W1R:6-T960@4W1O8VL@
M56YI=',@*%)357,I(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/E-E<"X@,S`L(#(P,30\8G(^4F5S=')I8W1E9"!3=&]C:R!5
M;FET<R`H4E-5<RD@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^2G5N+B`S,"P@,C`Q-#QB<CY3=&]C:R!!<'!R96-I871I;VX@
M4FEG:'1S("A305)S*2!;365M8F5R73QB<CX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y397`N(#,P+"`R,#$T/&)R/DUI;FEM=6T@6TUE;6)E<ET\
M8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^4V5P+B`S,"P@,C`Q
M-#QB<CY-87AI;75M(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#X\<W1R;VYG/DYO=&4@-2`M($5Q=6ET>2!);F-E;G1I
M=F4@4&QA;B`H1&5T86EL<RD@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%L;&]C
M871E9"!3:&%R92UB87-E9"!#;VUP96YS871I;VX@17AP96YS93PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`S.3`L-3<X/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`S-C@L-C`S/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q
M+#$Y-BPS-C$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XD(#$L,34V+#DR.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3:&%R92UB87-E9"!#;VUP
M96YS871I;VX@07)R86YG96UE;G0@8GD@4VAA<F4M8F%S960@4&%Y;65N="!!
M=V%R9"P@3W!T:6]N<RP@1W)A;G1S(&EN(%!E<FEO9"P@1W)O<W,@*&EN(%-H
M87)E<RD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<L,#`P/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$S
M.2PR-#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E-H87)E+6)A<V5D($-O;7!E;G-A=&EO;B!!<G)A
M;F=E;65N="!B>2!3:&%R92UB87-E9"!087EM96YT($%W87)D+"!%<75I='D@
M26YS=')U;65N=',@3W1H97(@=&AA;B!/<'1I;VYS+"!'<F%N=',@:6X@4&5R
M:6]D("AI;B!3:&%R97,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C,P+#<P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/CDL,S8U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-H87)E+6)A<V5D($-O;7!E;G-A
M=&EO;B!!<G)A;F=E;65N="!B>2!3:&%R92UB87-E9"!087EM96YT($%W87)D
M+"!!=V%R9"!697-T:6YG(%!E<FEO9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG-"!Y96%R<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)S0@>65A<G,\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)S$@>65A<CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<T('EE
M87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y%;7!L;WEE92!397)V:6-E(%-H87)E+6)A<V5D($-O;7!E;G-A=&EO
M;BP@3F]N=F5S=&5D($%W87)D<RP@0V]M<&5N<V%T:6]N($-O<W0@3F]T('EE
M="!296-O9VYI>F5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT
M+#(P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^-"PR,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%;7!L;WEE92!397)V:6-E
M(%-H87)E+6)A<V5D($-O;7!E;G-A=&EO;BP@3F]N=F5S=&5D($%W87)D<RP@
M0V]M<&5N<V%T:6]N($-O<W0@3F]T('EE="!296-O9VYI>F5D+"!097)I;V0@
M9F]R(%)E8V]G;FET:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<S('EE87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3:&%R96)A<V5D0V]M<&5N<V%T:6]N
M07)R86YG96UE;G1">5-H87)E8F%S961087EM96YT07=A<F1/<'1I;VYS06YD
M4W1O8VM!<'!R96-I871I;VY2:6=H='-%>&5R8VES97-);E!E<FEO9%1O=&%L
M26YT<FEN<VEC5F%L=64\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,C4L-#<S+#`X.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C0L,#DU+#@S,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F]C965D<R!F<F]M
M(%-T;V-K($]P=&EO;G,@17AE<F-I<V5D/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ-RPU,3,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XQ+#@P-"PW-S,\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#,W.2PR.30\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#DS,BPV-#D\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^4W1O8VL@4F5P=7)C:&%S960@86YD(%)E=&ER960@1'5R:6YG
M(%!E<FEO9"P@4VAA<F5S("AI;B!3:&%R97,I/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,S,L-S<T/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-H87)E0F%S961#
M;VUP96YS871I;VY!<G)A;F=E;65N=$)Y4VAA<F5"87-E9%!A>6UE;G1!=V%R
M9$]P=&EO;G-!;F13=&]C:T%P<')E8VEA=&EO;E)I9VAT<T]U='-T86YD:6YG
M3G5M8F5R("AI;B!3:&%R97,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/CDS-BPP.3<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-H87)E0F%S961#;VUP96YS871I
M;VY!<G)A;F=E;65N=$)Y4VAA<F5"87-E9%!A>6UE;G1!=V%R9$]P=&EO;G-!
M;F13=&]C:T%P<')E8VEA=&EO;E)I9VAT<U=E:6=H=&5D079E<F%G945X97)C
M:7-E4')I8V4@*&EN($1O;&QA<G,@<&5R('-H87)E*3PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^)"`Q,RXU-#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$S+C4T/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3
M:&%R94)A<V5D0V]M<&5N<V%T:6]N07)R86YG96UE;G1">5-H87)E0F%S9610
M87EM96YT07=A<F1/<'1I;VYS06YD4W1O8VM!<'!R96-I871I;VY2:6=H='-/
M=71S=&%N9&EN9TEN=')I;G-I8U9A;'5E/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XD(#(Q+#@P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`R,2PX,#`L,#`P/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y3:&%R94)A<V5D0V]M<&5N<V%T:6]N07)R86YG96UE;G1">5-H87)E0F%S
M961087EM96YT07=A<F1/<'1I;VYS06YD4W1O8VM!<'!R96-I871I;VY2:6=H
M='-/=71S=&%N9&EN9U=E:6=H=&5D079E<F%G95)E;6%I;FEN9T-O;G1R86-T
M=6%L5&5R;3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG-B!Y
M96%R<R`R.3(@9&%Y<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4VAA<F5"87-E9$-O;7!E;G-A=&EO
M;D%R<F%N9V5M96YT0GE3:&%R94)A<V5D4&%Y;65N=$%W87)D0V]N=')A8W1U
M86Q497)M4F%N9V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)S$P('EE87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM
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M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q
M=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R
M<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C
M/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO
M<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$
M<F5P;W)T(&ED/3-$240P14I.044^#0H@("`@("`\='(^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^
M3F]T92`U("T@17%U:71Y($EN8V5N=&EV92!0;&%N("A$971A:6QS*2`M($%S
M<W5M<'1I;VYS(%5S960@=&\@17-T:6UA=&4@1F%I<B!686QU92!O9B!3=&]C
M:R!/<'1I;VYS(&%N9"!3=&]C:R!!<'!R96-I871I;VX@4FEG:'1S($%W87)D
M<SQB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C
M;VQS<&%N/3-$,3XS($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H(&-O;'-P86X],T0R/CD@36]N=&AS($5N9&5D/"]T:#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M/E-E<"X@,S`L(#(P,30\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^4V5P+B`S,"P@,C`Q-#QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y397`N(#,P+"`R,#$S/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#X\<W1R;VYG/DYO=&4@-2`M($5Q=6ET>2!);F-E;G1I=F4@
M4&QA;B`H1&5T86EL<RD@+2!!<W-U;7!T:6]N<R!5<V5D('1O($5S=&EM871E
M($9A:7(@5F%L=64@;V8@4W1O8VL@3W!T:6]N<R!A;F0@4W1O8VL@07!P<F5C
M:6%T:6]N(%)I9VAT<R!!=V%R9',@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5X<&5C=&5D('9O
M;&%T:6QI='D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4S+C(X
M)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C4S+C(X)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C4W+C8P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^17AP96-T960@;&EV97,@*'EE87)S*3PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)S0@>65A<G,\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG-"!Y96%R<SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<T('EE
M87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y%>'!E8W1E9"!D:79I9&5N9"!Y:65L9#PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,"XP,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XP+C`P)3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C`N,#`E/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y-:6YI;75M(%M-96UB
M97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O
M;F<^3F]T92`U("T@17%U:71Y($EN8V5N=&EV92!0;&%N("A$971A:6QS*2`M
M($%S<W5M<'1I;VYS(%5S960@=&\@17-T:6UA=&4@1F%I<B!686QU92!O9B!3
M=&]C:R!/<'1I;VYS(&%N9"!3=&]C:R!!<'!R96-I871I;VX@4FEG:'1S($%W
M87)D<R!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^4FES:R!F<F5E(&EN=&5R97-T(')A=&4\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$N,S`E/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2XQ-B4\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP+C8Q)3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M36%X:6UU;2!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#X\<W1R;VYG/DYO=&4@-2`M($5Q=6ET>2!);F-E;G1I=F4@4&QA
M;B`H1&5T86EL<RD@+2!!<W-U;7!T:6]N<R!5<V5D('1O($5S=&EM871E($9A
M:7(@5F%L=64@;V8@4W1O8VL@3W!T:6]N<R!A;F0@4W1O8VL@07!P<F5C:6%T
M:6]N(%)I9VAT<R!!=V%R9',@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)I<VL@9G)E92!I;G1E
M<F5S="!R871E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+C,Y
M)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C$N,SDE/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,"XW,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE
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M"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#
M;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F
M+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W
M+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^
M/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@
M:60],T1)1#!%2$5!0SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY.;W1E(#8@
M+2!%87)N:6YG<R!097(@4VAA<F4@*$1E=&%I;',I/&)R/CPO<W1R;VYG/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0R/C,@36]N
M=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A
M;CTS1#(^.2!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^4V5P+B`S,"P@,C`Q-#QB
M<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y397`N(#,P+"`R,#$S
M/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/E-E<"X@,S`L(#(P
M,30\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^4V5P+B`S,"P@
M,C`Q,SQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T
M<F]N9SY%87)N:6YG<R!097(@4VAA<F4@6T%B<W1R86-T73PO<W1R;VYG/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06YT:61I;'5T
M:79E(%-E8W5R:71I97,@17AC;'5D960@9G)O;2!#;VUP=71A=&EO;B!O9B!%
M87)N:6YG<R!097(@4VAA<F4L($%M;W5N=#PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,3(R+#DV-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ,3@L-S(U/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.#@L,C<X/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-
M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]B834Q-S$Q,U\P9#(W7S0S
M-C%?83=B85\Q,&$V,V$S.#4T,F,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z
M+R\O0SHO8F$U,3<Q,3-?,&0R-U\T,S8Q7V$W8F%?,3!A-C-A,S@U-#)C+U=O
M<FMS:&5E=',O4VAE970S-BYH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D
M:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M
M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@
M("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G
M=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT
M+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H
M:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@
M/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14Q.04,^#0H@("`@("`\
M='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P
M86X],T0R/CQS=')O;F<^3F]T92`V("T@16%R;FEN9W,@4&5R(%-H87)E("A$
M971A:6QS*2`M($)A<VEC(&%N9"!$:6QU=&5D($5A<FYI;F=S(%!E<B!3:&%R
M93QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C
M;VQS<&%N/3-$,CXS($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H(&-O;'-P86X],T0R/CD@36]N=&AS($5N9&5D/"]T:#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M/E-E<"X@,S`L(#(P,30\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^4V5P+B`S,"P@,C`Q,SQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y397`N(#,P+"`R,#$T/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H/E-E<"X@,S`L(#(P,3,\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/CQS=')O;F<^0F%S:6,@86YD($1I;'5T960@16%R;FEN
M9W,@4&5R(%-H87)E(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-H87)E<R!U<V5D(&EN('1H92!C
M86QC=6QA=&EO;B!O9B!B87-I8R!E87)N:6YG<R!P97(@<VAA<F4\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$T+#<U."PW.#$\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,RPV.#(L-#0Y
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,30L-C(V+#DS,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C$S+#4S-"PS,S0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^169F96-T(&]F(&1I;'5T
M:79E('-E8W5R:71I97,Z/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y3=&]C:R!O<'1I;VYS+"!305)S+"!A;F0@4E-!
M<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-C<V+#`Y-#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L,C<V
M+#4Q-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C@T,BPS,#0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ+#$S.2PU-#4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R974^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$:6QU=&5D('-H87)E<R!U<V5D(&EN
M('1H92!C86QC=6QA=&EO;B!O9B!E87)N:6YG<R!P97(@<VAA<F4\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$U+#0S-"PX-S4\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-"PY-3@L.38U
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,34L-#8Y+#(S-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C$T+#8W,RPX-SD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM
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M<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M
M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H
M87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S
M<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO
M/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,]
M,T1R97!O<G0@:60],T1)1#!%-D5!0SX-"B`@("`@(#QT<CX-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#$^/'-T<F]N
M9SY.;W1E(#<@+2!);G9E;G1O<FEE<R`H1&5T86EL<RD@+2!);G9E;G1O<FEE
M<R`H55-$("0I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H/E-E<"X@,S`L(#(P,30\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^/'-T<F]N9SY);G9E;G1O<FEE<R!;06)S=')A8W1=
M/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M4F%W(&UA=&5R:6%L<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M)"`V+#@T,RPT-#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XD(#4L.3(V+#`S,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5V]R:RUI;BUP<F]C97-S/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#,R-2PV-C<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#,P."PR,S,\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D9I;FES:&5D(&=O;V1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XT+#0Q,RPS-#@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XR+#<V,BPU,C(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R974^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;#PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`Q,RPU.#(L-#4V/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q,"PY.38L-S@U/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO
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M>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A
M9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E
M;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4]
M,T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M
M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^
M#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14A%04,^#0H@
M("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q
M(')O=W-P86X],T0R/CQS=')O;F<^3F]T92`X("T@26YT86YG:6)L92!!<W-E
M=',@86YD($=O;V1W:6QL("A$971A:6QS*2`H55-$("0I/&)R/CPO<W1R;VYG
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0R/C,@
M36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L
M<W!A;CTS1#(^.2!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^4V5P+B`S,"P@,C`Q
M-#QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y397`N(#,P+"`R
M,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/E-E<"X@,S`L
M(#(P,30\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^4V5P+B`S
M,"P@,C`Q,SQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M/'-T<F]N9SY';V]D=VEL;"!A;F0@26YT86YG:6)L92!!<W-E=',@1&ES8VQO
M<W5R92!;06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y!;6]R=&EZ871I;VX@;V8@26YT86YG:6)L92!!
M<W-E=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-3$X+#8Y
M.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/B0@-3(Q+#,X-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/B0@,2PU.3,L,C8P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q+#4U-2PW.38\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*
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M.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@
M(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T
M97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O
M:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI
M<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\
M=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%1T9"1SX-"B`@("`@(#QT
M<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A
M;CTS1#(^/'-T<F]N9SY.;W1E(#@@+2`@26YT86YG:6)L92!!<W-E=',@86YD
M($=O;V1W:6QL("A$971A:6QS*2`M($EN=&%N9VEB;&4@07-S971S("A54T0@
M)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@
M8V]L<W!A;CTS1#$^.2!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ,B!-;VYT:',@16YD960\+W1H/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^4V5P+B`S,"P@,C`Q-#QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y$96,N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#X\<W1R;VYG/DYO=&4@."`M($EN=&%N9VEB;&4@07-S971S
M(&%N9"!';V]D=VEL;"`H1&5T86EL<RD@+2!);G1A;F=I8FQE($%S<V5T<R!;
M3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y'<F]S<R!686QU93PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^)"`R."PY,#(L-C@V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0W5R<F5N8WD@5')A;G-L871I;VX@
M061J=7-T;65N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,RPP
M,34L-3`S*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D%C8W5M=6QA=&5D($%M;W)T:7IA=&EO;CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XH.2PX-3,L,C,Y*3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!";V]K(%9A
M;'5E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-BPP,S,L.30T
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,3@L.3DX+#0P.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^1&5V96QO<&5D(%1E8VAN;VQO9WD@4FEG:'1S(%M-96UB
M97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N
M9SY.;W1E(#@@+2!);G1A;F=I8FQE($%S<V5T<R!A;F0@1V]O9'=I;&P@*$1E
M=&%I;',I("T@26YT86YG:6)L92!!<W-E=',@6TQI;F4@271E;7-=/"]S=')O
M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1W)O<W,@
M5F%L=64\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$V+#<P,"PP
M,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y#=7)R96YC>2!4<F%N<VQA=&EO;B!!9&IU<W1M96YT/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q+#@R."PR,30I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06-C=6UU;&%T
M960@06UO<G1I>F%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M/B@T+#<W.2PQ,C,I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^3F5T($)O;VL@5F%L=64\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$P+#`Y,BPV-C,\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,2PW-3,L,#`S/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y5<V5F=6P@
M3&EF93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<Q-2!Y96%R
M<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^26X@4')O8V5S<R!297-E87)C:"!A;F0@1&5V96QO<&UE;G0@6TUE;6)E
M<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG
M/DYO=&4@."`M($EN=&%N9VEB;&4@07-S971S(&%N9"!';V]D=VEL;"`H1&5T
M86EL<RD@+2!);G1A;F=I8FQE($%S<V5T<R!;3&EN92!)=&5M<UT\+W-T<F]N
M9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y'<F]S<R!6
M86QU93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-2PU,#(L-C@V
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^0W5R<F5N8WD@5')A;G-L871I;VX@061J=7-T;65N=#PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XH-C,X+#0R-BD\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.970@0F]O:R!686QU
M93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-"PX-C0L,C8P/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-2PR
M.#8L,3(W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y5<V5F=6P@3&EF93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1I<W1R:6)U=&EO;B!2:6=H=',@6TUE
M;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R
M;VYG/DYO=&4@."`M($EN=&%N9VEB;&4@07-S971S(&%N9"!';V]D=VEL;"`H
M1&5T86EL<RD@+2!);G1A;F=I8FQE($%S<V5T<R!;3&EN92!)=&5M<UT\+W-T
M<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y'<F]S
M<R!686QU93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-"PW,#`L
M,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^0W5R<F5N8WD@5')A;G-L871I;VX@061J=7-T;65N=#PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-#0P+#DU,RD\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!8V-U;75L871E
M9"!!;6]R=&EZ871I;VX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^
M*#0L,#@T+#DT-"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y.970@0F]O:R!686QU93PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,3<T+#$P,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C@V,RPV-34\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E5S969U;"!,:69E/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)S4@>65A<G,\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!A=&5N
M=',@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#X\<W1R;VYG/DYO=&4@."`M($EN=&%N9VEB;&4@07-S971S(&%N9"!';V]D
M=VEL;"`H1&5T86EL<RD@+2!);G1A;F=I8FQE($%S<V5T<R!;3&EN92!)=&5M
M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y'<F]S<R!686QU93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,2PP,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^0W5R<F5N8WD@5')A;G-L871I;VX@061J=7-T;65N=#PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,3`W+#DQ,"D\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!8V-U
M;75L871E9"!!;6]R=&EZ871I;VX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^*#(W,2PR,#@I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^3F5T($)O;VL@5F%L=64\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C8R,"PX.#(\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW,3DL-3<T/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y5<V5F=6P@3&EF
M93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<Q-B!Y96%R<SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M16QE=F5S<R!4<F%D92!.86UE(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY.;W1E(#@@+2!);G1A;F=I8FQE
M($%S<V5T<R!A;F0@1V]O9'=I;&P@*$1E=&%I;',I("T@26YT86YG:6)L92!!
M<W-E=',@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^1W)O<W,@5F%L=64\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$L,#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%C8W5M=6QA=&5D($%M;W)T
M:7IA=&EO;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-S$W+#DV
M-"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y.970@0F]O:R!686QU93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^)"`R.#(L,#,V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`S-S8L,#4P/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y5<V5F=6P@3&EF93PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<Y('EE87)S/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-
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M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@
M("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G
M=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT
M+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H
M:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@
M/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14A$04,^#0H@("`@("`\
M='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P
M86X],T0R/CQS=')O;F<^3F]T92`X("T@($EN=&%N9VEB;&4@07-S971S(&%N
M9"!';V]D=VEL;"`H1&5T86EL<RD@+2!#:&%N9V5S(&EN($-A<G)Y:6YG(%9A
M;'5E(&]F($=O;V1W:6QL("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,R!-;VYT:',@16YD
M960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XY
M($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y397`N(#,P+"`R,#$T/&)R/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/E-E<"X@,S`L(#(P,30\8G(^/"]T
M:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^0VAA;F=E
M<R!I;B!#87)R>6EN9R!686QU92!O9B!';V]D=VEL;"!;06)S=')A8W1=/"]S
M=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F%L
M86YC92P@8F5G:6YN:6YG/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XD(#DL,S8P+#@X-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/B0@.2PT-#,L.#DT/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%9F9E8W0@;V8@9F]R96EG;B!C
M=7)R96YC>2!A9&IU<W1M96YT<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;3XH-C4X+#4X.2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B@W-#$L-3DY*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F%L86YC92P@96YD:6YG/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#@L-S`R+#(Y-3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@."PW,#(L
M,CDU/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B
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M/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4
M>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R
M:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$
M;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-
M"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P
M139+04,^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O
M;'-P86X],T0Q(')O=W-P86X],T0Q/CQS=')O;F<^3F]T92`Y("T@06-C<G5E
M9"!%>'!E;G-E<R`H1&5T86EL<RD@+2!!8V-R=65D($5X<&5N<V5S("A54T0@
M)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M4V5P+B`S,"P@,C`Q-#QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y$96,N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#X\<W1R;VYG/D%C8W)U960@17AP96YS97,@6T%B<W1R86-T73PO
M<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DQA
M8F]R(&%N9"!R96QA=&5D(&5X<&5N<V5S/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XD(#(L.#0R+#(S-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,BPX-S`L,30W/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;&EN:6-A;"!T
M<FEA;"!C;W-T<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.38R
M+#`S,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C@X,BPV-3$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E!R;V9E<W-I;VYA;"!F965S/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XS.#(L-#(S/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S@S+#(S,3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4F5S96%R8V@@9W)A
M;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU-C(L-34X/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-C$P
M+#0Y.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^4F5S=')U8W1U<FEN9R!C;W-T<SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,3$L.3`Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,C0L-C,X/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/=&AE<CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^-#DR+#4S.#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<V-BPW,38\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;W4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;#PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`U+#(U,RPV.3,\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#4L-3,W
M+#@X,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A
M8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?
M8F$U,3<Q,3-?,&0R-U\T,S8Q7V$W8F%?,3!A-C-A,S@U-#)C#0I#;VYT96YT
M+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+V)A-3$W,3$S7S!D,C=?-#,V,5]A-V)A
M7S$P838S83,X-30R8R]7;W)K<VAE971S+U-H965T-#(N:'1M;`T*0V]N=&5N
M="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N
M="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M
M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M
M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C
M<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@
M1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^
M#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$
M,$5&1SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L
M<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY.;W1E(#$P("T@0V]M;6ET
M;65N=',@86YD($-O;G1I;F=E;F-I97,@*$1E=&%I;',I("A54T0@)"D\8G(^
M/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A
M;CTS1#$^.2!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^4V5P+B`S,"P@,C`Q-#QB
M<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY#
M;VUM:71M96YT<R!A;F0@0V]N=&EN9V5N8VEE<R!$:7-C;&]S=7)E(%M!8G-T
M<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/E!R;V1U8W0@5V%R<F%N='D@06-C<G5A;#PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y0<F]D=6-T(%=A<G)A;G1Y($5X<&5N<V4\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^
M#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?8F$U,3<Q,3-?,&0R-U\T
M,S8Q7V$W8F%?,3!A-C-A,S@U-#)C#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE
M.B\O+T,Z+V)A-3$W,3$S7S!D,C=?-#,V,5]A-V)A7S$P838S83,X-30R8R]7
M;W)K<VAE971S+U-H965T-#,N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O
M9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT
M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@
M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$
M)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X
M="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4
M:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@
M(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5604%%/@T*("`@("`@
M/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S
M<&%N/3-$,CX\<W1R;VYG/DYO=&4@,3$@+2!-:71E:R!-;VYO=FES8R!!9W)E
M96UE;G0@*$1E=&%I;',I("A-:6QT96L@34].3U9)4T,@06=R965M96YT(%M-
M96UB97)=+"!54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,2!-;VYT:',@16YD960\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,CXS($UO;G1H<R!%
M;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H/DIU;BX@,S`L(#(P,30\8G(^/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q-#QB<CX\+W1H/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^36EL=&5K($U/3D]625-#($%G<F5E
M;65N="!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#X\<W1R;VYG/DYO=&4@,3$@+2!-:71E:R!-;VYO=FES8R!!9W)E96UE
M;G0@*$1E=&%I;',I(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VYT<F%C="!497)M+"!996%R
M<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)S$U('EE87)S/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D1E9F5R<F5D(%)E=F5N=64\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/B0@,BPU,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D1E9F5R<F5D(%)E=F5N=64L(%)E=F5N=64@
M4F5C;V=N:7IE9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR
M+#(P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/E)E=F5N=64@4F5C;V=N:71I;VXL($UI;&5S=&]N92!-971H
M;V0L(%)E=F5N=64@4F5C;V=N:7IE9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/B0@-2PP,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q-RPU,#`L,#`P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-
M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]B834Q-S$Q,U\P9#(W7S0S
M-C%?83=B85\Q,&$V,V$S.#4T,F,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z
M+R\O0SHO8F$U,3<Q,3-?,&0R-U\T,S8Q7V$W8F%?,3!A-C-A,S@U-#)C+U=O
M<FMS:&5E=',O4VAE970T-"YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D
M:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M
M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@
M("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G
M=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT
M+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H
M:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@
M/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P15E"04<^#0H@("`@("`\
M='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P
M86X],T0R/CQS=')O;F<^3F]T92`Q,B`M($EN8V]M92!487AE<R`H1&5T86EL
M<RD@*%531"`D*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:"!C;VQS<&%N/3-$,CXS($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0R/CD@36]N=&AS($5N9&5D
M/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/E-E<"X@,S`L(#(P,30\8G(^/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@^4V5P+B`S,"P@,C`Q,SQB<CX\+W1H/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:#Y397`N(#,P+"`R,#$T/&)R/CPO=&@^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H/E-E<"X@,S`L(#(P,3,\8G(^/"]T:#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^3F]T92`Q,B`M($EN8V]M
M92!487AE<R`H1&5T86EL<RD@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y);F-O;64@5&%X($5X
M<&5N<V4@*$)E;F5F:70I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XD(#0L,3(U+#,U-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/B0@,BPW-S8L,3DY/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q."PX-S(L-#,U/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`X+#$T-RPR
M.#(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D5F9F5C=&EV92!);F-O;64@5&%X(%)A=&4@4F5C;VYC:6QI871I;VXL
M(%!E<F-E;G0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0P+C`P
M)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C,V+C`P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C,X+C`P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C,W+C`P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^16%R;&EE<W0@5&%X(%EE87(@6TUE;6)E
M<ET@?"!$;VUE<W1I8R!487@@075T:&]R:71Y(%M-96UB97)=('P@26YT97)N
M86P@4F5V96YU92!397)V:6-E("A)4E,I(%M-96UB97)=/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/DYO=&4@,3(@+2!)
M;F-O;64@5&%X97,@*$1E=&%I;',I(%M,:6YE($ET96US73PO<W1R;VYG/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W!E;B!487@@
M665A<CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG,C`Q,3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D5A<FQI97-T(%1A>"!996%R(%M-96UB97)=('P@1F]R96EG;B!487@@075T
M:&]R:71Y(%M-96UB97)=('P@36EN:7-T<GD@;V8@16-O;F]M:6,@069F86ER
M<R!A;F0@1FEN86YC92P@271A;'D@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^3F]T92`Q,B`M($EN8V]M
M92!487AE<R`H1&5T86EL<RD@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/<&5N(%1A>"!996%R
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<R,#`Y/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^36EL
M97-T;VYE(&%N9"!#;VYT<F%C="!2979E;G5E(%M-96UB97)=/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/DYO=&4@,3(@
M+2!);F-O;64@5&%X97,@*$1E=&%I;',I(%M,:6YE($ET96US73PO<W1R;VYG
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]N=')A
M8W1S(%)E=F5N=64\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M)"`R-"PV-3(L-S<X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?
M3F5X=%!A<G1?8F$U,3<Q,3-?,&0R-U\T,S8Q7V$W8F%?,3!A-C-A,S@U-#)C
M#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+V)A-3$W,3$S7S!D,C=?
M-#,V,5]A-V)A7S$P838S83,X-30R8R]7;W)K<VAE971S+U-H965T-#4N:'1M
M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L
M90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI
M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS
M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU
M=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H
M;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP
M=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R
M="!I9#TS1$E$,$5713X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY.;W1E(#$S
M("T@4V5G;65N="!A;F0@1V5O9W)A<&AI8R!);F9O<FUA=&EO;B`H1&5T86EL
M<RD\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@
M8V]L<W!A;CTS1#$^.2!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^4V5P+B`S,"P@
M,C`Q-#QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T
M<F]N9SY396=M96YT(%)E<&]R=&EN9R!;06)S=')A8W1=/"]S=')O;F<^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.=6UB97(@;V8@4F5P
M;W)T86)L92!396=M96YT<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A
M8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?
M8F$U,3<Q,3-?,&0R-U\T,S8Q7V$W8F%?,3!A-C-A,S@U-#)C#0I#;VYT96YT
M+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+V)A-3$W,3$S7S!D,C=?-#,V,5]A-V)A
M7S$P838S83,X-30R8R]7;W)K<VAE971S+U-H965T-#8N:'1M;`T*0V]N=&5N
M="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N
M="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M
M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M
M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C
M<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@
M1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^
M#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$
M,$574D%'/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C
M;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/DYO=&4@,3,@+2!396=M
M96YT(&%N9"!'96]G<F%P:&EC($EN9F]R;6%T:6]N("A$971A:6QS*2`M(%!R
M;V1U8W0@4F5V96YU92!B>2!0<F]D=6-T($=R;W5P("A54T0@)"D\8G(^/"]S
M=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS
M1#(^,R!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:"!C;VQS<&%N/3-$,CXY($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y397`N(#,P
M+"`R,#$T/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/E-E<"X@
M,S`L(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^4V5P
M+B`S,"P@,C`Q-#QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y3
M97`N(#,P+"`R,#$S/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#X\<W1R;VYG/E-E9VUE;G0@4F5P;W)T:6YG($EN9F]R;6%T:6]N(%M,
M:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^4')O9'5C="!2979E;G5E/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XD(#(Q+#DW-2PS,3(\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$W+#`R,RPS-#8\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#4W+#4Y
M,RPX-S,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XD(#4Q+#4X-2PR-#(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D]R=&AO8FEO;&]G:6-S(%M-96UB97)=/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E-E
M9VUE;G0@4F5P;W)T:6YG($EN9F]R;6%T:6]N(%M,:6YE($ET96US73PO<W1R
M;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')O
M9'5C="!2979E;G5E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M."PX.3DL.#<S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,3(L.#,P+#4V-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C0X+#<U,"PR-S<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT,"PV,C`L,S,Y/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$97)M
M86P@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/CQS=')O;F<^4V5G;65N="!297!O<G1I;F<@26YF;W)M871I;VX@6TQI
M;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y0<F]D=6-T(%)E=F5N=64\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C0P,2PS-34\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XR-C<L-S8V/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.3,X+#DV-CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L,#8V+#0P.3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M4W5R9VEC86P@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/CQS=')O;F<^4V5G;65N="!297!O<G1I;F<@26YF;W)M871I
M;VX@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y0<F]D=6-T(%)E=F5N=64\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C$L-#4R+#DT-CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L,3,V+#(T.#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0L-3@Q+#0Y
M-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C,L.34U+#$S-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^3W!H=&AA;&UI8R!;365M8F5R73PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY396=M96YT(%)E<&]R
M=&EN9R!);F9O<FUA=&EO;B!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R;V1U8W0@4F5V96YU
M93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S8V+#$S.#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L-#(U
M+#8P.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/CDS."PQ,S0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XR+#@Q."PT,#<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E9E=&5R:6YA<GD@6TUE;6)E<ET\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4V5G
M;65N="!297!O<G1I;F<@26YF;W)M871I;VX@6TQI;F4@271E;7-=/"]S=')O
M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F]D
M=6-T(%)E=F5N=64\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@
M.#4U+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/B0@,2PS-C,L,34W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^)"`R+#,X-2PP,#`\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#,L,3(T+#DU,SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\
M+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?8F$U,3<Q,3-?
M,&0R-U\T,S8Q7V$W8F%?,3!A-C-A,S@U-#)C#0I#;VYT96YT+4QO8V%T:6]N
M.B!F:6QE.B\O+T,Z+V)A-3$W,3$S7S!D,C=?-#,V,5]A-V)A7S$P838S83,X
M-30R8R]7;W)K<VAE971S+U-H965T-#<N:'1M;`T*0V]N=&5N="U4<F%N<V9E
M<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T
M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE
M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT
M96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E
M/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E
M;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y
M/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5.3T%'/@T*
M("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$
M,2!R;W=S<&%N/3-$,CX\<W1R;VYG/DYO=&4@,3,@+2!396=M96YT(&%N9"!'
M96]G<F%P:&EC($EN9F]R;6%T:6]N("A$971A:6QS*2`M(%!R;V1U8W0@4F5V
M96YU92!B>2!'96]G<F%P:&EC($QO8V%T:6]N("A54T0@)"D\8G(^/"]S=')O
M;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^
M,R!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C
M;VQS<&%N/3-$,CXY($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y397`N(#,P+"`R
M,#$T/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/E-E<"X@,S`L
M(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^4V5P+B`S
M,"P@,C`Q-#QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y397`N
M(#,P+"`R,#$S/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#X\<W1R;VYG/D=E;V=R87!H:6,@3&]C871I;VXZ/"]S=')O;F<^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!2979E;G5E
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#(R+#`U-2PT,C,\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD
M(#$W+#<U-"PT,S@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XD(#@R+#,T,"PS-S`\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#4S+#@R.2PX,C8\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!E<F-E;G1A
M9V4@;V8@4F5V96YU93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,3`P+C`P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$P,"XP,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ,#`N,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,3`P+C`P)3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^56YI=&5D(%-T871E<R!;
M365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M/'-T<F]N9SY'96]G<F%P:&EC($QO8V%T:6]N.CPO<W1R;VYG/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5&]T86P@4F5V96YU93PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3@L-#4U+#$V-SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$T+#0X
M-2PX,C$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XW,BPY,S4L-S(R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^-#(L,C4Q+#,S-CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4&5R8V5N=&%G92!O9B!2979E
M;G5E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX-"XP,"4\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX,BXP
M,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XX.2XP,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XW."XP,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D5U<F]P92!;365M8F5R73PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY'96]G<F%P:&EC($QO
M8V%T:6]N.CPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^5&]T86P@4F5V96YU93PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,2PW.#0L-#$T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,2PV-38L-C4V/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-2PR-S0L,#<Q/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-2PR,C8L-C$Y
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y097)C96YT86=E(&]F(%)E=F5N=64\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C@N,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^.2XP,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XV+C`P)3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$P+C`P)3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W1H97(@;&]C871I
M;VX@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/CQS=')O;F<^1V5O9W)A<&AI8R!,;V-A=&EO;CH\+W-T<F]N9SX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1O=&%L(%)E=F5N
M=64\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,2PX,34L.#0R
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M)"`Q+#8Q,2PY-C$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XD(#0L,3,P+#4W-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-BPS-3$L.#<Q/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y097)C96YT86=E
M(&]F(%)E=F5N=64\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C@N
M,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^.2XP,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XU+C`P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$R+C`P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM
M+2TM+3U?3F5X=%!A<G1?8F$U,3<Q,3-?,&0R-U\T,S8Q7V$W8F%?,3!A-C-A
M,S@U-#)C#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+V)A-3$W,3$S
M7S!D,C=?-#,V,5]A-V)A7S$P838S83,X-30R8R]7;W)K<VAE971S+U-H965T
M-#@N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R
M:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S
M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE
M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA
M<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R
M8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\
M+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS
M1')E<&]R="!I9#TS1$E$,$5.-$%%/@T*("`@("`@/'1R/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG
M/DYO=&4@,30@+2!297-T<G5C='5R:6YG($-R961I=',@*$1E=&%I;',I("A5
M4T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@@8V]L<W!A;CTS1#,^,R!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XY($UO;G1H<R!%;F1E9#PO=&@^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y397`N(#,P+"`R,#$T/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H/E-E<"X@,S`L(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^1&5C+B`S,2P@,C`Q,CQB<CX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y397`N(#,P+"`R,#$S/&)R/CPO=&@^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/DYO=&4@,30@+2!297-T<G5C='5R
M:6YG($-R961I=',@*$1E=&%I;',I(%M,:6YE($ET96US73PO<W1R;VYG/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4F5S=')U8W1U
M<FEN9R!#;W-T<R!A;F0@07-S970@26UP86ER;65N="!#:&%R9V5S/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,BPU,#`L,#`P/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4F5S
M=')U8W1U<FEN9R!#<F5D:70\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$Y-BPP.#0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ.38L,#@T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C0T,BPX-CD\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYO;BU#87-H(%1E<FUI;F%T
M:6]N($%N9"!);7!A:7)M96YT($]F($E04B9A;7`[1"!;365M8F5R73PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY.;W1E
M(#$T("T@4F5S=')U8W1U<FEN9R!#<F5D:71S("A$971A:6QS*2!;3&EN92!)
M=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/E)E<W1R=6-T=7)I;F<@0V]S=',@86YD($%S<V5T($EM<&%I<FUE
M;G0@0VAA<F=E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M+#(P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y.;VYC87-H($1I<W!O<V%L(&]F(%!R;W!E<G1Y(&%N9"!%
M<75I<&UE;G0@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/CQS=')O;F<^3F]T92`Q-"`M(%)E<W1R=6-T=7)I;F<@0W)E
M9&ET<R`H1&5T86EL<RD@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y297-T<G5C='5R:6YG($-O
M<W1S(&%N9"!!<W-E="!);7!A:7)M96YT($-H87)G97,\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,S`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1I<W!O<V%L(&]F(&EN
M=F5N=&]R>2!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^/'-T<F]N9SY.;W1E(#$T("T@4F5S=')U8W1U<FEN9R!#<F5D
M:71S("A$971A:6QS*2!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)E<W1R=6-T=7)I;F<@0V]S
M=',@86YD($%S<V5T($EM<&%I<FUE;G0@0VAA<F=E<SPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XD(#$P,"PP,#`\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO
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M8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\
M345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X
M="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA
M=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@
M0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A
M8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P15%)044^#0H@("`@("`\='(^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X]
M,T0R/CQS=')O;F<^3F]T92`Q-"`M(%)E<W1R=6-T=7)I;F<@0W)E9&ET<R`H
M1&5T86EL<RD@+2!297-T<G5C='5R:6YG($%C8W)U86P@06-T:79I='D@*%53
M1"`D*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:"!C;VQS<&%N/3-$,3XY($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y397`N(#,P
M+"`R,#$T/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\
M<W1R;VYG/DYO=&4@,30@+2!297-T<G5C='5R:6YG($-R961I=',@*$1E=&%I
M;',I("T@4F5S=')U8W1U<FEN9R!!8V-R=6%L($%C=&EV:71Y(%M,:6YE($ET
M96US73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^0F%L86YC93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`R
M-"PV,S@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D-A<V@@4')O8V5E9',@*$1I<V)U<G-E;65N=',I/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q,2PU-34I/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y&;W)E:6=N($5X8VAA
M;F=E($EM<&%C=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,2PQ
M-S0I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y"86QA;F-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M,2PY,#D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D5M<&QO>65E('1E<FUI;F%T:6]N(&-O<W1S(%M-96UB97)=/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/DYO=&4@
M,30@+2!297-T<G5C='5R:6YG($-R961I=',@*$1E=&%I;',I("T@4F5S=')U
M8W1U<FEN9R!!8V-R=6%L($%C=&EV:71Y(%M,:6YE($ET96US73PO<W1R;VYG
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F%L86YC93PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C$L-S`Y/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#87-H(%!R
M;V-E961S("A$:7-B=7)S96UE;G1S*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;3XH,3`L,3,P*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^1F]R96EG;B!%>&-H86YG92!);7!A8W0\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$L,#4P*3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F%L86YC93PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3`L-3(Y/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!8W1I=FET
M>2!497)M:6YA=&EO;B!A;F0@1F%C:6QI='D@0VQO<W5R92!#;W-T<R!;365M
M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N
M9SY.;W1E(#$T("T@4F5S=')U8W1U<FEN9R!#<F5D:71S("A$971A:6QS*2`M
M(%)E<W1R=6-T=7)I;F<@06-C<G5A;"!!8W1I=FET>2!;3&EN92!)=&5M<UT\
M+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D)A
M;&%N8V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L.3(Y/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#
M87-H(%!R;V-E961S("A$:7-B=7)S96UE;G1S*3PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XH,2PT,C4I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y&;W)E:6=N($5X8VAA;F=E($EM<&%C
M=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,3(T*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F%L86YC
M93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q+#,X,#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\
M+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?8F$U,3<Q,3-?
M,&0R-U\T,S8Q7V$W8F%?,3!A-C-A,S@U-#)C#0I#;VYT96YT+4QO8V%T:6]N
M.B!F:6QE.B\O+T,Z+V)A-3$W,3$S7S!D,C=?-#,V,5]A-V)A7S$P838S83,X
M-30R8R]7;W)K<VAE971S+V9I;&5L:7-T+GAM;`T*0V]N=&5N="U4<F%N<V9E
M<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T
M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\>&UL('AM;&YS.F\]
M,T0B=7)N.G-C:&5M87,M;6EC<F]S;V9T+6-O;3IO9F9I8V4Z;V9F:6-E(CX-
M"B`\;SI-86EN1FEL92!(4F5F/3-$(BXN+U=O<FMB;V]K+FAT;6PB+SX-"B`\
M;SI&:6QE($A2968],T0B4VAE970P,2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F
M/3-$(E-H965T,#(N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#`S
M+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970P-"YH=&UL(B\^#0H@
M/&\Z1FEL92!(4F5F/3-$(E-H965T,#4N:'1M;"(O/@T*(#QO.D9I;&4@2%)E
M9CTS1")3:&5E=#`V+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970P
M-RYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,#@N:'1M;"(O/@T*
M(#QO.D9I;&4@2%)E9CTS1")3:&5E=#`Y+FAT;6PB+SX-"B`\;SI&:6QE($A2
M968],T0B4VAE970Q,"YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T
M,3$N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#$R+FAT;6PB+SX-
M"B`\;SI&:6QE($A2968],T0B4VAE970Q,RYH=&UL(B\^#0H@/&\Z1FEL92!(
M4F5F/3-$(E-H965T,30N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E
M=#$U+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970Q-BYH=&UL(B\^
M#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,3<N:'1M;"(O/@T*(#QO.D9I;&4@
M2%)E9CTS1")3:&5E=#$X+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE
M970Q.2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,C`N:'1M;"(O
M/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#(Q+FAT;6PB+SX-"B`\;SI&:6QE
M($A2968],T0B4VAE970R,BYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H
M965T,C,N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#(T+FAT;6PB
M+SX-"B`\;SI&:6QE($A2968],T0B4VAE970R-2YH=&UL(B\^#0H@/&\Z1FEL
M92!(4F5F/3-$(E-H965T,C8N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3
M:&5E=#(W+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970R."YH=&UL
M(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,CDN:'1M;"(O/@T*(#QO.D9I
M;&4@2%)E9CTS1")3:&5E=#,P+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B
M4VAE970S,2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,S(N:'1M
M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#,S+FAT;6PB+SX-"B`\;SI&
M:6QE($A2968],T0B4VAE970S-"YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$
M(E-H965T,S4N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#,V+FAT
M;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970S-RYH=&UL(B\^#0H@/&\Z
M1FEL92!(4F5F/3-$(E-H965T,S@N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS
M1")3:&5E=#,Y+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970T,"YH
M=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T-#$N:'1M;"(O/@T*(#QO
M.D9I;&4@2%)E9CTS1")3:&5E=#0R+FAT;6PB+SX-"B`\;SI&:6QE($A2968]
M,T0B4VAE970T,RYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T-#0N
M:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#0U+FAT;6PB+SX-"B`\
M;SI&:6QE($A2968],T0B4VAE970T-BYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F
M/3-$(E-H965T-#<N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#0X
M+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970T.2YH=&UL(B\^#0H\
M+WAM;#X-"BTM+2TM+3U?3F5X=%!A<G1?8F$U,3<Q,3-?,&0R-U\T,S8Q7V$W
38F%?,3!A-C-A,S@U-#)C+2T-"@``
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EVAAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 11 - Mitek Monovisc Agreement (Details) (Miltek MONOVISC Agreement [Member], USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="2">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Miltek MONOVISC Agreement [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_Note11MitekMonoviscAgreementDetailsLineItems', window );"><strong>Note 11 - Mitek Monovisc Agreement (Details) [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_ContractTermYears', window );">Contract Term, Years</a></td>
        <td class="text">15 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred Revenue</a></td>
        <td class="nump">$ 2,500,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueRevenueRecognized', window );">Deferred Revenue, Revenue Recognized</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,200,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized', window );">Revenue Recognition, Milestone Method, Revenue Recognized</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 5,000,000<span></span></td>
        <td class="nump">$ 17,500,000<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anik_ContractTermYears">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The contract term of the Miltek MONOVISC agreement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>anik_ContractTermYears</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>anik_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anik_Note11MitekMonoviscAgreementDetailsLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>anik_Note11MitekMonoviscAgreementDetailsLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>anik_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of deferred revenue as of balance sheet date. Deferred revenue represents collections of cash or other assets related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 13<br><br> -Section A<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 605<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 13.A.4(a).Q1 Response)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012821&amp;loc=d3e214044-122780<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredRevenue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueRevenueRecognized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of previously reported deferred or unearned revenue that was recognized as revenue during the period. Deferred revenue is a liability related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 605<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 13.A.4(a).Q1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012821&amp;loc=d3e214044-122780<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 13<br><br> -Section A<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredRevenueRevenueRecognized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of consideration recognized during the period for the milestone or milestones.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 605<br><br> -SubTopic 28<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=19771982&amp;loc=SL6892177-166501<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 14 - Restructuring Credits (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</a></td>
        <td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
      <tr style="vertical-align: bottom">
        <td>
          &#160;
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="11" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          Restructuring Accrual
        </td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>
          &#160;
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" nowrap="nowrap" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Employee
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Severance and
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Related Benefits
          </p>
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" nowrap="nowrap" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Activity
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Termination and
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Facility Closure
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Costs
          </p>
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" nowrap="nowrap" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          Total
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="width: 67%; text-align: left">
          December 31, 2013
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          21,709
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          2,929
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          24,638
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left">
          Cash Proceeds (Disbursements)
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          (10,130
        </td>
        <td style="text-align: left">
          )
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          (1,425
        </td>
        <td style="text-align: left">
          )
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          (11,555
        </td>
        <td style="text-align: left">
          )
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; padding-bottom: 1.1pt">
          Foreign Exchange Impact
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          (1,050
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          )
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          (124
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          )
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          (1,174
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          )
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; padding-bottom: 2.75pt">
          September 30, 2014
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          10,529
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          1,380
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          11,909
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
      </tr>
    </table><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RestructuringAndRelatedActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 420<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 420<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140904-122747<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E2F">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 13 - Segment and Geographic Information (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information, by Segment [Table Text Block]</a></td>
        <td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
      <tr style="vertical-align: bottom">
        <td colspan="3" style="font-weight: bold">
          &#160;
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="7" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          Three Months Ended September 30,
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="7" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          Nine Months Ended September 30,
        </td>
      </tr>
      <tr style="vertical-align: bottom">
        <td colspan="3" style="font-weight: bold">
          &#160;
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          2014
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          2013
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          2014
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          2013
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 54%; text-align: left">
          Orthobiologics
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          18,899,873
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          12,830,566
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          48,750,277
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          40,620,339
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: left">
          Dermal
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          401,355
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          267,766
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          938,966
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          1,066,409
        </td>
        <td style="text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: left">
          Surgical
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          1,452,946
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          1,136,248
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          4,581,496
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          3,955,134
        </td>
        <td style="text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: left">
          Ophthalmic
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          366,138
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          1,425,609
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          938,134
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          2,818,407
        </td>
        <td style="text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="padding-bottom: 1.1pt; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt; text-align: left">
          Veterinary
        </td>
        <td style="padding-bottom: 1.1pt; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          855,000
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          1,363,157
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          2,385,000
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          3,124,953
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="padding-bottom: 2.75pt; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt; text-align: right">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          21,975,312
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          17,023,346
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          57,593,873
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          51,585,242
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
      </tr>
    </table><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_ScheduleOfRevenueAndOperatingIncomeByGeographicalAreasTableTextBlock', window );">Schedule of Revenue and Operating Income by Geographical Areas [Table Text Block]</a></td>
        <td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
      <tr style="vertical-align: bottom">
        <td style="font-weight: bold">
          &#160;
        </td>
        <td style="font-weight: bold">
          &#160;
        </td>
        <td colspan="15" style="font-weight: bold; text-align: center">
          Three Months Ended September 30,
        </td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="font-weight: bold">
          &#160;
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="7" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          2014
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="7" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          2013
        </td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="font-weight: bold">
          &#160;
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Total
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Revenue
          </p>
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Percentage of
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Revenue
          </p>
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Total
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Revenue
          </p>
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Percentage of
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Revenue
          </p>
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="font-weight: bold; text-align: left">
          Geographic Location:
        </td>
        <td style="font-weight: bold">
          &#160;
        </td>
        <td style="font-weight: bold; text-align: left">
          &#160;
        </td>
        <td style="font-weight: bold; text-align: right">
          &#160;
        </td>
        <td style="font-weight: bold; text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="font-weight: bold">
          &#160;
        </td>
        <td style="font-weight: bold; text-align: left">
          &#160;
        </td>
        <td style="font-weight: bold; text-align: right">
          &#160;
        </td>
        <td style="font-weight: bold; text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="width: 56%; text-align: left; padding-left: 10pt">
          United States
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          18,455,167
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 8%; text-align: right">
          84
        </td>
        <td style="width: 1%; text-align: left">
          %
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          14,485,821
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 8%; text-align: right">
          82
        </td>
        <td style="width: 1%; text-align: left">
          %
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; padding-left: 10pt">
          Europe
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          1,784,414
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          8
        </td>
        <td style="text-align: left">
          %
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          1,656,656
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          9
        </td>
        <td style="text-align: left">
          %
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">
          Other
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          1,815,842
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          8
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          %
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          1,611,961
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          9
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          %
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; padding-bottom: 2.75pt; padding-left: 20pt">
          Total
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          22,055,423
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          100
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          %
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          17,754,438
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          100
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          %
        </td>
      </tr>
    </table><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
      <tr style="vertical-align: bottom">
        <td style="font-weight: bold">
          &#160;
        </td>
        <td style="font-weight: bold">
          &#160;
        </td>
        <td colspan="15" style="font-weight: bold; text-align: center">
          Nine Months Ended September 30,
        </td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="font-weight: bold">
          &#160;
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="7" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          2014
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="7" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          2013
        </td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="font-weight: bold">
          &#160;
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Total
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Revenue
          </p>
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Percentage of
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Revenue
          </p>
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Total
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Revenue
          </p>
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Percentage of
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Revenue
          </p>
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="font-weight: bold; text-align: left">
          Geographic Location:
        </td>
        <td style="font-weight: bold">
          &#160;
        </td>
        <td style="font-weight: bold; text-align: left">
          &#160;
        </td>
        <td style="font-weight: bold; text-align: right">
          &#160;
        </td>
        <td style="font-weight: bold; text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="font-weight: bold">
          &#160;
        </td>
        <td style="font-weight: bold; text-align: left">
          &#160;
        </td>
        <td style="font-weight: bold; text-align: right">
          &#160;
        </td>
        <td style="font-weight: bold; text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="width: 56%; text-align: left; padding-left: 10pt">
          United States
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          72,935,722
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 8%; text-align: right">
          89
        </td>
        <td style="width: 1%; text-align: left">
          %
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          42,251,336
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 8%; text-align: right">
          78
        </td>
        <td style="width: 1%; text-align: left">
          %
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; padding-left: 10pt">
          Europe
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          5,274,071
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          6
        </td>
        <td style="text-align: left">
          %
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          5,226,619
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          10
        </td>
        <td style="text-align: left">
          %
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">
          Other
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          4,130,577
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          5
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          %
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          6,351,871
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          12
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          %
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; padding-bottom: 2.75pt; padding-left: 20pt">
          Total
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          82,340,370
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          100
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          %
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          53,829,826
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          100
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          %
        </td>
      </tr>
    </table><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anik_ScheduleOfRevenueAndOperatingIncomeByGeographicalAreasTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents schedule of revenue and operating income, by geographical areas.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>anik_ScheduleOfRevenueAndOperatingIncomeByGeographicalAreasTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>anik_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 280<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 21<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6534315&amp;loc=d3e8721-108599<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 280<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 25<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6534315&amp;loc=d3e8813-108599<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 280<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 30<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6534315&amp;loc=d3e8906-108599<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 280<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 22<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6534315&amp;loc=d3e8736-108599<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SegmentReportingAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EYBAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 12 - Income Taxes (Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="2">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_Note12IncomeTaxesDetailsLineItems', window );"><strong>Note 12 - Income Taxes (Details) [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense (Benefit)</a></td>
        <td class="nump">$ 4,125,355<span></span></td>
        <td class="nump">$ 2,776,199<span></span></td>
        <td class="nump">$ 18,872,435<span></span></td>
        <td class="nump">$ 8,147,282<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective Income Tax Rate Reconciliation, Percent</a></td>
        <td class="nump">40.00%<span></span></td>
        <td class="nump">36.00%<span></span></td>
        <td class="nump">38.00%<span></span></td>
        <td class="nump">37.00%<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Earliest Tax Year [Member] | Domestic Tax Authority [Member] | Internal Revenue Service (IRS) [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_Note12IncomeTaxesDetailsLineItems', window );"><strong>Note 12 - Income Taxes (Details) [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OpenTaxYear', window );">Open Tax Year</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">2011<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Earliest Tax Year [Member] | Foreign Tax Authority [Member] | Ministry of Economic Affairs and Finance, Italy [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_Note12IncomeTaxesDetailsLineItems', window );"><strong>Note 12 - Income Taxes (Details) [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OpenTaxYear', window );">Open Tax Year</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">2009<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Milestone and Contract Revenue [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_Note12IncomeTaxesDetailsLineItems', window );"><strong>Note 12 - Income Taxes (Details) [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractsRevenue', window );">Contracts Revenue</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 24,652,778<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anik_Note12IncomeTaxesDetailsLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>anik_Note12IncomeTaxesDetailsLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>anik_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractsRevenue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Revenue earned during the period arising from products sold or services provided under the terms of a contract, not elsewhere specified in the taxonomy. May include government contracts, construction contracts, and any other contract related to a particular project or product.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ContractsRevenue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 13<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(h)(2))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph h<br><br> -Subparagraph 2<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EffectiveIncomeTaxRateContinuingOperations</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(h))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph h<br><br> -Article 4<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Income Tax Expense (or Benefit)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6515339<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -Subparagraph (a),(b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxExpenseBenefit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OpenTaxYear">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tax year that remains open to examination under enacted tax laws, in CCYY format.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 15<br><br> -Subparagraph (e)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32718-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OpenTaxYear</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:gYearItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ENIAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 2 - Basis of Presentation (Details) (USD $)<br>In Millions, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Increase to Cash Provided by Financing Activities [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_Note2BasisofPresentationDetailsLineItems', window );"><strong>Note 2 - Basis of Presentation (Details) [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustment', window );">Prior Period Reclassification Adjustment</a></td>
        <td class="nump">$ 2.5<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Decrease to Cash Provided by Operating Activities [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_Note2BasisofPresentationDetailsLineItems', window );"><strong>Note 2 - Basis of Presentation (Details) [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustment', window );">Prior Period Reclassification Adjustment</a></td>
        <td class="num">$ (2.5)<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anik_Note2BasisofPresentationDetailsLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>anik_Note2BasisofPresentationDetailsLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>anik_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of a reclassification adjustment made to prior period financial statement amounts.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PriorPeriodReclassificationAdjustment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EAKAC">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Note 3 - Marketable Securities (Details) - Marketable Securities (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2014

</div>
          <div>US States and Political Subdivisions Debt Securities [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Certificates of Deposit [Member]</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_Note3MarketableSecuritiesDetailsMarketableSecuritiesLineItems', window );"><strong>Note 3 - Marketable Securities (Details) - Marketable Securities [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized Cost</a></td>
        <td class="nump">$ 19,999,169<span></span></td>
        <td class="nump">$ 14,999,169<span></span></td>
        <td class="nump">$ 5,000,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
        <td class="nump">699<span></span></td>
        <td class="nump">699<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
        <td class="num">(268)<span></span></td>
        <td class="num">(268)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Fair Value</a></td>
        <td class="nump">$ 19,999,600<span></span></td>
        <td class="nump">$ 14,999,600<span></span></td>
        <td class="nump">$ 5,000,000<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anik_Note3MarketableSecuritiesDetailsMarketableSecuritiesLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>anik_Note3MarketableSecuritiesDetailsMarketableSecuritiesLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>anik_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecurities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of investment in debt and equity securities categorized neither as held-to-maturity nor trading.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 25<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28360136&amp;loc=d3e22054-111558<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -Subparagraph (aa)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27232-111563<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6871852&amp;loc=d3e26610-111562<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AvailableForSaleSecurities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before tax of unrealized gain in accumulated other comprehensive income (AOCI) on investments in debt and equity securities classified as available-for-sale.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27161-111563<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before tax of unrealized loss in accumulated other comprehensive income (AOCI) on investments in debt and equity securities classified as available-for-sale.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27161-111563<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This item represents the cost of debt and equity securities, which are categorized neither as held-to-maturity nor trading, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AvailableForSaleSecuritiesAmortizedCost</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 3 - Marketable Securities<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockSupplementAbstract', window );"><strong>Disclosure Text Block Supplement [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock', window );">Cash, Cash Equivalents, and Marketable Securities [Text Block]</a></td>
        <td class="text"><table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
      <tr style="vertical-align: top">
        <td style="width: 6%">
          <b>3.</b>
        </td>
        <td style="width: 94%">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">
            <b>Marketable Securities</b>
          </p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">
            <b></b>
          </p>
        </td>
      </tr>
    </table><br/><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
      <tr style="vertical-align: bottom">
        <td style="font-weight: bold">
          &#160;
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="15" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          September 30, 2014
        </td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="font-weight: bold">
          &#160;
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Amortized
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Cost
          </p>
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Unrealized
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Gains, Net of Tax
          </p>
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Unrealized
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Losses, Net of Tax
          </p>
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Fair
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Value
          </p>
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="width: 56%; text-align: left">
          United States Treasury securities
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          14,999,169
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          699
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          (268
        </td>
        <td style="width: 1%; text-align: left">
          )
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          14,999,600
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; padding-bottom: 1.1pt">
          Bank certificates of deposit
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          5,000,000
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          -
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          -
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          5,000,000
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          19,999,169
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          699
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          (268
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          )
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          19,999,600
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
      </tr>
    </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">
      The Company considers securities with maturities of three months or less from the purchase date to be cash equivalents. Interest is recorded when earned. All of the Company&#8217;s investments are classified as available-for-sale and are carried at fair value with unrealized gains and losses recorded as a component of accumulated other comprehensive income, net of related income taxes.
    </p><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockSupplementAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DisclosureTextBlockSupplementAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E5VAG">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Note 4 - Fair Value Measurements (Details) - Fair Value of Financial Instruments (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsLineItems', window );"><strong>Note 4 - Fair Value Measurements (Details) - Fair Value of Financial Instruments [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Marketable securities</a></td>
        <td class="nump">$ 19,999,600<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Fair Value, Inputs, Level 1 [Member] | US States and Political Subdivisions Debt Securities [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsLineItems', window );"><strong>Note 4 - Fair Value Measurements (Details) - Fair Value of Financial Instruments [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Marketable securities</a></td>
        <td class="nump">14,999,600<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Fair Value, Inputs, Level 1 [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsLineItems', window );"><strong>Note 4 - Fair Value Measurements (Details) - Fair Value of Financial Instruments [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Marketable securities</a></td>
        <td class="nump">14,999,600<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Fair Value, Inputs, Level 2 [Member] | Money Market Funds [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsLineItems', window );"><strong>Note 4 - Fair Value Measurements (Details) - Fair Value of Financial Instruments [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds</a></td>
        <td class="nump">49,285,168<span></span></td>
        <td class="nump">34,266,501<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Fair Value, Inputs, Level 2 [Member] | Certificates of Deposit [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsLineItems', window );"><strong>Note 4 - Fair Value Measurements (Details) - Fair Value of Financial Instruments [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Marketable securities</a></td>
        <td class="nump">5,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Fair Value, Inputs, Level 2 [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsLineItems', window );"><strong>Note 4 - Fair Value Measurements (Details) - Fair Value of Financial Instruments [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Marketable securities</a></td>
        <td class="nump">5,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Money Market Funds [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsLineItems', window );"><strong>Note 4 - Fair Value Measurements (Details) - Fair Value of Financial Instruments [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds</a></td>
        <td class="nump">49,285,168<span></span></td>
        <td class="nump">34,266,501<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">US States and Political Subdivisions Debt Securities [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsLineItems', window );"><strong>Note 4 - Fair Value Measurements (Details) - Fair Value of Financial Instruments [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Marketable securities</a></td>
        <td class="nump">14,999,600<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Certificates of Deposit [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsLineItems', window );"><strong>Note 4 - Fair Value Measurements (Details) - Fair Value of Financial Instruments [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Marketable securities</a></td>
        <td class="nump">$ 5,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anik_Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>anik_Note4FairValueMeasurementsDetailsFairValueofFinancialInstrumentsLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>anik_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecurities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of investment in debt and equity securities categorized neither as held-to-maturity nor trading.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 25<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28360136&amp;loc=d3e22054-111558<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -Subparagraph (aa)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27232-111563<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6871852&amp;loc=d3e26610-111562<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AvailableForSaleSecurities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash Equivalents<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsFairValueDisclosure</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EHDAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 8 -  Intangible Assets and Goodwill (Details) - Changes in Carrying Value of Goodwill (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_ChangesInCarryingValueOfGoodwillAbstract', window );"><strong>Changes in Carrying Value of Goodwill [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, beginning</a></td>
        <td class="nump">$ 9,360,884<span></span></td>
        <td class="nump">$ 9,443,894<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAdjustments', window );">Effect of foreign currency adjustments</a></td>
        <td class="num">(658,589)<span></span></td>
        <td class="num">(741,599)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, ending</a></td>
        <td class="nump">$ 8,702,295<span></span></td>
        <td class="nump">$ 8,702,295<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anik_ChangesInCarryingValueOfGoodwillAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>anik_ChangesInCarryingValueOfGoodwillAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>anik_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 20<br><br> -Section 45<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6388280&amp;loc=d3e13770-109266<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Goodwill</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTranslationAdjustments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of increase (decrease) from foreign currency translation adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (f)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GoodwillTranslationAdjustments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EQQAG">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
        <td class="nump">$ 71,772,194<span></span></td>
        <td class="nump">$ 63,333,160<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
        <td class="nump">19,999,600<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of reserves of $546,455 and $593,023 at September 30, 2014 and December 31, 2013, respectively</a></td>
        <td class="nump">20,170,095<span></span></td>
        <td class="nump">18,736,845<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
        <td class="nump">13,582,456<span></span></td>
        <td class="nump">10,996,785<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidTaxes', window );">Prepaid income taxes</a></td>
        <td class="nump">1,343,576<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetCurrent', window );">Current portion deferred income taxes</a></td>
        <td class="nump">659,040<span></span></td>
        <td class="nump">659,040<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
        <td class="nump">1,128,693<span></span></td>
        <td class="nump">865,957<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
        <td class="nump">128,655,654<span></span></td>
        <td class="nump">94,591,787<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, at cost</a></td>
        <td class="nump">53,379,965<span></span></td>
        <td class="nump">52,413,423<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation</a></td>
        <td class="num">(21,343,322)<span></span></td>
        <td class="num">(19,474,712)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );"></a></td>
        <td class="nump">32,036,643<span></span></td>
        <td class="nump">32,938,711<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_DepositsAndOtherAssetsNoncurrent', window );">Long-term deposits and other</a></td>
        <td class="nump">69,054<span></span></td>
        <td class="nump">69,080<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
        <td class="nump">16,033,944<span></span></td>
        <td class="nump">18,998,409<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
        <td class="nump">8,702,295<span></span></td>
        <td class="nump">9,443,894<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
        <td class="nump">185,497,590<span></span></td>
        <td class="nump">156,041,881<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
        <td class="nump">1,167,545<span></span></td>
        <td class="nump">2,793,911<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
        <td class="nump">5,253,693<span></span></td>
        <td class="nump">5,537,881<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue</a></td>
        <td class="nump">12,885<span></span></td>
        <td class="nump">180,433<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes payable</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">770,276<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
        <td class="nump">6,434,123<span></span></td>
        <td class="nump">9,282,501<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
        <td class="nump">948,858<span></span></td>
        <td class="nump">1,133,544<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">Long-term deferred revenue</a></td>
        <td class="nump">56,573<span></span></td>
        <td class="nump">2,054,941<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesNoncurrent', window );">Deferred tax liability</a></td>
        <td class="nump">8,353,531<span></span></td>
        <td class="nump">7,936,864<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 10)</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#x2019; equity:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $.01 par value; 1,250,000 shares authorized, no shares issued and outstanding at September 30, 2014 and December 31, 2013, respectively</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $.01 par value; 30,000,000 shares authorized, 14,800,453 and 14,289,308 shares issued and outstanding at September 30, 2014 and December 31, 2013, respectively</a></td>
        <td class="nump">148,004<span></span></td>
        <td class="nump">142,893<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in-capital</a></td>
        <td class="nump">76,064,383<span></span></td>
        <td class="nump">70,606,031<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Accumulated other comprehensive loss</a></td>
        <td class="num">(3,595,487)<span></span></td>
        <td class="num">(1,699,095)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
        <td class="nump">97,087,605<span></span></td>
        <td class="nump">66,584,202<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#x2019; equity</a></td>
        <td class="nump">169,704,505<span></span></td>
        <td class="nump">135,634,031<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Stockholders&#x2019; Equity</a></td>
        <td class="nump">$ 185,497,590<span></span></td>
        <td class="nump">$ 156,041,881<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anik_DepositsAndOtherAssetsNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents non-current deposits and other assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>anik_DepositsAndOtherAssetsNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>anik_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 19<br><br><br><br> -Subparagraph a<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19(a))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountsPayableCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.3-4)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 3<br><br><br><br> -Subparagraph a(1)<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 4<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountsReceivableNetCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 15<br><br><br><br> -Article 9<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 15<br><br><br><br> -Subparagraph b(1)<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccruedIncomeTaxesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccruedLiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 360<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (c)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.14)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 14<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 11<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=d3e637-108580<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 14<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=d3e681-108580<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 14A<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=SL7669686-108580<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 10A<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=SL7669646-108580<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 830<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 12<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6915805&amp;loc=d3e32022-110900<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 830<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.30(a)(1))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdditionalPaidInCapitalCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.18)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 12<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 18<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Assets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.9)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6801-107765<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 9<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AssetsCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AssetsCurrentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash Equivalents<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 1<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3044-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsAtCarryingValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 450<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14326-108349<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.25)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 25<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 19<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 17<br><br><br><br> -Article 9<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 942<br><br><br><br> -SubTopic 210<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.9-03.17)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br><br><br><br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 210<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-03.(a),19)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommitmentsAndContingencies</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The carrying amount of consideration received or receivable as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer, including sales, license fees, and royalties, but excluding interest income.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 605<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SAB TOPIC 13.A.4(a).Q1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012821&amp;loc=d3e214044-122780<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 8<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 13<br><br><br><br> -Section A<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredRevenueCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The noncurrent portion of deferred revenue amount as of balance sheet date. Deferred revenue is a liability related to a revenue producing activity for which revenue has not yet been recognized, and is not expected to be recognized in the next twelve months. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 605<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SAB TOPIC 13.A.4(a).Q1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012821&amp;loc=d3e214044-122780<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 8<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 13<br><br><br><br> -Section A<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredRevenueNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards expected to be realized or consumed within one year or operating cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=37586315&amp;loc=d3e31917-109318<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=37586315&amp;loc=d3e31931-109318<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 5<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=37586315&amp;loc=d3e31928-109318<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 9<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=37586315&amp;loc=d3e31958-109318<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsNetCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of deferred tax liability attributable to taxable temporary differences, net of deferred tax asset attributable to deductible temporary differences and carryforwards net of valuation allowances expected to be realized or consumed after one year (or the normal operating cycle, if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=37586315&amp;loc=d3e31917-109318<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=37586315&amp;loc=d3e31931-109318<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 9<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=37586315&amp;loc=d3e31958-109318<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxLiabilitiesNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6388280&amp;loc=d3e13770-109266<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Goodwill</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph ((a)(1),(b))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IntangibleAssetsNetExcludingGoodwill</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.6(a))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 330<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 35<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6386567&amp;loc=d3e3927-108312<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InventoryNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.32)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 25<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 32<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesAndStockholdersEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.21)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 21<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesCurrentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of investments in debt and equity securities, including, but not limited to, held-to-maturity, trading and available-for-sale expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.2)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 320<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6871852&amp;loc=d3e26626-111562<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 2<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (f)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_MarketableSecuritiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate carrying amount, as of the balance sheet date, of noncurrent obligations not separately disclosed in the balance sheet. Noncurrent liabilities are expected to be paid after one year (or the normal operating cycle, if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.24)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 24<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherLiabilitiesNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Article 3<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.28)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 8<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PrepaidExpenseAndOtherAssetsCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidTaxes">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Current Assets<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6509628<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6787-107765<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 340<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 05<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=47804770&amp;loc=d3e5865-108316<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 340<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 05<br><br><br><br> -Paragraph 5<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=47804770&amp;loc=d3e5879-108316<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (g)(4)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PrepaidTaxes</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 360<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.13)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentGross</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 360<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.13)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 13<br><br><br><br> -Subparagraph a<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 8<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Article 3<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.31(a)(3))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RetainedEarningsAccumulatedDeficit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 310<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SAB TOPIC 4.E)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 4<br><br><br><br> -Section E<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29-31)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29, 30, 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EWE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 13 - Segment and Geographic Information (Details)<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of Reportable Segments</a></td>
        <td class="nump">1<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NumberOfReportableSegments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:integerItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SegmentReportingAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 1 - Nature of Business<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Disclosure Text Block [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Nature of Operations [Text Block]</a></td>
        <td class="text"><table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
      <tr style="vertical-align: top">
        <td style="width: 6%">
          <b>1.</b>
        </td>
        <td style="width: 94%">
          <b>Nature of Business</b>
        </td>
      </tr>
    </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">
      Anika Therapeutics,&#160;Inc. (together with its subsidiaries, &#8220;Anika,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; or &#8220;our&#8221;) develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair. These products are based on hyaluronic acid (&#8220;HA&#8221;), a naturally occurring, biocompatible polymer found throughout the body. Due to its unique biophysical and biochemical properties, HA plays an important role in a number of physiological functions such as the protection and lubrication of soft tissues and joints, the maintenance of the structural integrity of tissues, and the transport of molecules to and within cells.
    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
      The Company is subject to risks common to companies in the biotechnology and medical device industries including, but not limited to, development by the Company or its competitors of new technological innovations, dependence on key personnel, protection of proprietary information and technology, commercialization of existing and new products, and compliance with the U.S. Food and Drug Administration (&#8220;FDA&#8221;) and foreign regulations and approval requirements, as well as the ability to grow the Company&#8217;s business.
    </p><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DisclosureTextBlockAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for the nature of an entity's business, the major products or services it sells or provides and its principal markets, including the locations of those markets. If the entity operates in more than one business, the disclosure also indicates the relative importance of its operations in each business and the basis for the determination (for example, assets, revenues, or earnings).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6003-108592<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NatureOfOperations</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EHEAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 6 - Earnings Per Share (Details)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="2">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
        <td class="nump">122,967<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="nump">118,725<span></span></td>
        <td class="nump">88,278<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Antidilution<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6505113<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Diluted Earnings Per Share<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6510752<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Contingent Stock Agreement<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6508534<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 4 - Fair Value Measurements (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</a></td>
        <td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
      <tr style="vertical-align: bottom">
        <td style="text-align: left; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="11" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Fair Value Measurements at Reporting
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Date Using
          </p>
        </td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="text-align: left; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" nowrap="nowrap" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          September 30, 2014
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" nowrap="nowrap" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Quoted Prices in
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Active Markets
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            for Identical Assets
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            (Level 1)
          </p>
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" nowrap="nowrap" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Significant Other
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Observable Inputs
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            (Level 2)
          </p>
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" nowrap="nowrap" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Significant
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Unobservable
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Inputs
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            (Level 3)
          </p>
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="width: 56%; text-align: left; padding-bottom: 2.75pt">
          Money market funds
        </td>
        <td style="width: 1%; padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="width: 1%; border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="width: 8%; border-bottom: Black 2.75pt double; text-align: right">
          49,285,168
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left; width: 1%">
          &#160;
        </td>
        <td style="width: 1%; padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="width: 1%; border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="width: 8%; border-bottom: Black 2.75pt double; text-align: right">
          -
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left; width: 1%">
          &#160;
        </td>
        <td style="width: 1%; padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="width: 1%; border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="width: 8%; border-bottom: Black 2.75pt double; text-align: right">
          49,285,168
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left; width: 1%">
          &#160;
        </td>
        <td style="width: 1%; padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="width: 1%; border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="width: 8%; border-bottom: Black 2.75pt double; text-align: right">
          -
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left; width: 1%">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left">
          Marketable securities:
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left">
          United States Treasury securities
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          14,999,600
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          14,999,600
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          -
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          -
        </td>
        <td style="text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; padding-bottom: 1.1pt">
          Bank certificates of deposit
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          5,000,000
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          -
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          5,000,000
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          -
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; padding-bottom: 2.75pt">
          Total marketable securities
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          19,999,600
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          14,999,600
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          5,000,000
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          -
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
      </tr>
    </table><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
      <tr style="vertical-align: bottom">
        <td style="text-align: left">
          &#160;
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="11" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          Fair Value Measurements at Reporting<br />
          Date Using
        </td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="text-align: left">
          &#160;
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" nowrap="nowrap" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          December 31, 2013
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" nowrap="nowrap" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          Quoted Prices in<br />
          Active Markets<br />
          &#160;for Identical Assets&#160;<br />
          &#160;(Level 1)
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" nowrap="nowrap" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          Significant Other<br />
          Observable Inputs&#160;<br />
          (Level 2)
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" nowrap="nowrap" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Significant
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Unobservable
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Inputs
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            (Level 3)
          </p>
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="width: 56%; text-align: left; padding-bottom: 2.75pt">
          Money market funds
        </td>
        <td style="width: 1%; padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="width: 1%; border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="width: 8%; border-bottom: Black 2.75pt double; text-align: right">
          34,266,501
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left; width: 1%">
          &#160;
        </td>
        <td style="width: 1%; padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="width: 1%; border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="width: 8%; border-bottom: Black 2.75pt double; text-align: right">
          -
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left; width: 1%">
          &#160;
        </td>
        <td style="width: 1%; padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="width: 1%; border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="width: 8%; border-bottom: Black 2.75pt double; text-align: right">
          34,266,501
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left; width: 1%">
          &#160;
        </td>
        <td style="width: 1%; padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="width: 1%; border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="width: 8%; border-bottom: Black 2.75pt double; text-align: right">
          -
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left; width: 1%">
          &#160;
        </td>
      </tr>
    </table><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19190-110258<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a),(b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueDisclosuresAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>38
<FILENAME>0001171843-14-005281-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001171843-14-005281-xbrl.zip
M4$L#!!0````(`$`P9D4#/IB"?WH``)5)!P`1`!P`86YI:RTR,#$T,#DS,"YX
M;6Q55`D``R=56U0G55M4=7@+``$$)0X```0Y`0``[%W;<YRXFG_?JOT?>OVT
M^^`8)*ZNQ%4=VSG'9Y.TRW9FSCZE,*AM9FCH(VC'/G_]2C3M%C0"T0CZ,F0>
M)J%!W^^[Z_))^OA?IZ>COZ$082=!WNCQ;>1?_G<R^Y_1Z>@RFLWO77]T$R;D
M5S?Q7Q!Y%KX@3/Y-?G].DOGYV=FO7[\^N.35V/4QBJ,%=E%,'XQ.3R]&],]_
M_L='2N02(TKB?/0[H?,]>ADI^@C`<]T^5Y31CX?+$5!4;?D1^>+U$0>CUUD0
MQI].&$+T\8<(/YT!18%G?A@G3NBBD^6;Y_17O^'[WOH#]F7C;/GCZM5%?/KD
M.//W=Z=._)B^F_UP1M&?*NHI5%>?>*C0=(S<#T_1RQGYH>3UP`__K,!.?WYT
MXC7VH.+E?WXE;S/0D[<YBDNQI[^4H'%"/X^&/G"29V()<[1(?#?5<?JA8D-E
M]9D?1QI0S2H=+-]8?9!9SOL'99:T9KDHHE\P;5BU;?LL_?7]U;CL/0)`/?OG
MMZ_W[C.:.:?OYG"Q--/1Z"-MXSQ.?[Y#TU':YCF5T:>3V)_-`RK^]-DS1M-/
M)U0HIRL9?'B-O9.SBV5#;D2\YC49^=ZG$U?Y.8XG4ZC<HSE]>4V/O(C"Q$_>
M+MX?D$>^1Q].?>)E*124XV5E19<W_WMRH9`_EFUIT/QXMOZ,;?]L36#U:(ZP
M'WEYDJDHDHNE(=BG4/EXMGKVWM+ZNR6/9QF3JY;R3*M+IM4KY))6X7XS#4]5
M0*R_-=/@YQ<<S=1_+`(JR8=HGW5.&,7)%8G)F=9-$@$^GJV?CD;LVRCTF'>7
M%K)ZMJ6P("LLN!;6/MI*3EBP@;"@)&%IF;"<\/`L2^W;LG166`=F6<+"DF59
M1BY0@ST4$1.H@:1`;>92\C[:12X[R4G)5J;IB9OL:>3(]4-418:F[8W`^8]%
M^M>?-Z%+QB0Q>H@NG?CY%D<O!+KW^>V+'Y)NH1\^C>F@QT]\%']#LT>$^Q08
MC0SH:8;6C*?/EJ.2<_0Z#WS73Y:X1IY/7HS]*/QTDHU'SJ\QCO!EA#$B3$1A
M/`Z]6R(V?)L*;^S]L8@3VGI\AXAX$T3__OF-^4?V8NB-9]$B3,:O?GQR03N\
MYXWE]O&L%'8AM)V]\]M?MC%D!%!5X9K8%2J5U&1.Q]N#A?$LK*G8J@SL".Q+
MS8\??_ZXOZ<R3"4>!40.KA/<+QX](A.JH@.TI9OP!2VMY8$,MI>6L/I-C%NN
M";36?Q=C8Y`?'/^\1)C*U*5\3J97:![%*PY.UF`.68L5'':;'CH8Y1.%Y1WR
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M\NE2;80/KZ/0C24T0?#@)P&:3&]".H/E+9R`6:TN%^_^%CW(,49#U!B'+'.P
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M/>AYYWIND><SJVCK\\5ZMIOP%D<NBNE61$1K`,:$P%)"E,&#6P_;RB2$A'!P
M55$:?XYKT/I^:'WG?0"M6#DW6,9^6$8'/0(-<'L$@];W0^L[[Q]HQ?V[5SY=
M['U<K-?[#G`A>[M^(H?SP]HYHW%/QQI4VZ=J=Y_I]>)H?U#_3CQ;6CHW^`/\
M0;4[\NR=Y.SB_M9;TEB8'.*6^6U4GN/VH,ZZT2QN;AY4V$,56?\YV"[DX$'-
MW7JJK%RK*]Q<.ZBP:T_=14[5BP?+70?H!<7Q`W8\]-V9H>.>$DDW;Y2S?%C#
M7[VXP7308Z]ZE!:`-^K'!HWVJ-'=Q^/5\739AHM>1[);A2]#2OC*]C4N;5U=
MF[WZ\YL?).C/;Y/OD]]N[B_'3QBAPE3]H=C_%9HBC)%W1XPZ7*`QQK00C[:W
MWH.2FGTERSU.S*O4J`4=0)7E`/FSZ`?]]ZM_QK=562EM8PNA^LW!V9:%0;<[
M\NV&TP)0BF_S]Q4.EK!+2^A]FZ%>M<TP0'$2A6@<>I?D&WKO7";+PYE[2!6<
MH::7Z!%VPB3.*[^:RRX/0]WY_*#!K]BZBF9$,+Y[2>\#P&]+KG^F%Q"&3I")
MZ![A%]]%-ZL-N3^O'1SXY+L'Y_7_D(/?#66_K61=D.$2K@GV\2)YCC"!6ECL
M*9.)Y(-3-S'0`5>Q<*12"Y*/VW!>L]LA<AA*-7W<]>N&RO66+Q%&_E.8=Q:Z
M.2LF_YQ,KTD[T<QWQ].IXV-Z$N_R@A9TDSC!6XWO['^4%?6?,BG)-581[VFF
MEL&9.G(F_H;;"2:Z>_1II;SOQ@>60VYQY"W<9(*SJ,ST-<KX.N8]N`;W5LE!
MQ=U,D_9^%:;!K_8;5'P<=7P&]P;/0<4[7^R0I&*#FXNO$)XYP<$M<54HE^7H
MN$\F-4QN_AW4>L`YEU_%-ZCU@/.LS<VS@UH/-[>:"C>WWB_P$[V,Z0!G>BI4
MF^>JO^+:WM.KJ7+3ZZ!9F3[;>X8U`3?##IJ5Z;.])UF3?RS<H%F9/MM_GN5?
MPS"9/R?/3C#SW;5N#UZQ1:;Z7*?N/]7J_)GD0;ER/;?_;,L_+&Y0KF3/[3_A
MFOS9XT&Y<CVW_YQK<7/N;R@A387.:IG_*)1;9.JX<Z[-S;F#<B5[;N\YU^(7
M_@W*E>RYO>=<2^7FW$&YDCVW]YQK\>NFZ,5(](XDTOH!;@]/<=//_X:B)^S,
MG^FT!:/E3>[ZK<WO/0%;_/*I0=.=:7HGV9A?135H>E]V7LG1-+^8:M!TES[=
M?Y[FUU1=+W`T/[QC`RI4_%['SG!VS)7-%K^R:E"N9,_M/QOSZZL&Y4KVW/X3
M,+_*:E"N9,_M/>?:_%JK2?*,\-?(3>^1/<`E_KK^50E_1UQZ9?-+KP9%'U,E
MELVOQ!H4?4R%63:_,&M0]#'5:=G97-?$34BK8'W"&-C'(]9RX@*GJB(J+B#I
M&"Y;YXGKY_<HO'3BYP>$9WZ8&L\X]&YF<\?'U#(FTYO;NZM;'/V!W/7Y/8?A
M,G<H3O#"31;8#Y\NHS@AG-%+4O`+N^[37`"]K0SMQ%2,*E-QB:2N_'@>Q4XP
MF=[2`0%.WHC`KO^U\(N7[AR;F8@RWU/<W8EUF%SK6$OF)GPAW$3,ZO`Q&0*7
MS^,."U;Q1.+9/(C>$&+B)A79H>W?%M-Y-;-=*KZ#0XGMXG'^8S?Q7PB4?`K\
MXKA^0)Y>!E&\P"BOW-%Q!?>F$CBH6P!4A5^F5>O%1Z7FW;GQSD?&JL(_=FP[
M_S\JR]B?`+`'E@**ET@,0:+O7"_K(@E5*=Z,.3C['CF['(TO0G^I[D7LL4N.
M,^103B[\.-*`:I[_N+_Z>+9Z.%JW1[]G_LTV=XMP_.Q@%#->[A'A>2C'!_WD
M^V*&L$.&0Q<C5G>U(-9"++:2;_\*T5,6P]5O932HFOSS)>`23M=4BFV]RWK-
M6XULWJ52D#4'0G5C<_).KE.=;XW^O"FSS>8R)Z"S6?0<8O(_.C'QX@2(GE:<
M7#H8OQ&_^,T)%FA$/[Y#TZ71C#*32A^X2CYDG(P\Y/HS)X@_G2@G%Z9JFD"U
M-4*_"<$+Z3`+=X`78!J0_%$-I2W,;P[^$R7.8X#ND4OB2N*C^'*!,?EV>QFJ
M-OEC*`RX"C(;D,:N2\\^C>^0BP@;Y)OO*&F-B3PR%<76UYBJZ)38W;:PJO6H
M6B8T+&U[6.^S-.2M%AJ#N@4TW5C#8-O=4)$HT1K>%6(EIJ4+$KW%:.[XWH/S
MBN(VG&I0-QE&V68O"B17Q^/3LW+3JW]D6**AVXK&^$8%D0LI<&HBR=9P,LE=
MO\Y)1X6>#9\NTBT_:A]#5&`9-MS04Q4UGLELB[!:<!:1G&XV!9B/*9)D142E
MZX;.)*T"V>VH5O-O:[JMFI;));H1JU9K"K<!Z0&R"PM_PU'<PJ=U"$T22G16
M%U64+B0BJY:1#C02<`#<'AE)!XO9(B`C7N\*S3%I/.W1D[\'*.O:CV<13OQ_
MI\^YS;?(G#1D0@!R*4H*IK+4WSFS-3G)UDS-5/M@EOMFJTP.@0(-0Q.QN"S)
M2H)5+5<(;&B9JMH85G82WCR*_23.!U6Z9MDZ&=L*#9M"5"[D@:I)R;9B*8U!
M,1=?Y*XK)/*\?G6#A4<&`7^+(N^7'P0M<HVA0&AK&MMIJZ=W(1=B79_:MBU-
ML5M!;"\IRU0`8`<<:TI%E;7GF6@$6NRHE4]L*8(6%F#IFFV27F,Q\9?W;EKH
M43<43;4LM990-F2Z==[H>$E"W],P];(Q69Y`>QC5_`/3AC8;,H5AX`7ROOK.
M(YWQDS&@UX$.<YUQ+HVRE-X<34VG2H=FWBJ$T13N.Y/1\V;'K^7-ER39YCCJ
M0IY"^FCU0,I4\WX=C`35F"3FL8-K+HFBT<JT5M+[T52VSUUN&&T`U`1C8`%=
M49L!6%:XKE^4T;NQ-6*>UAH'GX8L/#5FJD*HLWV'&D"53B-#0&30;/+=AD73
M'DE-L"?]4%M3A;#P9ZDDVX\%=?)?"2@>J8H)-,FF1'*C81G:]M`NH]G,3V;I
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M#2WZ4*9B$6]B>*JG5K34=OAJ)HL,W=*``MK@2]WK.0H\A&,Z#Y>\M9D@(A+3
M=%9@F\U?M*%?$X>A;D`M%UIJZ3,=!I*CI4IC<[*DCECEV*0QO,93+,WAC8,@
M^D5O!"5>?!4M'I/I(MA<Q6X_":$9FLZ&EB9D-W*'+,PU4Q4V5-B1:"O,^4[8
MK8,G.-TVZ:7]BUN$[VE=3@[LNL!)6-+@Y$+YH.0FZD7(EJXD2,-;(>6N\*9O
MQ=D5N?]&WAIG4XG>?/]"9XIT6A_(@UFD5K:4O3VX"O%U!NXFCA>MI58#:4FC
M;BS4`$^=H"3BF2P26@E)ER"Z%1)#2#:REN*J1,9T_'L+=0(TNP/:),:U!2HY
MN$%E^:<48&WTV!Y7G?U)QB4EI"WG*/3RF8*-,"(#46WT3V<N%$L*(GEA34!0
MQ0`B#9L$D55CNW<"%&=3NW2I-JZIKN`>:+Q1K$-&&Y"M7RFCM!D;FN+A'KM;
M'&"8I/\+-:-K/-S#88L=<C(6@Q8[Y]\-'NX1ID4\JF[I0&NEK^RP;UDF9"DJ
MN^C,H;0QA=`<D*@-F5!5;(Z$\HA:0Q(U(Z"99#1JFT*@VL,2M28`-$VW-#%4
M7%"R0A%0=#U7^U@@T@J%>``R=5H;TPT*47NQ`)V2,I5N4`@'&V@!VP*<8%R*
M@NX3FTS3.'0?!9X,N]!-0#,[FSIS-$KZ8<(81*U"A\0L#*L3#*(VH>H:W?T!
M*D%LC4+4)E1#)[UDLUH=Q=GL&#G8I;N-KHCI!%%:MIG5O<NP$+I_R#*8X%I)
M\4(2.N&(8J@D18*>T8E:E:$:BLGNY^@%G7`$4H!MF]IVZ.Y1$-""310B[`2T
M[MJ;^:$?)]A)_!<DT0`UA>317,X0(ET2Q%M#%K5*J%J68=C[`%DX`*H:X</>
M#K-LT,+Q4M&AH1F@!>BTKCN_EQLCKWH-4#@XV89BK0K:2VA<M$(A*B1-HYNW
M1%"P28>N-V72JBR-$4XCJFG8@%V(+%+9*$01!R&J$)+)+-6HQ-!*&*+.!DG/
M3[%,M1-AB-H%I+T-`YK"("9SNEV>V,VZ5$"*92C$/H'*5D9N$BJ.<!MB$1[=
MFH8!V`F)4BAMD(B:B&9#W=;8>"Q?*N(C6>*\JM4,RPTAA$FT6;Z1F=3W*(Q6
MGTH:V=HV:\(B5&4C%36N4PA(]&F,53):X0Z!`:'='*Q4K*(&>JJ2:*KK6XBV
MB/>]!HK079:'+LC;F;E'8?P932.,F!+ZZU?2M8BPE][F=Y.@65KE2K[$4=H3
M62&1%"EM0\WSV1G@C5UB.Q&->."&4-/-GB2S+X;3()F8NL6.H8[><,1SFV*8
M&M1V)QK20A:@/I-1R[2ZTR\\:%:!#C<CQ0:MLOS2&)2HDP+2O5)MNQ]0PGG.
MLDR@04%1M88E:I>6JIG``EO(BJ0VN1UT0S65W!QQCD(+`*)VH]FZ"=BM4[(`
M"(_7%%VA:P95"+:$(#S5`<GH6=6!.(15Q?&J!N6S$_NN4/&+D&&D93#L6FDI
MO0M9F(1L)<4$C;XP"9D/P00^L/O?N\4D9$\$D_J!-6<13+\C_^DY0=[XA>3!
M)_1]00\FG$PW"BP*6+>WL*RX@_1<3+8FNA&.S>`@DPTAHURR`0T+:)J]EVP(
MV7&F#0,8-KNY>8_8$#+]3!LZ/49'D\9&T7^N_&"1($]VM%7X'IM1%,@#3;`U
MB+H5T:0;;*+15_W`EH;T@TTT"BL?V/U9XM@XYII]T+3`KD$TULE0R3+U6L?A
M(=F8(I++28.`3#J55NZ8LOWBI$%,UC7#!NPDZ'YQTB`L:X8)+;,^20ISPMOF
M^"/$R`EHH?'?HR`]>,CQ0]J/GH3K,U''V(_)3U?I6MEM>C*RR*Y,X2$ZNRNN
M*Z`EL6,7,A&>J-HSF?"VPSIN=MK<UGMW1:WD5#7H<8K%<T.D8RVN:O4N$.$U
M7-70S.*I)1V(8_<F(NHTIRI)9!9;VWFD)B)>V&2JJKU?)B(])NALQA>AW$!]
MN_+7[D3;R)<@6^"^`]%V8>=\T99\(+6;H]DJ,/(;AWCT2HX%V@::<.&Q9<)"
MS6_7T(3W-%B&8BJJ*HI-"CCAN6A-`R8PMP3''MQ;.*]7RER];AI:_NPN+KW-
M$[*V@B9<<:6;=BX6-H"VFI9%'I4U$;0T@9$08D"#W6142JH](&'S4G4RH+6;
M`KK%T8M/[^@I.<Y!RDJQIMA,-[R*W&:%47:5PN]D<(*NHE]2%`>``I1<R4.1
M"O^N""$@#;8M6.QJ@@"0]9!M><=I>MK49+H\4E:55/8*V3!03;&HL>M7%\4Q
M"5_9,BNE66Z&[Z5PV55/-4?)B2K7!M`PV3VMK1"536]VQ:&H@DB85MEUG?8,
M%M?F,2)?7J'E_V_"S;-=Y-0/:(J6=\-ZPN6U!*WP"M?*:89A6OG2/A'`-6!7
M/B_)_`&U?V!5@60HRD(GG,@UJ!B%ZIH6Z+++2E:'9I9>6B)I<`,UUN6V@](Y
M/\*FK$,UMZ;:$3_IN^N@(P\_T'/;EL4HER1UGO]F9Y-+L1V;'J0,1*)&1K5)
M2!8`*MP9`9IA"D4W!F<]S,*9YG)$:I%N;J4[;A(6S1P-\`J;JZ$!#2H=X"T<
MKRQ%N*1K;.D:K$);("L;JG@84`LG?LF!NGG>N\1X8)JFJB@BQKM)7S`R-`<O
MWO4T=+NR<U&)721=K,^ZEATU5,/,':C?!(!8JFN,7=C2H0ES]SFUP$YOPG/B
MYW08[B'O\]N/F.JKH^$8T`$`T,R77PK2WS`9.="%$Z*IZG:N[+H%=.(%Z>GI
M#]'8_=?"QZCL,E$IPRIZ;:G*[J$6(BT?L*B8E<9(B[-7+D)>NN>`'@0RF3(]
M5"D3(CI4K,*U?!44-V;7BCQM==^;^.P'P0\J)%IQLUL'L(6G"&%^(FQKV!P/
MI8/*6'YP(WTE$B`@F\W%`926WTL`+RQS6U>,^KA<BISO@?3HN,D\W>US_8JP
MZ\=(SCDST"1]?HWCA654RXX);0%47*P0&.S8>@N@XC-Z7_S0"=U]FD0M0=1J
M$K4AA]U/HO(8+`V?=R@]L?XA(BW_[B?/S\O"JR\1[FY=RH":92LE:;4IF-([
M"N998Y/IURA\>D!X=H4>I20!%12..>41$XOY';F&!L@P0JF/F^5FT@%P\64X
MV["@(@/X]72*W&0R)4[S[(1/Z(Z8U22DC?T_>U_"W+:1)?Q7\'F3*:<69'"3
MM'=4)5MV1C/Q$4E.XFQMN2"B*2(&`0:'9.;7?^]UXR9`@B1(@E*G:L8B"72_
MNU]WOP.;`\$_N#S?@VNTY@:Q^=9-E>7\R?LF`)0SA%J"O?&1MS',UR7;#/*E
M^(3*YUB49GE+V$K%/TT=2?ETCTT`*)=B:0GVQN9D-!H.1OG[^<V`;P+].6B0
M[R]`6=;V73(*Q7B5I4M7S*8>#-8!6YIP.8!E5S`'A7K&2VU:-*R&F<^'WPQ,
MB]@OWKBA'2ZNR!TM+N6&[\T9:2J=9^>N_=44;F"[9<Y)%-KC0!2`=?W_^;%N
MZ-PBAH]<>.,(EY2;Q;SYK++4^X7-D'_]K#!PW.[BK1V,3><S,?TWKG4!RMUX
MDEY/5GH8QKUJM+,R'7<H#SV,)?+#."RK?IQ5H$L:_)"G[=H"T2EXYT`F"TGU
MUC'O&A-A`M,3-F%A@+,E`7H-O_BF<^E:Y-M_R*+Q#.AB#$=@V`8%O(JC50AL
MS!'P23#6R+W#8O51T'C:SR0HS%<Y6DE6V:._>D[DAJ:_>&L[Q&\^XWLO/V%I
ME,J9Z$^O0<KN/+\Y0<_'8^+@`1CLG^@(^6D+0RX)[V_$<?[C>@_N-9A<SP7O
M`RNT^UNB6#/:V;+R9VKU%KYI3E(EU8::D6KG8HO,9K/]HE;-E1OIK,JPL=\W
M-3[X_SUIU$/_L':TY?-8$%H?S[_2"A^-)_R'$[ZD!WL"2(\3S$WT./_YC[\B
M+WPIL7_H+W/3LI9_"<*%0^+O'FPKG+X09$GZ_J4P@>GQ[WDHW-@S<)S?DP?A
MRIN9KLB^$(5K0&GR4KCU?(OXO;'G..8\("^$Y"\VZC_N8)I$1_`_"K!?F/F>
M@.X"2WJF8]^Y+X30F]>\'+]N50%N?)]_*7N#O7.+7\M]_//'V_(C]-O0VFBZ
MD5:8KWI"QEC!FPBOHL!V86><!Z`!!.Q[O_`\^PYYCE_3N?P?DS_G!5B;LW%F
M^G<VT%YZ*:#<]6RPX/BNU-=MM\B-!+8*'^(?YFS^\K]D0WJ)SH3P//3N")[I
M"@^P319LV`D$T6U@6[:)<2FBP)X?*HKTDHXFIE_(`,>4Y!_`';7I+@J/Y'Y^
M('6_1$'A%\_/_^A%?N[''V#MIG5G`38@4C0QL5(ET`U69A#LV0R/FFCJ5X#@
M)8@+<]^SHC&@-X'10QOM)7X7$IK((0I3S!<#1P*'H0$A?A\)%Y#L36P,<XLG
M!X+G"M,%N'N^Y\+0H-"6\#P'\;_.\P"+@BFX*&6FXRP$;XS75C"3*-S:WA@I
M%MIH'.:>LP#@`;X(0`BGOA?=3;THI$2^]:Q%7[@`F$./,@G\G;_@$PPQGRX"
M5$T*.0XY)3/Z><X.DBD7_W4NS!US@502[!FNQ.`S"KX'\]HNPD>S)E$+Z'">
MX]W1,2:1.V;6+HC&4\&D-,W1C4[J1+<^/$T_PPB!-PEC"C.N_.G9X"B+]-69
M"7\3W'93G<.ODFJC,!W^=N=CASS\C0TATC'P071T`X0=?YT![./(02Y[]`F4
M7\"%VMA^41/G^]!">'0#3011$F+U$&RJ8W\"!1%VWPZ^!E1R@7SPF8J$BR<A
M@`WEO8W4GKK(E`5%=48LRAW0!'N,'+0B(")[9>Q$%I,N$!W7"P7'GMGHL(2>
MF*@.O<NX7=#1$Z!`*U"N<'8"+H8'[A=0V04RI)/3.6W7]>[9"HCCS0GBCLQT
MA:_@FX+$@4/B$D?,2PG*%4@C@(A^&8P!2C@S4P'*T!,+*IR*%/EFTX-Y^C3"
ME.BDF*C]W+&I3%$KAGA]ZE_WA;>>9]$G+OSH3LC7^85Q\QK[]J*@LO2="4O[
M`FMP%SGQFH_?FW.8'79_\`.]L*''=B+JQ@/(7J(C[$YZ@1R]\[V'/*V3F>3!
MRP#8Q%:=-2*;.\M:\D0J#B^3M>R"!&/?GL?)`UB9`O9!'\%<`LSTY1N0WU<.
MM@9^7.Y,%WP9Y="^#.4OZDN>PSD8NNC,-#*C>2MJCIF%7+!MOPGF#LT;B*^%
M<9OTK\!S;(MNTR;LB!>T-<"6:U17XS6>WA"@B00XI^8]&%I"7+`LL/C[\$/)
M/LXC/XAPT02%QN]]7'LR9XH-F1F*>&W+Q0_@$\E1*(XZ@^6-FJ&2$W7]YO62
M*<(U&M#VK<S&F2Q"$8D`=A50G.-:>,>*FH.?`;^3.2(8KR*?7$HFVG@N*-@^
MM)3Y&:G?4TTXMKP09N"2O!E`M>ZLB@%?\BG[`JUUV(O9R)9U<YP9V%O303SS
M7"&XBKG(,`;=`K:A/>*6F!V_*`130D)<9L%.V/<H!6#,!/`CA41:JK!C2Z;E
MP<2X;B:X`C4%"_:CCA=0/S.V^E1`-F8"+DJ7[&]O#HL16]Y`/\P["@1UDNBA
M\#9RC2;<1%G!92A-1@9NXZOQ"NJY#O6N7%R!<0V+W='\"S_`&HMWA+A6@[A/
MP!F&E^A$%/2U,"6Y,XD:)$ID4FFY1II0?U.51`%7%>8;`G4CAPD4RDRB]%ZV
MY::^.WJ"4Y\0Y@S`,M<#SPDT8DXW\(&`'HE5,0E]'D]Z8Z?!#*;"Q/$>LF&W
M&:R_=T=SO9.Y?_L8P$[$`9%')IE4G&&4/^/-0>9T53DXINM&N).HFFAB.\3*
M=I[G[%%V5(@>Y5L0TLS&RE+O/RFOT`+$W+D`867,D<68)S=%<6I/A&`+B,8A
MT0_;06_6HKN?^W1'D\P,N@,4(]_FX`83:PET9%`">X9EC(36%UZ#HX+J#*8%
MWF2P">:,6=W,-H(*.R:L)1.;>OG(&72ODX4JCI),WI_G7`-*)\#HP423AQM#
M,,-(][0&-EI!;T:VVD_U`MB$,UFO$N&<A-=(\SF@QO(G*80STZ+;C!46*!4M
MY$2%@@?V-X%R.F'QOR.79-REQ`-JC4-@JT\F#MVBH;"8WX#6K'`K74M('-%"
MYXG91%AO=_/!]*T`26L'&0)3,]E[QR1F.]]J</%9>!5W.+$1I3_.X^MK7'DR
M#IG9U3D\^)W2UX69[3BI7IH,)]@X,XFSX^L_BFUYV$ER(YX?-C$%L4"M)$:`
M]R4`75'9UM`].0C`ZS$FWU7D*TCH$OER*@Z3,L3B52@Q!_%8B5YL)D(^B34G
M2%4PG)IA:A$L`F]9L<K#WA:TS81-,!H'H&[$SG[\Q!$P[^[`6X2GQ`2<@I)O
M8*P;[QLWWQ(N9T\#B.R8_"JU.>-2Z9-5-ZZCI5TER`'^^26YD[[QBG$:%1$:
M[ZB]S%_A]70,OI;*'=$;`%O1&'U'%&6I%L<+4HEB14AU-8J][7%<OCDOWV*[
M5E4`\F,]'>C$\8!ZP..!G9W06A(44,ID*+?SK;E/R1NL8\%;S8`:R%H[,\GT
MHUH+ZC4G3Y1:07\I;*4ZU>?6#13DU@M#;U8C?A4B2WW#!UJU$5]VK!6\RMSB
M;15D:;:70DSU'@,<:-.7YV&]^FP%`C`#6.C&0,AZ!0,K(*-><DS6,<%3DM2@
M)<"^<DPPQQ1D@7H&=7:F8O>R!&A3<>9RT(X<J`<1@]7&E)G('BQK]&PA_IB,
MN]IPQM6'P!7=SI#O,C=VGMO!2G.AV!=CLEJK9>(<0BRP9@\L8=@E##9L6+VL
M_`P7$RXF`I9U(D4YX3+2.1EY:]K^$82#A8JWO`78P&<"Z@.U[WR,_$&'WO-?
M"/[=[7-%TD1%'8J*KO]0[9ZOVA/JQO=%5CMD$M:PL7@[>(,'%9&_$(+L^G)I
MTDVWJ'+]CGAGYRZ=8B7"9<9_MRM*P])\/BI9#85E31R-1J)LC`Z+9(O$?=+\
M,T:CY6$Y[TZ"=\\58U@Q\)Y1_(%;S#8LIB%)'=:Z/:S\OTUA+6Y^C%+&K('?
MF<?VE>E^I5>8[.J`W2):A-Z=+1.X,>G7^[XM"_0Z_W6-"!P3F+(2E,#114F2
M\'\5\YXF>;APM"8</2X1IX\]EP@N$7P!.86CE?7.EM(?Z*V?\JU2C(H)#R*-
M;%[!\J);AQQH%[$I("NW%Z-=#V1:)@L7C:Z(QFYG/5PL'JE8['J,U#)1MC]?
MX@+1ZA*RPPG5,6U%E6?%OCM^X8)\NC1-7K*P'DSN.HJ&ML\P%38-?6<9'7&8
MN><#K8*`!:C3^.K('T\Q[-VB64PT3)N&=Y,L"C;.3",!31[S"6;<87[*%#/0
M3-_%[+-SQREE-16R76Q:0S1.H_%ABBPU`Z/Z[TW;0>KV)I[?"V!6EE&,#YJ^
M3Y\*:;Z5<$_O)"F:479S?H?1#BSIGEYH9T#2G`',_/'<.'C='(^C6<1"]SU:
MXF&<;\$6IW:(@LNNQ),H?_8U1OD3&ER>EXSZZ/(M8HJ7@J_W$8'<T0C+C?<Q
MS<^#GV!8'0^OY'*`PYYZ^`L/K^1"L<08'E[)Q:3S8L+#*T]!1GAX)0^OW&F*
MS@<+\?#*$^4?#Z\\7=[Q\,I3Y!H/K^3AE=T/_V@!F,<<'<.%@P?3<8G@$L$E
M@B\@6Y&G6T<K/+SRL<7&\/!*+AKMGO5PL7BD8L'#*[E`5"TACS:\,HN>6QLG
M1]]/`^7.DS!"[&=LYE]*(TAH.,>J.J5RH?NE]N73-;N=.G>MC^!P4E_O.KK%
MZK58-;>B)BDV'M6`0;#$9Y@T!*U<6G;%:UD4XT^^%P39/3>&)KPBV*4%KYOW
MCBNL6HW0;`;O1DRM'1*OW0](@AY8Z-UH4`"XHF]-_9@'$F8C7U^W'IJS]A52
M*73-5;^\SAT:?YA<L"/C2L!96>!&<)>5L"7Z'P3VO=A!J2@YRXV53\"^K<;A
MI.W6:M2Z:H\:"-5V=@8#>&@TS476D.:1UNC>X"AJ;Q6ZM4,W\*(!6BQ<ZAV-
M$6(U_O-0M.)YT@F/DMCS-LMML6E'#/+-#K'YP9B(68\%;$!!VR303@NLT<)#
MUH%F3+*N3JQQA$.;3\!P9A!@"*(OS$V;=:S`[E(3X@NFX-A)4S[LD>0*5`J=
M0@,J&#]\P*8J,^J1PR@H:O;<Q'R>M/<G3!+-XA87%+:JIQF\44`[;"*"K']A
M!F$*3E\XQ^2=6]J]#5MFQ$E#BX0,N82@64XLL+$H37KJ@:GP\T]-X;/ICZ<+
M47B8VN-IEH84K!HPPQ`?LMUYA)U&`]:_BCV((&5OB[0Q"PE0L.Q@RM*0)J#,
MWD/P0GC^,[:;%.0?!.\V(/X]-3GQJ$D[41028C$!"%B?,]I)AU&4D<-&J6(M
M3I%V09YX@-'+9"+E!R$`@T`=#TR!HCE/RU.G;3MR/Q&;/FS9<?,7VJDC^?22
M)ES%DZC%22)W>0+`@E$]I-UU@*D`:(@BZF,3DUA8+#,T$_;$/<6"0K,L$-ZX
M7R=MCN0]%`0O[I"2<KIV#)3`'(REV4'4TZ2TN-,J0&B[]@R61SI4Q!J[5"%*
M7[=(2'Q\`R0CT?),0OK"!Y<VLTG:C%$I%PM`LARV@&(YRSH(Y*(C"TEQG>NX
MU20/$%NRY7(!XV:UL8)0NL<RG"075FESO]%T]=.L&)H"2;]#FX6,BC4S,6U4
M07<#8"5N>0!2,S0S0]_^EEI/S%^D'<-H;T;;MZC%7:2_WQ/7\GQ@*,-@6>I+
MQL=.LCU]W*B(PL(F8+)!ZNZ3ML-CGUBP/F&/WD/T%-Y0\"KIN"(YM9SORIH)
MK]<XNE3G#+NPGA2=S\`L.TPM9]_M&#;&$_(:!"@\1HK)\O8DVS:5==ET[9QD
MLKR'08O"&CNB:2Y3+C4C>P3L`A/_/P5L^K6S[RE@@EN0[2R(ZSWXYCS^DGTX
MO*)LF_/-R7L$._0+\U\_ICO+,OD.87/.V6[V7;R;/3P`N'^^3/?/YVS_?`0X
MLK.`[4TO5Z,CJ-%U[K#C`STD*3]S$/GYD.WE+MDF[BA@9"=-7(Q/5HR/(3B?
M\L=G1X$@4YMC:8VZB]9T*U!Y50YXHZ#E(B7>>2Y9)(=4$P"QE83P!H"TNV/(
MS;QCY%4[P6BYK,A=X](*$&DC41GJHFP,#QF8EIUY?7\(#G+9V8OLM)P_Q&7F
M"<@,MS=<=IZDO=F#T[=C^G^=C[BE2+8VT"&!KIVK(E'RM##C[.@49IP=G<*,
MLZ,3F'7K)*0YDN^J`DU>+(W/)?!D,./LZ!1FG!V=PHRSHQ.8G=(>LN4ZL4]+
M`G<O:,@-`F?'8V7']N>`G`V/F0W=WDWR:JN\6%['R<.%@]?6Y!+!S047#FXN
MU@'3O;.(C2NLWGBAZ=0DC;;F8/&*>4^Q8AX7C7V*QL[',5PT'JEH[,_)XM)Q
M^M)QV`#"MOA3Y6FQ[VIJ8)U"P8J-'<9]W%$]LL1R7IJB*<6.49JB23$)ILC"
MCU7"FJOYL/?=&5>V6M'I5&+I!1G'11QD6L1!78*?$W=KXOX2%:LNK%+.8G&$
MXI/51*JJ9I#]6IJK>HA<(0+.]Q9+HY3+!)097WAZ*9N_EHG%]W+I]YQY/-6^
M>GZ>:L]3[>M)Q%/M3RI]4069,0Q1E^1#GD+PU-?'(#LGG?K*98;;&RX[)R4[
M)VUO-CHPSUJ7K.Q(4M%0)7V>;=[C0SWK@WN55(A_A07B=VUJTMTS_$.>*S[M
MDK'\9+_+)_OM;GMYT6EN078!H<.'<[SH]`G9H?+U1_F)@]@<7G0Z_H\7G3Y1
M->)%I_-@\*+3CT",CR$X_":,WX3QF[!'<KK(B\!RV7F2)]-<9KB]X;)S4K)S
MTO9F#TX?+SJ]O[E.MC`=9T<G,>/LZ!1FG!V=P*Q;)R&\Z/33DT#.CDYBQMG1
M*<PX.SJ!V2GM(7G1Z1TDD%<YYNS@[*AC1^>J'7,V=`*C;N\F>='I1U8HE%>1
MY<)12YO3JR++)8*;"RX<W%R<[%D$+SK]F`J$\J+37#3J1(,7G>:B42T:O.@T
MEXZG673Z!*I4;.PD[N->ZI$ED_-R%$TIQ@M-<V7;4G0ZE4S*"TWS0M.\T#0O
M-,V9EX>0I]?S]/K]G4SS]/J6W;JGDK+("[]RV7F2Z:Y<9KB]X;)S4K)STO9F
M_2%Y177IAM6BS^(1TW+3K\U@>NY:^,^;OR+[WG3P5*^B:+40N38K,AT%UK-B
MU6E9_7(>?)BDQ::_4->.G2:\1<?N'3WF>2989&S/3"?XYS/IV9DV4H:Z;`PS
M;!H#4U$WNQU$M$:(?$F'9?L+ZNDK^T"R@.+YO6D[*`-O/?\:7KO.8CQ6X:27
M</ITS3)9`(B/L!>E^X;KZ-:R[^W`]MQJ9LG::#0R)"G#HQZ:LU;`-K8"NY(U
M<@LHM<2,00FKU[FPZ`^3"Q8470FN+M'_#@KML#FT&^C$9IBT@<>HA,<>A:0-
M>!6I`;QMT'8?-E21&?#R!1GCF7ZSQ4#5P-D#7Z]#BX&B-$)D`^;LB&0!Q>RG
M#Y/7WFQ.W,`,P0Y>$0>TTWKM!6%P/35]`@X`L3Z:"WI=MVO;B.IK]_JK^BKG
M<Z-;]]0Q7+['KSE::G`Z%GKSVG.I>B_5^+[.W:0GY?BUWJ>.VFWYD6V<XI%6
MF*]Z0A2:<"%<NGCPC%<X'QW3S<'0AK?)[@'2/N#SI?/P9GQDAZ?T')4ZT+:+
MUT?PN:_;;O4IY,V4""C;IKL02!""(F'R4`C?3O`V^I[>1GL3``@EVINC_`>"
MZ5KQ-^9\[H/^4;U@&P8PN_0*&L>@OGWO>CSU'!@5!V,/SCR+.'UVX9U.X</\
MOCW&&S4VMAT(L]C;%FX7=,`[WW3#GH47W7.\=</WP@P%M@D8*O+@92`$J)I!
MGZ)81(:8XVD!(\%\,'U+L"(_@3R<^H10/%W;);T9\&`JS(',GA4(!.AJ517%
MQ^?1CHF(S)S0*S]G(0H/9I!2UQ)@OA07@>)21S$&70]1Q0<HV6`G!*!0#H&6
M>@_X@QD$T8SQYD51Q.85XL5L#5/ZQF:F6410P0"M"`_:(B*H:'RJU'_=U5?K
M42O%6ZY!!3V6+ZY6&ISVKD92\W5#!?D=RF\@O$'!S=O/"ACV?FN3@E90H$VA
MVN8^IX'0'"1+97UP5ML7GI2P:***9&[O4GF[T+%3)J6Z*2D;WS1N>J/8R-<9
MR/6^SI4=?!4F:"=LI`^L5(*/R]+V$A)/JGY?)1EUU)7[JO3]CC,.-IJQG:3T
M1*I2I%<@.-H:P:63V>H)]W*:78]2:U-TF'%[4.CEY+4EJ*N6FS??T*D$%_+>
M@RVH[>#&9/G=XQ:=6&)<?BI=[2O#[UMD7N4\!R/"D:G9IA9L1,BM@V;`8=PP
M8F8CM7!@OQ4(SQ?$](,?EFC084YJQU:)PY8_XWIS\!4#+W$LXEK"PB:.M?QZ
MA]DE]:7M_4*^9'17]%<>@I[F*549Y2Z?5.U^SK/.92_!GMM`O[?=5:=2^SB4
MVAY8?E#%#ZI.EY3\H&K]I)L>5,D&/ZAJ,N/A#ZHVH:K4-^1'S4>I/VCD.?.3
M+'Z2=5QJ#OJ&=#1J\N,L?IRU"Y&>*K7Y<18_SGJZM-SX1.M(87T^&>,NTA*^
M4T>2J`^&-$SM.]48BH:DTN`^C)3KW6(4*^Q3LT!7@7S#OS'2S,^BXG8-AL/!
M"`NJ+$Q&8_#B>+UEV&51'AFB:L@,>OBH&^)(&6T$?QNQ?)N`/X=7:0D?G#P&
M)H#Q:/PP>`\L"+$*<C8:;'/IJX$Y2]\'K\"%_2^`&PAF((S-8%I\=6[:=&Q\
M,0,=26G/;82F+Q3EM2I&\`"RFA=6GP@/^'\#6HT/22^K(U'1I%+@*8V9!%K!
M2D(82S$:=^?`S2*/^WF(7$^XR@)3KRDTYXPYSY-P4T5Z>75]'J0?Y9<_""`E
M2^]AEYOR:Y^*KS5$L(!7+5H%1$:@/+J`$Z:3@)#,Z!O!JCC:5Q[&QL(#%S;(
M4.CYP0KHEHC>##CX<@",1RKFH4LCDV=SQUL0TN+,1<$2V=0H-F4*97/CKU9*
M@ULP350KB3^V`WI9`3R_C\^DX/-"\&"_`/8B\@7JP@L3WYM16&G0+U"43M,7
M.J:/YP(M-@:F)):*:AW<BO8T*<*$QRW:K@+^PC?`I@+L8S#4Q`PC'^%'TX;<
M]V,N!$A2.YCB1\")A/`,O(PGMQ14-'B`>6Q+D0T(',S&?H\-<\%0CC&!`V.G
M/0Q@A[>2R.H@#LX.2H';#0+;23@%["<FR@B\D2P\V1ASW[LU;]F!!Y#7'$]M
M<I\,FR?%G6<ZU%1W23*HH:BRGR'392`79@1XWRBVH`+?:7U%F-F.DX@3K:(=
MN;BPW[GVW^5U#WF27R!=S^TA,].D@%1AZ_,/\@;V^ORJ8&#K%#VS*U4FT"XD
M?U!9L@,&*_Q+DDT)P'M+%]H$-6H`3('=0!"K9\)G\XXD2@+T4/L2,PZ=LP*H
M+HQ;M@O+F!O8XU7I($CHQ!BN,0X-G"XJ2=\INJ@-5%$:CIC3IXG22!>'JEI>
MKS&Y"^E.X+.5F=D$G&6(6\OT8,O7=_)`U.%#[)JJ`_!=1J`5\>>AI(F#0?RS
M(HY4132T41F)BPRF@*#A$OZ*3!]V)0A^JF7IFFB.P0E%&T.3<:+;`)Q28*J#
M3G-(?Y"!4(,!FMP98!7GP^25"Q;09'4K\D]DK@$)075=>Q;-@'Q@F,&F+<#Z
M?J.&$DP?7IK!>!2.6>Q9'DB"XVW;GQ$8ULEBC5A7.)HCU0!A&BR+L!>%@*M+
M4=O(*."*56D<V;)28052\4Q3F;Z3U;ZNH?0Q;J$$">;=G4_NT&.H4,22M57D
M_C`QMTS\*N8%9L&Z&R^/H0]K501:#H(VPQ$-&"&V2.\]-\VP2@@%"]H2G<RP
M"FUXLFK_-#4MNFGI!20,'2HWZ;+?22.8*-S,7`BX2@43EHL6;]&B.=UH)HH#
M6--O)I$S`3Y0]&(2)DY)7F.HA^#AZAEO*F,'A@TN,MDA-GW`C,"Y\.G"<AN%
MF%<;!!$NC$RQ/3]3\=0XQ'ES,0Y]MA$IS"'`*^DRR$35+8LF@(82PO:4<3FQ
M]?EWS.*Z51YOO(.*G4$D"A:QPP$SCTVX(RX(K`-R7>%K%WQLE%.`+G.U4<Q`
M,4W@M$N_619U:C9AU)!*30Q)P0/+.8^Y(ZU5XIEE'>^8.UR5Y^[`#_AN]EI^
MX#?QZ<"J;.LX!3ERRBG(I1SJD:0/<N4TFLV\7$MC9X#5/,!J!K!:!M@8&I+:
M`8#KD[Q+)0_DD:$:\C80MPVRG@=Y!8UE63=&RFAWD*L?/_?!,-Q1F_AJL:08
MU%Q\8"O03W1G=NE^I"[:3[X7Y`H],`.XC=Q?OG_[[&Q0J.NP!TC/CDV+1A)*
M:2&K(T7;-S7:D@V6I'_I!J$?44M*R_+>3$VW<O9U`J/62<R7[$R/KJ3+-2@H
M[=H@VX8H=9:66E-:TM-1V)1WB::=I*A>I\.K*?J%'N1^F*3'N#6$AJV1?A3Y
M[22QC:;$KJ&F*@U:65..14[Z?[^RG0L;6MZ10F<?M<\M$*0"L`,B/=A.!_>+
M?'D)>!,?[ERSO57U;+#)9P>L;$]&VQSF?\>MRGLO_$P`]?1@<X5#62JLE5>(
MGO[L3%-*U;/V!F19&O8V$6/`6\^/O\+GY*9NU]E']?,!B%$)8T(AT[6_,EF\
M72^+MS7^W;G+!/X\=R)_10_DW\2'":EQHA!?)H=9K.--"[LJ1=<&JC2$/4H'
M$,JI8P>@:6,'J$DC?:BJW:%N0;L_^MZ8$"M`7.C`\3QOTBN)%DY&Y($NY\X9
MULY9-D$[`=GT-$0>2MI@L"&8Y943'[LB\\@?3Y&!P*TK=JO`;BD88Z[9<>,:
M#VK(X#Z?^PEQ_QU13?Y2(P#7YU?7-=Z4K*J#@99;0#>`LU(C=]C0UDOPA^QL
M_'U$#\7;VI2#;RZ-!GD5/`P"AZ/=;_%MQ3F[K$ADE/98*F@'L+:2F"O\#P4%
MJ*]K>Z??*B2.(H;-5X,U[IL"UH7Y;\<"_NP(Y"OQ\RJY0'N=72K<X)U"8Y_/
M^*R,E(M#$K$A"A6[B#WNHD:UNZAW[-XYW37)^]PU'0A=5:I'U_Q60'>OF\06
ME*<D-5?X?'/IEZ7/NXI^%0#EX[KQE%B10SY,JH?(NT*_)A%<YUDES1N\9]RE
MFN^IU2XH)G!TMVX!K[#)*VQV-MN>%R[@A0LZ7+B`5]AL-B.OL'E(QG4PP937
M)>#YI1TKE\9+$IQBDOR3+$G0?;WA)0ER4_&2!.W1LE.BOUR/X#2/IH2R+G?W
M=&KWLQU>59,?3O'#J8Z3DA].K9^45]5\+(=3O*IF`4%>59.?7IT"-7E5S8P8
M_`B+'V&=!+7Y$18_PGJZM%Q_BI6+C&LUPFM%!NU/GF=AF"461"EFZ`0WOND&
MYAC'2Z=X1ZN`X;;J+>RJ+N--U17M])Q$WLXCGY0#_.7:5-EB.&0N)E=[=@;<
MDM7*%,/6P%X5)7D@VM2F:)1B)RMH,WKDM&D<1KM,&]EXY+1I''/[!.5&5>LR
MO];)C92O7?(X::/5TV:UW$B#X]GB#8.HWYJV3W,J<FMBX@O^FIX@K+<_3;+G
M*'%T51FV$-C>'.ZV*CBT1*E&B5Z<4DV34AFE!D8;]15VH]0VB;"K9L2<AG*R
M3*V65:2+[`6>RO(*!\!\52K)X\:\7@N.BGG;^G41'SNTN-)([53R:@IUM\C4
M?)EYTF1JOL8<F4QO3!]3-8./Q*<#[Y*45A_*4Q_^4QODT[SX:FTX4-4E6[,[
M@BUNP8WZ*/OD:M_HYR_V=[O%'&GUE^[IA`ES!>"N0-E;B"QHX\2,SM6!/C38
M5B`02()P6N:8%O(?8Z<76G>5%J$]OWXM*(8D4E3L%82BOXG"P]0>3W-M`K#^
MK.E:M,PLUMC%*O,1+;^+A5_CQBSX<1F<O@"::X\K`0WB@5AI77I>CH.X),1Z
MT%BDUKPW;8>J6N@52F]CP6QLM1&7Y$W*,@M)66:7E8KP)J6"W?E*R[FZY:Q$
M>5^XL!T*3@>A14K3"O#ILQ8"BR6SYUZ(]#>=PNNT!O*]Z1"LC%R!ZZ>T('?H
M$S.(_$5<99CU71#!W&<EZ'-=`#!^;4IKNY.T1K$BORR7L0<`3+3,:2G_;#`S
MI-/>$M``6J\X+GR<5/+W\0FLQXP2+`KV1,`ZOS[K.I$,.H\+L="9X&U7B`(V
M5U+`I$3,>-:$YH7*RQ7D*:K_L6MG,R5B35-J1;3066K[*OR,=3":XW@/P8M\
MN>;U1,D6QEVB7U<$O&ZU9M90M<':R.+::E:>?5XP500&'CX(L"I)O&'$X@9Q
M@7FHEQ/`2[+:9J3E4R#H4AASF9Y[##YIH#P'CC+OG$!4A=GN5R"HL5^&C)-M
M+=E43C8N;9V3MAVM\X;1@>OX%;MGNE$*.G;()*S!-:E\B.Y[W*,3H!Q'#FM$
M!IN#V[HMY/9RE;B1^R\5(*^F1'&8%N<=EN8MQQ7F)Y4U<:`/Q<%0/E%D.1\9
M'U71&"JBIHU.%%G.1\9'33040QRIZHDBR_G(^*B*NJJ)JJIU&-D].!#+L=,K
MD5R-61ZQ-Y,)&8>%T\^`C"/?#FT2O-B`R/N/"EZ-2+MS[25GX)"8<79T"C/.
MCDYAQMG1"<RZM=,N(UES,))]C0^QRY(ZW^RZV!4<>].*<7OO\Z""[(T9<I!2
M$!472+7'+FN\J6,"4Z$>>7",`39;UK;G1:=(PP6C-<&0105$0Y>-BGE/DSQ<
M.%H3CJ&FB*K$K<9CP+YEJR&K(U'7](IY.T^>[IU<+#MA2G^@K[B>2B+.@K67
M(!77'RVI3P6(!Y%9-J]@>=&M0PY\F+<I0"M/^7114S5Q.-`?#7FXB+0L(IHX
MTH?BR.`BPD6DWHH8(U%1!X^&/%Q$6K<BQD"%A6;KZ]UCDJ?*6V/?'3^W@G4$
M%TS:!!B]+5E1P%H/Z.F7+`_%@:(G/MH#`=<K'YJ_4]RU*,"8F+9DWQ-GP8[;
MZ`RN1Q,+G,C*N80T`R%U"5?$@M^2L0G.)`MYIU@EL?KRX*5@S^8F7J.Y5:\^
MF`%`$=J]Y(J-!M[C#PRLXH\TS2`C79$6>1+444#M+U-_.!25P7`MP9?(7#M'
M-^F:J4_57P4=*<?:Y]I<UR6TE3/?SF'N9.KK]-+TS3=&"DQW>YV1X<.D/.[Y
M#/9)X;H&M4V22EGW644!_<K0:`6ZBHZ+A\"Z><]9,"5@21X'UHUZ*%.LI<>!
M<*,<5XKP<`CF:Q](%W#.2G:5WZ#I0N>N%9\N[-Q]L<OY/!L?^ZP\W=G/^6$G
MHIAY,L_)$Y0G\W1:('AZQ>F0C2?S<&GKGK1U*\2()_.<9-`Y3^;I+&H\F><)
M\I$G\W06-9[,PY-Y=D>$Q\=S=G07,\Z.3F'&V=$)S+JUT^;)/"LF?+S1USR9
MAPL&3^;APL&3>;A@\&2>KIU<\&2>#23DT<18\V0>+B(\F8>+"$_FX2+"DWDV
M\=;8=ZM:"V\4IUP1Y?U;W#GCG#5Q>$][8<0OL\B3#UF:R+GU9Q2$V#"HM:0%
M8V!((RW#;$MXRID9^T&K>7R^K`P,/=^^=GN\#H%8\W0+V"G#1OE$^-4\O4"&
M;1[L\MKGUZ5[#U][_N+"#L:.%T2/MS]6R98=JT76X-`MLA(6VR3(S=R&P:=3
M'"5[,X<32FE@!V'24XAUL0$Q>R$4P>;-:Y;EZ`F'[+O>@V_.XR_9APK6MA\G
MO*2D1;5ARM`#\T,5(OZ8#"RMX(]02@TIS\,48(_3LV#QM=-RD>F0R%R0<2PQ
MLKCT\Z&D1MU!:KIUJQ^;^T$YRG!%_/R5^0`$`Y&PP=U;GN#T0S>_VQ6E34(V
M#7&HJ:*FR16C=REJD[.PEH6Z.%(,45*ECK.P>]=7]?>$OWG^5_"K>[2'9A!L
M0-7]W,AV-7A-$55%%PUC4#%L5Y![<AR18!E6=\K>Y!&%U9YR'O.WMHN=GRWA
MSL/J13M0F\=WM!;?H8F:K(JJ-MR%'YTB#Q>.UH1#$0>&(NJ*<HK"T3WOJ2[X
M9UT(=H$&-UYH.FWIQNE=N&Z_46CUHE45=<RCU8V.D(7?Q7=&-"1Q-#+$P?`D
M(WE.Y4H&HQN#T,3(2#.DMS*.]T!\O*(9>WA5X^,,7TDH"@]V.&5?WA*L]&B1
MD/@SVX57HP"_H'<ZMA\@$&+\EQ>%PHR$4\_J+VUM,>%E4O1E[1QH<2'([,A-
M%!P3>,HR98`4T<0<AY&/4WNP]DR)"9/D:5U?F''596I%;$,6)9&^^#KR??B+
MEV_CUUG\;H)?9W&1X==9*1OY=5;+]OL$[D+X==;)LY!?9_'KK'W-Q:^S3I`C
M_#J+7V=M?L+T*&XL^'46%PY^G<6OL_B=!;_.XJ+!K[/67F=5I92NOBRIN&=)
M7[@R']ZE1U-I:EX46*6\/.G+>?!A4IED*#T[,X::JFERQ;5/?OPVX)`9'/(%
M&9>S`@$.?:08DBKM``=NHR_=C_$F>FN"*+#)-/*=O:HG*.=4;@[&:GHHL+."
MC=768"0[AI_HAF%K:H!HJ.#A5H!1F&!W,-90`YPI\*4:@?$__Z_7$_[WMW>_
M:O_WO[^/Y]&WSZX^LOX>W-]]7KB?+J*'GP;^:/`?Y<]/-XO`&=R/_Y:<?X?#
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MF7/2#-M$(@0F$C26(!&9/(A+L)Q>E`?*MHO=2SV7!6_0QICCOR([L)-B5^>N
M_=6D/43-.8E`/@+ANN_WG;[P/&F>J4@OV5/LA_1K^>4/(AT2&^29[H(-[1-+
MN#=]VXLP@B.EMIE1^RZF=DY*;G*CD'O3B6A`"HZ]>BB?./3)L1E,A8GC/03"
M!!08WPS(\CLB_"L\@)+BOSAZ%)!)Y`B.?4_8@.;,`R7YF]4"8W$K03I+Z-4-
M7$(E=][MP_.F/Y[2T2UR3QQO3NL-Y,E[^?&*?L+_7>3I6X$V+`DA>`O.0IB:
M]SB513"&)B1Y+'P"$]_;Y`&@9MU74?'A'4`!QPD8^@#DGUCE'0.`(J`.HSR@
MSD)L+#N8>TQ4Q#@:!V-M'GR8K>=-)L^#'VB[5_,6GO8P#B@>,$^/3VYH.T(0
M`0F2@"%&73L`J;8(%:$%!1F[O\8,(%9_R3^M#.DYD%*E6I675$9B8`FPQ?%P
MFPX<L!)&(66PYZSM4WZ;(3CD9@!_N&Z$O.@+Y[!2("GP4U&34#UB3@-CS7BF
M\I#V!)0%_@@P2FL\!4&A45/"+89C(8_'MC^.9EA;8DQ_02D(L3]N'.HU-GU_
M@2PU68O-."\_1F!F+BA+;HD`2N(@OF.,LZ*+(.WR&P]3T*+B&(RME#H$!&4.
M`C+W$:F^\,8$D<AA$Q(@#D4<)KPUL3X?2(E)^_^"$0B8O:+S`2+!&"$NJC[3
M3PJF;U$SY$2D`%!?N)P4*)A1Q1*SQ_![E/*0N+"S>G!Q9&0R0&C/J"F8P`AL
M_-419X<6S\ME,TE9LMS;FFIX(0B#QD.L*-&P!LWNA[-MYAX][8:D6W=BVU\$
M02?H(LN'#[RJ4-XE0$^+BH?OSKILZ;;U[[GQV)_QV)J]/_D>^#N_T@6?DVXC
MTBV[*+L$5;*3WO%B:8J]AW/>^*8;Q%6<RXPYQ/RY6G(-9N>2>6C)/!_#7BAB
M._FCR$?^:*$1!%Q&#BTC[V'O]\KSOAY>.N*EBPL%%PHN%'L1BD_LE.IG>]+(
M1>Q6B&5\]J&6;SY6I'=<L,-F/+<FXZD+(-PMMA49GA^`_\F&.)`D49*DPR+)
M\SO:X=]S61PJH'KR@9L$_[`KDD^=;YHX&(Q$63EPDV[.MQWM)=C*D2(:!F^N
M?IK\D\6!KL)ZQ_G7.=3*?%Q]^2+K2\-V"=$]^-I[2VB\K(CM2(,W"A$>&Q!\
M/W<!7<VLTT5=@F5AN%,#59[KV")'GANP)=44XR#\V,BM>EI\Z'%UZ`(;-'%H
M:*)B[%0(@'.DU25#&1JP`^3I\8?BR))#672"TJC3;J'5K5/;YDA>V$'HV[=1
MZ/DLW-CVW&!JSWG!C'H;G9S%+@_;%>2>%D>>:YHDCG3U(/S@3N0*/HC24!-'
MVM;'W)P-+;!!'FBB+#6+,^3&:=_<&!JJ:.@['(-Q;K3E/.I=X\%1CA^KH/YH
MAC2=AQO56J.*'A_W^CK$D>>R-!!'LG00?G!WHYX/RD`6%6G(^7!</AB*)`Z'
MRB&XP*W36FX,Y)&H#S3.C>.[?;+1.2YT^[1PPS*:;QQR3Q/[?=,B@FO.R/*,
M6U?]XL42MRZ6V(K+VBGR<.%H33BVO_#M%$VX1+0F$<\',NRGC%U2O%LDSO8A
ML%PDVBNW.U1$2=W!?>H4:;A@M"88ZL`0)5WB@M'BA*M1/C@`RW&]12!&[1KH
M/6%_E!/VE=@VK+!=Q)G7V#X0(*NR$I2A.(K#A[M!%EYCNRNB\5P5)1FCR[=.
M6&F9+.VYSUPDMA2)D3C455%11QTA"Q>)8XN$C#W>U%WBH_@"\EA%`WR+T5#4
MI*Y8BY,4C3I?^XA[R2H0UFRN3XT.57LL]MWQ:Y%CU63S[LXG=[2><;X2%ODV
M)VY`\D6VEXM>/YB!\)T.VFF,1K1P[7>Z(HOJ<$!+(F.AVG#J$]*;`1+3N.)U
M(!`7JP#7E+[%&I`BIG#.L4+Z/<&"S*V`*8OZ2*7)0Q10^*CKXF!DI*"ZMKLS
MI`4&'[OH\.NL]'2AJG1:?SFI^%[D%D5N$V(\$!])'1<E#GA)XG4&:.=*3TEC
MA&53U]@(=JK:U"/LHWY#56EYAKT7)WN'2AL(;ZBVEG\^"`1%$W'PZ5DAYK73
M<FWID+:\A^6&Z\K)Z<H>[@]V"-1:DOB][J:./-M!MVUK9M_[CNW@V.\'C:Y&
MXW86L^/?3\8[B4&YKM.*`I^O3`<;^XC"+0%#[.*.:VF6QH3M;,6L@U8\&XFJ
M@>'[6L7H>\;S$1<].S`+-4T5AZ.NL[!;+LVNL>>3"?:1\R9XP@/+IRN,DSX0
M9MH6(=B!(3QHK+T`4T,?BOIPM`,W>(#I(Q.)@8:GUJ<D$L?WV#:^6$O]->+2
M/IHMR3V_Z]WNKG<H#B1%5$9ZQ;3\NI=+QXE+QT;7P5GO^<VZIY=[K^=[''V8
ME`<0(M=FC=:CP'I6[+RNQ)W7(Z?<>5VPR-B>F4[PSV?2LS-='AJC40;OZAG;
M@T_-PZ=F\*EE^!19'0X.#U]]Y_HB?+(^4A5#V@#`MB#4\Q"NH*"LZ_I@9&P,
MH>G:7U]<CZ?$BASR8?*6EB?\&3LR4UE."A;2;\J#O%J\,__T_->.&00WJ!^I
MA#>E\MD3O6\^V#GL";4HVM_Y2R?HPEO@\A:XW'CLRWCP%KBGWB^0M\#E+7"[
M*9F\!2Z7$=[ME`L%%XJG*12\!2YO@;M;=`5O@7O:_.,M<$^4;[P%[DGRC;?`
M/7'^\1:XG46-M\!M-9ZI>6@];X&[=B[>`O?4.,);X':##[P%;B?8P%O@=HTC
MO`5NI]I9\!:XC4YMFR/)6^!N;J-Y"]QN<82WP.T*'W@+W`ZP@;?`[1(W>`O<
MSCB/O`5N'<-Y"US>`O?4.,);X':$#[P%;B?XP%O@=HD;O`5N9]P^W@)W0R1Y
M"]Q'45^&M\#EPE%+&]X"]Q%@SUO@<I'8ITCP%KA<,"IIPUO@\A:X[1IHW@)W
MU6D";X%[($!X"UPN&KP%+A<)W@*7BT3K(L%;X'+1J!,-W@+WY%J_;@W"DVN!
M^S\_[J=,;+$*;?D]6IKO==P6]7P&>[AP9:UA_<MY\&&2%I?]DM8QN4G+F%PA
MYX)WM*!CN8"N,9#POQC7!L"<K8`]5U/N/-?*8Q7X1EV5W`T1Z<E#9:C(6@TB
MU9"=K6)$K@!:H1;9_IC1TP:#D:RH-3C4`'262'5:=[G\XGL2OODV=B+4KK1+
MZQYE2I)&BF&H657F)@#M`8T!0T.^(&,L8;HI&O)`5R5I9S3>UMH(5F*)5E@J
M`CXLE[]NC,+91UG_G$'<9.YVS=&H)#J7[D>6_GT59W^#Y;S(LKXK*:_KDF(,
MC6/9)$VJM4G;8-,SU*&FU&&SVC"UI@IML$4;&EJA'/QQU%J32VJ]E8@I0T-6
M!H?7;4VIU>V&>'P+7KBV\\]GH1^19S^VJKV:6C;\29X=B.<*4ZEM[D2L@GH+
ME:TMMM\4A9X&NQB];NFMU=*6'8AM&=#3I*$&._2-/8=V-7-+Z.6!)F^USK8,
MOE[V%YJ!/S140]=W!G\+6V+4^PEUH)]]W,8_:-/&#$I"$F=QU+F2&QN65NW*
ML-:NK`*[)TO@R->!76],VK4EFQ"ZIPQD11INL?-H60<W`=H`B(?*T?V14<EL
MK`)Y((_T@79XMT.7:DU%$5S80!C'-1"Z7!*!.%+W!@-UWYLS\O_;>_KG1HUD
M_Q5J*WF55(U]?'\D][;*V=WD[=7MVK7>W-7]E,(PLD@0Z`#9<?[ZUST#$DB`
MD``9V;.7O;4EF.GOZ9[I[AG*4@RJ;<=!?6$IEF,>OFP/+,+'`:_:JJR9A\OR
ML*"K6]K7"73-,F7CB$BFKQ9JC5K8`/;;&^<YPWFY*A<[`N`<'*@/O#YWO,GL
M0I,5PY"?V[UO)^>%8QN:JCF'6H.*4&YVJPNY7>\[O[CKR0Y.C.J>_]2[Z?O:
M=NW,U/D\9%*-YZ/X,7&7^8?\EQI^CWRS%T(XX`TX\X1VNBY@Z(D_`97FJ?0A
M\OG=*J>'H'I%VLFGYW>R[9U6:,N$M.5S$%&A*V>G*R.D$O>HV=R1^%$3*YYY
MMI-F<.R9??3DC9-C/PX:4RW,GRQFSU^JD`<2UG:+]Y:[?GYR0S?R*)'N*!CB
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M`IJ^#U(OC--5LBGP.?*@M?XXM?D(MB[L.N@T=7VTL'L^6Q>N='`1LGC9J(7-
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MP(Z(K\(2C.8(%#TMI/O$C80/T"AK!O@`AF'O##D5Q%X7-TQ%)KHS/6Z<JP\`
M5B!+5EZV2C"-@T<#N\,+^2O^*`IQY.-[U@M;,"`O5)V8FCTU7DS/!SCP;.@Z
MF]/D6***3,;!,AEU!QP/K<=2-RG2",$83#`LTR16G]LHGXLTTW:2=LUDQSM6
MRO00-ZR<")"V<P,#1$$CIJ/53'L6"8]".D:5#D.SB&TKYRH==6:4?U:3VK5)
MM3PR=[*QG<WNV]6NZJ*[S<E<]C-QST0Z5XE0(IWKY'(CTKE$.I=(YVJ;8M*Y
M0"*=Z^Q9*-*Y1#K7>'.)=*YSXH9(YSIFE[(929'.)=*YSI4;(IVK+V(BG4ND
M<YT?-T0ZU[`^@$CG$NE<Y\H+D<[5#3&1SG6663LBG4L(ADCG$NE<HQXTO-"$
M'9'.):3C%:=SU74WW)=]M=WL\,-B&<9/E'[AQ]*E]]ZQ]M:];IW3554K-4'<
M.]?NA8F]P-NZ?WP'/`M@MHX"C]W[EI.Z.&K[BB=M[S"T[DTYQU1E3<FOE]LW
MS?:MGGW`:J>8;:NF<018I4Q#?*5\(/$S'4#0-%O55:V2T=@RS[8&'`]5.[4T
M6U.1B8=!5:9ML7?["]NZ[4TFPP37R:ZRKW:*06!I)XZIR+IS""P%%2L[6?A&
M\D![4T91'+G4?+1ECAJI/A*B/<9)-S7[6(A8:+^[$/0F$X2J1AFJ]GFV.7<\
M5.VD@C@)PJ1CH7H7+Q8![RI[%?GO8%J@,(V\5]$P]I#@;+2.L8I<:1E[K*O6
ML6<LFZ7$=):35V%[!9A!_#0V[X`=57.?,XA\BN^V]%;]&(&4)9D;1-A--<A8
M<]4L<;T,AL7FJD")I1L]28]NPL\'LY@_MDK!XZ4)?#!W,_;H,HE],$$I?`^@
M1*N9B_:(]VN=Q<D"7RT])Z5+T-(9B!`V;P8ZPXN11/DM*OF0&>"'@/DT#$#>
MGHJ6K_D0E]+7$H@+]TD"G8\+6#M`YL=2%&<P[PSM)B720Q"C;R?%B7274->;
M2SCRDEVLCA\&H-UA"!"N(+R'89=`O"<>9B#!\,YG*:5>0MG3,=M"Q<>2@&8N
MP!\P2O#KA0$7'#R;!XD/4\!`E](U?.QY+J[^5?H7;(%Y0QS&IXL(B$?3+6ZX
M]\#+-&,CH^3"XQ+8*,PC=9,@Q=.=>(6M<PE'1^+,91-$@!?UI<<@FQ/VN1>Z
MP0*?8S^D"'%.E5Q8<DHC&"Q[%>;DI,'?@$[W,)Q/&4?SJ0KF>^XJA2_OGAB6
M$;T'(P+JQ2B/TL?(MPB8'Y06;,^)<;D)DZK\!^X@]I*[X7B8&WBD&5AJO'Q"
M6L9AX#UQ\0B#19!Q(M(_E\R87TH_N0@;L*@T*9_35A7KQU2:!T#OA.7/`;#!
M`Q\?:+BX"R+.7:0B&W9G7B\&4791VLH,O@,1QXO#V8>PFL/ZA<R8N4$B/;CA
MBN9$2.F&^UQU@.<)I=Q8!:FT`'\;UKZJ;A3Z/@<MBV(`FK=4+O$/A27_EF/'
ME"UG_-(-_,N*[:KKK7P"N[5&!!3E'RO0!(O@O9HRD7ZAT5]/"\0X6<8))\PL
M"`%)%_FR#%$ZUNI1IGS`^?PKWLCN2[<9T#V58&W/@,$9/+5*,KS2B3VT_AAH
M\\E-4]`%D.,,*)]2^@=JURK*[1J*OKL`/G/:TO^N`K[@)\CI&>=/";)<7=9&
M:P,>-TZ^].OE[:5TPVW1Y_A2,HBB:\12=52CC5U#*#Y=?[[^U\?;=[FF6/J/
M]6@B7JD+0(%12`,P7KN/(/"/\2KTUY!L`9*6(<&G#:(Y#M$,9:.G046!RT;8
M9Z^D,8Q?`%T+*K.-GUBF"N>YON$YCE`>ON#[[S%2=A$S88#5)PQFG+9IYC*^
MYP-4=#MT'U-@5:VHL(EBR0]2-$U<QY<)_7WE!Z#?:&M!+NH&Y7I4P@%%EB-1
M$2LN;2P5AW*<-M`?.VLS)BB`8.K`#(#9H<D";1>=F**7K1A8-[;`!]%#'#Y0
ME$BPC4D0K])\K04=X@NS1RGZS9M5+Y>I")=?S'=>)2DSJ7<K^!KB[=*B<A5F
M\WAU/V<O@&*`DM)T8WZ;9T+3#-\!3F"9_&`&%GH59L@[8!<P*ZN:?#^F*?,_
ML-3#X_P!KR0.5X5_T#XAC#MW'T`")%PK6!ZWZ\/:`J_D;A2,@DO0#!@+KBN^
M'J=!QIP+F`A@8VBA%Y,[8;C6N^E<FH7QX^7.;F2M0&P"J\-"I9T[.F[XFOUO
MOB8]L0C-;;UDI3T:E3>0U0_]MG7^_#:'(6XO:88DGV0+DO?@,D$PZG\!AR!:
MT1<?9TXBRE1.'F5^@N7M#[P7/7X`#DM7A1OWP@+,HB81USNE:@%9I2"SXV#+
M7+!3LXS2Z.*)NF#O8'&+F.E>^[?2=_ARL<2I<D'!PF_84+!X1/GQ>[Y>OJ<W
MJR?I]BE"DRKQ]V[!400+^`E-,ZP!$/.`T096Y,:7OW*=P&*P=/$9(,3'R+LD
M:'CIGUX(*\<##=&;2?Z`@&_'?4$OJ;Q\)4"(X(%Y/-)J.4N`[N!9/S',8+YO
M5&+(,I%E&4>H4`W'"7"MB"X2.EM%/M/H[3'\P&?+"5L4P,6!Q\(XHGGX@&3`
MT.\J"OYPJVX".J&T6'-\,#IAO.10W8'6Y4O#XSP`OR6(`&\?HZ,[C+60/0F]
M7T'0C!&#NX3UZ<$-M^+TO*X15K8'?(%]P[U'W'KC$UQ*5QBX\66)2(^X%'KQ
M?13\E3M".Q0#T\"^J`=8@D4MB,&9><\]8G933)"`&_3?%<3:\"[`N/'`=GCT
M\_NK"CIK[FYPR0$K4,G]1B9N-=%(!<'UW34K\-[*NQNX7#=Q`/C.4$8WJ)#T
M'>@+DC'8_V11)(@HR)::RQ;G8T+!)4E9S,C=CD7.S3M^0R.7!+X,P;=L'>*E
MJ8R8?"<'WLC0J]BH>TF&"SYAX.]YL`JP81EUO'Q+%YP#\#QP0P.>P!IX'R0&
M)"P`<4S1>=E,S/#B9/P8=64F<Q8W6@>A,8R;H4J4U4ZQUC"[50Y!=`<Q.2)<
MD08,FFK$H5&T*R*1J_(N*.B$HSA4N9BN:>!OY#B;`_<A,@!CEN)-FO`@CRHT
MA4<5+-"X`EJ&DF+PCTHT8X8)E'Y!$^84\@"P).((R@*WLB"N!$>Y_"SN4P'3
M2!>#>@D1G)\K*887ZWV<)K.]M3BX292'A^@S\,VI)B8:^'G(/%LNX/O(F1OI
M%+Z$";;$Z%*26H.@C3^WWU5[6SHK>Y?OXGT%:OP'\$NW+@TTN"/'SS$4<.2*
M'W_[%(1`LX)D:XI]8FO$F[<WBO&?_+!L9X[M$XTMD%MO,30K)RO[P-@ZH@*M
M@C^-M-H]S-]Z8/W/FG]MH%K;3K`".H$_'@:TV@[T#DP[84SU"=3_3X7$?J*P
M!/O/@99B;3/C<#!KCS8'Q=7FN(+A*N*8_/;,[KA>F&_><E2'QA5<OWA!O[I_
MOOAP;#NV>+:03#UY2,:9+`&7J^=\YQV$W20Q#VOXAF_`D<P027"T$RI]HQ-%
M-8AF&&RY_4:QB6VI1->,]<XW]SGP6W`3Z05S/G(?N_!!*FV,<G<,7"/<VV*!
M$@'G,C]8X?M3\"E"(25LHQG67EW^EDVAV=]>=H!:)99E$L5Q.-0V]H@@JJWV
M`EH[%&C-S(&VOJV^RJ,_@#NA+CNVJ>*P#F`8E!7@&@G*W!KPZT`(`MQCA.4;
M#V3S*0!-FN63=)U\AS`#S$W60<8L=]N^P2(=`_EE(R@;'XY[=]QC6?MF;IK&
MX&T6AY',!V5.*]\3H*4=@;(O?@E`TSSN!+<==X5]L-4K=HB81T^?XXQ*/*"N
M4H<=N^TPF(U?G'BRD2O"PV7<Y2&TBZ%2'AFE[F+[69B#2Q>2T4]@EJA$S?P@
M=!6Y#VX0%F>6191(?8R3I"\L;,>_[QF$'NXJLPBKK.T<J((]_&`SR$_$XM+&
M0AXL:(0?%.?1W0,&U#E9X'TD_>8T,H_GV:$C/_?$HT/`CG]X68)C<H<'>"B4
MEI0`\,U62916MFL0L36Y0?$#F#_8Y$BP9U)V'L6I!I]]S-Q"U4MRBQ/`C&R?
MG@?74KJZ^YUM\^/ND;LH#HKOV+8)2#9S"_`]=P4^2<)IB_+GKN</:72?<5G$
MS(CUS;?<C,"K;.<,)N#Z!\.DM`0&IC9`:`@L+3Z;@:/"=IC0"*W///*M@<V(
M>S'`MSY^N64TX<<5\"[;N]O"A5&P(#`[^4-JLIF6JV0)\*:U$,K.`!"R"!YT
M#F>\1PL8H0U!0$I0;E@Z,6'&7!V>I+'>4\A)`:;'+1T9E<Y[&'79B4PUM@;3
MA(DH?"_2C0!=$'6DFIL6LA;@9A3?"HAAL0V#/W`C*9O#"[C)R,ZI\0%V-'P'
MQ&7B&TNK##CW%V5Z,UOA$6]A"$F>ZY%M=I:8N*<IQ3RK+:./E@N?S4^G0)8P
MCT7RW"1Y`M@?W<2_E/Y-^6XG$";?E]PD_;"C+O@.E@*?IY:LLD<:W,_3(N?$
MK7X/XH@@KAB@J#FU8":X'06N[U\,868P2CO2=;0J[49SF\*V`M.5-V?[G`P!
M)"EN5"0^V^3`+=L\N0-5G&V=`5XUBS+HU(Y%+Y_<==O&:`MN:F*A#\5"N7[O
M"S".G_BM@%77FQ/%=;P'ZDVW`CXU#Y168<OYF?KFK7RIEZ*Y[I./!WFGDS\&
M>3D?=@J0:V6::QO(M5W(S6E!;I1IW@ZY-1#DQ5Y:VF6OS&F2B=_6NPWYL3@.
MF8]8OPFE@Z\,KG+Y:+T*R-:!,2`1`6:XW5<%RI0;@7J/60T0R+_#YL[)$P?D
MMX]X(@?K03X/+%</X'/#TIY__\%-0E@ELWRV8O\178A2AO4&G)TD[T9(E49(
M?P:;&MQ'54`_!1$FS3Q=SS[`./$B\*YFF"R'J0<_L_6/LF5\']SEO/X*W!6P
M;^D]KJ)?*.YP@]1,8P\(_8V+%!9;[G1L-:ONM-7SS/L\O?VGEF*ZTK;.9CW$
MQ;%RO+X#4K^^QATWFTZ.=R[`S.7^A<;WB;N$$`%\RG4^<HDL1Y-DRIM@Y5@0
M$UUQ]R%A^LP=N;6;F7)2D2(?JTB3XC$5^G\^UWX>U+/`PO/XR#P#U%WY+',1
MCY9POX+]Q$KJ>4YOC7M^.:5((T]26N_'W&WRMK'L?LD2\=(\_$Q_D*2]<=(Y
MM.D_O!-!>R^6^N[C._:;A209#ADV=Q#O7<*],U6';C`#@%"E@=6%!G7-Q`_J
MO5[IP\`V@#_QD_(/-1N;1Y\JO%*"?@ZB=GH>MT@(I1M-1CK18%`98?L2NY`)
MLNTE6Z].):^7;$+:1I6VG@9[G,LUGNLN!D/O?JD'RQV^"P#E^\`[M*'FE)!^
MY1=08#J$XQ#;T@3_SI)_*K'!.35,4_#O'/FGV\0R9*):EN#?6?)/)J8J$TUS
M)LR_$;R<T9KVG[*9\WO**F;'GTBTNM[;ZEJ7%9:D*;@Q!6ZHID4LLT<#7L&-
M`;GA0"CI"&Y,A!L*D4V3Z'A'PN0X,JW]C&FN^K>KY)[U-YH<]UZK/NF&2AS=
MK!EV*LB]-HXHFDE4W18<F0A'=&+8H">.T)&I<$0CCF&`GO0ZH#D?+^!%Q/O7
MRWDV=\-%X$V,8:]4A<"-5OI<_R.X,:P;IAK$G&18\SHY@F$_7V"FB=CKXH9*
M;,6&L-^J&?:YD9M6V%^;8])^NC$L6WL"\"^*+2<C;&K]/`"(N^@F=!>=#6X^
M-M`Z6N<G11HA&(,)AD(T4R.*T6M!F!1YA'`,)APJT>S";@CA.'_L!Q4.L!JJ
M3AQC^-L;S_.*TP,WEYHN,7U&9:@#88\0G`:(9Z%#2Q0E;NQ<0U)9+A3B6`;1
M%'4B9!&B,1714"PBJQK1]*,S?(5HO%#1,"QB.%J?Y'TA&B]5-!1B0`"BZF>Y
MH-3YF/RS"31;B+&M6JE_P/VFYT08%_>613[ON+ZD"5:SN?>L#3F['BT,I:P\
M!NG7B)0]STK>L'_#IG=!Z\TVC-^OL'%!YVKIP:W,^+-5RRX5HX99G>HN&\.%
M03H.]`P?SX:]KZ-GPHNH4'X6LIVH0EGH2POC3U^:ONNK<`_D(HN7S`O)?RW&
M;6^&Q5T1:6>&G:960T]<]`S<D8NZR85<G%HN;BI.IY`.(1UE]@BK(>3BI5J-
M$0ZG>B1"[>%^Z]E,J9/E/_-=A1^F&WL.A?7HLX]^*'=R[,=!8ZI9F.>%F5`\
MH7@3%L\7H7@C+/D'YJ,4[=/,FA8N&T<4?^,;X`W>W*\1ZZQ\R^[@V:5F9SJ+
MQCSX!W/UL4#/%(V5)H?:(7RT>]2_'(?FMT+S^FF>3G3;(+:JG*EX3H]_SZ-Y
MZLZ@4]"\:87X!Z[W6PA_6"7QDAY"Y=?E="K$LL&:]#MC%%60`W+$/@$;#EJ`
M7Q?Y%6(:)OZM&78JR+TNCCA348CGCX.;U\*M.MCV);*,^36[</5(`HN*I0%K
M'6T%7'I=K9GW/,DCA&.X"NDI2,3Q4;N0A`'-A*DHQ#&5FGG/DSQ".`83CN,]
MI5.;B7/98M@N_*SZ5>KVUD.9#CP):""E$$4Z1U9]JD0V#**KHGYK.J)Q>H!:
M-]-Y!XEID&8X'^O\Q&(:%D.QB&7H1-?LB9!%6`QA,<8XT>&?-51[GD/EXL%>
M8_=]-E&X>&#AXM1O]IT0<U]-_9TH6Q1EBV?*^',O-!$%2$(NZMCS$@J0A'2,
MQ1YA-81<O%2K,:T#!U&V**JG1/7407.=;?644#RA>.<FGB]"\498\D798M<I
MIEL\9:G$T0QBJ4?W[13%4V.A=E#QE+,SZ!2*I\Z+<R?5/%V%.$DAFG9TGVVA
M>6.A=I`%[7&AI"A;%&6+'>;:YW0:1+5T(EN]TJ!%E=:`'#%/P`91MMBF$*I)
M3$7<+3L5CB@]+C04A8NB<''$';E!BTYTHF@R,2QQ2:,0CAW:&%.0"%&X.`%)
M,(D&L;_=SV.?%'F$<`Q7U=JC$9(H712EBR^Q$,E6B:;+1+/DB9!%%"(]!T`O
MJQ#IA8K%-"R&H1%;=>"ON,=T.J(A+,;PISK\LYK2Q;__;95>W+ON\H=;>K^@
M4?:%+F/PPJ+[]T'JA7&Z2NA7`/"G,/;^>,M&^WOQQN<55JM=S_@K.'@^1BJM
MH@!&FOWOFR6\_T;RX@BQ9)]X^F\_)_%"^8<;8<G3UUB3;^D2?WPC^=0+%FZ8
M_N\;^<U;90-;\TQOUZBOP;KUYM1?A?1ZMHW2QV@6)PN6`/K34_[E&KFN0+YE
M;)Y\M>?!;G;[UN01^=GCG?Q.(D?]]*5N@]QU*0BZ@7KJ-;A"Z9Z_,.1%E.4^
M"]FZEN4*L@EI.YLB\($W(Y\YA\W0VR<N3WJ=9//X+@"4[P,O[2.D(B=Q"[53
M7T)C.PZQK:,;O`G^/2O_5&)C^H`I<H+/DG^Z32Q#)JHE+H$Z3_[)Q%1EHFG.
MA/DW@I?3,W^MR2D:0FJZS_6>)@OLV##Z1"+=<V^ZIRXK1#.,G2&G@MCKXH9J
M6L0R3<&-27##@5#2$=R8"#<4(ILFT>4IE@I,:S]CFJO^[2JY1]2GQ[W7JD^Z
MH1)'%S>&38<CBF825;<%1R;"$9T8-NB)(W1D*AS1B(.7=VM3O/A3Q/OU<UTO
MY]G<#1>!-S&&O5(5`C=:T7HT0Q#<&-8-4PUB3C*L>9T<P;"?+S#31.QU<4,E
MMF)#V-^K3O=\%OP>87]#:7H;[L.RM2<`_Z(938+(39Z>"0!16SFAVDH;W'Q9
M[M&,8E*D$8(QX%6RFJD1Q1"-&X1P[-!&)9I=V`TA'.>/_:#"`59#U8EC],J)
M?B[R//_F4E.%_C,J0QT(HS?FGBP=6J*HR=673J/T6%6(8QE$4XYNJCRYLELA
M&H-=J"NK&M%T494N1&.K88%%#$?KD[PO1..EBH9"#`A`5/TL%Y0Z'Y-_5C0M
M*'4J.*[`OZY5@!O2-+\MZY<X]M//--OT+EBE_E;K`E/-VP*LPJVV`+]5RZ,^
ML2+B[88&MNTXH+HE3&KF?]L31*T,HK8!4>L$HFIKLF&:XX+8V%RA"XBZ;1FR
M:EGC@FB403R4BKILJK*F.>.":#;*(L]R;P!-T0QC7,"L1@EL`4PU+6MLN;,;
MY:X%,$>SG;$!<QJEK04P139-7=XK9/U`L^1&*2NR*NN!TPW5T?>2K:]!MI1&
M66L'3]%,5;='!T]ME+A6\'3#5G1G?.IIC7+7"I[F&(:BZ:.#IS>OMNN\GGH`
M35/1NG"W)X!&\UK;#J"BJX:Y7W?[06<V+[/MT(')Z\;>G@!:S8ML.X"JK=BZ
M/*X+8-F-TK<Y+JZ%SC8,69;')Y_3*'U[``3CIRG&N.2SY4;IVP.=JME=Z-</
M.J51]/9`IRFJ[AC=?'@W"OXH12OY0U>1?[VDB<L#%B]>T)^>-E?4NN%50MWT
M*X8]HC=9IS9)G1LB]0E0GVFV:F<5Q:CA5*?6*HTG`H,T%>MY0G0V['T=;=%>
M1!.B9R';B9H0"7UI8?SINT\A&,O*?`L7HJ?H(HN7/TB`2_YK,:[<PH2BE;RT
M,\/?EB-/G+LGNW)1-[F0BU/+Q0U-$![WGDKQ3$B'D`YA-81<O`JK,4+^68]:
MASW<;TV_VH3YTC]CCYU3_C#=V',HK$>???2\NY-C/PX:4RVT.B_,A.()Q9NP
M>+X(Q1MAR3\PY;SHD&S6=&G<<^EN&>M?(YC5EVXS-Z/I+C4[TUGTWL0_6(Z+
M/3A,T3MU<J@=PD>[1XG[<6@>?]?:9#EW6LW3B6X;Q%:5,Q7/Z?'O>32OQ[VQ
M(VK>M$+\`]?[+80_K))X20^A\NMR.A5BV6!-^ITQBD8G`W+$/@$;#EJ`7Q?Y
M%6(:)OZM&78JR+TNCCA348CGCX.;U\*M5C?M2V09\^ML3I-C"2R:$@S8SL16
MP*77U9IYSY,\0CB&:X(T!8D8[H9T(0D]S(2I*,0QE9IYSY,\0C@&$X[C/:53
MFXESV6+8[NU2]:O4[:V',AUX$M!`2B'J\(]L[*(2V3"(KHH6#=,1C=,#U+J9
MSIO$38,TP_E8YR<6T[`8BD4L0R>Z9D^$+,)B"(LQQHD._ZQHZ,(`G7RMXN&>
M8O>]-5&L>&"QXN<@:J]5'#T,.!OFOIJ:.U&J*$H5SY3QYUY<(HJ.A%S4L><E
M%!T)Z1B+/<)J"+EXJ59C6H<,HE115$R)BJF#YCK;BBFA>$+QSDT\7X3BC;#D
MBU+%KE-,MV#*4HFC&<12CV['+PJFQD+MH((I9V?0*11,G1?G3JIYN@IQDD(T
M[>CK<X3FC87:01:TQSWQHE11E"IVF&N?TVD0U=*);/5*?1:560-RQ#P!&T2I
M8IM"J"8Q%:=FV*D@][HXHO2XIUP4*XIBQ1%WY`8M--&)HLG$L,3=ZT(X=FAC
M3$$B1+'B!"3!)!K$_G8_CWU2Y!'",5PE:X_F1Z)<490KOL3B(ULEFBX3S9(G
M0A91?/0<`+VLXJ,7*A;3L!B&1FS5@;]'GZ],3EO.7S2$Q1C^5(=_MKE_?K#K
M'/=<_KGO[LKF2^AY"@?/X&BX@EXW#,5LN/JS<FLOPW:3DWL]@V^+'-DU=,M5
M0H<"3WWS5KZT]9S.]3.W7RJ\CW!:XX6I^PFGZ[9AJ\J8A#L6/$XX=43"-=XX
MNI]PENIHAJ6J8Q+N6/`XX9P1"6<T7C.[EW"ZJAJ*IC5<`CX,X8X%CQ'.LD<D
MG-EH1/B9=;V26K:N*PT75W.*]:/7X5`Q2LG[*74TH:Q&H]%&*-,PX;_Q"'4X
M5)Q0^W7Q:$+9C4:BA5"&:NFRU6KU^Q'J<*@XH<SQ".4T&H560JFFJ31<:#\$
MH0Z'BA%*D4<CE",W6@-V:%B4S30X8HIAZV.NBL>#U]5F]2"=TF@?.I#.5!3'
M'-,3.QZ\KE:L!^G41HNQGW2ZHLF&-:;W?SQXG'3&F*33&FW(?M*9FJ'8[2M!
M7](=#1ZW=!T"@'X`-@9V6[`HE_)^J]L/E,90Z?2@-`8?IP>ET9T_'I1"VK_0
M-$M67K9*@NC^*O*_T!!"`__*RX*'(`MH^CY(O3!.`:CU-D=7.KUE>T#K3E#U
M_9Z:>T3M%&&EP5^4)_5L]7]J[!-5?Q+6X;`MBY>-.T_-:<GFL;VHJEM^,/X=
M?J'HEVRKZJXV1>K0G&E'/QJZ>O`JHB.]2Z@?9&D)X"$VY]ADR=^*'Y<[0M$%
MF:)@G-6.LPW&(/(IOBM?&D%4SXF/D?2>>KP%%4BS2B2PU=*[>+%THR?)C:)X
M%7G49Y_F"H+E[4`"*0O2%#2:1C`GI8PZ,Q#],,B>I""2KN[<*):^TF1!B?0Q
M<\,GR8?'L[@\`]_WM57%^C&%E]P[_CH\M*"P&@+E`R^3$GJ_`GV-DR?XQ(U\
M-_%3"=@"Y`O2.4!W]\0&Y:ZT&TF?@$F@A$"KJWL:>4_2=\5$JOSCAT]7Z]^4
M'[\'84FD*__!97A^A97*73X5([BA=)/$/K`?J/PX#[RY=$<]=P%HSV84K0>0
M(Y+`*JQ<@$XAK#?1)0X#4)<%9QD"7$'T$(</,(TK/<;)'S"SA\_A^+`R2FXJ
M/8*=P'_=-(V]`&T4_@BD<(&<?APM@*$I'[]@4D(]-`S^UH3PN!3`$T&"[TC>
M'(2#(I$9J6;Q*LGFTG\![`Q8#RQ%[N._[G*9Q'^"M<THL.P;]=*0%D$8`GR7
MTO6,O9RQD^].TR7<T!9LKY&9F.\^QR#-6U,KEVHQM?3H[HP5Q=&%YZ9SD/5D
M`:SB)(S\]7,E<!"O2/IX\X5Q'O^^EV"NWX&%1/I&OM3:)O*#=!FG@#&,LD0)
M2[(G-A'][RI8XOB$_0KC*%W'`4F`]T"B+Z5_@V8!*T.:Y7I6(SAEM-SUHH7,
MY/+V#F!RX;=E0A^">)4"^3CV^#R\6U;YQR3(,AI=Q+/9!@,&;QJ'/L'I5R$>
M!^#P55@\;OT0@6\@B"&RK7/,=5TEMND4TI7-$TK9-Q&VO%OPEG>TIN4=@L^F
M7')M"H$@91.Y?![SN";65Z8K81@_(OY\E4]7"Q@*5NET6P<\+UD!?W,./3'3
MPD05J'`!<A/$?A,5]!\D:2_F9]!O\HADG]8$Z7&2Q";1\491FES`05O>5."N
M>C-7N<".G]#U6GE<=#6*XD?P*_(/^2^G9_ZN\>S3<>@#K%GQ$]CY[2E&[W5T
M"V%>@OX:6V)./GT>/$H_T8C.<#G<EILZ((3H3DATKXH%^N2R\W7+5^T@.4.#
M\',1I+W+X[GG`.)=G#+%$7HSKMYT35*>5KYVL=%DM1?`EQ%=[V)H>1"^,\?Y
M]S$X:1\*52&6?/S]2*()Q;,RCSBJ(UAWEJS3B:D=?WWA"9@WPEK1LU"Z^93A
M'6X0WB2Q1ZF?2M^]#]*[59)2MHWZ?0TU165^\><[1<::Y8,H="1BWPLN-'.!
MZ.KQ]<&"!X/P0"&&8>P,^5Q<F):OWK%I1=.:_G.<0/`321_^].9N=$^ECXNE
MZV6[TXJ*XQ&`V5-Q#-9'-N2C.3$@80XR3T(<QA('M==U14(>7IH\$,72ST8<
MIA>W-/4A:,1S]]AXE\JOJ&QT&A7%$"@9ZL`WB8MRXA<@%T2S15L*(15;4J$0
MI\>^^G/*1=T"RC^K263=E!H<DWR]4]E4&82='L)(5Y@:^7&=YO<N3SIL*Z+(
M\[BOO0P3'K_&FO*>>OAC.<G\PGCS5C5D_-.`1CL$;\>!W6B"_;?/<80[G:73
M99AA,_CU[./-E_<W/.%QMP`#T574/NB.@Z_9AB^F?K[/,RJO9S=Y7B9,]*'(
M::Q'5.N%YTB86HV8;E#\6*2,-C"PM[BRBHKJ:RS?LPWR3D4U6/7FF/*Z.4+-
M'#7EUJ5.%:7'X1>:/-"?GKX^+>$[1*QOQ<9D<RD/#E%:(Y%QHMM)I%R(3,J7
MS^-)I=4@A"*3LO?T(I/RW$579%**3,K7H3<BD_)P*1(97?A'9%*>,_-$)N79
MLDYD4AY\(ME\V"LR*44FY7ES0612/C\/1"9E=^1$)N6+2I42F91"'#;B(#(I
MA3R4Y4%D4HI,RMXL/_O<*)%)*>1"9%(*J1"9E*5.S8<G0K7E'^;OM::CV;]=
MI=>S(@E-^ZU(4"B=N;)CQ]I6TZIBR4Y#'EH^>7MV9Q<(G2T(BW/H:@9D<4";
MG\^VP.RH'4#N";12A7D;!-W4['TP5.:_<9_8[BL$_M5DI#889+GYRH9#N*P`
M!J5LPR98ME-#CX-9:82Y)]\5734Z(3$`&ITZ;2-,BF$<!52=R'Q-W"@-.5W\
MWU=IQII]GD)`+A39:$I';0.N@^TZ`JG1).@"(OFCL!R#>5U%[$*!:',LJ-L9
MH7(C>*S1,3K9Z9XP:ELP]C4RX+P>9-@/A5BNPKMC3YS]ZW%E_O<T]9)@B7AB
M6_W'*\^#4!U;`M\D,>\(SDS2YSC[#\VN_'B)27QGVB[_D.V+:?3+-R;=+Q]?
MW0B,=%LT;*_`/(B+S*8<L"TT/+J_-709/)RC32`W+WZ,I'^L(LKVF7B+_9_!
MD$1>X(:UQ))^BN&?2MOZGZ]N?ZKTK6>MU/WZUW]=^FY&X7T&P=7MK_R'[Z7/
M,1<>A)1A=!@>"/\%WA)0`@S[T-,HY9F8%P`$5F)4/OSN:[P,/,E2[.]_*,.+
M[;%OYVY"+WYR4T"E<'6D?\\I;R2.%C?-N[=?/2))P`(]!#ZV&'<SR95N:`*C
M+%@*\U<L9LE@ZE7H2W<49IH'E'7;GV&/>QSO"S8\3P,@#3#_(8"7;EA7;E(A
M2HG,!]*'7Q&0X"P)R%P.Y+($9,:!Y-^P.P12Z0%,,M"#=Y%GWW@%#NXN#LD:
MAS3'@7<6)_A\EM#\TH"M><$Z^T'&NOA_G:]2+H0U@*5S-G449SA<0F<A@(C-
M]".\<0%[\[-&Z/#R/7@($"FCG,W<()$>W'#%+H?`+UUD%DX5I-**"^,,;QP`
M'+S0!;T+"O)X94GQ8!$M0&#3>_%]!'3VB\[R>1-U^(V3.D`P\=;:%%OSW[%E
MA0W;@-YC$(95N@+)\PD3N@2FH8O%;KO8@<O-LB2X6_&U*^_IS^'Y+N772'"8
MZIDT=\M9NFX(C/*?`!2*3?;!W"34Y_<Z1&"H[E>!S\`&\FUNFBC:R1<W/]Q1
M,%P1\J-Z`85Y*7UPD_!)<G%I1OAAF"4Z+UE6S%*,`=]XJP0@R.!YBCS<<#C@
M!\B,I?`<`E;<OX&W7F#"/H@5.V%@0C=;V[04;][D=U54S4W5E(_2W;^3&5\S
M`BSS)_>I;)C!SJYMZ^VO:#'9MQ>R`V:/C5%<9C0#%P<(&66)BVK\&&1SZ1VX
MRB"."2#.'18<(W]?2E?`!;!T3/912/@XN9@S3N6V@]M!$',^"C>@IFP0J9C\
MR^:E?"9^241N>N!]?D<$".I:C=8SPL"N].@^<5WQ*8R><9@R]/MG_$H0T*A%
M@(;Y/HYA40'IRX69C>H5F++1X+\%VG4^8FXWTER3HA1,-K_E`]_<J`F#$N3N
MSR5_.D;=9!^&N<TIDAFX[,<IW07FLD+CBL8D-$OBS=T2;!0WBK!2"WX*,",\
M6*#BQPF3>J[.:4FSN-U=YT0K!M<PPKE-N9HMEV'`;S=CAO.Y5&URRG6PDW2U
M3(*PDS+:&V4LF`?$PTKR&)T+?.&ZN%DF9:JQJ3)/\T=982W[!5D41TSGN+/Q
M@0GFK@[;J!3H@.#Z&KE)$C^"5/@4^,'U%U[WRT#$&R!`,R*N'OD8/@1UH!<@
MY`%S`*1?+V\OI5^NKFXN*U-6_8DX0I&KW";CLM6*(9##SQ6+H)2[$IZT+O$+
M;QO-XC&ND>LAURLA8@GA(DC8/=B?=![,<@6'U8P-SM;3N?M`P7D!*?D=/N+:
MAU++;5S!'C[7_[@PQ8]IF2[(G(T\\^MG8/2R&X!C;)R`.N'G'D\]Z:O4!);'
M&RZN5]JX<6PI)T8)7+\J2PT<K\Y;,4S+';/DK^7QNY@Y26D*7I)73)I*<PK4
M*#_Y?0M+<U'QP.!P\[QM\[I:.KUJP_P8,$8;QTTV]_4*+P,`*",,UKPP!"@A
M3$!P<@"D,'>'.!'UAF3F+H+P"<(*')=(_T?#!XHQ.Y@N6,@NML+6JIN_Z_.S
MXYMV,[K923EJFZ0X1_C[W_Z\2T*^H?;_4$L#!!0````(`$`P9D6=\6YGZPP`
M`*Z:```5`!P`86YI:RTR,#$T,#DS,%]C86PN>&UL550)``,G55M4)U5;5'5X
M"P`!!"4.```$.0$``.U=;5/;.A;^OC/['[+<+[MS)TT@4`K3=B8D0+D7"$T"
M%.[<Z2BV0E3\$B0[)/SZE10;[,2R'5NR$W;[I1`</4?/(QV=HS=__E>U6CF%
M%L3`@7IE,*N@UK\=\S^5:J5EF^.>ABIGED/_JCEH`NEGU@1B^CO]^\AQQH>U
MVO/S\P>-/DHTA"&Q7:Q!PCZH5*M?*^S?/__QF8&T,&00AY5;BG-I3RKUO<I.
MXW#OX+!>KUSW6Y6=^O;N_$OT&P:R'@>`P,K4-"SR92L`-AU@XX.-'VH[]7JC
MYC^X-7_R<,H^"#W_W.!/;Q\<'-3X7U\?)2CJ05KL=NW'Q7E/&T$35)%%'&!I
M#("@0\(_/+<UX"#;2F%71?@$^ZWJ/U9E'U6W=ZJ-[0]3HF]]G3-7J7S&M@&[
M<%CAIA\ZLS'\LD60.3:81?RS$8;#+UO`0H]5QF']H%%G9?S&/OF)?U+-B&T@
MG;%_!`Q6E]X(0F>KPHJ^[IZ%:L&^!)P157P,70=I7,L:>[(F+*BFR%K6`C$<
M08O0MG=F44-@+J.CRN.VRS&]-P*T=-O0(2;'3RYR9GU:R/;*)HO*J7V59>D1
M($@#EMY&ADMY.0;80M8#N8*88_?!P%B=Z52%2J3[C+HBR[$Q@B2;P4L%2#2N
MJ6G8I21,Q[2U934PLA!J)#=1`X;F&MP-G5.#0J;"J0,M'>J^L:RTW+W<)X=B
M&[86PC.8/[2Q#V>``32^;+FD^@#`^&>3$.B0EHLQI3O,GV<2=XQ#0`;<.WK?
MJS%>:]!PB/\)9[I:W_:<Y&_1`#5_V,E@:@N04=/2V7^LYTV`04LD3:<%,)[1
MUGP##!>JJ$(ZX%I`@X#^31RN(\":;R/]<4G\\##D/5$CKFGRTJK(@:;__2&V
MS00E'7ME_FQ,?=N7+>H:GR%Z&#GL1Z]=KRS9!<"/T&%=HP<U%R.'=F>%;2T.
M;NWEB>7*$V5'ABC4<]DN5;X+-4A;`06\A(Y*#Q"'%W8(:RE,/%^>,HT%9;))
MXX]ZLTNH1(I0^6O?(\)L>$3ORN@"5QB.`=+[8`J)"IY#Y:\]SV$V/)[W9/#<
MAD-(85G1<RO4>IHXN+57(98K3Y2/$AN_%[G2B*##@DWE@6`:V+=D=5U52D6>
MI];^XIB0*T97%YP'6E)YG$>.O)&T+D:FF7F]PO888F=V11,IATK)HN*Q2:%.
ML4T4C0NQB&O2_*/;?3Q7@@!U-6%X?MZ&8YL@FIB$^M:E;6E1ODF0Y"<6LA[#
M09#IE)47Q)L9PTT'6`^(1K2O(\[Q5#-<G6:#I[:M/R/#4!.&IL!=5Z>4CC1!
MM)K14ZD4(TCXVKJ?)6(7P]/L@ZNFN2:K*-1IY\-00]Q*^K,!>>4MO6G:V$$O
M_'.A'U24.<NQ;?V\G7SZET/D:KZ6<8[``!FJYZPB4'(V9SY9<05F;*:B@&F=
M!:2RFYI8M:@YG46:9$Y^>BL$Q30C,5CI065J141LB6++C%W$3[2[<`(M5V47
M$2!M1A<1T20S`/5$GR_W\ODG]5TD`FRSND@46\)P,YLN/<?6'D.KW"H$B4#)
MM3YHFZ9M\4+5+04N8I2;I8AU"BW\+1$C>R:EJ>N(F0J,*X!H`VV!,7*`$0!6
MTJ&340-3$.NK3QKVA&-@WJ2'3S-$;+XYMPDYL3$%L^9>1IOU,;"(QZ#^RR4.
M"[QI^ML94F>D./^19F;Y66[*1J%"(JF+E5WH`&2];28*I7)#I"$EHW@*U(WH
M]&G8DSN)%`@R:.9<S!"?B+E&L7`L*4'I8G(4*8DC[^\!$-'<MQR)8M#*#6ZR
M2!-'G=HT4JU(8K!UREU2RQ3#G6B(RKT!H;`.E8BYB3XOF4AQ"IH]G4,\?F%6
MMFS+H<,DC7&0FBT[<7";*%@L?<F+*)M2S:BG8C;+?*XM;,TN<,-VU`F''/VC
M!PQ(?`>J9KO@(D2>&:5`46PQCQ1@\BM.Z6.D0*M00XXD2&98&43H03Q!&BQ"
MA2!4^3YF125"/$D.(%LVX;[9/T*B9E1;P,C:>%A!G2%OF#WJ;579&H0HO=>*
M!`H/LPN\B*96,TZQ$$@M9L<VVK1!&C9?Z_;L43.[$@=8\L1*&CT2&)-YCJ('
M#8/M^>$'=`VV44$WD86(@P$[CZM0I93(Y7O;-(JEI5&8&&;99$B;B8-=S7$Q
MA6[1O&9QLE*PKS#J>VO<*\1U7<[6JKD&L\Z8G5*G`&]3TTHFJR)@2N8_IN:B
MJ"(NM"NYQZ:LS7*C6_:LU5P'H5X7.*AY\^S5I59YYM&LZ@@.;0P#:^''4^HQ
MJ!7(`GAV1BO(9R?H-VG=#5XA!V+:%50T2Y7FECL)6X`0H?G;J.8G,PGRP>?E
M>\V7VF?[P,I.WJ7`_9^2.IT2<M>]:9%JQZ<P0/GN/++"8144BBY[F\FK$5YK
M.:(QXU#-,K,(:F,DC6!).$3G6*84;$M0N2LD%6ZNM=>(PJ\M#(&!7J#^C:;Y
M+%\!R&*('>OMN'X3(T+_U.:1]A7$R-;+("*WK:^-G%\.]=?MQ<WNWW_]T,;N
M],[:.]!?]B</=S/KNNT^G^[C@_T_=WY=]V?$V)]H+W7C#^?3=>O\2K^[-QI[
MUH]!I]4^FYWVGSX]WM[U]LSC7>NLK8]:'^^O[QNM???^;/AR=#-^OKF?N-9+
M[Q*"/?-[OV_<[1Y_-.$3=3`O/\@]O+-/AI.+6G,RWMX'^,KMUDYOZ^:C-?QS
MW/CC^Z_KH^NG^N#;S;>[P67S^-/):&^(SA_/+K2;[\9@7-_M3+O='[^TWWO$
M/="NNN,3_6%:/]V9C%^>F^2Y_Z-K7O3K)_=H=O<1_?YT5__6:MS_0OL?3;SM
MW'^"C0=C[^]*J]?UKL`J+SQ?H<\MK8LK:=:R??RJFYW8Y6?\F$CAN],465IN
M$"B[@>6536[\%V&@RA82!U?VFG(**H+Z+D0=\2G9!M0G73N/7_$I>C%9=/=<
MUDD6=L$$(*,K;$\0->EH=DW8Z8+7'+S)[I7D(X"B5"DM^O\3OE6R@Q4US=S+
M5]V)]7:Z<^%0IYI-6&*XLEUO/HUBB10[K(QK7,SE'`$RW[U"':4RP01(FZV5
MB#Y9:UD^#C>/T*)IJ-6VW8$S=`W_B*L*L6+Q-MT)QI,I\QJRUPO.;FFB!=OV
MLY*>%8&RZ1)%$2?SWC(Z"-*\F,`VG/]_9BT<&%<TY9@`NOFR)=(J\Z*S2+B%
M0^:%";F(6VZVI$#')6(EWX*V#+IPBJ`8*1=!WU^?7*+5$_*3TCX96&`JVL<*
MX-^?LC%4>QH?J-&8S[:\'18IW/_&X)>\>TBVQ'%,^^E\7=*E9*]+!6U$^+5U
MM*J=X?RNIVT5PB8@EKYA.)^827SZ\FU'[-G+IN#Q5(.$4$?@+1&S+0#1*6M!
M<X+Y#-KDD"JG%'[;6%K;EYS^O-V!7FP&%,#=9)73$>N+V5`D9N#=*L6H&`1\
M9^-MB$M?.&F[JI?QO/NG_1@]\A[J8D1-9<D[4SL=^WXSV%/7##C>6S4*E#T2
M^?VE2M$$^\I&7#(J<P66.152V@IL%'KV*M+2-0AUOKV4G8'H#`-]14F6D("X
MKEE"C.@+JQ.Q?`KW8V53#\SX%0)]NZD]N0C#J+<4*1$Q%?":K@ZFE3(=N:)M
MNW($+?1"ZQ70WYFTR1=7RXGV!6:?(`M86EDC2A2ZI!&%7?_1&?.#"L=3B#5$
MH)+#Z<F@:QL#Q6@O'%BB:96Y'RC]A$=!;3>?06LY*Y%2^9Q22+X6PW>=7<@O
M0^S;U+!;Y(Q&\PWJ)S8N;E-29ELVN3ED%T`TDF5N"UV:;L^-Z0S/;>NA#['9
MA@-%%XL*L-9S#B.EF&(&Q3<`9-M:'_EVV?EID<7T6H5\*^&7?65#!JX6MNFF
MGNQ(N(_F'54_,C1/>"_9.ZI^W-@LY\+GX^$0:DYG2..%$;`>8)<.#QTKNCI*
M(K15\#=<Y-6XCG_]0]'G5&AD@#1@Z6UDN,[;#=>T\CQPZ/-5KAQ1P2VO(]2;
M$XK^`"]=<P!Q9^C!<0S2<1WB4!LHL(JFN*H)V<=5`=(2!">]P*H*#"A]=C5C
MXPCVO14IESOC&@DNLO[MQ&1ARJ<PY=VV@30RQ!Y8+=H3!U:G<WO=TMY-G]',
M+GB^H(,F1L!0M#0:!53V%3[+&D6>FPB3(S[#G_-8BXT?V:*YS>:7E&H01BI[
M[2"U#`L$R3Z]]XISPBY4'$&=WU.J5(@PTL8(L4!0POF\HMVXMV_;OVPOX,JS
MOOUI[5Y,N6(F:HX->P:A-T593$V20<M?`DJ4-I1C)K,H:63@]Y!ZMK7H'VAZ
M:/39X,/OD8S43'`!:V(A9;N<5`JDY$/V>.`ATO%F2,<;Q-XX=P*+Z/TBQ-(S
MA97Z2Q)],MZ,&FP9_EW6IQA8F7I)=`$;XJ52,"'S+';HEF2&AR<J7PT<![<1
M+BP5;\+WS&2_&JS0X"4!<;/<5Q)]J[XVYW.-00P`@7RJ_;]02P,$%`````@`
M0#!F15T?<H;H+@``P,<"`!4`'`!A;FEK+3(P,30P.3,P7V1E9BYX;6Q55`D`
M`R=56U0G55M4=7@+``$$)0X```0Y`0``[7UM<^,X<O#WIRK_P9E\>5(IG^UY
MW=G:395LV7/*C2V?;,_L;"JU19.0A!V*U(*D;<VO#P!2$DF!)`"B"<KQ?;@=
MVU)WH]_0:#2Z?_G7P\.#3RA`Q(F1=W"_.L!G_S]>_/O!X<%9N%C>N/A@%,3T
MKVZ,'Q#]7?"`"/V9_GT>Q\N?CXX>'Q__YM*/1BXF*`H3XJ*(_>+@\/`_#]C_
M_N7__<*0G!'$4/Q\\)7BN0H?#H[?';Q^\_.[CS\?'Q_<W9X=O#X^>9M^B7[#
MQ\'W>R="!T\+/XA^?95#]G1/_+^%9';T^OCXS='Z@Z_23_[\Q'Y1^/SC&_[I
MDX\?/Q[QOVX^&F'1!RG8DZ/?+C_?N'.T<`YQ$,5.X#($$?XYXK_\'+I.C,-`
M@JZ#RD^PGP[7'SMDOSH\>7WXYN1O3Y&W(9%^QHLW:/(`WAVE?WS%&79P\`L)
M?31!TP.^QI_CU1+]^BK"BZ7/2.>_FQ,T_?65$^#OAXS9QQ_?'#-D_\9^\P?Y
M@PHW"GWL,3&=.CY;],T<H?C5`0-]-QD5ELN^Y,1SJAI+E,38Y4(_8I\\J@1T
M])^I0D!2^\>U0U!`":,T.7YDC/@R7*BU,+,C:(Z"B!K<**!TH59K$,'CM)LA
M_69.V3(/?0^1Z/RO!,>K6PKD1)GD*CA'QM3[*HS1R943)P2%T],DP@&*U-5#
M#,4@0QF"UZ=.A*-P>DT]*M4Y[FNT*!4",JFY#,F;2X=\1[%S[Z,;Y"8$QQCI
M,58,B=)KCMBW%PXF7QP_09?(B:@4%Y0O>M16@#*L"^]2:Z"62Z%3$[ZF+DF+
M7"$@T[KP_MPA`0YFT34BW*2U2-V%8IBI'T8TC@GBD.AJ:@&`8>)^HA&7$\PP
MM8)!%*$X<@+O4QAZC]CWM8BM!7BTCM),D?]QX+HD0=[YTY)N.IK\W0%BU`F<
M'--=<8%C;K"4&72_C*FZH<#5U8=ZB(8WL9-+'*/OEV$0/N#('<P(XJY'C_`J
M8(9I?IV&'K?.DRZ'"Q",:^W)FQLT8PMGMH'"&:5BCMU1,`W)0G__;89J?B%O
M)RB*2>+2$(5J(#UV>5AS@ZL`9=C=G;R[0H_4W,.$F\P-XY5#/$V2JX"956=A
MH'++?C08^&3P#+-;'+6TH+T6H''U%D4Q+8BO`6=TQ]F):%K07`7+.*_S04X+
M>@5@C)-:%^*T(%T"K%G'4HY[6M!>`<JT]V[:X5JL0!:VX5!%N.NU648=0*.6
M4+F+*--=#<F86]QL&^'T`@<.C90=?Q0P1FTW$&6ZI8`:-`'J%9+%DNEB=!<A
M+P[/HQA3Y40Y0F[BT/T^3C]$-9G_.%@N":+$L5].\&P>1X-'%J?HK1J&"F.2
M9DDHE^(<8C^)J4,2;5_*:Y8":E#2Y4U,F>`=`$:)*VY3NA2*H!@D\VQ.X:,(
M!V<.(2LJKDPW"UNJ>K9;"JI11RO:6M6M5@3$F-%=D]"C6\X$4:U+T/TJ^_D3
M"9.E'KW-$,UMQ&5<V^U_??=F9@U5<$WF10N[/Q>ZXP_8?2J[Y-!:13-$LR&1
MZ!IA2,,#K'&_U@2O@_1Y&]+KX!DF?>><UX;N2F!F-:7NP-2&?!FXIN\R:G.Z
M;18C!=ALPKLBR]MJ%0TPS2X@G_UM1;4(D''-:3JXMEJ!+'#CJQ*>8ULMI1:B
M`<\T#%U^\!L$WCFU,>:W]1/ZM<#RX:5#7%F2*ZJ#UL4]K"SH'5^)AQ>LA",,
M#CTT=1(_?G60H<FO8`,#!_$1_<I1]IFCW:^OS1.8V'#AX$";UO3;.46&H'9.
M01`WN4>'&\QJ!(L`@.L#9\WA`BWN$5'D;^&KVZ`%@DR'75FK$.>LKZ0Y2519
M<8"9@7VFR`MDH:<8!1[RUH2Q;[<N4,L\#L7LAVX!G<^.!R%98_.=>^3_^BJ)
M#F>.L_SCAL:P?/.C9*(1_6<DY!=?]=2)[OG2LR\?,8]UA/PX6O^&^[##XY.L
M&/#?:K#DU$R?Z.P0`DAP\5!2$.R`%&FFBK`F)=,).:7)OC,EX4)&+G%8S8B0
M>(C\^NJ8?I:K\\\N#="HOIW[_%/4)-(->/MW/XR0]^LKNI455JDICQMZMG`(
M#@=/&%:/"HBR#<&X<(3NM598!7T4"JK(H5UYE>6A*Y$,S5T0+9&+IQAYPVQ#
M`Y!*);+""LP*9W>GKI6,2#,+`JIF6+.0S(KHC^/.A00MH77@!R,BQK!,2"=U
MEJ0GI_34?I805D0]N*=1O^/&$!(2(P*33C$,T]^#*OC3+!`M:9PYT9P>8]A_
M6#[KP?%9*F(0%S+H$-*10[P)`&W(JU93\R*39&*CX].2H.B"-J,90FYUZ/9#
M6K4,:S0S/9^7UJ%%$^0BJAX4]16*`854BZ_HO/LKIWJF98)Z;=@?KN]F5U<(
M1#(%^/MA+T669'Q_8]9`K@E:.MC+BH+-L[T`?S_87F1)QO:W9MD^1%-$"6%(
M4KI@W5(=NOT02BW#,AF]`S&-K#B`AAECELHJ4`QH,;5H(8^CYBVIGH.9\-X;
M3QV`2THD$VM"4=#6RD,/5*1\3<(E(O&*W=3SNQL:JR_9>>P3"2.@;:<6HUW[
MD3N.-C&M,0[3#9B31>*SM/P0;4L3Z;]]Q%D4>(-%2&+\@_^^DDB@X-H,;5:W
M/,EDA#$Y-,:-FNZU$B50`%^+S[+S;6G1^?B^.M!4%12O&Z`*$T8XCHH;PE48
MN*)]L:+XH!%(CPU*D@N-(:1V&%(NFZ+"/G]R_<3#P6S[IACBP"N!M_=)63GN
M-<>06J*#%(_H]7=_Q;##Z@]`X3I<G-Y_75]S(&/Q3X:U^3-V[K'/LZZ#[/5)
MH=L+Y)60-.Y]B,SE&9E)\J/9&#V'OX/;O!IL%BU*59DKY%=UVV>^D&&=5+]V
M5BRCWL$=1`F3U1BM665%%Q!E7L%D)[)'0+LD`@FG`IE=SZ<LH"J6R=0OM$J9
M9P^'.LB6ES#MD0%5\0HL9\2T(5?5#V]``F1[:$`BEDGD:TR%#=V$"[9/.(WJ
M61\;0&T[/!&10U>5DS$CEAIL>QK%U?&OJTT(5F;5R'KCZI2E5L/`YL*2UG?M
MG9E;(\Z^!!/:`JSFILP&IEDSN7VS.=AI&6A>B'7H]E9^M3R4N8/0?5G19;JI
M/L&TCV*3R#+5WEWH5L"DQLZQ@U4DB]"`/522R@*J2$;()(DTDK8'#`-8<>S@
ML)HX5_5M1>X`OJ;P/,X(Q[]V,#U<G#E+'#M^C@20TV\SUOVQ'!D60@6%N?H*
M?I`0].C_'$;114@0G@7I4=!=W1(GB'Q><3'P_DRB.+N]'T]I.`1<\F*,3.L7
MCDHZ`B&GY@A52Z<FK&M"L&V$5JCAF6(7@\0Z$ECWQR7(L%`B2#44HG83FMHV
M2'FUK0](Y2[/8.ZN;=Q9[^\9L)F;,D79:7^(HV*#B-Q?.NX<49X.]-)(XJ61
MQ$LCB9=&$FM\+XTDFC7SI9'$2R,)B;.S[X>/;-^EIZYAF-S'T\3??3,,60.@
M1,`^E!0JLA3FL7PQDTG#J3'AU'L\F;8=)P:=`:[$;#US(??*0XZ+$IDM$V+D
MV*)!$L]#@G]L0VXX\>U@W`<#;&(:V.O[':RC*$JZ$U.&K?>U\76<:DX(&1/.
M.(G9+&+V^J0K">51[J68"CQKOJML>R_6Y;XE@W8?O)\4^QIS0FTEU\5658>N
MQZ\8I;@E\33+C(C@MJ@J5'L1^57RJ?E!ERG)`.]/M?CV4T:BW:GZO58OLMZB
M>?(M$F,O^>Z7?/=+OOLEW_V2[W[)=[_DNT5R<GP490\66".$"*C#C1#//AP?
MQ0R"25+G<=T@\H!=U(4\\JCV(M"MY!-8WCF/L0.)],`XZE6Q2AIY*9A^4TC#
M%8<]Z%A/M(1\9%&-;!]\5@VK8'+]9V$4C_E$U.@F](&R)T44=N70J(S%<WF)
M.U`O*"8H0G01K&W\D-JC'_(.;!F)$$*I1VBS-%=)0`U\`YJ2<(-\GW7Z0@$E
MU6=-#[T%91(CDXW^!!2;)&;+L8"2"&69:;9+!&_`)Q@R6!1:1>=!T?=Z;S+5
M*P;K[<#<)ZOE79,%M;L4</3^-G*7*T!7Q1NUV+Y(`8VX<FCLONU0BK3RS`'M
MMXD(-;X46R;ZJS`(UV2`#9B0P&O19&ITM-1P4X)]4-%9[D47)3Y]G9Y0I!GQ
M81"=HFE(4*Z9R_D3=<"4'APX9,65D#4CH-^DC/'Y<M,%P<@<CMS>>U=060%U
M=-W0DBGV*8V%IC#O\JI068X8.["P7241,!PHITZ]$^P>7$2P%ZG`$D^,=_#E
M\>ZI$V%W@VE=-23./U4$^PT@^IQ5DF*!1!F(ELZO'VZN,7(Z('1?C,C"1J6@
M<7E#J&`43"[V*\*S>8R\P0-UK#-TE;!EC*<[52=@TE(CP(YU:0I2D;?FKP;3
MJ0+83R@1[9Q>(Y`>5R5*<D&FJLJ,Y\MHZ<+WK5%9B@"4%+#.!VY8!O=XO\):
M,\R=%"ZJDF#%Z+1EJLQ@X_TQ.>EU#5J4?*(4H-Z>CQ5XL98#@-%5$7`7$.3X
MK&#\[Z'/IZC0U3*JQL%V*N^`X(C^:<B3UU0#<>A!=CD"HW4OCF=PDEJK%T!-
ME&HS)JKNZ=2RSEMH`5':6_<#+:&U4AEOR59'L"T%Z8.X84U-5F5V%`!@SQ*@
MAA1\';H>G[JDN+6VTL:KYNZ?LO!XM-!OZI;"/'FE6Q#Z\G[EY?W*R_N5E_<K
M+^]77MZOO+Q?*2=ESIQH?N&'C_RZ=U,#,J`QXD-Z@%1)S$@#Z_U=G3Q;).3R
M<E-=G]-4U<'FRVMCA4><ONWI*+H-)XB&'"[VT0;S;4C_R=9P3<('3*/>TU5;
M0S*+T5ZV6D>R$"P''/A$SU@N=K(C]6`1DAC_X#]"V&P=.GM2!K&/XE"A&B[#
MA9A9#4#:48'N]&!BK<#TC"5:Q5LP0^64LEA-T$$10J2U^&QNMN"BK>>TS/-2
MW=K-![JHD*R^$ARC8?@(8JH"+,]:FB*NPDUPVUYA#7&T#"/.Q_$TG7Q_`B'/
M!HP6RY[`1=O$;*#',.=/+HJB6^<IJ_5EH:%X.Q"L!Z1TIQ5!MLH;P=6CI9PD
M7O!H9"OF3C!#T2B'DFLK#0KS0RN4<A9J()^=N+7X*CW_0^<%!D%4P88H_>\H
MV.US#;.O2^"U)7P]M2^]LY!@*U`B>!?Y.JH`\NCU"&T\B0038X&3<#V.=A%?
M$[1TL+>>]YN]WZ%+X54"Z<*ZD:T4)<]*Z'*\ASQJE2GBB$LK[$;Z0LQ6L]D`
M`A>S%ZQ=0/5N<>VLNM^!UTB?FU1WF"HS7]N<0"G,/.V=R;2,]YE%53ML!>II
MOXM\O1]DC<2Z$6@9Z7,STAVFRIQ]S!II[JUUU_ZW`OUS$W(-HXT_AV[8Y=G;
M^72.4^>^N0;_LPJ?Z_@LTXM?NZ"CF*"YBYC&=93D5,"^7^4".NQM/AFU+*1B
MI_+(5"%5'3"+]Q/:M1WRG`(:Q$Y]>Y9(';A_)9B@2X=\1S'S]]N74R"7PE*(
M>V)_$CI<N/:58RI0BI&:O8N0QPEGS73'TUPJ!.3BL`%C7PQ358H-?(3+,.[H
M#R6%.I5X=>T[0<RZ]-'?+A=`(T,5L#\3\ZQAK^'ML6&'%BRDPP!(A+TG$C83
M``G9:_AJ?Y?V"QPX@6LH`*H#UA<_JQT`U7(**'54\/)LUM5XR5N[G3\AXN((
M:KQH$]+>U*!+:&_EIBEF)U1#3/DB#<&:[!;3B`BRE@IN(?V6(@":U9UM]Q/D
MLY%PMR&E[RN.Y_.T5<1%2+JK;M:F91^U09_Q9MNJK^F9H&5&T7CZ.0QFMX@L
MAN@>)(BNQ&4O>]A"DM6<`[MWK0CA.G+="MB?581<YY9--Q@^GTZ1&X^G=-/@
MB>T)=1+C@%%%CV#L/^P8]D`/WD#/$I3P]\-L5<M6E3@,=KLC1IAV8"K?2$`(
M6@G_7@I:C<-P,Y:%9`RHIR%D11?#IZ1W)^$RXOWTU)),;>X<:J>%S548HY,K
M)TX("J>G280#>D)H,8-YB".V,@KNEI)U2C_\'7)R6QVZ%@_:.3_&TVTG>9`@
M9A>+Y2Y_$L(K!"D"-DEF#^PH^FO613D*I]<$1=1*T].,;GST+#1];?%#%+D$
M+[-7RYQ-XP*;-D@AUJ9!A=VV'(J&HL-EZ=YT=DSIC?#.5%L/!0R]29;+M%56
MQV8E0*QO8"PN*,<&@2=B'JB%Z9!AL5&DDCJ4HS%E=DM-3;!C9F\O'$QX"'E)
M#P>4'SS+TR(^V\#;LAATM&XMOC:7\"+`H"94C]#F\#H9F>:-I(%U/=]YWJ6=
M-NFYF9H"?D"L*L!`$#>>YG/<64Z<CUWD6?![E@5?9\R[V9"T*-+?J:01G^81
M@YI<6Y)Z<YQJHUR%[D)M9=3KX]G[\D2/%OM<&12DR5;BTL^]ER""6EDU,KN'
MK"81ULV"45)Y>QK_(?\FNLW[C*SSS=8_0.I[';HV`U-WH(*J?2T^ZZ,M&P4J
M['PD9%VO??Y/HR!V@AFF9[.T<M<)O$]AZ#UBWW_5ICU3!H.>_LH8NC$2-0):
MW.I((0*U)$4*+.85M+2BT(A*D=FR'1_M&-_'[#'A9JJ\MO/.WB"R9`N'Z?B@
MAZ0Z=/H[4.F1^QIXX8UT1R:E2XK=B$U""_+&I,WOGF<H3H[IV6R!TQ98=#]+
M1U//4."F89[N1)DUR$$)9#<;FAH!;<H49!#!9LO5*+"XH6EI16GTCA*S^[VA
MG9Q<XAA]OPP#UMC5'<P(XAES7:,K=53HQM":D;;)FU="A\WD-6.UF4&7EG.Q
MU7<S)_N^4[W.]9%H<]S:@.DJ`U&-KDT&8@<J<`:B!I_U#$2C0$N=*VI8U^L,
MQ,F;FW00%\L\H'!&/S;'[BB8AF2QJ1#25:D,]`0MV1R`8`9I%)6X],<BE2!V
M9!<R:"V/Y6D0:V%^@`P3^YRD/GD[071YB1OST;QG=,O#K6H0"N!HU)G=7C6]
MOS7U\D<6N?X[I@8,'9F1%AU6IX4J*T;Q$90.VWM<^W/R[@H]9CD2NJ0;MD$Y
MQ-/.(#R+@M5<">5X6N#/-:&GOB1PTQ(IRL!O*!YXX3*&>2.N1TAO*A*DZE8U
MF=WK<$]8N,IGA1I^]O`\ZE<[KU1MK$GMD_'(%:6V+3^U:B_B"M2\P;P4HJ:`
MTVO`C$O>.)@P8;-@A!?Z=U.;*DN#Y7U(NV)5FL?]-BI1#6O.I%Y*6=MM6C?N
M''D):PFW4PPY>*0A=+[S#5.K=%IC%"6+]'=<%+`I#K,4]B:L-%7H:EJ"O0Y)
M=^I>V^^N^UW^NI5^&39S\RX]W`^QG[">-1T:JAHI^U,ZJ\WL/N<L\X6U[:WI
M6=37;N6\@7^6=A7OTHH:<-LU&\6R6WF.]OP:N*X(=V,]+V6XU0U%MYIPP62$
M/M.8WN,H,ZFEORE3<+JZ=/X,R9GO1+4Q9T7G4?-8][$T%TH`4C<#+;SPQL"Z
M<;R[Z*Q>];2NQ*YEI'3O[W[47;=./S^+\NNM1'?+@+L,41JQ6S4<Q1IK%:;V
M.:!OK-)I%Z?L>9W.-EM2@IUCT.DJ^V-7B2TE4O:HGD>7V8;GB93BGJP*E4U6
M73>P2XOR3E=;>W'\`6LRV"K6;('(<II21LH&N=H<A/2MIJM]IN29EW;E%2.'
MB_Z`R`/5B5L*@Z7`HZZ<K#P9%H]VK<JZM%C>XWQ+9?F)^LT?]U65-2U#^@OL
M1Z(_T06A48P6D93K;X=!U=2T4=[N3ALUN*#;[3!1$#-R?+]H/.:$N]G66G!U
MUZ#"(*9F<)Y6O_SZ*DKW5D.Q33XA&_'7:<S,!T\8:+SH#A;(2&5.OTG<Y!X=
MTM_2\W]NED5+T1=,H-P@HLQ'F/Q6$=,9]?.SD.`?/"B^+.P1<!(48H6K'%L+
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M>I<`1,_P4XJ74C&>#NF9/L(QG##KT%G-!^O)KY9[,K<G>@U6'FCDPF(4-EO*
MR4<N@P5+R?Q(:\4@Y">+VMI\$6.AOC*SX0;EUI#@NLDBX6F`3R2,HKN`(,=G
M-'VB7#I%TY!5P3UUK`F21%D<Y-FEELB*"&8:G`YAG^E/O=.=(E'_UW6G)*+&
M^72&=:=;I;`V%K)#4<M.:.X^T[IY-!).L[EYCC\*6`YY^X1)H^9BPV#QRZB,
MPPW(U3.P9K#I[.9&2%#+SK;'!!;'52=JC>I#(6EK@/&M$[CMWL:=KC;__#NF
MQDK<^>HS>D`^5$Y7$G,_\KS&#$OX9JZ!]U#Y1.&:=BD9%I*F("H@14`W.<::
M#+&:K0@E+<=IV:>1L!*'228KR]QF4KDCB4OEG%O[=UZ[RPNI.W#I)62`MML?
M)UYF,%S:1O*U]5T0WK,B#$;[*%@F,?US2%?FXZP$;DMQ!T[>-*V@:7G5#4%L
M7!HOY#5D!K]=&"89>&>!4+2>[$+VU*R+/8H3$O%]]03NHJ@.G=6+(JUX7"A[
M$2/A+OI$:%]W*[_7SU9^KU7N_,S)[TVW\GOS;.7WIB2_ZDL8;?E=A@%:I0GC
MBR3P``LF*C#U0VI`L7"A3U@%IZ$R-"^E,?V1O6)!C?G:C)=ZFNZ%+E.%4^?1
M]03M1',VZJ,X)5O0D0U$[-+(;5Z=&K_)T>"]<4/GJQ-=_*Y?WY2.S177<_40
MK)9/P5S`-;!,)O!Z*6+HC4@5"AJJBU(.;)4TY#K<W5&*XO`\BO&";A\Y5N1;
MXSE!VBEOL%P2Y*9;TP3/YG'$N^BU?G@FZF.9"<<TJ>H5$U:(TW7,'1.L5H[1
M.6%0+J>Z>,.F)A=J/;I7@O9O^W2WN(D3S,!>]6V!@P4E\I>#MDR[,"!CRVV8
MMW\<`=R1,0^^@YO[FINY';W=8;-TZJ8MHV$NNTJLMGM!)<MMN3LDW2PH7?<B
M60`F/PL(+&>^!)9<2%06F6&XL<T&B_,$S/("@IZSO,@,H+O2;;-MUE2/)2.O
MP@`MEGZX0O2(1!ZPBZ);XM!=R&6\V;3>OD3Q//0F./I^01`:T?B!H"B>T%T,
M0G`09%H2?V\"4%`5D'#++?4UWW9^0`@S)A:SGJ[$_>/S6=XU;UDW1C=&WI?0
MIV!\*@QX_84CVVHFKG_*#*@?8!G`[<B$>NKO5:B_161Q`J;4,-1:?C37*VT&
MT@>9G&>/?/00/V`/!=Y>>>@"T58N.?NITK#*T=?GB7RZAK.9KB&<`:/[/+$T
MN4-N&DQ%`E@6EO:AXRMBVH*\P0-ETPQ=)4QOL\$_T3B)(];S-[MW=R&,78T`
MBYN1HECSAJ;(9.-%WYS^\^F4&NAXRNFG7F?W0E5*(R7`6(M^-40DS1JX&DVA
M=F1+V%&1@?=GDG:<Z<P8)4BQ:);R:MUHD3(\!WN04>$CJFCJT!57DF`OBC+O
MBZOY+-5AI?L(ICQC2S=:R<%1V@=$WVO5:I2/<)HXCY<T<"38\<&ZC>XBLE5D
M4\/[<F=#`7?@7GUL$'X-R?=1<$U"%T6P\BABLN=95$52XI!$>\DV\F#SE:)Y
MEAT&E4<1T_[(H\0AF/98&VQ7"'8&(8-OO<%AM>8))<!YTM=I-N5Q5ZW[$-5-
M[\MR.N5/[.1D&DO`6B'1FVVBB5:MM$T;`>!YH[I*S82H"]5F^OPU4#6F]YQ0
M;IH?6!,*!?3]:"[4UH0*3Q!5F`_7.*":BBT-5\X"`;:=4"2ADR*JNEX2ZE8C
M*7<QQV'JWA3)`&H$H2-ZRRT>.I4^:!W>D+UZ#I?LWM*=!Z$?SE;I91-<F5@3
M2HN3E30]85ZXC0R%FA.2'5C9("?V\)VETE)26-0`.2I$!K'=)ZCMI2K)7J`R
MPB&FQV1\GVRO@@&MLPJ7C2L@DW99R4.P>J-K)V;OYN!D541@^W5_>QF5&"91
M0Z-Q9^I3LXU8Q:6'&#4BZ53=DXJ_NJ^^K98=S54>>C<311)Y,_,SAY`5NY-;
MA$GY#K3RIJ(9CN4B-Z.I!2F^F4U4"_'R.F4_K2G:W*#*);TD0=DN&P<56Q7[
MC.]`0NRY(0+9Q!).B9;TJF!9K9(&E5TE]^`J/<LD7*'X_,GU$W:)O5X73$@O
M@==F%P-3@E9CM,R6:#H/<Q>A:>)_QE.0JEPIO,])T'*,S@3]KE'0W5]VG<U9
M(6^$@_7FGQ40KYF2N_S2V#$RZ*,B]/$&NE(UB32P%B<L2"^8]W360A)5B>25
M?<=S&6]XM]$ZB;#0K%!JH\>]E51#?-A<J&JA@X[K4AH\]E0@B-I-7B^!4G(V
M5=]MLRN?9X\T)XA'?9^Q<\]>J6$4G26$`)7K-B.UZ8X:1)37:0GNF<V$YPD\
MHW]@'1]O65T=F\HH%EF],E4#L5<[)2$`23X`I:HSQ-<DG**(W:0Y_@4"M9@&
MC!:W!`5K:6*;Z>:5>?K65QJ?Z.ZC92AB`#WW4Q(<,)U_7@N;HJ,0W#AAW4\9
M;O*```VD#EVO/9D4O^!.Y6,6\61D=K/Y-V#<#U?6Q#:)TW6;G:<;2>V[D)KE
M\[Y!/MT?->CFZ%$O,$$/*$C0_2K[^1,)D^7ZW*'WHCZMK)R@)<OK!K-1,`W)
MPLD6("KL-?0H7@:O;D'(C3M'7N+3$V@-FM-5]D=!D:^A-6J0T5FW2AT%*+RV
MU^%Q^T)?O6*$U%K&).LY!%70*\1C<Z"<`8,HU"@(^0CW<"O#QQI'K;M%P97A
M5B.S/LZS3G\%\A'Q"Z;RKA(A3+ELK8AL%L6V%A!(G2L/C,8DGH?WF!5CTHA"
MH>)'^$4[$9ZT/]@<;L6K-N^I.+(AHA[45V!MX0M62ZCD.5I<I.$,&L=PDY`9
M2]@I,++T%9MEFO*<+*\3I@)FO)S'<\=?8%?%YLM?LEB/KF#L.TMMS%ZI\_,+
M8B_5`X>L%/BY\Z6]X.?N4AL337K'-,='47:DY0]Q@=X?"_'8W<FT3UU"ELE&
M#O;S%I]0.*,?FV/W,U,-BFYS:ZKWJ/?D3<9*5AVS`9YC9U8JTTQ(1;JCYKTO
M!&[-ZPRSY*@]>S:-%_+RI/HY-*`B%5Y)&Y>2B9$;>NZ;#1EDD+>D.3Y4:J4:
MF<W\"K3M%5Q_-;O!7D=GB\ICA$O`5".SGH!I5/6"H*J9!I.%J40(DX6IE9/-
M+(P9*<&E8NY8`:Z7SF95.$0(OF;YN5NC6]CL>*(E0U5DGB<D7`+.#"K`MYJU
MD>*_F"WF^WZF1W`6_J^W,)6$@^![-K,X\IHM7#%,*F<W2%"J#ZWYNLWW#5T$
MW'6<@^N`FS^D=Y#2L)?-D-3.J@2&7&LU=7NYID$[TZL9&D\IC@R;E*U4?-5>
MJ9@<=VN7W>,*^D)U&Z_+H0&;&^,''*^TREJVWN5M`?8901[>#/NM0ZN1!FJ/
M2G=G:(5>,<O3#DUG=2T`&E#,W[1DM\4)J06ZPR@>!%Y640HV-[4!)916*"1N
MC%A/9<6NB,U0YY];^IGQM(`>+EE3C<QZLD92S_,RJV$=T$#*2HPP.9M:<=G,
MV9@4EFSF1J=S3O:BBTVXP@&/P_B3(I4..O4@[-Y'-OJ.;=.<!DX`U=ALW.X6
M+=64"\?EP_/.*(Z$(%61*`.UG'>3EY(ZNZ#&:HH>L("'&FL\EOL@F0U!ZSD*
ME\[(1J5%%R$IH(:08B4NJ\UU8.18S5>PKGPBU1$^O._*0L7(K:8E.[/9"L9+
MU:YUGZIAO'G-!A5%X?2:T!4$<3Y+VV;H0`U8]6R,%+`V^98:!&H9E49`W>=,
M5"11R(HT,\5>WN.<D)"<A80@/F2<%4!>$QR2:T3_W\LU&V%&FMT@GZYR/V0?
M#+RTVR!4L@2$3K!]4S[%(FLPA4M+$)G!E%_DJ*%;>8ERN`R,#%KKN1A(VRN\
MZ961`=Q#-0GT,'D=226PF>'ID0I()HATVHVZ!#D1N@W/G&A^34(V--H[96.F
MG,#EL2(/$K%2X8\Z5)NE$PIN,-=H5)EO,-.$ATA(QYCN<4ZL*S]EH);32SH2
M5&<<5*(IYU0FR&6MO_$4NQV<:^40VRLAT`GL%9DJ]QS0SJ'UW?E?"3V>4U=#
M2<4/Z-IW3!Q::\"J'UJE@+4YM-8@4#NT-@+J_M"J(HG"H;69*?8.K8-'AW@L
MWP]UVBPBZ,=X.5DM+81]14;!Q?A\EC9UH\@["Q>LRU#J!0EAO4_YIGFZVGXF
M2^YRZK8DTM"7+@EVG!P(G7"!I=0Q4F@-A;)"$.%`56I`4`OTU@-*F>P.L;.B
M3U*G3[UK'4856`W7!G@/<HDZ.T2..X#LAWMWD@??02ZGKK*JK&<[;(8=])=#
M`>/N2JRVZZ1DN0TZ(_,6QZQMV"CPZ#'>2^`>^(H1V2\0U?$X%4PSW<BX$MU7
M',]Y[W&6;YWCY6UX3FF/5X#EH(HD=&)<-9ZL5JUK1=G$6["WV(J4`-61ZLC9
MKAN%$K6<VU5/UYR&-(`<3X>8)5Y#HI)PKOBJU;>JFLYIDZBI8@>8G?%2'>SR
M9\NA^QTPKA,BLM@A"C+#L5,,M<MAJ--V"1U[DAY-;NXZ$VP)H=7GS78D7&8Y
MS#&,HQHLE]118+ZN=-3QS6!R`R?K9J2V>S5T)'()[LN4M>J)_I+R=)$LX,1<
M1&!9I()\0UX2)68`/6"Z=)Z`65Y`T'.6%YD!-5_(YW^G3E5HT]GL`Y#+(CG,
M-L?>Z-P$JC(6JG2AT4=7N>CQDD?1Z>R>49!>U/,!V58N`S3(W%>5`1$95()(
MF]@U<]CC!1XK\*XWMW,G$"ZC5TJG2KO5%T:=JZ&R9&5&?7>KG/S_OM"3!@YF
M*94GO5)`$7TV7S9UKF-"`<&TDEZ_2LXZ6XM)O@J#!TH-2@F+;L.8#8;<_IV]
MAZ6,^L9ZY[CA+,`_$(A+@R-V+WT8H.QDIIGW2]]2.^%/0OFOV.=`W%K'*[#\
M$KMWNEDA9XD!=%JC-1C=]\TN_+XB6F4S`\3YG?,G1%P<H4VDP%<_"F*"@PB[
M?!"XU-V%91+W:6/N`[_6FOK!]%GEFH0N0EYT07G$"<SH75,%LB,W(]W7<ZH$
M.S-)_F3\U,G03=`R(>Z<*2'O[!-C@KPA?P:?*A=74J"6\0KX]S)R4N-P)N>/
MQH*AK1]JD0BI]D/C)(Y8<UBZD*M$?B14A_38?=.COVUT):YUOM1T,RBX17Q%
M[#_4DAX0<69H[26O"0W^+*M?+6G[MCU9%>-:+0W=/W=G5[IA=<=T[=E9SY[\
MUHIH+.'?W5)*%C9!3"Z\A6/`NU,GCL]ZS_5'1V4)?E'>MA)?:W7=54&'6EVB
MC]_DPZJE$./_I5A1S/*U7E2G_M>69^>A^/MSAS"%CNBQB:]K^TI<+T=<`B<>
MVF$HFUN%2[_8A.J)A_V$:<L-<NEYDC5Q.']R_83RF*43F%(D:2N!\72'`-ZK
M!:06Q0AA-JLPFQ2C4)IB1@Q2[['LF-U/(S8"9H;O?32((A1';!Y,&'J/V/=S
M?1JTE'@-AVYP92Q#'+EI&UQ(NU0CH,6%%!4TB?&/3`W*N$#LL!ZCW7[66H(O
MV%T#/R6+U>V8U,DQ=0H+G+;RH>;$]F/J%5#@4M^1[WVBI6HYV(,R[$Z,2HV`
M%D:5C9[ZZK"0)UYE#5^!+B!$F*R^W-&2<^GN0<@^N!X=)8R`%;$5F)Z5P%3J
M7JVZNY-+'*/OEV$0/M!U#F8$\>.)MJ?;-H.NA[QS=&J>HB0+4._MH`0*Q:E/
M,L``M_J:\4Z*HBD.<9+BD8'N3UI>;(BFB!#D91/<<@=NR(90$EA[T`!$1;OS
MKDV&IW#[4CUVN&?Y4GCM]A215W9Y<<*.VY;!#?/Z7E:<=A_<PTD4;C3W)?:9
M5QE?C;^,;LXV7D7A[7T]!)OI)A7GL]DE&Q@"-.5IG3AF6>-OR"%R@=7NM^PF
MV[5#$\'RH9Z<E92B`V]E^V9-1RJ5W`*;T%/"M/D/Y'N$1IS[9T[R[)0:MZ/1
M<R*/B'&+.E04Q6&`+E$\#[U.!*M!Q1X;J0[/&U\CV4ULO!X%]!?HUGDJY&TU
M$P,":!H9C%HHVCM_%6C%=$4E!+``K"9#(</O8EJBF@&M<Q%Z/<><IVSZ!E37
MOP*"?G2A;E3#0M.P(H?`9CNOT0"V\"NAL#X[2*A\0M[#]]XK8@+JK;<K`*M]
M\Q39#]`/;XUI8X^#A.[C!,<K*']4@0DN``9R2U4<ZTQ`<'ZJ$I?E'O7U2EHO
M'.!A\U4(8?Q8K8#LIB;;RPAFQGPU5M9TK3MGM\%FO^]R2W>WY5MCJL:@I+KT
M>CL#%?KE_,J*VRPN^#&-=7B[\H4=#U51\X:Z0@,;K)BE;%B-:QCPPI8=7UB1
M#A!_<T_\6MW:)1HQ&>"SR)/)<MJZ5VI6G6HF@YTEZ]"5G8\&IVTXDO9\AFJB
MOLG\9H5P[%8M(T'M3K<!BLUWMPTVF[_*;>(%5-J*4L3:?[EG[!4"6<$UBQ4C
MLMA+O>E$7+BD$G,)2B@7(4%X%H#+1(C'[K,`%:F(V0240#EWB(^I$E#2V,4_
MG%#$B"P:2D5FN]"$2\P<L&SO*(@1"1P_<Y)9[Z\19!OY)I2]\F3UC>`;N0?5
MD)RR):*6.IZ>NV$0+K`[F$X=3%@M?#I/'(UBQP=T>(H4[)%,57D+G6;.7B:<
MHH!R#N2-414JVXU6I"^5&WD&,X3C?#IE\^(?T`;OQ(E1^A8EP<$L&PP?!B`9
M307LEFN:5,6HPE>X.1OKXT,$6#:X@\-F:T9E.>UR"*QQ-A5YD(5$$'+(@]\K
M$13XTO,"KS<W:=D.>_..PAG]V!R[HV`:D@6WYK8/X#/P$[1DSYF#&>2SW$I<
MVOM]VD=N/$U!LB1IA@-D\ZC!9G,H6X,$\YI?QZ]^/UA_RR>&)6[,^U:>$>3A
M.-+LO[+U''50=UQ(<W&A'#C-#'PC!L5*R&90D*%L356DDE"*Y9$2[#'P9E.W
MXCM/6AC%O!EK1$^_<)/9&U#VX+)+6J%WI@?6L1+NAIB]B&+^,T<`8,5E)3+K
MM9>2VEPH!ZQF'5#&IQ(C4'UFG;ALWN.;%!9,?5/F$((S)YJSQVTX2%O)!=YH
ML70P81YY/!U=3X;7)/R3'G05+NDTP-J]A&CT,;E-3YUC0"\S*2DN)66(HV48
M.?YX2M'272!>48I8;\&EXG-9%7B69S\JR4N>22#U,EO4H^"!(@O%%WP50JG^
M]KY83,WZX;)B._Z7I<5YH["MK9[-'3*#F7.@@MYZ^EHY^M=B,M`.)J!=LFYG
M]WM6!TYH'L*$ZY<<6ME]8F$8NGRT(7.^0<R[WV[R:JHY!0_A/];P<F`JD@AY
M$47(_=LL?*"KQZE)TW^4+;D1NOINP$"FJYZ@&;N[<X*8W?&U)U0(U88VR\J$
MJ6\U.TQ7V>2I8ON6.<W@T"QD(E7Y7%R]>5?,<)PEA%`4%SAR'9]E^L\#;^C$
M!KA="=G2UJG*_6K.-#MJ30_#^@Z&`>\@G\X:RG6--^5O:G'LB6ADN-5\6Z@I
MI.ODWL?NA1\Z-9<_:C+)@]P#OR3@@\SMH#K#!Y0BCU%UX3L&#*`(SDK=@BJK
M2QQH',.JS^(ABER"^1@+@YS.0]V'T$;,#HEAHKH>'[$J!W]$0_.G?Z"5,2=?
M`FLGZZ#IULLLD1B0J<W^=(_?W`G?Q$Z<&#B#U$+?"\=3SY_&29>:\O@2^DD0
M.V1U@7U4;EJG+X@RV'TRAQV6&)\^N<7%49S1&'<6$F.^J`ATKR+,$C]DIC!J
M<OXK\OU_!.%C<(.<*`R0-XJBI*ZX6DT&5>#W2AJ5/&H>0]@B]9"^J3!V*A:#
MW0^'5,$2F>%[+02P/8!?T-\83!"6`>_%OES)%8EA<2U%D(H=1`AYT/MP3*AA
MC-1PMKH\_B]'#!6;-L\9\;]02P,$%`````@`0#!F13W-G[+P3@```O$#`!4`
M'`!A;FEK+3(P,30P.3,P7VQA8BYX;6Q55`D``R=56U0G55M4=7@+``$$)0X`
M``0Y`0``Y7W[<]RXD?#O7]7W/^"2JY1=)ZTE>YU]))>JT<O1Q7I$DNULMJZN
M*!(C<<TA)R!'UNQ??P`(OH8`"(`$0.]=U67M,='=Z&XT&HWNQI__;7\?O(,I
M1$$!(W"_!?'QBV+U$NR#XVRUO@UC<)X6^%_#(GZ"^+?T"2+\=_SOCT6Q_O'5
MJR]?OGP3XD_S,$8PSS8HA#GY`>SO_P60__O__^_/!,DQ@@3%C^`3QG.9/8&#
MM^#UFQ_?_O#CP0'X<'<,7A\<?EL.PB.2./U\'^00/*^2-/_/W[60/=^CY)L,
M/;QZ?7#PYE7UX>_*+W]\)C]TOO_RAGY]^,,//[RB_UI_FL>\#S'8PU?_N'A_
M&S["5;`?IWD1I"%!D,<_YO3']UD8%'&6*M`%A%^0O^U7G^V3G_8/7^^_.?SF
M.8]^]Y>2<P#\&64)O(%+0$G_L=BNX7_^+H]7ZX101'][1'#)IR1!Z!49_RJ%
M#X3Y!,L/!,OA'PF6W[.?WP?W,/D=(%]^N#D73NJ'#JQRT*N&T(3\\!X3U"$5
M/A<PC6!4$4M`2-A&,5`AU8`)Z"SL`$T(_S-4P:28__-WFWS_(0C6_W-;8/I6
M,"VNEF=QBF47!\EUEL=$8HO[O"#*S.4=)649Y/>4'@;N%='+5S`I\NJ7??++
M_L$AD]7OM?!BAE63(E1WIE6M'RU>E;(S9L3_)/<)71!X</J`Y97N?[C]W5_J
MH2!;@GHPJ$:#GZOQ__WGDH2_M*1%_KY`79$%**RHQ'\<F!G[XE68X86W+O8[
MDURB;&4F["(SX,TK<T4\#O+'11J1_YS^:Q,_!0G&ER^*XP"A;9P^?`R2#7\5
MC]1$-<2O=F5F51F5:!)H(QD$@C0"(?D#;(8WRN=#][3DVU8^=5Y,;2[6$,59
MA)4?%>^G$-:!CK1`4(![^!"G*09!#$M)S6]=B`=TI5D0XVD:32+$0UTAXAV=
M)[[?J@`/.P+4V@(N`O09%L%]`F]AN$%X>X'Y\08AC,F&X9>A<VON)90(C'PS
M`N3U$,_>A8+XVAHU-.F6-=?2HD489ANLFS<PA%A/,?Q+6%A4(RF^5]6QSI$F
MR8@1J%(U!*!ZS!Y((75F,7D0/<&<_/G?WW[[Q[UOW[ZEAN[?W_[P9N_@]1MB
MX&ZQ7L#5/3[GOCG8*T^FY),3#*[\]9#^^F:/@%M#>CA.MGXW,A4E:2OK(%\[
M!D-/7Y,D^T(.S6<9.LDV]\5RD_31V51@+0)>]?8NNPJM0]P8#7\1I^`D2Y(`
MY2]][])&*M%15VVN&6_:Y^D3AI&A+5X0-K2S`]_MMMQ&+5"MZA/_NR]/#FV5
MZ$UFZM-2D15!(G.Q=RG@'8?N")"OC),'YHOG&L%U$$=WP3/,;2R>#GRWBZ>-
M6K!XV"<@3L-L!4%!/O7K%O#DT19];U*F3NH)7$)L?`FD19[#(K?KH\K0N54+
M"26B>%;YKV"=(1I-C1@$@=KX41P%>;;U:(@+IFK%]//T>0W3'.+S^E7Q"%&)
MPJ)ZJ:!U[#<JD#1@E6`Y-*>'F8R,KI7,HVE2$2W'8@WRP7@+LZY</#5R[+FH
MJ`WU7$#(C%5`1WAV9`:5@Z\&IJ8G6T-4;*\Q5PJL9R1*N"9W1N]0EEMR;J08
MG1L<&35"6U,.HC8&5B/V2%0ES/+"L\%1$6C7U@RRP-S,A.%FM4G(9?H)7..#
M?$R3"O"?$TBO(=-HL2(>PJ_T=R$IEB*`T]`VH2O&RS^PRUF!BK^'>?XC"!HD
MV(%KL/CVVZ96JYV8X72,-?<(!5`MA6ND^%Q'PV7$"-35\Y:M(BXED]N*\FA:
MW""-/^,#RIKD=^1=A_$23X#GZ)$A5"$.?GAS0-5!#8B;HZ<2+2+KE:4/^P5$
M*V*U*`#.<<"IIFB)AZB*^O1WEJ=F&+C`?(OO$U@?:$^?PV03Q>G#NRR+OL1)
M8L/>*.%UF4>F0I`PF%P-9><'>DOA/1JJ+MANE%21#Q;\=+Q@<R@/1:L1QPM1
MXV_!499]!C3EP:N+;ELV!Z-,@LUEWU[:3EV*@25<_;-7M9")OK_T?*3,#:VQ
MHR`AMY=[30:<9RNHRM(#&^9,*8&M304O1ZUF*4RCKX>?AV-2BDOC9B\FZ?X*
MM<0KC4#.*/(H#CF.31:O<AFN@ZWMY!@^)K>79GPBAK)=UN77OE5!*BI>CA5G
MEB-R`=$&1N_CX#Y.;.>3BI&YSID2$2+6&/)]?>/EU7D9%-F.RDAF.GDF^;!]
MEM$SG._R=?/[8,3M474A?@.?8+JQ:=`%F/QD072)$"S/ZF.`RJ\]&W2YJ'A9
M#IQ9CC3HYS3U@Z;AV#?H'&1^#'J?$&$@J<F,X;@!WAP!N>@XAD8P8^-;1#>.
M@-`#<+P;*3L`W=R%I!GFV=2H;4J2W=],2VB$O`55=.TQC;9(L+F,6XO)$"@-
M'0"2^H)D/FHS++^V^@Q,?,0I=6?_LZM&8F2.-RLA(0I7;`)'9P9NCER'Y',V
MWJY:::+.S-$@3F_YPCK&J?:9L0]46Z:M[VP357D*4H6E1LJLZ4*V6L7%BI;R
MIM%QEA9Q^@#3,+93CB!#Y[C!@I@241IZ,Z(L]6Z/`2\NLP*"PX.77FV6@C@[
M-=T#3!B1A5[J[&V1A9^M->[@H9D\Y"-/+^H1(,XI9_8H)Y_N@7__YN`0G\P0
M>"*C_@0.]UZ_/=@[.#@`^6.`2-+YIGC,4/PKC/9`FE6_QGE.`G4T!653D%Y+
MY"YG@B)<3QGM(C79R6#G<GG,U707YG6`KA#M<1-1\-<0W1)^VU=:(6;WF7(J
M9*EJ=ZW8[:I:T@&CU..7WHN\-(0O5D4IE\8DTK>14(CYHK8&]G6RA]%]Y8Z$
M&E45[)E1W[Z?FEC%VL9EQ)C"TQ[L<[JYN%(PALUEB$-,AJ96E=OPC#9/G@"'
M5*DU\Q$Q#A[DJ\8U<:5-;92^5:I%BZ9>M7RZV2D71ZA#&K;+B#'=`?%1)4OM
MGB=Z.%PJTBYRR2DT2T6GB#?T""$Z1AQ^N_<]_M=OW[ZA1P/\U]??_[#WYN![
MZZ<+3UNN2&EVS\`]OD^CJ"Z/%2IH'?MQ"B0I*;GR8<*SBND<)%1Y8^S?M1"X
M.$'(T+D/[`DH4=(VV;G!LX*IG!F&IC\F4-R!:^^P($+E.B0BH$-'BW;."3/8
M!X<."K))FX<T>E`MGQ"D^+SKT?#YH*-,DK/!7/1IX&PPR($1S1.CB'8A#Y+K
M(([.T^-@'1=!TL)H)3%L&*O3BXAA>D29O_5`0+K$[,?I?EB.]6ZTU"7;R1M3
MX\28NX-663]-'2%/?R#X"-,<'WK*A+7W69Z?90C&#VF9D11N[U"0Y@DM]%]$
MOVSR@A5I7RWO@F<K.FJ!3`_=;*>>@S@%ONY/08N[0=C&!1*,QK?9M:AX@K85
MDS+=W,C?P"*(4QB=!HB4`N:=QAK+.(RM),(H8'5JY(?I$>AV-1!`-M+KB5E=
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M1N4ZN""@0U2E@O\9F\#T80^L8CRPR%)8YX$38\A;L;ZUB"-)D2+M<F`:57*@
M0I;,^?`!JDN#U,V=1^&V0#`BC;!FP%47Y=`S(3VC_57Q=8RU/LYR[*)1VW^+
MSQ-VKM"Z*)PGCW30"^_)<NJ6KX5.DY_K,:YTNC=B_>D9YWK<P!QB\LCSC">8
M`4E&&\"RCO]V(J,RA(Z#HA)2A/'0<@SX0[!:_PE$S3COWK:2*+MQT:'YCPJ)
MPB0A+2'ID_<)Z5<=K>(T)J<_DN%G4<44,3OW&97($D42RL%[X*$<SO0OZ(#P
MKH)Z,N]L<NK,,>Q*C;6]0-C0;Q#&<XQ@M'OS(VA$S1LWG9D:;K4O(D)LH)HO
M04@_]7;[.,3XNL6T:'Z./`<9#3P7LLOD\EN/';U'<'A<EU[BBI#H-%N>ENJ^
M=W`X;YRY2X'TN$9:Z@>D%KK?$<^7519):=>I[,UQ1"K[5<6&YM+?AG+PT+CO
MW,>A0MY<B\BGTI0L]7NG+I%4I].-8(XC^_Y#+)"B!,E4[S)+ZS5D[5E8!;R.
M^_X/$B3N^T^'5B\:OF!FYV6W_[^G#O/*XMWI,*_&C1'VJ96+A&DNVU=L,.BK
M>E$>P66&8*N)W.DS=D8S%,5I@+;G!5S11BHD@IM1W[4BVX[&VB/7PUN^UB8C
M-[OW%.R,GHQUH(7=A667\:/7(T;)EOL1/@@N[>3FB5"YC@<(Z!#?[3[%.7G#
M%DMH5L_7#HBNKX#\*5M(/QI^R45(#N_4QZP(_AZP`>`%&^*Y*\DT(MA]?T)K
M`>,]V:ZKWT7@)>^Q0X)@G9(7?LK5Z?DF@2N0MB;T9^,VQ:J'7_1@4H^=7PD_
M1ZVG*EFY*ND]"O(XM+&N^(@F=PJ';#&7C,$U-M@CRH^N2(77UAGQK$>HSB<8
M/SP6,%H\8;?N`5YN2)N%JV6O?,Z:2ND1X/AV6(LX@0+2?P-?&"00E*!(V0\M
MO>P575(U+3&\]!X.-%*/MM+J<]!]'I\VC;S-I_P:;'(L8RS`XA&+.$C"35FJ
M1)('[JDB5+4QC07R;8#<RWA,2LJN%3R)DTUAIT&`")45?U)WSV/$C-[UYK#E
M[<A0MNFUIVVN1`*-9<"=M`[0)<&MOZU)G:@Y=OGY!)O?C.SBD)(H6$8I&YV'
M6`V(Y&V`E;#SP8U0N@7^WY'T@7DFGJA>^D.*8)"0)CQ_S1+ZR&X0I^2(>97>
MPG"#R@HQ%)/\\A-ZNW]-G_RTV1_`&JVN8["V)B(PG@U8\(`!`F(O:W#TPHZL
MI2)X]FTG;2MC[PT56S(8^9"/1O^"(*3]"]+(>;<.2Y0Z?T!H\BD(5B$#R-ZL
M"K>@:("`H(;B_:!N5P-5EN`$[!^30R2ARM=ZLK8ZAI.,%*B29Z9Q6M-4YTG2
MHL9_9$I'X*KJ.Y4R<L#;U$$9.@^-&B3DB-O0]?3,[R6I@@1W&L])ISQ!ZX5^
M4P='#1<DB+VU61#3I-)<H=/\(UAG>=7[8X8=%H;%+NBK,,`B4XT\@5C1PSA@
M>_IBE:$B_I7^U88>RM"Y?A].2(GP:;AF!*W@#EIC/#\Y."C$[LMP\JD;6S=V
MBPEI[P]L/*VID0"38_O%)4)HL/#RW;\G7U,WK/J\JA3P?>B7RZYCD\33-G_W
MC>6WX?/&2;:Y+Y:;9!&&V28MK*032?&Y?T%+3(Q2/F#$!H&`C?*M2RKB[#X!
M,L`!\T#.>?J$=\\,;3^AN(`GV1<KYHB#Q7U"Z2X)BKFD;)CG8@&1E+K9B]PI
MFBM'$U,\B7/L-M(&P%?+19[#(C^TH2@#&*?,AADN+E4C2J!&[ZH0=I!`XH,'
M]&O?ED=-HFVE4IB\\:W.Z7,(\QR?&5F>+4F\Y^^>=8'5@KR`0X/;5A(@1A$T
M6=1+735'$2P*B`7/X+X$5];BP6>(PCBG:DS;E8)LW2W-\Z7.DRA0)_MB-#_'
ME7D@B/&<P/*_YVFUR=_`$,9/P7UBI26$$EX/RJU"E[CK./T0H/I+[T4(RK+=
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MVEDC6#?ZMHMT)K9MARSA72U[)WTFS;6592I7-M[D+=BV5@\0U]NI`/U,E$](
MH+SW3*]5QTQT<%#<2J9/P(TI]9)ZD*3Y3'G"<[[W2O"[+V_5(4^@EW1`ZXR<
M-",\7P3J2U[A["%FS9@C\24LCH/\D5ZH1C`ZVG[(R6)P=)>C@=U#SJ@Z=9*"
MUQ!#("W:*0APOVWUUPSJ\?X[K6@JP4[;$!TV&>?7!%N21)C?98OP7YL8P8L`
M?88%,=5--8V51!LEQ!/JIWK@1HDT40`2T_,8E#>&JWI8JYS+[^%&2]R=1!QE
MGHS(]`HAC&@/.O*VQ=6R%:2TDG(Q@-%Q`Q(Y->*4'3JHO*X69EQX2O52D.=.
MLM<0!XP3+GKZBY%A4UILKS$_"]+A&/]*'SIP8NS$V.=A\83T*9B]-1M+`]:P
M&NA;&[7E+[5^<OZ8FD#!GD^N*'-O;B,/^WS<1@YU.F[C"]:[X"5-=\R_"@=2
MH@X*#J2(89-LVR1%ZJK,D#IEJ5-6VO4,(_60JBVG2&D#5\@W\[Z5RV0LW,V%
M'/'0WE6),,'#GBU9T:&`C07U8*]!$GN"&M>T4CFW\"Q.@S2<4;8KCR#W33#'
MD#MEKNN\,UTERF.6Z2KBYHBE4'F2-S`A3OE=ANGX%!>/CV4OD[,,N2N5,Z;%
M0T:L*:T"[;^(TWBU69'K%_"E`0.J3F6@+,<+O@0H\KT`QJH,[R!CQ,81:G\#
MUPSSU9*D-MU!M#J!]U8.VT)</K(;1<0(W<$8&YQUD(!J&%')"`_PZP$.R:_[
M?J1DRA9N51SY#!K8YW,\5O<'N,?C935\]H=BQ;U?DTVFA^+3Y1*&Q=42NQJ/
MF,GP!IN)JY1@7J01^0^)%ST%";14Q:R%W^GCNCJ4"32U&@H0'@OBU1KK)K&2
M1'O]6DD3L7<\4UWFC'JDD0NV[)6W>UEN0T>U\+M_O$^'/'&*#_UGTAN5FE82
M$*=_@`U$K_$"$QWH-$/29=(8A3V)\S#)\@V"=_"Y.,(??[;9%TF&SG$_&C$E
MPF[,U0A`A@`ZAM?RR-,FKB#*3E>:`088=SCJP[W=K-<)[:OD6+<XB+UK69\F
M+7UKA@M4;RZZ)Q;Z@!8*&&2JC[R<"IMJ*,7G^@9%1HPHBM,DV#1CYJ1K*@)M
MJ]@@#\:UNRG[L-[AKQ?/L:7\V!X6'^UNNB1(JIC+#P'Y$NL-_M:_SH@%M=OQ
MAC-+<_WX<$L["I+'OJ\SD@8;!LGMYCZ*RY9`^04D;>YMZ(PB9M=ZI$:6J*/[
M+2A'4Y^_'@_:```)BG4,5PG2NW>FIPIMK=3@F;FF+IZ"."$VDD2K@XZI+-L5
MDM"UG?>655$[#:DH$B4JOJN^`>0CS\$]3=&V54^'"V-.H1(\8;A9;>B]RCN4
MY7GS4`'I)%4^H6RI+?1XHAPGNXXF>/@E#?*YW^C*9*JBJ.<:G#/.HS5!3YJH
MS4[]NT1]!>K?(7A8_<GGOJL-)E.6L0N@SSL+"\"M9CM]AT5,AN@ME2!&X&.0
MM,JKYZ6`>IK%27]PD_DE)XF7I'@A+SKZZL5P,.[2"V)7<(F/)?B0<K4\*5OK
MV#O:RM"YC>Y**!&]U-$:07("V9C9G%(51-FYJAI@@&G,EE@Z:NB:\+#5F*T4
MG^L8B8R8P9T!M`;-Y3D.%6FVM6J0`?IACB"-/S=PKY8L-R5(SE,,=T,3J_@*
M1D92M3GXX<T!51HM6$Z"%CH4#6L0-DLU`-""P+T#<*E/)D(D>J7-GA$YF36:
MHRTML3Q.@CRW=3$@1N;XZ"4D1!0?(Q\!^E7_AL"KB1*)C6N?N+,U/@1=9"G<
MEI[FV2:-+%X."#"Y=9[X1(@N)<G'H/P:T,]GXS+)Q=:YB!3/V-11XN<*<390
M=\EF/.0NC]7*5$E5K6PS`99$3KXU3%O(P]ED(G9,L_/5?_QK#!&>Z./V/7S"
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ME.]-_/"(::'5[%JQ8VO(79UPK,Y"'#*LT`&"#Q09J#"";O2ZVT2&Y(J6O[0Q
M@Q(U*''/H(K'B5K6T7"KPC..@#9M$MYE64207F8I7*V3;`OA+41/<0CS.Q1@
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MG92Y_$\#E,;I`^F%17<:F_=60EQN._L)J!#Y*^QS@+\O;Y/XD6TO??P&A-?I
MV2>;MLD.0H/>V#&)PT6*?8YD@UT/-6T2W.&HPG*7_Z](D4!SZ&AZ5\+&@SGJ
MDHD8ZSL/'0:-R(/\!,F]"(P63Q`%#_!R0PP?PTD1Y5>;(B\PJTEKU.B73=EQ
MQH8-,R7%<;3%D$R!)M^VV^SO@=O%#?Y?HM@WMPOOJ;PCE:-M(\=PS3@:0CHD
MI?B?M\W%O<U-6(;.;01"0HFD$Q8=T2K)\V]!-02YVQE+-GVC)(P*J+`AGV#O
MY8USM\]RL`]H@+!_GO.M4\+Q>IL4S6_$EEAKSTWPY2(H((J#Q%JGO#XBE]4G
M7`J$X9LO8%5]XWMGDLJ(:PIZ,YQ"0SYEZ/-Y2E]/RNVJ2!>3I]VD0X1`3<@W
M^W&ZORZ_\GLI)!<45T_Z<S2-\=8@S^(TSA]96H55+>EB\J0E'2)$.=+L&_!`
M/O+\JKQ,3%P=Z<_05$<(A"]QDN"#WGF*O=^'^#Z!Y6NW;GQ6/0(<'[6TB!-H
M6@6#'JH:**`$,^3M^E!((YUHZZD^V[1/6,SWZ@+7=(L%@UWZQGP2A`[RKO+,
M)`]W2`XM9UDRX3'%M-@>%O!]_`1["G>TO0A^R9#=QA(:Z)V7U:K3)MDJ"[A/
M07`,V#UI-(#!B/I3>"HPTM>(3L&1)M?,+VE.2"U3MB;)-^%CFB79P[;,%+=W
M;3>$TN4!<(`648U0-0HTPZH2A?Y5GY?:'S6Q=HI[%%AA8".YAI?VICP.$-J2
M:.<JV^Q&U!4W31X<1SZ:*CTBMXQ\N=,><@9;IT0PPEU4-&G#*&,7.,VW3\K<
MI3HJGALIBP"4TS(L-9I$[0@W",$TW(+6*-`,\W**-!":4)$DS)C(06^ZX[*.
MZ)R'A57]=0$LC^X[GR)1A5[S-6A_[LUU,I&8V+.7\,**H_\AA\M-\CY>6LD0
M5L+KTF]2(4C4H)M^`,@7?GTD'6&J.><[<Q\586<1V!N80])RAV1"E`X:,8KV
MG',UQ*XCJPHT"8,6@`T&U>@R;Z89WW?9_81A-23>C<JJ<F=$FXH"Q?>;IHS8
MXN%0A,MI(I^("G'/B/KSF9T#!T2WT]U!/.DQB>#7>!M.;2I-%X'K$%<'N^A1
M^_*;V20"<T725H;^I`S;.)\FV!;EQ+>/X&6P@CPM$+C<@J$6GI87O4$@(4.4
MTUM^#.C7@'SN=WM1D$'M1$LF:IS%>TQ?\<[/TRI`P-I5U'<T.G<FRL!<QH!4
MB1(=ZLOAY('L"D#3&Z6^O)M!6R$C<=:ZI<6EL;?)*D&C::^/I;$EY_?%6E&E
MT^42A@71-O(X4/R0@K"*,P7-8,\)D&J2Y5T"3QE4:C;'+7F<A;0(680AV@2)
MU:9L,G1N3V(22H2.3SF"'KJJ,3.X.-809=<MDC/`K+T9@00C4F2;YIK9M:*Q
M;IN+\8D01Q[)UZ#ZW'OBB8H0FEY<DKD:&Y13UF6(-=)['P?WI"U)#/,RYF^G
M9FX0J>N3U"!%`HW"KGN&J(5!K$4C9.+Q;5Z4!=NIIU-B@^%YC.GO,?X'\C3Q
M'4D(IHT;N9HFMSIB(&ZV)25:1'XW^QX49``(R0B_W005!;-KB>03'_7.;XG@
M&F5+?"S$#E20G$&K)FD`H^LG2J74B!R>UM=@";V_/ZHDP\[;@\.S-KN-98"K
M,/4[[)@;61T^`!\.#Y<24?E(=?OP0#_V>XQ7$<6NG1%/UMCMP2`+M`F+#8K3
M!P(?/4&+UD6&SNTY2D*)6'V:$3N[E9<>,L.BZW25&9BP:<3GJGB$B"FH&Z]Y
M`*/C+4I.C4"7Z"#O*;)JHFLKD<)DC4W1<;9:Q65LB+R_E*4%5E28AAB^FT(4
M/0(<JYD6<2*'NX%!CVH=*`-U*#[TTT@C.F]Y:3/-6'M/X!+B18#WZ">8MI\)
ML_I6Q"!2U_&#08J$^=SE.,`&SE`;E27<3>E6X8=Y\<!Y&F8K>!<\N^HO(4;G
M.B-)2(DP#XF,`'C(8(,)3^E'@Z+L)AW)&6#JS]W"!V(P;^":)&VF#S;528C+
M;6]Q`16B?CGEYZ#^WGOT7%5TG>:DLDD;YQI<HRS"9PQF[8ZV[._O4+99:UVJ
M*`%RD6ZK3(TX&$4^K?>U^RVH?J+#?>]NVF*K@Q+*3#'?W1C(*\3>?K!5OLG%
MX]C!Y]$@URGV5`][%F,>[X++)-:YQ17-UBRP>86*Q^P^)B5S<<A-<Q38&>Y`
M"Y*7Y[?QJ!!%#CJ?<K,9W=L/&?MK>R&<I-&-_0E$JR#1D'1G@.L$QC9RX0F(
M?.(]/57(W%J.O;D8>PNW&_1`[LTTI+@S9'(_42[&+G:1?\@^\OW2IH3%M2PY
M$S(M,+Y:/Q:/0;**0QWSNSMH:I=NP.[NH!?9W/HSSS4%4D8WAI8W*\-<A8^0
M-"Q+`[35D&IOD%NI[J(72+7Y;`Y2%3&ZEBIW5H92W77=W\'L`07KQSA\3P:1
M1,TQAS4).(=9*>I4J1_=&AB@`C*33I7Z(A4>Y`88->I]KB(HZ-,G#8X@L76J
M$R-S_3J6B!!19XK69YQV.EY"2T."Z\26I/,U.^%](!6_$86L<[[C#+-Q)2+?
MD/I$B`JSZ8>@_'(.NY*8Z[7U$$S.3,K7$#,^+8('>+6\A)5)4MN$^$-=;CA<
M"D2;2_TQJ?M@W_H]Q<N9WVP7XFF.V1I.-RA;<VL3)\JU;L-W>U?51BTJ`:*?
MS*1DF2>*3G;T[GR,(C@TEZ3R,'3.C)QQCN,`'!)DB3X@J7W%.41W)(QOSI""
M&8YHJ-%)0%ND$<NM7X1%_$2SB&S>-*HC=]G#19DJI91$^F8'J[YH0/@_GQ@K
M@#!]<9!5ID&L+I:RO(RAV&H=B94`.;N_5*%&2<78V$J]MC-(G]"66VWCE+EB
M?H')2[JU;MXJ/!9.N6N(XHPX^ZC@;8XR<H3O:.&_AKXZ,*K(:2B)NG?<F9#3
MIVEDPN<#%49_C7P^&)-,4+ZPFY]EJ`/>2D*!"-=T>O)#J2<I?*`5BK+,`@$Q
MHBSA('\L.W;!*`<O3N+\?H.=80KBI?><]2$I[I2*BR<^YJS*4T]NEP-7MIZ/
MW)LK*Z-*U&.<=;XX?0YIGQ)POEKC_==WW%-;TD-63,R3J8Y6I`"5.L@4G[47
MO@=0>M.]/BU*GNW==CV/E\'51"E4,\'T30]$52'\'42K.*5J2PN<=7J(R4$X
M3[:2TR.*S[%!H&A&E36`<PC3JTFIZ3(VS`'#+BKEX:D%%ZOB61"2,K'M<9FD
MKJL^VD#=W^_HDBCLRL(.U2TX-*A300(,%#CF*YZ'(F8S@;<*FPTX9URC53:F
M9L6*-J.-?$0NMT0N!=*F]@4(Z)@?O6Y_4A%U>B0()SC"CVJ5M&(UI`\C/V9)
MA!?_Z;\VPA#@-#JCC-MQ\H(J7:+&0.>+H_/WYW?GI[=@<7D";N^NCO_VUZOW
M)Z<WMW_X_?>O#[_[$SC]^X?SNY_\1B9T1=_612T6&5NO?KVU(W7T:<?$9`P8
MLZ09Z->B#8M-H$H3VS:WUDQNOQQF7FF:J_:`RCQ!.O!'SR%J/9.D8(0,]>AJ
M#5%`*@;ES1(G:O4A1.:ZRX>($&'*./N^[H/WH^]0UJ#@.HT^I/,U2^XZ"O(X
MO(1%6;E\#='M8R`J5Q<<!@=`N&PZ+2=%>-N%!X$4%B`NJ]$QFT%.!GI3#PW1
MU,<VA;F;%77%R::`T3@=&03B,"5PB!;A:Q9TV*"BN"\,4Q104RRFP@#C`C*:
MI72<K=8(/F(K%3_!$LO[+-?KX:L$R%FZA@HUTGRSL#VVTJ`7"1[^\D>?E4L:
MXNIFHJDPP[`6AEQWGB79E_P,$UIO>T-9::+G$52!.7T>09$HV7WPDHP'1)8@
MJUV;H`;A=_?2%6'S)((.9\Q"XDW#^[OL!I*9Q`FLS>%=AO](J+A&V5,<P>AH
M.U8%I\7HLHOPE(2+0NP-#E!D`%58VCLM_IW\+21JOV:X2.W7H-Y[B+_;T*XF
M.#^Y0,:_8=-@*!^93-MM",U>LE$#Z6SSUZ-K^$F;EMJ6S[63&R5N=,R#X382
M:_]%&W563>$DG*=/,)_*29`!\^8D2(A2=!+B"L(\G00%$?*=A"'.&#D)'0QG
M<1I@0SN-=LF`>=,N"5&*VK6L(,Q3NQ1$R->N(<Z8]O2[#(H-@E=+9B>SU$I*
M&`>+Z_:C?1($&E5^2$HOFT_!SW?PN0!'F)>?VTD5?_ZW_7WP\Z>+C]_^]\__
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M]F9_W],EK5B/V[%K@1*89XX?;?(XA7E^`O,0Q6N6I4*"H/G5\AKK,"F');\2
M_:'J8V-Y&5#A^))$GT)1F)P!`BU(U&^EL,BJ;4/CKUM/MRSFNM)684-.FO=>
MQ[L0^7]R5?@4)*QA]D6`/L."O+9V"\,-HON1514W(</E=;(!?1*/9@]0OZ8%
M;(\J>0,/-`!%2NZE+[NYMG2ZLQMR<\3EM7.-'M1==\IKHJ8B5:2_S,CJ:NN>
MJI:9J=E9$"/ZNF[3F]NNFLD1.E4S*2FBXA\\ACVYW!HUJWU=2:1M#1OFPR0:
M5D:\+F!`$$17Z0U19U((0IT%-TJG2H/KTZ`N@8/:N0=*2*`"!;#W60-CWJG4
M.GI574U=X6JS#BL-@ZT\VUR%00Z48F!R"$[,X3`=PUMN7@_RFO2A)(\ZH#4\
MYQ'^6V-+KY8D)P"F.3T&L6X@M%*$YI=@;8115?]KU0J.)<GY"SWCZ!5F+-4O
MJN#3>1MNW9*&0MX#%/;^/0$.*NAS.MQ,I&*=1X`F8+EY].HV?(31)L&X>S@6
M7P)4UBM<T1A#3DQ\6865YYM5^1O=SJPNH8DI=+VBIB5?E)C.D)#EQ5E"@&+"
MJXO@`@S9'JC1@18^J8?B);7=BH9VTN&G%Y'Y@CP-4(H=IKS*A;2ZML3('`>'
MA82(*J[9]P`/*#5>=#_C7F$')=CIEBB=N''(ME'I700T.WN11BSWUJ7]UB/%
M=1MF,S(5#')?5_=`F>I/XKE5-O?L#H8C58AO8/5Y:U9-<KI<PK"X6E*X\1/G
MM*%T5%0`X^Z\.$R,R%C2@405(S:4>WATWYA"64A-<PHU'HPX1)(<GA3_\[;Q
MRZV:1RD^U\ZJC!CAPYEL2.?=S+GLQ2K2[+Z;.<"`*4Y:-1)6Q.MR#Q[`[6W3
ME=.EL,O6`/9`5>4]OYLH71W@;Z(*O#)V'-]E6?0E3A*\)Y^G!69VC&&785U'
M!E&3`I<W_'JDB=[O8$"H]]>`J2X/AJRH+]4U4XRV`AMPS[0Q6;-6SF+R`L5[
M["I$%&\$E\TONV0<;2^"7S)TG`2Y-+`E>GYN<JS.Z@HF)UW!8I>8``7,%D.%
MC/W87QWW6T`Q`HIRP,*[]VBMZ5WS)I\504WAU53+VY$CTT?G]MD."24*NE]O
M`A(-]NN@",7)]TGX3#!-25^$8;9)B_PZV!+V8/VF'=AANW+'D3MB2HIC3]J0
M3&&SP1(:8."H>68`00NBBK?BI5'<./WIM)(;P=@)PK=]9"Y/BX/8?=G<(<(4
M3#!/G>=[]Z6J!WSKK,0N4V-]G*U6<5D)C%?'<9:2"CB8ANYLM"8%3I/"M4@3
MY8,W0*@E[H"9JPTV4XM."K@^[\9D#\$E1`A&[,DZ1ZJK@-5I@NXP/<(7ZLN!
M]8.X,U5+=3%WDG34V#(F:9?U30B>G5T\2/"YOW@0$R.\>*`-.?"8857S<_4P
M+,_NU<,`"T8<TN$#L:(W<)TA8D,=:9@*6M<7#L,DB5S'<B2HA\[RODM#TAU/
M49$M$QQH=E&=I\L,K6A*U=&6_:.K?$(M4KQ=C6F1J9(@V-/D%L0]$F*MOICO
M<<A(BP0Y?]KL-4M):3`R)P+[M'5KFM+X'VT[;Z(C&(R[AAB!R)4#,!G%"HI?
M>:;D"-6TX&5^!%;[-@9`4<PE/#NY`G'N$T:RWFQ1-)#?L^>$M?*S),.=79V)
M:1!=`-<#0#7":P7/L`QJ;1F8ZT1/H?(>\'7DLAK1X38(:D+BF!>B9WFX&J,O
M6@]'2SSAD8XP[_V_H^T=AD'J@')73K`Z&4Z?9M"G3\D!:.L[`T9V?@*N+$W+
MYYTVIJTT?)]7CZFC@JIUBYJKY27\PF[3,-9KE*7XCV'Y=.QE5OP$BT64K?'J
MLQ-G-2'$>?FE"97"@&S3'0FK-H8&&G"@"P]@@&`+"\!`SB>@,4J!NA%<4]:.
MJ.5"*$/'&4(PI(5B>(.Y1G&&KNGSW:T.NF0]XGV'_/EHV_H+^S"-%BM"K*WG
M6JW0Z?3:PL8,%+I$+S,$*&K0PKW[4*RG3<.F\G4JV&RQWK@?-#ZVDD,JO,NZ
M#:@Y#30UGAK5ASKY"I`_-*I-H/ABA<(AO<ZKY][K/N<UL/81H?_(K8=CK+'4
MZ].M&0--<Y1/(!<9ITNZAI)J`W7_'JXNB4+W1J*E371/KJ7NG\@Q%'KS9(X)
M]\S?Q"7E[^188,OSZ")P[6YWL(NV>_(-]P%X7QL[5RB=E,7>M$8&YN(0^\*T
M"P+/%$T8>>LA<AESX%(@BYS1;UE3#:_/;2L)JQ?VXDYUQ%E_!^B'-,8^W^T'
M9RJS@]#I^4-*BJH.T5'@!1Z7O^3L5C/0*+Y,)9K%8<28'*F[N"@+(".\R46;
M(+&U+_$1N;1&7`H$FD2_+8M@JZ][FY4/[9&*JZTUXLF:>M='&=X#29\`<BS-
MD(X/+1@Z_2V/W$_FDR'JB4X^)AI0?^YW1U*00?->J'BB8VP%M3^+]1I#C<N&
M:O'#8Y'?+FYN[6U)PTB=]Q\;HDCVUC5H#P3E2/`"C^5N4!Z?OE:1<^\%[$&N
MF+O-._G""X3(8U0TE<CB:4H!J\]D<@X]JLGDK:&BL]@,DLDE8I8DDXO88AS_
MO(B3`GZ^N+J\^GA^>[QX0)`"U]@"Y1`<QS6EQ(CZY-(QH!H$ZE%<L^6A:ZZ*
MB)JNN8,<,'63F`J2OJ-92@MM>J9)H"+\D5-[R'+-X-(@/&V5EJ3YN&]#G*N!
ME/VU^,73-.VA'2?XF(9AL;(JDL#%D.@9B0$H[H/+@S2)[44YKJZO(R/K[<>W
MKZ,GM;;=4."&<72XKEA9;(K'#,7%UI9C(\#D-O&.3\1P=5+]^4R<%KG8N"5)
M_1F;YK^=8(!Y$8?'Y*H7;>V=Q/B(7$9PN!2('%[V[:["S"((*)59Q[$5SGA4
M0\9=);P,5M:.4!)L+G5'3(:&O=D#9-!LK<ZN&.66IS/_4>J$/8@T2-@^>`O1
M4QS"<YM!H2&4;A5+2HM0N\I1M4/$QH$7>"0_%.1)R92$V]6T88:,4#>LPBR_
MR=9-10>!Z^AB![OH=@+;I/*CN=R@<X72N8_H36M40_\DQMLBAOD3#)`],\-'
MY-*X<"D0=_"GW](MBWP]$V='*JZ=SOV"R8XP%V<9@O%#:MT[YN)Q7.',HT'T
MR%KYZ:!W[,F>R*36>2=--&/C(_A%G,8YAG6U/,5T9JLX7"R708Q(%FZ9M@C/
MBR"QJ$F:%+@T1WJD"2-#)1#ZD@,#`Q@<&BQBD/8`A343*V:F%YTW4/699QJ$
MOLQ2DLUX!]$*`V;/69^OUA@;"7-?+<^O;TZN4?8+#'4N,0S`6K"`\GBE/HT"
M-<6`]FD:;`L46)"FNC4P<+4$&-P?@M7Z3R?S"&F:2[Z.<1IR4#=^5>$*,:Z3
M.%]G>9"0Q]:S-43%%J,D[U2O-:_9=."YCZ5K4"=62@(!5""(#:V`4-M9@YE!
MMHJ!<-M*J,4JLV8)#?CZ!0"=T@#A:.=63TB*^/W(6G_B^KT1OSNMFD2:O'WI
ME$VCZ:U"JQL8DN;>\3)FC1GJPBL;7I\:8K?W,THT"32,CJVB%+NC03/<KU>G
M)>ZV,Z?.&N..W0G]=Q@U3RBV'S,]?29_A#9441&S\]H2);)$12?5X,YKGIV'
M<QD`[V=?/<%WRE34.32B]2$7=BOEZFC+?_23O??Y#G]8Y.=IN7C>H2RW$L6U
M0:;S3-/IYR#*314MBG::(.EC)WX*MWX$M\2*W0IF_<DO&#-X@7^AX_.7OJ_.
M+.IP)R?6DOP\+%[B<Q?;\Y1T.:&UYU?%(T1WCT'*I756*UJ7=J<9O:YF96_A
MEX2`%B6`D@(*3(O8+`CLP5=E#@Q7Q20VPD3^HZH_3`FE__.1I+&D#R4MA[,R
M#SSZG';FFI!P>ZN\K-IFV-@2_EJ7K40C)UF:(L&,N,8\7:V3;`NK;`H^:9=9
M^H2QPI*`_"XK@J3][Z016=F-"9]9LX<T_M5.:S![Q+IM@61K&J(+?(:OS@42
M+=L]4&,MUR7>7CO+FG;=JSJ0-7B]EM);U^!.*H%5T8W91JU15AJ:LPRQG\AW
M5C9:QS-PG$/A=G:^+,%>Y823?FLM@GZ;%D*Z-)R8#;'P#5O?$\KNAUV3>T%D
M89%&@H+=TV>(PCB']<&!SN\\+5"<YG'X,4@V.T%G4=-\OR2Z>^C7ZSQE#K\W
MHKQF0,QC:33/`?A7CQ'A0H+Y!J[Q8GDD]-%^WD6,8'1"&QV7>,L@CI4SO0Y^
MMV$[#<JD_2!:,%B_>`H%E&#J$'H)B1\S\]8C0E,S>NTB=/AG7+L_-@@O7H!7
MFR(OL,PPN9<;Y:P1E_2X21=P/2W9GN>&@AG$KGWI=G=C<RCP&1J`3Y#\!QNO
M)XB"!UAMR-<H#C5\9/>DN7V*RLL<G=L(&3'47)QD21*@'*RQ^<@)CI?^,C/]
M+@D')F10-48<NVW;/-.SMF.Z',7E?,W/IY,A.DW_ANS$H+Z[]3/XI^:9&H@=
MXW8#5T&<XM^KAC2;("'%&_.Q'*H$_^9,BN+$?=H:11)_ZT9(<TVYM4XZ:N36
M;.U0<$.^MVMWN!B_AC@'C_"I%SX/QU=XRI!IU?B5)Q3$F&O]15K$49QLBO@)
MWL)P@^B+(:?/8;*)8'2&F4*HW!24R*OE:8#(`LZO(:)$E@\U62GFF(0PI['U
M24@6U8&T8(,&.*B@`Z*_H`6?5JDS#"0:7X;]]D")Q7,&W*1:UZDDF4P$HQ;5
MBCP@_RM#@GUT+,GX/H&+/(>%G==SY!@=YZ+(J1%I>&M0^8)!-0R4XWSKK))0
M.\HXS`;C=A_7*(LV8?$I(/M&L5V$(<+[@IT"3RXFUQ6=/"*$)9ST8U!]#=CG
M7I.$Y`+KEF@*YVI>'=P!:;$&4X#)J[;(*RQ[VK);3SD#;9'43DKF:G2DJKQ,
MXF*2;E9J/<#[HQP>;7K(!9*NFSF3#_=HJ['<:\J/D-?U88$_M3&^R<Z3`S9L
MP"X*Q]['#GK%AR4\OVW-%8KDJ8AQWL,.L/H_-HLK!G&ZW2.&R%%4F[WJ#[QR
MA5D\12(4KD2[^-PP]3ZZT(@W7+>COX#%8Q8YT3\#*AP;+GT*!UZX:$':`\W#
M!B4PN>;Z>6+05$^Z[PX:<='8EIXNE^2]\R=8=ZJ^"0I(-NXXW<3I`WN0-TNM
M'/PUL+NUK^J$B6I)*@"@U=&<P*#ZFH9Q$K-2DFN(Z6[%M+S4@&AK0:=^0X]9
MIH:X\B9SB\Y?#X?+DN1=Y`,'@;SG_/DQ?"*YM%6$.[41A;E8I5+6L-B&&K3!
MN]2`%EZ!\,D7=:MIWPU=.%)H"WUW-B/D76:D7BUOX#I#17"?P%OX0/LOV!"_
M!)M+;1"3(>I36:9)9TO0#`'5&.\=MH9EV%:>@<F/?=][$Q:TXH&4#9)T`!K5
M;MJM'C\&Z,%.=8T.>M>MKS1HDST&7D&@=;!E=VD*I-W$EX'Q_\Z\GB;TW@C7
MX)9Y1=@YK7TE\,C+FL?8NWK($+N;L?G>RR!6IS?4P_0(GWVI!N;@YY.,Y/',
MX!TA59%V7WE18H%QU<9E5L`W%P'Z#)G)K2ZA3_`/<9+S_NF._%4ISFX.W6$\
MWIA(8?-H?.A[`_9!,["=`O&"@7TI_.)G"MUK1^F12M'J+SV&MTZU^GV<PO,"
MKM1ND,9A<%8U/XI,:_I-,`"*PO-KQI/HR2AE[S+;W&$XP^X'3:J_@$&^030S
M+Z]__&L,$>;)X[;<"VWX#GH$N'ZQ1X<XT5,^^'-`OP?U@-DX%T;B[[SPH\TA
MXPAT#;5,+&((HZOTAJP*XEH?!7F<?TBS^QRB)[)>SM/UINC&48^V=/@QZ0GN
M0*NGIM7U0<_61$39<?3T1[_CK1&O2\22VG%7DPUN&[Z=3G:G;[G+G&U/];]E
MR_*=I)BT.:G[GNIY_>,Q.3EI3D>OS%GZ%KM"K>VCC:'C+K6^R9:@1M7I^;M[
M./#E-DVF2AWW:1HQF+_G-8X"_2/$--B<-AJ8C&QG*X9_W/CJ5HW\X#&=2(P=
M.UKB8R\ZV0;O\E:FA5<4`R=?<,\"?J+<?3ETHM@[\QEC+=]6[=%)1D/\!*\Q
M7YC.8=]ELRJK+S_D,"JRT[R(5T$!6\I(:S)9B68@+-%D#2"U_`_GA#D-Z;B>
MG<Q4O\5FN'Z;@-$#"$$=0]TB"Q"Z0)&!BK(=*UXV;&/DT;ND\I<VA:`DD35C
M[3M%7HR[K\70V0>\J,:((XE#>O7=,R_$N6S/X&N2LS<H/)_QMVY4Y`ZF-S4Q
M31_$GFY<P/>8U&BWF/$B^"5#-*YR&:R@Q?"A)@EN<UXUJ1/%Q2F4?0JF7P6[
M!R@H%@HDP.83,S?3CTZ<SX"#A@\X%_#[711X&;W+LNA+G"1L(>Y^H><S&R-P
MO6.9$BK;=;['>TI/>^EF44'N;#_]3^<2F!NK)AVC/XK3+C5=W[<;A<1M<'H,
MJ79U?D:AM2F49JSN<V[S1U7`T[Y5Y2,9%B\YQ<@<7],+"9'7PC.?GHV83QQN
M4(B<PGC!W(UCLK?A(XPV";Q:LFSJ,KV:]F)<9FC%+AK9/W+\A8E>&#`@P^GC
M@/KTB9J*,4CTX%E^#FI@H`5MC[X$R+[P&L":0%<Z;PX8\G*$N90@$C@&$ZFU
M"EZG>JQ`D$AQ9<HZAYW>1-@=O53ES7A%?`>S!Q2L'^,P2.SMVV)DCO=M(2$"
M56M_V-^N/>J46&X<11),UZSE.7$X#]\PR,31K(&WU)1YG<Q58)65]]OFV_<$
M`?Y0[]P_-5[GZ0@33T!V9#HDB<^5J:0GI1I&QUZVSTU5RZ:J@0'>]UNC*M2<
M`(*7<Y0E+>P<K6P(;`[K3C\*80.WX]H9"U/PM0*Y3LY7O@KE00Y;PAO3\XM4
MNI$ZX%:QI3TG2HS,L1,E)$2P&,CW9>5WNP!W-L&/02&V/2KYW$=8]F^[);L(
M1G&=%-?Y)]:V<D':FL3%5M.!&H?&:>K0.%JEAIDD;>Z4@Y?0.[:X^P5#`BHL
MO&L43Q9X$MWI&MOQO!^1:6.,W<"K&8_*]9WB>)(=K`U^$.8K6Q\##LDT<C!-
M&EE$OVQ8YX"S#)TBE*'C#"'2[@K[0M:\$!6TKKNB#Y,D*OYJ1M*'[^E8T`R>
M1\A'0]*=+NF*;#%W6E[3VK!L>8TE2ASSEA>NYY8,`G+J>`Q1(S.?K[%MI,.)
MP]L&T+*>L^B:H"J[CLE3XLR(C5\"7W]K5P+F>O-6(6JT?@DVW]DIFGQ_56:5
MZ0XZ^&!0+GHQB/X/.0HNTHADE]K-S;1"I]/V2#9F(.IN6N9CTW'SB3'85+7.
MA8\M1H^*DL4%N6,_3R/L_D;8$?X4%X\W,"D;KS[&Z[OL-"VPU"S&SC1)<)O>
MK$F=L+]=,X#6&-`A<VEJ8*@$G=B;`9N,,SLE1023U??-JQYODOJY6?BVJK)3
MK1JQ73ZF[]LJ`9M1>9:2;ZND7[/R;75DJJILT_BV.^].M#P`LL?;VVB5\+K,
M,U,A2/%)DGE$@W0D*WF)1,R(,57VAX<7<0$_7V1I]A3GX>(!08K":.=4`N8\
M^JY`E#2^?DBZ#1(0H((!:B"2C=1;\%Q#HMWPN"JCC%VT`0P&ET&J`-T6U:B2
M-8G:\??7.:K>P.V,#M-&Y-'>!<_7$,599/'PNH/"=;I'%[THR2-X!N5GLRF;
M%8BF<Z3DS,VX@J5^8V:Q*1XS9#6@(<3EN.TYGPIAL_/ZO:%ZP%SB$T/"Z[8Z
METQ[3*2L#]AN9%F*SW7C3QDQ&@JU)ZS=GX=:R0.X@TPPC$`PKY]$A;.4]EOC
M*)7`-1*-=9H]+R!"_E!?\[7?LYN*"&KO13;3$0F&KVO5JMM\:Q['A!`<N\,B
M.J3^[VM:%EZ9BT[W]UG$+`?ET_5NI3P8=8+G0#8X24FAN"^[D9%CK#:S"D4J
MR6U0A_K'(@L9G!.F+/LJXQJD:72*Y6SB/\J25$^.G*042H;`P&"I@7-=L*1$
MU7A=FU/01TNNZCK'"_A,*\DH"VF38GH=S9,H30.&T3'^!U*)>X?B(*%OLQUO
M$,(#"64'7&=V7:9`Y2`LOP1!"0J$#!8H"#`0$FC?^'-DAF;8$YL:2Z:^+U*5
M%%8GB*?^^`X%Z1@I(08'/%!`WWBLV)/-3"0="1NFMX>#LJG>Z[V#:$7>;\U%
M`KE[A'A!E!^#`G]-4B8+_.-%G-`X^-7EU<?SVV,05+'A;[SNMKV)]>0AF+KS
MY7$"UUD>TPY`5YBAJ&PI=8GGI[Q$TBS=KY9)Q,#1&MF,``0!A>ASH0S-L2<<
M-:8XE]5NXR^\IC>K31(4,%JL2'N1\H5&!9'%35.U@/5?:V"!H`7,[SI2G'%/
M@%J<\N)`[%+X#F5Y?AP@M"5%1JMLH[3TB`E\("-!R(82X>&QQ#[VA#PO67)F
M/"A'(9<F#UMI"_`.[ZAYF;_8JM8Q6HM%`PH$#2R?)E1MMH/RDS')@_]Q#1%)
MV@H>X-7R$E9]!A37W;H>3!9;"@OL&]+Q?I<9?TX]R<BF[GQCXYSU""6''"$L
M:O,6TN_(FLE(-V^\;WV)BT<`G_&/&0)1G.--'!^D@K)4D[P!&I6G9B:].(O\
MBHHS;<X-@H`U7G:MILM>JPDU]I+.TP@NQ6VIC[9-8VH:,+J#S\51DH6?%==:
MWNIO6.+93VCK;^)FQC5R]F/?HMYOP8IV!`\)"1Y/U9,SL*<PED1D(5%%0]NJ
M1$?LC^.%&Y2-]$C`^VC;;HBV0##05["V<C$37AY?*E18H0@NVCOSH=U%+B#X
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MEKT?GNZ]]G2K^>7G:5DU<Y<5Y'END_/&ON+"V)>=-_:&#AS54B`W)BQ\NP<*
M0K7D^.%IH7@3&7_!>-8@EW6]O8S[Q7,LN84KHWWMV@+RO=]43>X4.!<#PHGZ
MB-4*R>%=XK0,2!5P#>N!/CW$D:P_=*KJ=9]>[+'%:;FNT^@L".,$_WJ<9/D&
M09J!=P%EY^>ZTVL+$,"00`4*,%B``@,_E^!\-JO7G3HG'<Z$=QX\`!-"!Y9<
M4,F[:,F;;+[+2MXAD_=.#NK_%4$?NLP-/\K(9KL\B4DWUPP-K%7Z-;A:@OK[
M.2Q'_AQZLI!-U7E81TS,P/(A]]&E&+*6&'SN6J/9?^BN<=D))%>%\"X[#O+'
M:Y0]Q1&,CK;U[>*BSM:0+P0&!]QE@$`"%2APM`4U,-!`XRP3'XFH>I/G)*::
M<,_#MF5"J,*ZBV!8BAT?`4,B]G4E=GS&;.[KFY0?OY?S7N3M=/?"!*Z"9'"I
MKLB3>_T%Z$<D-<$\=N_,QD,^?I>$@451?NXQ+JC%3Y?[#$O_(SU&\6D-[W?;
M`2VM\@6Q<U4/F<>N(9I*G]_R2;L/Z$L)&E#M.H&3IK*ST9[M^322.'389>$T
M@4\P)XG7$23M1^2+@'T-Z.>L^8K_XP5_#CV>RZ;JW(Z+B1E0^TH$!15!BH=Z
M/8"/YKU#FW^Z6B?9%L+665\A_%6-ZH2_1)$N#P*03JHO"`4>N-\'AJD:6!6P
M$E([9M4+3_T&I.-R;SA/0^[QX@R3EH8:A_$*$/<T7D,;.(U[J6K29$!/H(8L
M]%1R:$"KPJ$\KJ1?9/U#^;*6ON!0_G]&ZG9*=H2+^R).8%YD*<G=K])[V,65
M?#'7`^D=4#6T:9P]BY4[.+N>S!3YX2%6ID39P#I<U4(C%SEUJX1>1>)O15!.
M@UQEDXFJQT3=?GAP&74Z4S0=FGLKR(=0Q!/B"61H^E[VLT&Z>&OFCM,T)(E#
MF.9TC^*V#_GJ!>1XZ[G$7BW>%[M7KN>K=1`C0M?5\OSZY@3OFK_`<&`179*C
M&'$I=E,3&F@T7H?A`09P%H<V?0[TA&K*1/>'.S-*!S8TVE2&2'XW22%N))]1
MR?\A6*W_=.)QB_,F;)=G1=+\!E/8Q#4Q-6N(BBTFE#R`LQ[>$1D(T(ZT5U#H
MHJ[AS"'HJ#%AGCCUF.7!Z]2D<7BY4MFV@_;K2K9DV<(*I-=HID.A.O50K]:/
MQ6.0K.)0O@2;[V:Q3>Z2W>,Y?UX^\EMYE`RLB6:(WQBE$9?=IK)>H>(QNX^S
M)'N(PX%@8_?;&9RF>,3W>2R<H7N'343+D#YWAOE,>!O%<9=>$^T>^)YT/\:B
M&%!KVBRQ^G8F838._7T^B^;H)2@@H&9`M<M.E0D;YO$L,8+AC@_YMQOT0%J_
MR+6Z^HJKS^YKLSHT]QC+FY*?-EL]0@;T-V<#/(>MM/G;TUGUQO%WP?,13.$R
M+LXP`54QVM625JNQXK7C#)%<Y]Y2DK:0-P+LT-<WH4_RT!N#!0@P4$$C1W,*
M#S"`H($X`X]KC.QK;33FHQ>38$JM0G.]`FO!/=,"PN2FZ!P?XLN"W*IZ/:PQ
M^'3_O(I_^EPRX4K_0+KU1;=8*882,,HO0?GI+([V?=I[$A!-ST,PC$_*P*;;
M8;K?([XQMYU&J3["`J(X#892L9OO9J'*NV3W6,N?EX\H%8^2`2U^JH?X56$C
M+N]&J=3=QQ/&2A*\38NXV)ZGRPRMRKN7^YQF'2BYBTJ`W)4]*%`C<`:KH31<
M7PX&K='@YVJ\[PH>#<DU^?BJ?'%C#JLG0EG#C?PN6X3_VL0(7@3H,RQ((]5;
M&&X032$3F<EJ,,F[8\-!,QXT`'P_WJPTR[;(#-CC]*UD<E=+LI/P?\C-SU.0
M$"K++BA5;N`)*U4428^F-9"E1O_0`K-7O;U=9]6^J&"]]/P"KLZ\>?+4YYL+
MPUE15S;"'G@:JOQH#[#/?"^M#LT\EG,FY?C-^6H1WT#Z_LI=AD]>G^+B\3%+
M2$NZLPSQFWH-FCT&D)@_$LAHP038MH/;5LNI-EPO88NQS)!91S/&NGX2O&?+
MJ^OS:RS=HGV'KK/?54"PT21@RB9B-23/YE)]RDJ;WP##G.Z`%7%8R3HO5`S*
MCJS,SHA9+,?=:<CDP9^RRXWJ?1S<D_8UV/D9V*U:7\YFR^I3S^.V:(Z.-Z]+
M6'1+/#[DY.T,3@,&8=8;+'9JHNZWX`4!`^+T);=7B6\)J4^:)SE=EKGUW/$^
MB.`C2?=^@N5+%IC>JR7>.H6.>GM(]8#XB_=9GK_<`T2ZV9+X'WM@410HOM^4
MIR^\1UT'G>7FQ6$73Y?KGP]Q1_N-YPC&_U,>N#'L59;2Z#IU2]IMB;N!%C9Q
M.ND<AM\\9$^O,)Q7)/9"_D"#,/L'A_MO#FD81A&'*X='C1Q!$(;%7<J1Y17<
M7NG)YJ`UVI>%T!,G42T-;C@U!.6Y2'[*\^P^ED2(#W5^_/C=<SJV["0?I3'O
M4L9R8AJDEU.9_-3:"W?Y[T4`:E/E"4B'2081[&91?8))\K<T^Y+>8C19BC?:
M/-_L)CJ8&U01>/>V5$")W(R20?N?R2A0#0/E.$]+6UEP7=,IF_R(+?D&/L0D
M])T6I&7'5#JS`]6)51=AEZM'\RUM=>-=)_CRZ*H"9WZC#,C'+-FD18"V9W$"
MFW?*QRK!+EA'QS8A`7)%J#\&Y=?>+K@&Y=)5!MXD708B=MX$)&<B<>5)M;=W
M3E">72S.!'C;N7">+69KKCLJL>.@@`\9VDZUZKI`W6_2'?SR)4<_!=6W7@[)
M`\+H+K7^U$9LO->;^R0.SY(L**82?1ND"Q/`Q2P7>?DAH%_ZR1Z42J`K[]U9
M=?("E,5=I1V<Q7D8).5%YQG^;8)]5@S:F<<E)&$HPZ0<4-USTR$^(QJ#4JI4
M0SYA0S^,A;=+F#_!`)VFT0DV-.-51`C9Y<X@(D*@(^SS2D7(`(!'`#+$HX,^
M)*1*0Z2S=1K@.@T0>=F-9%?0<-M)G&P*&`F[(++/R:(L`XY[@`WQ&L$63(/G
MI4EG[/C>B';U(W>TS^3:77P[5/:9I)?6[$MO9P\1Z?R+`M[T/(0BF3=.4OA)
MKZ@XW6`-8.YZEN9'<)DA=I-Q%SS#_/09GYTS%-$\TO,"KG)2UD^Z3&5)4CZJ
M"S&9P@O5SN&EK)9H\((&,;BGF*O##L6]!SK8`46_![H$@(H"SR<CB[P5!$SM
MBM)_F+QJ!"VY*Q9$QULCYQ<2;Q&G%@GO\<%EQ**3N8'_`M$3%"?)M[X%[&,_
M!Q<9^3RNBZ?I-K^Y+_U%&*(-C%KI'9J+@0$`+0CS6Q3]6:JM#1%W3*IDB3NZ
MP*>5B)Y8DF""6_8N.#>JU,,K.#C4WP#RD<>C`I?GU?F@/Q/_&],)7$)\:HE8
MDTW-]5B-KAK$^O=;Y--36XA<GC@^0^R>9XZ"/`YUSF]T@-\-BSL'E<-;:[+^
M5P@VR]F&9EJ','XB^5WZFQ8%`!H(L]RT=F:IO&EQN>-:;C3%@I/"1DX50TE^
M90**8JJ?WR6E,DWN)98R>TR]C2H\6@9&)PMC\L$ZO%'F$C`4XV;![5[LTE=P
MFRN4W<!V?X8N#V>"S&%R8,PG2;:N(<T_V9HS:=ZBUF69TQ"T>*NX#K9C=E$V
M?':NYL[T]+;/#D\<NYHW<,VJ6ZZ6[[/T@30B/H'WPC!H\SW9$LF(?=*G&9`Q
MGJ4BF@H_3"*;MDO3=_H<DN>S.CUI^-5[G#=&A&<""A2TNSS1B+6H,G*/^U:/
MYP/$&,9P#QKC.>W_0'*-L.;&475*9=<PBS2B3IY1"C8#6=U#T3NITBON)V//
MQ-RJ<$'-!JOSTSSCZQB2MTR2\S2"SW^#D^5\[8)UGFFY0\!`84OY,:!?`_RY
MY\PO@5!V*E<X,YR!7ZRQ$PSXQ7*S/RN_6-'*Z[+,;>U1B$];&UJT?T(:,84Q
MW6_PGQ/(WGY8K#)4Q+_2W[4+Y5OP01O!'JA14//>1K*G7$KOI11J(H[Q5&5:
M:7@^8-']BMR#EWE(YM=LY=;?0.+>M\W##1#/66WS'^+9B"V_A(B/&41_T@?2
M?6^*W$\I='?7<C(R!MP`IE3U(%".FD'AA5QF.XZ!>.JNSPCJQQJ-W@7Z!TAY
M.X-Y'R`5^QM,P&G7RO$NB%,2YK]*R]=K8DK=LCS7'(JD3T95F6[88V@-)4&?
MW5.A#]G*Y\43G@HGIDCU)ZF_5A+]&\#N[+R``L4L?YK"W<OQ]YSDWY,//\6_
M.U?7R[;EB6!'DW9.(+V](,J)TUEL%;K^U$Y\L?4>P!F:#F^]JK'`_ZT&R=IJ
MY:::W6^TDX7[=QSS<+:%<U6^[)"QRK"$ILZJ.H%YB.)UNV/>!-EN;:C.BJMX
MV`=3WUK?^JNPDTFCEP>W.SM##:C,]AW^;KHMET)S54W91CJTM9)OO&<4M'F]
MNWW6DW";;ZR^1[:__$.`/<$_L6URJ(V7%SNLMEG*MD?--=6`#`KZF/1=V\;W
M5]8RR._IS-C`<GG!I,BK7W;7F0"#TZV\BUNPZ.J/P,_T,S_OWL@%TM6"WJ1,
M$KIZX-['*:1E-E:UH,'BVMONDS"L$.33LH[+7U/\84%QM:,[2_TS;P_@;0C3
M`,79XCFVJR(=1"[OX;@4B)2$?0)^)A_-Q&;P1,15CMX$FRV$S02KS^=*U_%/
M^&\D'$B-]_\"4$L#!!0````(`$`P9D5%WTLT&2\``.C0`@`5`!P`86YI:RTR
M,#$T,#DS,%]P<F4N>&UL550)``,G55M4)U5;5'5X"P`!!"4.```$.0$``.U]
M6W/CMK+N^ZDZ_\%[]LO9M6IB>RY))I6L*EFV9VG'MKPL>R:37;M2-`E)R%"$
M`I*V-;_^`"0E\0*2N!*DX_6P,K:E[L;7W4"CT6C\_!^O7Q]\!`'`3@2\@_O-
M`1S_OVCU7P>O#\9HM9ZY\&`21.2O;@0?`/E=\``P^9G\?1E%ZY\.#Q\?'[]S
MR4=#%V(0HAB[(*2_.'C]^I\']'__]__\3)F,,:`L?CKX3/A<H8>#H_<';][^
M]/[#3T='!W>WXX,W1\?OTB^1;_@P^'KOA.#@:>4'X2^O<LR>[K'_'<*+PS='
M1V\/MQ]\E7[RIR?ZB\+G']\FGS[^\.'#8?+7W4=#R/H@(7M\^-OEQ<Q=@I7S
M&@9AY`0N91#"G\+DEQ?(=2*(`@ZY#FH_07]ZO?W8:_JKU\=O7K\]_NXI]%[]
M,T7NX.!GC'QP`^8'B>@_19LU^.55"%=KGTJ4_&Z)P?R75TX`O[ZF&!Y]>'M$
M:?PG_<T?^`^BLQ#YT*/HGS@^'<ML"4#TZH"2OKN9%$9!O^1$2Z+Q-8@CZ":Z
M/*2?/*PE=-B!M']<.Q@$1#`BD^.'VH0OTS4U%NI-&"Q!$!(_F@1$+J`T!A:]
M1'8]HL^6!)8E\CV`P[._8AAM;@F18V&1Z^@<_E.7I%<H`L=73A1C@.8G<0@#
M$(J;!YN*1D`I@S<G3@A#-+\F$R6QN60*D9*424BGY5(F;R\=_!5$SKT/9L"-
M,8P@D`.638G(JT_8=^<.Q)\</P:7P`F)%E<$%SEI:TAIMH7WJ3<0SR74B0M?
MDRE)2EPF(=VV\/V9@P,8+,)K@!.7EA*U2D4SJ#],2'@21`C+6FJ!@&;A?B2!
ME!,L(/&"41B"*'0"[R-"WB/T?2EA&PD>;H,O7>)_&+DNCH%W]K0FBXXDOA4B
M6B>!XR.R*JY@E#@L`8.LEQ$Q-Q"XLO;03%'S(G9\"2/P]1(%Z`&&[FB!03+U
MR`E>1TRSS&_2T./6>9)%N$!!N]4>OYV!!1TX]0V`%D2*)70GP1SAE?SZVTY5
M_T#>W8`PPK%+0A1B@60WY4')!:Z&E.;I[OC]%7@D[H[BQ&5F%"L'>Y(BUQ'3
M:\[,0.66_J@Q\,GH:8:;';4HR-Y(4+MYLZ(8!>$;R&E=<2H1C8+,=;2T8YT/
M<A3D99#1+FI3B*,@.@=9O1-+.>Y1D+V&E.[9NVV%4Q@!+VW-H0ISU5,91A-!
MK9Y0NXH(RUU/2=NTN%LVT/P<!@Z)E!U_$E"@]@N(L-Q<1#6Z`)D5XM6:VF)X
M%P(O0F=A!(EQ@IP@LPBY7Z?IAX@E)S^.UFL,B'#TES=PL8S"T2.-4^1&;48*
M;9JF22B7\#R%?AR1"8FU?`F/F8NH1DV7%S%A@2L$M`I77*9D)611T2CF>$GH
M@Q`&8P?C#5%79IN%)54\V\U%5>M$RUI:Q;V6142;TUUCY)$EYP80JXO!_2;[
M^2-&\5I.WG:*^A;B,J_]\K\]4M,SACJZ.O.BA=4_4;KCC^@Q*3WDD!I%.T6]
M(1'K&.&4A`=0XGRMC5X'Z7,5T9OH:1:]LL]3D;N6F%Y+:=HPJ8C/0U?W649C
M3E=E,%R$]2:\:[*\2J-HH:EW`/GLKY+4+$+:+:=MXZHT`E[BVD?%W,<J#:61
MHH:9Z12YR<9O%'AGQ,?HO"V?T&\DE@\OU[EE[8*(5Q`</$4@\("W%9V25BZL
MV6F:</>16V#HT\`&X2T_W[D'_B^OXO#UPG'6?\R(F(G;3O<;YFL40BK[Z)XH
MQW&C(LJ9J$F-TMP)[Y-"I8S<(47_$/A1N/U-HH_71\=9O=)_"O'-IA#Y067A
ME4'QB^&6O*3$3L"$_#,T*NV>2\Y>2Q8[PL4!.-C=RD3^63'78JU:]HG#=5(L
M]=I=0G]GZ7.,5G*&%Z%ZW2+L`?S+J^/OCM3-94:".@=#-'J"9O508+07VZ8:
M"J["!+R(C@[<,X)W0;@&+IQ#X)VBE0,#(]C7,CO\9T\\@65^!4W4XY5IXRC5
M1A\&TVY/N2DO$_]-)KZ<.:4;@W&,J8PFURXVHWZX<64=R4-?@U#.>`Z(['-`
M_NY=I.#6RI8(EFA`065C)UR2<(K^A^ZK'QR?;HE&42&39T*%?(SS`[.@U$:#
MSNN5$T8=>I92,^LT*1N6">4VL1N*2ALARZV]W2HRJZP);X`+B)D1Z:Y`9%"3
MC?RLA[#<RFR&+;?X=3S];H^D-E?`B/H*](?B>450,N6\[=S5KC%8.]#+"B;U
MZZ9`?RBZ*8*2Z>9=Y[HYS7@1.5+1S<Z"3>R&HKE&R#)%OK?E9-D1+`FAIC3Q
M5AB40=]K9&M[5RKJD\T89AK^7FF-T[$O-+X?M!^6"!AU[>909;,0H<CQ+U0=
M$ZT!CC;T>#5)N)-MS9KN;S]B%!I:#QLYVG9'O@U^&VPV-P[Q*O;IP<4IV!>=
MD7_[($$Q\$8KA"/X+?E][3@,;3+TR&9Y+>;,`6G3A,2^Y4-J3`%84/Z[.4+O
M%&%H,]/(S_JDKS@_:-OKB"[2Q.[HH4]87*:N4."RUNN:\^E6(KWVS'8(-&QT
M)/,#Q:(;8B5G3ZX?>S!8[&^DFL@;</`=0+Z=#S\=NQ\Y_9K4(>N"<9]U5=&'
MQ;V*N4W*$+QFBT&FAQ^4=R!RJKB`SCWTD\3[*+LO4>A/8O*$D9OW,+8E_%!F
M.O^Q\PU*3L0.3I`;N%EU4%&;KU&RF1-FQ3.K:V=#3UXZ.*TJ<;(<?+9;-NNH
MJHR6M;/C[)9,=12&-%C#S/9$*ZS%.M!TI(!D77%[")!=O^G@R*3$:5"N6(>6
MCO-B%5?,%=";=T4&LT&Z(@LT&_F6^D%T$^?8WPZV6G%S4&/[9"1)$>7$JDN5
MZ5%@`[?!!JI-"/9H=32KV'IF/9I>A57;`*&6*BOE<I'.'+>59W]"(6DMU^.I
M8665JV?>W^L<5=H*ZE=R$[L!Z[<115MG(=TF`)M3?L-4*T?>3^T,1+X(+.67
M"&CLR@&+C>V[.B+J8\*D)[$G/=>BP*S.*CPL'Y^(SJ)%?#0$MW)Y`\]+KG4Z
M_K4#R<9K[*PAV0CE!#220&CG.B3WXP'18HR;*RM*]E>,9P<N4!B>(PS@(DCW
MTN[F%CM!Z*>@>W_&8935HDSG)+8S7.NE34SK&0U!0S*A*2VI+"G#NZ'=(H)]
M`[A"?=L<NM!(?,;!=4B3"P^(.FY;2'=)*`^FFYC;OFOS6W=SI*TO:VFDEL)&
M#<60=\CM>,H7,575_?-AN:/-MC-/YYUNRJ\PO32^>6E\PR/MQ4OCFR8EO#2^
M:0+\I?'-2^.;7C>^\7WT2)=(LF<[1?%]-(_]:LL!D[4:0@+TQNPJ2T]AFRP&
MJK7ZN&):EH1'4YP,T$N2?OMGV$PGM&LY]V?!;=0W+XXV*P2*,B8"A:,X6B(,
MO^WC;',ZKG`<ABNWP6:MH(XEV"0,X^YTF7'K1R0FK,0M5O:RCRRIIG%$7X*F
ME[RZ4F.>Y4!U64!-2ZY1]52QR[64A^TP)ELN`*TU?,E)U\7RV<2NUW>2N?#2
M<U%2CQ[-+9MUK`82U]8B)7^]4CV0K0AE>,ULY#=41;)63*6+DQD(EM/]C//H
M5ZKYS>D\)924$U;(=Y3NYQ)!/G)YR?T/*O<O8I#\QP`OYP`OYP`OYP"]&$SW
MYP`SQP=A=O6%MC,)#77"8O+IC1$U!E%LB*PE[_/BS`!^@"[H0FEY5OU9$[D5
M5T#*9CX^+U0':NN%FS5;;)W*%-U,R\79-=EYT)M$VP=738;]]<RL*Y#+W1K`
MLG9:,D8AB9N367N&?$.YGB(+V\IJM=EB@J"$C\7+.3<$*C),^BK)*9D!?)1T
MF<Q&84)SS0SMAH1"6FQ!3LMR)[?8`=^G?0M!0$;CTS:QW@H&D(Z$/H1K4+><
MG*U',D)ZYH6S\^F6\21G4:DU35A9WQN`WS&'*W&@7-/:6'ZIHY7=6\%-K74%
M'OU(P[3DP,NXR!_]:VD2N3.Q_<4IH^%DCDU/TAQ\860>'OG#?0TW429!!`A:
M42I09D=7*$!;28T]A<3!UZH'-IARJ:<Q!X`60\_<%48ROK1[1$SDRL:'@O`$
MS!$&N0909T]D62`BP\#!F\28:3,1\DTBD9\@DH[9C&&8$W<`,[I1;<F7F6A9
M''8R9UYR0F*]N9G[J'6LK,?$'7ACU9P8D-M[XY3,AV:#@R(#ZQKG\_L2*KJN
M*PJO&B=."-V=,-L*-79JL&;CTT+"=@ZI61]MX]=3)23E.-L[SUNA$E%-.!";
MD97%D\\<\XY4@Y)"KAW@$"CN7S\#N%B2;?#H@<SR"W`5K^X!GLXK=4O&5"HF
M@"T7%=>V(+!==_PYA7Y,I%.;3UN)]+IRMAT"#:5Z6N;33-(N9M0M*VO!":]A
M-LVL.[QTS:TZI]9,N$ZJ:45%L.2O,CH71M=F^4$AAO[CJ)N]15_GW5I0,@U]
MZ.P`I:FKEM!"R$7(:HZGQ@*I/OA0L%9Y52?>78"!X]/[+?]"?O).FP,#*O,T
MF`$WQFG/'0Q#\J?3Y,R(3"L0>2:;UAF3U7JNH,%^S"O*VF.XHFWWB*>D#[-V
MWB[1D*1]G;-,*TA/?T[]1F?+A/IA$&;=D=>N*E9BIU,?0SJ3UM'$KM?;?"Z\
MMBN,>L7K@;6K><F>I]!<\);0/'ZE?D]M.N^ZISX/XY<+>'^3"WBBCQ>\7+M[
MN7;W<NWNY=K=SIS&3K@\]]%C4MFPJYX:D>CP(=U\BN1ZN(GUQFJ881$_)A8K
MQ/XN%1FB!MI>G]&EMO9;JO`6W0`7!2[TP4ZN6T3^24=XC=$#),'MR4;5!_5R
MM+1]D5&Z9JCM/J)(.+K0R;;HHQ7"$?R6_&C"TYO863(`(WY3?'ZO`6*;+[UO
MZU_2'C)D2VY,[36<GJO&ZX"UVPN5#"8D8C#Z\YI0>2,_:TN\<=4WPZPAH2U9
M6?U`AHSPYC.&$3A%CT:\G,'E^2J:!:FM9U3W1WFG,%QG;R-,YZ,P!%%X;$+5
M+1QM;;J,:[T-:8F[6G47(64G^K,G%X3AK?.4U?+3N):](#'&;J2X34D@*UDW
MXW:DJ"2)BSHU9B:6P5DZP0*$DYQ0B>&3J#;_PI)0'D>,Y/.R!E$\-320E;V8
MA0$QS%.0_G<25%]V,!-0</"U8A)RGE"Z><6!J<3V4/=Z4A5T&_H86B^:&=I)
MFYO0=P%&B:UAK:(UJ?D:@[4#Z;N)B3#9#4$RXJ0L(QU_-_KGDN3Y&`8?\!)[
M2=,6D\A7`J(;"V%RMG>08,`HV-C:;KQ2OXI=.YONPX(MTV>E^0JB"@U!BG<5
M]7D^D1''(#_&SA1?YON<XL$*I@H=&DJJUZ3X[2*5]:WL1NMEIL_*W2N(*MSU
M-^SNN28474_W->R?E24TH"S?9L"8320!"NT\DC[QV/E2T,#_^6P-FD"6OR>M
MX9IM)05V%U++[2C%+,!]0&4F,MC*GS`JM7`J#(\F-D)=M7U-Q&P=,\DHDQ\A
MBZ\S.ILLRSUR_XHA!I<._@HBNN3L[P@:*1;@8MP'U^6P[4(Y`!^B/4CSDMG%
M!<!+!DD[T4_GN6R3D3/D%HZ]<&Y1=;>`V'5_F5HS)(*2:2O:7/M.$-$&L>2W
M2>/L3KR[GOMS</$&;'7F;.6+N5G!!&/0'09J+.Y],`4]@1H36UU=?54"M7,8
M.(&K*5!K(M:+N5PF4&M$2,>KO!H6:WHO;[I.>H.>/0'LPM#4>^AM3/MQ<X/#
MJFO7;#:6%N_>\!<*,89MMYJ+)9"=Y+R"=2CB+Q_PZ6@KN0U-;H!/@X=;1,;Q
M&4;+9=H!YASA[JX`2,LR.).11UUK>"CY#M$ZDWXZOT#!XA;@U2FX-[(MJ.5E
M*5VKH/)ZV&P?T->$I!TM%@+<GT^XW[00:&C8+1=&S.?`C:9SLIPEIQ(WQ+2F
M`96>OJA,_D,WJ0^.#PS=!A+BWP/_%RWG%H)73X]PR7Y%3)G25F_EXR83AB#$
M?WB&(`:OPHF=6A?_9G%'9%K#>$,&_<GQS=1T\#$>X)K`B:A\D]5U8DNSR,&1
M<K3'):R91KD"!O`L32#7:5>FW5EJ!6=!-2%LH>79%8K`\943Q1B@^4D<PH!L
MF5])'E6<PM#U44AHW1*93LB'OYIL<M;$3N$-FP2,Z7S_:H^1Z+K*Q7K#,`[U
M%4)H!E#ZLFV6?.$-?4TB1//K')-7\K/TL_"([;1P"D(7PW76"R,!:EH`:L?4
MQ-@DI+#=/TK0H61PUN!P%KWM+;.D0J4E3A7Q6;Q>^TD7KXX]C\%8W@=I1%*.
M2@*/!9]1)Y01PVKO12&#*$>"PH#K:O%OR1W?G3L0)R'N)=GD$LR2M*AL-+@C
MMM=!S1&U'MMLY*>RTV81-NIES0SM-I_DT6K>CUK`&_;Z]3YMICL)7,("/@!:
M-J0E6IS.\Z=+V6E4\B)X<OYT3\^?MF=5W2QK4A+)KW?<C$_RC(UZI:I(/=K?
MJ9A7H3V>JI8&OU_\OOQRFNQJ6:9CTJMK>4D?598I&G7$>F:V-WQM2FQZ<D^W
M5UATBA_R[3%4V][MYQB3+M'$3N7.;86J4<]HY&=]_>%0*;-+'Q.\P:\</TX(
MY6`!R5XRO6/@!-Y'A+Q'Z/NO9.?A+0&R52V3[\:/Q`10./_B8F34V00EL)H&
MD;*+0O-$0;@U]D:VY)\?LBO<60L?I;1D=O>;9I`2JHYO=-?6Q$Y^,2OU,MD2
M+W2YZ,CU9$6Q'1]RV$'>Z:01'W96Y?B(["57,.W:2%;%,0KH"3X(W.WI@%P*
M?4]T5"+:S=HH)H!*;0@/([/G!&(26%T;I>RB]"Z>$-S#7QN/CR]A!+Y>HH!V
M3'='"PR2LP)YYRQUSNG&(=N9JCW/44/=;):RG:O=`P1N31??X6C'<N"+WIM<
MKR#I_=^.1E=9DWIV2IW*RE0-9TT:^/4@:]*JTE+?H0;P!I\U.7X[`PNZU-!L
M"4`+\K$E="?!'.'5KEA+[D6=E.X-6-,W?H*%T>=9ZWC)OZ]9HMB1Z_"PM;WI
M:E-LX?4?'AB'GIX_?G<#"`2Q&\68C'%,I(?R91X%6B3^S<[^VMH2Z+J'R,M<
MMOU**X>./$U*#LO/B@N;1O%>I@SP`Z_`.GY_!1ZSM`\9]HPN<P[V%+(>SZ("
M.5<1.YT7$+K&9`\:!VY:JD8@_`*BD8?6D9D^&G*"6(\A!0N1)>$>?'#)+$=.
M'EG6>27F>10D=UYZW%IDW"__XJLR[J">V*Y+L4N*=S[U4EF<$DY/4C.(O&EP
M0ZV!!C[)[8]NBHUY9;"^FDF7('.C/'R_8U4F[[U./9C\VQ<HS]PE\&+:)K12
MX#IZ)"%[OAT9-;[40<(P7J6_2Y1A-C>C5T+K;J^_?%FW#@<?`%>JF147ZF$7
M->_-HTR;KA?N*/!.H1_3-F$=^K*8*+9SKR(%T=)P#ST?FR^75G2X9U$UO3>$
M'?UQ^F9&EX[6PMNV9PD64_-C.NQC]*:JZES\^U)<S1SIWDK.80`C<$%V#E["
MS0/S_6_*S$\VE\Z?"(]])VR,:VM:4>OG.LQ::P/HZSH.49C#=][7S;1=96?Y
M$$RY]+X12DVO4O2DQEXMU_XLJNSWVJ[6>G<9_K1RM^Q6@J7T(K`.?3_16B.E
M&@@-O%1JG_4IT<Y!=++)_MA5BDY(%-N;#Z&2*EFXM;FA1/B;U1G3=]NW#233
MPLJ3S=ZC'']$F\$J1;P*C*PG9'FL0`^D&J*<'E;<*>9ZGGGA7=YR<KS(#P`_
M$*.Y)33H04#8U13-+X;5[:=2T9T4Z,/-&-76^Z@<DK*(FG3%1GXRU0FUI5"G
MY!?0#^M1XUG[Y*F++^@RO(B!@4D$5J&QT>PY6)TH>.R4S@T*YI!;M]6:J(3)
M]4HZ^XR>H*%'R2M<K`58R@Y8;J-2AJ^JEY__X_7K@__Y?/GIW?_^SV_N.G[Z
M$KS_X'W[X6'Q91/<G<:/'W_`'W[X]<V?=[>;T/_AP?UVY/]W]./=^.+:^_*[
M__9]\-O]='PZV7R\_>O'KY^_S-ZOSMX%DU-O.?[^][O?WXY_B'^?S+^=?%H_
M?OK](0Z^S:Z`\W[U[]M;_\N[L^]7X*_-)/KV6_@[^(+.YP^7AZ.']?$/#KZ.
M;PX_?CY:?0WFOZ[?_O>__[P[N?OKZ/Y?G_[UY?YJ=/;C^?+]'%Y\G5RZG_[M
MWZ^/WDV?;FY^^]/]QRR,/[C7-^MS;_%T]/'-P_K;XRA\O/WM9G5Y>W3^.]Q\
M^1[^`WW^]Z^GWGMP/\?1';I%X,OOM_^8_>_!>';S^K5L7'8WFQ$K23(3UXAF
M&$A4.XOO/;+\AK1JX!*L[@$V8<.<G*UO'.H].F^XO#CFP@_IG,`8D!W,G'`@
M_*;S4[*C"6%D3E%-["SGU?ATTXA7<7;1,.>/"9L%PO!;`H0YM7!PM5MGS*<<
M'O!RS]59,C@MBYQB@%>#@IBMCAX()\J"O@[H%**I%4V,?$MKTTP8+"]K.U:K
M)?HN],/A15K3CE2G*;ANO(J3G?A'C,+P+L#`\:G$'QT8G(`YHL5V3QT;":=0
MMM+-71H0KWYTI"([LZT+\E/O;*LHU-_:MDKZD7A#UK1M=6LT=A(B'9J"U*.R
MO3G*V%VD0?/LH53'GP0T3[R_U25:O+&C.6729"=.:Y)QO+2$_:3^)EMF(ES(
M\.83U3EU/D#QI*D>;M92&8)FN]VK:#`B+3G5':N3S>Z?_X+$Y[&[W%R`!^";
MRK-R<K::>]7FZLQ;B"V0E_6KJN%)L(Z)RU`&Q^92)TWL+&>TQ&R=J3(6AL6T
MHS8=O>E61V^>HX[>:,Q$LNB_[59';Y^CCMZR,Y%J.LI/UU493]&*[.6-:HU+
M`-O5>QH4R0=T;J^CT,TX)VY2-I]<=.@@/"DQLYFH,!V0E'$MY<7ERF!0`#;I
MUOD\#CR#QYXUG/HS7;+-MM`'I@:LTMGFRX%T#W0E>"Y]K#;[O9Q,2RF)YX!:
M[=B/LZO,78#N:?$DG863\(?\&9$YVH=9X?M^+!W$)[IE'9;GFE-97:0SY#A!
M8TZP!(_<1.B$2_J\0O%-9D8O*"/3(C=S:R<86M.WY9>P.8'7V#>+VSZ:REB/
MN-+1S13LU4YHUV@+5%INV;R<0/9%VP*GD1(GSA'`(;CH0;>[7#^NNQ!X$3H+
M([@B<5\.LWPC+R=(^WJ-UD0D-UW2;^!B&85)SR_Y^Q\E06ZK@DP+@HQ:!!$Z
M^C3&7/8"":L!86;,9C3&>_#8N6"B6<V.A10_NK4BG*VPVK17;R/M[OU%3W[B
MQ@D6QB[E[(G;B\)L362%MQ#V(&LY_K^$`5S%*X,IV0(#ZUF"BI$6<J]%,+2D
M7"^=)\,`%QCT'.`B&%HL.&%H#MX\>;NWN9N`+8#`/$?]&\V5]L(F#2?8^_[#
MM,<7#2*N4`!6:Q]M`-FPX0?H@O`6.T0NETJRZT9\":(E\FY@^/4<`S`)R+8,
MA-$-&9<)MS`AIM5*+YMQ=J'O@@G]ZVM'K6#/^4[=(XSIC$53%B<;=LOM?(I^
M"S_M#N=&P/N$?$+&)_HR;]_FQ/Y;1+*<QF[0.&PF,_==Z)L'>"\RP%N`5\?&
MC-Z,M#;/PGIE[8:,0<.%H?Y,[Z?P`7H@\`8UN1>$MGB3NE?6;M8RAGR#*GG)
MP-F]9,!\;D/T!E7I=02^-S=JTKN\M*1/\3\#:DG`&ST0>!;@*J:;U^S]E7`:
M1R%M6IH58K@F9@$Q`6PM8((ZS7N@(,+RFP3V"2"W19S-Y\2YI_-DB&3&:FN6
M5F.Q'&3L1-P2*N2!1%/#;SV.FXVM8ELC[\\X[4#2F0MSB&++F?DMO=6/>0"W
M4833,OG4B=WA!%\K@J6@3?\,7P^R0I4'BAQ_/\=;BIK*[R.)1DBY[PNM+:SO
M24<^NW=W;IS'2Q+(8NCXQCH95AE9.1-H`+[<L(H!C:TN/CMQ/B/\=1)<8^2"
MT*RJBIPL34FBVBK!8ZTSSDX@^FQ.N,QRZ$;U5>0T$'V5X+'6;68GT!4P^RH=
MI=^#=HKUMLE44X**PK:LN&3;6[.+;QU)+MQ%(H*K=\V7I;JC-#TLER7:V$/F
M$56)@<0QG22_2N;/Q*`N"B5_-F;59IO;UAK(&X2>PKMSOA?AC%V4%F!O]8A?
MU7$+%\A$,-?0?.*47L9':WK>XRX#Y*/%)LW$FZM\:F-IM1I*PN;SZFN%LUS[
M)QW@9$$Q?3>#=D2@^_R4-TW1F&Q@S,/8]CU>-25R@JO#^R"9^>%]O#\`,^AV
M=;SL-IQ6=;A:!+5<P;YV(GK[R9Q6B@RL5]DJ:J,$E\JEW#.?>%Q(*](\<.6L
MF)6X=0<V[*\.<U*JPR'#]IWJJ9KNR'`_$BJMP88#@B(,4_O2@&?F\=YFK;:.
MN%A]'UE>!]3R`TE[Y;&#\8:>B:U07#Z`Y$P5L.C8K&73L5>G^N+"J_,WPRMF
M1NN<_13;W;DF7\Z!D]30-J1<RJR#S48E;"6)LF^!GCW5D,@IE\>KH66OL-J4
M1FM1LU7W61;P"D1G3ZX?TV/F[8#-[&LY^`YI)66J7PQE^3)(HR'F70CFL7\!
MYT9J>+GX/AM#X$-9?J]A^_G5\9)6!8<PV(8@637R%K-=*PXA&\VH3HI4ISNJ
M0H=(W,04,ODF9\[\[&@GY!%51]X!*K.=1%"Z!A@B;Q8Y.)(O5BT+Q!.BZE5@
M8R0[3*T:#%B5E/O'D7%/'*;"_CA2"3U31SP+O%YTC7)='`./WC`)0H5'OTMT
MQ'HVU7Q798(ZR^X,9Z^^7T#GGEZ*A"`<QQ@;*LAN9VIM]6G13][*.:#K/#62
MB3\FOZ-MAF]I921]XI"MS68[JR=B*?O*H9OV\6O);LBU+$QEN\9H#D+:^=GQ
MSX%1/VOA:*U%%K^/M6&FHR91SL6VI\D?25`BY5YL`GV>^)I'KN6:I61S'T`[
M6[I13%LR4_'P`S#H5DWL^CLU<H&E*3<@K,$IC;JR0703@[1P',#<V(99[M"P
M:X?L5).#5F*[_KY7+^FVM6DBR[9'9IH;\`""&-QOLI\_8A2O]SLH(0LKDCPI
MD!3:3'$1DNYWX2Z!%_NTU2=8T"S%#5C3\YA@,0GF"*^R=P&R/S+JOC5UL)`0
M0WK(]1PJ.6NM8^3A:R7#+V*JA988,L:CZ17(3,8ISGJ(F:H&9_*Q_<Z9@M<6
MRN:8&)84)*2=*8Z6Z![2`F0ROPK4SC&_:!OF)ANC.+)'JZOOA!#PIX!HW1<`
MO/`%RT5J;3@7!R>?%RGW]1!">!;C!<W4"&!<^HK=@N<VD,OCT_V``O\<LEY&
M2\=?05=D_BA_R>IMCM:)HS)$734/8E!_`O1*>N#@C0#4E2_U&NKJ$'55,"O%
M+4DW_:S[J;EBY7IF?5]:.>"R76JL.1CCVY9HN5U"W\H)LV@_N;5MZ+HZDX]M
MRQ/9_A7TPP1-=Y.Q'N0^/@*T(!];0O>"6A%AESM#5DJ!5"DK)4(:R(G[!JUR
M.WZ;&0>M;ML1SQE(5NK&BQC/H$SPE7W92)\<-8F43C"X*+ZL8S^=TF[VVQLG
MV@U04[(E>1:8RK5GY/BF,B[US&Q>5#$T-Q16F'J4%>[\WM%*6R]]V%D@RF=\
MS?HMT58SI&BRQJMQE9:K78HQ6AM\U*5`WW(RATM);&"4WL])#AFW/B:2.6!\
MSVZFA@M!YG"MY6Q*P75><'.[VWIFUO<8(C[0@%GQ(ONS6_B,Q9R5N[=BUJRX
M3VG>EPQ=B\Q-<A-BMII=YC?L'20X;.8V^'88M<!T7OQ[#3!]S<%9@.F<2)#)
MPI<$8'_54M##!WS=<#5=![&0,RJ4YB65061]<R/X`*.-9+U,$TFAZ9>+D.BD
MDLRA[PJDQT19</>.>3LBW)D0-3:=CDPBSZ/.RM8L*V*AN_!&T694BC&8=;3T
MCL$H\+)R6F//&[>PM!<':?'AVBIE%KJ*.;CMY1WZ,!8,$IR2>R(BC:F:2=C>
M+7':9]*5J@4,;8D>P8L6F8WLI2)#.'?<Y-6^L8_"&`-1I0D3M9Z>$]"C.&+Z
MJGXD9]%;\IGIO#!&<ZF->F8#<E8.Y$H;]:&O";IB*0WO+K,NSQA?Z;=\K![4
M:(MEV^XB:>_=(-DJ-'EJ,#Q'N""DD7JB.EX#=-Y&==>#*K$.?4A5'H!%<OM:
M3=TL0V2VF^C*V=G,AQ?@"[M_#>K6'A]AR6BFX4?=G/_<-9[K$B)1J,OH$F(I
M>T=1>T.?:0O1_#K'),-,]"V3+62G,'33R/V62'?BTY=VF8D[;8W%:]G)U7\U
M8"*6PFLE)).D:R`JGH;C(F9[K\%A4-NHNUUU&MKFGV&,\!@1CW<I?5J4?$U\
M&E\GGIWK]$0GC^P$^&23^R'[8."E'6E-9=^,R&DOQ.-URT)AB1%5*16H3`(7
M`R<$MVCLA,MKC.C3W]X)?3_+"=QD>4K6)2A4IR5.U6YQBTD?2CO-"J-LJSKL
M%#`EG9)`P8ED[4&8J/6TH6F+$(?9T@W#7:>%_9#)_K,$C[F<(P];VQ&!:5L1
M4D%ME5&/UT?^0%)##C*GFAO@TJ<BX!RZ'>0I^!A;JAD1C>6+U^&X$-7R4+K%
MS>G[L[]BLD$G:SEA`1_`M>_HVYQ.YV.THOUN$MFSGHC)65/RP/@]62N\;?ZO
MF_VKE$1R6]P&9,6VN*V$9+:X#43%M[A<Q&PO:'K,<CNSMVM7PRYX].A@CY[I
MF=J^%AE875IYW:40.Q3QT5;!`]WD7@MROYJ[2,)F9/5Z-=/<*IG:*CB:7KPL
M4:>WB\*;V5UG*B@QM+MY%]5%&2VE_,G^<@7-`Z[)\%V8SI7)^XNST<W,G%;:
MF5K?1[<JAP,X=CV&H'[H<G5"EZO\@C;"F+9I3Y:OD\W^,]F2E@B_'P'9UI&9
MUNQ+?D;D[+E_FM%-Z;U-R8F6BF"L'G5'W%X:6R:6R(&BI?/')0S@*EZ9FR>+
M#*S/B16CRH-;`J,<,,@![#P9!KC`H.<`%\'0LOHG#`U&7SGR5L/>1F`+(&A(
MU-W"B/8OF@0>?(!>;*ZW`YN1M=(1F2FY!JOR&BAHWB>(+*_3^2FD.6:$14Y\
M:KYJN0U`HTE1/.M&;+M70T7PSS!:)ND8>N"PA.M;=$:,)=H8K/X6%*'OJI:&
MMG)UIO_3!'\:,]>'4#H5YR=_)[MM9ER?M74WDJ/CX]S7Y%WC(0LOJEI.60SM
ML>NV<=-UXFOIBRB3(#U*2A[+MK+%EA!SD"9E1%]ZGK_NUOZV^-'BVB3?D/2Q
MN5TZ`7.DO3)*4=E[F6HP8Z;":M7S'%;'QIO\WR<0TJJA="#'O3)0EGQ]W%N9
ML4&F=G2\]257*YS=5,ZZ%K-'=86"!R(P2&4/;^EK./F_T^-?@N47VC/$18L`
M?@-&ID1SP@YO#C2H.`UOEDE/>L:&E;I:<E$N^17]G)%IL>,1]'3#:<=V:Y2L
MX>$VL3<X=I4PS6O#?4T83;O(LP]!SYX`=F$(=B%*`LLDB#`,0N@F3TIS9>,L
MBSB8Y=ZV*N7?K%/>/%UCY`+@A><$O&0,V9"V@AM9XMN9#G)CS8%EIND?;"64
M$[%NP#K&[I(:<](P(X)$B-/D<FEJI(FQ&^JG+<!_>/&:&+R9,?S890BFFORI
MG^JF<132CIYDF%<Q_[-4'<ICL<9>:D7J2DV9'7YX'G;X&=#_$-][`-A9@.WD
M>XU)$&K9)!M%&]229TM]VS1S=^UA._%$V=B^8[F&M`VUHK>M>79Y#-+)0$M>
M>0/HF7C2="U(+G_$CD_;Y_7'<GD%?C%I64UO;5WQV*0;6R])G]2LF356)L>_
M0P3*AGIK+2J''Q8O@7Y_YF#J!2'9P27#WM\`E<V!EPB:O-U9RTOZ1&E$;,B#
M?DPM:09<LKFE/0O.GEP_)BC3!`BUFCC5QG1>$2"Y\&ZD%DB+8);;DK281J$^
M2(\B=+VZ8,D]?YS0QT06\-X'HS`$44A?%D'(>X2^G_=4.6/?4B+K9YG/_LJL
M2?\5$T`A/4C,`4?P6V8L95Y&_+69H^TKT5*J+_AG"Z+ZZO8LN=[Q$9E@5C#M
M3T+<CB[_9(8!@4OFH8+OR9EDCOJH3+T3YQ,30.THACYW]-FA,5:TR1I$&CI_
M87&R7+HMI6G&^]P5`&T]^E22QV`%=`VG9Z;0<K'S`-\J2F;,XTL8@:^7*$`/
M!(;1`H-D0Z5ALCS-L,A>=>IF@FQG*OT&=#-2@D\9\1"3F+XY:%<VV*K"7A1Z
MQECL&,-K;[L'";@TJJ$Q3$FR7-["9+<8#JX6N],+>%-^%N:!4J6QS"7TJ5C3
MJ^FGR6R\$TO@UF$SA5ZY2(,A4LQ;L+!]'[%Y,.8N(7+QM7I%6DS-8G@RI\.>
M3QYBJV*E>Z60=6XSSC3=_`4XF&^9K7[+8G9>-("@$#.&;?$68,F4.Y@%[+[L
M(Z&P6JCT7)[3HK?=?TQ>\6CE.3!/Y,?2XH,L>5DHEB34`&&$`G`)HB7R.E&\
MA!1#=7(9P'5<$+.<#7XS"<@OP*WS5,K^2EGMCE@WF8PF=G(M;EEX"*8M:BD(
MSP5UY"32$XU4K#>"XC";78Q:KZ"ZAA^"+5R<IZS/NZDV1@4&5JM(6ZV]T("E
M"(SBR\2YLW,?DFF64*<QL;GF7&Q&5O>@3%,K7,EC@Z.I.^V.O<%F1"46MH^'
M6Q&O8*)G4MFYV2@FH02F;[X;FEUJ.-D,T$4FF3J@U!(.NWB?T`Y)$#2F131X
M8VZR83.R.MDTFV!A5\1&J3+K2*G@'&$`%X%Q#3#YV)Y^^'7`ADE+$\RJ$.;F
M_UI>=G/\_'JH!TM'M^LJ==H9N;NE8<?-7II:;7'8PZ6EC?0DB``.'#_;ZF>=
M$"8F>\.WL>S9FE&VSZ)Z6M#3TR09!I!L#3?3^9F+`K2"[F@^=R"F)2OI.WUD
M5^OX!I<600D&I$%1;`VM1V9;]S?RZT\JA-/EFK"K?6..3T&9']-Z=!0D16&5
MA:DFY<3^9K\7F9K1RK==4GK.<9=[S@KQ:"HLDU"LSJ*%BC5[;S2NK+*B#0%M
MU15J;L&:JG@=P_:TTZJ&VM'VI+TREV]S)-)SW:C4P_FL\/4$!&`.S9Y\E%CU
M+IU<.:M@+E]EP.QX]B[M.I_3QUH?P$Z^&R<":3UT#(-%]OHO"LP\P,[/O6=9
MO49=BX"JJ5Y<XNY*NLZ$!HMB*CQZ%18UJK`*C\U.O,1@@NQ@Q(2>\N2'HZ("
M*,^@/.'M#"QH!0>]'PK0@GQL"=U),$=XE7!4+UG(&-R`-;WX%RQ,UBO4\I)>
MJM*64--Y2I+&/1D/(TM3`S>K68XV'>8]I`FQX5_N?)<\HAF[4=*^;DS$AU&A
MKD>R&"U'-.F1ESPP/*+K>7)_W:33\#,77?9;$1.L_&DG)7VQJHET94%0D_2B
M6!=D\14S4:O;;?4X=*KM9>4=%Q1&B9`AP`_FWJ)L86DO4N'VH\J3OTT(JJCI
M"@5C)US2<GL8I#@$WF2U=B"F\_UT/KF^.;W&Z$^R+Q%(JDF0M7WNS&FHJ?^(
M@V9GMTXD=8FDIS!<H]#QIW,B%=E#1ALB,.V=M!:\E"9"S_HQ@9A&^7&2WWE7
M+JR):7,OWB0@FTOR`>8)7HWNZK\](-=K@$!^GZTC'T;OMM&`.3<2@R6#M<P&
MI$H.Y$H%"T-8M44B4<6SQUK,Z5%TTHMGOR:-EPY>F&E_+L+>;NI=:(/0&((U
M(=QU9Q;&H#C/V:K?ZZF7,97#'+>^)_LL9"=.D9L\[D:#CN29UEP23SPQT42-
MG8NH"QQX"(E:K0?@'RFU&["@!35.$-&ZC/H9*@3N=POT<$B^F4Y.Y!_E.:F6
MJAW#%E$!->EZ4!1ODE#"6V'H>JN.<H&:E1VU#+A%#%3*4RFU<8RI<.<P=!V?
M'B><!=ZI$VE`MY:RM054!NUZ?"J/N4O.';0;%PJ2!M#I`R2YIL^Z9I)&'H/2
M!P]FQ4>SY35S'=_[T#WWD=.0\!931)[D8&8<!AHJ9324Y(C(X%$YSGU'@Y47
MR5G*9\M`6\(A]^"8>"UA@=XI"%T,D_[R&N'-4QU..,(&)??DEVPXDDU&@)9+
M^!,2,C_]"C;:YNP265MI$859N@Q,[F$M^5@[6Y%WA\`S@D+<D!401)U-?4!3
M2C-*N3>EY&:8E/PGY,<$`KPYASXH-W:21[],=G@V7P$F_S*2U%*9TDW(C4G@
MN4!8VQ13)#K`.+"$2OZ9'[4Y_3/P_5\#]!C,@!.B`'B3,(R;KAF)`5]'?H`J
MJ$4J_PZ-ZGX_O:NO;6O*)CNDR:8&F/QK+E*3S9;N?K][3GZC87ZO(SR@A;46
MFRWJ"AO.(NWM2]H&D,^3'DX$WP#/%OSW^Z"R)NW]\R&E2=^*3G[\_U!+`P04
M````"`!`,&9%G$U90*40``#WN```$0`<`&%N:6LM,C`Q-#`Y,S`N>'-D550)
M``,G55M4)U5;5'5X"P`!!"4.```$.0$``.U=[5/;.!/__LP\_X,>/O7FAB80
M*(5IF0GAY7(%PD&@I3<W-XZM)"JVY4HVD/[UCR3;21SKQ4X"]=WXOEQQ5JM=
M_7:UJ[4D?_C?YB8X@SXD5@@=,)@`U'D3>K^`3=#!7G!C(]#U0_:K':)'R)[Y
MCY"PO]GOXS`,#AJ-IZ>GMS8CI38BD.*(V)#R!V!S\Q#P__[[GP^\DPZ!O(L#
M\)GU<XD?07,7;+<.=O</FDUPV^^`[>;63MR(M7BF!]0>0\\"SY[KTX/G`7'1
MQXVY/OF3MYB,&MO-9JN!?!I:O@TW$GH_\N343D@:X22`#48!";(W0&B1$0PO
M+0_2P+)AIIGEHP<K'#/]`QB%R!::-;BDS?U6,^WLF68:/;52N;8:7R[.;X0>
M4\&P7T`V[&].Y8O;1723_S3K:6C1@6B5_B+$VFQN;;:VIH*YR'^0R;:UO[_?
M$+^FI#G*[/CRGP<69>,+7>A!/SS%Q#N&0RMRPX\;WR/+14,$G90;'[=E!I+U
MZ833AO,B[#;B'S<.F7D`P`W$\GT<6B'"_J$P,VYLXGD0('^(#]-G["D7_R#5
MX1H.@=#]@(_;QPV*O,#EEB.>C0D<?MS@\FZFXOWM6H.W3,*4Q"(VP2[4#VPC
M(#A@OH(8,K/1BQGD6F<'F__<8'U"]WPF\D;C<&WZ!`2^NCZL3\KL1N"UH-;Z
M@'+@\-458WTB'TG46I=2MN6^NE*L3SMRI6!EU>+4?:8(X/^XO>X6\'K1`8LD
M%+O(X3'AR'+YW'TSAC#<`,B)!^!O\K>2:$Z,5)`9#(=LXF7QZ8;9FIBJ1"SS
M'>A3%GGF68*$)Q!,*7ASZUN1@]@OOWQH+#+-=1@Q=CW_4/Q[T;B3Y@E)7MCY
MMEG[66P)](T7<%IH/86JD<$J[W'K1O'O*XNP\1A#1FZYM!"HBVU,&&^OBC%X
MD^U1!KI^]&O8H</31`+';.19@MCU&0U4PBVCS3M6!N56,92G)!3@(>@%/)]E
M#"BP?`=DN@5QO[6SKQOUMALVRR`OZ`]E.K^Z`0`F"R0^XP":]210T!QNQFSV
M'&/7@82>?(]0..%<MC(FH**1*Y?!?6<9W#L6'8-3%S_5P;P\H)<XA%N75A@1
MB(='$44^I-G0+:<PS."[#+QC1&T74]:._<&Y`)ZAQ9PX;BDOJ?/5[J=":_O(
MHHCBX=7<&.0`DQ*9DJMW4M!XRB6X<<SF^=639@G46A<6>8"A-7#A#;0C@O@J
M+0>;G,H<+_>DR/$H.F,(9AQKY$H@MW-J(7)GN1&\@!8?7A%X<M`IR`SSY'LI
M<#P,<G9`\`/S#.O)LA1XNW$"PK(_-@(L#[QBZ\(<=%(BTV2Y+T6.Q[V8&YBR
M`YQ?[7(E4'MW8A$?^2-Z!8G()G.0Y2GTCK;5E,+%(U[*"3!60/"J?:P46GM=
M_Y'ICHDLHF5^-&"T)<6(Q[8Y)K4CE8#F?9<I[H\0"_]M2F%(V<+X#&/G";EN
M#BHML6R4,^!M2\%[+\!+V8*8KUB>IYQE>-9PRN'<;]LVB:!S\ASP57'>VW($
MQM1QJR7%C4>WA!=(F=6>5V9-W>Q@ST.A2-J8O7<PRP7\$?1MV2RIIS873OA+
M=-EZNQF_TD\Y)W6Q.=ZU]Y6`=.L"A?#A`OOXD0UU>T2@R,GS:*H("P"I*)SP
MT"B8@I0KF+*M,2R!X79<".Y;SS(WS/QJ#'GR>HF(A$FY63"JT\ER$+5NX(C;
M-4\_(!XQLC&RN_X0$T]>[#*W,$(I+Z"(X)CPCI.6*7<PQ[YVP!+H[EQ#&I+(
M#B/"HE"'0`=)JBD*,L,"0EY-$<$QPPXD_.2>64.G@&[W$CZQI!!'(H&XX>YF
M$4<"GHJP0/R3EU5$6&1,P8PKF+*MW6_%,G2?_UFP&)W0ZAUQ6UYM4=:CP9N8
MK70S1@UEF;JT`DLML2DZ;LL+,YHJM1;0&M(RU6H%H!I2XYI_6UZK4=:N:_=<
M1PU;`:2*SNB4\L*-O*)=^^/*E6T%?!(2(W+R8LU"G;MVNC77NQ4`%FAB3ENW
MY64;<_5;AW(-<K$JN`)8!9DA<Y77=&3E\-I!7Z*XHP"S:+L"KKI2J:?VUW65
M?%1`ZXB-D;5L`4B?%]6`%M^!>,P6]<C-XZFC-4S%\E*0<CLB>)/PK<$L"J:R
MP).!44UE7&FV2A>"4@S+;%W\MT$KCD[_^?GB;N>O/[_80?1\[^_N.S_V'D?W
M$__V.'HZVR/[>Y^VO]WV)]3=>[1_--W?P_>WG?,KY_ZKV]KUOPQZG>/NY*S_
M_?W#Y_N;7>]DQ^\>.^/.NZ^W7UN=O>AK=_CCZ"YXNOOZ&/D_;BZAM>O]T>^[
M]SLG[SSX?=(-?WRA7^$]/AT^7C3:C\'6GD6NHNO&V>>F]^`//P6MW__X=GMT
M^[TY^.WNM_O!9?OD_>EX=XC.'[H7]MT?[B!H[O2>KZ^_?+-_O:'1OGUU'9PZ
MH^?FV?9C\..I39_Z7ZZ]BW[S]"N:W+]#OY+1WO#\W.V%(ZO7_]3YM.]\A^\O
M_P*=F^OD@/@Z3'Y:!\/#4^1;OHTLM^OST#"KB&6LOU`#_4S66J)^-N<'<S1L
MRIL*`>:DJ&>\%:MLJO"EHS6`7KK(5H>ODF"R]73D!;QW>LOZ#/$)#1'+T^&<
MS]Z$V'[HQ40LK1=_M@,V8LR%^,-K-!J'M/W$7R3EG?]E>C"'37EMKX#M\'7J
M3&;`A08A!JG8"W.)D!4DLHM53_QD7GP0RP]B!>KZX4HU8-4THR0TKV=;\FJB
MJ@ZLG61J)&5(\M6&S9SC&+E1"!UIO3Z#:*$&AN@A+RB:4$W61K;PY:3[PAO<
M:^SSV"]6]S,XYWXT8"JO+>;J_G-@&O:]UXB5?PV@FH*+M)$,6P9@>6FQR%L`
MW;1<HRSSRRQ8,N>441@\5%X_Y$\+(R@#N\[HB]XV,68#!RGR.Q8A$Q:TDAP[
M\T(N>]]$H1:FPG%+7FLL"WPB#$`^2,69)=NZ`R^U,<B6=Y+W=]G5F8S`N+C:
MD=<DY:_XYM=5!8[#U#`N<1I&%9$+-3+#+2^^F8_&U$%YG8=DE"`;Z,WXRNML
MVA,S-;0KGYU1XBDC,N3-._)R5^X@35V]>*E=%THTBS8T(:PXGUATTT7MKN5`
MOR+8B>SP&CY"/X*#2?+W&<%1D,^CS-3F,N2.XN!B6809>=(]2.3A]U.GCX1(
MM1$L9P2SH3_']FS3E-845&U,_JXX&KD>:YAKE4I5+ZI6WI"EC`%:Z@(S@V+#
MG693EC[,U[#F8<T,I%BI6FZ;7]_/;U_,>;F9N@"LY??:S7EUEB(1`:0RU#-\
M,=2/L2WV?[1]YX2M7/D^A853TEH*4U6LF:N4I.P`XP=BAJ:#T/].Y#XT,M\<
M$$_C9YGO$\3/V6/D!9B$P)=^<$+U58OX8QAIB-,TX7]MINTV^:/-K>W-UM;;
M9^I,KV\O*097/+Y`OIP8:;NEQ-!_WT(AB!!BON7(L@+1L`'=D$YY;<YX324J
M.3+Y#XD4&9S%5GQH]OG0;+U;79#YKX:4$P;[EQIY"D@D_51'47-)&_#.=_/#
MD'QQ1/3Z<6.ZW:8GW837'K!_6C;K//Z\@OAPS`%[QH)+-X0>]]T-8"54'S=8
M._YA!$$5L!'`3E^T<R*2S)T^<ET>"%-:&K'&*(SXKV(1DG:"&/NYV%I4T'EO
MR*JZL.6HG]]RU,ML.6H;MAQ59VQ>3+,%>\V.I]@/T59NQJC.\!055&TZ<[L%
MJJ.63"B="MFWME720R&96IGD=6`W^VZR-WTW61WE"DO:.%1[VL+KN.IHIQ),
M.V]D*R%'F:)8=50K)&7CL*".^6I/=375R*I))'0KW^KH6DA*):HBD%S",'YU
M4M%`IY9/-\4DL;'"RADEU!AGCZ_R)1]-.<>T0K-I(2F5QLD_UB&^U7%*L)=\
ML87;N##N2B4NA275QD3G6T3C'09]?`UMS%8$+IQ:1Q^S?_*.V.SVB!SH'$TJ
M/2;K54?C"M.$9-8^SKI\YQQ9`^16;&!*REO,/7CJ3*MJ"H4EU;E'ADFR8/X'
MJ*N35*>N["1MVK#Y\W74BZ=>YYP,A]`.>T,1^U@\R+?^^;H5D%&M8)7S8GT>
MK$BC8(`I$K.3B.;Q7'7)9O.($'&C\;Q6'O:959")3*^AY5*I8G$U.DQ_&L0?
M9&0*PP$*5TBO3)*K092\Q5R#GC,`%Q2UDQ[6L@9(Q-4$3/[!:2=RX[HC8W7.
M;-QAH]3UD]<D\9/%*L;1Y,+ZADG'M6B\?[8/G\,C%]L/Z=C$WZX^"-/G2X[.
MLL.P?KV47C'K*EED<B-+PWF<X,PO.]F2C$"KZJ.V@BK:\HCR@M#D):_F:HE7
MGC&=\&#,6A([&L!N=IB65T+CB<LP/4>^D(W^_'BRFOA*YU)?0IKP+78Q0[5L
M9W6%U.%J5?X5,ZGUJ&*<DC3W-;S0;0'5LLA7UU_K\*\H3<7,_:=HKEMZ%CSB
MJCA762TC7UJ/%QB@BMG=2AH4?RW+Q*`T?5?8]OB5_-5=,Q817I//Y4R)6#Z-
M=X[-E4-?<BFY9OT5"FAC:^[MMVU''M\_QQ9C'B8A^I&(_F)&L.IZNJ@&FITY
M\6ODCLN6G6S)U"<L2^E@&M+.BU=-5E7>*+K&_I.VUY!"B]CC,V8]_R"5Y6(;
M\\BB!Y\*G[&H5@1=MWJO.)X5"[@OH9C&&:\8I+RS$>P-+V'*;EIUBCRN(J=X
MY8*30BY#F41[M*3`D8:*.=5JVFA74DOSKIJ[K*Z'*8G7W#A<2;,QRJLU#$WK
MBD%?2%(3N)IU=27!-<J[;/VD8N`6DE0'KM@DQ<^-.'QK$?1IO#XAA.^KX'1'
MDQG)E341AYIX_<.X6?SDF:&#*-^<<17KC4->7N0C19$M*BX57KW]Y(%1ORWC
MG1Z9Y3HJ+5<O"OF2P&&&?!EY`T@63)QSI:_]0NT5M36ZR8O(\1GR_['%\",D
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M<Q/(Y@%=+[`0X51LPKJZ/F8&\HV%T.KHNX34FJJ-;S->LRF:M6/2AA-^7]_W
M"`75@KJ,N&J+[@7C<&RY'K*KHUE.)MTU#20<XP'"+AXANT(3JU0NI>F)XY/I
MWJ,**2$12_M"+"(COJ6Q.AHL2*03OF\]'T$?#E'(3Y6GKYZRMZ!U,.%+B$J!
MM)3<VASMEI_D=&Y"*ZQ2JB*12CVMW<&0=>Y;5<K]<S)IIC7=5;'5.>Y>2$HQ
MZ8GK6./+*&.E_P]02P$"'@,4````"`!`,&9%`SZ8@G]Z``"520<`$0`8````
M```!````I($`````86YI:RTR,#$T,#DS,"YX;6Q55`4``R=56U1U>`L``00E
M#@``!#D!``!02P$"'@,4````"`!`,&9%G?%N9^L,``"NF@``%0`8```````!
M````I('*>@``86YI:RTR,#$T,#DS,%]C86PN>&UL550%``,G55M4=7@+``$$
M)0X```0Y`0``4$L!`AX#%`````@`0#!F15T?<H;H+@``P,<"`!4`&```````
M`0```*2!!(@``&%N:6LM,C`Q-#`Y,S!?9&5F+GAM;%54!0`#)U5;5'5X"P`!
M!"4.```$.0$``%!+`0(>`Q0````(`$`P9D4]S9^R\$X```+Q`P`5`!@`````
M``$```"D@3NW``!A;FEK+3(P,30P.3,P7VQA8BYX;6Q55`4``R=56U1U>`L`
M`00E#@``!#D!``!02P$"'@,4````"`!`,&9%1=]+-!DO``#HT`(`%0`8````
M```!````I(%Z!@$`86YI:RTR,#$T,#DS,%]P<F4N>&UL550%``,G55M4=7@+
M``$$)0X```0Y`0``4$L!`AX#%`````@`0#!F19Q-64"E$```][@``!$`&```
M`````0```*2!XC4!`&%N:6LM,C`Q-#`Y,S`N>'-D550%``,G55M4=7@+``$$
?)0X```0Y`0``4$L%!@`````&``8`&@(``-)&`0``````
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ELNAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 6 - Earnings Per Share (Details) - Basic and Diluted Earnings Per Share<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="2">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_BasicAndDilutedEarningsPerShareAbstract', window );"><strong>Basic and Diluted Earnings Per Share [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Shares used in the calculation of basic earnings per share</a></td>
        <td class="nump">14,758,781<span></span></td>
        <td class="nump">13,682,449<span></span></td>
        <td class="nump">14,626,933<span></span></td>
        <td class="nump">13,534,334<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_EffectOfDilutiveSecuritiesAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Stock options, SARs, and RSAs</a></td>
        <td class="nump">676,094<span></span></td>
        <td class="nump">1,276,516<span></span></td>
        <td class="nump">842,304<span></span></td>
        <td class="nump">1,139,545<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted shares used in the calculation of earnings per share</a></td>
        <td class="nump">15,434,875<span></span></td>
        <td class="nump">14,958,965<span></span></td>
        <td class="nump">15,469,237<span></span></td>
        <td class="nump">14,673,879<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anik_BasicAndDilutedEarningsPerShareAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>anik_BasicAndDilutedEarningsPerShareAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>anik_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anik_EffectOfDilutiveSecuritiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>anik_EffectOfDilutiveSecuritiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>anik_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 16<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1505-109256<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 10<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1448-109256<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Weighted-Average Number of Common Shares Outstanding<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6528421<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 6 - Earnings Per Share (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</a></td>
        <td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
      <tr style="vertical-align: bottom">
        <td>
          &#160;
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="7" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          Three Months Ended September 30,
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="7" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          Nine Months Ended September 30,
        </td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="font-weight: bold">
          &#160;
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          2014
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          2013
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          2014
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          2013
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="width: 56%; text-align: left">
          Shares used in the calculation of basic earnings per share
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 8%; text-align: right">
          14,758,781
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 8%; text-align: right">
          13,682,449
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 8%; text-align: right">
          14,626,933
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 8%; text-align: right">
          13,534,334
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left">
          Effect of dilutive securities:
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">
          Stock options, SARs, and RSAs
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          676,094
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          1,276,516
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          842,304
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          1,139,545
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; padding-bottom: 2.75pt">
          Diluted shares used in the calculation of earnings per share
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          15,434,875
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          14,958,965
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          15,469,237
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          14,673,879
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
      </tr>
    </table><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 2 - Basis of Presentation<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Disclosure Text Block [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">Business Description and Basis of Presentation [Text Block]</a></td>
        <td class="text"><table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
      <tr style="vertical-align: top">
        <td style="width: 6%">
          <b>2.</b>
        </td>
        <td style="width: 94%">
          <b>Basis of Presentation</b>
        </td>
      </tr>
    </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
      The accompanying unaudited condensed consolidated financial statements and related notes have been prepared by the Company pursuant to the rules&#160;and regulations of the Securities and Exchange Commission (the &#8220;SEC&#8221;) and in accordance with accounting principles generally accepted in the United States (&#8220;U.S.&#8221;). The financial statements include the accounts of Anika Therapeutics, Inc. and its subsidiaries. Inter-company transactions and balances have been eliminated. The year-end consolidated balance sheet is derived from our audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the U.S. In the opinion of management, these unaudited condensed consolidated financial statements contain all adjustments (consisting only of normal recurring adjustments) necessary to fairly state the condensed consolidated financial position of the Company as of September 30, 2014, the results of its
      operations for the three and nine-month periods ended September 30, 2014 and 2013, and cash flows for the nine-month periods ended September 30, 2014 and 2013.
    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">
      The accompanying unaudited condensed consolidated financial statements and related notes should be read in conjunction with the Company&#8217;s annual financial statements filed with its Annual Report on Form&#160;10-K for the year ended December 31, 2013. The results of operations for the three and nine-month periods ended September 30, 2014 are not necessarily indicative of the results to be expected for the year ending December&#160;31, 2014. Certain prior period amounts have been reclassified to conform to the current period presentation. There was no impact on operating income.
    </p><br/><p style="font-size: 10pt; text-indent: 0.5in; margin: 0">
      A revision was made on the condensed consolidated statement of cash flows for the six months ended June 30, 2014 to correctly reflect the tax benefit from exercise of certain equity awards. This revision has an impact on the statement of cash flows as a reduction of cash provided by operating activities of $2.5 million with a corresponding increase to cash provided by financing activities related to the tax benefit from exercise of stock options for the six months ended June 30, 2014 of the same amount. This revision has no impact on the statement of operations or cash position. The revision to the condensed consolidated statement of cash flows represents amounts that are not deemed to be material, individually or in the aggregate, to the prior period condensed consolidated financial statements.
    </p><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DisclosureTextBlockAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EWOAC">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Accounts receivable, net of reserves (in Dollars)</a></td>
        <td class="nump">$ 546,455<span></span></td>
        <td class="nump">$ 593,023<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in Dollars per share)</a></td>
        <td class="nump">$ 0.01<span></span></td>
        <td class="nump">$ 0.01<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
        <td class="nump">1,250,000<span></span></td>
        <td class="nump">1,250,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">0<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">0<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in Dollars per share)</a></td>
        <td class="nump">$ 0.01<span></span></td>
        <td class="nump">$ 0.01<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
        <td class="nump">30,000,000<span></span></td>
        <td class="nump">30,000,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
        <td class="nump">14,800,453<span></span></td>
        <td class="nump">14,289,308<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock,shares outstanding</a></td>
        <td class="nump">14,800,453<span></span></td>
        <td class="nump">14,289,308<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>A valuation allowance for trade and other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 4<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 310<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=35738203&amp;loc=d3e5074-111524<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.4)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Face amount or stated value per share of common stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockParOrStatedValuePerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesIssued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockParOrStatedValuePerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockSharesIssued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 12 - Income Taxes<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Tax Disclosure [Text Block]</a></td>
        <td class="text"><table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
      <tr style="vertical-align: top">
        <td style="width: 6%">
          <b>12.</b>
        </td>
        <td style="width: 94%">
          <b>Income Taxes</b>
        </td>
      </tr>
    </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">
      Provisions for income taxes were $4,125,355 and $18,872,435 for the three and nine-month periods ended September 30, 2014, respectively, based on effective tax rates of 40% and 38%. Provisions for income taxes were $2,776,199 and $8,147,282 for the three and nine-month periods ended September 30, 2013, respectively, based on effective tax rates of 36% and 37%, respectively. The increase in income taxes over the three-month period ended September 30, 2014 was primarily due to increased net income. The increase in income taxes over the nine-month period ended September 30, 2014 was primarily due to increased net income, which reflected $24,652,778 in milestone and contract revenue associated with our U.S. license agreement for MONOVISC. See the previous discussion under Note 11. The increase in the effective tax rate for each of the periods ended 2014, as compared to the same periods ended in 2013, was driven primarily by the unavailability of the federal R&amp;D tax credit in
      2014, due to its expiration on December 31, 2013, and a relative decrease to our estimated production activities deduction.
    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">
      The Company files income tax returns in the U.S. on a federal basis, in certain U.S. states, and in Italy. The associated tax filings remain subject to examination by applicable tax authorities for a certain length of time following the tax year to which those filings relate. Our filings from 2011 through the present tax year remain subject to examination by the IRS and other taxing authorities for U.S. federal and state tax purposes. Our filings from 2009 through the present tax year remain subject to examination by the appropriate governmental authorities in Italy.
    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">
      In connection with the preparation of the financial statements, the Company performed an analysis to ascertain if it was more likely than not that it would be able to utilize, in future periods, the net deferred tax assets associated with its net operating loss carryforward. We have concluded that the positive evidence outweighs the negative evidence and, thus, those deferred tax assets are realizable on a &#8220;more likely than not&#8221; basis. As such, we have not recorded a valuation allowance at September 30, 2014 or December 31, 2013.&#160;
    </p><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 15<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32718-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(h))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph h<br><br> -Article 4<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32559-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ENGAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Document And Entity Information<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
        <th class="th">
          <div>Oct. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_DocumentAndEntityInformationAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
        <td class="text">Anika Therapeutics, Inc.<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
        <td class="text">10-Q<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
        <td class="text">--12-31<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">14,504,014<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
        <td class="text">false<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
        <td class="text">0000898437<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
        <td class="text">Yes<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
        <td class="text">No<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
        <td class="text">Accelerated Filer<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
        <td class="text">No<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
        <td class="text">Sep. 30,
				 2014<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
        <td class="text">2014<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
        <td class="text">Q3<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anik_DocumentAndEntityInformationAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>anik_DocumentAndEntityInformationAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>anik_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_AmendmentFlag</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:booleanItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>End date of current fiscal year in the format --MM-DD.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_CurrentFiscalYearEndDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:gMonthDayItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentFiscalPeriodFocus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:fiscalPeriodItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentFiscalYearFocus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:gYearItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentPeriodEndDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:dateItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentType</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:submissionTypeItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation 12B<br><br> -Number 240<br><br> -Section 12b<br><br> -Subsection 1<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCentralIndexKey</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:centralIndexKeyItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCommonStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCurrentReportingStatus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:yesNoItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityFilerCategory</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:filerCategoryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation 12B<br><br> -Number 240<br><br> -Section 12b<br><br> -Subsection 1<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityRegistrantName</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:normalizedStringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityVoluntaryFilers</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:yesNoItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityWellKnownSeasonedIssuer</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:yesNoItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 13 - Segment and Geographic Information<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting Disclosure [Text Block]</a></td>
        <td class="text"><table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%; border-collapse: collapse">
      <tr style="vertical-align: top">
        <td style="width: 6%">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">
            <b>&#160;13.</b>
          </p>
        </td>
        <td style="width: 94%">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">
            <b>&#160;Segment and Geographic Information</b>
          </p>
        </td>
      </tr>
    </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">
      The Company has one reportable operating segment, the results of which are disclosed in the accompanying unaudited condensed consolidated financial statements.
    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">
      Product revenue by product group is as follows:
    </p><br/><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
      <tr style="vertical-align: bottom">
        <td colspan="3" style="font-weight: bold">
          &#160;
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="7" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          Three Months Ended September 30,
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="7" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          Nine Months Ended September 30,
        </td>
      </tr>
      <tr style="vertical-align: bottom">
        <td colspan="3" style="font-weight: bold">
          &#160;
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          2014
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          2013
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          2014
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          2013
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 54%; text-align: left">
          Orthobiologics
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          18,899,873
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          12,830,566
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          48,750,277
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          40,620,339
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: left">
          Dermal
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          401,355
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          267,766
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          938,966
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          1,066,409
        </td>
        <td style="text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: left">
          Surgical
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          1,452,946
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          1,136,248
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          4,581,496
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          3,955,134
        </td>
        <td style="text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: left">
          Ophthalmic
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          366,138
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          1,425,609
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          938,134
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          2,818,407
        </td>
        <td style="text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="padding-bottom: 1.1pt; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt; text-align: left">
          Veterinary
        </td>
        <td style="padding-bottom: 1.1pt; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          855,000
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          1,363,157
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          2,385,000
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          3,124,953
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="padding-bottom: 2.75pt; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt; text-align: right">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          21,975,312
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          17,023,346
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          57,593,873
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          51,585,242
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
      </tr>
    </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">
      Total revenue by geographic location and as a percentage of overall total revenue, for the three and nine-month periods ended September 30, 2014 and 2013 are as follows;
    </p><br/><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
      <tr style="vertical-align: bottom">
        <td style="font-weight: bold">
          &#160;
        </td>
        <td style="font-weight: bold">
          &#160;
        </td>
        <td colspan="15" style="font-weight: bold; text-align: center">
          Three Months Ended September 30,
        </td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="font-weight: bold">
          &#160;
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="7" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          2014
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="7" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          2013
        </td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="font-weight: bold">
          &#160;
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Total
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Revenue
          </p>
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Percentage of
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Revenue
          </p>
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Total
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Revenue
          </p>
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Percentage of
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Revenue
          </p>
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="font-weight: bold; text-align: left">
          Geographic Location:
        </td>
        <td style="font-weight: bold">
          &#160;
        </td>
        <td style="font-weight: bold; text-align: left">
          &#160;
        </td>
        <td style="font-weight: bold; text-align: right">
          &#160;
        </td>
        <td style="font-weight: bold; text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="font-weight: bold">
          &#160;
        </td>
        <td style="font-weight: bold; text-align: left">
          &#160;
        </td>
        <td style="font-weight: bold; text-align: right">
          &#160;
        </td>
        <td style="font-weight: bold; text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="width: 56%; text-align: left; padding-left: 10pt">
          United States
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          18,455,167
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 8%; text-align: right">
          84
        </td>
        <td style="width: 1%; text-align: left">
          %
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          14,485,821
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 8%; text-align: right">
          82
        </td>
        <td style="width: 1%; text-align: left">
          %
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; padding-left: 10pt">
          Europe
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          1,784,414
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          8
        </td>
        <td style="text-align: left">
          %
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          1,656,656
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          9
        </td>
        <td style="text-align: left">
          %
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">
          Other
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          1,815,842
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          8
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          %
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          1,611,961
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          9
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          %
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; padding-bottom: 2.75pt; padding-left: 20pt">
          Total
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          22,055,423
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          100
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          %
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          17,754,438
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          100
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          %
        </td>
      </tr>
    </table><br/><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
      <tr style="vertical-align: bottom">
        <td style="font-weight: bold">
          &#160;
        </td>
        <td style="font-weight: bold">
          &#160;
        </td>
        <td colspan="15" style="font-weight: bold; text-align: center">
          Nine Months Ended September 30,
        </td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="font-weight: bold">
          &#160;
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="7" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          2014
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="7" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          2013
        </td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="font-weight: bold">
          &#160;
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Total
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Revenue
          </p>
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Percentage of
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Revenue
          </p>
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Total
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Revenue
          </p>
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Percentage of
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Revenue
          </p>
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="font-weight: bold; text-align: left">
          Geographic Location:
        </td>
        <td style="font-weight: bold">
          &#160;
        </td>
        <td style="font-weight: bold; text-align: left">
          &#160;
        </td>
        <td style="font-weight: bold; text-align: right">
          &#160;
        </td>
        <td style="font-weight: bold; text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="font-weight: bold">
          &#160;
        </td>
        <td style="font-weight: bold; text-align: left">
          &#160;
        </td>
        <td style="font-weight: bold; text-align: right">
          &#160;
        </td>
        <td style="font-weight: bold; text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="width: 56%; text-align: left; padding-left: 10pt">
          United States
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          72,935,722
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 8%; text-align: right">
          89
        </td>
        <td style="width: 1%; text-align: left">
          %
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          42,251,336
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 8%; text-align: right">
          78
        </td>
        <td style="width: 1%; text-align: left">
          %
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; padding-left: 10pt">
          Europe
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          5,274,071
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          6
        </td>
        <td style="text-align: left">
          %
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          5,226,619
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          10
        </td>
        <td style="text-align: left">
          %
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">
          Other
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          4,130,577
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          5
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          %
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          6,351,871
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          12
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          %
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; padding-bottom: 2.75pt; padding-left: 20pt">
          Total
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          82,340,370
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          100
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          %
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          53,829,826
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          100
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          %
        </td>
      </tr>
    </table><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SegmentReportingAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 280<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 29<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6534315&amp;loc=d3e8864-108599<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 280<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 32<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6534315&amp;loc=d3e8933-108599<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 280<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 26<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6534315&amp;loc=d3e8844-108599<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 280<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 10<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6534315&amp;loc=d3e8538-108599<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 280<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6534315&amp;loc=d3e8380-108599<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 280<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 34<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6534315&amp;loc=d3e8981-108599<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 280<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 35<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6534315&amp;loc=d3e8984-108599<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 280<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 41<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6534315&amp;loc=d3e9038-108599<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 280<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 30<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6534315&amp;loc=d3e8906-108599<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 280<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 42<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6534315&amp;loc=d3e9054-108599<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 280<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 31<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6534315&amp;loc=d3e8924-108599<br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 280<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 40<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6534315&amp;loc=d3e9031-108599<br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 280<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 33<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6534315&amp;loc=d3e8971-108599<br><br><br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 280<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6534315&amp;loc=d3e8595-108599<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SegmentReportingDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ECHBG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="2">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueGoodsNet', window );">Product revenue</a></td>
        <td class="nump">$ 21,975,312<span></span></td>
        <td class="nump">$ 17,023,346<span></span></td>
        <td class="nump">$ 57,593,873<span></span></td>
        <td class="nump">$ 51,585,242<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueServicesNet', window );">Licensing, milestone and contract revenue</a></td>
        <td class="nump">80,111<span></span></td>
        <td class="nump">731,092<span></span></td>
        <td class="nump">24,746,497<span></span></td>
        <td class="nump">2,244,584<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Total revenue</a></td>
        <td class="nump">22,055,423<span></span></td>
        <td class="nump">17,754,438<span></span></td>
        <td class="nump">82,340,370<span></span></td>
        <td class="nump">53,829,826<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsSold', window );">Cost of product revenue</a></td>
        <td class="nump">5,724,800<span></span></td>
        <td class="nump">5,377,568<span></span></td>
        <td class="nump">15,418,732<span></span></td>
        <td class="nump">16,530,070<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research &amp; development</a></td>
        <td class="nump">1,999,867<span></span></td>
        <td class="nump">1,618,012<span></span></td>
        <td class="nump">6,160,740<span></span></td>
        <td class="nump">5,029,974<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general &amp; administrative</a></td>
        <td class="nump">4,044,538<span></span></td>
        <td class="nump">3,188,669<span></span></td>
        <td class="nump">11,401,399<span></span></td>
        <td class="nump">10,536,462<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_RestructuringCredit', window );">Restructuring credits</a></td>
        <td class="num">(196,084)<span></span></td>
        <td class="num">(196,084)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(442,869)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expenses</a></td>
        <td class="nump">11,769,205<span></span></td>
        <td class="nump">9,988,165<span></span></td>
        <td class="nump">32,980,871<span></span></td>
        <td class="nump">31,653,637<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
        <td class="nump">10,286,218<span></span></td>
        <td class="nump">7,766,273<span></span></td>
        <td class="nump">49,359,499<span></span></td>
        <td class="nump">22,176,189<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income (expense), net</a></td>
        <td class="nump">9,937<span></span></td>
        <td class="num">(32,816)<span></span></td>
        <td class="nump">16,339<span></span></td>
        <td class="num">(108,755)<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
        <td class="nump">10,296,155<span></span></td>
        <td class="nump">7,733,457<span></span></td>
        <td class="nump">49,375,838<span></span></td>
        <td class="nump">22,067,434<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
        <td class="nump">4,125,355<span></span></td>
        <td class="nump">2,776,199<span></span></td>
        <td class="nump">18,872,435<span></span></td>
        <td class="nump">8,147,282<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
        <td class="nump">6,170,800<span></span></td>
        <td class="nump">4,957,258<span></span></td>
        <td class="nump">30,503,403<span></span></td>
        <td class="nump">13,920,152<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized gain on securities, net of tax</a></td>
        <td class="nump">431<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">431<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
        <td class="num">(1,679,968)<span></span></td>
        <td class="nump">916,474<span></span></td>
        <td class="num">(1,896,823)<span></span></td>
        <td class="nump">507,119<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss)</a></td>
        <td class="num">(1,679,537)<span></span></td>
        <td class="nump">916,474<span></span></td>
        <td class="num">(1,896,392)<span></span></td>
        <td class="nump">507,119<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_BasicNetIncomePerShareAbstract', window );"><strong>Basic net income per share:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income (in Dollars per share)</a></td>
        <td class="nump">$ 0.42<span></span></td>
        <td class="nump">$ 0.36<span></span></td>
        <td class="nump">$ 2.09<span></span></td>
        <td class="nump">$ 1.03<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average common shares outstanding (in Shares)</a></td>
        <td class="nump">14,758,781<span></span></td>
        <td class="nump">13,682,449<span></span></td>
        <td class="nump">14,626,933<span></span></td>
        <td class="nump">13,534,334<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_DilutedNetIncomePerShareAbstract', window );"><strong>Diluted net income per share:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income (in Dollars per share)</a></td>
        <td class="nump">$ 0.40<span></span></td>
        <td class="nump">$ 0.33<span></span></td>
        <td class="nump">$ 1.97<span></span></td>
        <td class="nump">$ 0.95<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average common shares outstanding (in Shares)</a></td>
        <td class="nump">15,434,875<span></span></td>
        <td class="nump">14,958,965<span></span></td>
        <td class="nump">15,469,237<span></span></td>
        <td class="nump">14,673,879<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
        <td class="nump">6,170,800<span></span></td>
        <td class="nump">4,957,258<span></span></td>
        <td class="nump">30,503,403<span></span></td>
        <td class="nump">13,920,152<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized gain on securities, net of tax</a></td>
        <td class="nump">431<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">431<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
        <td class="num">(1,679,968)<span></span></td>
        <td class="nump">916,474<span></span></td>
        <td class="num">(1,896,823)<span></span></td>
        <td class="nump">507,119<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss)</a></td>
        <td class="num">(1,679,537)<span></span></td>
        <td class="nump">916,474<span></span></td>
        <td class="num">(1,896,392)<span></span></td>
        <td class="nump">507,119<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
        <td class="nump">$ 4,491,263<span></span></td>
        <td class="nump">$ 5,873,732<span></span></td>
        <td class="nump">$ 28,607,011<span></span></td>
        <td class="nump">$ 14,427,271<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anik_BasicNetIncomePerShareAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>anik_BasicNetIncomePerShareAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>anik_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anik_DilutedNetIncomePerShareAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>anik_DilutedNetIncomePerShareAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>anik_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anik_RestructuringCredit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of credit associated with exit or disposal activities during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>anik_RestructuringCredit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>anik_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=35737396<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=d3e557-108580<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ComprehensiveIncomeNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsSold">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total costs related to goods produced and sold during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 2<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.2(a))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CostOfGoodsSold</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total costs of sales and operating expenses for the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CostsAndExpenses</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1252-109256<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 55<br><br> -Paragraph 52<br><br> -URI http://asc.fasb.org/extlink&amp;oid=32703322&amp;loc=d3e4984-109258<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.21)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.19)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.9-04.23)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 18<br><br> -Article 7<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 20<br><br> -Article 5<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 21<br><br> -Article 9<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareBasic</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1252-109256<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.21)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 18<br><br> -Article 7<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 20<br><br> -Article 5<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 21<br><br> -Article 9<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareDiluted</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses from ongoing operations, after income or loss from equity method investments, but before income taxes, extraordinary items, and noncontrolling interest.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 940<br><br> -SubTopic 20<br><br> -Section 25<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=35710027&amp;loc=d3e41242-110953<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 10<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(h))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph h<br><br> -Article 4<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Income Tax Expense (or Benefit)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6515339<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -Subparagraph (a),(b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxExpenseBenefit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net amount of nonoperating interest income (expense).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InterestIncomeExpenseNonoperatingNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.19)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.18)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 19<br><br> -Article 5<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 20<br><br> -Article 9<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingExpensesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net result for the period of deducting operating expenses from operating revenues.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 10A<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=SL7669646-108580<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 30<br><br> -Section 45<br><br> -Paragraph 20<br><br> -Subparagraph (b,c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6915805&amp;loc=d3e32211-110900<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 1A<br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=SL7669619-108580<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherComprehensiveIncomeLossNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after tax, before reclassification adjustments, of unrealized holding gain (loss) on available-for-sale securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=d3e637-108580<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 10A<br><br> -Subparagraph (e)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=SL7669646-108580<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 985<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 730<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ResearchAndDevelopmentExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueGoodsNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.1(a))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SalesRevenueGoodsNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SalesRevenueNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueServicesNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate revenue during the period from services rendered in the normal course of business, after deducting allowances and discounts.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.1(d))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SalesRevenueServicesNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.4)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 4<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 330<br><br> -SubTopic 10<br><br> -Section 30<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=34747878&amp;loc=d3e3636-108311<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SellingGeneralAndAdministrativeExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 16<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1505-109256<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 10<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1448-109256<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Weighted-Average Number of Common Shares Outstanding<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6528421<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 7 - Inventories<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventory Disclosure [Text Block]</a></td>
        <td class="text"><table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
      <tr style="vertical-align: top">
        <td style="width: 6%">
          <b>7.</b>
        </td>
        <td style="width: 94%">
          <b>Inventories</b>
        </td>
      </tr>
    </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">
      Inventories consist of the following:
    </p><br/><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
      <tr style="vertical-align: bottom">
        <td style="font-weight: bold">
          &#160;
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" nowrap="nowrap" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            September 30,
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            2014
          </p>
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" nowrap="nowrap" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            December 31,
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            2013
          </p>
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="width: 78%; text-align: left">
          Raw materials
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          6,843,441
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          5,926,030
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left">
          Work-in-process
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          2,325,667
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          2,308,233
        </td>
        <td style="text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; padding-bottom: 1.1pt">
          Finished goods
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          4,413,348
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          2,762,522
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; padding-bottom: 2.75pt; padding-left: 10pt">
          Total
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          13,582,456
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          10,996,785
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
      </tr>
    </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">
      Inventories are stated at the lower of cost or market, with cost being determined using the first-in, first-out method. Work-in-process and finished goods inventories include materials, labor, and manufacturing overhead.
    </p><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InventoryDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for inventory. This may include, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the major classes of inventory, and the nature of the cost elements included in inventory. If inventory is stated above cost, accrued net losses on firm purchase commitments for inventory and losses resulting from valuing inventory at the lower-of-cost-or-market may also be included. For LIFO inventory, may disclose the amount and basis for determining the excess of replacement or current cost over stated LIFO value and the effects of a LIFO quantities liquidation that impacts net income.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.6)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 6<br><br> -Subparagraph a, b, c<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InventoryDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 6 - Earnings Per Share<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share [Text Block]</a></td>
        <td class="text"><table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
      <tr style="vertical-align: top">
        <td style="width: 6%">
          <b>6.</b>
        </td>
        <td style="width: 94%">
          <b>Earnings Per Share</b>
        </td>
      </tr>
    </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">
      The Company reports earnings per share in accordance with ASC 260, <i>Earnings Per Share</i>, which establishes standards for computing and presenting earnings per share. Basic earnings per share is computed by dividing net income available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing net income available to common shareholders by the weighted average number of common shares outstanding and the number of dilutive potential common share equivalents during the period. Under the treasury stock method, unexercised &#8220;in-the-money&#8221; stock options are assumed to be exercised at the beginning of the period or at issuance, if later. The assumed proceeds are then used to purchase common shares at the average market price during the period.
    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">
      Basic and diluted earnings per share for the three and nine-month periods ended September 30, 2014 and 2013 are as follows:&#160;
    </p><br/><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
      <tr style="vertical-align: bottom">
        <td>
          &#160;
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="7" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          Three Months Ended September 30,
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="7" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          Nine Months Ended September 30,
        </td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="font-weight: bold">
          &#160;
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          2014
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          2013
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          2014
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          2013
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="width: 56%; text-align: left">
          Shares used in the calculation of basic earnings per share
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 8%; text-align: right">
          14,758,781
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 8%; text-align: right">
          13,682,449
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 8%; text-align: right">
          14,626,933
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 8%; text-align: right">
          13,534,334
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left">
          Effect of dilutive securities:
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">
          Stock options, SARs, and RSAs
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          676,094
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          1,276,516
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          842,304
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          1,139,545
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; padding-bottom: 2.75pt">
          Diluted shares used in the calculation of earnings per share
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          15,434,875
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          14,958,965
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          15,469,237
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          14,673,879
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
      </tr>
    </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">
      Equity awards of 122,967 and 118,725 shares were outstanding for the three and nine-month periods ended September 30, 2014, respectively, and were not included in the computation of diluted earnings per share because the awards&#8217; impact on earnings per share was anti-dilutive. There were no anti-dilutive equity awards for the three month period ended September 30, 2013. Equity awards of 88,278 shares were outstanding for the nine-month period ended September 30, 2013, and were not included in the computation of diluted earnings per share because the awards&#8217; impact on earnings per share was anti-dilutive.&#160;&#160;&#160;
    </p><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for earnings per share.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1278-109256<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1252-109256<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 55<br><br> -Paragraph 52<br><br> -URI http://asc.fasb.org/extlink&amp;oid=32703322&amp;loc=d3e4984-109258<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.21)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 5 - Equity Incentive Plan (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</a></td>
        <td class="text"><table border="0" cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
      <tr>
        <td style="font-weight: bold">
          &#160;
        </td>
        <td colspan="7" style="text-align: center">
          <p style="margin-top: 0; margin-bottom: 0">
            <b>Three Months Ended</b>
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            <b>September 30,</b>
          </p>
        </td>
      </tr>
      <tr>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="text-align: center; border-bottom: Black 1.1pt solid">
          <b>2014</b>
        </td>
        <td style="font-weight: bold; text-align: center; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="text-align: center; border-bottom: Black 1.1pt solid">
          <b>2013</b>
        </td>
      </tr>
      <tr style="background-color: rgb(204,238,255)">
        <td style="width: 71%">
          Risk free interest rate
        </td>
        <td style="width: 3%; text-align: center">
          1.30%
        </td>
        <td style="width: 7%; text-align: center">
          -
        </td>
        <td style="text-align: center; width: 3%">
          1.39%
        </td>
        <td style="text-align: right; width: 3%">
          &#160;
        </td>
        <td style="width: 3%">
          &#160;
        </td>
        <td style="width: 7%; text-align: center">
          -
        </td>
        <td style="text-align: center; width: 3%">
        </td>
      </tr>
      <tr style="background-color: White">
        <td>
          Expected volatility
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: center">
          53.28%
        </td>
        <td style="text-align: center">
        </td>
        <td>
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: center">
          -
        </td>
        <td style="text-align: center">
        </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
        <td>
          Expected lives (years)
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: center">
          4
        </td>
        <td style="text-align: center">
        </td>
        <td style="text-align: right">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: center">
          -
        </td>
        <td style="text-align: center">
        </td>
      </tr>
      <tr style="background-color: White">
        <td>
          Expected dividend yield
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: center">
          0.00%
        </td>
        <td style="text-align: center">
        </td>
        <td>
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: center">
          -
        </td>
        <td style="text-align: center">
        </td>
      </tr>
    </table><table border="0" cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
      <tr>
        <td style="font-weight: bold">
          &#160;
        </td>
        <td colspan="7">
          <p style="margin-top: 0; margin-bottom: 0; text-align: center">
            <b>Nine Months Ended</b>
          </p>
          <p style="margin-top: 0; margin-bottom: 0; text-align: center">
            <b>September 30,</b>
          </p>
        </td>
      </tr>
      <tr>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="text-align: center; border-bottom: Black 1.1pt solid">
          <b>2014</b>
        </td>
        <td style="font-weight: bold; text-align: center; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="text-align: center; border-bottom: Black 1.1pt solid">
          <b>2013</b>
        </td>
      </tr>
      <tr style="background-color: rgb(204,238,255)">
        <td style="width: 71%">
          Risk free interest rate
        </td>
        <td style="width: 3%; text-align: center">
          1.16%
        </td>
        <td style="width: 7%; text-align: center">
          -
        </td>
        <td style="text-align: center; width: 3%">
          1.39%
        </td>
        <td style="text-align: right; width: 3%">
          &#160;
        </td>
        <td style="width: 3%; text-align: center">
          0.61%
        </td>
        <td style="width: 7%; text-align: center">
          -
        </td>
        <td style="text-align: center; width: 3%">
          0.70%
        </td>
      </tr>
      <tr style="background-color: White">
        <td>
          Expected volatility
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: center">
          53.28%
        </td>
        <td style="text-align: center">
        </td>
        <td>
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: center">
          57.60%
        </td>
        <td style="text-align: center">
        </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
        <td>
          Expected lives (years)
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: center">
          4
        </td>
        <td style="text-align: center">
        </td>
        <td style="text-align: right">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: center">
          4
        </td>
        <td style="text-align: center">
        </td>
      </tr>
      <tr style="background-color: White">
        <td>
          Expected dividend yield
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: center">
          0.00%
        </td>
        <td style="text-align: center">
        </td>
        <td>
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: center">
          0.00%
        </td>
        <td style="text-align: center">
        </td>
      </tr>
    </table><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 14 - Restructuring Credits<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring and Related Activities Disclosure [Text Block]</a></td>
        <td class="text"><table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%; border-collapse: collapse">
      <tr style="vertical-align: top">
        <td style="width: 6%; font: 10pt Times New Roman, Times, Serif">
          <b>14.</b>
        </td>
        <td style="width: 94%; font: 10pt Times New Roman, Times, Serif">
          <b>Restructuring Credits</b>
        </td>
      </tr>
    </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">
      In December 2012, the Company announced the closure of its tissue engineering facility in Abano Terme, Italy due to the Company&#8217;s inability to meet strict regulatory standards established by the European Medicines Agency (&#8220;EMA&#8221;) for Advanced Therapy Medicinal Products, which became effective on January 1, 2013. The restructuring plan involved a workforce reduction as well as associated asset abandonments. The Company recorded restructuring and impairment charges in the fourth quarter of 2012 of approximately $2.5 million. Of the total restructuring and impairment charges related to the tissue engineering operation, approximately $1.2 million was related to the non-cash termination and related impairment of an IPR&amp;D project, $0.3 million was related to the disposal of property and equipment, and $0.1 million was related to the disposal of inventory. We completed the restructuring plan and related activities in 2013. Certain previously impaired and
      written-off equipment was sold, resulting in restructuring credits of $196,084 and $442,869 in the three and nine months ended September 30, 2013, respectively.
    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">
      The following table summarizes restructuring accrual activity for the nine-period ended September 30, 2014:
    </p><br/><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
      <tr style="vertical-align: bottom">
        <td>
          &#160;
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="11" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          Restructuring Accrual
        </td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>
          &#160;
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" nowrap="nowrap" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Employee
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Severance and
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Related Benefits
          </p>
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" nowrap="nowrap" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Activity
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Termination and
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Facility Closure
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Costs
          </p>
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" nowrap="nowrap" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          Total
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="width: 67%; text-align: left">
          December 31, 2013
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          21,709
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          2,929
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          24,638
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left">
          Cash Proceeds (Disbursements)
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          (10,130
        </td>
        <td style="text-align: left">
          )
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          (1,425
        </td>
        <td style="text-align: left">
          )
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          (11,555
        </td>
        <td style="text-align: left">
          )
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; padding-bottom: 1.1pt">
          Foreign Exchange Impact
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          (1,050
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          )
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          (124
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          )
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          (1,174
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          )
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; padding-bottom: 2.75pt">
          September 30, 2014
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          10,529
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          1,380
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          11,909
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
      </tr>
    </table><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RestructuringAndRelatedActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 420<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 5.P.3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140864-122747<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 5<br><br> -Section P<br><br> -Subsection 3, 4<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 420<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 420<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SAB TOPIC 5.P.4)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140904-122747<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 10 - Commitments and Contingencies<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies Disclosure [Text Block]</a></td>
        <td class="text"><table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
      <tr style="vertical-align: top">
        <td style="width: 6%">
          <b>10.</b>
        </td>
        <td style="width: 94%">
          <b>Commitments and Contingencies</b>
        </td>
      </tr>
    </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">
      In certain of its contracts, the Company warrants to its customers that the products it manufactures conform to the product specifications as in effect at the time of delivery of the product. The Company may also warrant that the products it manufactures do not infringe, violate or breach any patent or intellectual property rights, trade secret or other proprietary information of any third party. On occasion, the Company contractually indemnifies its customers against any and all losses arising out of, or in any way connected with, any claim or claims of breach of its warranties or any actual or alleged defect in any product caused by the negligence or acts or omissions of the Company.&#160;The Company maintains a products liability insurance policy that limits its exposure. Based on the Company&#8217;s historical activity in combination with its insurance policy coverage, the Company believes the estimated fair value of these indemnification agreements is minimal. The Company
      has no accrued warranties and has no history of claims paid.
    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">
      On July 7, 2010, Genzyme Corporation filed a complaint against the Company in the United States District Court for the District of Massachusetts seeking unspecified damages and equitable relief. The complaint alleged that the Company infringed U.S. Patent No. 5,143,724 by manufacturing MONOVISC&#174; in the United States for sale outside the United States and would infringe U.S. Patent Nos. 5,143,724 and 5,399,351&#160;if the Company manufactured and sold MONOVISC in the United States. On March 7, 2014, Genzyme and the Company filed a joint motion to lift the stay in Genzyme&#8217;s lawsuit against the Company and to dismiss with prejudice all of Genzyme&#8217;s claims. On March 10, 2014, the District Court granted the motion to dismiss with prejudice all of Genzyme&#8217;s claims against the Company and the case was terminated.
    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">
      The Company is also involved in various other legal proceedings arising in the normal course of business.&#160;Although the outcomes of these other legal proceedings are inherently difficult to predict, the Company does not expect the resolution of these other legal proceedings to have a material adverse effect on its financial position, results of operations or cash flow.&#160;
    </p><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommitmentsAndContingenciesDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for commitments and contingencies.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.25)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6449706&amp;loc=d3e16207-108621<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 460<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6398077&amp;loc=d3e12565-110249<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 450<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14435-108349<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 440<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6394976&amp;loc=d3e25287-109308<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 8 - Intangible Assets and Goodwill<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Intangible Assets Disclosure [Text Block]</a></td>
        <td class="text"><table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
      <tr style="vertical-align: top">
        <td style="width: 6%">
          <b>8.&#160;&#160;</b>
        </td>
        <td style="width: 94%; text-align: justify">
          <b>Intangible Assets and Goodwill</b>
        </td>
      </tr>
    </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">
      In connection with the acquisition of Anika Therapeutics S.r.l. (&#8220;Anika S.r.l.&#8221;), the Company acquired various intangible assets and goodwill.&#160;The Company evaluated the various intangible assets and related cash flows from these intangible assets, as well as the useful lives and amortization methods related to these intangible assets.&#160;The in-process research and development (&#8220;IPR&amp;D&#8221;) intangible assets initially have indefinite lives and are reviewed periodically to assess the project status, valuation, and disposition, including write-off(s) for abandoned projects.&#160;Until such determination is made, they are not amortized.&#160;
    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">
      The Company reviews its long-lived assets for impairment at least annually. Additionally, the Company will initiate a review for impairment if events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable or that the useful lives of the assets are no longer appropriate. Each impairment test will be based on a comparison of the undiscounted cash flows to the recorded value of the asset. If impairment is indicated, the asset is written down to its estimated fair value.
    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">
      Intangible assets as of September 30, 2014 and December 31, 2013 consist of the following:
    </p><br/><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
      <tr style="vertical-align: bottom">
        <td>
          &#160;
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center">
          &#160;
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="11" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          September 30, 2014
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="7" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          December 31, 2013
        </td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>
          &#160;
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          Gross Value
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Currency
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Translation
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Adjustment
          </p>
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Accumulated
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Amortization
          </p>
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Net Book
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Value
          </p>
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Net Book
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Value
          </p>
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          Useful Life
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="width: 34%; text-align: left">
          Developed technology
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          16,700,000
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          (1,828,214
        </td>
        <td style="width: 1%; text-align: left">
          )
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          (4,779,123
        </td>
        <td style="width: 1%; text-align: left">
          )
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          10,092,663
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          11,753,003
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 8%; text-align: center">
          15
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left">
          In-process research &amp; development
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          5,502,686
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          (638,426
        </td>
        <td style="text-align: left">
          )
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          -
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          4,864,260
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          5,286,127
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: center">
          Indefinite
        </td>
        <td style="text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left">
          Distributor relationships
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          4,700,000
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          (440,953
        </td>
        <td style="text-align: left">
          )
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          (4,084,944
        </td>
        <td style="text-align: left">
          )
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          174,103
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          863,655
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: center">
          5
        </td>
        <td style="text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td>
          Patents
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          1,000,000
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          (107,910
        </td>
        <td style="text-align: left">
          )
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          (271,208
        </td>
        <td style="text-align: left">
          )
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          620,882
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          719,574
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: center">
          16
        </td>
        <td style="text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; padding-bottom: 1.1pt">
          Elevess trade name
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          1,000,000
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          -
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          (717,964
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          )
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          282,036
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          376,050
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt; text-align: center">
          9
        </td>
        <td style="padding-bottom: 1.1pt; text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="padding-bottom: 2.75pt; padding-left: 10pt">
          Total
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          28,902,686
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          (3,015,503
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          )
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          (9,853,239
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          )
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          16,033,944
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          18,998,409
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt; text-align: right">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt; text-align: left">
          &#160;
        </td>
      </tr>
    </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">
      The aggregate amortization expense related to intangible assets was $518,699 and $521,387 for the three-month periods ended September 30, 2014 and 2013, respectively. The aggregate amortization expense related to intangible assets was $1,593,260 and $1,555,796 for the nine-month periods ended September 30, 2014 and 2013, respectively.
    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">
      Changes in the carrying value of goodwill for the three and nine-month periods ended September 30, 2014 were as follows:
    </p><br/><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
      <tr style="vertical-align: bottom">
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          Goodwill
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" nowrap="nowrap" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Three
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Months Ended
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            September 30,
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            2014
          </p>
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" nowrap="nowrap" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Nine
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Months Ended
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            September 30,
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            2014
          </p>
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="font-weight: bold">
          &#160;
        </td>
        <td style="font-weight: bold">
          &#160;
        </td>
        <td style="font-weight: bold; text-align: left">
          &#160;
        </td>
        <td style="font-weight: bold; text-align: right">
          &#160;
        </td>
        <td style="font-weight: bold; text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="width: 78%; text-align: left">
          Balance, beginning
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          9,360,884
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          9,443,894
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; padding-bottom: 1.1pt">
          Effect of foreign currency adjustments
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          (658,589
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          )
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          (741,599
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          )
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="padding-bottom: 2.75pt">
          Balance, ending
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          8,702,295
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          8,702,295
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
      </tr>
    </table><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final.  May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16265-109275<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16373-109275<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13854-109267<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 9 - Accrued Expenses<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</a></td>
        <td class="text"><table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
      <tr style="vertical-align: top">
        <td style="width: 6%">
          <b>9.</b>
        </td>
        <td style="width: 94%">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">
            <b>Accrued Expenses</b>
          </p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">
          </p>
        </td>
      </tr>
    </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">
      Accrued expenses consist of the following:
    </p><br/><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
      <tr style="vertical-align: bottom">
        <td style="text-align: left; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" nowrap="nowrap" style="text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            <b>September 30,</b>
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            <b>2014</b>
          </p>
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" nowrap="nowrap" style="text-align: right; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0; text-align: center">
            <b>December&#160;31,</b>
          </p>
          <p style="margin-top: 0; margin-bottom: 0; text-align: center">
            <b>2013</b>
          </p>
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="width: 78%; text-align: left">
          Labor and related expenses
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          2,842,234
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          2,870,147
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left">
          Clinical trial costs
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          962,031
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          882,651
        </td>
        <td style="text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left">
          Professional fees
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          382,423
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          383,231
        </td>
        <td style="text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left">
          Research grants
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          562,558
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          610,498
        </td>
        <td style="text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left">
          Restructuring costs
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          11,909
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          24,638
        </td>
        <td style="text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; padding-bottom: 1.1pt">
          Other
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          492,538
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          766,716
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; padding-bottom: 2.75pt; padding-left: 10pt">
          Total
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          5,253,693
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          5,537,881
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
      </tr>
    </table><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.19(a),20,24)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 19<br><br> -Subparagraph a<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 20, 24<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PayablesAndAccrualsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 11 - Mitek Monovisc Agreement<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueDisclosureAbstract', window );"><strong>Deferred Revenue Disclosure [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueDisclosureTextBlock', window );">Deferred Revenue Disclosure [Text Block]</a></td>
        <td class="text"><table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
      <tr style="vertical-align: top">
        <td style="width: 6%">
          <b>11.</b>
        </td>
        <td style="width: 94%">
          <b>Mitek Monovisc Agreement</b>
        </td>
      </tr>
    </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">
      In December 2011, the Company entered into a fifteen-year licensing agreement (the &#8220;Mitek MONOVISC Agreement&#8221;) with DePuy Synthes Mitek Sports Medicine, a division of DePuy Orthopaedics, Inc., to exclusively market MONOVISC in the U.S. The Company received an upfront payment of $2,500,000 in December 2011. This non-refundable upfront payment did not have standalone value without Anika&#8217;s completion of development obligations which included obtaining regulatory approval of the product and resolving the patent litigation. As a result, we recognized the upfront payment over the development obligation period. During the first quarter of 2014, the Company received FDA approval of MONOVISC and resolved the patent lawsuit with Genzyme Corporation. As a result of the full delivery of its development obligations under this agreement, the Company recognized approximately $2,200,000 which represents the remaining balance of deferred revenue relating to the initial
      $2,500,000 payment in accordance with current generally accepted principles on revenue recognition. In the first quarter of 2014, the Company also received a milestone payment of $17,500,000 as a result of achieving FDA approval for MONOVISC and resolving the patent litigation with Genzyme. This milestone payment was fully recognized as revenue during the three months ended March 31, 2014. On April 15, 2014 the first U.S. commercial sale of MONOVISC was made by our commercial partner, DePuy Synthes Mitek Sports Medicine. Under the terms of the Mitek MONOVISC Agreement, the Company earned and collected a milestone payment of $5 million, which was fully recognized as revenue in the second quarter of 2014.
    </p><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredRevenueDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for deferred revenues at the end of the reporting period, and description and amounts of significant changes that occurred during the reporting period. Deferred revenue is a liability as of the balance sheet date related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 8<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 13<br><br> -Section A<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 605<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 13.A.3(b).Q1(c),(b).Q2,(c).Q3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012821&amp;loc=d3e214044-122780<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredRevenueDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EJNAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 5 - Equity Incentive Plan (Details) - Assumptions Used to Estimate Fair Value of Stock Options and Stock Appreciation Rights Awards<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
        <th class="th" colspan="2">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_Note5EquityIncentivePlanDetailsAssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsLineItems', window );"><strong>Note 5 - Equity Incentive Plan (Details) - Assumptions Used to Estimate Fair Value of Stock Options and Stock Appreciation Rights Awards [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
        <td class="nump">53.28%<span></span></td>
        <td class="nump">53.28%<span></span></td>
        <td class="nump">57.60%<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected lives (years)</a></td>
        <td class="text">4 years<span></span></td>
        <td class="text">4 years<span></span></td>
        <td class="text">4 years<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
        <td class="nump">0.00%<span></span></td>
        <td class="nump">0.00%<span></span></td>
        <td class="nump">0.00%<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Minimum [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_Note5EquityIncentivePlanDetailsAssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsLineItems', window );"><strong>Note 5 - Equity Incentive Plan (Details) - Assumptions Used to Estimate Fair Value of Stock Options and Stock Appreciation Rights Awards [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate', window );">Risk free interest rate</a></td>
        <td class="nump">1.30%<span></span></td>
        <td class="nump">1.16%<span></span></td>
        <td class="nump">0.61%<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Maximum [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_Note5EquityIncentivePlanDetailsAssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsLineItems', window );"><strong>Note 5 - Equity Incentive Plan (Details) - Assumptions Used to Estimate Fair Value of Stock Options and Stock Appreciation Rights Awards [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate', window );">Risk free interest rate</a></td>
        <td class="nump">1.39%<span></span></td>
        <td class="nump">1.39%<span></span></td>
        <td class="nump">0.70%<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anik_Note5EquityIncentivePlanDetailsAssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>anik_Note5EquityIncentivePlanDetailsAssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>anik_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)(iii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 14.D.2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)(i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 14<br><br> -Section D<br><br> -Subsection 2<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)(ii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The risk-free interest rate assumption that is used in valuing a nonvested share or option award issued to other than an employee.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 50<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6406099&amp;loc=d3e25284-112666<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)(iv)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 3 - Marketable Securities (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockSupplementAbstract', window );"><strong>Disclosure Text Block Supplement [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesTextBlock', window );">Marketable Securities [Table Text Block]</a></td>
        <td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
      <tr style="vertical-align: bottom">
        <td style="font-weight: bold">
          &#160;
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="15" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          September 30, 2014
        </td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="font-weight: bold">
          &#160;
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Amortized
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Cost
          </p>
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Unrealized
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Gains, Net of Tax
          </p>
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Unrealized
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Losses, Net of Tax
          </p>
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Fair
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Value
          </p>
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="width: 56%; text-align: left">
          United States Treasury securities
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          14,999,169
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          699
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          (268
        </td>
        <td style="width: 1%; text-align: left">
          )
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          14,999,600
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; padding-bottom: 1.1pt">
          Bank certificates of deposit
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          5,000,000
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          -
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          -
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          5,000,000
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          19,999,169
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          699
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          (268
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          )
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          19,999,600
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
      </tr>
    </table><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockSupplementAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DisclosureTextBlockSupplementAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6871852&amp;loc=d3e26610-111562<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6871852&amp;loc=d3e26626-111562<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 210<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.9-03.4)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.2,12)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -Subparagraph (d)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27232-111563<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27161-111563<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_MarketableSecuritiesTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E2F">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 8 - Intangible Assets and Goodwill (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTableTextBlock', window );">Schedule of Finite Lived and Indefinite Lived Intangible Assets by Major Class [Table Text Block]</a></td>
        <td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
      <tr style="vertical-align: bottom">
        <td>
          &#160;
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center">
          &#160;
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="11" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          September 30, 2014
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="7" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          December 31, 2013
        </td>
      </tr>
      <tr style="vertical-align: bottom">
        <td>
          &#160;
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          Gross Value
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Currency
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Translation
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Adjustment
          </p>
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Accumulated
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Amortization
          </p>
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Net Book
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Value
          </p>
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Net Book
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Value
          </p>
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          Useful Life
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="width: 34%; text-align: left">
          Developed technology
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          16,700,000
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          (1,828,214
        </td>
        <td style="width: 1%; text-align: left">
          )
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          (4,779,123
        </td>
        <td style="width: 1%; text-align: left">
          )
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          10,092,663
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          11,753,003
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 8%; text-align: center">
          15
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left">
          In-process research &amp; development
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          5,502,686
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          (638,426
        </td>
        <td style="text-align: left">
          )
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          -
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          4,864,260
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          5,286,127
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: center">
          Indefinite
        </td>
        <td style="text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left">
          Distributor relationships
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          4,700,000
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          (440,953
        </td>
        <td style="text-align: left">
          )
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          (4,084,944
        </td>
        <td style="text-align: left">
          )
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          174,103
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          863,655
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: center">
          5
        </td>
        <td style="text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td>
          Patents
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          1,000,000
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          (107,910
        </td>
        <td style="text-align: left">
          )
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          (271,208
        </td>
        <td style="text-align: left">
          )
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          620,882
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          719,574
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: center">
          16
        </td>
        <td style="text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; padding-bottom: 1.1pt">
          Elevess trade name
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          1,000,000
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          -
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          (717,964
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          )
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          282,036
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          376,050
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt; text-align: center">
          9
        </td>
        <td style="padding-bottom: 1.1pt; text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="padding-bottom: 2.75pt; padding-left: 10pt">
          Total
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          28,902,686
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          (3,015,503
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          )
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          (9,853,239
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          )
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          16,033,944
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          18,998,409
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt; text-align: right">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt; text-align: left">
          &#160;
        </td>
      </tr>
    </table><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill [Table Text Block]</a></td>
        <td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
      <tr style="vertical-align: bottom">
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          Goodwill
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" nowrap="nowrap" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Three
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Months Ended
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            September 30,
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            2014
          </p>
        </td>
        <td style="font-weight: bold; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" nowrap="nowrap" style="font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            Nine
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            Months Ended
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            September 30,
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            2014
          </p>
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="font-weight: bold">
          &#160;
        </td>
        <td style="font-weight: bold">
          &#160;
        </td>
        <td style="font-weight: bold; text-align: left">
          &#160;
        </td>
        <td style="font-weight: bold; text-align: right">
          &#160;
        </td>
        <td style="font-weight: bold; text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="width: 78%; text-align: left">
          Balance, beginning
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          9,360,884
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          9,443,894
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; padding-bottom: 1.1pt">
          Effect of foreign currency adjustments
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          (658,589
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          )
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          (741,599
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          )
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="padding-bottom: 2.75pt">
          Balance, ending
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          8,702,295
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          8,702,295
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
      </tr>
    </table><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anik_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the schedule of finite-lived and indefinite-lived intangible assets by major class.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>anik_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>anik_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13854-109267<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfGoodwillTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EQIAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 14 - Restructuring Credits (Details) - Restructuring Accrual Activity (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_Note14RestructuringCreditsDetailsRestructuringAccrualActivityLineItems', window );"><strong>Note 14 - Restructuring Credits (Details) - Restructuring Accrual Activity [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
        <td class="nump">$ 24,638<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash Proceeds (Disbursements)</a></td>
        <td class="num">(11,555)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAdjustment', window );">Foreign Exchange Impact</a></td>
        <td class="num">(1,174)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
        <td class="nump">11,909<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Employee termination costs [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_Note14RestructuringCreditsDetailsRestructuringAccrualActivityLineItems', window );"><strong>Note 14 - Restructuring Credits (Details) - Restructuring Accrual Activity [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
        <td class="nump">21,709<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash Proceeds (Disbursements)</a></td>
        <td class="num">(10,130)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAdjustment', window );">Foreign Exchange Impact</a></td>
        <td class="num">(1,050)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
        <td class="nump">10,529<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Activity Termination and Facility Closure Costs [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_Note14RestructuringCreditsDetailsRestructuringAccrualActivityLineItems', window );"><strong>Note 14 - Restructuring Credits (Details) - Restructuring Accrual Activity [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
        <td class="nump">2,929<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash Proceeds (Disbursements)</a></td>
        <td class="num">(1,425)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAdjustment', window );">Foreign Exchange Impact</a></td>
        <td class="num">(124)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
        <td class="nump">$ 1,380<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anik_Note14RestructuringCreditsDetailsRestructuringAccrualActivityLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>anik_Note14RestructuringCreditsDetailsRestructuringAccrualActivityLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>anik_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsForRestructuring</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 420<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SAB TOPIC 5.P.4(b))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140904-122747<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 5<br><br> -Section P<br><br> -Subsection 3, 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RestructuringReserve</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveTranslationAdjustment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of foreign currency translation adjustment increasing or decreasing the accrual for a specified type of restructuring cost.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 5<br><br> -Section P<br><br> -Subsection 3, 4<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 420<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140904-122747<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 420<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RestructuringReserveTranslationAdjustment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E6KAC">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Note 9 - Accrued Expenses (Details) - Accrued Expenses (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_AccruedExpensesAbstract', window );"><strong>Accrued Expenses [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Labor and related expenses</a></td>
        <td class="nump">$ 2,842,234<span></span></td>
        <td class="nump">$ 2,870,147<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_AccruedClinicalTrialCostsCurrent', window );">Clinical trial costs</a></td>
        <td class="nump">962,031<span></span></td>
        <td class="nump">882,651<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Professional fees</a></td>
        <td class="nump">382,423<span></span></td>
        <td class="nump">383,231<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_AccruedResearchGrantsCurrent', window );">Research grants</a></td>
        <td class="nump">562,558<span></span></td>
        <td class="nump">610,498<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveCurrent', window );">Restructuring costs</a></td>
        <td class="nump">11,909<span></span></td>
        <td class="nump">24,638<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
        <td class="nump">492,538<span></span></td>
        <td class="nump">766,716<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total</a></td>
        <td class="nump">$ 5,253,693<span></span></td>
        <td class="nump">$ 5,537,881<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anik_AccruedClinicalTrialCostsCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents current accrued clinical trial costs.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>anik_AccruedClinicalTrialCostsCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>anik_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anik_AccruedExpensesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>anik_AccruedExpensesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>anik_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anik_AccruedResearchGrantsCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents current accrued research grants.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>anik_AccruedResearchGrantsCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>anik_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 20<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.20)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccruedLiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 20<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Current Liabilities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.20)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccruedProfessionalFeesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 20<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.20)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EmployeeRelatedLiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of obligations incurred through that date and payable arising from transactions not otherwise specified in the taxonomy. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 20<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Current Liabilities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.20)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 9<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e7018-107765<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherAccruedLiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 5<br><br> -Section P<br><br> -Subsection 4<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 420<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RestructuringReserveCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ECRAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_CashFlowsFromOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
        <td class="nump">$ 30,503,403<span></span></td>
        <td class="nump">$ 13,920,152<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_AdjustmentsToReconcileNetIncomeToNetCashProvidedByOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
        <td class="nump">3,576,441<span></span></td>
        <td class="nump">3,579,474<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
        <td class="nump">1,196,361<span></span></td>
        <td class="nump">1,156,929<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for doubtful accounts</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">24,098<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Provision for inventory</a></td>
        <td class="nump">220,207<span></span></td>
        <td class="nump">165,803<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Gain on sale of assets</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(442,341)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities', window );">Tax benefit from exercise of stock options</a></td>
        <td class="num">(9,236,708)<span></span></td>
        <td class="num">(764,181)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_ChangesInOperatingAssetsAndLiabilitiesAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
        <td class="num">(1,840,407)<span></span></td>
        <td class="nump">4,667,839<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
        <td class="num">(2,923,628)<span></span></td>
        <td class="num">(3,430,655)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses, other current and long-term assets</a></td>
        <td class="nump">183,481<span></span></td>
        <td class="nump">531,449<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Long-term deposits and other</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">25,497<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
        <td class="num">(992,822)<span></span></td>
        <td class="nump">124,679<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses</a></td>
        <td class="num">(989,291)<span></span></td>
        <td class="num">(642,430)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
        <td class="num">(2,078,543)<span></span></td>
        <td class="num">(2,150,000)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes</a></td>
        <td class="nump">7,771,001<span></span></td>
        <td class="nump">766,598<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities', window );">Other long-term liabilities</a></td>
        <td class="num">(167,123)<span></span></td>
        <td class="num">(373,712)<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
        <td class="nump">25,222,372<span></span></td>
        <td class="nump">17,159,199<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_CashFlowsFromInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchase of marketable securities</a></td>
        <td class="num">(19,999,169)<span></span></td>
        <td class="nump">0<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfOtherAssets1', window );">Proceeds from sale of assets</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">530,865<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
        <td class="num">(920,132)<span></span></td>
        <td class="num">(235,803)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
        <td class="num">(20,919,301)<span></span></td>
        <td class="nump">295,062<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_anik_CashFlowsFromFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
        <td class="nump">1,379,294<span></span></td>
        <td class="nump">2,932,649<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities', window );">Tax benefit from exercise of stock options</a></td>
        <td class="nump">9,236,708<span></span></td>
        <td class="nump">764,181<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Minimum tax withholding on share based awards</a></td>
        <td class="num">(6,348,900)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Principal payments on debt</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(1,200,000)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
        <td class="nump">4,267,102<span></span></td>
        <td class="nump">2,496,830<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Exchange rate impact on cash</a></td>
        <td class="num">(131,139)<span></span></td>
        <td class="nump">36,870<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Increase in cash and cash equivalents</a></td>
        <td class="nump">8,439,034<span></span></td>
        <td class="nump">19,987,961<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at beginning of period</a></td>
        <td class="nump">63,333,160<span></span></td>
        <td class="nump">44,067,477<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at end of period</a></td>
        <td class="nump">$ 71,772,194<span></span></td>
        <td class="nump">$ 64,055,438<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anik_AdjustmentsToReconcileNetIncomeToNetCashProvidedByOperatingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>anik_AdjustmentsToReconcileNetIncomeToNetCashProvidedByOperatingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>anik_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anik_CashFlowsFromFinancingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>anik_CashFlowsFromFinancingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>anik_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anik_CashFlowsFromInvestingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>anik_CashFlowsFromInvestingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>anik_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anik_CashFlowsFromOperatingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>anik_CashFlowsFromOperatingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>anik_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_anik_ChangesInOperatingAssetsAndLiabilitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>anik_ChangesInOperatingAssetsAndLiabilitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>anik_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash Equivalents<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3044-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsAtCarryingValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 230<br><br> -Section 45<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450594&amp;loc=d3e33268-110906<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DepreciationAndAmortization</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 230<br><br> -Section 45<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450594&amp;loc=d3e33268-110906<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash inflow from realized tax benefit related to deductible compensation cost reported on the entity's tax return for equity instruments in excess of the compensation cost for those instruments recognized for financial reporting purposes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 20<br><br> -Section 55<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=32706628&amp;loc=d3e11374-113907<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash outflow for realized tax benefit related to deductible compensation cost reported on the entity's tax return for equity instruments in excess of the compensation cost for those instruments recognized for financial reporting purposes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 20<br><br> -Section 55<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=32706628&amp;loc=d3e11374-113907<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=8077374&amp;loc=d3e2443-110228<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GainLossOnDispositionOfAssets1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInAccountsPayable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInAccountsReceivable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInAccruedLiabilities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period, excluding the portion taken into income, in the liability reflecting revenue yet to be earned for which cash or other forms of consideration was received or recorded as a receivable.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInDeferredRevenue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInInventories</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in other noncurrent operating liabilities not separately disclosed in the statement of cash flows.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in other assets used in operating activities not separately disclosed in the statement of cash flows. May include changes in other current assets, other noncurrent assets, or a combination of other current and noncurrent assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInOtherOperatingAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the value of prepaid expenses and other assets not separately disclosed in the statement of cash flows, for example, deferred expenses, intangible assets, or income taxes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Charge to cost of goods sold that represents the reduction of the carrying amount of inventory, generally attributable to obsolescence or market conditions.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 330<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28360613&amp;loc=d3e4542-108314<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InventoryWriteDown</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 26<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3574-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInFinancingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 26<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3574-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInInvestingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 25<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3536-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInOperatingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.19)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.18)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 19<br><br> -Article 5<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 20<br><br> -Article 9<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash outflow to satisfy an employee's income tax withholding obligation as part of a net-share settlement of a share-based award.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 15<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3291-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Cash outflow for purchase of trading, available-for-sale securities and held-to-maturity securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Investing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6871852&amp;loc=d3e26853-111562<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 13<br><br> -Subparagraph (a),(b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3213-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsToAcquireMarketableSecurities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Investing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 13<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3213-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfOtherAssets1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash inflow from the sale of other assets as part of operating activities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 25<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3536-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromSaleOfOtherAssets1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow associated with the amount received from holders exercising their stock options. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (j)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromStockOptionsExercised</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of expense related to write-down of receivables to the amount expected to be collected. Includes, but is not limited to, accounts receivable and notes receivable.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.5)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 5<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProvisionForDoubtfulAccounts</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 15<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3291-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RepaymentsOfLongTermDebt</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensation</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 5 - Equity Incentive Plan<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Disclosure of Compensation Related Costs, Share-based Payments [Text Block]</a></td>
        <td class="text"><table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
      <tr style="vertical-align: top">
        <td style="width: 6%">
          <b>5.</b>
        </td>
        <td style="width: 94%">
          <b>Equity Incentive Plan</b>
        </td>
      </tr>
    </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">
      The Company estimates the fair value of stock options and stock appreciation rights using the Black-Scholes valuation model. Fair value of restricted stock is measured by the grant-date price of the Company&#8217;s shares. The fair value of each stock option award during the three and nine-month periods ended September 30, 2014 and 2013, respectively, was estimated on the grant date using the Black-Scholes option-pricing model with the following assumptions:
    </p><br/><table border="0" cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
      <tr>
        <td style="font-weight: bold">
          &#160;
        </td>
        <td colspan="7" style="text-align: center">
          <p style="margin-top: 0; margin-bottom: 0">
            <b>Three Months Ended</b>
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            <b>September 30,</b>
          </p>
        </td>
      </tr>
      <tr>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="text-align: center; border-bottom: Black 1.1pt solid">
          <b>2014</b>
        </td>
        <td style="font-weight: bold; text-align: center; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="text-align: center; border-bottom: Black 1.1pt solid">
          <b>2013</b>
        </td>
      </tr>
      <tr style="background-color: rgb(204,238,255)">
        <td style="width: 71%">
          Risk free interest rate
        </td>
        <td style="width: 3%; text-align: center">
          1.30%
        </td>
        <td style="width: 7%; text-align: center">
          -
        </td>
        <td style="text-align: center; width: 3%">
          1.39%
        </td>
        <td style="text-align: right; width: 3%">
          &#160;
        </td>
        <td style="width: 3%">
          &#160;
        </td>
        <td style="width: 7%; text-align: center">
          -
        </td>
        <td style="text-align: center; width: 3%">
        </td>
      </tr>
      <tr style="background-color: White">
        <td>
          Expected volatility
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: center">
          53.28%
        </td>
        <td style="text-align: center">
        </td>
        <td>
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: center">
          -
        </td>
        <td style="text-align: center">
        </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
        <td>
          Expected lives (years)
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: center">
          4
        </td>
        <td style="text-align: center">
        </td>
        <td style="text-align: right">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: center">
          -
        </td>
        <td style="text-align: center">
        </td>
      </tr>
      <tr style="background-color: White">
        <td>
          Expected dividend yield
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: center">
          0.00%
        </td>
        <td style="text-align: center">
        </td>
        <td>
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: center">
          -
        </td>
        <td style="text-align: center">
        </td>
      </tr>
    </table><br/><table border="0" cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
      <tr>
        <td style="font-weight: bold">
          &#160;
        </td>
        <td colspan="7">
          <p style="margin-top: 0; margin-bottom: 0; text-align: center">
            <b>Nine Months Ended</b>
          </p>
          <p style="margin-top: 0; margin-bottom: 0; text-align: center">
            <b>September 30,</b>
          </p>
        </td>
      </tr>
      <tr>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="text-align: center; border-bottom: Black 1.1pt solid">
          <b>2014</b>
        </td>
        <td style="font-weight: bold; text-align: center; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" style="text-align: center; border-bottom: Black 1.1pt solid">
          <b>2013</b>
        </td>
      </tr>
      <tr style="background-color: rgb(204,238,255)">
        <td style="width: 71%">
          Risk free interest rate
        </td>
        <td style="width: 3%; text-align: center">
          1.16%
        </td>
        <td style="width: 7%; text-align: center">
          -
        </td>
        <td style="text-align: center; width: 3%">
          1.39%
        </td>
        <td style="text-align: right; width: 3%">
          &#160;
        </td>
        <td style="width: 3%; text-align: center">
          0.61%
        </td>
        <td style="width: 7%; text-align: center">
          -
        </td>
        <td style="text-align: center; width: 3%">
          0.70%
        </td>
      </tr>
      <tr style="background-color: White">
        <td>
          Expected volatility
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: center">
          53.28%
        </td>
        <td style="text-align: center">
        </td>
        <td>
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: center">
          57.60%
        </td>
        <td style="text-align: center">
        </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
        <td>
          Expected lives (years)
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: center">
          4
        </td>
        <td style="text-align: center">
        </td>
        <td style="text-align: right">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: center">
          4
        </td>
        <td style="text-align: center">
        </td>
      </tr>
      <tr style="background-color: White">
        <td>
          Expected dividend yield
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: center">
          0.00%
        </td>
        <td style="text-align: center">
        </td>
        <td>
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: center">
          0.00%
        </td>
        <td style="text-align: center">
        </td>
      </tr>
    </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">
      The Company recorded $390,578 and $368,603 of share-based compensation expense for the three-month periods ended September 30, 2014 and 2013, respectively, for equity compensation awards. The Company recorded $1,196,361 and $1,156,929 of share-based compensation expense for the nine-month periods ended September 30, 2014 and 2013, respectively, for equity compensation awards. The Company presents the expenses related to stock-based compensation awards in the same expense line items as cash compensation paid to the respective recipients.
    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">
      There were 7,000 and 139,240 stock options granted under the Plan during the three and nine-month periods ended September 30, 2014, respectively. There were no Restricted Stock Awards (&#8220;RSAs&#8221;) or Restricted Stock Units (&#8220;RSUs&#8221;) granted under the Plan during the three-month period ended September 30, 2014. There were 9,365 RSUs granted to members of the Company&#8217;s Board of Directors under the Plan during the nine-month period ended September 30, 2014. There were 30,700 RSAs granted to Company employees under the Plan during the nine-month period ended September 30, 2014. The stock options, RSAs and RSUs granted to employees and directors become exercisable or vest ratably over four years from the date of grant.
    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">
      A portion of the stock options granted during the nine-month period ended September 30, 2014 contained certain performance features, as compared to established targets, in addition to time-based vesting conditions. The compensation costs associated with these grants was estimated using the Black-Scholes valuation method factored for the estimated probability of achieving the performance goals.
    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">
      As of September 30, 2014, there was approximately $4.2 million of total unrecognized compensation cost related to non-vested stock options, stock appreciation rights (&#8220;SARs&#8221;), RSAs and RSUs granted under the Company&#8217;s incentive Plans. This cost is expected to be recognized over a weighted-average period of 3.0 years.
    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">
      The total intrinsic value of stock options and SARs exercised during the nine-month periods ended September 30, 2014 and 2013 was $25,473,089 and $4,095,833, respectively. Cash received from the exercise of stock options during the three and nine-month periods ended September 30, 2014 and 2013 were $17,513 and $1,379,294, and $1,804,773 and $2,932,649, respectively. During the second quarter of 2014, the Company acquired and subsequently retired 133,774 common shares related to an employee SARs exercise, to meet minimum statutory tax withholding requirements.
    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">
      There were 936,097 options and SARs outstanding under the Company&#8217;s incentive Plans as of September 30, 2014 with a weighted-average exercise price of $13.54 per share, an aggregate intrinsic value of approximately $21.8 million, and a weighted-average remaining contractual term of 6.8 years. None of the options or SARs outstanding at September 30, 2014 or 2013, respectively, had cash-settlement features.
    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">
      The Company may satisfy the awards upon exercise, or upon fulfillment of the vesting requirements for other equity-based awards, with either authorized but unissued shares or shares reacquired by the Company. Stock-based awards are granted with an exercise price equal to the market price of the Company&#8217;s stock on the date of grant. Awards containing service conditions generally become exercisable ratably over one to four years, have a ten year contractual term and sometimes contain performance conditions.&#160;
    </p><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 50<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6406099&amp;loc=d3e25284-112666<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 40<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6418621&amp;loc=d3e17540-113929<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5444-113901<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 14<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 9 - Accrued Expenses (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities [Table Text Block]</a></td>
        <td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
      <tr style="vertical-align: bottom">
        <td style="text-align: left; padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" nowrap="nowrap" style="text-align: center; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0">
            <b>September 30,</b>
          </p>
          <p style="margin-top: 0; margin-bottom: 0">
            <b>2014</b>
          </p>
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td colspan="3" nowrap="nowrap" style="text-align: right; border-bottom: Black 1.1pt solid">
          <p style="margin-top: 0; margin-bottom: 0; text-align: center">
            <b>December&#160;31,</b>
          </p>
          <p style="margin-top: 0; margin-bottom: 0; text-align: center">
            <b>2013</b>
          </p>
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="width: 78%; text-align: left">
          Labor and related expenses
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          2,842,234
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 1%; text-align: left">
          $
        </td>
        <td style="width: 8%; text-align: right">
          2,870,147
        </td>
        <td style="width: 1%; text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left">
          Clinical trial costs
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          962,031
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          882,651
        </td>
        <td style="text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left">
          Professional fees
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          382,423
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          383,231
        </td>
        <td style="text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left">
          Research grants
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          562,558
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          610,498
        </td>
        <td style="text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left">
          Restructuring costs
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          11,909
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td>
          &#160;
        </td>
        <td style="text-align: left">
          &#160;
        </td>
        <td style="text-align: right">
          24,638
        </td>
        <td style="text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; padding-bottom: 1.1pt">
          Other
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          492,538
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 1.1pt">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: right">
          766,716
        </td>
        <td style="border-bottom: Black 1.1pt solid; text-align: left">
          &#160;
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; padding-bottom: 2.75pt; padding-left: 10pt">
          Total
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          5,253,693
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
        <td style="padding-bottom: 2.75pt">
          &#160;
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          $
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: right">
          5,537,881
        </td>
        <td style="border-bottom: Black 2.75pt double; text-align: left">
          &#160;
        </td>
      </tr>
    </table><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PayablesAndAccrualsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the components of accrued liabilities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<FilingSummary xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <Version>2.4.0.8</Version>
  <ProcessingTime />
  <ReportFormat>Html</ReportFormat>
  <ContextCount>104</ContextCount>
  <ElementCount>182</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>40</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Disclosure - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
    </Report>
    <Report>
      <IsDefault>true</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>001 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/ConsolidatedBalanceSheet</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/ConsolidatedBalanceSheet_Parentheticals</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>003 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/ConsolidatedComprehensiveIncome</Role>
      <ShortName>Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>004 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/ShareholdersEquityType1</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (Unaudited)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>005 - Disclosure - Note 1 - Nature of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/Note1NatureofBusiness</Role>
      <ShortName>Note 1 - Nature of Business</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>006 - Disclosure - Note 2 - Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/Note2BasisofPresentation</Role>
      <ShortName>Note 2 - Basis of Presentation</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>007 - Disclosure - Note 3 - Marketable Securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/Note3MarketableSecurities</Role>
      <ShortName>Note 3 - Marketable Securities</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>008 - Disclosure - Note 4 - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/Note4FairValueMeasurements</Role>
      <ShortName>Note 4 - Fair Value Measurements</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>009 - Disclosure - Note 5 - Equity Incentive Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/Note5EquityIncentivePlan</Role>
      <ShortName>Note 5 - Equity Incentive Plan</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>010 - Disclosure - Note 6 - Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/Note6EarningsPerShare</Role>
      <ShortName>Note 6 - Earnings Per Share</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>011 - Disclosure - Note 7 - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/Note7Inventories</Role>
      <ShortName>Note 7 - Inventories</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>012 - Disclosure - Note 8 - Intangible Assets and Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/Note8IntangibleAssetsandGoodwill</Role>
      <ShortName>Note 8 - Intangible Assets and Goodwill</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>013 - Disclosure - Note 9 - Accrued Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/Note9AccruedExpenses</Role>
      <ShortName>Note 9 - Accrued Expenses</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>014 - Disclosure - Note 10 - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/Note10CommitmentsandContingencies</Role>
      <ShortName>Note 10 - Commitments and Contingencies</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>015 - Disclosure - Note 11 - Mitek Monovisc Agreement</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/Note11MitekMonoviscAgreement</Role>
      <ShortName>Note 11 - Mitek Monovisc Agreement</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>016 - Disclosure - Note 12 - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/Note12IncomeTaxes</Role>
      <ShortName>Note 12 - Income Taxes</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>017 - Disclosure - Note 13 - Segment and Geographic Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/Note13SegmentandGeographicInformation</Role>
      <ShortName>Note 13 - Segment and Geographic Information</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>018 - Disclosure - Note 14 - Restructuring Credits</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/Note14RestructuringCredits</Role>
      <ShortName>Note 14 - Restructuring Credits</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>019 - Disclosure - Note 15 - New Accounting Standards</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/Note15NewAccountingStandards</Role>
      <ShortName>Note 15 - New Accounting Standards</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>020 - Disclosure - Note 3 - Marketable Securities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/Note3MarketableSecuritiesTables</Role>
      <ShortName>Note 3 - Marketable Securities (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>021 - Disclosure - Note 4 - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/Note4FairValueMeasurementsTables</Role>
      <ShortName>Note 4 - Fair Value Measurements (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>022 - Disclosure - Note 5 - Equity Incentive Plan (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/Note5EquityIncentivePlanTables</Role>
      <ShortName>Note 5 - Equity Incentive Plan (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>023 - Disclosure - Note 6 - Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/Note6EarningsPerShareTables</Role>
      <ShortName>Note 6 - Earnings Per Share (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>024 - Disclosure - Note 7 - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/Note7InventoriesTables</Role>
      <ShortName>Note 7 - Inventories (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>025 - Disclosure - Note 8 - Intangible Assets and Goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/Note8IntangibleAssetsandGoodwillTables</Role>
      <ShortName>Note 8 - Intangible Assets and Goodwill (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>026 - Disclosure - Note 9 - Accrued Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/Note9AccruedExpensesTables</Role>
      <ShortName>Note 9 - Accrued Expenses (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>027 - Disclosure - Note 13 - Segment and Geographic Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/Note13SegmentandGeographicInformationTables</Role>
      <ShortName>Note 13 - Segment and Geographic Information (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>028 - Disclosure - Note 14 - Restructuring Credits (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/Note14RestructuringCreditsTables</Role>
      <ShortName>Note 14 - Restructuring Credits (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>029 - Disclosure - Note 2 - Basis of Presentation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/Note2BasisofPresentationDetails</Role>
      <ShortName>Note 2 - Basis of Presentation (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>030 - Disclosure - Note 3 - Marketable Securities (Details) - Marketable Securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/MarketableSecuritiesTable</Role>
      <ShortName>Note 3 - Marketable Securities (Details) - Marketable Securities</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>031 - Disclosure - Note 4 - Fair Value Measurements (Details) - Fair Value of Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/FairValueofFinancialInstrumentsTable</Role>
      <ShortName>Note 4 - Fair Value Measurements (Details) - Fair Value of Financial Instruments</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>032 - Disclosure - Note 5 - Equity Incentive Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/Note5EquityIncentivePlanDetails</Role>
      <ShortName>Note 5 - Equity Incentive Plan (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>033 - Disclosure - Note 5 - Equity Incentive Plan (Details) - Assumptions Used to Estimate Fair Value of Stock Options and Stock Appreciation Rights Awards</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/AssumptionsUsedtoEstimateFairValueofStockOptionsandStockAppreciationRightsAwardsTable</Role>
      <ShortName>Note 5 - Equity Incentive Plan (Details) - Assumptions Used to Estimate Fair Value of Stock Options and Stock Appreciation Rights Awards</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>034 - Disclosure - Note 6 - Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/Note6EarningsPerShareDetails</Role>
      <ShortName>Note 6 - Earnings Per Share (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>035 - Disclosure - Note 6 - Earnings Per Share (Details) - Basic and Diluted Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/BasicandDilutedEarningsPerShareTable</Role>
      <ShortName>Note 6 - Earnings Per Share (Details) - Basic and Diluted Earnings Per Share</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>036 - Disclosure - Note 7 - Inventories (Details) - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/InventoriesTable</Role>
      <ShortName>Note 7 - Inventories (Details) - Inventories</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>037 - Disclosure - Note 8 - Intangible Assets and Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/Note8IntangibleAssetsandGoodwillDetails</Role>
      <ShortName>Note 8 - Intangible Assets and Goodwill (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>038 - Disclosure - Note 8 -  Intangible Assets and Goodwill (Details) - Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/IntangibleAssetsTable</Role>
      <ShortName>Note 8 -  Intangible Assets and Goodwill (Details) - Intangible Assets</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>039 - Disclosure - Note 8 -  Intangible Assets and Goodwill (Details) - Changes in Carrying Value of Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/ChangesinCarryingValueofGoodwillTable</Role>
      <ShortName>Note 8 -  Intangible Assets and Goodwill (Details) - Changes in Carrying Value of Goodwill</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>040 - Disclosure - Note 9 - Accrued Expenses (Details) - Accrued Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/AccruedExpensesTable</Role>
      <ShortName>Note 9 - Accrued Expenses (Details) - Accrued Expenses</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>041 - Disclosure - Note 10 - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/Note10CommitmentsandContingenciesDetails</Role>
      <ShortName>Note 10 - Commitments and Contingencies (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>042 - Disclosure - Note 11 - Mitek Monovisc Agreement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/Note11MitekMonoviscAgreementDetails</Role>
      <ShortName>Note 11 - Mitek Monovisc Agreement (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>043 - Disclosure - Note 12 - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/Note12IncomeTaxesDetails</Role>
      <ShortName>Note 12 - Income Taxes (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>044 - Disclosure - Note 13 - Segment and Geographic Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/Note13SegmentandGeographicInformationDetails</Role>
      <ShortName>Note 13 - Segment and Geographic Information (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>045 - Disclosure - Note 13 - Segment and Geographic Information (Details) - Product Revenue by Product Group</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/ProductRevenuebyProductGroupTable</Role>
      <ShortName>Note 13 - Segment and Geographic Information (Details) - Product Revenue by Product Group</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>046 - Disclosure - Note 13 - Segment and Geographic Information (Details) - Product Revenue by Geographic Location</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/ProductRevenuebyGeographicLocationTable</Role>
      <ShortName>Note 13 - Segment and Geographic Information (Details) - Product Revenue by Geographic Location</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>047 - Disclosure - Note 14 - Restructuring Credits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/Note14RestructuringCreditsDetails</Role>
      <ShortName>Note 14 - Restructuring Credits (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>048 - Disclosure - Note 14 - Restructuring Credits (Details) - Restructuring Accrual Activity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anikatherapeutics.com/role/RestructuringAccrualActivityTable</Role>
      <ShortName>Note 14 - Restructuring Credits (Details) - Restructuring Accrual Activity</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Info">'Monetary' elements on report '047 - Disclosure - Note 14 - Restructuring Credits (Details)' had a mix of different decimal attribute values.</Log>
    <Log type="Info">Process Flow-Through: 001 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Jun. 30, 2014'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Sep. 30, 2013'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2012'</Log>
    <Log type="Info">Process Flow-Through: 002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals)</Log>
    <Log type="Info">Process Flow-Through: 003 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited)</Log>
    <Log type="Info">Process Flow-Through: 004 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</Log>
  </Logs>
  <InputFiles>
    <File>anik-20140930.xml</File>
    <File>anik-20140930.xsd</File>
    <File>anik-20140930_cal.xml</File>
    <File>anik-20140930_def.xml</File>
    <File>anik-20140930_lab.xml</File>
    <File>anik-20140930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles />
  <BaseTaxonomies />
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EHEAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 8 - Intangible Assets and Goodwill (Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="2">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
        <td class="nump">$ 518,699<span></span></td>
        <td class="nump">$ 521,387<span></span></td>
        <td class="nump">$ 1,593,260<span></span></td>
        <td class="nump">$ 1,555,796<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 45<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AmortizationOfIntangibleAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 15 - New Accounting Standards<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Disclosure Text Block [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted', window );">Description of New Accounting Pronouncements Not yet Adopted [Text Block]</a></td>
        <td class="text"><table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%; border-collapse: collapse">
      <tr style="vertical-align: top">
        <td style="width: 6%; font: 10pt Times New Roman, Times, Serif">
          <b>15.</b>
        </td>
        <td style="width: 94%; font: 10pt Times New Roman, Times, Serif">
          <b>New Accounting Standards</b>
        </td>
      </tr>
    </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
      <font style="font-size: 10pt">In June 2014, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update ("ASU") No.</font> <font style="font-size: 10pt">2014-12, &#8220;Compensation - Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide that a Performance Target Could be Achieved after the Requisite Service Period,</font>&#8221; <font style="font-size: 10pt">which requires that a performance target that affects vesting, and that could be achieved after the requisite service period, be treated as a performance condition. Thus, the performance target should not be reflected in estimating the grant date fair value of the award. This update further clarifies that compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved and should represent the compensation cost attributable to the period(s) for which the requisite service has
      already been rendered. The new guidance is effective for the Company beginning January 1, 2016. Early adoption is permitted. The Company is currently evaluating the impact of this new standard on its consolidated financial statements.</font>
    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
      In May 2014, the FASB issued ASU No. 2014-09, "Revenue from Contracts with Customers." ASU 2014-09 supersedes the revenue recognition requirements in "Topic 605, Revenue Recognition" and requires entities to recognize revenue in a way that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. ASU 2014-09 is effective retrospectively for annual or interim reporting periods beginning after December 15, 2016, with early application not permitted. The Company is currently evaluating the impact of this new standard on its consolidated financial statements.
    </p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
      <font style="font-size: 10pt">In April 2014, the FASB issued ASU No. 2014-08, "Reporting of Discontinued Operations and Disclosures of Disposals of Components of an Entity." ASU 2014-08 provides a narrower definition of discontinued operations than that provided under existing U.S. GAAP. ASU 2014-08 requires that only a disposal of a component of an entity, or a group of components of an entity, which disposal represents a strategic shift that has, or will have, a major effect on the reporting entity's operations and financial results, should be reported in the financial statements as a discontinued operation. ASU 2014-08 also provides guidance on the financial statement presentations and disclosures of discontinued operations. ASU 2014-08 is effective prospectively for disposals (or classifications as held for disposal) of components of an entity that occur in annual or interim periods beginning after December 15, 2014. The Company does not expect the adoption of ASU 2014-08 to
      have a material impact on its consolidated financial statements.<font style="font-family: Arial, Helvetica, Sans-Serif"></font></font>&#160;
    </p><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for a new accounting pronouncement that has been issued but not yet adopted.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 250<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 5<br><br> -Subparagraph (SAB TOPIC 11.M)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26874127&amp;loc=d3e31137-122693<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 11<br><br> -Section M<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DisclosureTextBlockAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
